data_2kkx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kkx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 . . . . . 0 C--O 1.22 -0.492 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.68 -45.39 70.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -167.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 35.3 t -71.52 -36.8 71.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.723 0.409 . . . . 0.0 110.693 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' ILE . 83.6 mt -63.23 -42.05 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -68.16 -31.95 71.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.467 1.107 . . . . 0.0 112.307 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -58.62 -46.55 86.82 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 168.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -67.08 -40.6 87.01 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.735 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 94' ' ' ILE . 85.3 mt -64.16 -44.8 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.247 0.476 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -66.82 -35.15 79.39 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.318 0.647 . . . . 0.0 112.48 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.679 0.391 . . . . 0.0 111.441 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.5 m -64.42 -21.33 66.61 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.58 1.152 . . . . 0.0 113.266 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.27 173.34 4.88 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 121.468 0.651 . . . . 0.0 112.316 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.23 159.51 36.12 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.777 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.7 t -77.41 108.67 10.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.79 134.64 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.102 -171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.2 m -135.82 94.86 14.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.244 1.017 . . . . 0.0 108.982 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HB3' HD13 ' A' ' 117' ' ' ILE . 24.2 Cg_endo -58.18 -35.31 98.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.715 2.943 . . . . 0.0 113.833 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -31.66 32.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.008 0.523 . . . . 0.0 111.372 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -75.65 -40.4 56.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.565 0.346 . . . . 0.0 110.733 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 95.6 mt -71.82 -14.92 62.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.75 0.82 . . . . 0.0 111.946 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 64.27 10.52 5.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.763 1.225 . . . . 0.0 111.965 -172.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.467 ' SG ' ' HZ ' ' A' ' 186' ' ' PHE . 58.8 m -94.52 130.82 32.41 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.897 0.879 . . . . 0.0 110.156 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.41 155.02 72.08 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.612 2.208 . . . . 0.0 111.574 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 63.5 mt -52.57 -49.77 64.3 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.189 0.931 . . . . 0.0 111.962 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.24 -41.2 71.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.242 1.017 . . . . 0.0 112.941 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.06 63.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.509 0.724 . . . . 0.0 111.785 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.518 ' HB ' HD22 ' A' ' 143' ' ' LEU . 25.5 pt -126.63 17.8 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.663 0.785 . . . . 0.0 110.756 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 39.6 tt0 -69.84 137.59 51.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 111.064 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 34.9 t -73.7 112.11 14.95 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.97 -4.31 15.19 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.754 2.302 . . . . 0.0 112.759 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 mt -83.33 -54.82 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.837 0.855 . . . . 0.0 109.311 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -88.68 -12.38 42.56 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.079 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.11 36.34 18.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.954 0.902 . . . . 0.0 111.464 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -148.51 151.57 35.36 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.163 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.8 tm0? -68.73 115.47 31.07 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.7 Cg_endo -71.82 160.11 48.79 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.569 2.18 . . . . 0.0 113.258 -167.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.2 pt-20 -83.9 -31.04 25.9 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.158 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.558 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.23 145.41 31.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.191 1.396 . . . . 0.0 108.203 174.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.02 169.69 40.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.871 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.77 153.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.187 1.395 . . . . 0.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -97.96 117.15 31.64 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 73.7 t -110.92 123.31 66.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.627 ' HB3' HD12 ' A' ' 188' ' ' ILE . 18.4 ptmt -71.03 108.35 4.55 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.74 0.781 . . . . 0.0 110.426 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -75.91 76.04 2.82 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 t -69.51 -32.51 71.41 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.353 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.07 -44.63 91.88 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.084 0.865 . . . . 0.0 110.813 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.21 -67.34 1.94 Allowed Glycine 0 C--N 1.348 1.211 0 O-C-N 123.704 0.628 . . . . 0.0 112.868 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.8 m -170.78 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.973 0.909 . . . . 0.0 110.305 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.08 23.68 12.45 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.405 1.097 . . . . 0.0 111.086 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.6 124.59 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.585 ' SG ' HD13 ' A' ' 188' ' ' ILE . 56.8 m -83.42 118.82 23.99 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.501 HG21 HD13 ' A' ' 161' ' ' LEU . 18.1 m -111.86 134.21 53.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.518 HD22 ' HB ' ' A' ' 117' ' ' ILE . 30.3 tp -90.41 103.29 15.99 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.721 0.638 . . . . 0.0 109.928 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 95.1 m-85 -97.05 136.91 36.93 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.6 t70 -57.8 130.48 46.67 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 128' ' ' LYS . . . -55.31 -43.36 74.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.251 0.969 . . . . 0.0 111.908 -172.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.67 42.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.869 0.468 . . . . 0.0 111.705 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.77 65.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.935 0.494 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -77.02 -39.63 49.51 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -55.17 -34.59 63.98 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.583 1.153 . . . . 0.0 111.437 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.2 tpm_? -63.1 -54.32 39.69 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.858 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.9 mt -55.31 -44.4 75.74 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.361 1.038 . . . . 0.0 111.681 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 166' ' ' ILE . 60.8 t -64.78 -47.4 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.736 0.647 . . . . 0.0 109.44 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.47 -32.15 82.1 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.542 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.3 mm-40 -82.96 -28.93 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.335 0.654 . . . . 0.0 111.164 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.04 14.3 42.98 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.491 0.495 . . . . 0.0 112.668 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.55 134.63 57.67 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.162 0.985 . . . . 0.0 109.664 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.47 -171.25 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.704 2.269 . . . . 0.0 112.627 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.488 ' ND1' HG23 ' A' ' 162' ' ' THR . 49.0 t-80 -61.24 123.95 78.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.614 0.766 . . . . 0.0 108.981 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.91 -11.22 29.03 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.129 1.886 . . . . 0.0 113.189 -167.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 142' ' ' THR . 88.6 mt -96.49 -65.93 0.94 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.178 0.591 . . . . 0.0 110.616 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.488 HG23 ' ND1' ' A' ' 159' ' ' HIS . 11.1 t -98.71 -3.15 36.51 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.863 0.465 . . . . 0.0 111.997 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 66.01 15.56 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.581 1.553 . . . . 0.0 112.537 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.42 150.54 82.54 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 123.162 0.585 . . . . 0.0 110.97 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.34 113.6 2.33 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.246 1.964 . . . . 0.0 109.92 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.483 HG23 HG21 ' A' ' 153' ' ' VAL . 72.3 mt -56.21 128.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 O-C-N 123.808 0.693 . . . . 0.0 110.291 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.4 t -143.83 157.94 44.02 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.061 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.94 -15.37 63.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.439 0.696 . . . . 0.0 111.462 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -67.5 -48.15 67.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.027 0.931 . . . . 0.0 111.804 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 43.6 pt -83.42 -5.36 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.91 139.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 188' ' ' ILE . 29.0 m -125.45 170.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 0.0 109.751 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.37 150.05 28.6 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.146 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -63.97 -18.79 64.62 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.882 0.739 . . . . 0.0 112.901 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.61 -24.2 24.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.411 0.684 . . . . 0.0 111.598 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -87.97 5.15 42.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.173 0.589 . . . . 0.0 110.563 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.6 p -129.0 130.71 47.0 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 157.74 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -67.36 119.04 11.55 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.459 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.1 t70 -99.59 134.94 41.75 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.92 -34.99 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.848 0.859 . . . . 0.0 111.957 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.6 t -80.61 -29.26 36.87 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.426 0.557 . . . . 0.0 110.695 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.516 ' HG3' HD11 ' A' ' 187' ' ' ILE . 25.4 mmt180 -82.2 -25.55 34.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.963 0.505 . . . . 0.0 110.404 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.7 18.19 79.79 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.824 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -166.66 164.38 16.78 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.467 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 93.8 m-85 -59.74 120.95 10.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.81 0.844 . . . . 0.0 111.405 175.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' A' ' 183' ' ' ARG . 13.2 pt -132.47 177.34 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.823 0.849 . . . . 0.0 109.227 168.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 133' ' ' LYS . 30.8 mm -76.06 153.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.262 0.625 . . . . 0.0 110.438 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 123.429 0.692 . . . . 0.0 111.325 175.141 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 121.297 0.57 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -68.92 -21.43 64.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.51 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 39.5 t -68.27 -40.45 81.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.3 mt -63.26 -48.08 89.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -53.83 -44.89 70.64 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.424 1.089 . . . . 0.0 111.465 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.85 95.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.508 0.723 . . . . 0.0 110.626 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -67.43 -32.9 74.08 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 123.253 0.621 . . . . 0.0 110.985 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 130' ' ' ILE . 91.0 mt -67.7 -41.29 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.899 0.479 . . . . 0.0 109.839 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 m -66.35 -39.55 89.26 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.7 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -82.21 -30.5 30.82 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.575 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 78.3 m -89.88 -15.54 31.95 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.71 168.55 17.52 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.696 0.76 . . . . 0.0 112.444 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -156.71 155.62 31.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.988 172.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 110.14 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.09 107.54 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.098 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 40.3 m -112.25 95.96 33.03 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.552 1.141 . . . . 0.0 108.558 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.5 -36.95 95.3 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.714 2.943 . . . . 0.0 114.376 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.08 36.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -78.52 -39.36 38.25 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 86.5 mt -72.74 -22.2 60.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.07 0.948 . . . . 0.0 111.271 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 56.36 11.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.287 1.035 . . . . 0.0 113.213 -172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 58.4 m -84.35 138.48 38.97 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 123.681 0.792 . . . . 0.0 109.588 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.19 142.84 99.73 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.123 1.882 . . . . 0.0 110.446 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 125' ' ' GLN . 82.3 mt -52.64 -40.5 62.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 111.998 -173.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.28 -44.05 75.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.026 0.93 . . . . 0.0 112.273 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.33 69.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.565 0.746 . . . . 0.0 111.117 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.452 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 24.2 pt -112.32 23.34 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.31 129.69 34.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.017 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 29.2 t -68.97 111.56 8.8 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 -8.62 23.81 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.694 2.263 . . . . 0.0 112.759 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.2 mt -78.06 -57.43 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.113 0.965 . . . . 0.0 109.086 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.8 p -91.32 -6.02 53.71 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.457 -171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.3 31.35 19.36 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.026 0.931 . . . . 0.0 111.957 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.64 154.26 41.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.536 ' HG3' HD21 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -67.24 113.99 16.44 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 94.4 Cg_endo -76.56 165.7 28.53 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.157 2.572 . . . . 0.0 113.773 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.9 pt-20 -79.94 -36.14 36.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.293 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -151.29 146.43 26.03 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 108.0 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.47 169.43 41.12 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.959 -0.638 . . . . 0.0 114.397 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 98' ' ' ILE . 11.6 pt -122.42 155.45 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 125.645 1.578 . . . . 0.0 109.863 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HE2' ' HD1' ' A' ' 174' ' ' HIS . 35.0 m-85 -94.82 121.88 36.87 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 88.6 t -127.02 121.56 58.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.609 ' HB3' HD13 ' A' ' 188' ' ' ILE . 20.8 ptmt -67.33 113.77 5.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.673 0.749 . . . . 0.0 110.425 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -71.29 85.37 0.79 Allowed 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 163.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.9 t -64.97 -45.97 83.44 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.163 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.84 -38.07 89.73 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.845 0.715 . . . . 0.0 111.235 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.11 -64.05 3.77 Favored Glycine 0 C--N 1.344 1.028 0 O-C-N 123.821 0.701 . . . . 0.0 112.684 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.9 m -160.56 14.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.29 0.636 . . . . 0.0 111.922 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.9 m-20 60.4 27.2 16.79 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.05 138.36 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.004 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.664 ' SG ' HD11 ' A' ' 188' ' ' ILE . 20.4 m -84.03 121.65 27.7 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.079 0.951 . . . . 0.0 108.56 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.1 m -118.91 141.7 48.42 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.7 tp -91.94 105.47 17.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 109.963 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 75.1 m-85 -98.94 143.36 29.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 15.8 t70 -60.96 129.62 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.73 81.02 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.906 0.754 . . . . 0.0 112.057 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.03 -28.26 60.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.78 0.432 . . . . 0.0 111.301 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.23 62.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.379 0.671 . . . . 0.0 111.477 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -76.06 -37.92 57.68 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.748 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.479 ' HB2' HG23 ' A' ' 98' ' ' ILE . 48.2 t -64.21 -32.76 74.47 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.256 0.622 . . . . 0.0 110.853 174.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.1 tpm_? -59.28 -53.35 59.21 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 123.833 0.708 . . . . 0.0 109.333 172.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.5 mt -53.66 -48.09 69.76 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.247 0.967 . . . . 0.0 111.572 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.36 -40.69 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.166 0.586 . . . . 0.0 110.471 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.94 76.44 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.826 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.8 mm-40 -90.71 -11.48 39.56 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.663 0.785 . . . . 0.0 111.208 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.31 75.89 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 123.048 0.356 . . . . 0.0 112.961 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.87 138.48 46.62 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.764 1.226 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.02 178.25 7.7 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.633 2.222 . . . . 0.0 112.581 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -51.92 132.47 39.09 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -173.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.21 -23.8 28.32 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.868 1.712 . . . . 0.0 113.426 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.32 -43.38 12.2 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 5.4 t -121.52 -14.1 8.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 63.42 28.18 15.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.519 1.128 . . . . 0.0 112.364 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.36 152.98 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.497 0.719 . . . . 0.0 110.131 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.78 114.71 2.53 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.738 2.292 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 170' ' ' ILE . 72.8 mt -66.3 138.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.744 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 t -150.77 164.27 36.59 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.398 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.69 -23.23 66.1 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.753 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 m -66.34 -43.16 86.88 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.682 0.793 . . . . 0.0 111.571 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 166' ' ' ILE . 49.2 pt -85.5 -10.27 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.32 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.676 HG13 HD12 ' A' ' 188' ' ' ILE . 33.3 m -135.03 175.75 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.017 1.327 . . . . 0.0 110.156 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 37.2 mtmm -99.89 166.68 10.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.349 0.659 . . . . 0.0 110.54 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.402 ' HD1' ' HE2' ' A' ' 131' ' ' PHE . 44.3 t60 -55.3 -43.45 74.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.62 0.768 . . . . 0.0 112.206 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.86 -21.54 47.38 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.225 0.61 . . . . 0.0 111.524 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -81.19 -25.0 37.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.707 0.803 . . . . 0.0 110.332 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.4 p -105.53 153.66 21.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.276 1.03 . . . . 0.0 108.856 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.81 162.32 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -72.72 134.19 44.91 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.44 120.04 37.53 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.53 -42.39 71.27 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.897 0.748 . . . . 0.0 112.353 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.5 t -72.09 -30.09 64.76 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.784 0.265 . . . . 0.0 110.697 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -76.96 -32.97 57.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.367 0.667 . . . . 0.0 110.291 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.07 89.69 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.719 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -141.06 157.25 45.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -68.81 128.71 37.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.765 0.826 . . . . 0.0 109.977 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.2 175.2 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.676 HD12 HG13 ' A' ' 172' ' ' VAL . 24.9 mm -79.75 143.07 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.506 0.723 . . . . 0.0 112.271 176.457 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 26.6 mp0 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.36 79.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.223 0.609 . . . . 0.0 111.44 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -66.44 -42.88 86.98 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.491 0.716 . . . . 0.0 109.872 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.94 -41.19 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.706 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 46.7 mm-40 -58.43 -41.82 85.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.609 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -60.16 -41.42 92.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.558 0.536 . . . . 0.0 110.634 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -44.54 88.65 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.507 0.504 . . . . 0.0 110.618 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.494 HD13 HG22 ' A' ' 153' ' ' VAL . 88.9 mt -59.21 -41.01 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.022 0.929 . . . . 0.0 109.951 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -64.66 -39.27 93.4 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.664 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -86.75 -23.59 25.41 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 79.7 m -89.25 -24.1 22.18 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.605 0.762 . . . . 0.0 111.657 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HB3' HG23 ' A' ' 130' ' ' ILE . 20.4 pttp -69.1 168.68 13.42 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.563 0.697 . . . . 0.0 112.015 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.95 164.87 37.94 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.695 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -67.92 99.12 0.81 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.477 HG12 ' NE2' ' A' ' 125' ' ' GLN . 59.8 t -70.66 96.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.496 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.3 m -100.05 98.61 7.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.185 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.14 -37.88 93.74 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.094 2.529 . . . . 0.0 113.772 -168.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.75 -31.54 68.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.461 0.704 . . . . 0.0 111.548 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -78.89 -36.75 41.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.964 0.505 . . . . 0.0 110.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.58 -21.62 63.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 69.5 -40.04 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.473 1.909 . . . . 0.0 113.56 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.45 134.59 76.72 Favored Pre-proline 0 C--N 1.353 0.729 0 C-N-CA 124.678 1.191 . . . . 0.0 109.419 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.47 166.93 10.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.205 2.604 . . . . 0.0 112.891 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 67.4 mt -51.17 -47.4 62.15 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.758 0.823 . . . . 0.0 111.581 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.25 -40.06 80.8 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.911 0.884 . . . . 0.0 112.461 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.51 65.65 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.459 0.704 . . . . 0.0 112.255 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.486 ' HB ' HD21 ' A' ' 143' ' ' LEU . 13.0 pt -120.35 11.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.06 0.944 . . . . 0.0 110.868 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 34.7 tt0 -70.3 134.42 47.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.51 1.124 . . . . 0.0 111.407 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.1 t -67.2 114.96 21.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 124.045 0.841 . . . . 0.0 109.211 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.527 ' HB2' HD23 ' A' ' 161' ' ' LEU . 92.3 Cg_endo -76.51 0.9 9.02 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.676 2.251 . . . . 0.0 113.049 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 160' ' ' PRO . 34.8 mt -84.79 -54.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.678 0.791 . . . . 0.0 109.084 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p -95.68 -8.3 35.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.735 -171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.27 42.23 25.51 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.36 1.064 . . . . 0.0 111.791 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.08 153.67 35.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.161 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.477 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.2 tm0? -72.18 118.7 69.52 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.34 163.46 34.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.897 2.398 . . . . 0.0 113.392 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 16.0 pt-20 -99.47 -20.71 16.3 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.413 172.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.9 133.09 26.29 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 125.629 1.571 . . . . 0.0 106.833 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.18 158.43 31.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.362 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.466 HD12 HG22 ' A' ' 98' ' ' ILE . 11.2 pt -113.77 156.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.905 1.282 . . . . 0.0 110.419 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.732 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 36.5 m-85 -99.32 118.34 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.932 172.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.45 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 91.5 t -123.17 119.39 57.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.732 ' HB3' HD12 ' A' ' 188' ' ' ILE . 21.8 ptmt -67.66 114.41 6.26 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.638 0.586 . . . . 0.0 111.299 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -73.71 82.79 1.59 Allowed 'General case' 0 C--O 1.252 1.217 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.8 t -62.19 -33.97 75.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.038 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.7 -36.05 81.59 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.488 0.715 . . . . 0.0 111.54 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.15 -62.96 5.77 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 124.15 0.906 . . . . 0.0 111.349 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t 174.98 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.482 1.513 . . . . 0.0 107.433 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 15.2 t70 65.46 16.79 10.7 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 121.866 0.841 . . . . 0.0 109.766 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.657 ' HA ' HG21 ' A' ' 187' ' ' ILE . 58.5 t -78.59 124.48 37.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.86 -171.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 18.6 t -85.75 133.43 34.0 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.9 m -119.64 138.63 53.13 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.592 0.757 . . . . 0.0 109.406 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.486 HD21 ' HB ' ' A' ' 117' ' ' ILE . 37.6 tp -91.18 107.82 19.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.184 0.516 . . . . 0.0 109.725 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 94.9 m-85 -98.56 155.37 17.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.347 1.059 . . . . 0.0 108.264 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.8 140.31 53.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.16 97.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.978 0.799 . . . . 0.0 111.195 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.4 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.196 0.598 . . . . 0.0 112.101 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.81 -42.22 58.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.165 0.586 . . . . 0.0 111.187 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -74.95 -38.43 61.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.594 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.5 t -57.03 -37.32 71.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.648 0.779 . . . . 0.0 111.01 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.3 tpm_? -60.13 -57.1 14.27 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.266 0.978 . . . . 0.0 110.251 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.32 -44.14 68.16 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.329 1.018 . . . . 0.0 111.7 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 HG23 ' A' ' 166' ' ' ILE . 94.2 t -62.56 -48.02 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.159 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.26 -25.08 73.6 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.014 0.821 . . . . 0.0 113.283 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.508 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 10.1 mm-40 -78.65 -23.24 45.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.996 0.518 . . . . 0.0 110.541 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.61 24.07 26.84 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.595 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 69.4 mt -87.3 156.94 53.94 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.335 1.054 . . . . 0.0 110.728 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.44 -177.12 3.65 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.933 2.422 . . . . 0.0 112.829 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.415 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.3 t-80 -61.56 126.71 87.32 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.389 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HG3' HG12 ' A' ' 121' ' ' ILE . 58.6 Cg_endo -64.92 -21.33 64.14 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.571 2.181 . . . . 0.0 113.371 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 120' ' ' PRO . 55.7 mt -89.57 -66.37 0.93 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.956 0.502 . . . . 0.0 110.995 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.415 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.4 t -104.56 -1.22 26.83 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.608 -167.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 62.24 26.61 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.94 1.296 . . . . 0.0 112.995 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -77.79 150.52 78.72 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.167 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.33 114.07 2.91 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.172 1.915 . . . . 0.0 110.072 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.5 HG23 HG21 ' A' ' 153' ' ' VAL . 62.8 mt -59.33 133.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 123.448 0.467 . . . . 0.0 110.226 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.7 t -151.55 166.19 31.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.719 0.808 . . . . 0.0 109.501 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.48 -18.98 65.27 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.37 1.068 . . . . 0.0 111.46 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -71.45 -42.43 68.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.802 0.841 . . . . 0.0 111.738 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 166' ' ' ILE . 32.6 pt -85.99 -8.56 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.4 tt -103.62 134.85 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.488 HG13 HD11 ' A' ' 188' ' ' ILE . 33.4 m -121.97 160.2 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.556 0.742 . . . . 0.0 109.892 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -73.32 149.67 42.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.864 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.432 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 20.5 p80 -63.7 -23.9 67.56 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.095 0.247 . . . . 0.0 111.452 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.81 -29.51 66.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.856 0.862 . . . . 0.0 110.873 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 189' ' ' LYS . 24.5 mm-40 -93.73 17.43 11.91 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 112.191 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 23.7 p -140.84 134.85 30.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.293 0.637 . . . . 0.0 109.365 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 159.51 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 107.561 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -67.36 139.94 57.21 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -116.34 138.56 51.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.62 -45.91 84.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.955 1.41 . . . . 0.0 110.72 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 50.1 m -66.03 -48.56 70.7 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.875 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.431 ' HG3' HG22 ' A' ' 187' ' ' ILE . 32.9 mmt180 -82.08 -24.3 35.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.468 0.707 . . . . 0.0 110.949 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.3 22.27 73.7 Favored Glycine 0 N--CA 1.472 1.042 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.833 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -165.11 164.71 20.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.632 . . . . 0.0 110.005 -170.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -59.8 120.26 9.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 110.54 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.657 HG21 ' HA ' ' A' ' 140' ' ' VAL . 2.8 pp -134.36 169.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.546 1.138 . . . . 0.0 108.786 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.732 HD12 ' HB3' ' A' ' 133' ' ' LYS . 15.6 mm -71.19 151.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 176' ' ' GLU . 53.3 mtpt . . . . . 0 N--CA 1.486 1.352 0 CA-C-N 118.363 0.529 . . . . 0.0 112.046 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.521 ' HA ' HD13 ' A' ' 94' ' ' ILE . 6.2 mp0 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.81 -49.37 68.5 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.139 0.899 . . . . 0.0 111.791 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 38.3 m -65.21 -36.93 85.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.895 0.878 . . . . 0.0 110.755 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 91' ' ' GLN . 44.3 mt -67.77 -45.76 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.576 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -54.41 -46.37 73.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.758 1.223 . . . . 0.0 111.2 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.6 m-80 -57.16 -49.96 74.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.769 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -63.72 -35.01 79.16 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 123.388 0.675 . . . . 0.0 111.603 -176.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 94' ' ' ILE . 93.9 mt -65.79 -44.48 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 t -65.66 -35.3 80.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.261 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.0 mm-40 -80.91 -49.79 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.903 0.481 . . . . 0.0 111.68 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -69.41 -21.52 63.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.413 1.085 . . . . 0.0 113.327 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.79 173.59 5.12 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -160.27 161.73 33.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.57 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -69.31 107.52 3.31 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.438 ' H ' ' HA ' ' A' ' 128' ' ' LYS . 92.8 t -72.64 99.32 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.298 0.57 . . . . 0.0 109.64 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 82.1 m -105.1 102.18 34.7 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.77 1.228 . . . . 0.0 108.014 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HB3' HD13 ' A' ' 117' ' ' ILE . 11.3 Cg_endo -53.84 -27.56 44.25 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.693 2.929 . . . . 0.0 113.422 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.5 -40.52 70.13 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.548 0.739 . . . . 0.0 110.635 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.484 HH11 HD22 ' A' ' 110' ' ' LEU . 2.6 tmt_? -73.6 -44.19 57.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.553 0.741 . . . . 0.0 109.587 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.484 HD22 HH11 ' A' ' 109' ' ' ARG . 95.9 mt -71.72 -22.31 61.64 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.555 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 55.7 14.3 1.24 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 0.0 112.917 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.9 m -99.83 136.43 20.23 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 124.237 1.015 . . . . 0.0 108.663 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -53.95 150.42 30.72 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.929 2.419 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.6 mt -53.26 -49.34 67.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.251 1.02 . . . . 0.0 112.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.7 -35.5 76.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.148 0.979 . . . . 0.0 112.519 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.97 69.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.087 0.555 . . . . 0.0 111.623 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.499 ' HB ' HD21 ' A' ' 143' ' ' LEU . 22.9 pt -109.18 4.3 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.21 0.604 . . . . 0.0 111.038 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 36.8 tt0 -60.71 134.99 57.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 31.7 t -67.04 114.31 17.57 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.128 0.971 . . . . 0.0 108.807 175.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.505 ' HB2' HD21 ' A' ' 161' ' ' LEU . 73.9 Cg_endo -70.62 -9.14 25.19 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.616 2.211 . . . . 0.0 112.782 -176.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.5 -55.43 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.833 0.853 . . . . 0.0 109.669 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -98.9 -6.19 29.38 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.557 -170.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.55 34.37 20.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.054 0.942 . . . . 0.0 112.257 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.05 148.03 49.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.783 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.02 108.75 3.0 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 171.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.46 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 56.1 Cg_endo -68.69 154.93 70.4 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.562 2.174 . . . . 0.0 113.11 -167.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.0 pt-20 -81.91 -30.55 31.83 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.715 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.53 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -153.03 142.6 21.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.991 1.316 . . . . 0.0 108.471 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.7 177.69 40.17 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.301 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.28 161.29 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.695 1.598 . . . . 0.0 109.251 -173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 60.6 m-85 -106.47 116.65 32.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.878 0.471 . . . . 0.0 110.355 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 97.0 t -117.12 121.6 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 22.2 ptmt -73.25 114.23 11.21 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.57 0.7 . . . . 0.0 110.626 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -68.15 88.31 0.29 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.4 t -61.09 -41.62 97.0 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.391 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.85 -32.01 72.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.29 0.636 . . . . 0.0 110.956 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.59 36.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.597 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.2 m 84.79 45.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.14 1.776 . . . . 0.0 111.442 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 61.16 22.67 12.95 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.716 1.206 . . . . 0.0 112.274 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.43 HG12 ' HB3' ' A' ' 185' ' ' ASN . 88.6 t -76.89 120.42 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.269 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 58.0 m -83.2 134.12 34.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.5 m -124.59 147.92 48.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.499 HD21 ' HB ' ' A' ' 117' ' ' ILE . 26.8 tp -89.87 105.34 17.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.306 0.574 . . . . 0.0 110.513 -175.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.446 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 79.2 m-85 -102.74 133.63 47.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.561 1.144 . . . . 0.0 108.316 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.7 t70 -57.21 130.73 47.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.666 0.666 . . . . 0.0 109.378 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.34 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.733 0.813 . . . . 0.0 112.215 -171.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.99 63.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.799 0.44 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.96 76.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.686 0.794 . . . . 0.0 111.795 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -75.54 -38.73 59.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.3 t -62.96 -28.76 70.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.489 0.716 . . . . 0.0 111.03 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.5 tpm_? -63.84 -52.94 57.81 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 123.937 0.773 . . . . 0.0 110.218 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -57.64 -42.96 84.48 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.946 0.778 . . . . 0.0 111.359 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.447 HG21 HG23 ' A' ' 166' ' ' ILE . 94.6 t -65.73 -44.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.829 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.01 -26.7 69.37 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.895 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 38.5 mm-40 -79.98 -30.29 39.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.95 20.78 35.36 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.454 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.94 150.66 78.44 Favored Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.216 1.006 . . . . 0.0 110.501 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.38 173.69 14.07 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.61 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.468 ' ND1' HG22 ' A' ' 162' ' ' THR . 59.6 t-80 -54.27 129.01 59.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.666 0.786 . . . . 0.0 110.366 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -62.06 -22.38 74.13 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.62 2.213 . . . . 0.0 113.673 -170.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 120' ' ' PRO . 60.5 mt -103.4 -53.16 2.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.745 0.418 . . . . 0.0 111.827 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.468 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -104.14 -8.33 19.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.08 22.45 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.468 1.107 . . . . 0.0 113.167 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -75.2 155.8 86.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.592 0.757 . . . . 0.0 109.984 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -58.35 115.23 2.39 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.403 2.069 . . . . 0.0 110.57 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.522 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.3 mt -63.31 131.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 t -153.66 162.11 41.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 109.923 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.92 65.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.145 0.978 . . . . 0.0 111.258 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.0 t -66.2 -48.31 71.07 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.1 0.96 . . . . 0.0 111.476 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.3 pt -88.92 -2.67 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.35 137.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.63 169.74 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 109.537 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -82.8 156.03 23.88 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.298 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -64.56 -23.65 67.34 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -87.9 -21.93 24.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.694 0.797 . . . . 0.0 109.892 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.76 -17.05 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.069 0.948 . . . . 0.0 111.471 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.4 p -128.62 154.64 46.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.087 0.955 . . . . 0.0 109.33 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.412 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -135.83 164.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.374 1.069 . . . . 0.0 108.714 178.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 21.3 p90 -78.96 121.7 25.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -105.65 127.03 52.82 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.06 -40.31 75.16 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.313 -170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 t -74.32 -24.26 59.18 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-N 117.531 0.15 . . . . 0.0 111.222 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -80.25 -30.49 38.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.85 25.01 70.54 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.22 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.43 ' HB3' HG12 ' A' ' 140' ' ' VAL . 78.0 m-20 -156.24 160.98 40.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.275 -171.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 60.4 m-85 -74.13 126.73 31.21 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 168.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.1 pt -132.5 177.31 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.664 0.785 . . . . 0.0 110.066 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.03 143.89 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.548 0.739 . . . . 0.0 109.88 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.412 ' HG2' HD12 ' A' ' 178' ' ' ILE . 60.0 mtpt . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.163 0.585 . . . . 0.0 112.378 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.508 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.8 mp0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -38.24 75.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.523 0.729 . . . . 0.0 111.742 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t -70.93 -43.63 67.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.87 0.868 . . . . 0.0 109.93 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 98' ' ' ILE . 73.6 mt -63.42 -50.23 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.41 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.64 -23.36 58.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.984 0.914 . . . . 0.0 112.036 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.42 -38.35 84.45 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -67.31 -37.32 83.15 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 123.05 0.54 . . . . 0.0 110.431 175.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.487 HG22 ' HB2' ' A' ' 150' ' ' SER . 90.7 mt -65.49 -38.08 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.208 0.603 . . . . 0.0 110.125 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -60.84 -40.44 92.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.394 1.078 . . . . 0.0 111.74 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -86.76 -40.19 15.24 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.0 m -76.82 -16.49 59.42 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.634 0.774 . . . . 0.0 111.785 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -71.03 154.89 41.42 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.385 0.612 . . . . 0.0 111.15 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.74 161.02 42.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.696 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.6 m -65.53 96.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 110.039 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.08 97.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 m -110.65 107.22 58.12 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.18 -20.86 67.58 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.159 2.573 . . . . 0.0 113.016 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.92 -35.16 29.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.43 1.092 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.81 -49.0 13.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.974 0.509 . . . . 0.0 110.418 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.3 mt -69.05 -21.31 64.11 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.148 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 55.38 19.39 3.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 112.772 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.47 134.15 40.79 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.36 149.11 76.13 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.182 1.922 . . . . 0.0 110.632 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.8 mt -52.13 -43.68 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.7 0.8 . . . . 0.0 111.407 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.34 -37.7 81.49 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.759 0.824 . . . . 0.0 112.541 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.09 71.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.14 0.576 . . . . 0.0 111.107 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.5 pt -117.09 31.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.986 0.914 . . . . 0.0 110.005 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -70.86 128.59 36.52 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.837 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -74.78 109.95 8.6 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 162.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.94 -11.55 27.55 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 123.085 2.523 . . . . 0.0 112.694 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.82 -52.84 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.603 0.761 . . . . 0.0 109.123 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.9 p -92.7 -12.6 31.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.504 1.122 . . . . 0.0 112.573 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 61.42 37.8 16.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.858 0.863 . . . . 0.0 111.32 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.36 151.92 37.32 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.65 115.51 44.63 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 160.91 36.09 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.886 2.391 . . . . 0.0 113.458 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.518 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 12.5 pt-20 -87.87 -20.74 25.6 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.33 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.61 134.53 22.52 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 108.346 178.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.15 166.66 37.12 Favored Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.459 HG13 HG21 ' A' ' 132' ' ' VAL . 9.9 pt -124.87 155.46 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 0.0 109.386 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.61 115.07 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 130' ' ' ILE . 71.7 t -123.23 122.75 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -66.24 120.3 13.02 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.483 0.658 . . . . 0.0 110.962 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -72.7 84.25 1.18 Allowed 'General case' 0 C--O 1.249 1.065 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 161.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.7 t -67.76 -57.05 6.99 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.426 -168.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.02 -31.85 69.71 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.018 0.527 . . . . 0.0 111.42 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -63.38 4.66 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.035 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.2 m -149.92 5.68 0.59 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 65.73 21.32 11.56 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.187 0.995 . . . . 0.0 111.201 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.29 143.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.489 1.116 . . . . 0.0 109.291 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 31.1 p -86.21 140.52 30.06 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 117.921 0.328 . . . . 0.0 110.174 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.4 m -126.84 148.34 49.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.482 1.113 . . . . 0.0 108.184 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.8 tp -89.2 123.89 33.86 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.932 0.493 . . . . 0.0 109.87 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -120.76 132.89 55.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.104 0.961 . . . . 0.0 108.674 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.07 130.5 38.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.466 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.57 -46.36 77.21 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.079 0.862 . . . . 0.0 111.792 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.6 68.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.118 0.567 . . . . 0.0 111.619 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.62 62.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.696 0.798 . . . . 0.0 111.542 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 153' ' ' VAL . 44.3 t80 -72.65 -41.85 64.99 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.803 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.487 ' HB2' HG22 ' A' ' 98' ' ' ILE . 23.1 t -63.5 -29.92 71.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.253 0.621 . . . . 0.0 110.867 176.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.8 tpm_? -61.53 -51.91 66.63 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 172.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -55.38 -43.93 75.6 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.295 0.997 . . . . 0.0 111.21 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.508 HG12 ' HG3' ' A' ' 91' ' ' GLN . 46.5 t -67.44 -45.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.737 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.46 -27.6 66.09 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.306 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 19.1 mm-40 -78.65 -33.97 46.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.09 0.556 . . . . 0.0 110.828 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.81 28.52 11.02 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.73 144.12 28.95 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.669 1.188 . . . . 0.0 109.509 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.8 -177.83 4.08 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.795 2.33 . . . . 0.0 112.503 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.404 ' ND1' HG22 ' A' ' 162' ' ' THR . 57.4 t-80 -54.53 129.86 62.68 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.404 1.082 . . . . 0.0 110.902 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.24 -24.03 78.17 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.831 2.354 . . . . 0.0 114.087 -171.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.4 mt -103.06 -56.65 2.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.807 0.443 . . . . 0.0 111.882 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.404 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.6 t -102.52 -8.69 20.83 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.691 0.396 . . . . 0.0 111.384 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 63.5 24.71 14.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 0.0 112.546 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.0 154.82 90.77 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 114.11 2.95 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.017 1.811 . . . . 0.0 110.215 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 170' ' ' ILE . 66.0 mt -63.05 134.75 28.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -149.37 163.39 37.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.074 0.95 . . . . 0.0 109.744 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.56 -18.09 65.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.851 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.5 t -70.96 -41.05 71.59 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 111.746 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -85.65 -11.41 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.1 tt -99.61 133.43 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 188' ' ' ILE . 27.5 m -129.04 174.12 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.18 0.992 . . . . 0.0 110.18 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -94.17 164.35 13.09 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.229 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -57.29 -39.95 76.77 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.5 -4.64 57.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.146 0.43 . . . . 0.0 111.679 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -87.23 -21.93 25.54 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.515 0.674 . . . . 0.0 109.613 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.6 p -102.75 142.09 34.47 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 158.0 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 17.0 p90 -75.22 122.9 24.36 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -99.06 129.93 45.36 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -70.37 -34.71 72.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.385 1.053 . . . . 0.0 111.663 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 t -74.78 -28.4 60.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.214 0.206 . . . . 0.0 110.955 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -82.14 -32.38 30.12 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 111.117 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.54 24.59 75.95 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.743 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -165.51 159.38 16.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.906 0.482 . . . . 0.0 109.876 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 90.7 m-85 -65.19 118.92 9.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.628 1.171 . . . . 0.0 111.111 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.56 -179.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 108.06 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 133' ' ' LYS . 8.7 mm -83.57 156.26 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 123.974 0.91 . . . . 0.0 112.432 176.385 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -38.1 77.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.978 0.799 . . . . 0.0 111.984 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 49.6 m -66.9 -39.22 87.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.292 0.637 . . . . 0.0 110.711 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 98' ' ' ILE . 58.0 mt -68.63 -41.88 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.605 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -56.87 -41.11 77.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.876 1.271 . . . . 0.0 110.887 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -61.39 -44.86 96.42 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.283 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -63.43 -39.65 95.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.964 0.506 . . . . 0.0 111.441 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 150' ' ' SER . 77.8 mt -65.3 -37.73 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.242 0.617 . . . . 0.0 110.333 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.1 t -62.3 -45.69 92.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.61 0.764 . . . . 0.0 111.789 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -78.17 -29.47 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.161 0.584 . . . . 0.0 112.187 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.8 -10.38 23.09 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.412 0.685 . . . . 0.0 112.496 -172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -74.24 160.17 31.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -152.1 160.26 43.47 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.361 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.7 t -66.78 100.06 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.083 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.75 107.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 84.1 m -118.69 87.11 31.36 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.816 0.847 . . . . 0.0 109.776 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.526 ' HB3' HD11 ' A' ' 117' ' ' ILE . 1.7 Cg_endo -43.88 -45.75 11.18 Favored 'Trans proline' 0 C--N 1.385 2.452 1 C-N-CA 125.42 4.08 . . . . 0.0 115.129 -176.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -20.48 55.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.064 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -91.3 -31.91 15.92 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.918 0.487 . . . . 0.0 110.575 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.59 -20.17 61.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.588 0.755 . . . . 0.0 110.341 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 59.12 18.98 6.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.507 1.523 . . . . 0.0 112.237 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.5 m -100.35 138.11 20.13 Favored Pre-proline 0 C--O 1.245 0.836 0 C-N-CA 124.165 0.986 . . . . 0.0 108.877 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.18 157.51 34.62 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.426 2.084 . . . . 0.0 111.357 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.501 HD22 ' HG3' ' A' ' 125' ' ' GLN . 71.8 mt -55.98 -38.78 70.89 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.083 0.553 . . . . 0.0 111.373 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.12 -38.38 82.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.02 0.928 . . . . 0.0 112.825 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.87 66.86 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.086 0.554 . . . . 0.0 111.593 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 107' ' ' PRO . 26.5 pt -124.08 16.43 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.856 0.862 . . . . 0.0 111.107 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.42 125.39 24.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.204 1.002 . . . . 0.0 110.221 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.91 111.47 10.72 Favored Pre-proline 0 C--N 1.354 0.775 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.96 -3.99 14.74 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.741 2.294 . . . . 0.0 112.105 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -84.98 -58.55 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.895 0.878 . . . . 0.0 109.403 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 p -88.4 -13.0 41.61 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.721 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.99 33.63 17.17 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.584 0.754 . . . . 0.0 111.533 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.88 152.76 46.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -73.13 110.43 8.54 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.409 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 57.7 Cg_endo -68.08 153.84 73.96 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.434 2.756 . . . . 0.0 114.266 -167.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -80.48 -38.8 29.24 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.605 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.1 pttm -138.64 143.58 39.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.177 1.391 . . . . 0.0 107.459 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.94 166.25 37.43 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.278 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.3 pt -121.64 155.27 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.985 1.314 . . . . 0.0 109.086 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.51 123.16 41.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.78 121.91 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.702 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.7 ptmt -71.09 119.0 14.59 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.751 0.657 . . . . 0.0 110.775 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -74.03 81.73 1.73 Allowed 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.1 t -68.87 -28.53 66.78 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.386 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.29 -37.42 85.4 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.353 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.35 -65.0 2.56 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -178.5 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.984 0.914 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 61.98 23.27 13.68 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.178 0.991 . . . . 0.0 111.379 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.16 118.35 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 186' ' ' PHE . 20.6 p -84.36 138.87 32.64 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.41 0.624 . . . . 0.0 110.032 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.3 m -127.83 145.03 51.06 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.18 0.992 . . . . 0.0 108.785 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 117' ' ' ILE . 61.0 tp -88.28 111.54 21.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -105.44 138.03 42.29 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.661 1.184 . . . . 0.0 108.022 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.7 t70 -59.1 135.44 57.63 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.381 0.537 . . . . 0.0 109.722 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.89 92.27 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.74 0.816 . . . . 0.0 111.777 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.36 -35.17 65.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.544 0.528 . . . . 0.0 111.072 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 -48.33 59.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.626 0.77 . . . . 0.0 112.007 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -70.0 -40.7 75.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.998 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 98' ' ' ILE . 32.5 t -62.44 -32.31 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.564 0.54 . . . . 0.0 111.13 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.438 ' HA ' ' HE ' ' A' ' 151' ' ' ARG . 1.4 tpm_? -64.65 -49.38 71.24 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 123.637 0.586 . . . . 0.0 110.401 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.69 -45.16 81.94 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.174 0.921 . . . . 0.0 111.182 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 166' ' ' ILE . 84.3 t -61.92 -46.77 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.217 0.607 . . . . 0.0 110.209 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.73 -31.19 79.95 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.041 0.838 . . . . 0.0 113.228 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.61 -15.66 53.97 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.653 0.781 . . . . 0.0 111.662 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.87 31.87 38.33 Favored Glycine 0 N--CA 1.47 0.966 0 O-C-N 123.204 0.315 . . . . 0.0 112.551 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.7 mt -90.24 150.82 43.86 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.663 1.185 . . . . 0.0 110.025 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.52 -179.43 5.31 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.685 2.257 . . . . 0.0 113.088 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.412 ' ND1' HG23 ' A' ' 162' ' ' THR . 47.1 t-80 -56.76 127.14 73.48 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.174 0.99 . . . . 0.0 111.317 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.09 -1.74 8.46 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.995 2.464 . . . . 0.0 114.069 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.63 -64.52 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.689 0.395 . . . . 0.0 110.624 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.412 HG23 ' ND1' ' A' ' 159' ' ' HIS . 10.1 t -98.39 -4.64 34.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.984 -167.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 61.55 20.96 11.7 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.496 1.118 . . . . 0.0 112.906 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.19 152.28 73.56 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.514 0.726 . . . . 0.0 110.589 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.78 115.06 2.69 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.056 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.478 HG21 HG22 ' A' ' 153' ' ' VAL . 70.3 mt -63.27 130.8 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.744 0.417 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -141.53 162.69 34.86 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 109.571 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.38 66.24 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.409 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.4 m -64.91 -41.68 95.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.51 0.724 . . . . 0.0 112.065 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.9 pt -85.61 -7.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.33 135.5 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.12 0.873 . . . . 0.0 109.337 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.19 179.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 109.844 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -101.66 164.96 11.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.837 0.455 . . . . 0.0 110.578 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.25 -15.61 33.18 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.32 -26.82 56.19 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.099 0.952 . . . . 0.0 109.339 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 28.9 p -105.02 161.07 14.53 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.933 165.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.33 162.98 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.386 0.674 . . . . 0.0 109.265 175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 27.8 p90 -72.59 135.01 45.44 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 163.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.403 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.0 t70 -119.02 127.05 53.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.55 -43.69 47.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.8 t -76.58 -28.48 56.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.172 0.442 . . . . 0.0 110.808 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -72.03 -31.8 66.53 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.22 81.2 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.598 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -149.33 150.12 31.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.026 0.93 . . . . 0.0 110.232 -170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.575 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 35.3 m-85 -63.42 119.24 9.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.668 0.787 . . . . 0.0 109.968 168.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.2 pt -127.15 177.84 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 0.0 109.723 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.702 HD13 ' HB3' ' A' ' 133' ' ' LYS . 37.1 mm -85.83 151.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.386 0.674 . . . . 0.0 110.129 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 121.101 0.477 . . . . 0.0 111.743 174.384 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 119.559 -0.257 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -41.47 67.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.927 0.891 . . . . 0.0 112.591 -168.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 41.4 t -65.7 -46.09 80.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.535 0.734 . . . . 0.0 110.04 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.5 mt -63.73 -41.14 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.128 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -59.8 -42.63 93.85 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.517 1.127 . . . . 0.0 110.622 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -61.87 -43.27 99.18 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.372 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -64.23 -31.32 72.47 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.242 0.617 . . . . 0.0 111.325 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 94' ' ' ILE . 95.3 mt -70.42 -40.57 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.309 0.644 . . . . 0.0 109.671 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 t -65.57 -33.42 75.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.312 0.645 . . . . 0.0 111.292 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -74.95 -46.75 33.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.293 1.037 . . . . 0.0 112.327 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.579 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 71.0 m -82.33 -17.35 46.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.48 0.712 . . . . 0.0 112.845 -169.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -70.55 165.7 22.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.447 0.641 . . . . 0.0 112.603 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -156.41 159.65 38.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.381 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.6 m -66.97 102.58 1.0 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.626 0.579 . . . . 0.0 109.713 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.433 HG12 ' NE2' ' A' ' 125' ' ' GLN . 58.7 t -77.06 102.46 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.191 0.596 . . . . 0.0 110.148 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.1 m -112.29 106.84 55.86 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.158 0.983 . . . . 0.0 108.745 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 24.1 Cg_endo -60.3 -18.95 55.49 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.3 2.667 . . . . 0.0 112.745 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.6 -35.9 70.66 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.557 0.743 . . . . 0.0 110.277 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -83.73 -49.47 9.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.084 0.554 . . . . 0.0 110.347 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.5 -23.18 65.44 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.381 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 54.02 21.02 2.69 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.434 1.094 . . . . 0.0 112.783 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -103.81 136.87 19.14 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.273 1.029 . . . . 0.0 108.337 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.9 154.16 28.15 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.753 2.302 . . . . 0.0 111.801 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.7 mt -49.88 -46.33 51.49 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.848 0.717 . . . . 0.0 111.271 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.35 -40.66 74.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.835 1.254 . . . . 0.0 113.038 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.46 66.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.762 0.825 . . . . 0.0 111.633 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.542 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.9 pt -114.63 7.68 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.211 1.005 . . . . 0.0 111.153 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 35.3 tt0 -68.18 136.05 53.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.146 0.978 . . . . 0.0 111.055 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.498 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 36.8 t -69.26 110.26 5.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 124.411 1.069 . . . . 0.0 108.405 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.72 -1.04 10.2 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.056 2.504 . . . . 0.0 112.735 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.498 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.5 mt -84.35 -52.83 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.142 1.377 . . . . 0.0 109.756 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -97.89 -9.34 26.48 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.322 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.9 37.37 15.27 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.193 0.997 . . . . 0.0 111.894 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.49 151.13 37.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.195 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 23.3 tm0? -71.04 118.12 62.69 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 94.9 Cg_endo -74.03 162.5 38.87 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.074 2.516 . . . . 0.0 114.07 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.603 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -82.47 -32.17 29.0 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.67 172.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.603 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.3 pttt -147.67 143.64 27.79 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.315 1.446 . . . . 0.0 107.345 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.69 160.6 33.79 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.183 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 HD11 HG21 ' A' ' 98' ' ' ILE . 10.2 pt -114.37 152.36 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.833 1.653 . . . . 0.0 109.365 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -93.66 120.38 33.86 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.442 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 98.4 t -120.34 119.51 60.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.64 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.8 ptmt -69.09 118.82 12.47 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.635 0.731 . . . . 0.0 110.417 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -70.19 81.38 0.52 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 163.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -67.34 -56.34 10.11 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.875 -168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.05 -28.42 68.2 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.533 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.98 -65.73 2.14 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.193 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 m -152.68 10.98 0.49 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.1 t70 66.39 14.42 9.69 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 124.047 0.939 . . . . 0.0 111.116 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.17 124.93 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.498 0.719 . . . . 0.0 110.037 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 26.1 p -84.56 132.79 34.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.0 m -121.48 147.0 46.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.542 HD23 ' HB ' ' A' ' 117' ' ' ILE . 27.0 tp -92.85 105.15 17.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 85.4 m-85 -99.77 140.04 34.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.619 1.168 . . . . 0.0 107.895 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.4 t70 -61.04 140.84 57.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.646 0.657 . . . . 0.0 109.676 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.44 74.93 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.106 0.879 . . . . 0.0 111.276 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.92 67.34 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.344 0.657 . . . . 0.0 111.621 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -48.12 60.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.478 0.711 . . . . 0.0 112.026 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 153' ' ' VAL . 41.7 t80 -71.17 -39.63 71.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.965 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.42 ' HB2' HG23 ' A' ' 98' ' ' ILE . 23.1 t -60.25 -35.44 75.51 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.822 0.701 . . . . 0.0 110.898 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 41.1 ttt85 -62.35 -53.41 55.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.016 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.74 -45.76 67.14 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.292 0.637 . . . . 0.0 112.054 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 166' ' ' ILE . 48.7 t -61.79 -49.67 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.69 -18.93 70.72 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.849 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.1 mm-40 -82.48 -29.08 30.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.387 0.675 . . . . 0.0 109.857 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.11 23.9 16.19 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 64.5 mt -91.46 147.97 36.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.397 1.079 . . . . 0.0 110.047 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.15 -167.02 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.939 2.426 . . . . 0.0 112.165 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.448 ' ND1' HG23 ' A' ' 162' ' ' THR . 45.0 t-80 -62.55 126.5 88.39 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 109.784 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -10.2 28.12 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.844 2.363 . . . . 0.0 113.851 -171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.08 -64.97 1.01 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.923 0.489 . . . . 0.0 110.04 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.448 HG23 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -98.0 -5.06 34.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.291 0.636 . . . . 0.0 112.097 -167.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 62.66 21.64 12.84 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.526 1.13 . . . . 0.0 112.746 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -80.46 151.52 71.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.138 0.575 . . . . 0.0 111.009 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.2 118.91 5.81 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.521 2.147 . . . . 0.0 111.357 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.485 ' HA ' HD13 ' A' ' 170' ' ' ILE . 71.8 mt -64.93 135.02 28.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.349 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 t -148.78 163.36 37.59 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.844 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.96 -24.12 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.946 0.898 . . . . 0.0 111.356 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -64.74 -45.85 84.72 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.665 0.786 . . . . 0.0 111.928 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 166' ' ' ILE . 46.5 pt -80.98 -8.43 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.95 130.39 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 118.713 0.688 . . . . 0.0 109.391 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.6 m -132.73 173.84 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.211 1.404 . . . . 0.0 109.882 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 52.6 mtpt -101.5 169.85 8.59 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.029 0.442 . . . . 0.0 110.754 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -59.23 -28.53 66.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.523 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -78.66 -33.02 47.41 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.529 0.732 . . . . 0.0 111.387 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.62 -15.32 42.88 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.189 0.519 . . . . 0.0 110.857 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 30.5 p -112.9 146.94 38.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.603 0.761 . . . . 0.0 109.044 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.68 154.16 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 37.9 p90 -67.78 134.99 51.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 165.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.501 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.6 t70 -112.83 133.99 54.56 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.93 -49.97 33.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.598 1.159 . . . . 0.0 112.099 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 t -71.33 -24.55 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.049 0.386 . . . . 0.0 111.184 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.44 ' HA ' ' HE ' ' A' ' 183' ' ' ARG . 2.3 mmp_? -84.87 -34.05 22.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.358 0.663 . . . . 0.0 110.718 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.19 73.39 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.96 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -148.05 143.68 27.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.364 1.066 . . . . 0.0 109.481 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 25.5 m-85 -68.64 115.97 8.62 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 180' ' ' ASP . 24.1 pt -122.91 178.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.307 1.043 . . . . 0.0 108.611 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 133' ' ' LYS . 38.3 mm -83.87 155.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt . . . . . 0 C--O 1.242 0.701 0 CA-C-O 120.981 0.419 . . . . 0.0 110.39 174.105 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.54 -51.43 36.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -72.99 -43.18 62.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.473 0.309 . . . . 0.0 110.655 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.51 -49.35 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.476 0.71 . . . . 0.0 111.081 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.427 ' HA ' HD13 ' A' ' 98' ' ' ILE . 40.2 mt-30 -67.6 -29.55 68.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.567 0.747 . . . . 0.0 111.367 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 4.1 m-80 -62.35 -43.18 99.42 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 170.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -40.67 94.08 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 122.823 0.449 . . . . 0.0 110.078 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 130' ' ' ILE . 94.9 mt -61.43 -38.32 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.732 0.813 . . . . 0.0 111.136 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.3 m -70.48 -32.56 70.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.136 0.574 . . . . 0.0 110.964 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 34.8 mt-30 -83.55 -39.42 20.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.105 0.562 . . . . 0.0 111.633 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -80.13 -19.97 46.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.545 -171.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -69.78 162.39 27.94 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 123.531 0.519 . . . . 0.0 110.877 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -148.11 159.65 43.71 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -68.34 97.97 0.79 Allowed 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.06 97.62 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.9 m -108.21 102.12 44.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.851 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.484 ' HB3' HD12 ' A' ' 117' ' ' ILE . 12.9 Cg_endo -54.61 -29.75 62.27 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.666 2.91 . . . . 0.0 112.666 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.678 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 8.9 pt-20 -69.79 -35.42 74.86 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.635 1.174 . . . . 0.0 111.54 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.678 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 50.7 mtt180 -93.84 -36.4 12.26 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.669 0.787 . . . . 0.0 111.209 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.37 -18.43 62.37 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.705 0.802 . . . . 0.0 111.977 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 63.53 17.68 10.53 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.882 1.273 . . . . 0.0 111.483 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -104.46 129.48 24.96 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 124.309 1.044 . . . . 0.0 109.615 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.24 166.45 19.05 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.733 2.289 . . . . 0.0 111.748 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.7 mt -53.25 -47.14 69.31 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.737 0.648 . . . . 0.0 111.022 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -52.14 -43.38 64.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.98 0.912 . . . . 0.0 112.852 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.65 69.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.332 0.653 . . . . 0.0 111.415 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 107' ' ' PRO . 15.1 pt -122.01 29.42 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.905 0.882 . . . . 0.0 110.322 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -73.82 121.83 21.49 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.188 0.995 . . . . 0.0 109.439 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.1 t -68.74 114.95 25.97 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.28 -12.7 34.42 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.801 2.334 . . . . 0.0 112.755 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.61 -51.88 16.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.843 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.8 p -96.75 -19.54 18.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.348 1.059 . . . . 0.0 112.324 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 57.85 46.81 16.31 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.318 1.047 . . . . 0.0 111.823 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.46 152.64 38.41 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.802 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.451 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 23.3 tm0? -76.25 113.38 27.78 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.75 167.04 18.97 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.009 2.473 . . . . 0.0 113.451 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.02 -23.45 26.79 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -143.46 140.69 30.49 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.102 1.361 . . . . 0.0 108.43 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.45 157.08 29.39 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.335 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 98' ' ' ILE . 7.1 pt -110.77 161.26 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.038 1.335 . . . . 0.0 109.775 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -104.89 118.17 35.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.588 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.5 t -114.67 125.55 72.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.493 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.3 ptmt -73.75 114.61 12.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 124.004 0.815 . . . . 0.0 110.037 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -71.95 80.45 0.91 Allowed 'General case' 0 C--O 1.247 0.943 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 36.7 t -64.8 -49.43 70.71 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.716 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.73 -27.96 68.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.564 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.43 2.58 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.366 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.0 m -161.53 17.91 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.464 0.706 . . . . 0.0 111.198 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 13.6 t70 67.03 22.09 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.394 1.078 . . . . 0.0 111.235 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.526 ' HA ' HG21 ' A' ' 187' ' ' ILE . 90.5 t -96.19 134.67 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.319 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 55.9 m -87.0 139.83 30.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.624 0.77 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.2 m -127.28 147.72 50.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.249 1.02 . . . . 0.0 108.853 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 tp -85.28 112.48 20.81 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.03 0.443 . . . . 0.0 110.222 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.47 137.17 46.86 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -58.34 137.43 57.2 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.177 0.444 . . . . 0.0 109.95 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.42 85.97 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.159 0.912 . . . . 0.0 111.15 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.54 -34.29 62.94 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.783 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.8 -44.09 61.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 112.118 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' HG21 ' A' ' 153' ' ' VAL . 34.7 t80 -73.48 -39.0 65.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.761 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -63.08 -37.98 89.37 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.583 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 48.4 ttt180 -53.64 -53.2 55.32 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.765 0.666 . . . . 0.0 109.481 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.26 -42.52 73.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.01 0.819 . . . . 0.0 111.829 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 149' ' ' PHE . 58.8 t -64.57 -46.9 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.416 0.448 . . . . 0.0 110.091 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.38 -36.06 91.93 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.825 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 45.3 mt-10 -75.95 -27.47 57.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.644 0.777 . . . . 0.0 110.819 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.79 20.44 34.02 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.747 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.86 144.16 47.62 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.035 0.934 . . . . 0.0 109.573 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.83 -170.3 0.88 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.992 2.462 . . . . 0.0 112.422 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.472 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.4 t-80 -62.5 126.81 89.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.571 0.749 . . . . 0.0 109.343 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.87 -14.87 39.71 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.23 1.954 . . . . 0.0 113.331 -170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.8 mt -96.12 -66.01 0.93 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 122.589 0.356 . . . . 0.0 110.886 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.472 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.0 t -90.51 -10.1 44.84 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 63.31 16.81 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.755 1.222 . . . . 0.0 112.843 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -80.12 144.69 59.2 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 122.87 12.37 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.702 2.268 . . . . 0.0 111.544 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.403 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -62.25 131.85 27.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 123.54 0.525 . . . . 0.0 110.104 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -143.77 161.95 37.29 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.89 0.876 . . . . 0.0 109.172 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.57 -23.04 66.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.665 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.2 m -69.44 -22.35 63.67 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.018 0.927 . . . . 0.0 112.728 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 48.0 pt -105.9 -2.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -97.79 140.53 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.394 -0.816 . . . . 0.0 109.887 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.525 HG11 HD12 ' A' ' 188' ' ' ILE . 27.3 m -141.35 -179.89 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.793 1.237 . . . . 0.0 110.049 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.7 168.63 10.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.641 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.44 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 43.7 t-80 -68.02 -24.89 65.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.842 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.12 -22.2 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.766 0.426 . . . . 0.0 110.68 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -85.63 -21.54 28.38 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.218 0.533 . . . . 0.0 111.042 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.2 p -101.65 145.45 29.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 167.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 143.64 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -65.85 102.05 0.73 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -72.75 124.19 24.85 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.63 -34.59 67.44 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.189 0.996 . . . . 0.0 111.585 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.8 t -80.32 -25.43 39.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.119 0.168 . . . . 0.0 111.159 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -100.98 -14.63 17.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.811 0.445 . . . . 0.0 111.53 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.48 79.76 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.156 -0.802 . . . . 0.0 114.942 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -165.79 162.49 18.55 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 117.694 0.747 . . . . 0.0 110.47 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.92 125.76 24.9 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 111.754 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.526 HG21 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -133.34 169.51 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.443 1.097 . . . . 0.0 109.134 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.525 HD12 HG11 ' A' ' 172' ' ' VAL . 42.6 mm -70.88 140.3 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.421 0.688 . . . . 0.0 110.733 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.561 0.696 . . . . 0.0 111.884 175.256 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.517 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 21.2 mp0 . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.27 -55.5 12.49 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 113.48 -164.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -66.27 -34.79 78.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.281 0.632 . . . . 0.0 111.092 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 98' ' ' ILE . 67.1 mt -69.62 -45.18 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.697 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -57.89 -44.1 86.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.853 1.261 . . . . 0.0 111.214 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.07 -45.42 87.12 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.702 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HG2' ' HB2' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -66.82 -34.11 77.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.948 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.8 mt -65.84 -43.08 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.2 t -65.03 -33.94 77.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.792 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -77.77 -44.93 26.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.281 0.632 . . . . 0.0 111.829 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.431 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 82.8 m -76.61 -20.98 56.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.705 0.802 . . . . 0.0 112.675 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -71.08 168.27 17.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.645 0.736 . . . . 0.0 112.606 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -158.78 160.57 36.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.446 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.3 m -69.1 99.16 1.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.706 0.628 . . . . 0.0 109.469 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.32 119.89 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.411 0.685 . . . . 0.0 110.091 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 79.5 m -133.73 101.82 12.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.007 0.923 . . . . 0.0 109.386 -176.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 10.8 Cg_endo -52.39 -23.28 18.23 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.891 3.061 . . . . 0.0 114.008 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.9 pt-20 -73.14 -38.13 66.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.708 0.803 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.574 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 90.9 mtt-85 -93.43 -21.7 19.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.689 0.796 . . . . 0.0 111.514 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.17 -20.91 26.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.621 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.7 24.23 13.11 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.299 1.04 . . . . 0.0 111.46 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.4 m -110.31 137.21 20.56 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.128 0.971 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.1 162.67 28.65 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.275 1.983 . . . . 0.0 111.488 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 93.8 mt -54.26 -46.25 72.6 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.477 0.711 . . . . 0.0 111.289 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.13 -41.72 72.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.051 0.94 . . . . 0.0 112.694 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.98 68.88 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.579 0.752 . . . . 0.0 111.993 -175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 pt -122.95 30.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.039 0.936 . . . . 0.0 109.81 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 40.8 tt0 -78.62 134.98 37.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.442 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 18.7 t -71.49 114.94 32.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 109.185 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.36 -4.8 16.04 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.936 2.424 . . . . 0.0 113.497 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.493 HG12 ' HG3' ' A' ' 160' ' ' PRO . 59.7 mt -80.3 -53.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.87 0.868 . . . . 0.0 109.311 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -95.12 -11.01 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.148 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.63 37.06 19.49 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.986 0.914 . . . . 0.0 111.53 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.45 148.92 29.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.289 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 25.7 tm0? -72.05 118.64 68.88 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.282 0.633 . . . . 0.0 109.444 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.72 161.89 18.95 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.769 2.313 . . . . 0.0 113.493 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -88.02 -14.13 39.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.049 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -151.7 134.21 15.41 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.844 0.858 . . . . 0.0 109.93 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.23 165.38 38.55 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.31 -172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 143' ' ' LEU . 9.2 pt -114.41 158.97 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.654 1.582 . . . . 0.0 110.395 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.04 123.65 44.52 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 90.5 t -118.86 119.95 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.1 ptmt -74.83 114.15 12.95 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 123.763 0.664 . . . . 0.0 110.047 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -73.39 72.96 1.35 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 171.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 35.1 t -68.13 -55.41 12.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.819 -167.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -58.32 -34.39 70.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.178 0.991 . . . . 0.0 112.14 -173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.98 -62.4 2.36 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.637 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.9 t -149.33 3.93 0.59 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 22.9 t70 59.33 47.23 11.62 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.792 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.08 124.6 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 122.948 0.499 . . . . 0.0 110.26 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 65.1 m -84.21 128.68 34.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.251 0.621 . . . . 0.0 109.66 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.0 m -122.8 143.39 49.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.347 1.059 . . . . 0.0 109.66 -171.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 130' ' ' ILE . 46.9 tp -88.91 106.34 18.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.237 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 89.2 m-85 -99.43 149.96 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 148' ' ' ALA . 12.1 t70 -65.73 137.54 57.34 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.59 -52.96 62.84 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.985 0.803 . . . . 0.0 111.707 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.44 56.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.112 0.565 . . . . 0.0 111.966 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -75.6 -36.63 60.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.182 0.593 . . . . 0.0 110.771 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.41 ' O ' HG21 ' A' ' 153' ' ' VAL . 42.6 t80 -73.14 -38.43 66.27 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -61.51 -31.52 71.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.923 0.889 . . . . 0.0 110.839 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.0 tpm_? -63.21 -54.26 40.25 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.947 0.779 . . . . 0.0 109.564 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.3 mt -54.8 -47.0 74.57 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.252 0.97 . . . . 0.0 111.376 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 166' ' ' ILE . 99.4 t -60.67 -50.47 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.801 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.517 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -59.94 -32.83 76.38 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 124.112 0.883 . . . . 0.0 113.371 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 28.6 mm-40 -75.86 -30.93 59.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.392 0.677 . . . . 0.0 111.187 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.71 9.42 49.75 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.243 -171.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.74 139.76 74.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.934 0.894 . . . . 0.0 109.201 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.48 -164.55 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.404 2.07 . . . . 0.0 112.242 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.79 131.25 92.92 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.321 1.049 . . . . 0.0 110.143 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.493 ' HG3' HG12 ' A' ' 121' ' ' ILE . 72.1 Cg_endo -70.96 -24.7 23.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.296 1.998 . . . . 0.0 113.265 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -85.23 -59.21 2.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.966 0.506 . . . . 0.0 111.051 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -108.27 -7.86 15.84 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.939 -167.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 65.86 19.12 11.27 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.629 1.172 . . . . 0.0 112.247 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -71.36 144.42 89.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.174 0.589 . . . . 0.0 110.117 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.37 116.5 3.79 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.406 2.071 . . . . 0.0 110.816 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 153' ' ' VAL . 77.3 mt -61.21 132.91 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.66 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -147.15 164.79 31.97 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.278 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 97' ' ' LYS . . . -65.46 -24.62 67.21 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.541 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.8 t -69.3 -26.11 64.57 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.942 0.897 . . . . 0.0 112.333 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 166' ' ' ILE . 47.4 pt -100.69 -6.1 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 118.317 0.508 . . . . 0.0 112.236 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 168' ' ' ALA . 10.2 tt -100.7 136.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.05 0.841 . . . . 0.0 109.773 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 101' ' ' CYS . 28.7 m -138.04 171.57 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.142 1.377 . . . . 0.0 110.829 -174.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 43.9 mtmt -92.95 164.2 13.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.402 0.681 . . . . 0.0 110.595 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -66.1 -33.54 76.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.703 0.801 . . . . 0.0 111.61 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -80.28 -20.24 44.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.308 0.643 . . . . 0.0 110.848 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -84.8 -27.95 26.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.974 0.91 . . . . 0.0 110.998 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.3 p -105.7 151.67 24.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -136.78 158.95 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.166 0.987 . . . . 0.0 108.457 177.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -64.6 130.36 43.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' HB2' HG13 ' A' ' 187' ' ' ILE . 11.3 t70 -106.13 135.6 47.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.97 -50.68 10.74 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.363 1.039 . . . . 0.0 111.816 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -72.38 -26.4 61.88 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.795 0.27 . . . . 0.0 111.64 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -93.01 -28.65 16.26 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.892 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.15 28.51 44.77 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.489 0.493 . . . . 0.0 114.176 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -169.84 161.8 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.167 0.484 . . . . 0.0 110.313 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 88.5 m-85 -60.33 124.41 20.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.746 1.219 . . . . 0.0 111.879 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 180' ' ' ASP . 2.8 pp -139.14 177.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.165 1.386 . . . . 0.0 109.31 174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.0 mm -77.16 146.0 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.319 0.648 . . . . 0.0 110.569 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 123.502 0.721 . . . . 0.0 112.05 178.496 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 18.3 mp0 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 110.641 -0.133 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -30.21 70.97 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.416 0.286 . . . . 0.0 111.605 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -71.6 -48.03 50.8 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.169 0.588 . . . . 0.0 109.614 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.6 mt -60.03 -50.26 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.9 0.88 . . . . 0.0 110.217 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HA ' HD12 ' A' ' 98' ' ' ILE . 43.6 mt-30 -69.49 -28.36 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.309 1.044 . . . . 0.0 111.649 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.45 -44.26 96.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.32 -33.19 74.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.428 0.691 . . . . 0.0 110.886 177.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 95' ' ' GLN . 92.2 mt -63.17 -45.08 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 122.942 0.497 . . . . 0.0 109.73 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 m -65.51 -29.74 70.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.664 0.786 . . . . 0.0 112.52 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.98 -46.25 16.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.93 0.492 . . . . 0.0 111.819 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.1 -19.59 50.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.824 0.85 . . . . 0.0 112.878 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -67.27 172.24 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -156.47 157.09 34.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.974 172.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m -70.21 102.07 2.02 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.47 98.22 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.287 0.635 . . . . 0.0 109.797 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.6 m -103.48 103.23 34.48 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.992 0.917 . . . . 0.0 109.005 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.472 ' HB3' HD13 ' A' ' 117' ' ' ILE . 29.8 Cg_endo -60.22 -28.9 87.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.243 2.629 . . . . 0.0 112.506 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.66 -33.52 75.84 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.833 0.853 . . . . 0.0 110.756 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -88.12 -46.57 9.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.961 -174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.1 -22.98 63.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.366 0.666 . . . . 0.0 111.274 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 57.58 13.46 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.56 1.144 . . . . 0.0 113.662 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.59 133.92 31.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-O 118.289 -0.862 . . . . 0.0 108.752 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.34 149.29 23.23 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.983 2.455 . . . . 0.0 112.623 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.6 -46.7 63.64 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.114 0.966 . . . . 0.0 111.865 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.04 -36.83 78.15 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.865 0.866 . . . . 0.0 112.271 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.29 68.43 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.491 0.717 . . . . 0.0 111.459 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 107' ' ' PRO . 17.9 pt -107.65 5.34 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 110.807 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.9 128.15 35.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.428 1.091 . . . . 0.0 110.855 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.0 110.32 3.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.75 -3.07 13.14 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.814 2.342 . . . . 0.0 112.43 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.546 HG12 ' HG3' ' A' ' 160' ' ' PRO . 36.7 mt -81.04 -53.25 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.866 0.867 . . . . 0.0 109.197 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.1 p -96.32 -10.22 28.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.96 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.21 53.32 10.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.758 1.223 . . . . 0.0 111.449 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.12 160.59 38.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.026 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -73.76 120.3 80.53 Favored Pre-proline 0 CA--C 1.559 1.3 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 73.9 Cg_endo -76.05 157.97 38.22 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.203 2.602 . . . . 0.0 113.829 -173.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.526 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 10.7 pt-20 -81.24 -36.77 29.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.365 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.526 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.9 pttm -145.25 148.44 33.49 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.504 1.522 . . . . 0.0 107.369 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.04 159.81 32.65 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.302 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -113.98 166.45 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.527 1.531 . . . . 0.0 109.685 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -106.07 125.88 51.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.421 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 70.8 t -115.82 124.6 72.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.495 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.1 ptmt -74.92 104.44 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.904 0.859 . . . . 0.0 110.288 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -78.53 71.47 5.0 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 4.9 t -69.36 -26.89 64.9 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.419 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.7 -39.83 95.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.271 1.028 . . . . 0.0 110.709 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.39 -63.99 3.04 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -176.34 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.192 0.997 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 18.4 t70 62.44 27.26 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.412 1.085 . . . . 0.0 110.804 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.98 109.21 9.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.035 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 186' ' ' PHE . 58.4 m -83.49 119.62 24.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.3 m -118.86 145.33 45.78 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -170.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 117' ' ' ILE . 31.1 tp -86.63 103.9 15.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.484 0.659 . . . . 0.0 110.58 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.461 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 92.8 m-85 -102.84 133.4 47.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 107.905 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.5 t70 -56.59 134.17 54.18 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.605 0.639 . . . . 0.0 109.653 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.48 -44.75 80.93 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.018 0.824 . . . . 0.0 111.555 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.63 40.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.861 0.465 . . . . 0.0 111.758 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.45 38.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.44 0.696 . . . . 0.0 111.705 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.0 t80 -74.26 -39.48 62.98 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -61.66 -35.03 76.78 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.938 0.774 . . . . 0.0 110.961 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 10.7 tpt180 -57.3 -52.16 66.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.16 0.584 . . . . 0.0 109.499 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.8 mt -54.8 -41.93 71.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.041 0.838 . . . . 0.0 111.956 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 166' ' ' ILE . 21.9 t -69.02 -41.34 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 123.939 0.774 . . . . 0.0 109.768 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.93 -29.16 73.41 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.174 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -84.01 -24.21 30.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.213 0.605 . . . . 0.0 110.784 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 19.79 56.55 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.842 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.1 147.48 73.25 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.078 0.951 . . . . 0.0 110.668 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.53 175.87 10.8 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.411 2.074 . . . . 0.0 111.91 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -55.43 131.81 70.43 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.417 1.087 . . . . 0.0 111.114 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.546 ' HG3' HG12 ' A' ' 121' ' ' ILE . 71.7 Cg_endo -69.08 -17.82 40.47 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.413 2.075 . . . . 0.0 113.822 -169.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.05 -62.32 1.25 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.875 0.47 . . . . 0.0 111.302 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 t -104.99 -7.21 19.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.753 -168.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.29 26.11 14.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.54 1.136 . . . . 0.0 112.201 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.17 154.69 92.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.033 0.933 . . . . 0.0 110.116 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.07 113.36 2.58 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 121.919 1.746 . . . . 0.0 109.799 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.549 HG22 HG21 ' A' ' 153' ' ' VAL . 61.0 mt -60.87 122.58 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.2 t -147.32 162.41 39.01 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.809 0.844 . . . . 0.0 109.493 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.439 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -72.24 -14.88 61.89 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.84 0.456 . . . . 0.0 110.973 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.9 m -70.12 -30.61 67.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.729 0.812 . . . . 0.0 111.921 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.9 pt -99.5 -8.4 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 168' ' ' ALA . 8.4 tt -88.39 138.66 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.34 168.21 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.577 0.751 . . . . 0.0 111.135 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -90.35 153.27 20.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.812 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -65.02 -23.72 67.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -85.31 -21.96 28.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.57 0.748 . . . . 0.0 110.441 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.41 -17.86 37.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.993 . . . . 0.0 111.247 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 23.9 p -130.35 152.8 49.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.432 1.093 . . . . 0.0 109.325 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.93 164.88 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.746 1.218 . . . . 0.0 109.104 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 5.3 p90 -73.84 128.45 35.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.482 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.2 t70 -106.63 140.2 39.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -79.22 -48.66 13.8 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.756 0.822 . . . . 0.0 112.523 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.432 HG22 ' HE ' ' A' ' 183' ' ' ARG . 10.1 t -71.29 -24.68 62.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.472 0.578 . . . . 0.0 111.544 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.432 ' HE ' HG22 ' A' ' 182' ' ' THR . 5.0 mmp_? -81.2 -32.51 33.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 170.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.05 22.12 74.67 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.704 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -167.6 162.37 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.102 0.961 . . . . 0.0 108.87 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 70.7 m-85 -64.11 128.69 36.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.477 1.111 . . . . 0.0 112.012 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 180' ' ' ASP . 29.4 pt -132.57 177.35 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.644 1.177 . . . . 0.0 109.65 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 133' ' ' LYS . 48.7 mm -75.42 151.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.18 0.592 . . . . 0.0 109.6 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 123.102 0.561 . . . . 0.0 111.369 175.075 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.402 ' HG3' HG11 ' A' ' 153' ' ' VAL . 16.3 mp0 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -44.82 78.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.744 0.652 . . . . 0.0 111.473 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.9 t -67.03 -43.52 82.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 98' ' ' ILE . 63.6 mt -64.24 -44.54 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 123.713 0.633 . . . . 0.0 110.114 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.77 -44.05 90.55 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.526 1.13 . . . . 0.0 110.727 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.725 173.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.1 -35.49 81.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.714 0.805 . . . . 0.0 111.222 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 94' ' ' ILE . 94.3 mt -65.47 -41.36 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.6 t -64.27 -40.18 95.46 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.46 0.704 . . . . 0.0 111.69 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -80.39 -28.42 37.9 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 84.1 m -96.51 -18.08 20.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.121 0.568 . . . . 0.0 112.362 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.84 169.15 16.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 111.47 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -155.8 158.03 37.45 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m -68.05 96.53 0.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.03 100.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.235 0.614 . . . . 0.0 110.178 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.1 m -101.82 99.17 11.26 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.099 0.96 . . . . 0.0 108.581 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.75 -36.08 98.53 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.833 2.355 . . . . 0.0 112.331 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.16 -22.49 59.4 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.145 0.903 . . . . 0.0 111.87 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 12.8 mmp_? -91.72 -42.31 10.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.101 0.56 . . . . 0.0 111.091 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.527 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 96.9 mt -64.8 -19.21 65.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.654 0.782 . . . . 0.0 112.391 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 55.98 22.37 5.75 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.331 1.052 . . . . 0.0 112.442 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 55.8 m -95.24 141.54 23.36 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 123.9 0.88 . . . . 0.0 109.698 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.96 145.95 75.86 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.028 1.819 . . . . 0.0 110.236 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 99.5 mt -51.47 -43.82 62.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.967 0.907 . . . . 0.0 112.398 -173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.75 -36.8 79.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.61 0.764 . . . . 0.0 112.855 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.2 64.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.939 0.496 . . . . 0.0 110.865 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.04 27.92 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.943 0.897 . . . . 0.0 110.361 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.69 129.3 34.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.298 0.639 . . . . 0.0 109.35 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 t -68.74 111.9 9.7 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.25 0.46 9.37 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.748 2.299 . . . . 0.0 112.669 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -84.61 -55.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.702 0.801 . . . . 0.0 108.85 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.0 p -92.84 -8.83 42.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.828 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.56 39.74 21.18 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.545 1.138 . . . . 0.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.39 152.17 31.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -67.77 117.83 51.81 Favored Pre-proline 0 CA--C 1.557 1.246 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.73 166.31 23.76 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.084 2.523 . . . . 0.0 113.688 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.577 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.5 pt-20 -86.28 -28.0 24.04 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.846 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.577 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.52 145.41 31.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.089 1.356 . . . . 0.0 107.753 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.49 166.89 39.71 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.356 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -115.03 153.82 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 125.298 1.439 . . . . 0.0 109.496 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -97.04 122.15 39.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 79.6 t -114.68 123.73 70.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HB3' HD13 ' A' ' 188' ' ' ILE . 22.5 ptmt -69.04 107.44 3.15 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -73.36 89.66 1.62 Allowed 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -63.62 -36.73 84.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.173 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.5 -26.6 66.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.41 0.684 . . . . 0.0 110.818 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.4 13.83 43.92 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.462 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.0 m 77.26 44.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.31 1.444 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.89 24.46 14.47 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.607 1.163 . . . . 0.0 112.264 174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.49 ' HA ' HG22 ' A' ' 187' ' ' ILE . 98.0 t -79.94 125.53 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.171 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.4 129.62 34.77 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.632 0.773 . . . . 0.0 110.295 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.4 m -123.77 139.74 53.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.184 0.994 . . . . 0.0 109.002 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.1 tp -89.27 111.31 22.09 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.372 0.42 . . . . 0.0 110.061 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.427 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 84.5 m-85 -103.79 141.71 35.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.413 1.085 . . . . 0.0 108.243 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.52 132.26 51.87 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.781 0.675 . . . . 0.0 111.834 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.57 55.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.889 0.476 . . . . 0.0 111.455 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.13 69.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.72 0.808 . . . . 0.0 111.561 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.7 t80 -74.32 -40.41 62.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.543 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -63.84 -30.51 71.6 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.464 0.706 . . . . 0.0 111.011 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -62.43 -52.23 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.781 0.833 . . . . 0.0 109.686 172.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.43 -47.62 81.28 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 123.735 0.647 . . . . 0.0 111.228 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.472 HG22 HG21 ' A' ' 166' ' ' ILE . 97.2 t -61.15 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.269 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.54 92.45 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 124.069 0.856 . . . . 0.0 112.943 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -73.46 -23.31 60.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.168 0.587 . . . . 0.0 111.503 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.06 18.98 37.78 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.375 0.422 . . . . 0.0 112.872 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.0 149.4 70.03 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.734 1.213 . . . . 0.0 110.497 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.85 -174.44 2.23 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.984 2.456 . . . . 0.0 112.466 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 162' ' ' THR . 53.7 t-80 -64.55 127.54 92.45 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.821 0.848 . . . . 0.0 109.082 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.31 -17.92 49.91 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.217 1.945 . . . . 0.0 113.217 -168.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.0 mt -95.46 -62.83 1.23 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.184 0.594 . . . . 0.0 111.15 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.436 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.9 t -91.42 -11.67 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.527 0.331 . . . . 0.0 111.492 -172.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 59.63 23.43 12.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.119 1.368 . . . . 0.0 112.838 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -91.68 154.93 44.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.739 0.816 . . . . 0.0 109.77 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.91 123.53 12.42 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.438 2.092 . . . . 0.0 112.068 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.472 HG21 HG22 ' A' ' 153' ' ' VAL . 81.2 mt -63.33 136.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.149 0.58 . . . . 0.0 109.952 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -147.33 161.51 40.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.371 0.668 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' A' ' 171' ' ' ILE . . . -68.61 -19.87 64.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.403 1.081 . . . . 0.0 110.997 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -69.58 -24.96 63.76 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.954 0.902 . . . . 0.0 112.561 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 49.4 pt -105.21 -5.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 168' ' ' ALA . 9.6 tt -96.94 132.13 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.881 0.764 . . . . 0.0 109.486 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.33 175.4 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.311 1.044 . . . . 0.0 110.06 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.566 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 95.5 mttt -96.77 165.74 11.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.615 0.366 . . . . 0.0 110.662 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -63.53 -27.01 68.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.372 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -77.93 -27.18 49.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.66 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -85.88 -20.52 28.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.965 0.906 . . . . 0.0 111.785 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.1 p -117.41 150.96 38.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.01 0.924 . . . . 0.0 109.574 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 160.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.196 0.999 . . . . 0.0 108.753 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.94 140.12 57.84 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.33 139.41 53.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.879 0.471 . . . . 0.0 110.008 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.42 -52.69 9.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.331 1.052 . . . . 0.0 111.64 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -74.72 -26.71 59.99 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -80.83 -33.54 34.54 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.542 0.737 . . . . 0.0 109.824 169.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.74 25.89 48.14 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.626 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.34 170.73 2.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.228 0.611 . . . . 0.0 111.043 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.499 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 89.9 m-85 -61.88 122.05 14.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.692 1.197 . . . . 0.0 111.527 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.9 pp -134.71 173.95 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.713 1.205 . . . . 0.0 109.904 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 133' ' ' LYS . 43.8 mm -73.54 143.74 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.726 0.81 . . . . 0.0 110.684 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp . . . . . 0 C--O 1.24 0.578 0 C-N-CA 123.484 0.713 . . . . 0.0 112.05 178.09 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.415 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 16.2 mp0 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.454 -0.308 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.81 -49.37 49.06 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.232 1.013 . . . . 0.0 113.334 -164.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.495 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 17.2 m -70.29 -41.04 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.277 0.631 . . . . 0.0 109.95 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.7 mt -66.12 -45.33 90.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.381 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -57.69 -46.14 84.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.854 1.261 . . . . 0.0 110.704 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.74 -37.39 86.37 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.024 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -66.39 -44.4 83.17 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 123.216 0.606 . . . . 0.0 110.224 177.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.5 mt -60.49 -39.0 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 109.666 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -67.32 -41.08 85.88 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.132 0.973 . . . . 0.0 111.011 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -83.19 -14.56 53.15 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.672 0.789 . . . . 0.0 112.984 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 93.5 m -103.55 -25.37 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.309 0.644 . . . . 0.0 112.601 -173.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -68.92 166.09 18.58 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -156.72 158.05 36.22 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.373 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.5 m -67.07 100.65 0.78 Allowed 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.706 0.802 . . . . 0.0 109.47 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.75 101.61 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.0 m -112.33 96.87 37.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.489 ' HB3' HD12 ' A' ' 117' ' ' ILE . 8.0 Cg_endo -50.86 -23.52 11.88 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.938 3.092 . . . . 0.0 113.927 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.59 -30.18 59.51 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -93.47 -40.19 10.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.392 0.677 . . . . 0.0 111.135 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.06 -24.33 64.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.067 0.547 . . . . 0.0 110.237 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 45.41 50.42 10.11 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 124.889 1.276 . . . . 0.0 111.698 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.6 m -124.3 148.72 58.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.391 1.076 . . . . 0.0 110.038 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.67 141.67 97.45 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.348 2.032 . . . . 0.0 110.772 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.525 HD23 ' HG3' ' A' ' 125' ' ' GLN . 52.4 mt -55.06 -37.82 67.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.831 0.852 . . . . 0.0 111.666 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.01 -38.13 81.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.785 0.834 . . . . 0.0 112.192 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.27 66.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.065 0.546 . . . . 0.0 111.014 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 107' ' ' PRO . 33.3 pt -116.12 26.59 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.235 1.014 . . . . 0.0 110.302 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.57 127.54 33.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.308 1.043 . . . . 0.0 110.15 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.9 t -74.38 110.83 10.51 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.9 -2.75 12.68 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.78 2.32 . . . . 0.0 112.947 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.0 mt -85.12 -57.33 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.769 0.828 . . . . 0.0 109.499 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p -80.37 -23.67 40.32 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.024 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 62.74 49.9 3.58 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.124 0.964 . . . . 0.0 110.291 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.45 154.33 34.2 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.214 171.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.525 ' HG3' HD23 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -72.05 112.17 13.46 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.9 Cg_endo -71.32 159.78 50.73 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.205 2.604 . . . . 0.0 114.459 -167.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.534 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 6.4 pt-20 -80.81 -39.84 25.99 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.683 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.534 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -146.57 146.23 30.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.801 1.24 . . . . 0.0 108.044 178.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.35 42.36 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.461 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.2 pt -122.54 159.81 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.719 1.608 . . . . 0.0 109.197 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 141' ' ' CYS . 40.7 m-85 -104.85 119.8 39.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 170.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.3 121.43 66.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.662 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.9 ptmt -64.35 127.26 30.72 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 124.099 0.874 . . . . 0.0 112.77 -172.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -76.86 72.72 3.47 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -42.9 99.74 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.417 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.65 -40.38 92.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.502 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.63 -66.54 2.1 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.68 -171.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.497 ' HB2' HG23 ' A' ' 140' ' ' VAL . 42.7 m -161.3 22.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.162 0.585 . . . . 0.0 111.569 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.42 31.33 17.23 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.884 1.326 . . . . 0.0 110.314 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.577 ' HA ' HG23 ' A' ' 187' ' ' ILE . 60.0 t -81.72 177.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.413 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 131' ' ' PHE . 26.4 p -134.3 140.78 46.64 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.5 m -118.94 146.34 45.04 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.06 109.38 20.44 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.235 0.541 . . . . 0.0 110.67 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.24 130.72 54.71 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 108.173 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.1 t70 -55.56 132.11 47.87 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.889 0.768 . . . . 0.0 109.17 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.45 77.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 112.154 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -33.0 63.34 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.621 0.575 . . . . 0.0 110.963 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -72.23 -36.76 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -80.27 -36.81 34.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -63.92 -29.8 70.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.365 0.666 . . . . 0.0 110.789 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 8.5 tpt180 -59.18 -59.08 6.03 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.924 0.765 . . . . 0.0 108.995 169.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.26 -46.83 72.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.019 0.825 . . . . 0.0 111.915 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 166' ' ' ILE . 95.4 t -61.99 -48.93 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 110.135 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -62.97 -35.78 92.55 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 123.995 0.81 . . . . 0.0 113.045 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 8.9 mm-40 -67.81 -34.97 77.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.521 0.729 . . . . 0.0 110.289 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.65 27.32 8.05 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.305 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 54.4 mt -90.19 149.04 40.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.375 1.07 . . . . 0.0 109.779 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.21 -176.38 3.24 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.463 2.109 . . . . 0.0 112.399 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.09 128.61 81.76 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.204 1.002 . . . . 0.0 110.569 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.64 -13.76 37.9 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.323 2.015 . . . . 0.0 113.971 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.2 mt -101.17 -56.11 2.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.735 0.414 . . . . 0.0 111.766 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.5 t -104.01 -10.29 18.19 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.876 0.47 . . . . 0.0 111.271 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 63.75 21.46 12.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.623 1.169 . . . . 0.0 112.999 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.06 151.41 78.79 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.299 0.64 . . . . 0.0 109.873 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.16 122.73 12.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.778 2.319 . . . . 0.0 110.991 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.54 ' HA ' HD13 ' A' ' 170' ' ' ILE . 74.7 mt -66.34 128.38 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 t -146.13 159.61 43.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.161 0.984 . . . . 0.0 109.377 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.7 -19.7 65.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.612 0.765 . . . . 0.0 111.158 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -70.25 -39.51 74.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.929 0.891 . . . . 0.0 111.788 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 166' ' ' ILE . 47.6 pt -90.66 -12.19 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.16 137.34 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.144 0.884 . . . . 0.0 108.728 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 188' ' ' ILE . 28.8 m -130.22 171.67 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.283 1.033 . . . . 0.0 109.113 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 58.6 mtpt -88.52 165.72 14.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.159 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.732 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 21.0 t60 -73.62 -23.27 59.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.39 0.614 . . . . 0.0 109.649 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.44 -31.49 71.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.8 10.18 41.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.602 0.761 . . . . 0.0 111.726 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.9 p -139.57 138.07 35.93 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.635 -0.666 . . . . 0.0 110.457 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.409 HD13 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -133.82 162.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.756 1.223 . . . . 0.0 108.579 -174.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -66.47 124.46 22.83 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 166.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.542 ' HB2' HG12 ' A' ' 187' ' ' ILE . 12.4 t70 -105.32 134.02 49.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.83 -36.57 42.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.15 0.906 . . . . 0.0 112.337 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 180' ' ' ASP . 1.1 t -76.53 -23.64 53.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.452 ' HG3' HG21 ' A' ' 187' ' ' ILE . 40.0 mmt180 -86.98 -33.92 19.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.841 0.857 . . . . 0.0 110.661 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.84 18.63 77.65 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.45 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -148.41 150.71 33.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.413 1.085 . . . . 0.0 109.934 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -60.48 117.33 5.14 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.394 0.678 . . . . 0.0 110.303 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 140' ' ' VAL . 13.3 pt -129.68 178.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.828 0.851 . . . . 0.0 108.91 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 133' ' ' LYS . 8.8 mm -70.84 154.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.632 ' HZ2' ' HB3' ' A' ' 189' ' ' LYS . 9.6 mtpm? . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.273 0.559 . . . . 0.0 111.357 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.441 ' HG3' HG12 ' A' ' 153' ' ' VAL . 6.7 mp0 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.26 0.076 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -41.96 82.57 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.196 0.598 . . . . 0.0 111.615 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.434 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.7 t -72.84 -50.93 21.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.512 0.725 . . . . 0.0 110.609 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.8 mt -64.01 -44.37 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.303 0.641 . . . . 0.0 111.196 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.75 -27.73 64.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.119 0.567 . . . . 0.0 111.567 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.51 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 2.6 m-80 -64.58 -41.21 96.41 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.43 -34.69 78.89 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.86 0.864 . . . . 0.0 110.67 177.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 130' ' ' ILE . 92.8 mt -67.44 -37.74 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.279 0.631 . . . . 0.0 109.44 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.5 t -67.15 -36.49 81.95 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.5 mm-40 -74.56 -53.96 8.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.685 0.394 . . . . 0.0 110.737 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.624 ' SG ' ' HE3' ' A' ' 173' ' ' LYS . 72.5 m -71.81 -19.96 61.92 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.066 0.946 . . . . 0.0 112.983 -167.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.1 170.97 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.789 0.804 . . . . 0.0 112.825 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -160.02 156.68 27.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.935 173.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 p -70.95 104.5 2.98 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.405 HG13 ' NE2' ' A' ' 125' ' ' GLN . 45.6 t -77.72 96.98 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 -171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.81 105.41 41.27 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.6 -31.17 86.79 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.967 2.445 . . . . 0.0 113.522 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 -30.29 49.74 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.48 0.488 . . . . 0.0 110.581 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -78.79 -35.03 45.0 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.52 -19.23 53.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.536 0.734 . . . . 0.0 111.691 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 57.23 22.34 7.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.025 0.93 . . . . 0.0 112.621 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -104.94 146.35 32.49 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 123.717 0.807 . . . . 0.0 109.649 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.58 152.66 80.93 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.317 2.011 . . . . 0.0 111.101 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.34 -40.95 68.51 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.887 0.742 . . . . 0.0 111.549 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.64 -41.03 80.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.323 1.049 . . . . 0.0 112.688 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.82 62.91 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.435 0.694 . . . . 0.0 111.434 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 12.0 pt -126.5 33.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.899 0.879 . . . . 0.0 109.506 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 43.4 tt0 -84.47 137.94 33.07 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.829 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.5 t -76.85 113.64 31.92 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.84 0.49 8.2 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.168 2.579 . . . . 0.0 113.107 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.0 mt -85.24 -54.75 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p -86.28 -18.88 30.88 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.189 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 66.45 36.52 5.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.342 1.057 . . . . 0.0 111.445 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.73 151.7 30.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.479 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 25.5 tm0? -69.64 113.2 15.44 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.873 0.869 . . . . 0.0 108.673 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 92.5 Cg_endo -73.59 163.82 36.48 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.57 2.18 . . . . 0.0 113.867 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -17.69 28.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.189 0.996 . . . . 0.0 110.261 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HD3' ' HB3' ' A' ' 146' ' ' ALA . 1.3 pptp? -153.27 140.87 19.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.152 0.981 . . . . 0.0 108.957 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.77 168.49 41.38 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.507 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 98' ' ' ILE . 13.7 pt -121.0 156.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.547 1.539 . . . . 0.0 109.87 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.6 123.42 43.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 169.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 72.9 t -123.83 122.1 63.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.671 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -69.9 116.96 10.88 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.435 0.636 . . . . 0.0 110.164 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.05 85.28 1.81 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 27.9 t -66.19 -39.84 89.97 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.204 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.35 -35.79 82.04 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.978 0.911 . . . . 0.0 111.105 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.51 -63.97 2.89 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -169.8 23.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.415 0.686 . . . . 0.0 110.631 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.9 m-20 59.29 31.33 21.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.425 1.09 . . . . 0.0 111.698 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.2 t -94.08 128.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.186 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 27.7 p -84.39 132.11 34.62 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -124.52 146.61 48.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.402 HD11 ' O ' ' A' ' 130' ' ' ILE . 44.6 tp -90.43 115.33 27.51 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.4 m-85 -111.78 137.92 49.06 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.492 1.117 . . . . 0.0 108.114 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.723 0.692 . . . . 0.0 109.302 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -57.15 -42.83 81.74 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.93 0.769 . . . . 0.0 111.926 -173.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.69 -36.05 60.15 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.84 0.456 . . . . 0.0 111.593 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.78 69.28 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.125 0.57 . . . . 0.0 111.625 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.407 ' O ' HG21 ' A' ' 153' ' ' VAL . 36.6 t80 -71.62 -37.02 70.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.124 0.57 . . . . 0.0 109.881 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -63.03 -36.7 84.44 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.702 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 79.1 ttt180 -60.39 -45.88 91.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.63 -47.05 77.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.137 0.575 . . . . 0.0 111.224 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' A' ' 91' ' ' GLN . 38.7 t -66.04 -46.25 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.227 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.87 -33.07 84.16 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 124.262 0.976 . . . . 0.0 113.312 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 23.9 mm-40 -75.59 -32.22 60.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.08 21.8 10.6 Favored Glycine 0 N--CA 1.468 0.825 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.753 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 50.6 mt -85.18 153.08 59.35 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 0.0 111.146 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.0 174.95 11.9 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.216 2.611 . . . . 0.0 113.081 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -55.14 134.39 68.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.041 1.336 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.98 -26.14 58.83 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.654 2.236 . . . . 0.0 113.876 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.74 -60.7 1.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.6 t -105.34 -4.19 21.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.646 -167.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 60.22 28.19 17.76 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.106 0.963 . . . . 0.0 112.729 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -80.11 159.99 69.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.18 0.992 . . . . 0.0 111.371 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.4 112.72 2.66 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.119 1.879 . . . . 0.0 111.006 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 170' ' ' ILE . 72.9 mt -62.65 131.79 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.635 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 162.67 38.77 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.363 0.665 . . . . 0.0 110.446 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.12 66.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.705 0.802 . . . . 0.0 111.691 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -68.54 -41.0 80.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 111.581 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -84.94 -7.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.4 tt -97.95 132.83 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.015 0.825 . . . . 0.0 109.876 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 188' ' ' ILE . 27.6 m -133.76 178.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.136 1.375 . . . . 0.0 110.029 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.624 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 3.3 mptt -104.26 166.47 10.38 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.481 0.712 . . . . 0.0 109.755 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -70.78 -16.12 62.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.145 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -79.65 -35.29 39.51 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.577 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -83.72 -23.1 31.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.737 0.815 . . . . 0.0 110.602 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 31.7 p -115.78 142.2 47.07 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.867 0.867 . . . . 0.0 108.897 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.4 163.26 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.491 1.116 . . . . 0.0 109.045 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -71.49 136.82 47.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.432 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -119.44 132.88 55.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.87 -51.35 22.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.664 1.186 . . . . 0.0 111.906 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 t -73.15 -23.23 60.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.269 0.228 . . . . 0.0 111.536 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -81.03 -33.98 33.16 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.13 0.572 . . . . 0.0 110.561 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.84 76.11 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.284 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -146.46 146.89 30.73 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.2 1.0 . . . . 0.0 109.446 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.499 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 97.9 m-85 -66.7 116.43 7.61 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 167.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 180' ' ' ASP . 27.9 pt -127.21 178.95 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.075 0.95 . . . . 0.0 109.365 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.671 HD11 ' HB3' ' A' ' 133' ' ' LYS . 21.1 mm -85.82 148.28 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.541 0.736 . . . . 0.0 111.989 177.367 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.449 0.166 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.95 -45.39 67.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.282 1.033 . . . . 0.0 112.106 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 t -66.05 -39.24 89.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.63 0.772 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.2 mt -69.56 -45.51 77.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.938 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -58.92 -45.31 90.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.157 . . . . 0.0 111.219 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -59.77 -40.91 89.83 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -44.86 95.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.144 0.578 . . . . 0.0 110.727 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 150' ' ' SER . 87.7 mt -60.58 -39.19 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.804 0.842 . . . . 0.0 110.206 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.7 t -64.85 -40.12 94.65 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.988 0.915 . . . . 0.0 111.805 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -83.61 -27.33 29.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.284 0.634 . . . . 0.0 112.601 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.1 m -95.69 -12.23 25.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.578 0.751 . . . . 0.0 112.448 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -74.01 165.25 25.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.635 0.731 . . . . 0.0 112.877 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.06 154.59 35.18 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.422 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -75.61 105.06 6.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.2 130.91 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.918 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 39.3 m -122.38 81.56 46.04 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.695 0.798 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.97 -39.15 40.19 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.163 3.242 . . . . 0.0 113.802 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.6 pt-20 -60.95 -45.71 93.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.206 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.497 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 67.4 mtp180 -83.47 -31.59 26.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.088 0.555 . . . . 0.0 111.483 -174.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.33 -18.59 63.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.228 0.611 . . . . 0.0 111.013 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.65 2.67 3.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.301 1.44 . . . . 0.0 112.299 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 62.0 m -92.3 133.13 30.49 Favored Pre-proline 0 C--O 1.247 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 109.17 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.08 158.59 21.08 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.64 2.227 . . . . 0.0 112.164 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -53.47 -43.96 68.57 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.881 0.738 . . . . 0.0 111.488 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.4 -38.45 77.38 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.215 1.006 . . . . 0.0 112.731 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.99 64.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.694 0.798 . . . . 0.0 112.099 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.518 ' HB ' HD21 ' A' ' 143' ' ' LEU . 8.9 pt -127.24 11.59 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.739 0.816 . . . . 0.0 110.57 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 41.8 tt0 -63.98 132.53 50.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.991 0.916 . . . . 0.0 111.097 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 34.6 t -67.58 111.87 8.71 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.85 -3.56 13.97 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.54 2.16 . . . . 0.0 112.647 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.449 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -79.62 -54.0 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.469 1.108 . . . . 0.0 109.431 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p -101.09 -4.23 27.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.255 -169.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.32 33.34 20.86 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.88 0.872 . . . . 0.0 112.258 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.16 153.5 39.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.516 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 21.4 tm0? -70.61 123.85 89.84 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 72.6 Cg_endo -76.24 154.6 36.89 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.367 2.712 . . . . 0.0 114.386 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.495 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.5 pt-20 -83.26 -35.79 25.06 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.479 174.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 48.6 pttt -138.33 138.86 38.75 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.16 157.41 28.26 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.062 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -113.2 156.34 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.474 1.509 . . . . 0.0 109.602 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -98.81 116.88 32.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 65.4 t -116.54 122.36 69.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.3 ptmt -69.55 110.51 4.83 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.515 0.674 . . . . 0.0 109.413 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.07 81.11 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 162.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -69.49 -68.79 0.38 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.292 -167.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.43 -35.0 71.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.934 0.894 . . . . 0.0 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.49 -62.55 4.51 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.42 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 m -150.93 4.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -170.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 62.37 22.55 13.3 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.866 0.841 . . . . 0.0 111.061 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.87 129.99 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.67 0.788 . . . . 0.0 110.897 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 56.5 m -84.16 127.72 34.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.797 0.839 . . . . 0.0 108.838 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.6 m -126.04 146.98 49.68 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' A' ' 117' ' ' ILE . 40.3 tp -88.24 105.28 17.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.091 0.472 . . . . 0.0 109.897 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 85.8 m-85 -98.6 143.28 29.17 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.3 t70 -63.63 136.37 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.38 73.48 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.201 0.938 . . . . 0.0 111.593 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.0 -31.66 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.074 0.55 . . . . 0.0 111.696 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.587 0.755 . . . . 0.0 111.817 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -76.57 -37.77 56.02 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.481 ' HB2' HG23 ' A' ' 98' ' ' ILE . 27.5 t -63.27 -30.21 71.4 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.742 174.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.5 tpm_? -64.36 -52.64 57.31 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.384 172.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.61 -45.77 73.71 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 123.912 0.757 . . . . 0.0 111.392 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.02 -43.37 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.515 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.82 -16.66 74.62 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.027 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -91.12 -23.54 20.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.322 0.649 . . . . 0.0 110.992 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.11 13.4 58.94 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.439 0.462 . . . . 0.0 112.734 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.36 139.63 52.05 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.067 0.947 . . . . 0.0 109.924 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.83 -176.97 2.59 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.765 2.31 . . . . 0.0 113.012 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.401 ' ND1' HG21 ' A' ' 162' ' ' THR . 46.9 t-80 -58.65 126.32 79.46 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.121 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.428 ' HG3' HG12 ' A' ' 121' ' ' ILE . 66.1 Cg_endo -66.51 -15.71 48.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.79 2.327 . . . . 0.0 113.462 -170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.0 mt -97.32 -64.9 1.0 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.757 0.423 . . . . 0.0 111.243 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.401 HG21 ' ND1' ' A' ' 159' ' ' HIS . 9.7 t -94.33 -8.86 37.69 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 122.645 0.378 . . . . 0.0 111.796 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 61.04 21.02 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.904 1.281 . . . . 0.0 112.759 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -87.29 161.07 47.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.311 1.044 . . . . 0.0 110.213 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.21 121.06 8.58 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.018 1.812 . . . . 0.0 111.82 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 170' ' ' ILE . 71.3 mt -65.65 139.47 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.024 0.53 . . . . 0.0 109.584 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.2 t -153.41 165.34 36.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.398 0.436 . . . . 0.0 111.277 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.46 -22.89 66.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.352 1.061 . . . . 0.0 111.941 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -68.11 -43.69 77.87 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.715 0.806 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 166' ' ' ILE . 46.1 pt -85.19 -12.87 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.7 tt -98.61 136.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -137.47 173.57 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.927 1.291 . . . . 0.0 110.45 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -91.14 164.07 14.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -66.11 -25.17 66.88 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.686 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.21 -29.09 21.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.5 1.12 . . . . 0.0 110.639 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.06 -25.68 34.36 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.808 0.843 . . . . 0.0 111.357 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.2 p -104.76 154.97 19.31 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.0 157.12 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 19.2 p90 -71.0 122.19 19.57 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 187' ' ' ILE . 10.9 t70 -106.98 114.49 28.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.71 -21.52 44.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -168.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -83.55 -25.84 30.63 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.599 0.636 . . . . 0.0 110.803 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -79.95 -27.77 39.71 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.46 85.53 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.139 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -148.34 158.11 43.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.869 0.868 . . . . 0.0 109.854 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 64.6 m-85 -64.6 127.33 31.07 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 180' ' ' ASP . 22.0 pt -134.31 178.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.3 1.04 . . . . 0.0 108.8 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.53 HD12 HG11 ' A' ' 172' ' ' VAL . 33.9 mm -79.38 145.62 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 123.278 0.631 . . . . 0.0 112.232 179.245 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 22.3 mp0 . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.01 -50.33 36.5 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.745 0.818 . . . . 0.0 113.028 -164.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 40.4 t -65.57 -43.64 89.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.805 0.442 . . . . 0.0 110.481 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.5 mt -64.8 -46.03 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 153' ' ' VAL . 30.2 mm-40 -57.91 -47.75 81.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.717 1.207 . . . . 0.0 111.699 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -65.29 -35.8 82.13 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.077 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -64.7 -38.19 90.17 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 122.952 0.501 . . . . 0.0 110.634 176.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.479 HG21 ' HB2' ' A' ' 150' ' ' SER . 89.3 mt -65.82 -39.39 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.253 0.621 . . . . 0.0 109.966 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -64.58 -34.89 79.32 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.456 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -87.48 -27.9 22.38 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 75.6 m -93.39 -11.63 31.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -73.94 168.12 20.12 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.653 0.739 . . . . 0.0 111.849 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.88 157.32 34.66 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.449 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 p -68.8 98.6 0.94 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 ' NE2' ' A' ' 125' ' ' GLN . 63.2 t -72.37 99.7 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.7 m -111.2 104.75 56.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.169 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 9.9 Cg_endo -52.91 -26.58 31.9 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 -37.33 61.62 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.059 0.544 . . . . 0.0 110.409 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -83.78 -39.93 19.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 0.0 110.864 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.92 -20.89 62.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.505 0.722 . . . . 0.0 111.206 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HA ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER 53.78 36.16 23.25 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.639 1.176 . . . . 0.0 111.027 -176.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.3 140.57 26.67 Favored Pre-proline 0 C--O 1.248 1.018 0 C-N-CA 124.383 1.073 . . . . 0.0 108.874 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.0 157.22 50.06 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.18 1.92 . . . . 0.0 111.899 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.43 -46.62 66.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.661 0.784 . . . . 0.0 112.054 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 1.6 pm0 -67.68 -30.96 70.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.408 0.683 . . . . 0.0 112.444 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.08 -27.1 67.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.73 0.412 . . . . 0.0 111.43 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.466 ' HB ' HD21 ' A' ' 143' ' ' LEU . 16.8 pt -119.08 17.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.491 0.716 . . . . 0.0 110.604 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 46.5 tt0 -63.5 129.99 42.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.994 0.918 . . . . 0.0 110.542 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.1 t -67.75 109.74 4.31 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.547 ' HB2' HD22 ' A' ' 161' ' ' LEU . 87.7 Cg_endo -78.3 5.88 5.13 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.732 2.288 . . . . 0.0 112.734 -174.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -83.39 -53.95 10.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 124.124 0.969 . . . . 0.0 108.841 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.4 p -96.35 -10.29 28.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.924 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.49 39.06 25.39 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.206 1.002 . . . . 0.0 111.79 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.59 159.84 43.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.425 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.465 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 23.1 tm0? -74.62 121.22 84.76 Favored Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.4 159.16 36.45 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.075 2.517 . . . . 0.0 113.441 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.3 pt-20 -90.15 -26.09 20.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.692 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.2 pttt -147.06 140.39 25.43 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.3 158.67 31.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.824 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 98' ' ' ILE . 12.2 pt -110.84 155.09 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.739 1.216 . . . . 0.0 109.767 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -93.09 129.02 39.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 167.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.5 t -124.85 124.29 67.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 171.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.633 ' HB3' HD13 ' A' ' 188' ' ' ILE . 22.0 ptmt -64.93 105.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.029 0.919 . . . . 0.0 110.373 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.28 78.54 0.73 Allowed 'General case' 0 C--O 1.25 1.084 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.734 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 34.2 t -65.42 -37.57 87.31 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.156 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.51 -36.56 69.33 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.297 1.039 . . . . 0.0 112.251 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.47 -63.41 2.62 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.398 0.436 . . . . 0.0 113.049 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -169.61 30.83 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.269 0.628 . . . . 0.0 110.203 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.734 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 0.4 OUTLIER 65.13 26.12 12.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.022 0.929 . . . . 0.0 111.225 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.6 t -86.09 142.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.89 0.876 . . . . 0.0 110.021 -174.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 188' ' ' ILE . 60.6 m -85.46 122.54 29.74 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.6 m -118.17 137.31 53.07 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.466 HD21 ' HB ' ' A' ' 117' ' ' ILE . 56.7 tp -92.91 114.44 26.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.687 0.395 . . . . 0.0 110.487 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.34 150.77 26.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.632 1.173 . . . . 0.0 108.521 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.28 137.74 54.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.466 0.575 . . . . 0.0 109.548 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.23 86.25 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.022 0.826 . . . . 0.0 111.95 -175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.43 -36.92 66.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 0.0 111.698 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.01 56.64 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.412 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.62 -40.97 84.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.352 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.0 t -62.41 -36.88 83.73 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.748 0.655 . . . . 0.0 110.839 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 58.6 ttt180 -63.43 -48.85 76.05 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.73 -46.75 70.95 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.399 0.679 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.433 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t -62.42 -47.43 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.821 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -64.1 -29.3 74.52 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 124.191 0.932 . . . . 0.0 113.447 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 61.5 mm-40 -72.95 -25.34 60.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.199 0.6 . . . . 0.0 110.317 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 15.76 43.32 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.098 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.67 145.6 54.81 Favored Pre-proline 0 C--O 1.242 0.659 0 C-N-CA 123.866 0.867 . . . . 0.0 110.073 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.34 -179.47 5.1 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.551 2.168 . . . . 0.0 112.017 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -55.02 131.82 67.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.8 -26.31 79.38 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.924 2.416 . . . . 0.0 113.573 -172.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 120' ' ' PRO . 35.5 mt -97.75 -52.59 3.69 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.637 0.375 . . . . 0.0 111.308 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 67.8 p -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.412 0.685 . . . . 0.0 112.195 -168.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 64.04 22.24 12.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.555 1.142 . . . . 0.0 111.352 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.71 149.73 86.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.575 0.75 . . . . 0.0 110.296 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.22 111.19 1.53 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.219 1.946 . . . . 0.0 110.702 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.09 135.39 25.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.053 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.6 t -149.18 163.11 38.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.091 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 171' ' ' ILE . . . -64.75 -23.92 67.4 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.958 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -69.99 -26.16 63.95 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.887 0.875 . . . . 0.0 113.033 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.7 pt -100.7 -11.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.449 HG21 ' HA ' ' A' ' 168' ' ' ALA . 7.7 tt -94.39 134.04 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.606 HG11 HD12 ' A' ' 188' ' ' ILE . 26.9 m -133.81 172.11 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.528 1.131 . . . . 0.0 110.795 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 7.1 mtpm? -103.82 166.83 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.026 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -71.2 -18.11 62.49 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.12 -22.1 23.04 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.3 0.64 . . . . 0.0 110.544 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -75.88 -38.51 57.77 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.742 0.817 . . . . 0.0 109.546 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.38 140.95 29.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.616 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 152.91 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -66.15 128.8 37.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.53 ' HB2' HG12 ' A' ' 187' ' ' ILE . 14.0 t70 -108.03 135.3 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.29 -49.47 16.9 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.055 0.847 . . . . 0.0 111.655 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.7 t -73.76 -23.44 59.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.122 0.169 . . . . 0.0 111.412 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 3.4 mmp_? -83.65 -33.0 25.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.185 0.594 . . . . 0.0 110.549 171.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.68 26.32 59.04 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.918 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -171.37 162.93 6.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.186 0.595 . . . . 0.0 109.851 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -60.2 121.16 11.26 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.1 0.96 . . . . 0.0 111.13 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 180' ' ' ASP . 23.3 pt -126.73 174.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.196 171.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 133' ' ' LYS . 27.1 mm -70.74 151.05 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.349 0.659 . . . . 0.0 109.746 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.224 0.535 . . . . 0.0 111.393 172.752 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -35.66 81.0 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.352 0.408 . . . . 0.0 111.588 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 32.7 t -68.37 -43.51 77.2 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.44 0.696 . . . . 0.0 109.449 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 98' ' ' ILE . 64.6 mt -66.35 -46.61 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.579 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -58.53 -43.47 89.22 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.326 1.45 . . . . 0.0 111.346 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -41.78 96.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.268 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -69.23 -32.34 71.52 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 123.262 0.625 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 94' ' ' ILE . 83.5 mt -66.02 -40.86 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.2 m -63.05 -40.71 98.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 111.583 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -83.0 -22.68 33.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.514 0.726 . . . . 0.0 112.701 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 80.4 m -95.35 -22.89 17.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.999 0.52 . . . . 0.0 112.293 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -70.3 168.21 16.39 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.722 0.772 . . . . 0.0 112.508 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -156.12 157.7 36.44 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.599 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.0 p -72.22 99.65 2.41 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.463 HG11 HD21 ' A' ' 143' ' ' LEU . 21.9 t -71.56 109.25 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.249 -171.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.95 104.43 55.53 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.72 0.808 . . . . 0.0 109.458 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HB3' HD13 ' A' ' 117' ' ' ILE . 15.5 Cg_endo -59.92 -27.63 85.34 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.982 2.455 . . . . 0.0 112.647 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.72 -31.37 69.33 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.254 0.622 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -90.59 -30.61 17.1 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.656 0.782 . . . . 0.0 110.868 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.3 -23.04 57.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.846 0.458 . . . . 0.0 111.216 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 52.74 33.1 13.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.028 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -114.62 140.69 25.62 Favored Pre-proline 0 C--O 1.245 0.844 0 C-N-CA 124.424 1.09 . . . . 0.0 108.859 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.92 158.67 45.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.462 2.108 . . . . 0.0 111.785 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.32 -45.68 72.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.806 . . . . 0.0 111.8 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.68 -38.97 72.97 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.316 1.046 . . . . 0.0 113.062 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.04 65.42 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.161 0.585 . . . . 0.0 111.734 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 107' ' ' PRO . 19.5 pt -127.97 31.39 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.681 1.192 . . . . 0.0 109.535 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.66 125.02 27.79 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.379 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 10.4 t -68.47 109.93 4.94 Favored Pre-proline 0 C--N 1.349 0.557 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.91 -3.35 13.63 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.782 2.321 . . . . 0.0 112.852 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.2 -52.3 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.4 p -90.98 -10.64 41.61 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.96 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.29 36.26 23.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.851 1.261 . . . . 0.0 111.889 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.87 152.65 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.352 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.476 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 24.1 tm0? -68.21 121.38 80.03 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.523 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.52 164.2 28.73 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.116 2.544 . . . . 0.0 114.602 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 12.9 pt-20 -86.43 -29.82 22.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.463 173.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 52.0 pttt -141.62 135.07 29.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.7 1.6 . . . . 0.0 106.904 176.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -161.74 154.9 26.0 Favored Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.503 -175.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -110.19 159.38 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 125.251 1.42 . . . . 0.0 109.555 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 37.3 m-85 -103.34 118.15 36.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 169.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.7 t -115.16 121.49 67.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.9 ptmt -72.2 108.48 5.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.864 0.84 . . . . 0.0 110.627 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -66.55 83.36 0.1 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.42 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 46.4 t -64.21 -41.64 96.96 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.212 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.14 -32.27 73.88 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.006 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.29 -66.36 2.11 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.27 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.2 m -168.44 26.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.317 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 9.5 m-20 58.34 26.1 13.61 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.635 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.411 ' HA ' HG23 ' A' ' 187' ' ' ILE . 6.3 m -80.52 123.72 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.384 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 40.5 m -82.7 122.98 28.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.493 HG21 HD12 ' A' ' 161' ' ' LEU . 25.9 m -119.41 145.03 46.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD21 HG11 ' A' ' 105' ' ' VAL . 34.2 tp -86.65 114.13 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.35 0.407 . . . . 0.0 110.286 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -113.35 135.49 53.8 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.595 1.158 . . . . 0.0 108.466 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.26 137.62 57.91 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.674 0.39 . . . . 0.0 110.046 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.13 90.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.553 0.741 . . . . 0.0 111.672 -174.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.12 44.85 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.319 0.648 . . . . 0.0 112.124 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.42 -39.21 54.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.177 0.591 . . . . 0.0 111.673 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.0 t80 -72.15 -38.3 69.2 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -56.67 -38.73 72.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.069 0.948 . . . . 0.0 111.452 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -57.65 -52.16 66.55 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.817 0.698 . . . . 0.0 109.953 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.77 -46.52 81.42 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.149 0.906 . . . . 0.0 111.089 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.563 HG21 HG23 ' A' ' 166' ' ' ILE . 94.8 t -62.38 -47.07 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.744 . . . . 0.0 110.852 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.45 -34.37 88.1 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.715 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.493 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 16.4 mm-40 -75.27 -31.53 60.78 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.413 0.685 . . . . 0.0 111.218 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 25.68 20.07 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 86.7 mt -80.6 151.6 71.69 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.93 -179.43 5.11 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.469 2.112 . . . . 0.0 112.64 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.3 t-80 -59.26 127.85 84.72 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.333 1.053 . . . . 0.0 109.917 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.67 -2.99 12.99 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.305 2.003 . . . . 0.0 113.973 -170.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.493 HD12 HG21 ' A' ' 142' ' ' THR . 63.5 mt -104.26 -57.27 2.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.552 0.341 . . . . 0.0 111.018 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.436 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -105.0 -11.81 16.46 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 66.08 22.24 11.15 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.781 1.232 . . . . 0.0 113.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -76.84 152.26 82.65 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.345 0.658 . . . . 0.0 110.591 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.21 121.08 8.94 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.558 2.172 . . . . 0.0 111.837 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.563 HG23 HG21 ' A' ' 153' ' ' VAL . 71.5 mt -65.73 130.95 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -150.34 164.95 34.5 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.819 0.848 . . . . 0.0 110.609 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.04 67.64 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.373 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.0 m -66.3 -33.2 75.19 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.836 0.855 . . . . 0.0 112.841 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 166' ' ' ILE . 44.2 pt -99.39 -3.16 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.46 HG12 ' SG ' ' A' ' 101' ' ' CYS . 11.6 tt -102.16 134.2 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.4 167.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.529 1.132 . . . . 0.0 110.133 -173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 28.0 mtpp -85.97 161.43 19.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -65.69 -24.69 67.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.301 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.6 -22.24 28.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.052 0.541 . . . . 0.0 110.982 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -82.51 -24.11 34.29 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.396 0.678 . . . . 0.0 110.768 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.3 p -113.38 155.59 24.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.18 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.14 157.12 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.606 1.163 . . . . 0.0 108.424 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 7.1 p90 -70.59 129.92 40.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.77 126.74 55.55 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.28 -39.41 71.56 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.484 1.115 . . . . 0.0 112.486 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.6 t -84.03 -15.8 46.25 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.866 0.303 . . . . 0.0 111.747 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -83.22 -32.03 26.73 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 163.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.23 7.51 84.75 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.316 -170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -137.76 157.0 47.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.698 1.199 . . . . 0.0 108.836 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 80.8 m-85 -68.26 129.71 40.72 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -138.08 175.59 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.756 1.222 . . . . 0.0 109.778 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.13 148.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.492 0.717 . . . . 0.0 110.205 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 123.318 0.647 . . . . 0.0 111.248 176.081 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.49 ' HA ' HD12 ' A' ' 94' ' ' ILE . 12.4 mp0 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.02 -50.1 59.2 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.416 1.087 . . . . 0.0 112.154 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -63.73 -36.16 82.95 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.121 0.968 . . . . 0.0 111.1 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 91' ' ' GLN . 35.6 mt -71.31 -48.53 53.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.737 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -55.96 -46.07 78.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.563 1.145 . . . . 0.0 111.371 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.05 -45.12 93.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -32.89 74.57 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.93 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' A' ' 150' ' ' SER . 96.4 mt -65.2 -41.59 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 118.728 0.694 . . . . 0.0 109.903 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.8 t -64.91 -36.0 82.96 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.842 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -81.43 -30.47 33.48 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.847 0.859 . . . . 0.0 112.945 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 99.1 m -91.46 -19.5 22.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.868 0.867 . . . . 0.0 111.604 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -72.83 165.46 24.84 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.566 0.698 . . . . 0.0 111.938 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.91 159.43 34.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.943 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -69.91 97.02 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.7 t -66.36 113.43 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.374 0.669 . . . . 0.0 110.531 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.6 m -114.49 90.77 22.26 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.415 1.086 . . . . 0.0 109.093 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -58.44 -39.14 86.33 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.081 2.521 . . . . 0.0 113.293 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -38.01 65.67 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.05 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -74.83 -41.21 60.35 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.48 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 97.7 mt -68.44 -15.61 63.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 111.57 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 61.47 16.75 7.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 -172.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 61.6 m -93.11 124.62 57.54 Favored Pre-proline 0 C--O 1.243 0.755 0 C-N-CA 123.36 0.664 . . . . 0.0 109.5 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.46 150.99 78.12 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.557 2.171 . . . . 0.0 111.7 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.01 -47.92 67.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.903 0.881 . . . . 0.0 112.264 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.28 -35.16 78.15 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.383 0.673 . . . . 0.0 112.354 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.06 62.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.36 0.664 . . . . 0.0 111.792 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' ' 112' ' ' CYS . 24.5 pt -127.61 29.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.662 0.785 . . . . 0.0 110.221 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -79.04 132.48 36.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.789 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.17 111.34 7.59 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.34 -2.46 12.59 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.841 2.361 . . . . 0.0 112.172 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.5 mt -82.16 -55.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.6 p -95.23 -7.87 37.77 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.16 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.85 48.24 20.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.15 0.98 . . . . 0.0 111.257 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.81 149.98 20.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.757 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.66 116.42 51.51 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.4 161.2 37.93 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.78 2.32 . . . . 0.0 113.434 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.45 -19.03 20.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.712 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 147' ' ' ALA . 2.2 pptp? -144.87 128.8 17.44 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.71 167.3 37.78 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.859 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 98' ' ' ILE . 11.5 pt -122.03 151.81 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 109.348 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.53 115.61 28.96 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.411 HG23 HG13 ' A' ' 130' ' ' ILE . 64.2 t -117.69 122.39 69.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -69.71 122.39 19.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.432 0.634 . . . . 0.0 110.928 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -72.83 80.86 1.15 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 161.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 25.1 t -70.09 -44.86 68.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.781 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.28 -34.76 79.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.059 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.09 -64.86 2.22 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.835 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.9 m -157.44 18.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.318 0.559 . . . . 0.0 112.475 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.7 m-20 59.63 20.62 9.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.98 0.912 . . . . 0.0 112.283 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.7 124.08 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 28.0 p -85.5 133.12 34.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 m -121.81 145.56 47.94 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 117' ' ' ILE . 49.5 tp -91.19 108.81 20.13 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.53 136.42 42.39 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.42 132.31 52.72 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.629 0.65 . . . . 0.0 109.359 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.74 70.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.043 0.839 . . . . 0.0 111.892 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.442 ' HB3' ' HE2' ' A' ' 128' ' ' LYS . . . -75.29 -40.23 58.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.986 0.514 . . . . 0.0 111.599 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.37 89.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.064 0.545 . . . . 0.0 111.807 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 130' ' ' ILE . 33.5 t80 -76.97 -38.35 53.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.966 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 98' ' ' ILE . 28.8 t -64.08 -28.94 70.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.434 0.459 . . . . 0.0 110.819 175.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 13.0 tpt180 -64.39 -55.69 19.33 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.541 -0.754 . . . . 0.0 108.973 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.7 -45.6 70.47 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.088 0.867 . . . . 0.0 111.818 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.418 HG13 ' HB ' ' A' ' 94' ' ' ILE . 86.3 t -65.93 -47.56 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.298 0.639 . . . . 0.0 110.378 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.27 -17.88 68.73 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.274 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 63.7 mm-40 -87.15 -23.97 24.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.619 0.768 . . . . 0.0 110.857 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.03 36.79 12.35 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.54 149.12 36.12 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.57 1.148 . . . . 0.0 109.527 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -69.89 177.26 5.85 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.353 2.702 . . . . 0.0 113.531 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.445 ' ND1' HG21 ' A' ' 162' ' ' THR . 60.1 t-80 -59.81 124.66 77.52 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.58 -12.46 35.19 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.675 2.25 . . . . 0.0 114.202 -168.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.81 -66.97 0.87 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.643 0.377 . . . . 0.0 110.819 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.445 HG21 ' ND1' ' A' ' 159' ' ' HIS . 10.5 t -90.36 -8.66 50.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.57 0.348 . . . . 0.0 111.605 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 59.88 24.46 13.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.841 1.256 . . . . 0.0 112.961 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -88.75 155.77 50.28 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.93 0.892 . . . . 0.0 110.05 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -64.2 112.16 1.81 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.461 2.107 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.485 ' HA ' HD13 ' A' ' 170' ' ' ILE . 59.8 mt -56.64 140.05 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.788 0.835 . . . . 0.0 110.076 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 160.55 43.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.851 0.861 . . . . 0.0 109.849 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.22 -23.93 67.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.508 0.723 . . . . 0.0 111.903 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -67.49 -46.21 73.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 111.954 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 166' ' ' ILE . 49.7 pt -79.06 -10.43 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.43 HG12 ' SG ' ' A' ' 101' ' ' CYS . 10.5 tt -99.33 132.35 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.477 0.58 . . . . 0.0 109.614 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.67 174.02 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.461 1.104 . . . . 0.0 109.762 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 29.3 mtpp -91.1 166.18 13.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.664 0.386 . . . . 0.0 110.137 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -62.89 -34.97 78.53 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.552 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.2 -9.76 59.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.183 0.593 . . . . 0.0 111.351 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -93.88 -2.95 52.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.814 0.846 . . . . 0.0 110.551 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 29.8 p -134.9 144.26 47.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.161 0.984 . . . . 0.0 109.379 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.475 HG21 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -123.21 155.62 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.595 -0.691 . . . . 0.0 109.279 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -67.95 110.84 4.06 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 159.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.45 125.13 39.85 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -79.3 -36.17 40.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.552 0.741 . . . . 0.0 111.829 -169.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -74.84 -27.3 60.22 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.405 0.548 . . . . 0.0 110.402 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.448 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.6 mmt180 -77.5 -32.74 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.84 81.26 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.794 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -145.92 157.67 43.89 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.29 1.036 . . . . 0.0 109.42 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.34 118.57 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.179 0.591 . . . . 0.0 109.569 173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.448 HD13 ' HG3' ' A' ' 183' ' ' ARG . 27.2 pt -128.32 177.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 133' ' ' LYS . 39.6 mm -80.2 145.11 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HG2' HG21 ' A' ' 178' ' ' ILE . 48.6 mtpt . . . . . 0 N--CA 1.471 0.615 0 O-C-N 124.066 0.854 . . . . 0.0 111.654 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG3' HG11 ' A' ' 153' ' ' VAL . 24.9 mp0 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -47.59 30.1 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.357 1.063 . . . . 0.0 113.47 -170.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.423 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 18.8 m -65.07 -46.08 82.61 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.273 1.029 . . . . 0.0 111.227 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.504 HD12 HG21 ' A' ' 166' ' ' ILE . 62.1 mt -70.66 -46.24 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.159 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -55.18 -44.67 75.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.742 1.217 . . . . 0.0 110.616 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 93.9 m-20 -59.67 -46.26 89.59 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.319 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -61.2 -39.59 90.79 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.533 0.52 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 94' ' ' ILE . 87.1 mt -62.75 -37.48 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.364 0.665 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 t -65.51 -36.87 85.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.992 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 26.6 mt-30 -85.63 -31.16 22.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.113 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.5 m -87.83 -17.11 32.24 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.235 0.614 . . . . 0.0 111.766 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.19 169.26 17.42 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-O 121.21 0.529 . . . . 0.0 111.577 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.89 160.8 41.44 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.607 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 99.21 1.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.75 98.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.3 m -112.28 99.52 46.83 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.929 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.15 -31.65 46.33 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.875 3.05 . . . . 0.0 114.547 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.48 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 11.1 pt-20 -70.04 -43.56 71.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.747 0.819 . . . . 0.0 110.68 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 76.4 mtp180 -81.34 -26.69 35.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.086 0.554 . . . . 0.0 110.565 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.0 mt -77.81 -20.69 52.79 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.088 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 58.44 27.75 15.92 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.749 0.819 . . . . 0.0 111.331 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.4 m -116.52 144.72 33.72 Favored Pre-proline 0 C--O 1.245 0.834 0 C-N-CA 124.024 0.93 . . . . 0.0 109.995 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.92 160.98 44.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.43 2.087 . . . . 0.0 111.66 172.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -43.13 78.59 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.922 0.764 . . . . 0.0 112.014 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.1 -37.06 83.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.049 0.94 . . . . 0.0 112.606 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.62 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.069 0.548 . . . . 0.0 111.154 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.14 31.28 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.899 0.88 . . . . 0.0 110.007 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -85.23 131.54 34.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.697 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.423 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.8 t -67.75 114.22 18.79 Favored Pre-proline 0 C--N 1.346 0.434 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.62 -11.23 30.56 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.427 2.085 . . . . 0.0 112.862 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.423 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 36.1 mt -78.08 -56.23 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.851 0.86 . . . . 0.0 109.558 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p -99.33 -11.87 20.83 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.207 1.003 . . . . 0.0 111.932 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.24 27.7 17.38 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.362 1.065 . . . . 0.0 112.305 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -104.67 164.1 12.01 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.34 99.72 8.95 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 165.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 163.87 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.714 2.276 . . . . 0.0 113.759 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -94.93 -16.66 22.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.117 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -142.86 135.1 27.37 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.839 1.256 . . . . 0.0 108.184 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.47 29.95 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.879 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.93 158.96 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.532 1.133 . . . . 0.0 110.262 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -102.3 122.09 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.53 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.421 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 78.6 t -119.61 124.69 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.7 ptmt -69.02 117.1 10.25 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 123.823 0.702 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -74.93 80.65 2.16 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 166.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 t -58.83 -33.14 70.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.619 1.168 . . . . 0.0 110.748 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.94 -42.09 94.96 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.648 0.593 . . . . 0.0 111.581 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.51 -65.33 3.22 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.621 0.576 . . . . 0.0 111.817 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 t 176.65 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.603 1.161 . . . . 0.0 108.405 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.69 23.95 13.7 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.523 1.129 . . . . 0.0 110.413 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.11 109.96 10.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 60.8 m -83.64 131.89 34.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.819 0.448 . . . . 0.0 110.046 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.4 m -121.23 149.17 43.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 48.2 tp -88.71 104.48 16.92 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.324 0.583 . . . . 0.0 109.551 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.421 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 93.9 m-85 -97.61 136.73 37.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.47 134.71 56.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.7 -41.67 82.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.135 0.897 . . . . 0.0 111.638 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.95 -32.32 45.42 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.458 0.474 . . . . 0.0 111.799 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.68 62.83 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.518 0.727 . . . . 0.0 111.393 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.422 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.3 t80 -71.76 -39.29 70.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.8 t -61.91 -31.43 71.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 111.44 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.4 tpt180 -64.31 -52.87 56.34 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 123.564 0.54 . . . . 0.0 109.594 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.87 -42.74 76.36 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.859 0.724 . . . . 0.0 111.574 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 166' ' ' ILE . 94.4 t -63.15 -49.34 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.817 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.26 -16.12 68.65 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 124.134 0.896 . . . . 0.0 113.673 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.1 mm-40 -93.38 -11.94 31.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 111.107 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.67 30.24 56.53 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.35 0.407 . . . . 0.0 112.501 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -92.8 148.13 35.39 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.614 1.165 . . . . 0.0 109.787 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.16 -176.12 2.89 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.794 2.329 . . . . 0.0 112.584 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -55.64 132.13 71.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.261 1.025 . . . . 0.0 110.382 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.412 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 73.2 Cg_endo -68.91 -28.62 29.28 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.907 1.738 . . . . 0.0 113.303 -170.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.33 -56.49 3.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.557 0.343 . . . . 0.0 111.31 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 t -108.78 -8.79 15.29 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -169.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.412 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 32.9 mmt180 66.7 21.42 10.59 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.391 1.077 . . . . 0.0 112.634 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -72.27 141.08 83.04 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.143 0.577 . . . . 0.0 109.646 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.81 115.22 2.79 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.388 2.059 . . . . 0.0 111.677 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 153' ' ' VAL . 71.4 mt -60.95 127.97 21.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 CA-C-O 120.934 0.397 . . . . 0.0 110.491 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -148.17 165.23 31.51 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.142 0.977 . . . . 0.0 109.402 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.12 -20.18 66.07 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.655 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m -65.37 -44.27 88.13 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.307 0.643 . . . . 0.0 112.452 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 166' ' ' ILE . 46.7 pt -86.89 -7.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.24 129.96 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.02 178.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.065 0.946 . . . . 0.0 110.847 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.9 161.68 13.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.465 0.706 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -67.76 -22.76 65.19 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.7 0.8 . . . . 0.0 112.467 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.73 -22.71 23.21 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.947 0.499 . . . . 0.0 111.083 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.13 -26.88 28.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.034 0.934 . . . . 0.0 110.955 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 27.0 p -115.86 150.6 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.511 HD13 ' HG2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -133.71 160.7 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.051 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 32.3 p90 -69.12 115.0 7.9 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 165.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.542 ' HB2' HG12 ' A' ' 187' ' ' ILE . 11.3 t70 -91.79 129.95 37.66 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.44 -47.89 45.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.06 0.85 . . . . 0.0 110.731 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.2 t -78.28 -25.17 46.6 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.546 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.1 mmp_? -77.05 -30.86 55.81 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.231 169.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.83 14.34 59.62 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.685 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -171.75 168.67 6.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.522 0.661 . . . . 0.0 110.459 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 93.9 m-85 -60.13 121.52 12.11 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.077 0.951 . . . . 0.0 111.529 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.546 HD13 ' HG3' ' A' ' 183' ' ' ARG . 24.1 pt -131.73 178.16 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.327 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.418 HD13 ' HB3' ' A' ' 133' ' ' LYS . 47.2 mm -71.58 140.22 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.598 0.561 . . . . 0.0 109.586 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.511 ' HG2' HD13 ' A' ' 178' ' ' ILE . 54.2 mtpt . . . . . 0 N--CA 1.478 0.927 0 O-C-N 123.706 0.629 . . . . 0.0 110.906 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -47.61 71.9 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.869 0.731 . . . . 0.0 111.812 -170.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.446 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 37.1 t -66.85 -38.81 87.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.4 0.68 . . . . 0.0 111.192 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.8 mt -66.31 -43.78 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.718 0.636 . . . . 0.0 109.475 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -57.45 -44.58 84.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.022 . . . . 0.0 110.803 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -59.62 -43.44 93.79 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.425 0.453 . . . . 0.0 111.064 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.1 mpmm? -63.26 -35.34 80.02 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 111.298 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 94' ' ' ILE . 89.1 mt -67.57 -37.48 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 122.762 0.425 . . . . 0.0 110.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.6 t -63.45 -40.04 96.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.57 0.748 . . . . 0.0 111.33 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.02 -45.17 18.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.264 0.626 . . . . 0.0 112.146 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 73.3 m -82.3 -10.05 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.905 0.882 . . . . 0.0 112.741 -169.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.69 169.29 18.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.402 0.62 . . . . 0.0 112.473 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -158.03 160.36 37.36 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.963 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 m -70.04 99.81 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 114.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.173 0.589 . . . . 0.0 110.874 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.1 m -118.49 100.42 51.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.034 0.934 . . . . 0.0 109.229 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.57 -37.53 57.69 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.338 2.692 . . . . 0.0 113.293 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -15.26 56.98 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.875 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -88.94 -43.38 11.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 0.0 110.016 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.9 mt -72.57 -12.12 60.93 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 65.33 17.75 11.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.872 1.269 . . . . 0.0 111.538 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 71.8 m -104.61 136.0 19.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.741 0.816 . . . . 0.0 110.136 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.28 164.15 29.24 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.692 2.261 . . . . 0.0 111.125 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.8 mt -53.59 -47.43 70.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.42 0.688 . . . . 0.0 111.49 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.58 -41.83 70.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.857 1.263 . . . . 0.0 113.134 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.44 67.27 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.929 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.497 ' HB ' HD21 ' A' ' 143' ' ' LEU . 20.8 pt -126.51 23.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.244 1.018 . . . . 0.0 110.409 -177.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -69.86 128.32 35.98 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.435 0.694 . . . . 0.0 110.242 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 39.2 t -70.04 110.86 7.48 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.72 -3.06 13.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.882 2.388 . . . . 0.0 112.714 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.9 mt -76.27 -51.51 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.184 0.993 . . . . 0.0 109.236 176.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p -99.68 -15.39 18.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.978 -173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.39 47.9 15.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.516 1.126 . . . . 0.0 111.793 -172.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 163.44 37.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.573 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -78.12 116.63 60.38 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 60.0 Cg_endo -71.18 161.17 46.77 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.024 2.483 . . . . 0.0 113.819 -173.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -87.19 -37.86 16.92 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.37 175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -140.68 140.09 34.89 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.85 156.87 28.3 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.218 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -109.31 158.19 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 109.058 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -99.41 128.16 45.5 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 90.1 t -119.54 121.86 67.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.63 113.22 10.51 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.84 80.43 1.62 Allowed 'General case' 0 C--O 1.248 1.005 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -68.3 -30.39 69.38 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.223 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.86 -38.86 89.83 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.271 174.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.33 -67.46 1.83 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.103 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t 178.79 44.33 0.0 OUTLIER 'General case' 0 C--O 1.251 1.144 0 C-N-CA 123.864 0.865 . . . . 0.0 109.905 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 t70 70.31 8.33 6.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 123.951 0.901 . . . . 0.0 111.432 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.574 ' HA ' HG22 ' A' ' 187' ' ' ILE . 61.3 t -77.14 113.59 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.51 138.63 33.34 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 109.473 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.8 m -129.25 154.0 47.24 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 117' ' ' ILE . 37.5 tp -90.17 121.39 32.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.489 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.0 m-85 -117.34 133.7 55.68 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 124.991 1.317 . . . . 0.0 107.824 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.6 t70 -59.78 135.55 57.72 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 118.846 0.748 . . . . 0.0 109.656 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.4 71.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.898 0.879 . . . . 0.0 111.575 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.37 -34.72 65.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -71.56 -37.67 71.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 111.771 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -76.92 -36.65 56.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.384 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.9 t -62.59 -30.24 71.19 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 124.01 0.819 . . . . 0.0 110.831 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.5 ttm-85 -64.87 -53.5 45.72 Favored 'General case' 0 C--O 1.218 -0.564 0 O-C-N 124.02 0.825 . . . . 0.0 109.981 170.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 73.2 mt -52.94 -47.84 67.75 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.949 0.5 . . . . 0.0 111.475 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.61 -51.36 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.659 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.51 73.5 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.269 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 29.6 mm-40 -87.48 -23.86 24.3 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 117.36 0.58 . . . . 0.0 110.185 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.86 53.59 Favored Glycine 0 N--CA 1.47 0.945 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.62 140.31 59.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.084 0.954 . . . . 0.0 109.63 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.56 -168.08 0.53 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.748 2.298 . . . . 0.0 112.608 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -60.66 131.41 91.0 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.353 1.061 . . . . 0.0 110.043 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.415 ' HG3' HG12 ' A' ' 121' ' ' ILE . 70.2 Cg_endo -68.79 -24.42 34.46 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.37 2.047 . . . . 0.0 113.444 -172.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.74 -65.15 1.04 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.9 t -102.71 -9.4 20.07 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.299 -167.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 62.22 24.04 14.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.782 1.233 . . . . 0.0 112.063 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -79.16 148.35 71.09 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.334 0.654 . . . . 0.0 110.062 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.93 123.09 12.24 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.702 2.268 . . . . 0.0 111.854 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.94 134.3 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.292 0.637 . . . . 0.0 110.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.1 t -141.14 160.61 39.73 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.917 0.887 . . . . 0.0 109.559 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.04 -23.97 67.69 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.913 0.885 . . . . 0.0 111.545 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.7 t -67.56 -41.27 84.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.783 0.833 . . . . 0.0 112.267 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -85.0 -8.67 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.8 tt -98.0 133.57 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.82 0.736 . . . . 0.0 109.151 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 101' ' ' CYS . 27.1 m -138.04 174.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.725 1.21 . . . . 0.0 110.378 -172.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.528 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 40.8 mtpt -102.62 164.5 11.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.145 0.578 . . . . 0.0 110.843 -175.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -73.68 -17.59 61.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.918 0.487 . . . . 0.0 111.595 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.49 -32.77 28.63 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.11 -29.89 49.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.331 0.652 . . . . 0.0 110.721 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 31.6 p -113.55 155.51 25.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.599 0.759 . . . . 0.0 109.643 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -135.39 164.23 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.312 1.045 . . . . 0.0 108.839 179.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.27 127.51 33.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 162.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.435 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -107.52 139.18 42.43 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.883 -0.511 . . . . 0.0 110.027 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.17 -50.86 13.43 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.248 0.968 . . . . 0.0 111.757 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 15.0 t -71.06 -33.53 70.36 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.19 0.45 . . . . 0.0 111.18 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.514 ' HG3' HD11 ' A' ' 187' ' ' ILE . 26.8 mmt180 -76.3 -27.95 56.78 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.917 0.487 . . . . 0.0 110.088 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.83 24.31 72.47 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.194 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -170.11 163.68 9.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.831 0.853 . . . . 0.0 108.824 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 89.0 m-85 -59.82 127.68 33.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.975 0.91 . . . . 0.0 111.182 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' A' ' 140' ' ' VAL . 19.1 pt -138.71 -179.85 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.645 1.178 . . . . 0.0 108.989 170.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.8 152.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 122.995 0.518 . . . . 0.0 109.889 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.966 174.218 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -30.7 70.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 0.0 112.155 -174.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -68.29 -46.97 68.9 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.099 0.96 . . . . 0.0 109.788 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 98' ' ' ILE . 79.6 mt -64.48 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.683 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -61.11 -38.38 86.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.717 1.207 . . . . 0.0 112.537 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.9 -41.23 95.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.456 0.473 . . . . 0.0 110.238 173.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -39.23 89.31 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 123.369 0.418 . . . . 0.0 110.614 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 94' ' ' ILE . 74.9 mt -65.25 -46.08 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.79 0.436 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -65.4 -36.02 82.7 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.879 0.872 . . . . 0.0 112.25 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -82.4 -42.55 18.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.988 0.515 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.85 -6.97 59.54 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.83 0.852 . . . . 0.0 112.386 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -75.26 163.62 27.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.186 0.517 . . . . 0.0 111.56 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -157.2 159.58 37.85 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.988 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.4 p -73.35 100.75 3.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.933 0.77 . . . . 0.0 109.409 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.87 120.88 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.865 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.98 96.1 32.65 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 0.0 109.149 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.44 -34.45 33.06 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.493 3.462 . . . . 0.0 115.625 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.29 -34.88 65.99 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.892 0.477 . . . . 0.0 110.74 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -82.12 -36.47 27.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.763 0.825 . . . . 0.0 110.057 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.54 -17.52 62.31 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.055 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.88 34.62 23.9 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.697 1.199 . . . . 0.0 110.893 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 69.6 m -115.08 135.77 22.54 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.199 0.999 . . . . 0.0 109.171 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 17.9 Cg_endo -60.54 153.07 63.75 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.455 2.104 . . . . 0.0 111.708 169.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 59.4 mt -52.57 -48.07 66.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.354 1.061 . . . . 0.0 111.766 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.26 -35.98 78.76 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.336 1.055 . . . . 0.0 112.571 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -66.82 -25.39 66.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.67 . . . . 0.0 111.658 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 143' ' ' LEU . 25.3 pt -124.06 24.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.645 0.778 . . . . 0.0 110.46 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 42.0 tt0 -68.85 135.66 51.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.853 174.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.5 112.08 10.87 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.12 -6.7 19.78 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.861 2.374 . . . . 0.0 112.791 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.52 -53.21 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.788 0.835 . . . . 0.0 109.466 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -91.94 -11.1 37.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.65 0.78 . . . . 0.0 112.596 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.91 36.65 12.62 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.015 0.926 . . . . 0.0 111.431 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -151.64 149.1 28.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.482 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.1 tm0? -67.14 121.6 79.06 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 123.49 0.716 . . . . 0.0 109.371 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 153.21 41.19 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.535 2.157 . . . . 0.0 113.747 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.36 -17.18 32.98 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.46 170.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -150.72 130.69 13.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.594 1.157 . . . . 0.0 108.368 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.46 169.2 39.81 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.667 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -118.61 154.47 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.201 1.401 . . . . 0.0 110.058 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.36 121.26 37.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 95.2 t -120.11 122.52 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.675 ' HB3' HD13 ' A' ' 188' ' ' ILE . 20.5 ptmt -68.52 120.16 14.13 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.359 0.599 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -74.78 79.53 2.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 165.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.492 ' HB2' ' HE2' ' A' ' 133' ' ' LYS . 12.5 t -68.72 -36.86 78.96 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.244 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.3 -35.03 76.21 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.476 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.79 -64.1 2.0 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.307 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -171.55 27.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.906 0.482 . . . . 0.0 111.105 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.6 m-20 62.79 25.07 14.9 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.359 1.063 . . . . 0.0 111.78 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.6 t -85.92 124.52 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 0.0 109.225 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 28.6 p -83.27 130.13 35.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -174.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.2 m -120.34 140.08 51.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.097 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 117' ' ' ILE . 36.8 tp -89.54 107.49 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.356 0.598 . . . . 0.0 110.105 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.499 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 88.8 m-85 -99.99 145.95 27.28 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.24 134.66 54.12 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.51 78.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.757 0.66 . . . . 0.0 111.879 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -31.39 64.75 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.653 0.595 . . . . 0.0 111.678 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -73.3 -39.77 65.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.059 0.543 . . . . 0.0 111.739 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -75.97 -35.24 59.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.4 t -59.6 -38.75 82.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.061 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 15.6 tpt180 -57.77 -49.63 75.94 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 124.275 0.984 . . . . 0.0 110.101 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.84 -46.32 81.8 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.693 0.621 . . . . 0.0 111.658 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.436 HG21 HG21 ' A' ' 166' ' ' ILE . 70.5 t -65.4 -42.41 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.58 63.99 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.501 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.8 -12.51 55.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.277 0.631 . . . . 0.0 111.201 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.21 74.28 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.733 -0.212 . . . . 0.0 113.161 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.09 133.69 81.35 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.52 179.17 3.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.829 2.353 . . . . 0.0 112.641 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -58.07 128.08 80.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.73 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 44.7 Cg_endo -64.51 -25.32 62.85 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.617 2.211 . . . . 0.0 113.476 -167.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -53.7 4.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.958 0.503 . . . . 0.0 111.499 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 5.3 t -108.87 -13.01 14.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 36.6 mmt180 62.47 28.34 16.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.576 1.151 . . . . 0.0 112.129 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -83.18 158.35 64.25 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.623 0.769 . . . . 0.0 109.894 170.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.88 119.36 6.38 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.154 1.903 . . . . 0.0 111.495 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG21 HG21 ' A' ' 153' ' ' VAL . 68.1 mt -60.05 128.35 20.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 t -140.69 155.81 46.38 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.145 0.978 . . . . 0.0 109.1 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.91 -22.54 66.51 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.1 m -63.04 -32.28 73.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.391 1.076 . . . . 0.0 112.889 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -97.2 -7.8 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.5 tt -96.54 133.73 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.224 0.92 . . . . 0.0 109.475 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.14 178.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.208 1.403 . . . . 0.0 109.736 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -100.34 170.2 8.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.252 0.621 . . . . 0.0 110.729 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -68.86 -27.97 66.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.661 0.384 . . . . 0.0 110.947 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.75 -42.45 81.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.633 0.773 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.13 -12.28 60.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.314 -168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 27.7 p -118.69 151.05 38.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.897 0.879 . . . . 0.0 109.742 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.36 160.03 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 24.3 p90 -68.62 127.47 33.14 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.592 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.1 t70 -106.73 127.95 53.81 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.05 -42.34 63.23 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.099 0.875 . . . . 0.0 112.176 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -79.25 -16.09 57.0 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.753 0.252 . . . . 0.0 111.383 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.57 -29.79 19.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.125 0.57 . . . . 0.0 110.541 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.64 18.14 77.91 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.981 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -162.07 160.14 27.08 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.545 0.738 . . . . 0.0 109.176 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.582 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 87.4 m-85 -61.37 124.59 21.03 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.608 1.163 . . . . 0.0 111.737 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.5 pt -128.77 179.58 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.224 1.01 . . . . 0.0 108.432 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 133' ' ' LYS . 23.5 mm -79.92 149.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 122.549 0.34 . . . . 0.0 110.473 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? . . . . . 0 N--CA 1.468 0.438 0 C-N-CA 124.061 0.944 . . . . 0.0 112.693 179.258 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -70.65 -42.59 70.6 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.061 0.945 . . . . 0.0 111.674 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.68 -45.39 70.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -167.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 35.3 t -71.52 -36.8 71.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.723 0.409 . . . . 0.0 110.693 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' ILE . 83.6 mt -63.23 -42.05 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -68.16 -31.95 71.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.467 1.107 . . . . 0.0 112.307 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -58.62 -46.55 86.82 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 168.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -67.08 -40.6 87.01 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.735 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 94' ' ' ILE . 85.3 mt -64.16 -44.8 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.247 0.476 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -66.82 -35.15 79.39 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.318 0.647 . . . . 0.0 112.48 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.679 0.391 . . . . 0.0 111.441 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.5 m -64.42 -21.33 66.61 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.58 1.152 . . . . 0.0 113.266 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.27 173.34 4.88 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 121.468 0.651 . . . . 0.0 112.316 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.23 159.51 36.12 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.777 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.7 t -77.41 108.67 10.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.79 134.64 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.102 -171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.2 m -135.82 94.86 14.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.244 1.017 . . . . 0.0 108.982 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HB3' HD13 ' A' ' 117' ' ' ILE . 24.2 Cg_endo -58.18 -35.31 98.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.715 2.943 . . . . 0.0 113.833 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -31.66 32.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.008 0.523 . . . . 0.0 111.372 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -75.65 -40.4 56.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.565 0.346 . . . . 0.0 110.733 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 95.6 mt -71.82 -14.92 62.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.75 0.82 . . . . 0.0 111.946 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 64.27 10.52 5.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.763 1.225 . . . . 0.0 111.965 -172.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.467 ' SG ' ' HZ ' ' A' ' 186' ' ' PHE . 58.8 m -94.52 130.82 32.41 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.897 0.879 . . . . 0.0 110.156 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.41 155.02 72.08 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.612 2.208 . . . . 0.0 111.574 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 63.5 mt -52.57 -49.77 64.3 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.189 0.931 . . . . 0.0 111.962 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.24 -41.2 71.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.242 1.017 . . . . 0.0 112.941 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.06 63.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.509 0.724 . . . . 0.0 111.785 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.518 ' HB ' HD22 ' A' ' 143' ' ' LEU . 25.5 pt -126.63 17.8 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.663 0.785 . . . . 0.0 110.756 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 39.6 tt0 -69.84 137.59 51.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 111.064 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 34.9 t -73.7 112.11 14.95 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.97 -4.31 15.19 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.754 2.302 . . . . 0.0 112.759 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 mt -83.33 -54.82 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.837 0.855 . . . . 0.0 109.311 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -88.68 -12.38 42.56 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.079 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.11 36.34 18.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.954 0.902 . . . . 0.0 111.464 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -148.51 151.57 35.36 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.163 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.8 tm0? -68.73 115.47 31.07 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.7 Cg_endo -71.82 160.11 48.79 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.569 2.18 . . . . 0.0 113.258 -167.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.2 pt-20 -83.9 -31.04 25.9 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.158 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.558 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.23 145.41 31.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.191 1.396 . . . . 0.0 108.203 174.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.02 169.69 40.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.871 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.77 153.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.187 1.395 . . . . 0.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -97.96 117.15 31.64 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 73.7 t -110.92 123.31 66.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.627 ' HB3' HD12 ' A' ' 188' ' ' ILE . 18.4 ptmt -71.03 108.35 4.55 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.74 0.781 . . . . 0.0 110.426 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -75.91 76.04 2.82 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 t -69.51 -32.51 71.41 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.353 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.07 -44.63 91.88 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.084 0.865 . . . . 0.0 110.813 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.21 -67.34 1.94 Allowed Glycine 0 C--N 1.348 1.211 0 O-C-N 123.704 0.628 . . . . 0.0 112.868 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.8 m -170.78 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.973 0.909 . . . . 0.0 110.305 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.08 23.68 12.45 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.405 1.097 . . . . 0.0 111.086 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.6 124.59 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.585 ' SG ' HD13 ' A' ' 188' ' ' ILE . 56.8 m -83.42 118.82 23.99 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.501 HG21 HD13 ' A' ' 161' ' ' LEU . 18.1 m -111.86 134.21 53.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.518 HD22 ' HB ' ' A' ' 117' ' ' ILE . 30.3 tp -90.41 103.29 15.99 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.721 0.638 . . . . 0.0 109.928 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 95.1 m-85 -97.05 136.91 36.93 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.6 t70 -57.8 130.48 46.67 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 128' ' ' LYS . . . -55.31 -43.36 74.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.251 0.969 . . . . 0.0 111.908 -172.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.67 42.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.869 0.468 . . . . 0.0 111.705 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.77 65.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.935 0.494 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -77.02 -39.63 49.51 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -55.17 -34.59 63.98 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.583 1.153 . . . . 0.0 111.437 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.2 tpm_? -63.1 -54.32 39.69 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.858 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.9 mt -55.31 -44.4 75.74 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.361 1.038 . . . . 0.0 111.681 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 166' ' ' ILE . 60.8 t -64.78 -47.4 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.736 0.647 . . . . 0.0 109.44 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.47 -32.15 82.1 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.542 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.3 mm-40 -82.96 -28.93 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.335 0.654 . . . . 0.0 111.164 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.04 14.3 42.98 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.491 0.495 . . . . 0.0 112.668 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.55 134.63 57.67 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.162 0.985 . . . . 0.0 109.664 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.47 -171.25 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.704 2.269 . . . . 0.0 112.627 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.488 ' ND1' HG23 ' A' ' 162' ' ' THR . 49.0 t-80 -61.24 123.95 78.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.614 0.766 . . . . 0.0 108.981 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.91 -11.22 29.03 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.129 1.886 . . . . 0.0 113.189 -167.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 142' ' ' THR . 88.6 mt -96.49 -65.93 0.94 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.178 0.591 . . . . 0.0 110.616 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.488 HG23 ' ND1' ' A' ' 159' ' ' HIS . 11.1 t -98.71 -3.15 36.51 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.863 0.465 . . . . 0.0 111.997 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 66.01 15.56 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.581 1.553 . . . . 0.0 112.537 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.42 150.54 82.54 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 123.162 0.585 . . . . 0.0 110.97 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.34 113.6 2.33 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.246 1.964 . . . . 0.0 109.92 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.483 HG23 HG21 ' A' ' 153' ' ' VAL . 72.3 mt -56.21 128.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 O-C-N 123.808 0.693 . . . . 0.0 110.291 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.4 t -143.83 157.94 44.02 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.061 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.94 -15.37 63.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.439 0.696 . . . . 0.0 111.462 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -67.5 -48.15 67.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.027 0.931 . . . . 0.0 111.804 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 43.6 pt -83.42 -5.36 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.91 139.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 188' ' ' ILE . 29.0 m -125.45 170.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 0.0 109.751 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.37 150.05 28.6 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.146 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -63.97 -18.79 64.62 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.882 0.739 . . . . 0.0 112.901 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.61 -24.2 24.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.411 0.684 . . . . 0.0 111.598 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -87.97 5.15 42.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.173 0.589 . . . . 0.0 110.563 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.6 p -129.0 130.71 47.0 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 157.74 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -67.36 119.04 11.55 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.459 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.1 t70 -99.59 134.94 41.75 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.92 -34.99 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.848 0.859 . . . . 0.0 111.957 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.6 t -80.61 -29.26 36.87 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.426 0.557 . . . . 0.0 110.695 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.516 ' HG3' HD11 ' A' ' 187' ' ' ILE . 25.4 mmt180 -82.2 -25.55 34.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.963 0.505 . . . . 0.0 110.404 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.7 18.19 79.79 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.824 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -166.66 164.38 16.78 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.467 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 93.8 m-85 -59.74 120.95 10.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.81 0.844 . . . . 0.0 111.405 175.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' A' ' 183' ' ' ARG . 13.2 pt -132.47 177.34 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.823 0.849 . . . . 0.0 109.227 168.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 133' ' ' LYS . 30.8 mm -76.06 153.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.262 0.625 . . . . 0.0 110.438 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.38 163.33 25.44 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.429 0.692 . . . . 0.0 111.325 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.13 -43.51 63.89 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.3 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 . . . . . 0 C--O 1.244 0.809 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -67.13 -36.89 82.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.138 0.975 . . . . 0.0 110.513 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -68.92 -21.43 64.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.51 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 39.5 t -68.27 -40.45 81.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.3 mt -63.26 -48.08 89.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -53.83 -44.89 70.64 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.424 1.089 . . . . 0.0 111.465 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.85 95.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.508 0.723 . . . . 0.0 110.626 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -67.43 -32.9 74.08 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 123.253 0.621 . . . . 0.0 110.985 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 130' ' ' ILE . 91.0 mt -67.7 -41.29 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.899 0.479 . . . . 0.0 109.839 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 m -66.35 -39.55 89.26 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.7 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -82.21 -30.5 30.82 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.575 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 78.3 m -89.88 -15.54 31.95 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.71 168.55 17.52 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.696 0.76 . . . . 0.0 112.444 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -156.71 155.62 31.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.988 172.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 110.14 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.09 107.54 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.098 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 40.3 m -112.25 95.96 33.03 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.552 1.141 . . . . 0.0 108.558 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.5 -36.95 95.3 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.714 2.943 . . . . 0.0 114.376 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.08 36.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -78.52 -39.36 38.25 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 86.5 mt -72.74 -22.2 60.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.07 0.948 . . . . 0.0 111.271 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 56.36 11.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.287 1.035 . . . . 0.0 113.213 -172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 58.4 m -84.35 138.48 38.97 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 123.681 0.792 . . . . 0.0 109.588 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.19 142.84 99.73 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.123 1.882 . . . . 0.0 110.446 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 125' ' ' GLN . 82.3 mt -52.64 -40.5 62.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 111.998 -173.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.28 -44.05 75.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.026 0.93 . . . . 0.0 112.273 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.33 69.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.565 0.746 . . . . 0.0 111.117 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.452 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 24.2 pt -112.32 23.34 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.31 129.69 34.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.017 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 29.2 t -68.97 111.56 8.8 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 -8.62 23.81 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.694 2.263 . . . . 0.0 112.759 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.445 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.2 mt -78.06 -57.43 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.113 0.965 . . . . 0.0 109.086 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.8 p -91.32 -6.02 53.71 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.457 -171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.3 31.35 19.36 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.026 0.931 . . . . 0.0 111.957 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.64 154.26 41.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.536 ' HG3' HD21 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -67.24 113.99 16.44 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 94.4 Cg_endo -76.56 165.7 28.53 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.157 2.572 . . . . 0.0 113.773 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.9 pt-20 -79.94 -36.14 36.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.293 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -151.29 146.43 26.03 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 108.0 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.47 169.43 41.12 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.959 -0.638 . . . . 0.0 114.397 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 98' ' ' ILE . 11.6 pt -122.42 155.45 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 125.645 1.578 . . . . 0.0 109.863 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HE2' ' HD1' ' A' ' 174' ' ' HIS . 35.0 m-85 -94.82 121.88 36.87 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 88.6 t -127.02 121.56 58.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.609 ' HB3' HD13 ' A' ' 188' ' ' ILE . 20.8 ptmt -67.33 113.77 5.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.673 0.749 . . . . 0.0 110.425 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -71.29 85.37 0.79 Allowed 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 163.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.9 t -64.97 -45.97 83.44 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.163 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.84 -38.07 89.73 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.845 0.715 . . . . 0.0 111.235 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.11 -64.05 3.77 Favored Glycine 0 C--N 1.344 1.028 0 O-C-N 123.821 0.701 . . . . 0.0 112.684 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.9 m -160.56 14.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.29 0.636 . . . . 0.0 111.922 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.618 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.9 m-20 60.4 27.2 16.79 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.05 138.36 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.004 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.664 ' SG ' HD11 ' A' ' 188' ' ' ILE . 20.4 m -84.03 121.65 27.7 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.079 0.951 . . . . 0.0 108.56 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.1 m -118.91 141.7 48.42 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.7 tp -91.94 105.47 17.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 109.963 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 75.1 m-85 -98.94 143.36 29.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 15.8 t70 -60.96 129.62 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.73 81.02 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.906 0.754 . . . . 0.0 112.057 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.03 -28.26 60.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.78 0.432 . . . . 0.0 111.301 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.23 62.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.379 0.671 . . . . 0.0 111.477 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -76.06 -37.92 57.68 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.748 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.479 ' HB2' HG23 ' A' ' 98' ' ' ILE . 48.2 t -64.21 -32.76 74.47 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.256 0.622 . . . . 0.0 110.853 174.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.1 tpm_? -59.28 -53.35 59.21 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 123.833 0.708 . . . . 0.0 109.333 172.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.5 mt -53.66 -48.09 69.76 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.247 0.967 . . . . 0.0 111.572 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.36 -40.69 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.166 0.586 . . . . 0.0 110.471 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.94 76.44 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.826 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.8 mm-40 -90.71 -11.48 39.56 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.663 0.785 . . . . 0.0 111.208 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.31 75.89 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 123.048 0.356 . . . . 0.0 112.961 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.87 138.48 46.62 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.764 1.226 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.02 178.25 7.7 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.633 2.222 . . . . 0.0 112.581 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -51.92 132.47 39.09 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -173.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.21 -23.8 28.32 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.868 1.712 . . . . 0.0 113.426 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.32 -43.38 12.2 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 5.4 t -121.52 -14.1 8.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 63.42 28.18 15.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.519 1.128 . . . . 0.0 112.364 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.36 152.98 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.497 0.719 . . . . 0.0 110.131 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.78 114.71 2.53 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.738 2.292 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 170' ' ' ILE . 72.8 mt -66.3 138.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.744 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 t -150.77 164.27 36.59 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.398 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.69 -23.23 66.1 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.753 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 m -66.34 -43.16 86.88 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.682 0.793 . . . . 0.0 111.571 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 166' ' ' ILE . 49.2 pt -85.5 -10.27 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.32 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.676 HG13 HD12 ' A' ' 188' ' ' ILE . 33.3 m -135.03 175.75 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.017 1.327 . . . . 0.0 110.156 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 37.2 mtmm -99.89 166.68 10.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.349 0.659 . . . . 0.0 110.54 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.402 ' HD1' ' HE2' ' A' ' 131' ' ' PHE . 44.3 t60 -55.3 -43.45 74.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.62 0.768 . . . . 0.0 112.206 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.86 -21.54 47.38 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.225 0.61 . . . . 0.0 111.524 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -81.19 -25.0 37.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.707 0.803 . . . . 0.0 110.332 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.4 p -105.53 153.66 21.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.276 1.03 . . . . 0.0 108.856 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.81 162.32 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -72.72 134.19 44.91 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.44 120.04 37.53 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.53 -42.39 71.27 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.897 0.748 . . . . 0.0 112.353 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.5 t -72.09 -30.09 64.76 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.784 0.265 . . . . 0.0 110.697 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -76.96 -32.97 57.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.367 0.667 . . . . 0.0 110.291 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.07 89.69 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.719 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -141.06 157.25 45.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -68.81 128.71 37.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.765 0.826 . . . . 0.0 109.977 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.2 175.2 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.676 HD12 HG13 ' A' ' 172' ' ' VAL . 24.9 mm -79.75 143.07 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.5 159.55 12.72 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.506 0.723 . . . . 0.0 112.271 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.55 -8.55 28.42 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.595 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.247 0.954 0 C-N-CA 124.11 0.964 . . . . 0.0 109.541 177.091 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 26.6 mp0 -59.71 -49.73 76.58 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.68 0.613 . . . . 0.0 111.952 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.36 79.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.223 0.609 . . . . 0.0 111.44 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -66.44 -42.88 86.98 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.491 0.716 . . . . 0.0 109.872 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.94 -41.19 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.706 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 46.7 mm-40 -58.43 -41.82 85.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.609 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -60.16 -41.42 92.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.558 0.536 . . . . 0.0 110.634 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -44.54 88.65 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.507 0.504 . . . . 0.0 110.618 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.494 HD13 HG22 ' A' ' 153' ' ' VAL . 88.9 mt -59.21 -41.01 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.022 0.929 . . . . 0.0 109.951 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -64.66 -39.27 93.4 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.664 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -86.75 -23.59 25.41 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 79.7 m -89.25 -24.1 22.18 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.605 0.762 . . . . 0.0 111.657 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HB3' HG23 ' A' ' 130' ' ' ILE . 20.4 pttp -69.1 168.68 13.42 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.563 0.697 . . . . 0.0 112.015 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.95 164.87 37.94 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.695 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -67.92 99.12 0.81 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.477 HG12 ' NE2' ' A' ' 125' ' ' GLN . 59.8 t -70.66 96.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.496 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.3 m -100.05 98.61 7.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.185 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.14 -37.88 93.74 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.094 2.529 . . . . 0.0 113.772 -168.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.75 -31.54 68.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.461 0.704 . . . . 0.0 111.548 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -78.89 -36.75 41.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.964 0.505 . . . . 0.0 110.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.58 -21.62 63.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 69.5 -40.04 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.473 1.909 . . . . 0.0 113.56 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.45 134.59 76.72 Favored Pre-proline 0 C--N 1.353 0.729 0 C-N-CA 124.678 1.191 . . . . 0.0 109.419 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.47 166.93 10.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.205 2.604 . . . . 0.0 112.891 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 67.4 mt -51.17 -47.4 62.15 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.758 0.823 . . . . 0.0 111.581 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.25 -40.06 80.8 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.911 0.884 . . . . 0.0 112.461 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.51 65.65 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.459 0.704 . . . . 0.0 112.255 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.486 ' HB ' HD21 ' A' ' 143' ' ' LEU . 13.0 pt -120.35 11.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.06 0.944 . . . . 0.0 110.868 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 34.7 tt0 -70.3 134.42 47.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.51 1.124 . . . . 0.0 111.407 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.1 t -67.2 114.96 21.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 124.045 0.841 . . . . 0.0 109.211 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.527 ' HB2' HD23 ' A' ' 161' ' ' LEU . 92.3 Cg_endo -76.51 0.9 9.02 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.676 2.251 . . . . 0.0 113.049 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 160' ' ' PRO . 34.8 mt -84.79 -54.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.678 0.791 . . . . 0.0 109.084 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p -95.68 -8.3 35.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.735 -171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.27 42.23 25.51 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.36 1.064 . . . . 0.0 111.791 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.08 153.67 35.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.161 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.477 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.2 tm0? -72.18 118.7 69.52 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.34 163.46 34.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.897 2.398 . . . . 0.0 113.392 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 16.0 pt-20 -99.47 -20.71 16.3 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.413 172.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.9 133.09 26.29 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 125.629 1.571 . . . . 0.0 106.833 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.18 158.43 31.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.362 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.466 HD12 HG22 ' A' ' 98' ' ' ILE . 11.2 pt -113.77 156.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.905 1.282 . . . . 0.0 110.419 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.732 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 36.5 m-85 -99.32 118.34 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.932 172.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.45 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 91.5 t -123.17 119.39 57.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.732 ' HB3' HD12 ' A' ' 188' ' ' ILE . 21.8 ptmt -67.66 114.41 6.26 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.638 0.586 . . . . 0.0 111.299 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -73.71 82.79 1.59 Allowed 'General case' 0 C--O 1.252 1.217 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.8 t -62.19 -33.97 75.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.038 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.7 -36.05 81.59 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.488 0.715 . . . . 0.0 111.54 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.15 -62.96 5.77 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 124.15 0.906 . . . . 0.0 111.349 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t 174.98 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.482 1.513 . . . . 0.0 107.433 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 15.2 t70 65.46 16.79 10.7 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 121.866 0.841 . . . . 0.0 109.766 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.657 ' HA ' HG21 ' A' ' 187' ' ' ILE . 58.5 t -78.59 124.48 37.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.86 -171.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.732 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 18.6 t -85.75 133.43 34.0 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.9 m -119.64 138.63 53.13 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.592 0.757 . . . . 0.0 109.406 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.486 HD21 ' HB ' ' A' ' 117' ' ' ILE . 37.6 tp -91.18 107.82 19.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.184 0.516 . . . . 0.0 109.725 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 94.9 m-85 -98.56 155.37 17.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.347 1.059 . . . . 0.0 108.264 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.8 140.31 53.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.16 97.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.978 0.799 . . . . 0.0 111.195 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.4 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.196 0.598 . . . . 0.0 112.101 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.81 -42.22 58.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.165 0.586 . . . . 0.0 111.187 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -74.95 -38.43 61.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.594 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.5 t -57.03 -37.32 71.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.648 0.779 . . . . 0.0 111.01 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.3 tpm_? -60.13 -57.1 14.27 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.266 0.978 . . . . 0.0 110.251 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.32 -44.14 68.16 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.329 1.018 . . . . 0.0 111.7 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 HG23 ' A' ' 166' ' ' ILE . 94.2 t -62.56 -48.02 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.159 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.26 -25.08 73.6 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.014 0.821 . . . . 0.0 113.283 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.508 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 10.1 mm-40 -78.65 -23.24 45.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.996 0.518 . . . . 0.0 110.541 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.61 24.07 26.84 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.595 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 69.4 mt -87.3 156.94 53.94 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.335 1.054 . . . . 0.0 110.728 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.44 -177.12 3.65 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.933 2.422 . . . . 0.0 112.829 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.415 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.3 t-80 -61.56 126.71 87.32 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.389 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HG3' HG12 ' A' ' 121' ' ' ILE . 58.6 Cg_endo -64.92 -21.33 64.14 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.571 2.181 . . . . 0.0 113.371 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 120' ' ' PRO . 55.7 mt -89.57 -66.37 0.93 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.956 0.502 . . . . 0.0 110.995 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.415 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.4 t -104.56 -1.22 26.83 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.608 -167.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 62.24 26.61 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.94 1.296 . . . . 0.0 112.995 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -77.79 150.52 78.72 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.167 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.33 114.07 2.91 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.172 1.915 . . . . 0.0 110.072 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.5 HG23 HG21 ' A' ' 153' ' ' VAL . 62.8 mt -59.33 133.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 123.448 0.467 . . . . 0.0 110.226 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.7 t -151.55 166.19 31.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.719 0.808 . . . . 0.0 109.501 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.48 -18.98 65.27 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.37 1.068 . . . . 0.0 111.46 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -71.45 -42.43 68.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.802 0.841 . . . . 0.0 111.738 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 166' ' ' ILE . 32.6 pt -85.99 -8.56 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.4 tt -103.62 134.85 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.488 HG13 HD11 ' A' ' 188' ' ' ILE . 33.4 m -121.97 160.2 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.556 0.742 . . . . 0.0 109.892 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -73.32 149.67 42.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.864 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.432 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 20.5 p80 -63.7 -23.9 67.56 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.095 0.247 . . . . 0.0 111.452 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.81 -29.51 66.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.856 0.862 . . . . 0.0 110.873 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 189' ' ' LYS . 24.5 mm-40 -93.73 17.43 11.91 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 112.191 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 23.7 p -140.84 134.85 30.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.293 0.637 . . . . 0.0 109.365 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 159.51 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 107.561 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -67.36 139.94 57.21 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -116.34 138.56 51.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.62 -45.91 84.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.955 1.41 . . . . 0.0 110.72 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 50.1 m -66.03 -48.56 70.7 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.875 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.431 ' HG3' HG22 ' A' ' 187' ' ' ILE . 32.9 mmt180 -82.08 -24.3 35.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.468 0.707 . . . . 0.0 110.949 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.3 22.27 73.7 Favored Glycine 0 N--CA 1.472 1.042 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.833 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -165.11 164.71 20.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.632 . . . . 0.0 110.005 -170.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -59.8 120.26 9.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 110.54 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.657 HG21 ' HA ' ' A' ' 140' ' ' VAL . 2.8 pp -134.36 169.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.546 1.138 . . . . 0.0 108.786 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.732 HD12 ' HB3' ' A' ' 133' ' ' LYS . 15.6 mm -71.19 151.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 176' ' ' GLU . 53.3 mtpt -65.01 164.44 12.76 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.363 0.529 . . . . 0.0 112.046 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -126.18 74.19 0.42 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.899 -176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.598 0.759 . . . . 0.0 109.236 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 p . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.521 ' HA ' HD13 ' A' ' 94' ' ' ILE . 6.2 mp0 -52.66 -43.65 65.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.258 1.423 . . . . 0.0 112.47 -170.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.81 -49.37 68.5 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.139 0.899 . . . . 0.0 111.791 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 38.3 m -65.21 -36.93 85.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.895 0.878 . . . . 0.0 110.755 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 91' ' ' GLN . 44.3 mt -67.77 -45.76 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.576 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -54.41 -46.37 73.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.758 1.223 . . . . 0.0 111.2 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.6 m-80 -57.16 -49.96 74.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.769 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -63.72 -35.01 79.16 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 123.388 0.675 . . . . 0.0 111.603 -176.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 94' ' ' ILE . 93.9 mt -65.79 -44.48 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 t -65.66 -35.3 80.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.261 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.0 mm-40 -80.91 -49.79 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.903 0.481 . . . . 0.0 111.68 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -69.41 -21.52 63.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.413 1.085 . . . . 0.0 113.327 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.79 173.59 5.12 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -160.27 161.73 33.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.57 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -69.31 107.52 3.31 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.438 ' H ' ' HA ' ' A' ' 128' ' ' LYS . 92.8 t -72.64 99.32 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.298 0.57 . . . . 0.0 109.64 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 82.1 m -105.1 102.18 34.7 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.77 1.228 . . . . 0.0 108.014 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HB3' HD13 ' A' ' 117' ' ' ILE . 11.3 Cg_endo -53.84 -27.56 44.25 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.693 2.929 . . . . 0.0 113.422 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.5 -40.52 70.13 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.548 0.739 . . . . 0.0 110.635 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 HH11 HD22 ' A' ' 110' ' ' LEU . 2.6 tmt_? -73.6 -44.19 57.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.553 0.741 . . . . 0.0 109.587 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD22 HH11 ' A' ' 109' ' ' ARG . 95.9 mt -71.72 -22.31 61.64 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.555 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 55.7 14.3 1.24 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 0.0 112.917 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.9 m -99.83 136.43 20.23 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 124.237 1.015 . . . . 0.0 108.663 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -53.95 150.42 30.72 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.929 2.419 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.6 mt -53.26 -49.34 67.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.251 1.02 . . . . 0.0 112.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.7 -35.5 76.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.148 0.979 . . . . 0.0 112.519 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.97 69.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.087 0.555 . . . . 0.0 111.623 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.499 ' HB ' HD21 ' A' ' 143' ' ' LEU . 22.9 pt -109.18 4.3 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.21 0.604 . . . . 0.0 111.038 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 36.8 tt0 -60.71 134.99 57.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 31.7 t -67.04 114.31 17.57 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.128 0.971 . . . . 0.0 108.807 175.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.505 ' HB2' HD21 ' A' ' 161' ' ' LEU . 73.9 Cg_endo -70.62 -9.14 25.19 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.616 2.211 . . . . 0.0 112.782 -176.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.5 -55.43 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.833 0.853 . . . . 0.0 109.669 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -98.9 -6.19 29.38 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.557 -170.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.55 34.37 20.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.054 0.942 . . . . 0.0 112.257 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.05 148.03 49.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.783 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.02 108.75 3.0 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 171.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.46 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 56.1 Cg_endo -68.69 154.93 70.4 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.562 2.174 . . . . 0.0 113.11 -167.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.0 pt-20 -81.91 -30.55 31.83 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.715 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.53 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -153.03 142.6 21.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.991 1.316 . . . . 0.0 108.471 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.7 177.69 40.17 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.301 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.28 161.29 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.695 1.598 . . . . 0.0 109.251 -173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 60.6 m-85 -106.47 116.65 32.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.878 0.471 . . . . 0.0 110.355 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 97.0 t -117.12 121.6 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 22.2 ptmt -73.25 114.23 11.21 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.57 0.7 . . . . 0.0 110.626 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -68.15 88.31 0.29 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.4 t -61.09 -41.62 97.0 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.391 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.85 -32.01 72.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.29 0.636 . . . . 0.0 110.956 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.59 36.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.597 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.2 m 84.79 45.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.14 1.776 . . . . 0.0 111.442 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 61.16 22.67 12.95 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.716 1.206 . . . . 0.0 112.274 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.43 HG12 ' HB3' ' A' ' 185' ' ' ASN . 88.6 t -76.89 120.42 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.269 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 58.0 m -83.2 134.12 34.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.5 m -124.59 147.92 48.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.499 HD21 ' HB ' ' A' ' 117' ' ' ILE . 26.8 tp -89.87 105.34 17.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.306 0.574 . . . . 0.0 110.513 -175.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.446 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 79.2 m-85 -102.74 133.63 47.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.561 1.144 . . . . 0.0 108.316 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.7 t70 -57.21 130.73 47.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.666 0.666 . . . . 0.0 109.378 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.34 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.733 0.813 . . . . 0.0 112.215 -171.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.99 63.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.799 0.44 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.96 76.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.686 0.794 . . . . 0.0 111.795 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -75.54 -38.73 59.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.3 t -62.96 -28.76 70.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.489 0.716 . . . . 0.0 111.03 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.5 tpm_? -63.84 -52.94 57.81 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 123.937 0.773 . . . . 0.0 110.218 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -57.64 -42.96 84.48 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.946 0.778 . . . . 0.0 111.359 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.447 HG21 HG23 ' A' ' 166' ' ' ILE . 94.6 t -65.73 -44.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.829 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.01 -26.7 69.37 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.895 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 38.5 mm-40 -79.98 -30.29 39.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.95 20.78 35.36 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.454 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.94 150.66 78.44 Favored Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.216 1.006 . . . . 0.0 110.501 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.38 173.69 14.07 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.61 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.468 ' ND1' HG22 ' A' ' 162' ' ' THR . 59.6 t-80 -54.27 129.01 59.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.666 0.786 . . . . 0.0 110.366 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -62.06 -22.38 74.13 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.62 2.213 . . . . 0.0 113.673 -170.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 120' ' ' PRO . 60.5 mt -103.4 -53.16 2.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.745 0.418 . . . . 0.0 111.827 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.468 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -104.14 -8.33 19.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.08 22.45 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.468 1.107 . . . . 0.0 113.167 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -75.2 155.8 86.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.592 0.757 . . . . 0.0 109.984 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -58.35 115.23 2.39 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.403 2.069 . . . . 0.0 110.57 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.522 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.3 mt -63.31 131.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 t -153.66 162.11 41.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 109.923 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.92 65.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.145 0.978 . . . . 0.0 111.258 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.0 t -66.2 -48.31 71.07 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.1 0.96 . . . . 0.0 111.476 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.3 pt -88.92 -2.67 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.35 137.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.63 169.74 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 109.537 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -82.8 156.03 23.88 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.298 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -64.56 -23.65 67.34 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -87.9 -21.93 24.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.694 0.797 . . . . 0.0 109.892 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.76 -17.05 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.069 0.948 . . . . 0.0 111.471 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.4 p -128.62 154.64 46.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.087 0.955 . . . . 0.0 109.33 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.412 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -135.83 164.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.374 1.069 . . . . 0.0 108.714 178.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 21.3 p90 -78.96 121.7 25.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -105.65 127.03 52.82 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.06 -40.31 75.16 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.313 -170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 t -74.32 -24.26 59.18 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-N 117.531 0.15 . . . . 0.0 111.222 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -80.25 -30.49 38.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.85 25.01 70.54 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.22 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.43 ' HB3' HG12 ' A' ' 140' ' ' VAL . 78.0 m-20 -156.24 160.98 40.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.275 -171.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 60.4 m-85 -74.13 126.73 31.21 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 168.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.1 pt -132.5 177.31 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.664 0.785 . . . . 0.0 110.066 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.03 143.89 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.548 0.739 . . . . 0.0 109.88 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' HG2' HD12 ' A' ' 178' ' ' ILE . 60.0 mtpt -66.59 157.41 32.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.163 0.585 . . . . 0.0 112.378 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -80.43 -91.77 0.47 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 125.385 1.474 . . . . 0.0 111.323 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.508 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.8 mp0 -49.62 -50.76 41.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.37 1.068 . . . . 0.0 112.154 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -38.24 75.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.523 0.729 . . . . 0.0 111.742 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t -70.93 -43.63 67.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.87 0.868 . . . . 0.0 109.93 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 98' ' ' ILE . 73.6 mt -63.42 -50.23 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.41 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.64 -23.36 58.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.984 0.914 . . . . 0.0 112.036 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.42 -38.35 84.45 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -67.31 -37.32 83.15 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 123.05 0.54 . . . . 0.0 110.431 175.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.487 HG22 ' HB2' ' A' ' 150' ' ' SER . 90.7 mt -65.49 -38.08 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.208 0.603 . . . . 0.0 110.125 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -60.84 -40.44 92.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.394 1.078 . . . . 0.0 111.74 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -86.76 -40.19 15.24 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.0 m -76.82 -16.49 59.42 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.634 0.774 . . . . 0.0 111.785 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -71.03 154.89 41.42 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.385 0.612 . . . . 0.0 111.15 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.74 161.02 42.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.696 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.6 m -65.53 96.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 110.039 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.08 97.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 m -110.65 107.22 58.12 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.18 -20.86 67.58 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.159 2.573 . . . . 0.0 113.016 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.92 -35.16 29.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.43 1.092 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.81 -49.0 13.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.974 0.509 . . . . 0.0 110.418 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.3 mt -69.05 -21.31 64.11 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.148 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 55.38 19.39 3.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 112.772 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.47 134.15 40.79 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.36 149.11 76.13 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.182 1.922 . . . . 0.0 110.632 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.8 mt -52.13 -43.68 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.7 0.8 . . . . 0.0 111.407 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.34 -37.7 81.49 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.759 0.824 . . . . 0.0 112.541 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.09 71.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.14 0.576 . . . . 0.0 111.107 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.5 pt -117.09 31.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.986 0.914 . . . . 0.0 110.005 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -70.86 128.59 36.52 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.837 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -74.78 109.95 8.6 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 162.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.94 -11.55 27.55 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 123.085 2.523 . . . . 0.0 112.694 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.82 -52.84 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.603 0.761 . . . . 0.0 109.123 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.9 p -92.7 -12.6 31.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.504 1.122 . . . . 0.0 112.573 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 61.42 37.8 16.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.858 0.863 . . . . 0.0 111.32 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.36 151.92 37.32 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.65 115.51 44.63 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 160.91 36.09 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.886 2.391 . . . . 0.0 113.458 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.518 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 12.5 pt-20 -87.87 -20.74 25.6 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.33 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.61 134.53 22.52 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 108.346 178.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.15 166.66 37.12 Favored Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.459 HG13 HG21 ' A' ' 132' ' ' VAL . 9.9 pt -124.87 155.46 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 0.0 109.386 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.61 115.07 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 130' ' ' ILE . 71.7 t -123.23 122.75 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -66.24 120.3 13.02 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.483 0.658 . . . . 0.0 110.962 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -72.7 84.25 1.18 Allowed 'General case' 0 C--O 1.249 1.065 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 161.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.7 t -67.76 -57.05 6.99 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.426 -168.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.02 -31.85 69.71 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.018 0.527 . . . . 0.0 111.42 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -63.38 4.66 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.035 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.2 m -149.92 5.68 0.59 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 65.73 21.32 11.56 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.187 0.995 . . . . 0.0 111.201 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.29 143.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.489 1.116 . . . . 0.0 109.291 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 31.1 p -86.21 140.52 30.06 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 117.921 0.328 . . . . 0.0 110.174 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.4 m -126.84 148.34 49.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.482 1.113 . . . . 0.0 108.184 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.8 tp -89.2 123.89 33.86 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.932 0.493 . . . . 0.0 109.87 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -120.76 132.89 55.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.104 0.961 . . . . 0.0 108.674 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.07 130.5 38.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.466 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.57 -46.36 77.21 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.079 0.862 . . . . 0.0 111.792 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.6 68.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.118 0.567 . . . . 0.0 111.619 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.62 62.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.696 0.798 . . . . 0.0 111.542 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 153' ' ' VAL . 44.3 t80 -72.65 -41.85 64.99 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.803 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.487 ' HB2' HG22 ' A' ' 98' ' ' ILE . 23.1 t -63.5 -29.92 71.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.253 0.621 . . . . 0.0 110.867 176.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.8 tpm_? -61.53 -51.91 66.63 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 172.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -55.38 -43.93 75.6 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.295 0.997 . . . . 0.0 111.21 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.508 HG12 ' HG3' ' A' ' 91' ' ' GLN . 46.5 t -67.44 -45.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.737 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.46 -27.6 66.09 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.306 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 19.1 mm-40 -78.65 -33.97 46.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.09 0.556 . . . . 0.0 110.828 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.81 28.52 11.02 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.73 144.12 28.95 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.669 1.188 . . . . 0.0 109.509 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.8 -177.83 4.08 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.795 2.33 . . . . 0.0 112.503 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.404 ' ND1' HG22 ' A' ' 162' ' ' THR . 57.4 t-80 -54.53 129.86 62.68 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.404 1.082 . . . . 0.0 110.902 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.24 -24.03 78.17 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.831 2.354 . . . . 0.0 114.087 -171.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.4 mt -103.06 -56.65 2.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.807 0.443 . . . . 0.0 111.882 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.404 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.6 t -102.52 -8.69 20.83 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.691 0.396 . . . . 0.0 111.384 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 63.5 24.71 14.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 0.0 112.546 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.0 154.82 90.77 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 114.11 2.95 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.017 1.811 . . . . 0.0 110.215 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 170' ' ' ILE . 66.0 mt -63.05 134.75 28.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -149.37 163.39 37.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.074 0.95 . . . . 0.0 109.744 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.56 -18.09 65.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.851 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.5 t -70.96 -41.05 71.59 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 111.746 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -85.65 -11.41 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.1 tt -99.61 133.43 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 188' ' ' ILE . 27.5 m -129.04 174.12 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.18 0.992 . . . . 0.0 110.18 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -94.17 164.35 13.09 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.229 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -57.29 -39.95 76.77 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.5 -4.64 57.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.146 0.43 . . . . 0.0 111.679 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -87.23 -21.93 25.54 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.515 0.674 . . . . 0.0 109.613 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.6 p -102.75 142.09 34.47 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 158.0 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 17.0 p90 -75.22 122.9 24.36 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -99.06 129.93 45.36 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -70.37 -34.71 72.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.385 1.053 . . . . 0.0 111.663 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 t -74.78 -28.4 60.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.214 0.206 . . . . 0.0 110.955 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -82.14 -32.38 30.12 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 111.117 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.54 24.59 75.95 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.743 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -165.51 159.38 16.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.906 0.482 . . . . 0.0 109.876 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 90.7 m-85 -65.19 118.92 9.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.628 1.171 . . . . 0.0 111.111 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.56 -179.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 108.06 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 133' ' ' LYS . 8.7 mm -83.57 156.26 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -62.54 153.79 30.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.974 0.91 . . . . 0.0 112.432 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.45 -20.95 28.17 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.791 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 123.914 0.885 . . . . 0.0 109.46 177.508 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -62.39 -43.45 98.78 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 124.629 1.172 . . . . 0.0 111.956 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -38.1 77.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.978 0.799 . . . . 0.0 111.984 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 49.6 m -66.9 -39.22 87.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.292 0.637 . . . . 0.0 110.711 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 98' ' ' ILE . 58.0 mt -68.63 -41.88 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.605 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -56.87 -41.11 77.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.876 1.271 . . . . 0.0 110.887 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -61.39 -44.86 96.42 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.283 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -63.43 -39.65 95.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.964 0.506 . . . . 0.0 111.441 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 150' ' ' SER . 77.8 mt -65.3 -37.73 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.242 0.617 . . . . 0.0 110.333 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.1 t -62.3 -45.69 92.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.61 0.764 . . . . 0.0 111.789 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -78.17 -29.47 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.161 0.584 . . . . 0.0 112.187 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.8 -10.38 23.09 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.412 0.685 . . . . 0.0 112.496 -172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -74.24 160.17 31.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -152.1 160.26 43.47 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.361 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.7 t -66.78 100.06 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.083 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.75 107.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 84.1 m -118.69 87.11 31.36 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.816 0.847 . . . . 0.0 109.776 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.526 ' HB3' HD11 ' A' ' 117' ' ' ILE . 1.7 Cg_endo -43.88 -45.75 11.18 Favored 'Trans proline' 0 C--N 1.385 2.452 1 C-N-CA 125.42 4.08 . . . . 0.0 115.129 -176.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -20.48 55.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.064 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -91.3 -31.91 15.92 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.918 0.487 . . . . 0.0 110.575 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.59 -20.17 61.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.588 0.755 . . . . 0.0 110.341 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 59.12 18.98 6.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.507 1.523 . . . . 0.0 112.237 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.5 m -100.35 138.11 20.13 Favored Pre-proline 0 C--O 1.245 0.836 0 C-N-CA 124.165 0.986 . . . . 0.0 108.877 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.18 157.51 34.62 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.426 2.084 . . . . 0.0 111.357 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.501 HD22 ' HG3' ' A' ' 125' ' ' GLN . 71.8 mt -55.98 -38.78 70.89 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.083 0.553 . . . . 0.0 111.373 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.12 -38.38 82.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.02 0.928 . . . . 0.0 112.825 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.87 66.86 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.086 0.554 . . . . 0.0 111.593 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 107' ' ' PRO . 26.5 pt -124.08 16.43 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.856 0.862 . . . . 0.0 111.107 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.42 125.39 24.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.204 1.002 . . . . 0.0 110.221 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.91 111.47 10.72 Favored Pre-proline 0 C--N 1.354 0.775 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.96 -3.99 14.74 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.741 2.294 . . . . 0.0 112.105 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -84.98 -58.55 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.895 0.878 . . . . 0.0 109.403 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 p -88.4 -13.0 41.61 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.721 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.99 33.63 17.17 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.584 0.754 . . . . 0.0 111.533 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.88 152.76 46.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -73.13 110.43 8.54 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.409 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 57.7 Cg_endo -68.08 153.84 73.96 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.434 2.756 . . . . 0.0 114.266 -167.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -80.48 -38.8 29.24 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.605 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.1 pttm -138.64 143.58 39.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.177 1.391 . . . . 0.0 107.459 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.94 166.25 37.43 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.278 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.3 pt -121.64 155.27 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.985 1.314 . . . . 0.0 109.086 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.51 123.16 41.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.78 121.91 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.702 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.7 ptmt -71.09 119.0 14.59 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.751 0.657 . . . . 0.0 110.775 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -74.03 81.73 1.73 Allowed 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.1 t -68.87 -28.53 66.78 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.386 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.29 -37.42 85.4 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.353 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.35 -65.0 2.56 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -178.5 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.984 0.914 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 61.98 23.27 13.68 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.178 0.991 . . . . 0.0 111.379 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.16 118.35 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 186' ' ' PHE . 20.6 p -84.36 138.87 32.64 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.41 0.624 . . . . 0.0 110.032 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.3 m -127.83 145.03 51.06 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.18 0.992 . . . . 0.0 108.785 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 117' ' ' ILE . 61.0 tp -88.28 111.54 21.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -105.44 138.03 42.29 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.661 1.184 . . . . 0.0 108.022 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.7 t70 -59.1 135.44 57.63 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.381 0.537 . . . . 0.0 109.722 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.89 92.27 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.74 0.816 . . . . 0.0 111.777 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.36 -35.17 65.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.544 0.528 . . . . 0.0 111.072 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 -48.33 59.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.626 0.77 . . . . 0.0 112.007 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -70.0 -40.7 75.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.998 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 98' ' ' ILE . 32.5 t -62.44 -32.31 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.564 0.54 . . . . 0.0 111.13 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.438 ' HA ' ' HE ' ' A' ' 151' ' ' ARG . 1.4 tpm_? -64.65 -49.38 71.24 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 123.637 0.586 . . . . 0.0 110.401 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.69 -45.16 81.94 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.174 0.921 . . . . 0.0 111.182 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 166' ' ' ILE . 84.3 t -61.92 -46.77 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.217 0.607 . . . . 0.0 110.209 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.73 -31.19 79.95 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.041 0.838 . . . . 0.0 113.228 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.61 -15.66 53.97 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.653 0.781 . . . . 0.0 111.662 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.87 31.87 38.33 Favored Glycine 0 N--CA 1.47 0.966 0 O-C-N 123.204 0.315 . . . . 0.0 112.551 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.7 mt -90.24 150.82 43.86 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.663 1.185 . . . . 0.0 110.025 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.52 -179.43 5.31 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.685 2.257 . . . . 0.0 113.088 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.412 ' ND1' HG23 ' A' ' 162' ' ' THR . 47.1 t-80 -56.76 127.14 73.48 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.174 0.99 . . . . 0.0 111.317 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.09 -1.74 8.46 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.995 2.464 . . . . 0.0 114.069 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.63 -64.52 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.689 0.395 . . . . 0.0 110.624 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.412 HG23 ' ND1' ' A' ' 159' ' ' HIS . 10.1 t -98.39 -4.64 34.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.984 -167.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 61.55 20.96 11.7 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.496 1.118 . . . . 0.0 112.906 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.19 152.28 73.56 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.514 0.726 . . . . 0.0 110.589 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.78 115.06 2.69 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.056 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.478 HG21 HG22 ' A' ' 153' ' ' VAL . 70.3 mt -63.27 130.8 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.744 0.417 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -141.53 162.69 34.86 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 109.571 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.38 66.24 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.409 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.4 m -64.91 -41.68 95.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.51 0.724 . . . . 0.0 112.065 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.9 pt -85.61 -7.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.33 135.5 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.12 0.873 . . . . 0.0 109.337 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.19 179.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 109.844 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -101.66 164.96 11.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.837 0.455 . . . . 0.0 110.578 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.25 -15.61 33.18 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.32 -26.82 56.19 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.099 0.952 . . . . 0.0 109.339 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 28.9 p -105.02 161.07 14.53 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.933 165.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.33 162.98 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.386 0.674 . . . . 0.0 109.265 175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 27.8 p90 -72.59 135.01 45.44 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 163.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.403 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.0 t70 -119.02 127.05 53.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.55 -43.69 47.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.8 t -76.58 -28.48 56.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.172 0.442 . . . . 0.0 110.808 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -72.03 -31.8 66.53 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.22 81.2 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.598 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -149.33 150.12 31.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.026 0.93 . . . . 0.0 110.232 -170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.575 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 35.3 m-85 -63.42 119.24 9.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.668 0.787 . . . . 0.0 109.968 168.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.2 pt -127.15 177.84 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 0.0 109.723 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.702 HD13 ' HB3' ' A' ' 133' ' ' LYS . 37.1 mm -85.83 151.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.386 0.674 . . . . 0.0 110.129 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.94 155.23 37.11 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.101 0.477 . . . . 0.0 111.743 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -100.22 -41.23 2.85 Favored Glycine 0 N--CA 1.467 0.745 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 124.814 1.246 . . . . 0.0 108.485 174.203 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -73.89 -40.49 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.448 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -41.47 67.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.927 0.891 . . . . 0.0 112.591 -168.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 41.4 t -65.7 -46.09 80.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.535 0.734 . . . . 0.0 110.04 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.5 mt -63.73 -41.14 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.128 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -59.8 -42.63 93.85 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.517 1.127 . . . . 0.0 110.622 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -61.87 -43.27 99.18 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.372 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -64.23 -31.32 72.47 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.242 0.617 . . . . 0.0 111.325 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 94' ' ' ILE . 95.3 mt -70.42 -40.57 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.309 0.644 . . . . 0.0 109.671 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 t -65.57 -33.42 75.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.312 0.645 . . . . 0.0 111.292 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -74.95 -46.75 33.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.293 1.037 . . . . 0.0 112.327 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.579 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 71.0 m -82.33 -17.35 46.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.48 0.712 . . . . 0.0 112.845 -169.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -70.55 165.7 22.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.447 0.641 . . . . 0.0 112.603 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -156.41 159.65 38.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.381 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.6 m -66.97 102.58 1.0 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.626 0.579 . . . . 0.0 109.713 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.433 HG12 ' NE2' ' A' ' 125' ' ' GLN . 58.7 t -77.06 102.46 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.191 0.596 . . . . 0.0 110.148 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.1 m -112.29 106.84 55.86 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.158 0.983 . . . . 0.0 108.745 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 24.1 Cg_endo -60.3 -18.95 55.49 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.3 2.667 . . . . 0.0 112.745 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.6 -35.9 70.66 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.557 0.743 . . . . 0.0 110.277 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -83.73 -49.47 9.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.084 0.554 . . . . 0.0 110.347 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.5 -23.18 65.44 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.381 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 54.02 21.02 2.69 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.434 1.094 . . . . 0.0 112.783 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -103.81 136.87 19.14 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.273 1.029 . . . . 0.0 108.337 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.9 154.16 28.15 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.753 2.302 . . . . 0.0 111.801 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.7 mt -49.88 -46.33 51.49 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.848 0.717 . . . . 0.0 111.271 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.35 -40.66 74.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.835 1.254 . . . . 0.0 113.038 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.46 66.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.762 0.825 . . . . 0.0 111.633 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.542 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.9 pt -114.63 7.68 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.211 1.005 . . . . 0.0 111.153 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 35.3 tt0 -68.18 136.05 53.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.146 0.978 . . . . 0.0 111.055 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.498 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 36.8 t -69.26 110.26 5.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 124.411 1.069 . . . . 0.0 108.405 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.72 -1.04 10.2 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.056 2.504 . . . . 0.0 112.735 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.498 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.5 mt -84.35 -52.83 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.142 1.377 . . . . 0.0 109.756 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -97.89 -9.34 26.48 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.322 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.9 37.37 15.27 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.193 0.997 . . . . 0.0 111.894 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.49 151.13 37.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.195 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 23.3 tm0? -71.04 118.12 62.69 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 94.9 Cg_endo -74.03 162.5 38.87 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.074 2.516 . . . . 0.0 114.07 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.603 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -82.47 -32.17 29.0 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.67 172.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.603 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.3 pttt -147.67 143.64 27.79 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.315 1.446 . . . . 0.0 107.345 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.69 160.6 33.79 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.183 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 HD11 HG21 ' A' ' 98' ' ' ILE . 10.2 pt -114.37 152.36 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.833 1.653 . . . . 0.0 109.365 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -93.66 120.38 33.86 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.442 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 98.4 t -120.34 119.51 60.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.64 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.8 ptmt -69.09 118.82 12.47 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.635 0.731 . . . . 0.0 110.417 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -70.19 81.38 0.52 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 163.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -67.34 -56.34 10.11 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.875 -168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.05 -28.42 68.2 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.533 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.98 -65.73 2.14 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.193 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 m -152.68 10.98 0.49 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.1 t70 66.39 14.42 9.69 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 124.047 0.939 . . . . 0.0 111.116 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.17 124.93 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.498 0.719 . . . . 0.0 110.037 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 26.1 p -84.56 132.79 34.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.0 m -121.48 147.0 46.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.542 HD23 ' HB ' ' A' ' 117' ' ' ILE . 27.0 tp -92.85 105.15 17.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 85.4 m-85 -99.77 140.04 34.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.619 1.168 . . . . 0.0 107.895 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.4 t70 -61.04 140.84 57.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.646 0.657 . . . . 0.0 109.676 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.44 74.93 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.106 0.879 . . . . 0.0 111.276 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.92 67.34 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.344 0.657 . . . . 0.0 111.621 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -48.12 60.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.478 0.711 . . . . 0.0 112.026 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 153' ' ' VAL . 41.7 t80 -71.17 -39.63 71.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.965 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.42 ' HB2' HG23 ' A' ' 98' ' ' ILE . 23.1 t -60.25 -35.44 75.51 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.822 0.701 . . . . 0.0 110.898 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 41.1 ttt85 -62.35 -53.41 55.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.016 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.74 -45.76 67.14 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.292 0.637 . . . . 0.0 112.054 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 166' ' ' ILE . 48.7 t -61.79 -49.67 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.69 -18.93 70.72 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.849 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.1 mm-40 -82.48 -29.08 30.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.387 0.675 . . . . 0.0 109.857 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.11 23.9 16.19 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 64.5 mt -91.46 147.97 36.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.397 1.079 . . . . 0.0 110.047 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.15 -167.02 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.939 2.426 . . . . 0.0 112.165 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.448 ' ND1' HG23 ' A' ' 162' ' ' THR . 45.0 t-80 -62.55 126.5 88.39 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 109.784 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -10.2 28.12 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.844 2.363 . . . . 0.0 113.851 -171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.08 -64.97 1.01 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.923 0.489 . . . . 0.0 110.04 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.448 HG23 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -98.0 -5.06 34.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.291 0.636 . . . . 0.0 112.097 -167.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 62.66 21.64 12.84 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.526 1.13 . . . . 0.0 112.746 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -80.46 151.52 71.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.138 0.575 . . . . 0.0 111.009 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.2 118.91 5.81 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.521 2.147 . . . . 0.0 111.357 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.485 ' HA ' HD13 ' A' ' 170' ' ' ILE . 71.8 mt -64.93 135.02 28.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.349 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 t -148.78 163.36 37.59 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.844 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.96 -24.12 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.946 0.898 . . . . 0.0 111.356 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -64.74 -45.85 84.72 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.665 0.786 . . . . 0.0 111.928 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 166' ' ' ILE . 46.5 pt -80.98 -8.43 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.95 130.39 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 118.713 0.688 . . . . 0.0 109.391 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.6 m -132.73 173.84 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.211 1.404 . . . . 0.0 109.882 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 52.6 mtpt -101.5 169.85 8.59 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.029 0.442 . . . . 0.0 110.754 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -59.23 -28.53 66.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.523 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -78.66 -33.02 47.41 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.529 0.732 . . . . 0.0 111.387 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.62 -15.32 42.88 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.189 0.519 . . . . 0.0 110.857 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 30.5 p -112.9 146.94 38.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.603 0.761 . . . . 0.0 109.044 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.68 154.16 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 37.9 p90 -67.78 134.99 51.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 165.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.501 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.6 t70 -112.83 133.99 54.56 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.93 -49.97 33.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.598 1.159 . . . . 0.0 112.099 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 t -71.33 -24.55 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.049 0.386 . . . . 0.0 111.184 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.44 ' HA ' ' HE ' ' A' ' 183' ' ' ARG . 2.3 mmp_? -84.87 -34.05 22.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.358 0.663 . . . . 0.0 110.718 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.19 73.39 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.96 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -148.05 143.68 27.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.364 1.066 . . . . 0.0 109.481 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 25.5 m-85 -68.64 115.97 8.62 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 180' ' ' ASP . 24.1 pt -122.91 178.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.307 1.043 . . . . 0.0 108.611 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 133' ' ' LYS . 38.3 mm -83.87 155.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -68.06 159.36 31.01 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 120.981 0.419 . . . . 0.0 110.39 174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 149.21 67.95 0.01 OUTLIER Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.676 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 55.3 t30 . . . . . 0 CA--C 1.556 1.205 0 C-N-CA 124.314 1.045 . . . . 0.0 111.623 -175.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.084 0.469 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -67.29 -39.83 86.04 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.774 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.54 -51.43 36.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -72.99 -43.18 62.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.473 0.309 . . . . 0.0 110.655 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.51 -49.35 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.476 0.71 . . . . 0.0 111.081 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.427 ' HA ' HD13 ' A' ' 98' ' ' ILE . 40.2 mt-30 -67.6 -29.55 68.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.567 0.747 . . . . 0.0 111.367 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 4.1 m-80 -62.35 -43.18 99.42 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 170.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -40.67 94.08 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 122.823 0.449 . . . . 0.0 110.078 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 130' ' ' ILE . 94.9 mt -61.43 -38.32 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.732 0.813 . . . . 0.0 111.136 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.3 m -70.48 -32.56 70.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.136 0.574 . . . . 0.0 110.964 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 34.8 mt-30 -83.55 -39.42 20.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.105 0.562 . . . . 0.0 111.633 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -80.13 -19.97 46.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.545 -171.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -69.78 162.39 27.94 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 123.531 0.519 . . . . 0.0 110.877 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -148.11 159.65 43.71 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -68.34 97.97 0.79 Allowed 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.06 97.62 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.9 m -108.21 102.12 44.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.851 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.484 ' HB3' HD12 ' A' ' 117' ' ' ILE . 12.9 Cg_endo -54.61 -29.75 62.27 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.666 2.91 . . . . 0.0 112.666 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.678 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 8.9 pt-20 -69.79 -35.42 74.86 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.635 1.174 . . . . 0.0 111.54 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.678 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 50.7 mtt180 -93.84 -36.4 12.26 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.669 0.787 . . . . 0.0 111.209 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.37 -18.43 62.37 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.705 0.802 . . . . 0.0 111.977 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 63.53 17.68 10.53 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.882 1.273 . . . . 0.0 111.483 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -104.46 129.48 24.96 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 124.309 1.044 . . . . 0.0 109.615 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.24 166.45 19.05 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.733 2.289 . . . . 0.0 111.748 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.7 mt -53.25 -47.14 69.31 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.737 0.648 . . . . 0.0 111.022 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -52.14 -43.38 64.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.98 0.912 . . . . 0.0 112.852 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.65 69.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.332 0.653 . . . . 0.0 111.415 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 107' ' ' PRO . 15.1 pt -122.01 29.42 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.905 0.882 . . . . 0.0 110.322 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -73.82 121.83 21.49 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.188 0.995 . . . . 0.0 109.439 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.1 t -68.74 114.95 25.97 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.28 -12.7 34.42 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.801 2.334 . . . . 0.0 112.755 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.61 -51.88 16.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.843 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.8 p -96.75 -19.54 18.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.348 1.059 . . . . 0.0 112.324 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 57.85 46.81 16.31 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.318 1.047 . . . . 0.0 111.823 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.46 152.64 38.41 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.802 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.451 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 23.3 tm0? -76.25 113.38 27.78 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.75 167.04 18.97 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.009 2.473 . . . . 0.0 113.451 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.02 -23.45 26.79 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -143.46 140.69 30.49 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.102 1.361 . . . . 0.0 108.43 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.45 157.08 29.39 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.335 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 98' ' ' ILE . 7.1 pt -110.77 161.26 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.038 1.335 . . . . 0.0 109.775 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -104.89 118.17 35.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.588 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.5 t -114.67 125.55 72.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.493 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.3 ptmt -73.75 114.61 12.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 124.004 0.815 . . . . 0.0 110.037 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -71.95 80.45 0.91 Allowed 'General case' 0 C--O 1.247 0.943 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 36.7 t -64.8 -49.43 70.71 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.716 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.73 -27.96 68.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.564 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.43 2.58 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.366 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.0 m -161.53 17.91 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.464 0.706 . . . . 0.0 111.198 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 13.6 t70 67.03 22.09 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.394 1.078 . . . . 0.0 111.235 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.526 ' HA ' HG21 ' A' ' 187' ' ' ILE . 90.5 t -96.19 134.67 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.319 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 55.9 m -87.0 139.83 30.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.624 0.77 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.2 m -127.28 147.72 50.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.249 1.02 . . . . 0.0 108.853 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 tp -85.28 112.48 20.81 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.03 0.443 . . . . 0.0 110.222 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.47 137.17 46.86 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -58.34 137.43 57.2 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.177 0.444 . . . . 0.0 109.95 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.42 85.97 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.159 0.912 . . . . 0.0 111.15 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.54 -34.29 62.94 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.783 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.8 -44.09 61.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 112.118 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' HG21 ' A' ' 153' ' ' VAL . 34.7 t80 -73.48 -39.0 65.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.761 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -63.08 -37.98 89.37 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.583 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 48.4 ttt180 -53.64 -53.2 55.32 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.765 0.666 . . . . 0.0 109.481 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.26 -42.52 73.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.01 0.819 . . . . 0.0 111.829 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 149' ' ' PHE . 58.8 t -64.57 -46.9 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.416 0.448 . . . . 0.0 110.091 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.38 -36.06 91.93 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.825 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 45.3 mt-10 -75.95 -27.47 57.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.644 0.777 . . . . 0.0 110.819 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.79 20.44 34.02 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.747 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.86 144.16 47.62 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.035 0.934 . . . . 0.0 109.573 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.83 -170.3 0.88 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.992 2.462 . . . . 0.0 112.422 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.472 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.4 t-80 -62.5 126.81 89.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.571 0.749 . . . . 0.0 109.343 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.87 -14.87 39.71 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.23 1.954 . . . . 0.0 113.331 -170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.8 mt -96.12 -66.01 0.93 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 122.589 0.356 . . . . 0.0 110.886 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.472 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.0 t -90.51 -10.1 44.84 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 63.31 16.81 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.755 1.222 . . . . 0.0 112.843 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -80.12 144.69 59.2 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 122.87 12.37 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.702 2.268 . . . . 0.0 111.544 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.403 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -62.25 131.85 27.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 123.54 0.525 . . . . 0.0 110.104 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -143.77 161.95 37.29 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.89 0.876 . . . . 0.0 109.172 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.57 -23.04 66.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.665 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.2 m -69.44 -22.35 63.67 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.018 0.927 . . . . 0.0 112.728 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 48.0 pt -105.9 -2.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -97.79 140.53 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.394 -0.816 . . . . 0.0 109.887 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.525 HG11 HD12 ' A' ' 188' ' ' ILE . 27.3 m -141.35 -179.89 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.793 1.237 . . . . 0.0 110.049 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.7 168.63 10.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.641 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.44 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 43.7 t-80 -68.02 -24.89 65.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.842 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.12 -22.2 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.766 0.426 . . . . 0.0 110.68 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -85.63 -21.54 28.38 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.218 0.533 . . . . 0.0 111.042 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.2 p -101.65 145.45 29.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 167.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 143.64 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -65.85 102.05 0.73 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -72.75 124.19 24.85 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.63 -34.59 67.44 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.189 0.996 . . . . 0.0 111.585 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.8 t -80.32 -25.43 39.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.119 0.168 . . . . 0.0 111.159 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -100.98 -14.63 17.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.811 0.445 . . . . 0.0 111.53 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.48 79.76 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.156 -0.802 . . . . 0.0 114.942 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -165.79 162.49 18.55 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 117.694 0.747 . . . . 0.0 110.47 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.92 125.76 24.9 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 111.754 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.526 HG21 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -133.34 169.51 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.443 1.097 . . . . 0.0 109.134 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.525 HD12 HG11 ' A' ' 172' ' ' VAL . 42.6 mm -70.88 140.3 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.421 0.688 . . . . 0.0 110.733 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -63.75 165.32 8.58 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.561 0.696 . . . . 0.0 111.884 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.98 -24.66 24.44 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.513 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 124.139 0.975 . . . . 0.0 108.942 176.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.864 0.84 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.517 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 21.2 mp0 -79.6 -33.9 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.47 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.27 -55.5 12.49 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 113.48 -164.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -66.27 -34.79 78.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.281 0.632 . . . . 0.0 111.092 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 98' ' ' ILE . 67.1 mt -69.62 -45.18 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.697 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -57.89 -44.1 86.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.853 1.261 . . . . 0.0 111.214 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.07 -45.42 87.12 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.702 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HG2' ' HB2' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -66.82 -34.11 77.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.948 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.8 mt -65.84 -43.08 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.2 t -65.03 -33.94 77.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.792 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -77.77 -44.93 26.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.281 0.632 . . . . 0.0 111.829 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.431 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 82.8 m -76.61 -20.98 56.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.705 0.802 . . . . 0.0 112.675 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -71.08 168.27 17.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.645 0.736 . . . . 0.0 112.606 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -158.78 160.57 36.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.446 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.3 m -69.1 99.16 1.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.706 0.628 . . . . 0.0 109.469 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.32 119.89 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.411 0.685 . . . . 0.0 110.091 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 79.5 m -133.73 101.82 12.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.007 0.923 . . . . 0.0 109.386 -176.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 10.8 Cg_endo -52.39 -23.28 18.23 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.891 3.061 . . . . 0.0 114.008 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.9 pt-20 -73.14 -38.13 66.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.708 0.803 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.574 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 90.9 mtt-85 -93.43 -21.7 19.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.689 0.796 . . . . 0.0 111.514 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.17 -20.91 26.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.621 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.7 24.23 13.11 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.299 1.04 . . . . 0.0 111.46 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.4 m -110.31 137.21 20.56 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.128 0.971 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.1 162.67 28.65 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.275 1.983 . . . . 0.0 111.488 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 93.8 mt -54.26 -46.25 72.6 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.477 0.711 . . . . 0.0 111.289 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.13 -41.72 72.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.051 0.94 . . . . 0.0 112.694 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.98 68.88 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.579 0.752 . . . . 0.0 111.993 -175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 pt -122.95 30.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.039 0.936 . . . . 0.0 109.81 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 40.8 tt0 -78.62 134.98 37.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.442 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 18.7 t -71.49 114.94 32.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 109.185 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.36 -4.8 16.04 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.936 2.424 . . . . 0.0 113.497 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.493 HG12 ' HG3' ' A' ' 160' ' ' PRO . 59.7 mt -80.3 -53.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.87 0.868 . . . . 0.0 109.311 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -95.12 -11.01 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.148 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.63 37.06 19.49 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.986 0.914 . . . . 0.0 111.53 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.45 148.92 29.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.289 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 25.7 tm0? -72.05 118.64 68.88 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.282 0.633 . . . . 0.0 109.444 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.72 161.89 18.95 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.769 2.313 . . . . 0.0 113.493 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -88.02 -14.13 39.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.049 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -151.7 134.21 15.41 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.844 0.858 . . . . 0.0 109.93 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.23 165.38 38.55 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.31 -172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 143' ' ' LEU . 9.2 pt -114.41 158.97 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.654 1.582 . . . . 0.0 110.395 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.04 123.65 44.52 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 90.5 t -118.86 119.95 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.1 ptmt -74.83 114.15 12.95 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 123.763 0.664 . . . . 0.0 110.047 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -73.39 72.96 1.35 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 171.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 35.1 t -68.13 -55.41 12.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.819 -167.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -58.32 -34.39 70.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.178 0.991 . . . . 0.0 112.14 -173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.98 -62.4 2.36 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.637 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.9 t -149.33 3.93 0.59 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 22.9 t70 59.33 47.23 11.62 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.792 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.08 124.6 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 122.948 0.499 . . . . 0.0 110.26 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 65.1 m -84.21 128.68 34.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.251 0.621 . . . . 0.0 109.66 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.0 m -122.8 143.39 49.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.347 1.059 . . . . 0.0 109.66 -171.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 130' ' ' ILE . 46.9 tp -88.91 106.34 18.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.237 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 89.2 m-85 -99.43 149.96 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 148' ' ' ALA . 12.1 t70 -65.73 137.54 57.34 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.59 -52.96 62.84 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.985 0.803 . . . . 0.0 111.707 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.44 56.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.112 0.565 . . . . 0.0 111.966 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -75.6 -36.63 60.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.182 0.593 . . . . 0.0 110.771 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.41 ' O ' HG21 ' A' ' 153' ' ' VAL . 42.6 t80 -73.14 -38.43 66.27 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -61.51 -31.52 71.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.923 0.889 . . . . 0.0 110.839 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.0 tpm_? -63.21 -54.26 40.25 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.947 0.779 . . . . 0.0 109.564 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.3 mt -54.8 -47.0 74.57 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.252 0.97 . . . . 0.0 111.376 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 166' ' ' ILE . 99.4 t -60.67 -50.47 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.801 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.517 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -59.94 -32.83 76.38 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 124.112 0.883 . . . . 0.0 113.371 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 28.6 mm-40 -75.86 -30.93 59.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.392 0.677 . . . . 0.0 111.187 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.71 9.42 49.75 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.243 -171.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.74 139.76 74.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.934 0.894 . . . . 0.0 109.201 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.48 -164.55 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.404 2.07 . . . . 0.0 112.242 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.79 131.25 92.92 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.321 1.049 . . . . 0.0 110.143 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.493 ' HG3' HG12 ' A' ' 121' ' ' ILE . 72.1 Cg_endo -70.96 -24.7 23.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.296 1.998 . . . . 0.0 113.265 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -85.23 -59.21 2.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.966 0.506 . . . . 0.0 111.051 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -108.27 -7.86 15.84 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.939 -167.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 65.86 19.12 11.27 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.629 1.172 . . . . 0.0 112.247 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -71.36 144.42 89.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.174 0.589 . . . . 0.0 110.117 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.37 116.5 3.79 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.406 2.071 . . . . 0.0 110.816 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 153' ' ' VAL . 77.3 mt -61.21 132.91 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.66 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -147.15 164.79 31.97 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.278 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 97' ' ' LYS . . . -65.46 -24.62 67.21 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.541 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.8 t -69.3 -26.11 64.57 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.942 0.897 . . . . 0.0 112.333 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 166' ' ' ILE . 47.4 pt -100.69 -6.1 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 118.317 0.508 . . . . 0.0 112.236 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.417 HG23 ' HA ' ' A' ' 168' ' ' ALA . 10.2 tt -100.7 136.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.05 0.841 . . . . 0.0 109.773 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 101' ' ' CYS . 28.7 m -138.04 171.57 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.142 1.377 . . . . 0.0 110.829 -174.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 43.9 mtmt -92.95 164.2 13.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.402 0.681 . . . . 0.0 110.595 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -66.1 -33.54 76.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.703 0.801 . . . . 0.0 111.61 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -80.28 -20.24 44.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.308 0.643 . . . . 0.0 110.848 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -84.8 -27.95 26.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.974 0.91 . . . . 0.0 110.998 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.3 p -105.7 151.67 24.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -136.78 158.95 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.166 0.987 . . . . 0.0 108.457 177.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -64.6 130.36 43.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' HB2' HG13 ' A' ' 187' ' ' ILE . 11.3 t70 -106.13 135.6 47.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.97 -50.68 10.74 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.363 1.039 . . . . 0.0 111.816 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -72.38 -26.4 61.88 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.795 0.27 . . . . 0.0 111.64 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -93.01 -28.65 16.26 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.892 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.15 28.51 44.77 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.489 0.493 . . . . 0.0 114.176 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -169.84 161.8 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.167 0.484 . . . . 0.0 110.313 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 88.5 m-85 -60.33 124.41 20.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.746 1.219 . . . . 0.0 111.879 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 180' ' ' ASP . 2.8 pp -139.14 177.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.165 1.386 . . . . 0.0 109.31 174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.0 mm -77.16 146.0 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.319 0.648 . . . . 0.0 110.569 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.08 162.05 9.99 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.502 0.721 . . . . 0.0 112.05 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.88 66.97 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.0 t30 . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 126.006 1.722 . . . . 0.0 107.994 -166.574 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 119.791 -0.147 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 18.3 mp0 -59.74 -50.58 73.26 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.693 0.797 . . . . 0.0 110.641 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -30.21 70.97 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.416 0.286 . . . . 0.0 111.605 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -71.6 -48.03 50.8 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.169 0.588 . . . . 0.0 109.614 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.6 mt -60.03 -50.26 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.9 0.88 . . . . 0.0 110.217 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HA ' HD12 ' A' ' 98' ' ' ILE . 43.6 mt-30 -69.49 -28.36 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.309 1.044 . . . . 0.0 111.649 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.45 -44.26 96.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.32 -33.19 74.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.428 0.691 . . . . 0.0 110.886 177.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 95' ' ' GLN . 92.2 mt -63.17 -45.08 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 122.942 0.497 . . . . 0.0 109.73 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 m -65.51 -29.74 70.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.664 0.786 . . . . 0.0 112.52 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.98 -46.25 16.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.93 0.492 . . . . 0.0 111.819 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.1 -19.59 50.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.824 0.85 . . . . 0.0 112.878 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -67.27 172.24 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -156.47 157.09 34.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.974 172.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m -70.21 102.07 2.02 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.47 98.22 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.287 0.635 . . . . 0.0 109.797 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.6 m -103.48 103.23 34.48 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.992 0.917 . . . . 0.0 109.005 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.472 ' HB3' HD13 ' A' ' 117' ' ' ILE . 29.8 Cg_endo -60.22 -28.9 87.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.243 2.629 . . . . 0.0 112.506 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.66 -33.52 75.84 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.833 0.853 . . . . 0.0 110.756 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -88.12 -46.57 9.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.961 -174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.1 -22.98 63.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.366 0.666 . . . . 0.0 111.274 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 57.58 13.46 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.56 1.144 . . . . 0.0 113.662 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.59 133.92 31.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-O 118.289 -0.862 . . . . 0.0 108.752 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.34 149.29 23.23 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.983 2.455 . . . . 0.0 112.623 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.6 -46.7 63.64 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.114 0.966 . . . . 0.0 111.865 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.04 -36.83 78.15 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.865 0.866 . . . . 0.0 112.271 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.29 68.43 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.491 0.717 . . . . 0.0 111.459 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 107' ' ' PRO . 17.9 pt -107.65 5.34 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 110.807 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.9 128.15 35.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.428 1.091 . . . . 0.0 110.855 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.0 110.32 3.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.75 -3.07 13.14 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.814 2.342 . . . . 0.0 112.43 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.546 HG12 ' HG3' ' A' ' 160' ' ' PRO . 36.7 mt -81.04 -53.25 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.866 0.867 . . . . 0.0 109.197 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.1 p -96.32 -10.22 28.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.96 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.21 53.32 10.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.758 1.223 . . . . 0.0 111.449 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.12 160.59 38.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.026 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -73.76 120.3 80.53 Favored Pre-proline 0 CA--C 1.559 1.3 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 73.9 Cg_endo -76.05 157.97 38.22 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.203 2.602 . . . . 0.0 113.829 -173.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.526 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 10.7 pt-20 -81.24 -36.77 29.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.365 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.526 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.9 pttm -145.25 148.44 33.49 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.504 1.522 . . . . 0.0 107.369 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.04 159.81 32.65 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.302 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -113.98 166.45 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.527 1.531 . . . . 0.0 109.685 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -106.07 125.88 51.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.421 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 70.8 t -115.82 124.6 72.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.495 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.1 ptmt -74.92 104.44 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.904 0.859 . . . . 0.0 110.288 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -78.53 71.47 5.0 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 4.9 t -69.36 -26.89 64.9 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.419 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.7 -39.83 95.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.271 1.028 . . . . 0.0 110.709 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.39 -63.99 3.04 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -176.34 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.192 0.997 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 18.4 t70 62.44 27.26 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.412 1.085 . . . . 0.0 110.804 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.98 109.21 9.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.035 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 186' ' ' PHE . 58.4 m -83.49 119.62 24.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.3 m -118.86 145.33 45.78 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -170.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 117' ' ' ILE . 31.1 tp -86.63 103.9 15.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.484 0.659 . . . . 0.0 110.58 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.461 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 92.8 m-85 -102.84 133.4 47.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 107.905 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.5 t70 -56.59 134.17 54.18 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.605 0.639 . . . . 0.0 109.653 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.48 -44.75 80.93 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.018 0.824 . . . . 0.0 111.555 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.63 40.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.861 0.465 . . . . 0.0 111.758 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.45 38.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.44 0.696 . . . . 0.0 111.705 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.0 t80 -74.26 -39.48 62.98 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -61.66 -35.03 76.78 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.938 0.774 . . . . 0.0 110.961 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 10.7 tpt180 -57.3 -52.16 66.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.16 0.584 . . . . 0.0 109.499 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.8 mt -54.8 -41.93 71.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.041 0.838 . . . . 0.0 111.956 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 166' ' ' ILE . 21.9 t -69.02 -41.34 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 123.939 0.774 . . . . 0.0 109.768 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.93 -29.16 73.41 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.174 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -84.01 -24.21 30.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.213 0.605 . . . . 0.0 110.784 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 19.79 56.55 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.842 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.1 147.48 73.25 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.078 0.951 . . . . 0.0 110.668 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.53 175.87 10.8 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.411 2.074 . . . . 0.0 111.91 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -55.43 131.81 70.43 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.417 1.087 . . . . 0.0 111.114 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.546 ' HG3' HG12 ' A' ' 121' ' ' ILE . 71.7 Cg_endo -69.08 -17.82 40.47 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.413 2.075 . . . . 0.0 113.822 -169.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.05 -62.32 1.25 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.875 0.47 . . . . 0.0 111.302 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 t -104.99 -7.21 19.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.753 -168.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.29 26.11 14.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.54 1.136 . . . . 0.0 112.201 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.17 154.69 92.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.033 0.933 . . . . 0.0 110.116 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.07 113.36 2.58 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 121.919 1.746 . . . . 0.0 109.799 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.549 HG22 HG21 ' A' ' 153' ' ' VAL . 61.0 mt -60.87 122.58 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.2 t -147.32 162.41 39.01 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.809 0.844 . . . . 0.0 109.493 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.439 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -72.24 -14.88 61.89 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.84 0.456 . . . . 0.0 110.973 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.9 m -70.12 -30.61 67.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.729 0.812 . . . . 0.0 111.921 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.9 pt -99.5 -8.4 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 168' ' ' ALA . 8.4 tt -88.39 138.66 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.34 168.21 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.577 0.751 . . . . 0.0 111.135 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -90.35 153.27 20.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.812 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -65.02 -23.72 67.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -85.31 -21.96 28.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.57 0.748 . . . . 0.0 110.441 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.41 -17.86 37.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.993 . . . . 0.0 111.247 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 23.9 p -130.35 152.8 49.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.432 1.093 . . . . 0.0 109.325 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.93 164.88 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.746 1.218 . . . . 0.0 109.104 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 5.3 p90 -73.84 128.45 35.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.482 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.2 t70 -106.63 140.2 39.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -79.22 -48.66 13.8 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.756 0.822 . . . . 0.0 112.523 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.432 HG22 ' HE ' ' A' ' 183' ' ' ARG . 10.1 t -71.29 -24.68 62.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.472 0.578 . . . . 0.0 111.544 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.432 ' HE ' HG22 ' A' ' 182' ' ' THR . 5.0 mmp_? -81.2 -32.51 33.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 170.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.05 22.12 74.67 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.704 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -167.6 162.37 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.102 0.961 . . . . 0.0 108.87 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 70.7 m-85 -64.11 128.69 36.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.477 1.111 . . . . 0.0 112.012 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 180' ' ' ASP . 29.4 pt -132.57 177.35 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.644 1.177 . . . . 0.0 109.65 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 133' ' ' LYS . 48.7 mm -75.42 151.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.18 0.592 . . . . 0.0 109.6 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -73.13 159.31 33.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.102 0.561 . . . . 0.0 111.369 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -42.07 6.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.363 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 124.026 0.93 . . . . 0.0 109.122 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.402 ' HG3' HG11 ' A' ' 153' ' ' VAL . 16.3 mp0 -53.0 -47.68 68.08 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.736 0.814 . . . . 0.0 112.547 -176.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -44.82 78.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.744 0.652 . . . . 0.0 111.473 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.9 t -67.03 -43.52 82.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 98' ' ' ILE . 63.6 mt -64.24 -44.54 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 123.713 0.633 . . . . 0.0 110.114 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.77 -44.05 90.55 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.526 1.13 . . . . 0.0 110.727 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.725 173.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.1 -35.49 81.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.714 0.805 . . . . 0.0 111.222 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 94' ' ' ILE . 94.3 mt -65.47 -41.36 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.6 t -64.27 -40.18 95.46 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.46 0.704 . . . . 0.0 111.69 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -80.39 -28.42 37.9 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 84.1 m -96.51 -18.08 20.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.121 0.568 . . . . 0.0 112.362 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.84 169.15 16.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 111.47 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -155.8 158.03 37.45 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m -68.05 96.53 0.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.03 100.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.235 0.614 . . . . 0.0 110.178 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.1 m -101.82 99.17 11.26 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.099 0.96 . . . . 0.0 108.581 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.75 -36.08 98.53 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.833 2.355 . . . . 0.0 112.331 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.16 -22.49 59.4 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.145 0.903 . . . . 0.0 111.87 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 12.8 mmp_? -91.72 -42.31 10.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.101 0.56 . . . . 0.0 111.091 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.527 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 96.9 mt -64.8 -19.21 65.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.654 0.782 . . . . 0.0 112.391 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 55.98 22.37 5.75 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.331 1.052 . . . . 0.0 112.442 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 55.8 m -95.24 141.54 23.36 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 123.9 0.88 . . . . 0.0 109.698 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.96 145.95 75.86 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.028 1.819 . . . . 0.0 110.236 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 99.5 mt -51.47 -43.82 62.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.967 0.907 . . . . 0.0 112.398 -173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.75 -36.8 79.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.61 0.764 . . . . 0.0 112.855 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.2 64.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.939 0.496 . . . . 0.0 110.865 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.04 27.92 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.943 0.897 . . . . 0.0 110.361 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.69 129.3 34.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.298 0.639 . . . . 0.0 109.35 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 t -68.74 111.9 9.7 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.25 0.46 9.37 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.748 2.299 . . . . 0.0 112.669 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -84.61 -55.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.702 0.801 . . . . 0.0 108.85 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.0 p -92.84 -8.83 42.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.828 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.56 39.74 21.18 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.545 1.138 . . . . 0.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.39 152.17 31.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -67.77 117.83 51.81 Favored Pre-proline 0 CA--C 1.557 1.246 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.73 166.31 23.76 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.084 2.523 . . . . 0.0 113.688 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.577 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.5 pt-20 -86.28 -28.0 24.04 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.846 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.577 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.52 145.41 31.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.089 1.356 . . . . 0.0 107.753 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.49 166.89 39.71 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.356 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.1 pt -115.03 153.82 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 125.298 1.439 . . . . 0.0 109.496 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -97.04 122.15 39.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 79.6 t -114.68 123.73 70.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HB3' HD13 ' A' ' 188' ' ' ILE . 22.5 ptmt -69.04 107.44 3.15 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -73.36 89.66 1.62 Allowed 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -63.62 -36.73 84.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.173 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.5 -26.6 66.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.41 0.684 . . . . 0.0 110.818 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.4 13.83 43.92 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.462 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.0 m 77.26 44.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.31 1.444 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.89 24.46 14.47 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.607 1.163 . . . . 0.0 112.264 174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.49 ' HA ' HG22 ' A' ' 187' ' ' ILE . 98.0 t -79.94 125.53 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.171 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.4 129.62 34.77 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.632 0.773 . . . . 0.0 110.295 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.4 m -123.77 139.74 53.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.184 0.994 . . . . 0.0 109.002 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.1 tp -89.27 111.31 22.09 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.372 0.42 . . . . 0.0 110.061 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.427 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 84.5 m-85 -103.79 141.71 35.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.413 1.085 . . . . 0.0 108.243 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.52 132.26 51.87 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.781 0.675 . . . . 0.0 111.834 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.57 55.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.889 0.476 . . . . 0.0 111.455 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.13 69.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.72 0.808 . . . . 0.0 111.561 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.7 t80 -74.32 -40.41 62.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.543 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -63.84 -30.51 71.6 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.464 0.706 . . . . 0.0 111.011 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -62.43 -52.23 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.781 0.833 . . . . 0.0 109.686 172.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.43 -47.62 81.28 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 123.735 0.647 . . . . 0.0 111.228 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.472 HG22 HG21 ' A' ' 166' ' ' ILE . 97.2 t -61.15 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.269 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.54 92.45 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 124.069 0.856 . . . . 0.0 112.943 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -73.46 -23.31 60.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.168 0.587 . . . . 0.0 111.503 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.06 18.98 37.78 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.375 0.422 . . . . 0.0 112.872 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.0 149.4 70.03 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.734 1.213 . . . . 0.0 110.497 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.85 -174.44 2.23 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.984 2.456 . . . . 0.0 112.466 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 162' ' ' THR . 53.7 t-80 -64.55 127.54 92.45 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.821 0.848 . . . . 0.0 109.082 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.31 -17.92 49.91 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.217 1.945 . . . . 0.0 113.217 -168.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.0 mt -95.46 -62.83 1.23 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.184 0.594 . . . . 0.0 111.15 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.436 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.9 t -91.42 -11.67 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.527 0.331 . . . . 0.0 111.492 -172.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 59.63 23.43 12.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.119 1.368 . . . . 0.0 112.838 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -91.68 154.93 44.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.739 0.816 . . . . 0.0 109.77 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.91 123.53 12.42 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.438 2.092 . . . . 0.0 112.068 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.472 HG21 HG22 ' A' ' 153' ' ' VAL . 81.2 mt -63.33 136.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.149 0.58 . . . . 0.0 109.952 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -147.33 161.51 40.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.371 0.668 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' A' ' 171' ' ' ILE . . . -68.61 -19.87 64.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.403 1.081 . . . . 0.0 110.997 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -69.58 -24.96 63.76 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.954 0.902 . . . . 0.0 112.561 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 49.4 pt -105.21 -5.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 168' ' ' ALA . 9.6 tt -96.94 132.13 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.881 0.764 . . . . 0.0 109.486 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.33 175.4 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.311 1.044 . . . . 0.0 110.06 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.566 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 95.5 mttt -96.77 165.74 11.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.615 0.366 . . . . 0.0 110.662 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -63.53 -27.01 68.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.372 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -77.93 -27.18 49.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.66 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -85.88 -20.52 28.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.965 0.906 . . . . 0.0 111.785 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.1 p -117.41 150.96 38.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.01 0.924 . . . . 0.0 109.574 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 160.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.196 0.999 . . . . 0.0 108.753 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.94 140.12 57.84 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.33 139.41 53.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.879 0.471 . . . . 0.0 110.008 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.42 -52.69 9.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.331 1.052 . . . . 0.0 111.64 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -74.72 -26.71 59.99 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -80.83 -33.54 34.54 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.542 0.737 . . . . 0.0 109.824 169.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.74 25.89 48.14 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.626 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.34 170.73 2.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.228 0.611 . . . . 0.0 111.043 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.499 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 89.9 m-85 -61.88 122.05 14.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.692 1.197 . . . . 0.0 111.527 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.9 pp -134.71 173.95 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.713 1.205 . . . . 0.0 109.904 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 133' ' ' LYS . 43.8 mm -73.54 143.74 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.726 0.81 . . . . 0.0 110.684 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -66.12 150.56 48.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.484 0.713 . . . . 0.0 112.05 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -103.93 -20.92 10.04 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.379 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 CA--C 1.552 1.053 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.653 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.827 0.346 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.415 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 16.2 mp0 -84.86 -29.08 25.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.269 0.627 . . . . 0.0 111.254 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.81 -49.37 49.06 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.232 1.013 . . . . 0.0 113.334 -164.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.495 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 17.2 m -70.29 -41.04 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.277 0.631 . . . . 0.0 109.95 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.7 mt -66.12 -45.33 90.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.381 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -57.69 -46.14 84.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.854 1.261 . . . . 0.0 110.704 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.74 -37.39 86.37 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.024 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -66.39 -44.4 83.17 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 123.216 0.606 . . . . 0.0 110.224 177.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.5 mt -60.49 -39.0 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 109.666 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -67.32 -41.08 85.88 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.132 0.973 . . . . 0.0 111.011 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -83.19 -14.56 53.15 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.672 0.789 . . . . 0.0 112.984 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 93.5 m -103.55 -25.37 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.309 0.644 . . . . 0.0 112.601 -173.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -68.92 166.09 18.58 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -156.72 158.05 36.22 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.373 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.5 m -67.07 100.65 0.78 Allowed 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.706 0.802 . . . . 0.0 109.47 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.75 101.61 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.0 m -112.33 96.87 37.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.489 ' HB3' HD12 ' A' ' 117' ' ' ILE . 8.0 Cg_endo -50.86 -23.52 11.88 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.938 3.092 . . . . 0.0 113.927 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.59 -30.18 59.51 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -93.47 -40.19 10.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.392 0.677 . . . . 0.0 111.135 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.06 -24.33 64.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.067 0.547 . . . . 0.0 110.237 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 45.41 50.42 10.11 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 124.889 1.276 . . . . 0.0 111.698 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.6 m -124.3 148.72 58.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.391 1.076 . . . . 0.0 110.038 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.67 141.67 97.45 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.348 2.032 . . . . 0.0 110.772 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.525 HD23 ' HG3' ' A' ' 125' ' ' GLN . 52.4 mt -55.06 -37.82 67.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.831 0.852 . . . . 0.0 111.666 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.01 -38.13 81.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.785 0.834 . . . . 0.0 112.192 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.27 66.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.065 0.546 . . . . 0.0 111.014 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 107' ' ' PRO . 33.3 pt -116.12 26.59 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.235 1.014 . . . . 0.0 110.302 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.57 127.54 33.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.308 1.043 . . . . 0.0 110.15 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.9 t -74.38 110.83 10.51 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.9 -2.75 12.68 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.78 2.32 . . . . 0.0 112.947 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.0 mt -85.12 -57.33 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.769 0.828 . . . . 0.0 109.499 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p -80.37 -23.67 40.32 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.024 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 62.74 49.9 3.58 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.124 0.964 . . . . 0.0 110.291 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.45 154.33 34.2 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.214 171.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.525 ' HG3' HD23 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -72.05 112.17 13.46 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.9 Cg_endo -71.32 159.78 50.73 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.205 2.604 . . . . 0.0 114.459 -167.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.534 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 6.4 pt-20 -80.81 -39.84 25.99 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.683 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.534 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -146.57 146.23 30.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.801 1.24 . . . . 0.0 108.044 178.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.35 42.36 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.461 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.2 pt -122.54 159.81 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.719 1.608 . . . . 0.0 109.197 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 141' ' ' CYS . 40.7 m-85 -104.85 119.8 39.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 170.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.3 121.43 66.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.662 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.9 ptmt -64.35 127.26 30.72 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 124.099 0.874 . . . . 0.0 112.77 -172.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -76.86 72.72 3.47 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -42.9 99.74 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.417 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.65 -40.38 92.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.502 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.63 -66.54 2.1 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.68 -171.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.497 ' HB2' HG23 ' A' ' 140' ' ' VAL . 42.7 m -161.3 22.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.162 0.585 . . . . 0.0 111.569 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.42 31.33 17.23 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.884 1.326 . . . . 0.0 110.314 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.577 ' HA ' HG23 ' A' ' 187' ' ' ILE . 60.0 t -81.72 177.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.413 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 131' ' ' PHE . 26.4 p -134.3 140.78 46.64 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.5 m -118.94 146.34 45.04 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.06 109.38 20.44 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.235 0.541 . . . . 0.0 110.67 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.24 130.72 54.71 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 108.173 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.1 t70 -55.56 132.11 47.87 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.889 0.768 . . . . 0.0 109.17 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.45 77.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 112.154 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -33.0 63.34 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.621 0.575 . . . . 0.0 110.963 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -72.23 -36.76 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -80.27 -36.81 34.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -63.92 -29.8 70.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.365 0.666 . . . . 0.0 110.789 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 8.5 tpt180 -59.18 -59.08 6.03 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.924 0.765 . . . . 0.0 108.995 169.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.26 -46.83 72.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.019 0.825 . . . . 0.0 111.915 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 166' ' ' ILE . 95.4 t -61.99 -48.93 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 110.135 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -62.97 -35.78 92.55 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 123.995 0.81 . . . . 0.0 113.045 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 8.9 mm-40 -67.81 -34.97 77.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.521 0.729 . . . . 0.0 110.289 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.65 27.32 8.05 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.305 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 54.4 mt -90.19 149.04 40.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.375 1.07 . . . . 0.0 109.779 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.21 -176.38 3.24 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.463 2.109 . . . . 0.0 112.399 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.09 128.61 81.76 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.204 1.002 . . . . 0.0 110.569 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.64 -13.76 37.9 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.323 2.015 . . . . 0.0 113.971 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.2 mt -101.17 -56.11 2.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.735 0.414 . . . . 0.0 111.766 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.5 t -104.01 -10.29 18.19 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.876 0.47 . . . . 0.0 111.271 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 63.75 21.46 12.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.623 1.169 . . . . 0.0 112.999 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.06 151.41 78.79 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.299 0.64 . . . . 0.0 109.873 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.16 122.73 12.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.778 2.319 . . . . 0.0 110.991 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.54 ' HA ' HD13 ' A' ' 170' ' ' ILE . 74.7 mt -66.34 128.38 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 t -146.13 159.61 43.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.161 0.984 . . . . 0.0 109.377 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.7 -19.7 65.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.612 0.765 . . . . 0.0 111.158 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -70.25 -39.51 74.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.929 0.891 . . . . 0.0 111.788 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 166' ' ' ILE . 47.6 pt -90.66 -12.19 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.16 137.34 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.144 0.884 . . . . 0.0 108.728 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 188' ' ' ILE . 28.8 m -130.22 171.67 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.283 1.033 . . . . 0.0 109.113 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 58.6 mtpt -88.52 165.72 14.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.159 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.732 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 21.0 t60 -73.62 -23.27 59.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.39 0.614 . . . . 0.0 109.649 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.44 -31.49 71.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.8 10.18 41.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.602 0.761 . . . . 0.0 111.726 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.9 p -139.57 138.07 35.93 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.635 -0.666 . . . . 0.0 110.457 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.409 HD13 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -133.82 162.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.756 1.223 . . . . 0.0 108.579 -174.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -66.47 124.46 22.83 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 166.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.542 ' HB2' HG12 ' A' ' 187' ' ' ILE . 12.4 t70 -105.32 134.02 49.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.83 -36.57 42.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.15 0.906 . . . . 0.0 112.337 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 180' ' ' ASP . 1.1 t -76.53 -23.64 53.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.452 ' HG3' HG21 ' A' ' 187' ' ' ILE . 40.0 mmt180 -86.98 -33.92 19.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.841 0.857 . . . . 0.0 110.661 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.84 18.63 77.65 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.45 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -148.41 150.71 33.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.413 1.085 . . . . 0.0 109.934 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -60.48 117.33 5.14 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.394 0.678 . . . . 0.0 110.303 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 140' ' ' VAL . 13.3 pt -129.68 178.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.828 0.851 . . . . 0.0 108.91 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 133' ' ' LYS . 8.8 mm -70.84 154.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.632 ' HZ2' ' HB3' ' A' ' 189' ' ' LYS . 9.6 mtpm? -70.82 148.16 48.16 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.273 0.559 . . . . 0.0 111.357 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -107.45 -42.49 1.47 Allowed Glycine 0 N--CA 1.461 0.365 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.961 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 C--O 1.249 1.068 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.504 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.374 0.607 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.441 ' HG3' HG12 ' A' ' 153' ' ' VAL . 6.7 mp0 -60.9 -44.44 97.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.086 -176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -41.96 82.57 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.196 0.598 . . . . 0.0 111.615 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.7 t -72.84 -50.93 21.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.512 0.725 . . . . 0.0 110.609 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.8 mt -64.01 -44.37 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.303 0.641 . . . . 0.0 111.196 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.75 -27.73 64.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.119 0.567 . . . . 0.0 111.567 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.51 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 2.6 m-80 -64.58 -41.21 96.41 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.43 -34.69 78.89 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.86 0.864 . . . . 0.0 110.67 177.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 130' ' ' ILE . 92.8 mt -67.44 -37.74 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.279 0.631 . . . . 0.0 109.44 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.5 t -67.15 -36.49 81.95 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.5 mm-40 -74.56 -53.96 8.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.685 0.394 . . . . 0.0 110.737 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.624 ' SG ' ' HE3' ' A' ' 173' ' ' LYS . 72.5 m -71.81 -19.96 61.92 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.066 0.946 . . . . 0.0 112.983 -167.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.1 170.97 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.789 0.804 . . . . 0.0 112.825 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -160.02 156.68 27.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.935 173.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 p -70.95 104.5 2.98 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.405 HG13 ' NE2' ' A' ' 125' ' ' GLN . 45.6 t -77.72 96.98 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 -171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.81 105.41 41.27 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.6 -31.17 86.79 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.967 2.445 . . . . 0.0 113.522 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 -30.29 49.74 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.48 0.488 . . . . 0.0 110.581 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -78.79 -35.03 45.0 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.52 -19.23 53.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.536 0.734 . . . . 0.0 111.691 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 57.23 22.34 7.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.025 0.93 . . . . 0.0 112.621 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -104.94 146.35 32.49 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 123.717 0.807 . . . . 0.0 109.649 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.58 152.66 80.93 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.317 2.011 . . . . 0.0 111.101 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.34 -40.95 68.51 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.887 0.742 . . . . 0.0 111.549 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.64 -41.03 80.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.323 1.049 . . . . 0.0 112.688 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.82 62.91 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.435 0.694 . . . . 0.0 111.434 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 12.0 pt -126.5 33.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.899 0.879 . . . . 0.0 109.506 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 43.4 tt0 -84.47 137.94 33.07 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.829 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.5 t -76.85 113.64 31.92 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.84 0.49 8.2 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.168 2.579 . . . . 0.0 113.107 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.0 mt -85.24 -54.75 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p -86.28 -18.88 30.88 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.189 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 66.45 36.52 5.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.342 1.057 . . . . 0.0 111.445 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.73 151.7 30.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.479 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 25.5 tm0? -69.64 113.2 15.44 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.873 0.869 . . . . 0.0 108.673 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 92.5 Cg_endo -73.59 163.82 36.48 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.57 2.18 . . . . 0.0 113.867 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -17.69 28.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.189 0.996 . . . . 0.0 110.261 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HD3' ' HB3' ' A' ' 146' ' ' ALA . 1.3 pptp? -153.27 140.87 19.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.152 0.981 . . . . 0.0 108.957 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.77 168.49 41.38 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.507 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 98' ' ' ILE . 13.7 pt -121.0 156.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.547 1.539 . . . . 0.0 109.87 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.6 123.42 43.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 169.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 72.9 t -123.83 122.1 63.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.671 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -69.9 116.96 10.88 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.435 0.636 . . . . 0.0 110.164 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.05 85.28 1.81 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 27.9 t -66.19 -39.84 89.97 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.204 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.35 -35.79 82.04 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.978 0.911 . . . . 0.0 111.105 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.51 -63.97 2.89 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -169.8 23.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.415 0.686 . . . . 0.0 110.631 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.9 m-20 59.29 31.33 21.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.425 1.09 . . . . 0.0 111.698 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.2 t -94.08 128.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.186 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 27.7 p -84.39 132.11 34.62 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -124.52 146.61 48.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.402 HD11 ' O ' ' A' ' 130' ' ' ILE . 44.6 tp -90.43 115.33 27.51 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.4 m-85 -111.78 137.92 49.06 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.492 1.117 . . . . 0.0 108.114 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.723 0.692 . . . . 0.0 109.302 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -57.15 -42.83 81.74 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.93 0.769 . . . . 0.0 111.926 -173.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.69 -36.05 60.15 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.84 0.456 . . . . 0.0 111.593 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.78 69.28 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.125 0.57 . . . . 0.0 111.625 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.407 ' O ' HG21 ' A' ' 153' ' ' VAL . 36.6 t80 -71.62 -37.02 70.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.124 0.57 . . . . 0.0 109.881 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -63.03 -36.7 84.44 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.702 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 79.1 ttt180 -60.39 -45.88 91.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.63 -47.05 77.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.137 0.575 . . . . 0.0 111.224 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' A' ' 91' ' ' GLN . 38.7 t -66.04 -46.25 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.227 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.87 -33.07 84.16 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 124.262 0.976 . . . . 0.0 113.312 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 23.9 mm-40 -75.59 -32.22 60.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.08 21.8 10.6 Favored Glycine 0 N--CA 1.468 0.825 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.753 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 50.6 mt -85.18 153.08 59.35 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 0.0 111.146 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.0 174.95 11.9 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.216 2.611 . . . . 0.0 113.081 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -55.14 134.39 68.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.041 1.336 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.98 -26.14 58.83 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.654 2.236 . . . . 0.0 113.876 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.74 -60.7 1.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.6 t -105.34 -4.19 21.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.646 -167.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 60.22 28.19 17.76 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.106 0.963 . . . . 0.0 112.729 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -80.11 159.99 69.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.18 0.992 . . . . 0.0 111.371 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.4 112.72 2.66 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.119 1.879 . . . . 0.0 111.006 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 170' ' ' ILE . 72.9 mt -62.65 131.79 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.635 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 162.67 38.77 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.363 0.665 . . . . 0.0 110.446 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.12 66.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.705 0.802 . . . . 0.0 111.691 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -68.54 -41.0 80.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 111.581 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -84.94 -7.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.4 tt -97.95 132.83 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.015 0.825 . . . . 0.0 109.876 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 188' ' ' ILE . 27.6 m -133.76 178.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.136 1.375 . . . . 0.0 110.029 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.624 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 3.3 mptt -104.26 166.47 10.38 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.481 0.712 . . . . 0.0 109.755 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -70.78 -16.12 62.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.145 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -79.65 -35.29 39.51 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.577 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -83.72 -23.1 31.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.737 0.815 . . . . 0.0 110.602 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 31.7 p -115.78 142.2 47.07 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.867 0.867 . . . . 0.0 108.897 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.4 163.26 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.491 1.116 . . . . 0.0 109.045 -174.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -71.49 136.82 47.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.432 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -119.44 132.88 55.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.87 -51.35 22.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.664 1.186 . . . . 0.0 111.906 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 t -73.15 -23.23 60.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.269 0.228 . . . . 0.0 111.536 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -81.03 -33.98 33.16 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.13 0.572 . . . . 0.0 110.561 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.84 76.11 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.284 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -146.46 146.89 30.73 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.2 1.0 . . . . 0.0 109.446 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.499 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 97.9 m-85 -66.7 116.43 7.61 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 167.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 180' ' ' ASP . 27.9 pt -127.21 178.95 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.075 0.95 . . . . 0.0 109.365 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.671 HD11 ' HB3' ' A' ' 133' ' ' LYS . 21.1 mm -85.82 148.28 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -60.49 154.03 21.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.541 0.736 . . . . 0.0 111.989 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.76 62.92 4.48 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 . . . . . 0 CA--C 1.557 1.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.424 -168.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.955 -0.017 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -58.01 -41.33 82.9 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.95 -45.39 67.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.282 1.033 . . . . 0.0 112.106 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 t -66.05 -39.24 89.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.63 0.772 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.2 mt -69.56 -45.51 77.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.938 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -58.92 -45.31 90.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.157 . . . . 0.0 111.219 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -59.77 -40.91 89.83 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -44.86 95.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.144 0.578 . . . . 0.0 110.727 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 150' ' ' SER . 87.7 mt -60.58 -39.19 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.804 0.842 . . . . 0.0 110.206 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.7 t -64.85 -40.12 94.65 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.988 0.915 . . . . 0.0 111.805 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -83.61 -27.33 29.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.284 0.634 . . . . 0.0 112.601 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.1 m -95.69 -12.23 25.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.578 0.751 . . . . 0.0 112.448 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -74.01 165.25 25.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.635 0.731 . . . . 0.0 112.877 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.06 154.59 35.18 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.422 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -75.61 105.06 6.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.2 130.91 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.918 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 39.3 m -122.38 81.56 46.04 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.695 0.798 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.97 -39.15 40.19 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.163 3.242 . . . . 0.0 113.802 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.6 pt-20 -60.95 -45.71 93.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.206 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.497 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 67.4 mtp180 -83.47 -31.59 26.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.088 0.555 . . . . 0.0 111.483 -174.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.33 -18.59 63.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.228 0.611 . . . . 0.0 111.013 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.65 2.67 3.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.301 1.44 . . . . 0.0 112.299 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 62.0 m -92.3 133.13 30.49 Favored Pre-proline 0 C--O 1.247 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 109.17 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.08 158.59 21.08 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.64 2.227 . . . . 0.0 112.164 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -53.47 -43.96 68.57 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.881 0.738 . . . . 0.0 111.488 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.4 -38.45 77.38 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.215 1.006 . . . . 0.0 112.731 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.99 64.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.694 0.798 . . . . 0.0 112.099 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.518 ' HB ' HD21 ' A' ' 143' ' ' LEU . 8.9 pt -127.24 11.59 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.739 0.816 . . . . 0.0 110.57 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 41.8 tt0 -63.98 132.53 50.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.991 0.916 . . . . 0.0 111.097 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 34.6 t -67.58 111.87 8.71 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.85 -3.56 13.97 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.54 2.16 . . . . 0.0 112.647 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.449 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -79.62 -54.0 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.469 1.108 . . . . 0.0 109.431 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p -101.09 -4.23 27.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.255 -169.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.32 33.34 20.86 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.88 0.872 . . . . 0.0 112.258 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.16 153.5 39.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.516 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 21.4 tm0? -70.61 123.85 89.84 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 72.6 Cg_endo -76.24 154.6 36.89 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.367 2.712 . . . . 0.0 114.386 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.495 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.5 pt-20 -83.26 -35.79 25.06 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.479 174.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 48.6 pttt -138.33 138.86 38.75 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.16 157.41 28.26 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.062 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -113.2 156.34 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.474 1.509 . . . . 0.0 109.602 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -98.81 116.88 32.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 65.4 t -116.54 122.36 69.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.3 ptmt -69.55 110.51 4.83 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.515 0.674 . . . . 0.0 109.413 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.07 81.11 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 162.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -69.49 -68.79 0.38 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.292 -167.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.43 -35.0 71.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.934 0.894 . . . . 0.0 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.49 -62.55 4.51 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.42 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 m -150.93 4.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -170.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 62.37 22.55 13.3 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.866 0.841 . . . . 0.0 111.061 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.87 129.99 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.67 0.788 . . . . 0.0 110.897 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 56.5 m -84.16 127.72 34.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.797 0.839 . . . . 0.0 108.838 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.6 m -126.04 146.98 49.68 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' A' ' 117' ' ' ILE . 40.3 tp -88.24 105.28 17.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.091 0.472 . . . . 0.0 109.897 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 85.8 m-85 -98.6 143.28 29.17 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.3 t70 -63.63 136.37 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.38 73.48 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.201 0.938 . . . . 0.0 111.593 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.0 -31.66 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.074 0.55 . . . . 0.0 111.696 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.587 0.755 . . . . 0.0 111.817 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -76.57 -37.77 56.02 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.481 ' HB2' HG23 ' A' ' 98' ' ' ILE . 27.5 t -63.27 -30.21 71.4 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.742 174.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.5 tpm_? -64.36 -52.64 57.31 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.384 172.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.61 -45.77 73.71 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 123.912 0.757 . . . . 0.0 111.392 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.02 -43.37 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.515 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.82 -16.66 74.62 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.027 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -91.12 -23.54 20.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.322 0.649 . . . . 0.0 110.992 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.11 13.4 58.94 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.439 0.462 . . . . 0.0 112.734 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.36 139.63 52.05 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.067 0.947 . . . . 0.0 109.924 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.83 -176.97 2.59 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.765 2.31 . . . . 0.0 113.012 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.401 ' ND1' HG21 ' A' ' 162' ' ' THR . 46.9 t-80 -58.65 126.32 79.46 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.121 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.428 ' HG3' HG12 ' A' ' 121' ' ' ILE . 66.1 Cg_endo -66.51 -15.71 48.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.79 2.327 . . . . 0.0 113.462 -170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.0 mt -97.32 -64.9 1.0 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.757 0.423 . . . . 0.0 111.243 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.401 HG21 ' ND1' ' A' ' 159' ' ' HIS . 9.7 t -94.33 -8.86 37.69 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 122.645 0.378 . . . . 0.0 111.796 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 61.04 21.02 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.904 1.281 . . . . 0.0 112.759 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -87.29 161.07 47.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.311 1.044 . . . . 0.0 110.213 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.21 121.06 8.58 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.018 1.812 . . . . 0.0 111.82 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 170' ' ' ILE . 71.3 mt -65.65 139.47 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.024 0.53 . . . . 0.0 109.584 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.2 t -153.41 165.34 36.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.398 0.436 . . . . 0.0 111.277 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.46 -22.89 66.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.352 1.061 . . . . 0.0 111.941 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -68.11 -43.69 77.87 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.715 0.806 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 166' ' ' ILE . 46.1 pt -85.19 -12.87 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.7 tt -98.61 136.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -137.47 173.57 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.927 1.291 . . . . 0.0 110.45 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -91.14 164.07 14.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -66.11 -25.17 66.88 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.686 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.21 -29.09 21.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.5 1.12 . . . . 0.0 110.639 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.06 -25.68 34.36 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.808 0.843 . . . . 0.0 111.357 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.2 p -104.76 154.97 19.31 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.0 157.12 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 19.2 p90 -71.0 122.19 19.57 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 187' ' ' ILE . 10.9 t70 -106.98 114.49 28.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.71 -21.52 44.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -168.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -83.55 -25.84 30.63 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.599 0.636 . . . . 0.0 110.803 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -79.95 -27.77 39.71 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.46 85.53 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.139 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -148.34 158.11 43.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.869 0.868 . . . . 0.0 109.854 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 64.6 m-85 -64.6 127.33 31.07 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 180' ' ' ASP . 22.0 pt -134.31 178.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.3 1.04 . . . . 0.0 108.8 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.53 HD12 HG11 ' A' ' 172' ' ' VAL . 33.9 mm -79.38 145.62 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.98 163.29 8.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.278 0.631 . . . . 0.0 112.232 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.74 -55.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.64 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.619 1.168 . . . . 0.0 109.353 178.184 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 121.27 0.557 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 22.3 mp0 -74.28 -39.65 62.82 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.839 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.01 -50.33 36.5 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.745 0.818 . . . . 0.0 113.028 -164.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 40.4 t -65.57 -43.64 89.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.805 0.442 . . . . 0.0 110.481 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.5 mt -64.8 -46.03 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' NE2' ' HB ' ' A' ' 153' ' ' VAL . 30.2 mm-40 -57.91 -47.75 81.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.717 1.207 . . . . 0.0 111.699 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -65.29 -35.8 82.13 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.077 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -64.7 -38.19 90.17 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 122.952 0.501 . . . . 0.0 110.634 176.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.479 HG21 ' HB2' ' A' ' 150' ' ' SER . 89.3 mt -65.82 -39.39 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.253 0.621 . . . . 0.0 109.966 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -64.58 -34.89 79.32 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.456 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -87.48 -27.9 22.38 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 75.6 m -93.39 -11.63 31.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -73.94 168.12 20.12 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.653 0.739 . . . . 0.0 111.849 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.88 157.32 34.66 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.449 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 p -68.8 98.6 0.94 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG12 ' NE2' ' A' ' 125' ' ' GLN . 63.2 t -72.37 99.7 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.7 m -111.2 104.75 56.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.169 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 9.9 Cg_endo -52.91 -26.58 31.9 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 -37.33 61.62 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.059 0.544 . . . . 0.0 110.409 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -83.78 -39.93 19.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 0.0 110.864 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.92 -20.89 62.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.505 0.722 . . . . 0.0 111.206 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HA ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER 53.78 36.16 23.25 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.639 1.176 . . . . 0.0 111.027 -176.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.3 140.57 26.67 Favored Pre-proline 0 C--O 1.248 1.018 0 C-N-CA 124.383 1.073 . . . . 0.0 108.874 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.0 157.22 50.06 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.18 1.92 . . . . 0.0 111.899 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.43 -46.62 66.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.661 0.784 . . . . 0.0 112.054 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 1.6 pm0 -67.68 -30.96 70.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.408 0.683 . . . . 0.0 112.444 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.08 -27.1 67.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.73 0.412 . . . . 0.0 111.43 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.466 ' HB ' HD21 ' A' ' 143' ' ' LEU . 16.8 pt -119.08 17.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.491 0.716 . . . . 0.0 110.604 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 46.5 tt0 -63.5 129.99 42.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.994 0.918 . . . . 0.0 110.542 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.1 t -67.75 109.74 4.31 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.547 ' HB2' HD22 ' A' ' 161' ' ' LEU . 87.7 Cg_endo -78.3 5.88 5.13 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.732 2.288 . . . . 0.0 112.734 -174.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -83.39 -53.95 10.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 124.124 0.969 . . . . 0.0 108.841 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.4 p -96.35 -10.29 28.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.924 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.49 39.06 25.39 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.206 1.002 . . . . 0.0 111.79 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.59 159.84 43.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.425 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.465 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 23.1 tm0? -74.62 121.22 84.76 Favored Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.4 159.16 36.45 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.075 2.517 . . . . 0.0 113.441 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.3 pt-20 -90.15 -26.09 20.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.692 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.2 pttt -147.06 140.39 25.43 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.3 158.67 31.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.824 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 98' ' ' ILE . 12.2 pt -110.84 155.09 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.739 1.216 . . . . 0.0 109.767 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -93.09 129.02 39.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 167.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.5 t -124.85 124.29 67.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 171.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.633 ' HB3' HD13 ' A' ' 188' ' ' ILE . 22.0 ptmt -64.93 105.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.029 0.919 . . . . 0.0 110.373 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.28 78.54 0.73 Allowed 'General case' 0 C--O 1.25 1.084 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.734 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 34.2 t -65.42 -37.57 87.31 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.156 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.51 -36.56 69.33 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.297 1.039 . . . . 0.0 112.251 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.47 -63.41 2.62 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.398 0.436 . . . . 0.0 113.049 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -169.61 30.83 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.269 0.628 . . . . 0.0 110.203 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.734 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 0.4 OUTLIER 65.13 26.12 12.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.022 0.929 . . . . 0.0 111.225 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.6 t -86.09 142.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.89 0.876 . . . . 0.0 110.021 -174.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 188' ' ' ILE . 60.6 m -85.46 122.54 29.74 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.6 m -118.17 137.31 53.07 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.466 HD21 ' HB ' ' A' ' 117' ' ' ILE . 56.7 tp -92.91 114.44 26.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.687 0.395 . . . . 0.0 110.487 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.34 150.77 26.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.632 1.173 . . . . 0.0 108.521 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.28 137.74 54.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.466 0.575 . . . . 0.0 109.548 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.23 86.25 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.022 0.826 . . . . 0.0 111.95 -175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.43 -36.92 66.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 0.0 111.698 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.01 56.64 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.412 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.62 -40.97 84.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.352 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.0 t -62.41 -36.88 83.73 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.748 0.655 . . . . 0.0 110.839 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 58.6 ttt180 -63.43 -48.85 76.05 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.73 -46.75 70.95 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.399 0.679 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.433 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t -62.42 -47.43 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.821 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -64.1 -29.3 74.52 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 124.191 0.932 . . . . 0.0 113.447 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 61.5 mm-40 -72.95 -25.34 60.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.199 0.6 . . . . 0.0 110.317 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 15.76 43.32 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.098 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.67 145.6 54.81 Favored Pre-proline 0 C--O 1.242 0.659 0 C-N-CA 123.866 0.867 . . . . 0.0 110.073 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.34 -179.47 5.1 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.551 2.168 . . . . 0.0 112.017 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -55.02 131.82 67.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.8 -26.31 79.38 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.924 2.416 . . . . 0.0 113.573 -172.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 120' ' ' PRO . 35.5 mt -97.75 -52.59 3.69 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.637 0.375 . . . . 0.0 111.308 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 67.8 p -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.412 0.685 . . . . 0.0 112.195 -168.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 64.04 22.24 12.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.555 1.142 . . . . 0.0 111.352 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.71 149.73 86.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.575 0.75 . . . . 0.0 110.296 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.22 111.19 1.53 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.219 1.946 . . . . 0.0 110.702 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.09 135.39 25.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.053 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.6 t -149.18 163.11 38.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.091 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 171' ' ' ILE . . . -64.75 -23.92 67.4 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.958 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -69.99 -26.16 63.95 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.887 0.875 . . . . 0.0 113.033 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.7 pt -100.7 -11.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.449 HG21 ' HA ' ' A' ' 168' ' ' ALA . 7.7 tt -94.39 134.04 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.606 HG11 HD12 ' A' ' 188' ' ' ILE . 26.9 m -133.81 172.11 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.528 1.131 . . . . 0.0 110.795 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 7.1 mtpm? -103.82 166.83 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.026 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -71.2 -18.11 62.49 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.12 -22.1 23.04 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.3 0.64 . . . . 0.0 110.544 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -75.88 -38.51 57.77 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.742 0.817 . . . . 0.0 109.546 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.38 140.95 29.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.616 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 152.91 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -66.15 128.8 37.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.53 ' HB2' HG12 ' A' ' 187' ' ' ILE . 14.0 t70 -108.03 135.3 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.29 -49.47 16.9 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.055 0.847 . . . . 0.0 111.655 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.7 t -73.76 -23.44 59.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.122 0.169 . . . . 0.0 111.412 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 3.4 mmp_? -83.65 -33.0 25.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.185 0.594 . . . . 0.0 110.549 171.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.68 26.32 59.04 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.918 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -171.37 162.93 6.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.186 0.595 . . . . 0.0 109.851 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -60.2 121.16 11.26 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.1 0.96 . . . . 0.0 111.13 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 180' ' ' ASP . 23.3 pt -126.73 174.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.196 171.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 133' ' ' LYS . 27.1 mm -70.74 151.05 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.349 0.659 . . . . 0.0 109.746 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 148.31 51.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.224 0.535 . . . . 0.0 111.393 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.87 -26.24 3.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.173 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -62.29 -42.92 99.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -35.66 81.0 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.352 0.408 . . . . 0.0 111.588 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 32.7 t -68.37 -43.51 77.2 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.44 0.696 . . . . 0.0 109.449 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 98' ' ' ILE . 64.6 mt -66.35 -46.61 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.579 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -58.53 -43.47 89.22 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.326 1.45 . . . . 0.0 111.346 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -41.78 96.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.268 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -69.23 -32.34 71.52 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 123.262 0.625 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 94' ' ' ILE . 83.5 mt -66.02 -40.86 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.2 m -63.05 -40.71 98.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 111.583 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -83.0 -22.68 33.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.514 0.726 . . . . 0.0 112.701 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 80.4 m -95.35 -22.89 17.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.999 0.52 . . . . 0.0 112.293 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -70.3 168.21 16.39 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.722 0.772 . . . . 0.0 112.508 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -156.12 157.7 36.44 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.599 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.0 p -72.22 99.65 2.41 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.463 HG11 HD21 ' A' ' 143' ' ' LEU . 21.9 t -71.56 109.25 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.249 -171.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.95 104.43 55.53 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.72 0.808 . . . . 0.0 109.458 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HB3' HD13 ' A' ' 117' ' ' ILE . 15.5 Cg_endo -59.92 -27.63 85.34 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.982 2.455 . . . . 0.0 112.647 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.72 -31.37 69.33 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.254 0.622 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -90.59 -30.61 17.1 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.656 0.782 . . . . 0.0 110.868 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.3 -23.04 57.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.846 0.458 . . . . 0.0 111.216 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 52.74 33.1 13.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.028 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -114.62 140.69 25.62 Favored Pre-proline 0 C--O 1.245 0.844 0 C-N-CA 124.424 1.09 . . . . 0.0 108.859 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.92 158.67 45.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.462 2.108 . . . . 0.0 111.785 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.32 -45.68 72.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.806 . . . . 0.0 111.8 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.68 -38.97 72.97 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.316 1.046 . . . . 0.0 113.062 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.04 65.42 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.161 0.585 . . . . 0.0 111.734 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 107' ' ' PRO . 19.5 pt -127.97 31.39 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.681 1.192 . . . . 0.0 109.535 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.66 125.02 27.79 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.379 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 10.4 t -68.47 109.93 4.94 Favored Pre-proline 0 C--N 1.349 0.557 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.91 -3.35 13.63 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.782 2.321 . . . . 0.0 112.852 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.2 -52.3 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.4 p -90.98 -10.64 41.61 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.96 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.29 36.26 23.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.851 1.261 . . . . 0.0 111.889 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.87 152.65 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.352 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.476 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 24.1 tm0? -68.21 121.38 80.03 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.523 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.52 164.2 28.73 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.116 2.544 . . . . 0.0 114.602 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 12.9 pt-20 -86.43 -29.82 22.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.463 173.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 52.0 pttt -141.62 135.07 29.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.7 1.6 . . . . 0.0 106.904 176.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -161.74 154.9 26.0 Favored Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.503 -175.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -110.19 159.38 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 125.251 1.42 . . . . 0.0 109.555 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 37.3 m-85 -103.34 118.15 36.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 169.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.7 t -115.16 121.49 67.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.9 ptmt -72.2 108.48 5.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.864 0.84 . . . . 0.0 110.627 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -66.55 83.36 0.1 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.42 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 46.4 t -64.21 -41.64 96.96 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.212 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.14 -32.27 73.88 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.006 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.29 -66.36 2.11 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.27 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.2 m -168.44 26.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.317 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 9.5 m-20 58.34 26.1 13.61 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.635 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.411 ' HA ' HG23 ' A' ' 187' ' ' ILE . 6.3 m -80.52 123.72 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.384 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 40.5 m -82.7 122.98 28.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.493 HG21 HD12 ' A' ' 161' ' ' LEU . 25.9 m -119.41 145.03 46.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD21 HG11 ' A' ' 105' ' ' VAL . 34.2 tp -86.65 114.13 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.35 0.407 . . . . 0.0 110.286 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -113.35 135.49 53.8 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.595 1.158 . . . . 0.0 108.466 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.26 137.62 57.91 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.674 0.39 . . . . 0.0 110.046 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.13 90.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.553 0.741 . . . . 0.0 111.672 -174.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.12 44.85 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.319 0.648 . . . . 0.0 112.124 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.42 -39.21 54.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.177 0.591 . . . . 0.0 111.673 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.0 t80 -72.15 -38.3 69.2 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -56.67 -38.73 72.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.069 0.948 . . . . 0.0 111.452 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -57.65 -52.16 66.55 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.817 0.698 . . . . 0.0 109.953 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.77 -46.52 81.42 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.149 0.906 . . . . 0.0 111.089 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.563 HG21 HG23 ' A' ' 166' ' ' ILE . 94.8 t -62.38 -47.07 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.744 . . . . 0.0 110.852 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.45 -34.37 88.1 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.715 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.493 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 16.4 mm-40 -75.27 -31.53 60.78 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.413 0.685 . . . . 0.0 111.218 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 25.68 20.07 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 86.7 mt -80.6 151.6 71.69 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.93 -179.43 5.11 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.469 2.112 . . . . 0.0 112.64 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.3 t-80 -59.26 127.85 84.72 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.333 1.053 . . . . 0.0 109.917 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.67 -2.99 12.99 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.305 2.003 . . . . 0.0 113.973 -170.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.493 HD12 HG21 ' A' ' 142' ' ' THR . 63.5 mt -104.26 -57.27 2.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.552 0.341 . . . . 0.0 111.018 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.436 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -105.0 -11.81 16.46 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 66.08 22.24 11.15 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.781 1.232 . . . . 0.0 113.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -76.84 152.26 82.65 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.345 0.658 . . . . 0.0 110.591 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.21 121.08 8.94 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.558 2.172 . . . . 0.0 111.837 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.563 HG23 HG21 ' A' ' 153' ' ' VAL . 71.5 mt -65.73 130.95 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -150.34 164.95 34.5 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.819 0.848 . . . . 0.0 110.609 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.04 67.64 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.373 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.0 m -66.3 -33.2 75.19 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.836 0.855 . . . . 0.0 112.841 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 166' ' ' ILE . 44.2 pt -99.39 -3.16 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.46 HG12 ' SG ' ' A' ' 101' ' ' CYS . 11.6 tt -102.16 134.2 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.4 167.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.529 1.132 . . . . 0.0 110.133 -173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 28.0 mtpp -85.97 161.43 19.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -65.69 -24.69 67.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.301 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.6 -22.24 28.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.052 0.541 . . . . 0.0 110.982 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -82.51 -24.11 34.29 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.396 0.678 . . . . 0.0 110.768 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.3 p -113.38 155.59 24.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.18 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.14 157.12 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.606 1.163 . . . . 0.0 108.424 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 7.1 p90 -70.59 129.92 40.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.77 126.74 55.55 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.28 -39.41 71.56 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.484 1.115 . . . . 0.0 112.486 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.6 t -84.03 -15.8 46.25 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.866 0.303 . . . . 0.0 111.747 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -83.22 -32.03 26.73 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 163.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.23 7.51 84.75 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.316 -170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -137.76 157.0 47.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.698 1.199 . . . . 0.0 108.836 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 80.8 m-85 -68.26 129.71 40.72 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -138.08 175.59 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.756 1.222 . . . . 0.0 109.778 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.13 148.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.492 0.717 . . . . 0.0 110.205 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -64.82 163.79 13.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.318 0.647 . . . . 0.0 111.248 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -73.81 -45.17 28.6 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.869 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 123.869 0.868 . . . . 0.0 109.921 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.49 ' HA ' HD12 ' A' ' 94' ' ' ILE . 12.4 mp0 -63.29 -34.19 77.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.726 0.81 . . . . 0.0 111.584 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.02 -50.1 59.2 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.416 1.087 . . . . 0.0 112.154 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -63.73 -36.16 82.95 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.121 0.968 . . . . 0.0 111.1 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 91' ' ' GLN . 35.6 mt -71.31 -48.53 53.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.737 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -55.96 -46.07 78.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.563 1.145 . . . . 0.0 111.371 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.05 -45.12 93.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -32.89 74.57 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.93 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' A' ' 150' ' ' SER . 96.4 mt -65.2 -41.59 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 118.728 0.694 . . . . 0.0 109.903 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.8 t -64.91 -36.0 82.96 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.842 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -81.43 -30.47 33.48 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.847 0.859 . . . . 0.0 112.945 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 99.1 m -91.46 -19.5 22.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.868 0.867 . . . . 0.0 111.604 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -72.83 165.46 24.84 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.566 0.698 . . . . 0.0 111.938 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.91 159.43 34.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.943 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -69.91 97.02 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.7 t -66.36 113.43 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.374 0.669 . . . . 0.0 110.531 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.6 m -114.49 90.77 22.26 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.415 1.086 . . . . 0.0 109.093 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -58.44 -39.14 86.33 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.081 2.521 . . . . 0.0 113.293 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -38.01 65.67 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.05 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -74.83 -41.21 60.35 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.48 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 97.7 mt -68.44 -15.61 63.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 111.57 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 61.47 16.75 7.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 -172.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 61.6 m -93.11 124.62 57.54 Favored Pre-proline 0 C--O 1.243 0.755 0 C-N-CA 123.36 0.664 . . . . 0.0 109.5 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.46 150.99 78.12 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.557 2.171 . . . . 0.0 111.7 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.01 -47.92 67.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.903 0.881 . . . . 0.0 112.264 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.28 -35.16 78.15 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.383 0.673 . . . . 0.0 112.354 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.06 62.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.36 0.664 . . . . 0.0 111.792 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' ' 112' ' ' CYS . 24.5 pt -127.61 29.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.662 0.785 . . . . 0.0 110.221 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -79.04 132.48 36.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.789 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.17 111.34 7.59 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.34 -2.46 12.59 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.841 2.361 . . . . 0.0 112.172 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.5 mt -82.16 -55.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.6 p -95.23 -7.87 37.77 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.16 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.85 48.24 20.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.15 0.98 . . . . 0.0 111.257 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.81 149.98 20.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.757 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.66 116.42 51.51 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.4 161.2 37.93 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.78 2.32 . . . . 0.0 113.434 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.45 -19.03 20.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.712 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 147' ' ' ALA . 2.2 pptp? -144.87 128.8 17.44 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.71 167.3 37.78 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.859 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 98' ' ' ILE . 11.5 pt -122.03 151.81 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 109.348 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.53 115.61 28.96 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.411 HG23 HG13 ' A' ' 130' ' ' ILE . 64.2 t -117.69 122.39 69.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -69.71 122.39 19.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.432 0.634 . . . . 0.0 110.928 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -72.83 80.86 1.15 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 161.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 25.1 t -70.09 -44.86 68.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.781 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.28 -34.76 79.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.059 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.09 -64.86 2.22 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.835 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.9 m -157.44 18.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.318 0.559 . . . . 0.0 112.475 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.7 m-20 59.63 20.62 9.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.98 0.912 . . . . 0.0 112.283 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.7 124.08 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 28.0 p -85.5 133.12 34.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 m -121.81 145.56 47.94 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 117' ' ' ILE . 49.5 tp -91.19 108.81 20.13 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.53 136.42 42.39 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.42 132.31 52.72 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.629 0.65 . . . . 0.0 109.359 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.74 70.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.043 0.839 . . . . 0.0 111.892 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.442 ' HB3' ' HE2' ' A' ' 128' ' ' LYS . . . -75.29 -40.23 58.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.986 0.514 . . . . 0.0 111.599 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.37 89.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.064 0.545 . . . . 0.0 111.807 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 130' ' ' ILE . 33.5 t80 -76.97 -38.35 53.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.966 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 98' ' ' ILE . 28.8 t -64.08 -28.94 70.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.434 0.459 . . . . 0.0 110.819 175.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 13.0 tpt180 -64.39 -55.69 19.33 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.541 -0.754 . . . . 0.0 108.973 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.7 -45.6 70.47 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.088 0.867 . . . . 0.0 111.818 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.418 HG13 ' HB ' ' A' ' 94' ' ' ILE . 86.3 t -65.93 -47.56 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.298 0.639 . . . . 0.0 110.378 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.27 -17.88 68.73 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.274 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 63.7 mm-40 -87.15 -23.97 24.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.619 0.768 . . . . 0.0 110.857 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.03 36.79 12.35 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.54 149.12 36.12 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.57 1.148 . . . . 0.0 109.527 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -69.89 177.26 5.85 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.353 2.702 . . . . 0.0 113.531 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.445 ' ND1' HG21 ' A' ' 162' ' ' THR . 60.1 t-80 -59.81 124.66 77.52 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.58 -12.46 35.19 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.675 2.25 . . . . 0.0 114.202 -168.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.81 -66.97 0.87 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.643 0.377 . . . . 0.0 110.819 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.445 HG21 ' ND1' ' A' ' 159' ' ' HIS . 10.5 t -90.36 -8.66 50.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.57 0.348 . . . . 0.0 111.605 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 59.88 24.46 13.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.841 1.256 . . . . 0.0 112.961 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -88.75 155.77 50.28 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.93 0.892 . . . . 0.0 110.05 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -64.2 112.16 1.81 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.461 2.107 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.485 ' HA ' HD13 ' A' ' 170' ' ' ILE . 59.8 mt -56.64 140.05 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.788 0.835 . . . . 0.0 110.076 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 160.55 43.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.851 0.861 . . . . 0.0 109.849 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.22 -23.93 67.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.508 0.723 . . . . 0.0 111.903 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -67.49 -46.21 73.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 111.954 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 166' ' ' ILE . 49.7 pt -79.06 -10.43 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.43 HG12 ' SG ' ' A' ' 101' ' ' CYS . 10.5 tt -99.33 132.35 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.477 0.58 . . . . 0.0 109.614 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.67 174.02 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.461 1.104 . . . . 0.0 109.762 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 29.3 mtpp -91.1 166.18 13.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.664 0.386 . . . . 0.0 110.137 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -62.89 -34.97 78.53 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.552 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.2 -9.76 59.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.183 0.593 . . . . 0.0 111.351 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -93.88 -2.95 52.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.814 0.846 . . . . 0.0 110.551 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 29.8 p -134.9 144.26 47.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.161 0.984 . . . . 0.0 109.379 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.475 HG21 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -123.21 155.62 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.595 -0.691 . . . . 0.0 109.279 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -67.95 110.84 4.06 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 159.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.45 125.13 39.85 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -79.3 -36.17 40.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.552 0.741 . . . . 0.0 111.829 -169.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -74.84 -27.3 60.22 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.405 0.548 . . . . 0.0 110.402 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.448 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.6 mmt180 -77.5 -32.74 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.84 81.26 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.794 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -145.92 157.67 43.89 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.29 1.036 . . . . 0.0 109.42 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.34 118.57 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.179 0.591 . . . . 0.0 109.569 173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.448 HD13 ' HG3' ' A' ' 183' ' ' ARG . 27.2 pt -128.32 177.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 133' ' ' LYS . 39.6 mm -80.2 145.11 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HG2' HG21 ' A' ' 178' ' ' ILE . 48.6 mtpt -63.42 149.7 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.066 0.854 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.96 25.31 0.21 Allowed Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.511 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.751 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.591 0.234 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG3' HG11 ' A' ' 153' ' ' VAL . 24.9 mp0 -70.12 -46.11 65.48 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -170.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -47.59 30.1 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.357 1.063 . . . . 0.0 113.47 -170.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.423 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 18.8 m -65.07 -46.08 82.61 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.273 1.029 . . . . 0.0 111.227 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.504 HD12 HG21 ' A' ' 166' ' ' ILE . 62.1 mt -70.66 -46.24 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.159 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -55.18 -44.67 75.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.742 1.217 . . . . 0.0 110.616 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 93.9 m-20 -59.67 -46.26 89.59 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.319 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -61.2 -39.59 90.79 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.533 0.52 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 94' ' ' ILE . 87.1 mt -62.75 -37.48 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.364 0.665 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 t -65.51 -36.87 85.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.992 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 26.6 mt-30 -85.63 -31.16 22.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.113 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.5 m -87.83 -17.11 32.24 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.235 0.614 . . . . 0.0 111.766 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.19 169.26 17.42 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-O 121.21 0.529 . . . . 0.0 111.577 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.89 160.8 41.44 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.607 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 99.21 1.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.75 98.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.3 m -112.28 99.52 46.83 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.929 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.15 -31.65 46.33 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.875 3.05 . . . . 0.0 114.547 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.48 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 11.1 pt-20 -70.04 -43.56 71.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.747 0.819 . . . . 0.0 110.68 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 76.4 mtp180 -81.34 -26.69 35.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.086 0.554 . . . . 0.0 110.565 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.0 mt -77.81 -20.69 52.79 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.088 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 58.44 27.75 15.92 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.749 0.819 . . . . 0.0 111.331 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.4 m -116.52 144.72 33.72 Favored Pre-proline 0 C--O 1.245 0.834 0 C-N-CA 124.024 0.93 . . . . 0.0 109.995 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.92 160.98 44.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.43 2.087 . . . . 0.0 111.66 172.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -43.13 78.59 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.922 0.764 . . . . 0.0 112.014 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.1 -37.06 83.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.049 0.94 . . . . 0.0 112.606 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.62 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.069 0.548 . . . . 0.0 111.154 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.14 31.28 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.899 0.88 . . . . 0.0 110.007 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -85.23 131.54 34.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.697 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.423 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.8 t -67.75 114.22 18.79 Favored Pre-proline 0 C--N 1.346 0.434 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.62 -11.23 30.56 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.427 2.085 . . . . 0.0 112.862 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.423 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 36.1 mt -78.08 -56.23 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.851 0.86 . . . . 0.0 109.558 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p -99.33 -11.87 20.83 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.207 1.003 . . . . 0.0 111.932 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.24 27.7 17.38 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.362 1.065 . . . . 0.0 112.305 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -104.67 164.1 12.01 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.34 99.72 8.95 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 165.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 163.87 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.714 2.276 . . . . 0.0 113.759 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -94.93 -16.66 22.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.117 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -142.86 135.1 27.37 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.839 1.256 . . . . 0.0 108.184 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.47 29.95 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.879 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.93 158.96 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.532 1.133 . . . . 0.0 110.262 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -102.3 122.09 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.53 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.421 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 78.6 t -119.61 124.69 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HB3' HD13 ' A' ' 188' ' ' ILE . 21.7 ptmt -69.02 117.1 10.25 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 123.823 0.702 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -74.93 80.65 2.16 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 166.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 t -58.83 -33.14 70.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.619 1.168 . . . . 0.0 110.748 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.94 -42.09 94.96 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.648 0.593 . . . . 0.0 111.581 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.51 -65.33 3.22 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.621 0.576 . . . . 0.0 111.817 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 t 176.65 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.603 1.161 . . . . 0.0 108.405 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.69 23.95 13.7 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.523 1.129 . . . . 0.0 110.413 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.11 109.96 10.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 60.8 m -83.64 131.89 34.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.819 0.448 . . . . 0.0 110.046 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.4 m -121.23 149.17 43.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 48.2 tp -88.71 104.48 16.92 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.324 0.583 . . . . 0.0 109.551 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.421 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 93.9 m-85 -97.61 136.73 37.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.47 134.71 56.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.7 -41.67 82.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.135 0.897 . . . . 0.0 111.638 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.95 -32.32 45.42 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.458 0.474 . . . . 0.0 111.799 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.68 62.83 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.518 0.727 . . . . 0.0 111.393 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.422 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.3 t80 -71.76 -39.29 70.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.8 t -61.91 -31.43 71.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 111.44 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.4 tpt180 -64.31 -52.87 56.34 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 123.564 0.54 . . . . 0.0 109.594 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.87 -42.74 76.36 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.859 0.724 . . . . 0.0 111.574 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 166' ' ' ILE . 94.4 t -63.15 -49.34 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.817 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.26 -16.12 68.65 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 124.134 0.896 . . . . 0.0 113.673 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.1 mm-40 -93.38 -11.94 31.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 111.107 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.67 30.24 56.53 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.35 0.407 . . . . 0.0 112.501 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -92.8 148.13 35.39 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.614 1.165 . . . . 0.0 109.787 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.16 -176.12 2.89 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.794 2.329 . . . . 0.0 112.584 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -55.64 132.13 71.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.261 1.025 . . . . 0.0 110.382 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.412 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 73.2 Cg_endo -68.91 -28.62 29.28 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.907 1.738 . . . . 0.0 113.303 -170.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.33 -56.49 3.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.557 0.343 . . . . 0.0 111.31 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 t -108.78 -8.79 15.29 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -169.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.412 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 32.9 mmt180 66.7 21.42 10.59 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.391 1.077 . . . . 0.0 112.634 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -72.27 141.08 83.04 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.143 0.577 . . . . 0.0 109.646 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.81 115.22 2.79 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.388 2.059 . . . . 0.0 111.677 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 153' ' ' VAL . 71.4 mt -60.95 127.97 21.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 CA-C-O 120.934 0.397 . . . . 0.0 110.491 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -148.17 165.23 31.51 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.142 0.977 . . . . 0.0 109.402 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.12 -20.18 66.07 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.655 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m -65.37 -44.27 88.13 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.307 0.643 . . . . 0.0 112.452 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 166' ' ' ILE . 46.7 pt -86.89 -7.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.24 129.96 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.02 178.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.065 0.946 . . . . 0.0 110.847 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.9 161.68 13.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.465 0.706 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -67.76 -22.76 65.19 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.7 0.8 . . . . 0.0 112.467 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.73 -22.71 23.21 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.947 0.499 . . . . 0.0 111.083 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.13 -26.88 28.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.034 0.934 . . . . 0.0 110.955 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 27.0 p -115.86 150.6 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.511 HD13 ' HG2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -133.71 160.7 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.051 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 32.3 p90 -69.12 115.0 7.9 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 165.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.542 ' HB2' HG12 ' A' ' 187' ' ' ILE . 11.3 t70 -91.79 129.95 37.66 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.44 -47.89 45.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.06 0.85 . . . . 0.0 110.731 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.2 t -78.28 -25.17 46.6 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.546 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.1 mmp_? -77.05 -30.86 55.81 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.231 169.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.83 14.34 59.62 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.685 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -171.75 168.67 6.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.522 0.661 . . . . 0.0 110.459 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 93.9 m-85 -60.13 121.52 12.11 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.077 0.951 . . . . 0.0 111.529 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.546 HD13 ' HG3' ' A' ' 183' ' ' ARG . 24.1 pt -131.73 178.16 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.327 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.418 HD13 ' HB3' ' A' ' 133' ' ' LYS . 47.2 mm -71.58 140.22 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.598 0.561 . . . . 0.0 109.586 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.511 ' HG2' HD13 ' A' ' 178' ' ' ILE . 54.2 mtpt -60.4 148.06 38.63 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.706 0.629 . . . . 0.0 110.906 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.18 83.77 1.72 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.101 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -58.59 -48.68 80.15 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.412 -172.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -47.61 71.9 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.869 0.731 . . . . 0.0 111.812 -170.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.446 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 37.1 t -66.85 -38.81 87.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.4 0.68 . . . . 0.0 111.192 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.8 mt -66.31 -43.78 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.718 0.636 . . . . 0.0 109.475 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -57.45 -44.58 84.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.022 . . . . 0.0 110.803 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -59.62 -43.44 93.79 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.425 0.453 . . . . 0.0 111.064 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.1 mpmm? -63.26 -35.34 80.02 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 111.298 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 94' ' ' ILE . 89.1 mt -67.57 -37.48 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 122.762 0.425 . . . . 0.0 110.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.6 t -63.45 -40.04 96.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.57 0.748 . . . . 0.0 111.33 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.02 -45.17 18.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.264 0.626 . . . . 0.0 112.146 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 73.3 m -82.3 -10.05 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.905 0.882 . . . . 0.0 112.741 -169.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.69 169.29 18.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.402 0.62 . . . . 0.0 112.473 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -158.03 160.36 37.36 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.963 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 m -70.04 99.81 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 114.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.173 0.589 . . . . 0.0 110.874 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.1 m -118.49 100.42 51.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.034 0.934 . . . . 0.0 109.229 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.57 -37.53 57.69 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.338 2.692 . . . . 0.0 113.293 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -15.26 56.98 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.875 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -88.94 -43.38 11.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 0.0 110.016 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.9 mt -72.57 -12.12 60.93 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 65.33 17.75 11.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.872 1.269 . . . . 0.0 111.538 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 71.8 m -104.61 136.0 19.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.741 0.816 . . . . 0.0 110.136 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.28 164.15 29.24 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.692 2.261 . . . . 0.0 111.125 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.8 mt -53.59 -47.43 70.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.42 0.688 . . . . 0.0 111.49 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.58 -41.83 70.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.857 1.263 . . . . 0.0 113.134 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.44 67.27 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.929 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.497 ' HB ' HD21 ' A' ' 143' ' ' LEU . 20.8 pt -126.51 23.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.244 1.018 . . . . 0.0 110.409 -177.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -69.86 128.32 35.98 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.435 0.694 . . . . 0.0 110.242 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 39.2 t -70.04 110.86 7.48 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.72 -3.06 13.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.882 2.388 . . . . 0.0 112.714 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.9 mt -76.27 -51.51 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.184 0.993 . . . . 0.0 109.236 176.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p -99.68 -15.39 18.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.978 -173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.39 47.9 15.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.516 1.126 . . . . 0.0 111.793 -172.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 163.44 37.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.573 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -78.12 116.63 60.38 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 60.0 Cg_endo -71.18 161.17 46.77 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.024 2.483 . . . . 0.0 113.819 -173.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -87.19 -37.86 16.92 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.37 175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -140.68 140.09 34.89 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.85 156.87 28.3 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.218 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -109.31 158.19 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 109.058 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -99.41 128.16 45.5 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 90.1 t -119.54 121.86 67.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.63 113.22 10.51 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.84 80.43 1.62 Allowed 'General case' 0 C--O 1.248 1.005 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -68.3 -30.39 69.38 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.223 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.86 -38.86 89.83 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.271 174.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.33 -67.46 1.83 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.103 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t 178.79 44.33 0.0 OUTLIER 'General case' 0 C--O 1.251 1.144 0 C-N-CA 123.864 0.865 . . . . 0.0 109.905 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 t70 70.31 8.33 6.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 123.951 0.901 . . . . 0.0 111.432 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.574 ' HA ' HG22 ' A' ' 187' ' ' ILE . 61.3 t -77.14 113.59 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.51 138.63 33.34 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 109.473 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.8 m -129.25 154.0 47.24 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 117' ' ' ILE . 37.5 tp -90.17 121.39 32.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.489 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.0 m-85 -117.34 133.7 55.68 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 124.991 1.317 . . . . 0.0 107.824 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.6 t70 -59.78 135.55 57.72 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 118.846 0.748 . . . . 0.0 109.656 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.4 71.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.898 0.879 . . . . 0.0 111.575 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.37 -34.72 65.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -71.56 -37.67 71.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 111.771 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -76.92 -36.65 56.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.384 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.9 t -62.59 -30.24 71.19 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 124.01 0.819 . . . . 0.0 110.831 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.5 ttm-85 -64.87 -53.5 45.72 Favored 'General case' 0 C--O 1.218 -0.564 0 O-C-N 124.02 0.825 . . . . 0.0 109.981 170.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 73.2 mt -52.94 -47.84 67.75 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.949 0.5 . . . . 0.0 111.475 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.61 -51.36 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.659 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.51 73.5 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.269 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 29.6 mm-40 -87.48 -23.86 24.3 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 117.36 0.58 . . . . 0.0 110.185 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.86 53.59 Favored Glycine 0 N--CA 1.47 0.945 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.62 140.31 59.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.084 0.954 . . . . 0.0 109.63 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.56 -168.08 0.53 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.748 2.298 . . . . 0.0 112.608 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -60.66 131.41 91.0 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.353 1.061 . . . . 0.0 110.043 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.415 ' HG3' HG12 ' A' ' 121' ' ' ILE . 70.2 Cg_endo -68.79 -24.42 34.46 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.37 2.047 . . . . 0.0 113.444 -172.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.74 -65.15 1.04 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.9 t -102.71 -9.4 20.07 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.299 -167.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 62.22 24.04 14.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.782 1.233 . . . . 0.0 112.063 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -79.16 148.35 71.09 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.334 0.654 . . . . 0.0 110.062 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.93 123.09 12.24 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.702 2.268 . . . . 0.0 111.854 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.94 134.3 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.292 0.637 . . . . 0.0 110.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.1 t -141.14 160.61 39.73 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.917 0.887 . . . . 0.0 109.559 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.04 -23.97 67.69 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.913 0.885 . . . . 0.0 111.545 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.7 t -67.56 -41.27 84.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.783 0.833 . . . . 0.0 112.267 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -85.0 -8.67 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.8 tt -98.0 133.57 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.82 0.736 . . . . 0.0 109.151 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 101' ' ' CYS . 27.1 m -138.04 174.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.725 1.21 . . . . 0.0 110.378 -172.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.528 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 40.8 mtpt -102.62 164.5 11.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.145 0.578 . . . . 0.0 110.843 -175.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -73.68 -17.59 61.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.918 0.487 . . . . 0.0 111.595 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.49 -32.77 28.63 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.11 -29.89 49.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.331 0.652 . . . . 0.0 110.721 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 31.6 p -113.55 155.51 25.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.599 0.759 . . . . 0.0 109.643 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -135.39 164.23 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.312 1.045 . . . . 0.0 108.839 179.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.27 127.51 33.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 162.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.435 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -107.52 139.18 42.43 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.883 -0.511 . . . . 0.0 110.027 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.17 -50.86 13.43 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.248 0.968 . . . . 0.0 111.757 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 15.0 t -71.06 -33.53 70.36 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.19 0.45 . . . . 0.0 111.18 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.514 ' HG3' HD11 ' A' ' 187' ' ' ILE . 26.8 mmt180 -76.3 -27.95 56.78 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.917 0.487 . . . . 0.0 110.088 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.83 24.31 72.47 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.194 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -170.11 163.68 9.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.831 0.853 . . . . 0.0 108.824 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 89.0 m-85 -59.82 127.68 33.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.975 0.91 . . . . 0.0 111.182 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' A' ' 140' ' ' VAL . 19.1 pt -138.71 -179.85 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.645 1.178 . . . . 0.0 108.989 170.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.8 152.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 122.995 0.518 . . . . 0.0 109.889 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.85 104.37 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.966 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -117.35 -0.01 18.68 Favored Glycine 0 N--CA 1.465 0.591 0 CA-C-N 113.779 -1.555 . . . . 0.0 111.831 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 42.5 t30 . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 123.657 0.783 . . . . 0.0 109.074 178.061 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 110.556 -0.165 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -49.49 77.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.296 1.038 . . . . 0.0 111.878 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -30.7 70.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 0.0 112.155 -174.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -68.29 -46.97 68.9 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.099 0.96 . . . . 0.0 109.788 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 98' ' ' ILE . 79.6 mt -64.48 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.683 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -61.11 -38.38 86.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.717 1.207 . . . . 0.0 112.537 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.9 -41.23 95.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.456 0.473 . . . . 0.0 110.238 173.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -39.23 89.31 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 123.369 0.418 . . . . 0.0 110.614 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 94' ' ' ILE . 74.9 mt -65.25 -46.08 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.79 0.436 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -65.4 -36.02 82.7 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.879 0.872 . . . . 0.0 112.25 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -82.4 -42.55 18.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.988 0.515 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.85 -6.97 59.54 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.83 0.852 . . . . 0.0 112.386 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -75.26 163.62 27.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.186 0.517 . . . . 0.0 111.56 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -157.2 159.58 37.85 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.988 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.4 p -73.35 100.75 3.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.933 0.77 . . . . 0.0 109.409 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.87 120.88 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.865 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.98 96.1 32.65 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 0.0 109.149 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.44 -34.45 33.06 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.493 3.462 . . . . 0.0 115.625 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.29 -34.88 65.99 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.892 0.477 . . . . 0.0 110.74 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -82.12 -36.47 27.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.763 0.825 . . . . 0.0 110.057 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.54 -17.52 62.31 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.055 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.88 34.62 23.9 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.697 1.199 . . . . 0.0 110.893 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 69.6 m -115.08 135.77 22.54 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.199 0.999 . . . . 0.0 109.171 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 17.9 Cg_endo -60.54 153.07 63.75 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.455 2.104 . . . . 0.0 111.708 169.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 59.4 mt -52.57 -48.07 66.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.354 1.061 . . . . 0.0 111.766 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.26 -35.98 78.76 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.336 1.055 . . . . 0.0 112.571 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -66.82 -25.39 66.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.67 . . . . 0.0 111.658 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 143' ' ' LEU . 25.3 pt -124.06 24.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.645 0.778 . . . . 0.0 110.46 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 42.0 tt0 -68.85 135.66 51.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.853 174.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.5 112.08 10.87 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.12 -6.7 19.78 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.861 2.374 . . . . 0.0 112.791 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.52 -53.21 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.788 0.835 . . . . 0.0 109.466 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -91.94 -11.1 37.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.65 0.78 . . . . 0.0 112.596 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.91 36.65 12.62 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.015 0.926 . . . . 0.0 111.431 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -151.64 149.1 28.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.482 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.1 tm0? -67.14 121.6 79.06 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 123.49 0.716 . . . . 0.0 109.371 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 153.21 41.19 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.535 2.157 . . . . 0.0 113.747 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.36 -17.18 32.98 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.46 170.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -150.72 130.69 13.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.594 1.157 . . . . 0.0 108.368 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.46 169.2 39.81 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.667 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.8 pt -118.61 154.47 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.201 1.401 . . . . 0.0 110.058 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.36 121.26 37.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 95.2 t -120.11 122.52 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.675 ' HB3' HD13 ' A' ' 188' ' ' ILE . 20.5 ptmt -68.52 120.16 14.13 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.359 0.599 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -74.78 79.53 2.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 165.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.492 ' HB2' ' HE2' ' A' ' 133' ' ' LYS . 12.5 t -68.72 -36.86 78.96 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.244 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.3 -35.03 76.21 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.476 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.79 -64.1 2.0 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.307 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -171.55 27.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.906 0.482 . . . . 0.0 111.105 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.6 m-20 62.79 25.07 14.9 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.359 1.063 . . . . 0.0 111.78 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.6 t -85.92 124.52 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 0.0 109.225 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 28.6 p -83.27 130.13 35.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -174.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.2 m -120.34 140.08 51.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.097 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 117' ' ' ILE . 36.8 tp -89.54 107.49 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.356 0.598 . . . . 0.0 110.105 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.499 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 88.8 m-85 -99.99 145.95 27.28 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.24 134.66 54.12 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.51 78.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.757 0.66 . . . . 0.0 111.879 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -31.39 64.75 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.653 0.595 . . . . 0.0 111.678 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -73.3 -39.77 65.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.059 0.543 . . . . 0.0 111.739 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -75.97 -35.24 59.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.4 t -59.6 -38.75 82.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.061 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 15.6 tpt180 -57.77 -49.63 75.94 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 124.275 0.984 . . . . 0.0 110.101 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.84 -46.32 81.8 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.693 0.621 . . . . 0.0 111.658 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.436 HG21 HG21 ' A' ' 166' ' ' ILE . 70.5 t -65.4 -42.41 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.58 63.99 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.501 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.8 -12.51 55.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.277 0.631 . . . . 0.0 111.201 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.21 74.28 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.733 -0.212 . . . . 0.0 113.161 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.09 133.69 81.35 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.52 179.17 3.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.829 2.353 . . . . 0.0 112.641 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -58.07 128.08 80.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.73 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 44.7 Cg_endo -64.51 -25.32 62.85 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.617 2.211 . . . . 0.0 113.476 -167.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -53.7 4.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.958 0.503 . . . . 0.0 111.499 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 5.3 t -108.87 -13.01 14.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 36.6 mmt180 62.47 28.34 16.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.576 1.151 . . . . 0.0 112.129 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -83.18 158.35 64.25 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.623 0.769 . . . . 0.0 109.894 170.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.88 119.36 6.38 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.154 1.903 . . . . 0.0 111.495 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG21 HG21 ' A' ' 153' ' ' VAL . 68.1 mt -60.05 128.35 20.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 t -140.69 155.81 46.38 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.145 0.978 . . . . 0.0 109.1 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.91 -22.54 66.51 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.1 m -63.04 -32.28 73.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.391 1.076 . . . . 0.0 112.889 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -97.2 -7.8 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.5 tt -96.54 133.73 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.224 0.92 . . . . 0.0 109.475 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.14 178.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.208 1.403 . . . . 0.0 109.736 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -100.34 170.2 8.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.252 0.621 . . . . 0.0 110.729 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -68.86 -27.97 66.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.661 0.384 . . . . 0.0 110.947 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.75 -42.45 81.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.633 0.773 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.13 -12.28 60.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.314 -168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 27.7 p -118.69 151.05 38.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.897 0.879 . . . . 0.0 109.742 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.36 160.03 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 24.3 p90 -68.62 127.47 33.14 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.592 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.1 t70 -106.73 127.95 53.81 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.05 -42.34 63.23 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.099 0.875 . . . . 0.0 112.176 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -79.25 -16.09 57.0 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.753 0.252 . . . . 0.0 111.383 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.57 -29.79 19.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.125 0.57 . . . . 0.0 110.541 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.64 18.14 77.91 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.981 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -162.07 160.14 27.08 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.545 0.738 . . . . 0.0 109.176 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.582 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 87.4 m-85 -61.37 124.59 21.03 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.608 1.163 . . . . 0.0 111.737 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.5 pt -128.77 179.58 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.224 1.01 . . . . 0.0 108.432 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 133' ' ' LYS . 23.5 mm -79.92 149.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 122.549 0.34 . . . . 0.0 110.473 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -65.1 155.75 33.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.061 0.944 . . . . 0.0 112.693 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.62 -4.52 55.9 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.947 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 124.392 1.077 . . . . 0.0 109.091 176.731 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.685 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.68 -45.39 70.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -167.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 35.3 t -71.52 -36.8 71.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.723 0.409 . . . . 0.0 110.693 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 98' ' ' ILE . 83.6 mt -63.23 -42.05 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -68.16 -31.95 71.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.467 1.107 . . . . 0.0 112.307 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -58.62 -46.55 86.82 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 168.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -67.08 -40.6 87.01 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.735 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 94' ' ' ILE . 85.3 mt -64.16 -44.8 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.247 0.476 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -66.82 -35.15 79.39 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.318 0.647 . . . . 0.0 112.48 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.679 0.391 . . . . 0.0 111.441 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.5 m -64.42 -21.33 66.61 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.58 1.152 . . . . 0.0 113.266 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.27 173.34 4.88 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 121.468 0.651 . . . . 0.0 112.316 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.23 159.51 36.12 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.777 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.7 t -77.41 108.67 10.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.79 134.64 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.102 -171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.2 m -135.82 94.86 14.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.244 1.017 . . . . 0.0 108.982 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.41 ' HB3' HD11 ' A' ' 117' ' ' ILE . 24.2 Cg_endo -58.18 -35.31 98.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.715 2.943 . . . . 0.0 113.833 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -31.66 32.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.008 0.523 . . . . 0.0 111.372 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -75.65 -40.4 56.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.565 0.346 . . . . 0.0 110.733 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 95.6 mt -71.82 -14.92 62.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.75 0.82 . . . . 0.0 111.946 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 64.27 10.52 5.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.763 1.225 . . . . 0.0 111.965 -172.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.465 ' SG ' ' HZ ' ' A' ' 186' ' ' PHE . 58.8 m -94.52 130.82 32.41 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.897 0.879 . . . . 0.0 110.156 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.41 155.02 72.08 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.612 2.208 . . . . 0.0 111.574 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 63.5 mt -52.57 -49.77 64.3 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.189 0.931 . . . . 0.0 111.962 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.24 -41.2 71.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.242 1.017 . . . . 0.0 112.941 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.06 63.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.509 0.724 . . . . 0.0 111.785 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.564 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.5 pt -126.63 17.8 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.663 0.785 . . . . 0.0 110.756 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 39.6 tt0 -69.84 137.59 51.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 111.064 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.454 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 34.9 t -73.7 112.11 14.95 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.97 -4.31 15.19 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.754 2.302 . . . . 0.0 112.759 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 mt -83.33 -54.82 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.837 0.855 . . . . 0.0 109.311 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -88.68 -12.38 42.56 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.079 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.11 36.34 18.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.954 0.902 . . . . 0.0 111.464 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -148.51 151.57 35.36 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.163 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.73 115.47 31.07 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.7 Cg_endo -71.82 160.11 48.79 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.569 2.18 . . . . 0.0 113.258 -167.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.2 pt-20 -83.9 -31.04 25.9 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.158 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.23 145.41 31.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.191 1.396 . . . . 0.0 108.203 174.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.02 169.69 40.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.871 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.77 153.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.187 1.395 . . . . 0.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -97.96 117.15 31.64 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 73.7 t -110.92 123.31 66.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 188' ' ' ILE . 18.4 ptmt -71.03 108.35 4.55 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.74 0.781 . . . . 0.0 110.426 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.91 76.04 2.82 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 t -69.51 -32.51 71.41 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.353 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.07 -44.63 91.88 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.084 0.865 . . . . 0.0 110.813 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.21 -67.34 1.94 Allowed Glycine 0 C--N 1.348 1.211 0 O-C-N 123.704 0.628 . . . . 0.0 112.868 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.8 m -170.78 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.973 0.909 . . . . 0.0 110.305 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.08 23.68 12.45 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.405 1.097 . . . . 0.0 111.086 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.6 124.59 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.575 ' SG ' HD13 ' A' ' 188' ' ' ILE . 56.8 m -83.42 118.82 23.99 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.504 HG21 HD11 ' A' ' 161' ' ' LEU . 18.1 m -111.86 134.21 53.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 117' ' ' ILE . 30.3 tp -90.41 103.29 15.99 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.721 0.638 . . . . 0.0 109.928 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 95.1 m-85 -97.05 136.91 36.93 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.6 t70 -57.8 130.48 46.67 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.31 -43.36 74.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.251 0.969 . . . . 0.0 111.908 -172.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.67 42.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.869 0.468 . . . . 0.0 111.705 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.77 65.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.935 0.494 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -77.02 -39.63 49.51 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -55.17 -34.59 63.98 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.583 1.153 . . . . 0.0 111.437 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.2 tpm_? -63.1 -54.32 39.69 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.858 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.9 mt -55.31 -44.4 75.74 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.361 1.038 . . . . 0.0 111.681 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 166' ' ' ILE . 60.8 t -64.78 -47.4 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.736 0.647 . . . . 0.0 109.44 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.47 -32.15 82.1 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.542 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.3 mm-40 -82.96 -28.93 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.335 0.654 . . . . 0.0 111.164 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.04 14.3 42.98 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.491 0.495 . . . . 0.0 112.668 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.55 134.63 57.67 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.162 0.985 . . . . 0.0 109.664 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.47 -171.25 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.704 2.269 . . . . 0.0 112.627 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.492 ' ND1' HG22 ' A' ' 162' ' ' THR . 49.0 t-80 -61.24 123.95 78.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.614 0.766 . . . . 0.0 108.981 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.91 -11.22 29.03 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.129 1.886 . . . . 0.0 113.189 -167.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 142' ' ' THR . 88.6 mt -96.49 -65.93 0.94 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.178 0.591 . . . . 0.0 110.616 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.492 HG22 ' ND1' ' A' ' 159' ' ' HIS . 11.1 t -98.71 -3.15 36.51 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.863 0.465 . . . . 0.0 111.997 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 66.01 15.56 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.581 1.553 . . . . 0.0 112.537 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.42 150.54 82.54 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 123.162 0.585 . . . . 0.0 110.97 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.34 113.6 2.33 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.246 1.964 . . . . 0.0 109.92 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.503 HG21 HG22 ' A' ' 153' ' ' VAL . 72.3 mt -56.21 128.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 O-C-N 123.808 0.693 . . . . 0.0 110.291 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.4 t -143.83 157.94 44.02 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.061 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.94 -15.37 63.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.439 0.696 . . . . 0.0 111.462 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -67.5 -48.15 67.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.027 0.931 . . . . 0.0 111.804 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 43.6 pt -83.42 -5.36 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.91 139.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 188' ' ' ILE . 29.0 m -125.45 170.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 0.0 109.751 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.37 150.05 28.6 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.146 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.402 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 17.7 p-80 -63.97 -18.79 64.62 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.882 0.739 . . . . 0.0 112.901 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.61 -24.2 24.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.411 0.684 . . . . 0.0 111.598 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -87.97 5.15 42.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.173 0.589 . . . . 0.0 110.563 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 24.6 p -129.0 130.71 47.0 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.26 157.74 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -67.36 119.04 11.55 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.486 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.1 t70 -99.59 134.94 41.75 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.92 -34.99 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.848 0.859 . . . . 0.0 111.957 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.6 t -80.61 -29.26 36.87 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.426 0.557 . . . . 0.0 110.695 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.553 ' HG3' HD13 ' A' ' 187' ' ' ILE . 25.4 mmt180 -82.2 -25.55 34.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.963 0.505 . . . . 0.0 110.404 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.7 18.19 79.79 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.824 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -166.66 164.38 16.78 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 93.8 m-85 -59.74 120.95 10.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.81 0.844 . . . . 0.0 111.405 175.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.553 HD13 ' HG3' ' A' ' 183' ' ' ARG . 13.2 pt -132.47 177.34 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.823 0.849 . . . . 0.0 109.227 168.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 133' ' ' LYS . 30.8 mm -76.06 153.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.262 0.625 . . . . 0.0 110.438 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 123.429 0.692 . . . . 0.0 111.325 175.141 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 121.297 0.57 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -68.92 -21.43 64.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.51 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 39.5 t -68.27 -40.45 81.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.3 mt -63.26 -48.08 89.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -53.83 -44.89 70.64 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.424 1.089 . . . . 0.0 111.465 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -60.4 -44.85 95.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.508 0.723 . . . . 0.0 110.626 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -67.43 -32.9 74.08 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 123.253 0.621 . . . . 0.0 110.985 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.534 HG23 HD13 ' A' ' 130' ' ' ILE . 91.0 mt -67.7 -41.29 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.899 0.479 . . . . 0.0 109.839 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 m -66.35 -39.55 89.26 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.7 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -82.21 -30.5 30.82 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 78.3 m -89.88 -15.54 31.95 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.71 168.55 17.52 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.696 0.76 . . . . 0.0 112.444 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -156.71 155.62 31.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.988 172.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 110.14 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.09 107.54 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.098 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 40.3 m -112.25 95.96 33.03 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.552 1.141 . . . . 0.0 108.558 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.5 -36.95 95.3 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.714 2.943 . . . . 0.0 114.376 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.08 36.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -78.52 -39.36 38.25 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 86.5 mt -72.74 -22.2 60.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.07 0.948 . . . . 0.0 111.271 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 56.36 11.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.287 1.035 . . . . 0.0 113.213 -172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 58.4 m -84.35 138.48 38.97 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 123.681 0.792 . . . . 0.0 109.588 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.19 142.84 99.73 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.123 1.882 . . . . 0.0 110.446 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 125' ' ' GLN . 82.3 mt -52.64 -40.5 62.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 111.998 -173.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.28 -44.05 75.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.026 0.93 . . . . 0.0 112.273 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.33 69.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.565 0.746 . . . . 0.0 111.117 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 24.2 pt -112.32 23.34 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.31 129.69 34.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.017 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 29.2 t -68.97 111.56 8.8 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 -8.62 23.81 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.694 2.263 . . . . 0.0 112.759 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.2 mt -78.06 -57.43 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.113 0.965 . . . . 0.0 109.086 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.8 p -91.32 -6.02 53.71 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.457 -171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.3 31.35 19.36 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.026 0.931 . . . . 0.0 111.957 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.64 154.26 41.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.57 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -67.24 113.99 16.44 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 94.4 Cg_endo -76.56 165.7 28.53 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.157 2.572 . . . . 0.0 113.773 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.9 pt-20 -79.94 -36.14 36.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.293 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.554 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -151.29 146.43 26.03 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 108.0 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.47 169.43 41.12 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.959 -0.638 . . . . 0.0 114.397 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.534 HD13 HG23 ' A' ' 98' ' ' ILE . 11.6 pt -122.42 155.45 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 125.645 1.578 . . . . 0.0 109.863 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -94.82 121.88 36.87 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 88.6 t -127.02 121.56 58.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.623 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.8 ptmt -67.33 113.77 5.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.673 0.749 . . . . 0.0 110.425 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -71.29 85.37 0.79 Allowed 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 163.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.9 t -64.97 -45.97 83.44 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.163 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.84 -38.07 89.73 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.845 0.715 . . . . 0.0 111.235 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.11 -64.05 3.77 Favored Glycine 0 C--N 1.344 1.028 0 O-C-N 123.821 0.701 . . . . 0.0 112.684 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.9 m -160.56 14.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.29 0.636 . . . . 0.0 111.922 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.9 m-20 60.4 27.2 16.79 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.05 138.36 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.004 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.656 ' SG ' HD13 ' A' ' 188' ' ' ILE . 20.4 m -84.03 121.65 27.7 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.079 0.951 . . . . 0.0 108.56 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.1 m -118.91 141.7 48.42 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.7 tp -91.94 105.47 17.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 109.963 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 75.1 m-85 -98.94 143.36 29.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 15.8 t70 -60.96 129.62 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.73 81.02 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.906 0.754 . . . . 0.0 112.057 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.03 -28.26 60.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.78 0.432 . . . . 0.0 111.301 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.23 62.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.379 0.671 . . . . 0.0 111.477 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -76.06 -37.92 57.68 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.748 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 48.2 t -64.21 -32.76 74.47 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.256 0.622 . . . . 0.0 110.853 174.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.1 tpm_? -59.28 -53.35 59.21 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 123.833 0.708 . . . . 0.0 109.333 172.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.5 mt -53.66 -48.09 69.76 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.247 0.967 . . . . 0.0 111.572 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.36 -40.69 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.166 0.586 . . . . 0.0 110.471 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.94 76.44 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.826 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.8 mm-40 -90.71 -11.48 39.56 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.663 0.785 . . . . 0.0 111.208 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.31 75.89 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 123.048 0.356 . . . . 0.0 112.961 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.87 138.48 46.62 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.764 1.226 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.02 178.25 7.7 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.633 2.222 . . . . 0.0 112.581 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -51.92 132.47 39.09 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -173.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.21 -23.8 28.32 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.868 1.712 . . . . 0.0 113.426 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.32 -43.38 12.2 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.4 t -121.52 -14.1 8.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 63.42 28.18 15.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.519 1.128 . . . . 0.0 112.364 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 162' ' ' THR . 14.7 mm-40 -78.36 152.98 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.497 0.719 . . . . 0.0 110.131 172.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.78 114.71 2.53 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.738 2.292 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.465 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.8 mt -66.3 138.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.744 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 t -150.77 164.27 36.59 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.398 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.69 -23.23 66.1 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.753 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 m -66.34 -43.16 86.88 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.682 0.793 . . . . 0.0 111.571 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.2 pt -85.5 -10.27 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.32 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 188' ' ' ILE . 33.3 m -135.03 175.75 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.017 1.327 . . . . 0.0 110.156 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 37.2 mtmm -99.89 166.68 10.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.349 0.659 . . . . 0.0 110.54 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -55.3 -43.45 74.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.62 0.768 . . . . 0.0 112.206 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.86 -21.54 47.38 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.225 0.61 . . . . 0.0 111.524 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -81.19 -25.0 37.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.707 0.803 . . . . 0.0 110.332 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.4 p -105.53 153.66 21.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.276 1.03 . . . . 0.0 108.856 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.81 162.32 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -72.72 134.19 44.91 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.44 120.04 37.53 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.53 -42.39 71.27 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.897 0.748 . . . . 0.0 112.353 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.5 t -72.09 -30.09 64.76 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.784 0.265 . . . . 0.0 110.697 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -76.96 -32.97 57.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.367 0.667 . . . . 0.0 110.291 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.07 89.69 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.719 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -141.06 157.25 45.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -68.81 128.71 37.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.765 0.826 . . . . 0.0 109.977 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.2 175.2 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 172' ' ' VAL . 24.9 mm -79.75 143.07 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.506 0.723 . . . . 0.0 112.271 176.457 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 26.6 mp0 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.36 79.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.223 0.609 . . . . 0.0 111.44 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -66.44 -42.88 86.98 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.491 0.716 . . . . 0.0 109.872 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.94 -41.19 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.706 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 20.8 mm100 -58.43 -41.82 85.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.609 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -60.16 -41.42 92.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.558 0.536 . . . . 0.0 110.634 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -44.54 88.65 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.507 0.504 . . . . 0.0 110.618 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 130' ' ' ILE . 88.9 mt -59.21 -41.01 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.022 0.929 . . . . 0.0 109.951 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -64.66 -39.27 93.4 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.664 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -86.75 -23.59 25.41 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 79.7 m -89.25 -24.1 22.18 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.605 0.762 . . . . 0.0 111.657 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 130' ' ' ILE . 20.4 pttp -69.1 168.68 13.42 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.563 0.697 . . . . 0.0 112.015 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.95 164.87 37.94 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.695 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -67.92 99.12 0.81 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.66 96.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.496 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.3 m -100.05 98.61 7.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.185 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.14 -37.88 93.74 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.094 2.529 . . . . 0.0 113.772 -168.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.75 -31.54 68.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.461 0.704 . . . . 0.0 111.548 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -78.89 -36.75 41.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.964 0.505 . . . . 0.0 110.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.58 -21.62 63.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 69.5 -40.04 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.473 1.909 . . . . 0.0 113.56 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.45 134.59 76.72 Favored Pre-proline 0 C--N 1.353 0.729 0 C-N-CA 124.678 1.191 . . . . 0.0 109.419 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.47 166.93 10.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.205 2.604 . . . . 0.0 112.891 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 67.4 mt -51.17 -47.4 62.15 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.758 0.823 . . . . 0.0 111.581 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.25 -40.06 80.8 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.911 0.884 . . . . 0.0 112.461 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.51 65.65 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.459 0.704 . . . . 0.0 112.255 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' HD23 ' A' ' 143' ' ' LEU . 13.0 pt -120.35 11.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.06 0.944 . . . . 0.0 110.868 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 34.7 tt0 -70.3 134.42 47.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.51 1.124 . . . . 0.0 111.407 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.1 t -67.2 114.96 21.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 124.045 0.841 . . . . 0.0 109.211 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.558 ' HB2' HD21 ' A' ' 161' ' ' LEU . 92.3 Cg_endo -76.51 0.9 9.02 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.676 2.251 . . . . 0.0 113.049 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 160' ' ' PRO . 34.8 mt -84.79 -54.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.678 0.791 . . . . 0.0 109.084 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p -95.68 -8.3 35.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.735 -171.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.27 42.23 25.51 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.36 1.064 . . . . 0.0 111.791 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.08 153.67 35.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.161 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' HG2' HG13 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -72.18 118.7 69.52 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.34 163.46 34.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.897 2.398 . . . . 0.0 113.392 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 16.0 pt-20 -99.47 -20.71 16.3 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.413 172.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.9 133.09 26.29 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 125.629 1.571 . . . . 0.0 106.833 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.18 158.43 31.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.362 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.508 HG21 HG23 ' A' ' 98' ' ' ILE . 11.2 pt -113.77 156.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.905 1.282 . . . . 0.0 110.419 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.726 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 36.5 m-85 -99.32 118.34 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.932 172.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 91.5 t -123.17 119.39 57.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -67.66 114.41 6.26 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.638 0.586 . . . . 0.0 111.299 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -73.71 82.79 1.59 Allowed 'General case' 0 C--O 1.252 1.217 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.8 t -62.19 -33.97 75.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.038 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.7 -36.05 81.59 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.488 0.715 . . . . 0.0 111.54 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.15 -62.96 5.77 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 124.15 0.906 . . . . 0.0 111.349 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t 174.98 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.482 1.513 . . . . 0.0 107.433 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.46 16.79 10.7 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 121.866 0.841 . . . . 0.0 109.766 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 187' ' ' ILE . 58.5 t -78.59 124.48 37.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.86 -171.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 18.6 t -85.75 133.43 34.0 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.9 m -119.64 138.63 53.13 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.592 0.757 . . . . 0.0 109.406 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.6 tp -91.18 107.82 19.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.184 0.516 . . . . 0.0 109.725 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 94.9 m-85 -98.56 155.37 17.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.347 1.059 . . . . 0.0 108.264 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.8 140.31 53.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.16 97.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.978 0.799 . . . . 0.0 111.195 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.4 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.196 0.598 . . . . 0.0 112.101 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.81 -42.22 58.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.165 0.586 . . . . 0.0 111.187 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -74.95 -38.43 61.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.594 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.5 t -57.03 -37.32 71.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.648 0.779 . . . . 0.0 111.01 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.3 tpm_? -60.13 -57.1 14.27 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.266 0.978 . . . . 0.0 110.251 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.32 -44.14 68.16 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.329 1.018 . . . . 0.0 111.7 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 94.2 t -62.56 -48.02 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.159 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.26 -25.08 73.6 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.014 0.821 . . . . 0.0 113.283 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 10.1 mm-40 -78.65 -23.24 45.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.996 0.518 . . . . 0.0 110.541 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.61 24.07 26.84 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.595 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 69.4 mt -87.3 156.94 53.94 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.335 1.054 . . . . 0.0 110.728 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.44 -177.12 3.65 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.933 2.422 . . . . 0.0 112.829 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.425 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.3 t-80 -61.56 126.71 87.32 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.389 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.478 ' HG3' HG12 ' A' ' 121' ' ' ILE . 58.6 Cg_endo -64.92 -21.33 64.14 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.571 2.181 . . . . 0.0 113.371 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 120' ' ' PRO . 55.7 mt -89.57 -66.37 0.93 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.956 0.502 . . . . 0.0 110.995 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.4 t -104.56 -1.22 26.83 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.608 -167.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 62.24 26.61 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.94 1.296 . . . . 0.0 112.995 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -77.79 150.52 78.72 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.167 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.33 114.07 2.91 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.172 1.915 . . . . 0.0 110.072 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 62.8 mt -59.33 133.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 123.448 0.467 . . . . 0.0 110.226 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.7 t -151.55 166.19 31.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.719 0.808 . . . . 0.0 109.501 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.48 -18.98 65.27 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.37 1.068 . . . . 0.0 111.46 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -71.45 -42.43 68.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.802 0.841 . . . . 0.0 111.738 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 166' ' ' ILE . 32.6 pt -85.99 -8.56 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.4 tt -103.62 134.85 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.564 HG11 HD12 ' A' ' 188' ' ' ILE . 33.4 m -121.97 160.2 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.556 0.742 . . . . 0.0 109.892 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -73.32 149.67 42.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.864 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 20.5 p80 -63.7 -23.9 67.56 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.095 0.247 . . . . 0.0 111.452 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.81 -29.51 66.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.856 0.862 . . . . 0.0 110.873 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 189' ' ' LYS . 24.5 mm-40 -93.73 17.43 11.91 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 112.191 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 23.7 p -140.84 134.85 30.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.293 0.637 . . . . 0.0 109.365 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -131.86 159.51 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 107.561 -178.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -67.36 139.94 57.21 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -116.34 138.56 51.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.62 -45.91 84.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.955 1.41 . . . . 0.0 110.72 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 50.1 m -66.03 -48.56 70.7 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.875 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.538 ' HG3' HG21 ' A' ' 187' ' ' ILE . 32.9 mmt180 -82.08 -24.3 35.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.468 0.707 . . . . 0.0 110.949 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.3 22.27 73.7 Favored Glycine 0 N--CA 1.472 1.042 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.833 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -165.11 164.71 20.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.632 . . . . 0.0 110.005 -170.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -59.8 120.26 9.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 110.54 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.8 pp -134.36 169.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.546 1.138 . . . . 0.0 108.786 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 133' ' ' LYS . 15.6 mm -71.19 151.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 176' ' ' GLU . 53.3 mtpt . . . . . 0 N--CA 1.486 1.352 0 CA-C-N 118.363 0.529 . . . . 0.0 112.046 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.851 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.81 -49.37 68.5 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.139 0.899 . . . . 0.0 111.791 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 38.3 m -65.21 -36.93 85.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.895 0.878 . . . . 0.0 110.755 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 91' ' ' GLN . 44.3 mt -67.77 -45.76 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.576 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -54.41 -46.37 73.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.758 1.223 . . . . 0.0 111.2 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.6 m-80 -57.16 -49.96 74.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.769 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -63.72 -35.01 79.16 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 123.388 0.675 . . . . 0.0 111.603 -176.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 94' ' ' ILE . 93.9 mt -65.79 -44.48 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 t -65.66 -35.3 80.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.261 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.0 mm-40 -80.91 -49.79 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.903 0.481 . . . . 0.0 111.68 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -69.41 -21.52 63.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.413 1.085 . . . . 0.0 113.327 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.79 173.59 5.12 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -160.27 161.73 33.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.57 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -69.31 107.52 3.31 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 128' ' ' LYS . 92.8 t -72.64 99.32 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.298 0.57 . . . . 0.0 109.64 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 82.1 m -105.1 102.18 34.7 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.77 1.228 . . . . 0.0 108.014 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 11.3 Cg_endo -53.84 -27.56 44.25 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.693 2.929 . . . . 0.0 113.422 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.5 -40.52 70.13 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.548 0.739 . . . . 0.0 110.635 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.5 HH11 HD23 ' A' ' 110' ' ' LEU . 2.6 tmt_? -73.6 -44.19 57.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.553 0.741 . . . . 0.0 109.587 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 HH11 ' A' ' 109' ' ' ARG . 95.9 mt -71.72 -22.31 61.64 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.555 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 55.7 14.3 1.24 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 0.0 112.917 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.9 m -99.83 136.43 20.23 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 124.237 1.015 . . . . 0.0 108.663 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -53.95 150.42 30.72 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.929 2.419 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.6 mt -53.26 -49.34 67.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.251 1.02 . . . . 0.0 112.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.7 -35.5 76.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.148 0.979 . . . . 0.0 112.519 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.97 69.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.087 0.555 . . . . 0.0 111.623 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.514 ' HB ' HD23 ' A' ' 143' ' ' LEU . 22.9 pt -109.18 4.3 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.21 0.604 . . . . 0.0 111.038 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 4.6 tt0 -60.71 134.99 57.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 31.7 t -67.04 114.31 17.57 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.128 0.971 . . . . 0.0 108.807 175.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.526 ' HB2' HD21 ' A' ' 161' ' ' LEU . 73.9 Cg_endo -70.62 -9.14 25.19 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.616 2.211 . . . . 0.0 112.782 -176.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.5 -55.43 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.833 0.853 . . . . 0.0 109.669 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -98.9 -6.19 29.38 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.557 -170.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.55 34.37 20.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.054 0.942 . . . . 0.0 112.257 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.05 148.03 49.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.783 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.02 108.75 3.0 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 171.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 56.1 Cg_endo -68.69 154.93 70.4 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.562 2.174 . . . . 0.0 113.11 -167.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.0 pt-20 -81.91 -30.55 31.83 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.715 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -153.03 142.6 21.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.991 1.316 . . . . 0.0 108.471 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.7 177.69 40.17 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.301 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.28 161.29 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.695 1.598 . . . . 0.0 109.251 -173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 60.6 m-85 -106.47 116.65 32.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.878 0.471 . . . . 0.0 110.355 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 97.0 t -117.12 121.6 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 22.2 ptmt -73.25 114.23 11.21 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.57 0.7 . . . . 0.0 110.626 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -68.15 88.31 0.29 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.4 t -61.09 -41.62 97.0 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.391 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.85 -32.01 72.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.29 0.636 . . . . 0.0 110.956 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.59 36.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.597 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.2 m 84.79 45.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.14 1.776 . . . . 0.0 111.442 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 61.16 22.67 12.95 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.716 1.206 . . . . 0.0 112.274 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 185' ' ' ASN . 88.6 t -76.89 120.42 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.269 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 58.0 m -83.2 134.12 34.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.5 m -124.59 147.92 48.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 117' ' ' ILE . 26.8 tp -89.87 105.34 17.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.306 0.574 . . . . 0.0 110.513 -175.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 79.2 m-85 -102.74 133.63 47.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.561 1.144 . . . . 0.0 108.316 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.7 t70 -57.21 130.73 47.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.666 0.666 . . . . 0.0 109.378 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.34 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.733 0.813 . . . . 0.0 112.215 -171.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.99 63.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.799 0.44 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.96 76.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.686 0.794 . . . . 0.0 111.795 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -75.54 -38.73 59.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.3 t -62.96 -28.76 70.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.489 0.716 . . . . 0.0 111.03 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.5 tpm_? -63.84 -52.94 57.81 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 123.937 0.773 . . . . 0.0 110.218 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -57.64 -42.96 84.48 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.946 0.778 . . . . 0.0 111.359 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 166' ' ' ILE . 94.6 t -65.73 -44.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.829 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.01 -26.7 69.37 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.895 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 38.5 mm-40 -79.98 -30.29 39.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.95 20.78 35.36 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.454 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.94 150.66 78.44 Favored Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.216 1.006 . . . . 0.0 110.501 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.38 173.69 14.07 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.61 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.469 ' ND1' HG22 ' A' ' 162' ' ' THR . 59.6 t-80 -54.27 129.01 59.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.666 0.786 . . . . 0.0 110.366 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -62.06 -22.38 74.13 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.62 2.213 . . . . 0.0 113.673 -170.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 120' ' ' PRO . 60.5 mt -103.4 -53.16 2.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.745 0.418 . . . . 0.0 111.827 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.469 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -104.14 -8.33 19.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.08 22.45 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.468 1.107 . . . . 0.0 113.167 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -75.2 155.8 86.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.592 0.757 . . . . 0.0 109.984 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -58.35 115.23 2.39 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.403 2.069 . . . . 0.0 110.57 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.545 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.3 mt -63.31 131.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 t -153.66 162.11 41.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 109.923 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.92 65.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.145 0.978 . . . . 0.0 111.258 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.0 t -66.2 -48.31 71.07 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.1 0.96 . . . . 0.0 111.476 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.3 pt -88.92 -2.67 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.35 137.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.63 169.74 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 109.537 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 176' ' ' GLU . 52.1 mtmt -82.8 156.03 23.88 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.298 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -64.56 -23.65 67.34 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -87.9 -21.93 24.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.694 0.797 . . . . 0.0 109.892 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 7.1 tp10 -78.76 -17.05 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.069 0.948 . . . . 0.0 111.471 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.4 p -128.62 154.64 46.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.087 0.955 . . . . 0.0 109.33 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.435 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -135.83 164.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.374 1.069 . . . . 0.0 108.714 178.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 21.3 p90 -78.96 121.7 25.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -105.65 127.03 52.82 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.06 -40.31 75.16 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.313 -170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 t -74.32 -24.26 59.18 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-N 117.531 0.15 . . . . 0.0 111.222 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -80.25 -30.49 38.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.85 25.01 70.54 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.22 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 78.0 m-20 -156.24 160.98 40.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.275 -171.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 60.4 m-85 -74.13 126.73 31.21 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 168.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.1 pt -132.5 177.31 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.664 0.785 . . . . 0.0 110.066 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.03 143.89 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.548 0.739 . . . . 0.0 109.88 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.435 ' HG2' HD12 ' A' ' 178' ' ' ILE . 60.0 mtpt . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.163 0.585 . . . . 0.0 112.378 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.735 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -38.24 75.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.523 0.729 . . . . 0.0 111.742 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.4 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 29.4 t -70.93 -43.63 67.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.87 0.868 . . . . 0.0 109.93 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 98' ' ' ILE . 73.6 mt -63.42 -50.23 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.41 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.64 -23.36 58.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.984 0.914 . . . . 0.0 112.036 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.42 -38.35 84.45 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -67.31 -37.32 83.15 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 123.05 0.54 . . . . 0.0 110.431 175.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 150' ' ' SER . 90.7 mt -65.49 -38.08 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.208 0.603 . . . . 0.0 110.125 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -60.84 -40.44 92.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.394 1.078 . . . . 0.0 111.74 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -86.76 -40.19 15.24 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.0 m -76.82 -16.49 59.42 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.634 0.774 . . . . 0.0 111.785 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -71.03 154.89 41.42 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.385 0.612 . . . . 0.0 111.15 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.74 161.02 42.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.696 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.6 m -65.53 96.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 110.039 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.08 97.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 m -110.65 107.22 58.12 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.18 -20.86 67.58 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.159 2.573 . . . . 0.0 113.016 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.92 -35.16 29.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.43 1.092 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.81 -49.0 13.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.974 0.509 . . . . 0.0 110.418 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.3 mt -69.05 -21.31 64.11 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.148 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 55.38 19.39 3.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 112.772 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.47 134.15 40.79 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.36 149.11 76.13 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.182 1.922 . . . . 0.0 110.632 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.8 mt -52.13 -43.68 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.7 0.8 . . . . 0.0 111.407 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.34 -37.7 81.49 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.759 0.824 . . . . 0.0 112.541 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.09 71.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.14 0.576 . . . . 0.0 111.107 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.5 pt -117.09 31.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.986 0.914 . . . . 0.0 110.005 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -70.86 128.59 36.52 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.837 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -74.78 109.95 8.6 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 162.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.94 -11.55 27.55 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 123.085 2.523 . . . . 0.0 112.694 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.82 -52.84 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.603 0.761 . . . . 0.0 109.123 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.9 p -92.7 -12.6 31.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.504 1.122 . . . . 0.0 112.573 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 61.42 37.8 16.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.858 0.863 . . . . 0.0 111.32 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.36 151.92 37.32 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 115.51 44.63 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 160.91 36.09 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.886 2.391 . . . . 0.0 113.458 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 12.5 pt-20 -87.87 -20.74 25.6 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.33 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.61 134.53 22.52 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 108.346 178.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.15 166.66 37.12 Favored Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.463 HG13 HG23 ' A' ' 132' ' ' VAL . 9.9 pt -124.87 155.46 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 0.0 109.386 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.61 115.07 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 130' ' ' ILE . 71.7 t -123.23 122.75 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -66.24 120.3 13.02 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.483 0.658 . . . . 0.0 110.962 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -72.7 84.25 1.18 Allowed 'General case' 0 C--O 1.249 1.065 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 161.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.7 t -67.76 -57.05 6.99 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.426 -168.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.02 -31.85 69.71 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.018 0.527 . . . . 0.0 111.42 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -63.38 4.66 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.035 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.2 m -149.92 5.68 0.59 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 65.73 21.32 11.56 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.187 0.995 . . . . 0.0 111.201 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.29 143.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.489 1.116 . . . . 0.0 109.291 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 31.1 p -86.21 140.52 30.06 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 117.921 0.328 . . . . 0.0 110.174 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.4 m -126.84 148.34 49.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.482 1.113 . . . . 0.0 108.184 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.8 tp -89.2 123.89 33.86 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.932 0.493 . . . . 0.0 109.87 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -120.76 132.89 55.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.104 0.961 . . . . 0.0 108.674 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.07 130.5 38.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.57 -46.36 77.21 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.079 0.862 . . . . 0.0 111.792 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.6 68.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.118 0.567 . . . . 0.0 111.619 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.62 62.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.696 0.798 . . . . 0.0 111.542 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.65 -41.85 64.99 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.803 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -63.5 -29.92 71.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.253 0.621 . . . . 0.0 110.867 176.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.8 tpm_? -61.53 -51.91 66.63 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 172.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -55.38 -43.93 75.6 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.295 0.997 . . . . 0.0 111.21 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 91' ' ' GLN . 46.5 t -67.44 -45.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.737 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.46 -27.6 66.09 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.306 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 19.1 mm-40 -78.65 -33.97 46.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.09 0.556 . . . . 0.0 110.828 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.81 28.52 11.02 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.73 144.12 28.95 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.669 1.188 . . . . 0.0 109.509 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.8 -177.83 4.08 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.795 2.33 . . . . 0.0 112.503 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.413 ' ND1' HG22 ' A' ' 162' ' ' THR . 57.4 t-80 -54.53 129.86 62.68 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.404 1.082 . . . . 0.0 110.902 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.24 -24.03 78.17 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.831 2.354 . . . . 0.0 114.087 -171.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.4 mt -103.06 -56.65 2.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.807 0.443 . . . . 0.0 111.882 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.413 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.6 t -102.52 -8.69 20.83 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.691 0.396 . . . . 0.0 111.384 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 63.5 24.71 14.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 0.0 112.546 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.0 154.82 90.77 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 114.11 2.95 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.017 1.811 . . . . 0.0 110.215 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.542 ' HA ' HD11 ' A' ' 170' ' ' ILE . 66.0 mt -63.05 134.75 28.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -149.37 163.39 37.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.074 0.95 . . . . 0.0 109.744 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.56 -18.09 65.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.851 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.5 t -70.96 -41.05 71.59 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 111.746 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -85.65 -11.41 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 130' ' ' ILE . 11.1 tt -99.61 133.43 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 188' ' ' ILE . 27.5 m -129.04 174.12 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.18 0.992 . . . . 0.0 110.18 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -94.17 164.35 13.09 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.229 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -57.29 -39.95 76.77 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.5 -4.64 57.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.146 0.43 . . . . 0.0 111.679 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -87.23 -21.93 25.54 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.515 0.674 . . . . 0.0 109.613 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.6 p -102.75 142.09 34.47 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 158.0 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 17.0 p90 -75.22 122.9 24.36 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -99.06 129.93 45.36 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -70.37 -34.71 72.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.385 1.053 . . . . 0.0 111.663 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 t -74.78 -28.4 60.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.214 0.206 . . . . 0.0 110.955 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 187' ' ' ILE . 37.4 mmt180 -82.14 -32.38 30.12 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 111.117 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.54 24.59 75.95 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.743 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -165.51 159.38 16.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.906 0.482 . . . . 0.0 109.876 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 90.7 m-85 -65.19 118.92 9.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.628 1.171 . . . . 0.0 111.111 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.429 HD13 ' HG3' ' A' ' 183' ' ' ARG . 21.8 pt -128.56 -179.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 108.06 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 172' ' ' VAL . 8.7 mm -83.57 156.26 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 123.974 0.91 . . . . 0.0 112.432 176.385 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.813 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -38.1 77.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.978 0.799 . . . . 0.0 111.984 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 49.6 m -66.9 -39.22 87.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.292 0.637 . . . . 0.0 110.711 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 58.0 mt -68.63 -41.88 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.605 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -56.87 -41.11 77.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.876 1.271 . . . . 0.0 110.887 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -61.39 -44.86 96.42 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.283 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -63.43 -39.65 95.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.964 0.506 . . . . 0.0 111.441 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 150' ' ' SER . 77.8 mt -65.3 -37.73 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.242 0.617 . . . . 0.0 110.333 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.1 t -62.3 -45.69 92.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.61 0.764 . . . . 0.0 111.789 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -78.17 -29.47 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.161 0.584 . . . . 0.0 112.187 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.8 -10.38 23.09 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.412 0.685 . . . . 0.0 112.496 -172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -74.24 160.17 31.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -152.1 160.26 43.47 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.361 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.7 t -66.78 100.06 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.083 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.75 107.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 84.1 m -118.69 87.11 31.36 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.816 0.847 . . . . 0.0 109.776 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HB3' HD11 ' A' ' 117' ' ' ILE . 1.7 Cg_endo -43.88 -45.75 11.18 Favored 'Trans proline' 0 C--N 1.385 2.452 1 C-N-CA 125.42 4.08 . . . . 0.0 115.129 -176.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -20.48 55.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.064 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -91.3 -31.91 15.92 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.918 0.487 . . . . 0.0 110.575 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.59 -20.17 61.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.588 0.755 . . . . 0.0 110.341 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 59.12 18.98 6.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.507 1.523 . . . . 0.0 112.237 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.5 m -100.35 138.11 20.13 Favored Pre-proline 0 C--O 1.245 0.836 0 C-N-CA 124.165 0.986 . . . . 0.0 108.877 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.18 157.51 34.62 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.426 2.084 . . . . 0.0 111.357 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 71.8 mt -55.98 -38.78 70.89 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.083 0.553 . . . . 0.0 111.373 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.12 -38.38 82.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.02 0.928 . . . . 0.0 112.825 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.87 66.86 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.086 0.554 . . . . 0.0 111.593 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 107' ' ' PRO . 26.5 pt -124.08 16.43 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.856 0.862 . . . . 0.0 111.107 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.42 125.39 24.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.204 1.002 . . . . 0.0 110.221 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.91 111.47 10.72 Favored Pre-proline 0 C--N 1.354 0.775 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.96 -3.99 14.74 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.741 2.294 . . . . 0.0 112.105 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -84.98 -58.55 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.895 0.878 . . . . 0.0 109.403 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 p -88.4 -13.0 41.61 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.721 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.99 33.63 17.17 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.584 0.754 . . . . 0.0 111.533 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.88 152.76 46.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -73.13 110.43 8.54 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 57.7 Cg_endo -68.08 153.84 73.96 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.434 2.756 . . . . 0.0 114.266 -167.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -80.48 -38.8 29.24 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.605 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.1 pttm -138.64 143.58 39.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.177 1.391 . . . . 0.0 107.459 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.94 166.25 37.43 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.278 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 98' ' ' ILE . 11.3 pt -121.64 155.27 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.985 1.314 . . . . 0.0 109.086 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.51 123.16 41.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.78 121.91 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.701 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -71.09 119.0 14.59 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.751 0.657 . . . . 0.0 110.775 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -74.03 81.73 1.73 Allowed 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.1 t -68.87 -28.53 66.78 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.386 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.29 -37.42 85.4 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.353 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.35 -65.0 2.56 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -178.5 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.984 0.914 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 61.98 23.27 13.68 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.178 0.991 . . . . 0.0 111.379 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.16 118.35 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 186' ' ' PHE . 20.6 p -84.36 138.87 32.64 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.41 0.624 . . . . 0.0 110.032 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.3 m -127.83 145.03 51.06 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.18 0.992 . . . . 0.0 108.785 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 117' ' ' ILE . 61.0 tp -88.28 111.54 21.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -105.44 138.03 42.29 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.661 1.184 . . . . 0.0 108.022 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.7 t70 -59.1 135.44 57.63 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.381 0.537 . . . . 0.0 109.722 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.89 92.27 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.74 0.816 . . . . 0.0 111.777 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.36 -35.17 65.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.544 0.528 . . . . 0.0 111.072 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 -48.33 59.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.626 0.77 . . . . 0.0 112.007 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 130' ' ' ILE . 44.2 t80 -70.0 -40.7 75.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.998 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.512 ' HB2' HG21 ' A' ' 98' ' ' ILE . 32.5 t -62.44 -32.31 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.564 0.54 . . . . 0.0 111.13 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 151' ' ' ARG . 1.4 tpm_? -64.65 -49.38 71.24 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 123.637 0.586 . . . . 0.0 110.401 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.69 -45.16 81.94 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.174 0.921 . . . . 0.0 111.182 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 84.3 t -61.92 -46.77 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.217 0.607 . . . . 0.0 110.209 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.73 -31.19 79.95 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.041 0.838 . . . . 0.0 113.228 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.61 -15.66 53.97 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.653 0.781 . . . . 0.0 111.662 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.87 31.87 38.33 Favored Glycine 0 N--CA 1.47 0.966 0 O-C-N 123.204 0.315 . . . . 0.0 112.551 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.7 mt -90.24 150.82 43.86 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.663 1.185 . . . . 0.0 110.025 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.52 -179.43 5.31 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.685 2.257 . . . . 0.0 113.088 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.417 ' ND1' HG22 ' A' ' 162' ' ' THR . 47.1 t-80 -56.76 127.14 73.48 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.174 0.99 . . . . 0.0 111.317 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.09 -1.74 8.46 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.995 2.464 . . . . 0.0 114.069 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.63 -64.52 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.689 0.395 . . . . 0.0 110.624 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.417 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.1 t -98.39 -4.64 34.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.984 -167.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 61.55 20.96 11.7 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.496 1.118 . . . . 0.0 112.906 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.19 152.28 73.56 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.514 0.726 . . . . 0.0 110.589 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.78 115.06 2.69 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.056 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 70.3 mt -63.27 130.8 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.744 0.417 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -141.53 162.69 34.86 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 109.571 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.38 66.24 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.409 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.4 m -64.91 -41.68 95.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.51 0.724 . . . . 0.0 112.065 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.9 pt -85.61 -7.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.33 135.5 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.12 0.873 . . . . 0.0 109.337 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 188' ' ' ILE . 31.1 m -133.19 179.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 109.844 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -101.66 164.96 11.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.837 0.455 . . . . 0.0 110.578 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.25 -15.61 33.18 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.32 -26.82 56.19 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.099 0.952 . . . . 0.0 109.339 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 28.9 p -105.02 161.07 14.53 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.933 165.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -137.33 162.98 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.386 0.674 . . . . 0.0 109.265 175.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -72.59 135.01 45.44 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 163.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.0 t70 -119.02 127.05 53.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.55 -43.69 47.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.8 t -76.58 -28.48 56.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.172 0.442 . . . . 0.0 110.808 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -72.03 -31.8 66.53 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.22 81.2 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.598 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -149.33 150.12 31.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.026 0.93 . . . . 0.0 110.232 -170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.584 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 35.3 m-85 -63.42 119.24 9.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.668 0.787 . . . . 0.0 109.968 168.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.2 pt -127.15 177.84 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 0.0 109.723 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' A' ' 133' ' ' LYS . 37.1 mm -85.83 151.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.386 0.674 . . . . 0.0 110.129 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 121.101 0.477 . . . . 0.0 111.743 174.384 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.739 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 119.559 -0.257 . . . . 0.0 111.448 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -41.47 67.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.927 0.891 . . . . 0.0 112.591 -168.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 41.4 t -65.7 -46.09 80.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.535 0.734 . . . . 0.0 110.04 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.5 mt -63.73 -41.14 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.128 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -59.8 -42.63 93.85 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.517 1.127 . . . . 0.0 110.622 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -61.87 -43.27 99.18 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.372 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -64.23 -31.32 72.47 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.242 0.617 . . . . 0.0 111.325 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.457 HG23 HD13 ' A' ' 130' ' ' ILE . 95.3 mt -70.42 -40.57 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.309 0.644 . . . . 0.0 109.671 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 t -65.57 -33.42 75.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.312 0.645 . . . . 0.0 111.292 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -74.95 -46.75 33.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.293 1.037 . . . . 0.0 112.327 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.593 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 71.0 m -82.33 -17.35 46.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.48 0.712 . . . . 0.0 112.845 -169.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -70.55 165.7 22.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.447 0.641 . . . . 0.0 112.603 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -156.41 159.65 38.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.381 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.6 m -66.97 102.58 1.0 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.626 0.579 . . . . 0.0 109.713 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.06 102.46 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.191 0.596 . . . . 0.0 110.148 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.1 m -112.29 106.84 55.86 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.158 0.983 . . . . 0.0 108.745 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HB3' HD11 ' A' ' 117' ' ' ILE . 24.1 Cg_endo -60.3 -18.95 55.49 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.3 2.667 . . . . 0.0 112.745 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.6 -35.9 70.66 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.557 0.743 . . . . 0.0 110.277 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -83.73 -49.47 9.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.084 0.554 . . . . 0.0 110.347 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.5 -23.18 65.44 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.381 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 54.02 21.02 2.69 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.434 1.094 . . . . 0.0 112.783 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -103.81 136.87 19.14 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.273 1.029 . . . . 0.0 108.337 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.9 154.16 28.15 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.753 2.302 . . . . 0.0 111.801 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.7 mt -49.88 -46.33 51.49 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.848 0.717 . . . . 0.0 111.271 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.35 -40.66 74.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.835 1.254 . . . . 0.0 113.038 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.46 66.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.762 0.825 . . . . 0.0 111.633 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.576 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.9 pt -114.63 7.68 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.211 1.005 . . . . 0.0 111.153 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 35.3 tt0 -68.18 136.05 53.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.146 0.978 . . . . 0.0 111.055 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 36.8 t -69.26 110.26 5.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 124.411 1.069 . . . . 0.0 108.405 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.72 -1.04 10.2 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.056 2.504 . . . . 0.0 112.735 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.493 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.5 mt -84.35 -52.83 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.142 1.377 . . . . 0.0 109.756 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -97.89 -9.34 26.48 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.322 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.9 37.37 15.27 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.193 0.997 . . . . 0.0 111.894 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.49 151.13 37.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.195 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.2 tm0? -71.04 118.12 62.69 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 94.9 Cg_endo -74.03 162.5 38.87 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.074 2.516 . . . . 0.0 114.07 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.639 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -82.47 -32.17 29.0 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.67 172.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.639 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.3 pttt -147.67 143.64 27.79 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.315 1.446 . . . . 0.0 107.345 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.69 160.6 33.79 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.183 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 98' ' ' ILE . 10.2 pt -114.37 152.36 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.833 1.653 . . . . 0.0 109.365 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -93.66 120.38 33.86 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 98.4 t -120.34 119.51 60.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -69.09 118.82 12.47 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.635 0.731 . . . . 0.0 110.417 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -70.19 81.38 0.52 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 163.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -67.34 -56.34 10.11 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.875 -168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.05 -28.42 68.2 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.533 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.98 -65.73 2.14 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.193 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 m -152.68 10.98 0.49 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.1 t70 66.39 14.42 9.69 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 124.047 0.939 . . . . 0.0 111.116 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.17 124.93 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.498 0.719 . . . . 0.0 110.037 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 26.1 p -84.56 132.79 34.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.0 m -121.48 147.0 46.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 117' ' ' ILE . 27.0 tp -92.85 105.15 17.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 85.4 m-85 -99.77 140.04 34.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.619 1.168 . . . . 0.0 107.895 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.4 t70 -61.04 140.84 57.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.646 0.657 . . . . 0.0 109.676 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.44 74.93 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.106 0.879 . . . . 0.0 111.276 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.92 67.34 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.344 0.657 . . . . 0.0 111.621 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -48.12 60.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.478 0.711 . . . . 0.0 112.026 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 41.7 t80 -71.17 -39.63 71.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.965 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.44 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -60.25 -35.44 75.51 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.822 0.701 . . . . 0.0 110.898 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 41.1 ttt85 -62.35 -53.41 55.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.016 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.74 -45.76 67.14 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.292 0.637 . . . . 0.0 112.054 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 48.7 t -61.79 -49.67 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.69 -18.93 70.72 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.849 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.1 mm-40 -82.48 -29.08 30.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.387 0.675 . . . . 0.0 109.857 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.11 23.9 16.19 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 64.5 mt -91.46 147.97 36.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.397 1.079 . . . . 0.0 110.047 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.15 -167.02 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.939 2.426 . . . . 0.0 112.165 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' ND1' HG22 ' A' ' 162' ' ' THR . 45.0 t-80 -62.55 126.5 88.39 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 109.784 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -10.2 28.12 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.844 2.363 . . . . 0.0 113.851 -171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.08 -64.97 1.01 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.923 0.489 . . . . 0.0 110.04 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.457 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -98.0 -5.06 34.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.291 0.636 . . . . 0.0 112.097 -167.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 62.66 21.64 12.84 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.526 1.13 . . . . 0.0 112.746 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -80.46 151.52 71.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.138 0.575 . . . . 0.0 111.009 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.2 118.91 5.81 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.521 2.147 . . . . 0.0 111.357 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 71.8 mt -64.93 135.02 28.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.349 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 t -148.78 163.36 37.59 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.844 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.96 -24.12 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.946 0.898 . . . . 0.0 111.356 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -64.74 -45.85 84.72 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.665 0.786 . . . . 0.0 111.928 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.5 pt -80.98 -8.43 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.95 130.39 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 118.713 0.688 . . . . 0.0 109.391 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.6 m -132.73 173.84 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.211 1.404 . . . . 0.0 109.882 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.593 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 52.6 mtpt -101.5 169.85 8.59 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.029 0.442 . . . . 0.0 110.754 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -59.23 -28.53 66.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.523 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -78.66 -33.02 47.41 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.529 0.732 . . . . 0.0 111.387 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.62 -15.32 42.88 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.189 0.519 . . . . 0.0 110.857 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 30.5 p -112.9 146.94 38.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.603 0.761 . . . . 0.0 109.044 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.68 154.16 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 37.9 p90 -67.78 134.99 51.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 165.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.504 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.6 t70 -112.83 133.99 54.56 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.93 -49.97 33.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.598 1.159 . . . . 0.0 112.099 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 t -71.33 -24.55 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.049 0.386 . . . . 0.0 111.184 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.464 ' HA ' ' HE ' ' A' ' 183' ' ' ARG . 2.3 mmp_? -84.87 -34.05 22.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.358 0.663 . . . . 0.0 110.718 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.19 73.39 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.96 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -148.05 143.68 27.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.364 1.066 . . . . 0.0 109.481 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 25.5 m-85 -68.64 115.97 8.62 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 180' ' ' ASP . 24.1 pt -122.91 178.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.307 1.043 . . . . 0.0 108.611 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 133' ' ' LYS . 38.3 mm -83.87 155.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt . . . . . 0 C--O 1.242 0.701 0 CA-C-O 120.981 0.419 . . . . 0.0 110.39 174.105 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.54 -51.43 36.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -72.99 -43.18 62.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.473 0.309 . . . . 0.0 110.655 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.51 -49.35 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.476 0.71 . . . . 0.0 111.081 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.432 ' HA ' HD12 ' A' ' 98' ' ' ILE . 40.2 mt-30 -67.6 -29.55 68.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.567 0.747 . . . . 0.0 111.367 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 4.1 m-80 -62.35 -43.18 99.42 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 170.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -40.67 94.08 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 122.823 0.449 . . . . 0.0 110.078 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.499 HG23 HD13 ' A' ' 130' ' ' ILE . 94.9 mt -61.43 -38.32 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.732 0.813 . . . . 0.0 111.136 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.3 m -70.48 -32.56 70.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.136 0.574 . . . . 0.0 110.964 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 34.8 mt-30 -83.55 -39.42 20.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.105 0.562 . . . . 0.0 111.633 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -80.13 -19.97 46.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.545 -171.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -69.78 162.39 27.94 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 123.531 0.519 . . . . 0.0 110.877 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -148.11 159.65 43.71 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -68.34 97.97 0.79 Allowed 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.06 97.62 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 57.9 m -108.21 102.12 44.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.851 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 117' ' ' ILE . 12.9 Cg_endo -54.61 -29.75 62.27 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.666 2.91 . . . . 0.0 112.666 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 8.9 pt-20 -69.79 -35.42 74.86 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.635 1.174 . . . . 0.0 111.54 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.699 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 50.7 mtt180 -93.84 -36.4 12.26 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.669 0.787 . . . . 0.0 111.209 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.37 -18.43 62.37 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.705 0.802 . . . . 0.0 111.977 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 63.53 17.68 10.53 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.882 1.273 . . . . 0.0 111.483 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -104.46 129.48 24.96 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 124.309 1.044 . . . . 0.0 109.615 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.24 166.45 19.05 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.733 2.289 . . . . 0.0 111.748 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.7 mt -53.25 -47.14 69.31 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.737 0.648 . . . . 0.0 111.022 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -52.14 -43.38 64.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.98 0.912 . . . . 0.0 112.852 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.65 69.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.332 0.653 . . . . 0.0 111.415 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 107' ' ' PRO . 15.1 pt -122.01 29.42 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.905 0.882 . . . . 0.0 110.322 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -73.82 121.83 21.49 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.188 0.995 . . . . 0.0 109.439 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.1 t -68.74 114.95 25.97 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.28 -12.7 34.42 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.801 2.334 . . . . 0.0 112.755 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.61 -51.88 16.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.843 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.8 p -96.75 -19.54 18.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.348 1.059 . . . . 0.0 112.324 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 57.85 46.81 16.31 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.318 1.047 . . . . 0.0 111.823 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.46 152.64 38.41 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.802 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.25 113.38 27.78 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.75 167.04 18.97 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.009 2.473 . . . . 0.0 113.451 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.02 -23.45 26.79 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -143.46 140.69 30.49 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.102 1.361 . . . . 0.0 108.43 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.45 157.08 29.39 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.335 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 98' ' ' ILE . 7.1 pt -110.77 161.26 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.038 1.335 . . . . 0.0 109.775 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -104.89 118.17 35.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.588 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.5 t -114.67 125.55 72.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.3 ptmt -73.75 114.61 12.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 124.004 0.815 . . . . 0.0 110.037 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -71.95 80.45 0.91 Allowed 'General case' 0 C--O 1.247 0.943 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 36.7 t -64.8 -49.43 70.71 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.716 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.73 -27.96 68.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.564 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.43 2.58 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.366 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.0 m -161.53 17.91 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.464 0.706 . . . . 0.0 111.198 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 13.6 t70 67.03 22.09 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.394 1.078 . . . . 0.0 111.235 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 187' ' ' ILE . 90.5 t -96.19 134.67 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.319 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 55.9 m -87.0 139.83 30.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.624 0.77 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.2 m -127.28 147.72 50.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.249 1.02 . . . . 0.0 108.853 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 tp -85.28 112.48 20.81 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.03 0.443 . . . . 0.0 110.222 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.47 137.17 46.86 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -58.34 137.43 57.2 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.177 0.444 . . . . 0.0 109.95 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.42 85.97 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.159 0.912 . . . . 0.0 111.15 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.54 -34.29 62.94 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.783 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.8 -44.09 61.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 112.118 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -73.48 -39.0 65.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.761 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -63.08 -37.98 89.37 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.583 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 48.4 ttt180 -53.64 -53.2 55.32 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.765 0.666 . . . . 0.0 109.481 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.26 -42.52 73.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.01 0.819 . . . . 0.0 111.829 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 149' ' ' PHE . 58.8 t -64.57 -46.9 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.416 0.448 . . . . 0.0 110.091 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.38 -36.06 91.93 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.825 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 45.3 mt-10 -75.95 -27.47 57.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.644 0.777 . . . . 0.0 110.819 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.79 20.44 34.02 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.747 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.86 144.16 47.62 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.035 0.934 . . . . 0.0 109.573 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.83 -170.3 0.88 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.992 2.462 . . . . 0.0 112.422 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.478 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.4 t-80 -62.5 126.81 89.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.571 0.749 . . . . 0.0 109.343 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.87 -14.87 39.71 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.23 1.954 . . . . 0.0 113.331 -170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.8 mt -96.12 -66.01 0.93 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 122.589 0.356 . . . . 0.0 110.886 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.478 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.0 t -90.51 -10.1 44.84 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 63.31 16.81 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.755 1.222 . . . . 0.0 112.843 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -80.12 144.69 59.2 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 122.87 12.37 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.702 2.268 . . . . 0.0 111.544 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.405 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -62.25 131.85 27.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 123.54 0.525 . . . . 0.0 110.104 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -143.77 161.95 37.29 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.89 0.876 . . . . 0.0 109.172 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -66.57 -23.04 66.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.665 174.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.2 m -69.44 -22.35 63.67 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.018 0.927 . . . . 0.0 112.728 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 48.0 pt -105.9 -2.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.8 tt -97.79 140.53 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.394 -0.816 . . . . 0.0 109.887 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.553 HG11 HD12 ' A' ' 188' ' ' ILE . 27.3 m -141.35 -179.89 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.793 1.237 . . . . 0.0 110.049 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.7 168.63 10.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.641 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 83.9 t60 -68.02 -24.89 65.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.842 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.12 -22.2 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.766 0.426 . . . . 0.0 110.68 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -85.63 -21.54 28.38 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.218 0.533 . . . . 0.0 111.042 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.2 p -101.65 145.45 29.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 167.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -128.7 143.64 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -65.85 102.05 0.73 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -72.75 124.19 24.85 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.63 -34.59 67.44 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.189 0.996 . . . . 0.0 111.585 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.8 t -80.32 -25.43 39.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.119 0.168 . . . . 0.0 111.159 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -100.98 -14.63 17.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.811 0.445 . . . . 0.0 111.53 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.48 79.76 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.156 -0.802 . . . . 0.0 114.942 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -165.79 162.49 18.55 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 117.694 0.747 . . . . 0.0 110.47 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 83.9 m-85 -59.92 125.76 24.9 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 111.754 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -133.34 169.51 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.443 1.097 . . . . 0.0 109.134 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.553 HD12 HG11 ' A' ' 172' ' ' VAL . 42.6 mm -70.88 140.3 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.421 0.688 . . . . 0.0 110.733 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.561 0.696 . . . . 0.0 111.884 175.256 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.771 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.47 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.27 -55.5 12.49 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 113.48 -164.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -66.27 -34.79 78.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.281 0.632 . . . . 0.0 111.092 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 98' ' ' ILE . 67.1 mt -69.62 -45.18 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.697 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -57.89 -44.1 86.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.853 1.261 . . . . 0.0 111.214 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.07 -45.42 87.12 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.702 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG2' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -66.82 -34.11 77.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.948 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.8 mt -65.84 -43.08 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.2 t -65.03 -33.94 77.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.792 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -77.77 -44.93 26.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.281 0.632 . . . . 0.0 111.829 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 82.8 m -76.61 -20.98 56.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.705 0.802 . . . . 0.0 112.675 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -71.08 168.27 17.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.645 0.736 . . . . 0.0 112.606 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -158.78 160.57 36.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.446 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.3 m -69.1 99.16 1.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.706 0.628 . . . . 0.0 109.469 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.32 119.89 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.411 0.685 . . . . 0.0 110.091 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 79.5 m -133.73 101.82 12.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.007 0.923 . . . . 0.0 109.386 -176.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 10.8 Cg_endo -52.39 -23.28 18.23 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.891 3.061 . . . . 0.0 114.008 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.9 pt-20 -73.14 -38.13 66.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.708 0.803 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 90.9 mtt-85 -93.43 -21.7 19.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.689 0.796 . . . . 0.0 111.514 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.17 -20.91 26.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.621 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 59.7 24.23 13.11 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.299 1.04 . . . . 0.0 111.46 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.4 m -110.31 137.21 20.56 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.128 0.971 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.1 162.67 28.65 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.275 1.983 . . . . 0.0 111.488 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 93.8 mt -54.26 -46.25 72.6 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.477 0.711 . . . . 0.0 111.289 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.13 -41.72 72.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.051 0.94 . . . . 0.0 112.694 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.98 68.88 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.579 0.752 . . . . 0.0 111.993 -175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 pt -122.95 30.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.039 0.936 . . . . 0.0 109.81 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.4 tt0 -78.62 134.98 37.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.442 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 18.7 t -71.49 114.94 32.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 109.185 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.36 -4.8 16.04 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.936 2.424 . . . . 0.0 113.497 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.498 HG12 ' HG3' ' A' ' 160' ' ' PRO . 59.7 mt -80.3 -53.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.87 0.868 . . . . 0.0 109.311 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -95.12 -11.01 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.148 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.63 37.06 19.49 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.986 0.914 . . . . 0.0 111.53 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.45 148.92 29.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.289 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -72.05 118.64 68.88 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.282 0.633 . . . . 0.0 109.444 175.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.72 161.89 18.95 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.769 2.313 . . . . 0.0 113.493 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -88.02 -14.13 39.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.049 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -151.7 134.21 15.41 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.844 0.858 . . . . 0.0 109.93 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.23 165.38 38.55 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.31 -172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 143' ' ' LEU . 9.2 pt -114.41 158.97 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.654 1.582 . . . . 0.0 110.395 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.04 123.65 44.52 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 90.5 t -118.86 119.95 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.1 ptmt -74.83 114.15 12.95 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 123.763 0.664 . . . . 0.0 110.047 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -73.39 72.96 1.35 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 171.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 35.1 t -68.13 -55.41 12.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.819 -167.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -58.32 -34.39 70.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.178 0.991 . . . . 0.0 112.14 -173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.98 -62.4 2.36 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.637 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.9 t -149.33 3.93 0.59 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 22.9 t70 59.33 47.23 11.62 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.792 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.08 124.6 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 122.948 0.499 . . . . 0.0 110.26 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 65.1 m -84.21 128.68 34.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.251 0.621 . . . . 0.0 109.66 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.0 m -122.8 143.39 49.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.347 1.059 . . . . 0.0 109.66 -171.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 130' ' ' ILE . 46.9 tp -88.91 106.34 18.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.237 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 89.2 m-85 -99.43 149.96 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 12.1 t70 -65.73 137.54 57.34 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.59 -52.96 62.84 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.985 0.803 . . . . 0.0 111.707 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.44 56.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.112 0.565 . . . . 0.0 111.966 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.6 -36.63 60.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.182 0.593 . . . . 0.0 110.771 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.6 t80 -73.14 -38.43 66.27 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -61.51 -31.52 71.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.923 0.889 . . . . 0.0 110.839 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.0 tpm_? -63.21 -54.26 40.25 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.947 0.779 . . . . 0.0 109.564 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.3 mt -54.8 -47.0 74.57 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.252 0.97 . . . . 0.0 111.376 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 166' ' ' ILE . 99.4 t -60.67 -50.47 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.801 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -59.94 -32.83 76.38 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 124.112 0.883 . . . . 0.0 113.371 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 28.6 mm-40 -75.86 -30.93 59.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.392 0.677 . . . . 0.0 111.187 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.71 9.42 49.75 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.243 -171.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.74 139.76 74.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.934 0.894 . . . . 0.0 109.201 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.48 -164.55 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.404 2.07 . . . . 0.0 112.242 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.79 131.25 92.92 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.321 1.049 . . . . 0.0 110.143 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.498 ' HG3' HG12 ' A' ' 121' ' ' ILE . 72.1 Cg_endo -70.96 -24.7 23.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.296 1.998 . . . . 0.0 113.265 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -85.23 -59.21 2.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.966 0.506 . . . . 0.0 111.051 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -108.27 -7.86 15.84 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.939 -167.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 65.86 19.12 11.27 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.629 1.172 . . . . 0.0 112.247 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -71.36 144.42 89.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.174 0.589 . . . . 0.0 110.117 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.37 116.5 3.79 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.406 2.071 . . . . 0.0 110.816 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 153' ' ' VAL . 77.3 mt -61.21 132.91 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.66 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -147.15 164.79 31.97 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.278 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -65.46 -24.62 67.21 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.541 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.8 t -69.3 -26.11 64.57 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.942 0.897 . . . . 0.0 112.333 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.4 pt -100.69 -6.1 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 118.317 0.508 . . . . 0.0 112.236 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.2 tt -100.7 136.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.05 0.841 . . . . 0.0 109.773 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.04 171.57 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.142 1.377 . . . . 0.0 110.829 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 43.9 mtmt -92.95 164.2 13.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.402 0.681 . . . . 0.0 110.595 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -66.1 -33.54 76.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.703 0.801 . . . . 0.0 111.61 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -80.28 -20.24 44.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.308 0.643 . . . . 0.0 110.848 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -84.8 -27.95 26.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.974 0.91 . . . . 0.0 110.998 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.3 p -105.7 151.67 24.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -136.78 158.95 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.166 0.987 . . . . 0.0 108.457 177.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -64.6 130.36 43.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.538 ' HB2' HG13 ' A' ' 187' ' ' ILE . 11.3 t70 -106.13 135.6 47.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.97 -50.68 10.74 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.363 1.039 . . . . 0.0 111.816 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -72.38 -26.4 61.88 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.795 0.27 . . . . 0.0 111.64 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -93.01 -28.65 16.26 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.892 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.15 28.51 44.77 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.489 0.493 . . . . 0.0 114.176 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -169.84 161.8 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.167 0.484 . . . . 0.0 110.313 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 88.5 m-85 -60.33 124.41 20.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.746 1.219 . . . . 0.0 111.879 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' A' ' 180' ' ' ASP . 2.8 pp -139.14 177.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.165 1.386 . . . . 0.0 109.31 174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.0 mm -77.16 146.0 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.319 0.648 . . . . 0.0 110.569 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 123.502 0.721 . . . . 0.0 112.05 178.496 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.761 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 110.641 -0.133 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -30.21 70.97 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.416 0.286 . . . . 0.0 111.605 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -71.6 -48.03 50.8 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.169 0.588 . . . . 0.0 109.614 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.6 mt -60.03 -50.26 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.9 0.88 . . . . 0.0 110.217 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.478 ' HA ' HD12 ' A' ' 98' ' ' ILE . 43.6 mt-30 -69.49 -28.36 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.309 1.044 . . . . 0.0 111.649 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.45 -44.26 96.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.32 -33.19 74.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.428 0.691 . . . . 0.0 110.886 177.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 95' ' ' GLN . 92.2 mt -63.17 -45.08 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 122.942 0.497 . . . . 0.0 109.73 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 m -65.51 -29.74 70.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.664 0.786 . . . . 0.0 112.52 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.98 -46.25 16.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.93 0.492 . . . . 0.0 111.819 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.1 -19.59 50.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.824 0.85 . . . . 0.0 112.878 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -67.27 172.24 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -156.47 157.09 34.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.974 172.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m -70.21 102.07 2.02 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.47 98.22 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.287 0.635 . . . . 0.0 109.797 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.6 m -103.48 103.23 34.48 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.992 0.917 . . . . 0.0 109.005 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HB3' HD11 ' A' ' 117' ' ' ILE . 29.8 Cg_endo -60.22 -28.9 87.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.243 2.629 . . . . 0.0 112.506 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.66 -33.52 75.84 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.833 0.853 . . . . 0.0 110.756 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -88.12 -46.57 9.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.961 -174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.1 -22.98 63.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.366 0.666 . . . . 0.0 111.274 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 57.58 13.46 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.56 1.144 . . . . 0.0 113.662 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.59 133.92 31.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-O 118.289 -0.862 . . . . 0.0 108.752 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.34 149.29 23.23 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.983 2.455 . . . . 0.0 112.623 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.6 -46.7 63.64 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.114 0.966 . . . . 0.0 111.865 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.04 -36.83 78.15 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.865 0.866 . . . . 0.0 112.271 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.29 68.43 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.491 0.717 . . . . 0.0 111.459 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 107' ' ' PRO . 17.9 pt -107.65 5.34 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 110.807 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.9 128.15 35.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.428 1.091 . . . . 0.0 110.855 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.0 t -64.0 110.32 3.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.75 -3.07 13.14 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.814 2.342 . . . . 0.0 112.43 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.541 HG12 ' HG3' ' A' ' 160' ' ' PRO . 36.7 mt -81.04 -53.25 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.866 0.867 . . . . 0.0 109.197 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.1 p -96.32 -10.22 28.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.96 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.21 53.32 10.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.758 1.223 . . . . 0.0 111.449 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.12 160.59 38.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.026 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -73.76 120.3 80.53 Favored Pre-proline 0 CA--C 1.559 1.3 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 73.9 Cg_endo -76.05 157.97 38.22 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.203 2.602 . . . . 0.0 113.829 -173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 10.7 pt-20 -81.24 -36.77 29.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.365 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.9 pttm -145.25 148.44 33.49 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.504 1.522 . . . . 0.0 107.369 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.04 159.81 32.65 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.302 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -113.98 166.45 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.527 1.531 . . . . 0.0 109.685 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -106.07 125.88 51.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.421 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 70.8 t -115.82 124.6 72.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.1 ptmt -74.92 104.44 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.904 0.859 . . . . 0.0 110.288 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -78.53 71.47 5.0 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 4.9 t -69.36 -26.89 64.9 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.419 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.7 -39.83 95.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.271 1.028 . . . . 0.0 110.709 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.39 -63.99 3.04 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -176.34 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.192 0.997 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 18.4 t70 62.44 27.26 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.412 1.085 . . . . 0.0 110.804 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.98 109.21 9.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.035 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 186' ' ' PHE . 58.4 m -83.49 119.62 24.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.3 m -118.86 145.33 45.78 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -170.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' HB ' ' A' ' 117' ' ' ILE . 31.1 tp -86.63 103.9 15.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.484 0.659 . . . . 0.0 110.58 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 92.8 m-85 -102.84 133.4 47.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 107.905 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.5 t70 -56.59 134.17 54.18 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.605 0.639 . . . . 0.0 109.653 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.48 -44.75 80.93 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.018 0.824 . . . . 0.0 111.555 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.63 40.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.861 0.465 . . . . 0.0 111.758 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.45 38.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.44 0.696 . . . . 0.0 111.705 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.0 t80 -74.26 -39.48 62.98 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -61.66 -35.03 76.78 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.938 0.774 . . . . 0.0 110.961 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 10.7 tpt180 -57.3 -52.16 66.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.16 0.584 . . . . 0.0 109.499 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.8 mt -54.8 -41.93 71.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.041 0.838 . . . . 0.0 111.956 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 166' ' ' ILE . 21.9 t -69.02 -41.34 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 123.939 0.774 . . . . 0.0 109.768 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.93 -29.16 73.41 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.174 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -84.01 -24.21 30.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.213 0.605 . . . . 0.0 110.784 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 19.79 56.55 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.842 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.1 147.48 73.25 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.078 0.951 . . . . 0.0 110.668 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.53 175.87 10.8 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.411 2.074 . . . . 0.0 111.91 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -55.43 131.81 70.43 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.417 1.087 . . . . 0.0 111.114 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HG3' HG12 ' A' ' 121' ' ' ILE . 71.7 Cg_endo -69.08 -17.82 40.47 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.413 2.075 . . . . 0.0 113.822 -169.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.05 -62.32 1.25 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.875 0.47 . . . . 0.0 111.302 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 t -104.99 -7.21 19.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.753 -168.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.29 26.11 14.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.54 1.136 . . . . 0.0 112.201 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.17 154.69 92.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.033 0.933 . . . . 0.0 110.116 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.07 113.36 2.58 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 121.919 1.746 . . . . 0.0 109.799 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.573 HG21 HG22 ' A' ' 153' ' ' VAL . 61.0 mt -60.87 122.58 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.2 t -147.32 162.41 39.01 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.809 0.844 . . . . 0.0 109.493 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -72.24 -14.88 61.89 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.84 0.456 . . . . 0.0 110.973 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.9 m -70.12 -30.61 67.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.729 0.812 . . . . 0.0 111.921 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.9 pt -99.5 -8.4 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 168' ' ' ALA . 8.4 tt -88.39 138.66 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.34 168.21 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.577 0.751 . . . . 0.0 111.135 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -90.35 153.27 20.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.812 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -65.02 -23.72 67.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -85.31 -21.96 28.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.57 0.748 . . . . 0.0 110.441 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.41 -17.86 37.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.993 . . . . 0.0 111.247 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 23.9 p -130.35 152.8 49.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.432 1.093 . . . . 0.0 109.325 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.414 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -138.93 164.88 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.746 1.218 . . . . 0.0 109.104 -177.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 5.3 p90 -73.84 128.45 35.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.495 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.2 t70 -106.63 140.2 39.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -79.22 -48.66 13.8 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.756 0.822 . . . . 0.0 112.523 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.478 HG23 ' HE ' ' A' ' 183' ' ' ARG . 10.1 t -71.29 -24.68 62.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.472 0.578 . . . . 0.0 111.544 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HE ' HG23 ' A' ' 182' ' ' THR . 5.0 mmp_? -81.2 -32.51 33.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 170.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.05 22.12 74.67 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.704 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -167.6 162.37 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.102 0.961 . . . . 0.0 108.87 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 70.7 m-85 -64.11 128.69 36.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.477 1.111 . . . . 0.0 112.012 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 180' ' ' ASP . 29.4 pt -132.57 177.35 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.644 1.177 . . . . 0.0 109.65 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 133' ' ' LYS . 48.7 mm -75.42 151.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.18 0.592 . . . . 0.0 109.6 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.5 mtpm? . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 123.102 0.561 . . . . 0.0 111.369 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.412 ' HG3' HG12 ' A' ' 153' ' ' VAL . 16.3 mp0 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -44.82 78.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.744 0.652 . . . . 0.0 111.473 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.9 t -67.03 -43.52 82.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 98' ' ' ILE . 63.6 mt -64.24 -44.54 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 123.713 0.633 . . . . 0.0 110.114 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.77 -44.05 90.55 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.526 1.13 . . . . 0.0 110.727 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.725 173.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.1 -35.49 81.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.714 0.805 . . . . 0.0 111.222 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 94' ' ' ILE . 94.3 mt -65.47 -41.36 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.6 t -64.27 -40.18 95.46 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.46 0.704 . . . . 0.0 111.69 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -80.39 -28.42 37.9 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.574 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 84.1 m -96.51 -18.08 20.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.121 0.568 . . . . 0.0 112.362 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.84 169.15 16.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 111.47 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -155.8 158.03 37.45 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m -68.05 96.53 0.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.03 100.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.235 0.614 . . . . 0.0 110.178 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.1 m -101.82 99.17 11.26 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.099 0.96 . . . . 0.0 108.581 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.75 -36.08 98.53 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.833 2.355 . . . . 0.0 112.331 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.16 -22.49 59.4 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.145 0.903 . . . . 0.0 111.87 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.8 mmp_? -91.72 -42.31 10.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.101 0.56 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.535 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 96.9 mt -64.8 -19.21 65.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.654 0.782 . . . . 0.0 112.391 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 55.98 22.37 5.75 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.331 1.052 . . . . 0.0 112.442 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.619 ' HG ' ' HZ ' ' A' ' 186' ' ' PHE . 55.8 m -95.24 141.54 23.36 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 123.9 0.88 . . . . 0.0 109.698 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.96 145.95 75.86 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.028 1.819 . . . . 0.0 110.236 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 99.5 mt -51.47 -43.82 62.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.967 0.907 . . . . 0.0 112.398 -173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.75 -36.8 79.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.61 0.764 . . . . 0.0 112.855 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.2 64.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.939 0.496 . . . . 0.0 110.865 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.04 27.92 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.943 0.897 . . . . 0.0 110.361 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -85.69 129.3 34.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.298 0.639 . . . . 0.0 109.35 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 t -68.74 111.9 9.7 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.25 0.46 9.37 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.748 2.299 . . . . 0.0 112.669 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -84.61 -55.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.702 0.801 . . . . 0.0 108.85 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.0 p -92.84 -8.83 42.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.828 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.56 39.74 21.18 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.545 1.138 . . . . 0.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.39 152.17 31.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.77 117.83 51.81 Favored Pre-proline 0 CA--C 1.557 1.246 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.73 166.31 23.76 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.084 2.523 . . . . 0.0 113.688 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.5 pt-20 -86.28 -28.0 24.04 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.846 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.52 145.41 31.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.089 1.356 . . . . 0.0 107.753 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.49 166.89 39.71 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.356 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 143' ' ' LEU . 10.1 pt -115.03 153.82 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 125.298 1.439 . . . . 0.0 109.496 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -97.04 122.15 39.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 79.6 t -114.68 123.73 70.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.5 ptmt -69.04 107.44 3.15 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -73.36 89.66 1.62 Allowed 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -63.62 -36.73 84.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.173 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.5 -26.6 66.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.41 0.684 . . . . 0.0 110.818 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.4 13.83 43.92 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.462 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.0 m 77.26 44.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.31 1.444 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.89 24.46 14.47 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.607 1.163 . . . . 0.0 112.264 174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 187' ' ' ILE . 98.0 t -79.94 125.53 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.171 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.4 129.62 34.77 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.632 0.773 . . . . 0.0 110.295 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.4 m -123.77 139.74 53.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.184 0.994 . . . . 0.0 109.002 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 130' ' ' ILE . 45.1 tp -89.27 111.31 22.09 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.372 0.42 . . . . 0.0 110.061 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 84.5 m-85 -103.79 141.71 35.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.413 1.085 . . . . 0.0 108.243 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.52 132.26 51.87 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.781 0.675 . . . . 0.0 111.834 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.57 55.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.889 0.476 . . . . 0.0 111.455 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.13 69.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.72 0.808 . . . . 0.0 111.561 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.7 t80 -74.32 -40.41 62.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.543 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -63.84 -30.51 71.6 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.464 0.706 . . . . 0.0 111.011 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -62.43 -52.23 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.781 0.833 . . . . 0.0 109.686 172.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.43 -47.62 81.28 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 123.735 0.647 . . . . 0.0 111.228 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 166' ' ' ILE . 97.2 t -61.15 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.269 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.54 92.45 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 124.069 0.856 . . . . 0.0 112.943 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -73.46 -23.31 60.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.168 0.587 . . . . 0.0 111.503 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.06 18.98 37.78 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.375 0.422 . . . . 0.0 112.872 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.0 149.4 70.03 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.734 1.213 . . . . 0.0 110.497 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.85 -174.44 2.23 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.984 2.456 . . . . 0.0 112.466 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.44 ' ND1' HG22 ' A' ' 162' ' ' THR . 53.7 t-80 -64.55 127.54 92.45 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.821 0.848 . . . . 0.0 109.082 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.31 -17.92 49.91 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.217 1.945 . . . . 0.0 113.217 -168.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.0 mt -95.46 -62.83 1.23 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.184 0.594 . . . . 0.0 111.15 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.44 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.9 t -91.42 -11.67 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.527 0.331 . . . . 0.0 111.492 -172.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 59.63 23.43 12.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.119 1.368 . . . . 0.0 112.838 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 162' ' ' THR . 46.0 mm-40 -91.68 154.93 44.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.739 0.816 . . . . 0.0 109.77 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.91 123.53 12.42 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.438 2.092 . . . . 0.0 112.068 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 153' ' ' VAL . 81.2 mt -63.33 136.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.149 0.58 . . . . 0.0 109.952 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -147.33 161.51 40.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.371 0.668 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -68.61 -19.87 64.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.403 1.081 . . . . 0.0 110.997 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -69.58 -24.96 63.76 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.954 0.902 . . . . 0.0 112.561 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 49.4 pt -105.21 -5.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 168' ' ' ALA . 9.6 tt -96.94 132.13 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.881 0.764 . . . . 0.0 109.486 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.33 175.4 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.311 1.044 . . . . 0.0 110.06 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 95.5 mttt -96.77 165.74 11.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.615 0.366 . . . . 0.0 110.662 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -63.53 -27.01 68.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.372 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -77.93 -27.18 49.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.66 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -85.88 -20.52 28.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.965 0.906 . . . . 0.0 111.785 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.1 p -117.41 150.96 38.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.01 0.924 . . . . 0.0 109.574 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 160.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.196 0.999 . . . . 0.0 108.753 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.94 140.12 57.84 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.33 139.41 53.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.879 0.471 . . . . 0.0 110.008 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.42 -52.69 9.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.331 1.052 . . . . 0.0 111.64 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -74.72 -26.71 59.99 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -80.83 -33.54 34.54 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.542 0.737 . . . . 0.0 109.824 169.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.74 25.89 48.14 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.626 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.34 170.73 2.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.228 0.611 . . . . 0.0 111.043 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.619 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 89.9 m-85 -61.88 122.05 14.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.692 1.197 . . . . 0.0 111.527 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.9 pp -134.71 173.95 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.713 1.205 . . . . 0.0 109.904 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 133' ' ' LYS . 43.8 mm -73.54 143.74 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.726 0.81 . . . . 0.0 110.684 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp . . . . . 0 C--O 1.24 0.578 0 C-N-CA 123.484 0.713 . . . . 0.0 112.05 178.09 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.822 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.454 -0.308 . . . . 0.0 111.254 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.81 -49.37 49.06 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.232 1.013 . . . . 0.0 113.334 -164.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.508 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 17.2 m -70.29 -41.04 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.277 0.631 . . . . 0.0 109.95 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.7 mt -66.12 -45.33 90.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.381 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -57.69 -46.14 84.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.854 1.261 . . . . 0.0 110.704 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.74 -37.39 86.37 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.024 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -66.39 -44.4 83.17 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 123.216 0.606 . . . . 0.0 110.224 177.044 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.5 mt -60.49 -39.0 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 109.666 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -67.32 -41.08 85.88 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.132 0.973 . . . . 0.0 111.011 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -83.19 -14.56 53.15 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.672 0.789 . . . . 0.0 112.984 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 93.5 m -103.55 -25.37 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.309 0.644 . . . . 0.0 112.601 -173.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -68.92 166.09 18.58 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -156.72 158.05 36.22 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.373 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.5 m -67.07 100.65 0.78 Allowed 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.706 0.802 . . . . 0.0 109.47 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.75 101.61 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.0 m -112.33 96.87 37.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HB3' HD11 ' A' ' 117' ' ' ILE . 8.0 Cg_endo -50.86 -23.52 11.88 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.938 3.092 . . . . 0.0 113.927 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.59 -30.18 59.51 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -93.47 -40.19 10.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.392 0.677 . . . . 0.0 111.135 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.06 -24.33 64.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.067 0.547 . . . . 0.0 110.237 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 45.41 50.42 10.11 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 124.889 1.276 . . . . 0.0 111.698 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.6 m -124.3 148.72 58.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.391 1.076 . . . . 0.0 110.038 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.67 141.67 97.45 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.348 2.032 . . . . 0.0 110.772 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 52.4 mt -55.06 -37.82 67.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.831 0.852 . . . . 0.0 111.666 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.01 -38.13 81.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.785 0.834 . . . . 0.0 112.192 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.27 66.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.065 0.546 . . . . 0.0 111.014 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 107' ' ' PRO . 33.3 pt -116.12 26.59 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.235 1.014 . . . . 0.0 110.302 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.57 127.54 33.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.308 1.043 . . . . 0.0 110.15 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 t -74.38 110.83 10.51 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.9 -2.75 12.68 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.78 2.32 . . . . 0.0 112.947 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.0 mt -85.12 -57.33 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.769 0.828 . . . . 0.0 109.499 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p -80.37 -23.67 40.32 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.024 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 62.74 49.9 3.58 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.124 0.964 . . . . 0.0 110.291 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.45 154.33 34.2 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.214 171.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -72.05 112.17 13.46 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.9 Cg_endo -71.32 159.78 50.73 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.205 2.604 . . . . 0.0 114.459 -167.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 6.4 pt-20 -80.81 -39.84 25.99 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.683 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -146.57 146.23 30.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.801 1.24 . . . . 0.0 108.044 178.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.35 42.36 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.461 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.2 pt -122.54 159.81 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.719 1.608 . . . . 0.0 109.197 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 141' ' ' CYS . 40.7 m-85 -104.85 119.8 39.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 170.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.3 121.43 66.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.653 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.9 ptmt -64.35 127.26 30.72 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 124.099 0.874 . . . . 0.0 112.77 -172.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -76.86 72.72 3.47 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -42.9 99.74 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.417 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.65 -40.38 92.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.502 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.63 -66.54 2.1 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.68 -171.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' VAL . 42.7 m -161.3 22.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.162 0.585 . . . . 0.0 111.569 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.42 31.33 17.23 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.884 1.326 . . . . 0.0 110.314 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.614 ' HA ' HG22 ' A' ' 187' ' ' ILE . 60.0 t -81.72 177.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.413 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' PHE . 26.4 p -134.3 140.78 46.64 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.401 HG21 HD11 ' A' ' 161' ' ' LEU . 89.5 m -118.94 146.34 45.04 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.06 109.38 20.44 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.235 0.541 . . . . 0.0 110.67 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.24 130.72 54.71 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 108.173 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.1 t70 -55.56 132.11 47.87 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.889 0.768 . . . . 0.0 109.17 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.45 77.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 112.154 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -33.0 63.34 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.621 0.575 . . . . 0.0 110.963 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -72.23 -36.76 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.0 t80 -80.27 -36.81 34.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -63.92 -29.8 70.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.365 0.666 . . . . 0.0 110.789 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 8.5 tpt180 -59.18 -59.08 6.03 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.924 0.765 . . . . 0.0 108.995 169.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.26 -46.83 72.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.019 0.825 . . . . 0.0 111.915 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 166' ' ' ILE . 95.4 t -61.99 -48.93 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 110.135 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -62.97 -35.78 92.55 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 123.995 0.81 . . . . 0.0 113.045 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 8.9 mm-40 -67.81 -34.97 77.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.521 0.729 . . . . 0.0 110.289 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.65 27.32 8.05 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.305 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 54.4 mt -90.19 149.04 40.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.375 1.07 . . . . 0.0 109.779 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.21 -176.38 3.24 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.463 2.109 . . . . 0.0 112.399 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.09 128.61 81.76 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.204 1.002 . . . . 0.0 110.569 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.64 -13.76 37.9 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.323 2.015 . . . . 0.0 113.971 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 142' ' ' THR . 57.2 mt -101.17 -56.11 2.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.735 0.414 . . . . 0.0 111.766 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.5 t -104.01 -10.29 18.19 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.876 0.47 . . . . 0.0 111.271 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 63.75 21.46 12.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.623 1.169 . . . . 0.0 112.999 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.06 151.41 78.79 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.299 0.64 . . . . 0.0 109.873 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.16 122.73 12.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.778 2.319 . . . . 0.0 110.991 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.587 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.7 mt -66.34 128.38 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 t -146.13 159.61 43.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.161 0.984 . . . . 0.0 109.377 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.7 -19.7 65.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.612 0.765 . . . . 0.0 111.158 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -70.25 -39.51 74.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.929 0.891 . . . . 0.0 111.788 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.6 pt -90.66 -12.19 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.16 137.34 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.144 0.884 . . . . 0.0 108.728 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.52 HG11 HD12 ' A' ' 188' ' ' ILE . 28.8 m -130.22 171.67 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.283 1.033 . . . . 0.0 109.113 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 58.6 mtpt -88.52 165.72 14.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.159 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 21.0 t60 -73.62 -23.27 59.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.39 0.614 . . . . 0.0 109.649 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.44 -31.49 71.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.8 10.18 41.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.602 0.761 . . . . 0.0 111.726 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.9 p -139.57 138.07 35.93 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.635 -0.666 . . . . 0.0 110.457 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.82 162.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.756 1.223 . . . . 0.0 108.579 -174.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -66.47 124.46 22.83 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 166.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.568 ' HB2' HG12 ' A' ' 187' ' ' ILE . 12.4 t70 -105.32 134.02 49.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.83 -36.57 42.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.15 0.906 . . . . 0.0 112.337 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.408 HG22 ' OD1' ' A' ' 180' ' ' ASP . 1.1 t -76.53 -23.64 53.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' ' 187' ' ' ILE . 40.0 mmt180 -86.98 -33.92 19.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.841 0.857 . . . . 0.0 110.661 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.84 18.63 77.65 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.45 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -148.41 150.71 33.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.413 1.085 . . . . 0.0 109.934 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -60.48 117.33 5.14 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.394 0.678 . . . . 0.0 110.303 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 140' ' ' VAL . 13.3 pt -129.68 178.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.828 0.851 . . . . 0.0 108.91 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 133' ' ' LYS . 8.8 mm -70.84 154.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.427 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.6 mtpm? . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.273 0.559 . . . . 0.0 111.357 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.859 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.26 0.076 . . . . 0.0 111.086 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -41.96 82.57 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.196 0.598 . . . . 0.0 111.615 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.7 t -72.84 -50.93 21.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.512 0.725 . . . . 0.0 110.609 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.8 mt -64.01 -44.37 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.303 0.641 . . . . 0.0 111.196 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.75 -27.73 64.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.119 0.567 . . . . 0.0 111.567 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 2.6 m-80 -64.58 -41.21 96.41 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.43 -34.69 78.89 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.86 0.864 . . . . 0.0 110.67 177.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.535 HG23 HD13 ' A' ' 130' ' ' ILE . 92.8 mt -67.44 -37.74 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.279 0.631 . . . . 0.0 109.44 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.5 t -67.15 -36.49 81.95 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.5 mm-40 -74.56 -53.96 8.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.685 0.394 . . . . 0.0 110.737 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.638 ' SG ' ' HE3' ' A' ' 173' ' ' LYS . 72.5 m -71.81 -19.96 61.92 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.066 0.946 . . . . 0.0 112.983 -167.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.1 170.97 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.789 0.804 . . . . 0.0 112.825 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -160.02 156.68 27.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.935 173.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 p -70.95 104.5 2.98 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 143' ' ' LEU . 45.6 t -77.72 96.98 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 -171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.81 105.41 41.27 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.6 -31.17 86.79 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.967 2.445 . . . . 0.0 113.522 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 -30.29 49.74 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.48 0.488 . . . . 0.0 110.581 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -78.79 -35.03 45.0 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.52 -19.23 53.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.536 0.734 . . . . 0.0 111.691 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 57.23 22.34 7.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.025 0.93 . . . . 0.0 112.621 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -104.94 146.35 32.49 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 123.717 0.807 . . . . 0.0 109.649 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.58 152.66 80.93 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.317 2.011 . . . . 0.0 111.101 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.34 -40.95 68.51 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.887 0.742 . . . . 0.0 111.549 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.64 -41.03 80.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.323 1.049 . . . . 0.0 112.688 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.82 62.91 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.435 0.694 . . . . 0.0 111.434 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 12.0 pt -126.5 33.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.899 0.879 . . . . 0.0 109.506 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.6 tt0 -84.47 137.94 33.07 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.829 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.5 t -76.85 113.64 31.92 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.84 0.49 8.2 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.168 2.579 . . . . 0.0 113.107 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.0 mt -85.24 -54.75 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p -86.28 -18.88 30.88 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.189 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 66.45 36.52 5.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.342 1.057 . . . . 0.0 111.445 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.73 151.7 30.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.479 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -69.64 113.2 15.44 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.873 0.869 . . . . 0.0 108.673 174.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 92.5 Cg_endo -73.59 163.82 36.48 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.57 2.18 . . . . 0.0 113.867 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -17.69 28.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.189 0.996 . . . . 0.0 110.261 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 146' ' ' ALA . 1.3 pptp? -153.27 140.87 19.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.152 0.981 . . . . 0.0 108.957 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.77 168.49 41.38 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.507 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.535 HD13 HG23 ' A' ' 98' ' ' ILE . 13.7 pt -121.0 156.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.547 1.539 . . . . 0.0 109.87 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.6 123.42 43.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 169.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 72.9 t -123.83 122.1 63.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.678 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -69.9 116.96 10.88 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.435 0.636 . . . . 0.0 110.164 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.05 85.28 1.81 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 27.9 t -66.19 -39.84 89.97 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.204 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.35 -35.79 82.04 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.978 0.911 . . . . 0.0 111.105 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.51 -63.97 2.89 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -169.8 23.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.415 0.686 . . . . 0.0 110.631 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.9 m-20 59.29 31.33 21.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.425 1.09 . . . . 0.0 111.698 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.2 t -94.08 128.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.186 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 27.7 p -84.39 132.11 34.62 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -124.52 146.61 48.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 105' ' ' VAL . 44.6 tp -90.43 115.33 27.51 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.4 m-85 -111.78 137.92 49.06 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.492 1.117 . . . . 0.0 108.114 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.723 0.692 . . . . 0.0 109.302 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -57.15 -42.83 81.74 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.93 0.769 . . . . 0.0 111.926 -173.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.69 -36.05 60.15 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.84 0.456 . . . . 0.0 111.593 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.78 69.28 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.125 0.57 . . . . 0.0 111.625 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.6 t80 -71.62 -37.02 70.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.124 0.57 . . . . 0.0 109.881 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -63.03 -36.7 84.44 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.702 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 79.1 ttt180 -60.39 -45.88 91.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.63 -47.05 77.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.137 0.575 . . . . 0.0 111.224 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' A' ' 91' ' ' GLN . 38.7 t -66.04 -46.25 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.227 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.87 -33.07 84.16 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 124.262 0.976 . . . . 0.0 113.312 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.527 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 23.9 mm-40 -75.59 -32.22 60.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.08 21.8 10.6 Favored Glycine 0 N--CA 1.468 0.825 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.753 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 50.6 mt -85.18 153.08 59.35 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 0.0 111.146 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.0 174.95 11.9 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.216 2.611 . . . . 0.0 113.081 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -55.14 134.39 68.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.041 1.336 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.98 -26.14 58.83 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.654 2.236 . . . . 0.0 113.876 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.74 -60.7 1.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.6 t -105.34 -4.19 21.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.646 -167.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 60.22 28.19 17.76 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.106 0.963 . . . . 0.0 112.729 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -80.11 159.99 69.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.18 0.992 . . . . 0.0 111.371 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.4 112.72 2.66 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.119 1.879 . . . . 0.0 111.006 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.428 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.9 mt -62.65 131.79 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.635 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 162.67 38.77 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.363 0.665 . . . . 0.0 110.446 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.12 66.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.705 0.802 . . . . 0.0 111.691 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -68.54 -41.0 80.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 111.581 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -84.94 -7.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.4 tt -97.95 132.83 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.015 0.825 . . . . 0.0 109.876 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.467 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -133.76 178.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.136 1.375 . . . . 0.0 110.029 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.638 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 3.3 mptt -104.26 166.47 10.38 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.481 0.712 . . . . 0.0 109.755 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -70.78 -16.12 62.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.145 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -79.65 -35.29 39.51 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.577 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -83.72 -23.1 31.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.737 0.815 . . . . 0.0 110.602 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 31.7 p -115.78 142.2 47.07 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.867 0.867 . . . . 0.0 108.897 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.4 163.26 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.491 1.116 . . . . 0.0 109.045 -174.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -71.49 136.82 47.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -119.44 132.88 55.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.87 -51.35 22.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.664 1.186 . . . . 0.0 111.906 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 t -73.15 -23.23 60.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.269 0.228 . . . . 0.0 111.536 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.423 ' HG3' HD13 ' A' ' 187' ' ' ILE . 12.7 mmp_? -81.03 -33.98 33.16 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.13 0.572 . . . . 0.0 110.561 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.84 76.11 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.284 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -146.46 146.89 30.73 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.2 1.0 . . . . 0.0 109.446 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.514 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 97.9 m-85 -66.7 116.43 7.61 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 167.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.447 HG12 ' HB2' ' A' ' 180' ' ' ASP . 27.9 pt -127.21 178.95 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.075 0.95 . . . . 0.0 109.365 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 133' ' ' LYS . 21.1 mm -85.82 148.28 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.541 0.736 . . . . 0.0 111.989 177.367 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.449 0.166 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.95 -45.39 67.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.282 1.033 . . . . 0.0 112.106 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 t -66.05 -39.24 89.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.63 0.772 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.2 mt -69.56 -45.51 77.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.938 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.92 -45.31 90.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.157 . . . . 0.0 111.219 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -59.77 -40.91 89.83 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -62.85 -44.86 95.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.144 0.578 . . . . 0.0 110.727 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 150' ' ' SER . 87.7 mt -60.58 -39.19 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.804 0.842 . . . . 0.0 110.206 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.7 t -64.85 -40.12 94.65 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.988 0.915 . . . . 0.0 111.805 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -83.61 -27.33 29.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.284 0.634 . . . . 0.0 112.601 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.1 m -95.69 -12.23 25.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.578 0.751 . . . . 0.0 112.448 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -74.01 165.25 25.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.635 0.731 . . . . 0.0 112.877 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.06 154.59 35.18 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.422 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -75.61 105.06 6.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.2 130.91 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.918 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 39.3 m -122.38 81.56 46.04 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.695 0.798 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.97 -39.15 40.19 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.163 3.242 . . . . 0.0 113.802 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.6 pt-20 -60.95 -45.71 93.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.206 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 67.4 mtp180 -83.47 -31.59 26.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.088 0.555 . . . . 0.0 111.483 -174.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.33 -18.59 63.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.228 0.611 . . . . 0.0 111.013 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.65 2.67 3.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.301 1.44 . . . . 0.0 112.299 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 62.0 m -92.3 133.13 30.49 Favored Pre-proline 0 C--O 1.247 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 109.17 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.08 158.59 21.08 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.64 2.227 . . . . 0.0 112.164 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -53.47 -43.96 68.57 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.881 0.738 . . . . 0.0 111.488 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.4 -38.45 77.38 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.215 1.006 . . . . 0.0 112.731 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.99 64.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.694 0.798 . . . . 0.0 112.099 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.525 ' HB ' HD23 ' A' ' 143' ' ' LEU . 8.9 pt -127.24 11.59 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.739 0.816 . . . . 0.0 110.57 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.4 tt0 -63.98 132.53 50.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.991 0.916 . . . . 0.0 111.097 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 34.6 t -67.58 111.87 8.71 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.85 -3.56 13.97 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.54 2.16 . . . . 0.0 112.647 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -79.62 -54.0 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.469 1.108 . . . . 0.0 109.431 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p -101.09 -4.23 27.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.255 -169.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.32 33.34 20.86 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.88 0.872 . . . . 0.0 112.258 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.16 153.5 39.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.516 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 21.4 tm0? -70.61 123.85 89.84 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 72.6 Cg_endo -76.24 154.6 36.89 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.367 2.712 . . . . 0.0 114.386 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.5 pt-20 -83.26 -35.79 25.06 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.479 174.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 48.6 pttt -138.33 138.86 38.75 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.16 157.41 28.26 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.062 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 98' ' ' ILE . 9.8 pt -113.2 156.34 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.474 1.509 . . . . 0.0 109.602 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -98.81 116.88 32.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 65.4 t -116.54 122.36 69.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.3 ptmt -69.55 110.51 4.83 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.515 0.674 . . . . 0.0 109.413 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.07 81.11 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 162.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -69.49 -68.79 0.38 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.292 -167.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.43 -35.0 71.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.934 0.894 . . . . 0.0 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.49 -62.55 4.51 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.42 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 m -150.93 4.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -170.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 62.37 22.55 13.3 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.866 0.841 . . . . 0.0 111.061 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 185' ' ' ASN . 55.4 t -105.87 129.99 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.67 0.788 . . . . 0.0 110.897 -173.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 56.5 m -84.16 127.72 34.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.797 0.839 . . . . 0.0 108.838 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.6 m -126.04 146.98 49.68 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' A' ' 117' ' ' ILE . 40.3 tp -88.24 105.28 17.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.091 0.472 . . . . 0.0 109.897 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.424 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 85.8 m-85 -98.6 143.28 29.17 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.3 t70 -63.63 136.37 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.38 73.48 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.201 0.938 . . . . 0.0 111.593 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.0 -31.66 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.074 0.55 . . . . 0.0 111.696 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.587 0.755 . . . . 0.0 111.817 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -76.57 -37.77 56.02 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.495 ' HB2' HG21 ' A' ' 98' ' ' ILE . 27.5 t -63.27 -30.21 71.4 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.742 174.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.5 tpm_? -64.36 -52.64 57.31 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.384 172.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.61 -45.77 73.71 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 123.912 0.757 . . . . 0.0 111.392 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.02 -43.37 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.515 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.82 -16.66 74.62 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.027 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -91.12 -23.54 20.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.322 0.649 . . . . 0.0 110.992 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.11 13.4 58.94 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.439 0.462 . . . . 0.0 112.734 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.36 139.63 52.05 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.067 0.947 . . . . 0.0 109.924 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.83 -176.97 2.59 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.765 2.31 . . . . 0.0 113.012 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.406 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.9 t-80 -58.65 126.32 79.46 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.121 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.427 ' HG3' HG12 ' A' ' 121' ' ' ILE . 66.1 Cg_endo -66.51 -15.71 48.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.79 2.327 . . . . 0.0 113.462 -170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.0 mt -97.32 -64.9 1.0 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.757 0.423 . . . . 0.0 111.243 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.406 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.7 t -94.33 -8.86 37.69 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 122.645 0.378 . . . . 0.0 111.796 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 61.04 21.02 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.904 1.281 . . . . 0.0 112.759 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -87.29 161.07 47.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.311 1.044 . . . . 0.0 110.213 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.21 121.06 8.58 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.018 1.812 . . . . 0.0 111.82 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.484 ' HA ' HD11 ' A' ' 170' ' ' ILE . 71.3 mt -65.65 139.47 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.024 0.53 . . . . 0.0 109.584 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.2 t -153.41 165.34 36.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.398 0.436 . . . . 0.0 111.277 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.46 -22.89 66.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.352 1.061 . . . . 0.0 111.941 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -68.11 -43.69 77.87 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.715 0.806 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.1 pt -85.19 -12.87 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 97' ' ' LYS . 7.7 tt -98.61 136.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.593 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -137.47 173.57 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.927 1.291 . . . . 0.0 110.45 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -91.14 164.07 14.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -66.11 -25.17 66.88 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.686 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.21 -29.09 21.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.5 1.12 . . . . 0.0 110.639 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.06 -25.68 34.36 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.808 0.843 . . . . 0.0 111.357 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.2 p -104.76 154.97 19.31 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -132.0 157.12 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 19.2 p90 -71.0 122.19 19.57 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.435 ' HB2' HG12 ' A' ' 187' ' ' ILE . 10.9 t70 -106.98 114.49 28.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.71 -21.52 44.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -168.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -83.55 -25.84 30.63 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.599 0.636 . . . . 0.0 110.803 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -79.95 -27.77 39.71 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.46 85.53 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.139 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.412 ' HB3' HG13 ' A' ' 140' ' ' VAL . 18.7 m120 -148.34 158.11 43.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.869 0.868 . . . . 0.0 109.854 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 64.6 m-85 -64.6 127.33 31.07 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 180' ' ' ASP . 22.0 pt -134.31 178.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.3 1.04 . . . . 0.0 108.8 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.593 HD12 HG11 ' A' ' 172' ' ' VAL . 33.9 mm -79.38 145.62 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 123.278 0.631 . . . . 0.0 112.232 179.245 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.701 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.839 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.01 -50.33 36.5 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.745 0.818 . . . . 0.0 113.028 -164.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 40.4 t -65.57 -43.64 89.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.805 0.442 . . . . 0.0 110.481 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.5 mt -64.8 -46.03 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.91 -47.75 81.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.717 1.207 . . . . 0.0 111.699 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -65.29 -35.8 82.13 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.077 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -64.7 -38.19 90.17 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 122.952 0.501 . . . . 0.0 110.634 176.057 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.489 HG21 ' HB2' ' A' ' 150' ' ' SER . 89.3 mt -65.82 -39.39 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.253 0.621 . . . . 0.0 109.966 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -64.58 -34.89 79.32 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.456 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -87.48 -27.9 22.38 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 75.6 m -93.39 -11.63 31.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -73.94 168.12 20.12 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.653 0.739 . . . . 0.0 111.849 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.88 157.32 34.66 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.449 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 p -68.8 98.6 0.94 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.37 99.7 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 56.7 m -111.2 104.75 56.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.169 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 117' ' ' ILE . 9.9 Cg_endo -52.91 -26.58 31.9 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 -37.33 61.62 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.059 0.544 . . . . 0.0 110.409 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -83.78 -39.93 19.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 0.0 110.864 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.92 -20.89 62.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.505 0.722 . . . . 0.0 111.206 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 53.78 36.16 23.25 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.639 1.176 . . . . 0.0 111.027 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.3 140.57 26.67 Favored Pre-proline 0 C--O 1.248 1.018 0 C-N-CA 124.383 1.073 . . . . 0.0 108.874 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.0 157.22 50.06 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.18 1.92 . . . . 0.0 111.899 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.43 -46.62 66.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.661 0.784 . . . . 0.0 112.054 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 1.6 pm0 -67.68 -30.96 70.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.408 0.683 . . . . 0.0 112.444 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.08 -27.1 67.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.73 0.412 . . . . 0.0 111.43 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' HD23 ' A' ' 143' ' ' LEU . 16.8 pt -119.08 17.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.491 0.716 . . . . 0.0 110.604 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 46.5 tt0 -63.5 129.99 42.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.994 0.918 . . . . 0.0 110.542 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.42 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.1 t -67.75 109.74 4.31 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.566 ' HB2' HD21 ' A' ' 161' ' ' LEU . 87.7 Cg_endo -78.3 5.88 5.13 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.732 2.288 . . . . 0.0 112.734 -174.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -83.39 -53.95 10.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 124.124 0.969 . . . . 0.0 108.841 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.4 p -96.35 -10.29 28.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.924 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.49 39.06 25.39 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.206 1.002 . . . . 0.0 111.79 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.59 159.84 43.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.425 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -74.62 121.22 84.76 Favored Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 73.3 Cg_endo -76.4 159.16 36.45 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.075 2.517 . . . . 0.0 113.441 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.3 pt-20 -90.15 -26.09 20.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.692 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.2 pttt -147.06 140.39 25.43 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.3 158.67 31.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.824 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 98' ' ' ILE . 12.2 pt -110.84 155.09 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.739 1.216 . . . . 0.0 109.767 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -93.09 129.02 39.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 167.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.5 t -124.85 124.29 67.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 171.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.655 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -64.93 105.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.029 0.919 . . . . 0.0 110.373 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.28 78.54 0.73 Allowed 'General case' 0 C--O 1.25 1.084 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 34.2 t -65.42 -37.57 87.31 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.156 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.51 -36.56 69.33 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.297 1.039 . . . . 0.0 112.251 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.47 -63.41 2.62 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.398 0.436 . . . . 0.0 113.049 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -169.61 30.83 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.269 0.628 . . . . 0.0 110.203 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.7 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 0.4 OUTLIER 65.13 26.12 12.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.022 0.929 . . . . 0.0 111.225 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.6 t -86.09 142.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.89 0.876 . . . . 0.0 110.021 -174.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 188' ' ' ILE . 60.6 m -85.46 122.54 29.74 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.6 m -118.17 137.31 53.07 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 117' ' ' ILE . 56.7 tp -92.91 114.44 26.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.687 0.395 . . . . 0.0 110.487 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.34 150.77 26.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.632 1.173 . . . . 0.0 108.521 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.28 137.74 54.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.466 0.575 . . . . 0.0 109.548 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.23 86.25 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.022 0.826 . . . . 0.0 111.95 -175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.43 -36.92 66.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 0.0 111.698 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.01 56.64 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.412 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.62 -40.97 84.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.352 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.0 t -62.41 -36.88 83.73 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.748 0.655 . . . . 0.0 110.839 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 58.6 ttt180 -63.43 -48.85 76.05 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.73 -46.75 70.95 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.399 0.679 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.42 -47.43 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.821 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -64.1 -29.3 74.52 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 124.191 0.932 . . . . 0.0 113.447 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 61.5 mm-40 -72.95 -25.34 60.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.199 0.6 . . . . 0.0 110.317 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 15.76 43.32 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.098 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.67 145.6 54.81 Favored Pre-proline 0 C--O 1.242 0.659 0 C-N-CA 123.866 0.867 . . . . 0.0 110.073 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.34 -179.47 5.1 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.551 2.168 . . . . 0.0 112.017 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -55.02 131.82 67.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.8 -26.31 79.38 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.924 2.416 . . . . 0.0 113.573 -172.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.5 mt -97.75 -52.59 3.69 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.637 0.375 . . . . 0.0 111.308 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 67.8 p -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.412 0.685 . . . . 0.0 112.195 -168.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 64.04 22.24 12.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.555 1.142 . . . . 0.0 111.352 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.71 149.73 86.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.575 0.75 . . . . 0.0 110.296 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.22 111.19 1.53 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.219 1.946 . . . . 0.0 110.702 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.09 135.39 25.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.053 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.6 t -149.18 163.11 38.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.091 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -64.75 -23.92 67.4 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.958 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -69.99 -26.16 63.95 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.887 0.875 . . . . 0.0 113.033 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.7 pt -100.7 -11.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 168' ' ' ALA . 7.7 tt -94.39 134.04 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.607 HG11 HD12 ' A' ' 188' ' ' ILE . 26.9 m -133.81 172.11 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.528 1.131 . . . . 0.0 110.795 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 7.1 mtpm? -103.82 166.83 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.026 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -71.2 -18.11 62.49 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.12 -22.1 23.04 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.3 0.64 . . . . 0.0 110.544 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -75.88 -38.51 57.77 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.742 0.817 . . . . 0.0 109.546 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.38 140.95 29.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.616 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 152.91 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -66.15 128.8 37.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.546 ' HB2' HG12 ' A' ' 187' ' ' ILE . 14.0 t70 -108.03 135.3 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.29 -49.47 16.9 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.055 0.847 . . . . 0.0 111.655 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.7 t -73.76 -23.44 59.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.122 0.169 . . . . 0.0 111.412 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 3.4 mmp_? -83.65 -33.0 25.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.185 0.594 . . . . 0.0 110.549 171.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.68 26.32 59.04 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.918 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -171.37 162.93 6.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.186 0.595 . . . . 0.0 109.851 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -60.2 121.16 11.26 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.1 0.96 . . . . 0.0 111.13 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 180' ' ' ASP . 23.3 pt -126.73 174.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.196 171.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 133' ' ' LYS . 27.1 mm -70.74 151.05 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.349 0.659 . . . . 0.0 109.746 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.224 0.535 . . . . 0.0 111.393 172.752 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.828 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -35.66 81.0 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.352 0.408 . . . . 0.0 111.588 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 32.7 t -68.37 -43.51 77.2 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.44 0.696 . . . . 0.0 109.449 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 98' ' ' ILE . 64.6 mt -66.35 -46.61 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.579 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -58.53 -43.47 89.22 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.326 1.45 . . . . 0.0 111.346 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.77 -41.78 96.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.268 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -69.23 -32.34 71.52 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 123.262 0.625 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 94' ' ' ILE . 83.5 mt -66.02 -40.86 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.2 m -63.05 -40.71 98.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 111.583 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -83.0 -22.68 33.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.514 0.726 . . . . 0.0 112.701 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.592 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 80.4 m -95.35 -22.89 17.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.999 0.52 . . . . 0.0 112.293 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -70.3 168.21 16.39 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.722 0.772 . . . . 0.0 112.508 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -156.12 157.7 36.44 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.599 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.0 p -72.22 99.65 2.41 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 143' ' ' LEU . 21.9 t -71.56 109.25 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.249 -171.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.95 104.43 55.53 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.72 0.808 . . . . 0.0 109.458 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 117' ' ' ILE . 15.5 Cg_endo -59.92 -27.63 85.34 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.982 2.455 . . . . 0.0 112.647 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.72 -31.37 69.33 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.254 0.622 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -90.59 -30.61 17.1 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.656 0.782 . . . . 0.0 110.868 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.3 -23.04 57.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.846 0.458 . . . . 0.0 111.216 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 52.74 33.1 13.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.028 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -114.62 140.69 25.62 Favored Pre-proline 0 C--O 1.245 0.844 0 C-N-CA 124.424 1.09 . . . . 0.0 108.859 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.92 158.67 45.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.462 2.108 . . . . 0.0 111.785 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.32 -45.68 72.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.806 . . . . 0.0 111.8 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.68 -38.97 72.97 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.316 1.046 . . . . 0.0 113.062 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.04 65.42 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.161 0.585 . . . . 0.0 111.734 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 107' ' ' PRO . 19.5 pt -127.97 31.39 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.681 1.192 . . . . 0.0 109.535 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.66 125.02 27.79 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.379 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 10.4 t -68.47 109.93 4.94 Favored Pre-proline 0 C--N 1.349 0.557 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.91 -3.35 13.63 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.782 2.321 . . . . 0.0 112.852 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.2 -52.3 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.4 p -90.98 -10.64 41.61 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.96 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.29 36.26 23.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.851 1.261 . . . . 0.0 111.889 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.87 152.65 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.352 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.21 121.38 80.03 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.523 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.52 164.2 28.73 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.116 2.544 . . . . 0.0 114.602 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 12.9 pt-20 -86.43 -29.82 22.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.463 173.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 52.0 pttt -141.62 135.07 29.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.7 1.6 . . . . 0.0 106.904 176.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -161.74 154.9 26.0 Favored Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.503 -175.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -110.19 159.38 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 125.251 1.42 . . . . 0.0 109.555 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 37.3 m-85 -103.34 118.15 36.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 169.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.7 t -115.16 121.49 67.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 21.9 ptmt -72.2 108.48 5.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.864 0.84 . . . . 0.0 110.627 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -66.55 83.36 0.1 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.42 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 46.4 t -64.21 -41.64 96.96 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.212 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.14 -32.27 73.88 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.006 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.29 -66.36 2.11 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.27 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.2 m -168.44 26.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.317 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 9.5 m-20 58.34 26.1 13.61 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.635 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -80.52 123.72 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.384 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 40.5 m -82.7 122.98 28.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.499 HG21 HD11 ' A' ' 161' ' ' LEU . 25.9 m -119.41 145.03 46.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 105' ' ' VAL . 34.2 tp -86.65 114.13 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.35 0.407 . . . . 0.0 110.286 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -113.35 135.49 53.8 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.595 1.158 . . . . 0.0 108.466 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 13.1 t70 -59.26 137.62 57.91 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.674 0.39 . . . . 0.0 110.046 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.13 90.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.553 0.741 . . . . 0.0 111.672 -174.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.12 44.85 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.319 0.648 . . . . 0.0 112.124 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.42 -39.21 54.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.177 0.591 . . . . 0.0 111.673 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.0 t80 -72.15 -38.3 69.2 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -56.67 -38.73 72.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.069 0.948 . . . . 0.0 111.452 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -57.65 -52.16 66.55 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.817 0.698 . . . . 0.0 109.953 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.77 -46.52 81.42 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.149 0.906 . . . . 0.0 111.089 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 166' ' ' ILE . 94.8 t -62.38 -47.07 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.744 . . . . 0.0 110.852 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.45 -34.37 88.1 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.715 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 16.4 mm-40 -75.27 -31.53 60.78 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.413 0.685 . . . . 0.0 111.218 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 25.68 20.07 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 86.7 mt -80.6 151.6 71.69 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.93 -179.43 5.11 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.469 2.112 . . . . 0.0 112.64 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.3 t-80 -59.26 127.85 84.72 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.333 1.053 . . . . 0.0 109.917 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.67 -2.99 12.99 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.305 2.003 . . . . 0.0 113.973 -170.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 142' ' ' THR . 63.5 mt -104.26 -57.27 2.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.552 0.341 . . . . 0.0 111.018 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.441 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -105.0 -11.81 16.46 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 66.08 22.24 11.15 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.781 1.232 . . . . 0.0 113.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.434 ' H ' HG23 ' A' ' 162' ' ' THR . 31.2 mm-40 -76.84 152.26 82.65 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.345 0.658 . . . . 0.0 110.591 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.21 121.08 8.94 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.558 2.172 . . . . 0.0 111.837 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.603 HG21 HG22 ' A' ' 153' ' ' VAL . 71.5 mt -65.73 130.95 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -150.34 164.95 34.5 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.819 0.848 . . . . 0.0 110.609 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -63.55 -24.04 67.64 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.373 171.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.0 m -66.3 -33.2 75.19 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.836 0.855 . . . . 0.0 112.841 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 166' ' ' ILE . 44.2 pt -99.39 -3.16 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 101' ' ' CYS . 11.6 tt -102.16 134.2 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.4 167.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.529 1.132 . . . . 0.0 110.133 -173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 28.0 mtpp -85.97 161.43 19.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -65.69 -24.69 67.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.301 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.6 -22.24 28.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.052 0.541 . . . . 0.0 110.982 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -82.51 -24.11 34.29 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.396 0.678 . . . . 0.0 110.768 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.3 p -113.38 155.59 24.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.18 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.14 157.12 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.606 1.163 . . . . 0.0 108.424 177.417 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -70.59 129.92 40.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.77 126.74 55.55 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.28 -39.41 71.56 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.484 1.115 . . . . 0.0 112.486 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.6 t -84.03 -15.8 46.25 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.866 0.303 . . . . 0.0 111.747 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -83.22 -32.03 26.73 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 163.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.23 7.51 84.75 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.316 -170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -137.76 157.0 47.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.698 1.199 . . . . 0.0 108.836 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.26 129.71 40.72 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.08 175.59 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.756 1.222 . . . . 0.0 109.778 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.407 HD13 ' SG ' ' A' ' 141' ' ' CYS . 28.7 mm -76.13 148.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.492 0.717 . . . . 0.0 110.205 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 123.318 0.647 . . . . 0.0 111.248 176.081 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.827 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.02 -50.1 59.2 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.416 1.087 . . . . 0.0 112.154 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -63.73 -36.16 82.95 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.121 0.968 . . . . 0.0 111.1 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 91' ' ' GLN . 35.6 mt -71.31 -48.53 53.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.737 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -55.96 -46.07 78.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.563 1.145 . . . . 0.0 111.371 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.05 -45.12 93.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -32.89 74.57 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.93 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.483 HG23 HD13 ' A' ' 130' ' ' ILE . 96.4 mt -65.2 -41.59 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 118.728 0.694 . . . . 0.0 109.903 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.8 t -64.91 -36.0 82.96 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.842 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -81.43 -30.47 33.48 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.847 0.859 . . . . 0.0 112.945 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 99.1 m -91.46 -19.5 22.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.868 0.867 . . . . 0.0 111.604 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -72.83 165.46 24.84 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.566 0.698 . . . . 0.0 111.938 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.91 159.43 34.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.943 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -69.91 97.02 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.7 t -66.36 113.43 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.374 0.669 . . . . 0.0 110.531 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.6 m -114.49 90.77 22.26 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.415 1.086 . . . . 0.0 109.093 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -58.44 -39.14 86.33 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.081 2.521 . . . . 0.0 113.293 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -38.01 65.67 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.05 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -74.83 -41.21 60.35 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 97.7 mt -68.44 -15.61 63.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 111.57 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 61.47 16.75 7.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 -172.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 61.6 m -93.11 124.62 57.54 Favored Pre-proline 0 C--O 1.243 0.755 0 C-N-CA 123.36 0.664 . . . . 0.0 109.5 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.46 150.99 78.12 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.557 2.171 . . . . 0.0 111.7 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.01 -47.92 67.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.903 0.881 . . . . 0.0 112.264 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.28 -35.16 78.15 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.383 0.673 . . . . 0.0 112.354 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.06 62.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.36 0.664 . . . . 0.0 111.792 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 112' ' ' CYS . 24.5 pt -127.61 29.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.662 0.785 . . . . 0.0 110.221 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -79.04 132.48 36.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.789 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.17 111.34 7.59 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.34 -2.46 12.59 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.841 2.361 . . . . 0.0 112.172 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.5 mt -82.16 -55.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.6 p -95.23 -7.87 37.77 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.16 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.85 48.24 20.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.15 0.98 . . . . 0.0 111.257 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.81 149.98 20.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.757 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.66 116.42 51.51 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.4 161.2 37.93 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.78 2.32 . . . . 0.0 113.434 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.45 -19.03 20.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.712 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 2.2 pptp? -144.87 128.8 17.44 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.71 167.3 37.78 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.859 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 98' ' ' ILE . 11.5 pt -122.03 151.81 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 109.348 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.53 115.61 28.96 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 130' ' ' ILE . 64.2 t -117.69 122.39 69.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -69.71 122.39 19.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.432 0.634 . . . . 0.0 110.928 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -72.83 80.86 1.15 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 161.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 25.1 t -70.09 -44.86 68.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.781 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.28 -34.76 79.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.059 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.09 -64.86 2.22 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.835 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.9 m -157.44 18.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.318 0.559 . . . . 0.0 112.475 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.7 m-20 59.63 20.62 9.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.98 0.912 . . . . 0.0 112.283 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.7 124.08 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 28.0 p -85.5 133.12 34.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 m -121.81 145.56 47.94 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.19 108.81 20.13 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.53 136.42 42.39 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.42 132.31 52.72 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.629 0.65 . . . . 0.0 109.359 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.74 70.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.043 0.839 . . . . 0.0 111.892 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . . . -75.29 -40.23 58.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.986 0.514 . . . . 0.0 111.599 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.37 89.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.064 0.545 . . . . 0.0 111.807 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 130' ' ' ILE . 33.5 t80 -76.97 -38.35 53.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.966 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 98' ' ' ILE . 28.8 t -64.08 -28.94 70.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.434 0.459 . . . . 0.0 110.819 175.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 13.0 tpt180 -64.39 -55.69 19.33 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.541 -0.754 . . . . 0.0 108.973 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.7 -45.6 70.47 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.088 0.867 . . . . 0.0 111.818 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.414 HG11 ' HB ' ' A' ' 94' ' ' ILE . 86.3 t -65.93 -47.56 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.298 0.639 . . . . 0.0 110.378 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.27 -17.88 68.73 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.274 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 63.7 mm-40 -87.15 -23.97 24.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.619 0.768 . . . . 0.0 110.857 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.03 36.79 12.35 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.54 149.12 36.12 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.57 1.148 . . . . 0.0 109.527 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -69.89 177.26 5.85 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.353 2.702 . . . . 0.0 113.531 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.447 ' ND1' HG22 ' A' ' 162' ' ' THR . 60.1 t-80 -59.81 124.66 77.52 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.58 -12.46 35.19 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.675 2.25 . . . . 0.0 114.202 -168.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.81 -66.97 0.87 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.643 0.377 . . . . 0.0 110.819 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.447 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.5 t -90.36 -8.66 50.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.57 0.348 . . . . 0.0 111.605 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 59.88 24.46 13.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.841 1.256 . . . . 0.0 112.961 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -88.75 155.77 50.28 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.93 0.892 . . . . 0.0 110.05 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -64.2 112.16 1.81 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.461 2.107 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.519 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.8 mt -56.64 140.05 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.788 0.835 . . . . 0.0 110.076 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 160.55 43.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.851 0.861 . . . . 0.0 109.849 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.22 -23.93 67.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.508 0.723 . . . . 0.0 111.903 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -67.49 -46.21 73.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 111.954 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.7 pt -79.06 -10.43 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' A' ' 101' ' ' CYS . 10.5 tt -99.33 132.35 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.477 0.58 . . . . 0.0 109.614 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.67 174.02 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.461 1.104 . . . . 0.0 109.762 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 29.3 mtpp -91.1 166.18 13.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.664 0.386 . . . . 0.0 110.137 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -62.89 -34.97 78.53 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.552 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.2 -9.76 59.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.183 0.593 . . . . 0.0 111.351 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -93.88 -2.95 52.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.814 0.846 . . . . 0.0 110.551 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 29.8 p -134.9 144.26 47.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.161 0.984 . . . . 0.0 109.379 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -123.21 155.62 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.595 -0.691 . . . . 0.0 109.279 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -67.95 110.84 4.06 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 159.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.45 125.13 39.85 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -79.3 -36.17 40.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.552 0.741 . . . . 0.0 111.829 -169.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -74.84 -27.3 60.22 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.405 0.548 . . . . 0.0 110.402 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.6 mmt180 -77.5 -32.74 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.84 81.26 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.794 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -145.92 157.67 43.89 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.29 1.036 . . . . 0.0 109.42 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.452 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 37.1 m-85 -72.34 118.57 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.179 0.591 . . . . 0.0 109.569 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' A' ' 183' ' ' ARG . 27.2 pt -128.32 177.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 133' ' ' LYS . 39.6 mm -80.2 145.11 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 178' ' ' ILE . 48.6 mtpt . . . . . 0 N--CA 1.471 0.615 0 O-C-N 124.066 0.854 . . . . 0.0 111.654 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HG3' HG12 ' A' ' 153' ' ' VAL . 24.9 mp0 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -47.59 30.1 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.357 1.063 . . . . 0.0 113.47 -170.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.428 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 18.8 m -65.07 -46.08 82.61 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.273 1.029 . . . . 0.0 111.227 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.483 HD13 HG22 ' A' ' 166' ' ' ILE . 62.1 mt -70.66 -46.24 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.159 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -55.18 -44.67 75.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.742 1.217 . . . . 0.0 110.616 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.447 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 93.9 m-20 -59.67 -46.26 89.59 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.319 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -61.2 -39.59 90.79 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.533 0.52 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 87.1 mt -62.75 -37.48 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.364 0.665 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 t -65.51 -36.87 85.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.992 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 26.6 mt-30 -85.63 -31.16 22.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.113 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.5 m -87.83 -17.11 32.24 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.235 0.614 . . . . 0.0 111.766 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.19 169.26 17.42 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-O 121.21 0.529 . . . . 0.0 111.577 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.89 160.8 41.44 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.607 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 99.21 1.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.75 98.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.3 m -112.28 99.52 46.83 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.929 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.15 -31.65 46.33 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.875 3.05 . . . . 0.0 114.547 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 11.1 pt-20 -70.04 -43.56 71.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.747 0.819 . . . . 0.0 110.68 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 76.4 mtp180 -81.34 -26.69 35.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.086 0.554 . . . . 0.0 110.565 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.0 mt -77.81 -20.69 52.79 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.088 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 58.44 27.75 15.92 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.749 0.819 . . . . 0.0 111.331 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.4 m -116.52 144.72 33.72 Favored Pre-proline 0 C--O 1.245 0.834 0 C-N-CA 124.024 0.93 . . . . 0.0 109.995 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.92 160.98 44.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.43 2.087 . . . . 0.0 111.66 172.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -43.13 78.59 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.922 0.764 . . . . 0.0 112.014 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.1 -37.06 83.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.049 0.94 . . . . 0.0 112.606 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.62 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.069 0.548 . . . . 0.0 111.154 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.14 31.28 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.899 0.88 . . . . 0.0 110.007 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -85.23 131.54 34.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.697 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.8 t -67.75 114.22 18.79 Favored Pre-proline 0 C--N 1.346 0.434 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.62 -11.23 30.56 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.427 2.085 . . . . 0.0 112.862 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 36.1 mt -78.08 -56.23 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.851 0.86 . . . . 0.0 109.558 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p -99.33 -11.87 20.83 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.207 1.003 . . . . 0.0 111.932 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.24 27.7 17.38 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.362 1.065 . . . . 0.0 112.305 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -104.67 164.1 12.01 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.34 99.72 8.95 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 165.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 163.87 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.714 2.276 . . . . 0.0 113.759 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -94.93 -16.66 22.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.117 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -142.86 135.1 27.37 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.839 1.256 . . . . 0.0 108.184 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.47 29.95 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.879 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.93 158.96 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.532 1.133 . . . . 0.0 110.262 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -102.3 122.09 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.53 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 78.6 t -119.61 124.69 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -69.02 117.1 10.25 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 123.823 0.702 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -74.93 80.65 2.16 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 166.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 t -58.83 -33.14 70.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.619 1.168 . . . . 0.0 110.748 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.94 -42.09 94.96 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.648 0.593 . . . . 0.0 111.581 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.51 -65.33 3.22 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.621 0.576 . . . . 0.0 111.817 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 t 176.65 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.603 1.161 . . . . 0.0 108.405 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.69 23.95 13.7 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.523 1.129 . . . . 0.0 110.413 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.11 109.96 10.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 60.8 m -83.64 131.89 34.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.819 0.448 . . . . 0.0 110.046 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.4 m -121.23 149.17 43.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 48.2 tp -88.71 104.48 16.92 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.324 0.583 . . . . 0.0 109.551 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 93.9 m-85 -97.61 136.73 37.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.47 134.71 56.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.7 -41.67 82.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.135 0.897 . . . . 0.0 111.638 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.95 -32.32 45.42 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.458 0.474 . . . . 0.0 111.799 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.68 62.83 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.518 0.727 . . . . 0.0 111.393 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.3 t80 -71.76 -39.29 70.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.8 t -61.91 -31.43 71.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 111.44 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.4 tpt180 -64.31 -52.87 56.34 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 123.564 0.54 . . . . 0.0 109.594 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.87 -42.74 76.36 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.859 0.724 . . . . 0.0 111.574 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 166' ' ' ILE . 94.4 t -63.15 -49.34 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.817 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.26 -16.12 68.65 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 124.134 0.896 . . . . 0.0 113.673 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.1 mm-40 -93.38 -11.94 31.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 111.107 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.67 30.24 56.53 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.35 0.407 . . . . 0.0 112.501 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -92.8 148.13 35.39 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.614 1.165 . . . . 0.0 109.787 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.16 -176.12 2.89 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.794 2.329 . . . . 0.0 112.584 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -55.64 132.13 71.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.261 1.025 . . . . 0.0 110.382 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 73.2 Cg_endo -68.91 -28.62 29.28 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.907 1.738 . . . . 0.0 113.303 -170.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.33 -56.49 3.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.557 0.343 . . . . 0.0 111.31 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 t -108.78 -8.79 15.29 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -169.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 32.9 mmt180 66.7 21.42 10.59 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.391 1.077 . . . . 0.0 112.634 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -72.27 141.08 83.04 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.143 0.577 . . . . 0.0 109.646 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.81 115.22 2.79 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.388 2.059 . . . . 0.0 111.677 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.555 HG21 HG22 ' A' ' 153' ' ' VAL . 71.4 mt -60.95 127.97 21.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 CA-C-O 120.934 0.397 . . . . 0.0 110.491 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -148.17 165.23 31.51 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.142 0.977 . . . . 0.0 109.402 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.12 -20.18 66.07 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.655 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m -65.37 -44.27 88.13 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.307 0.643 . . . . 0.0 112.452 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.7 pt -86.89 -7.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.24 129.96 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.02 178.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.065 0.946 . . . . 0.0 110.847 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.9 161.68 13.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.465 0.706 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -67.76 -22.76 65.19 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.7 0.8 . . . . 0.0 112.467 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.73 -22.71 23.21 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.947 0.499 . . . . 0.0 111.083 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.13 -26.88 28.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.034 0.934 . . . . 0.0 110.955 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 27.0 p -115.86 150.6 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.535 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -133.71 160.7 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.051 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 32.3 p90 -69.12 115.0 7.9 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 165.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.554 ' HB2' HG12 ' A' ' 187' ' ' ILE . 11.3 t70 -91.79 129.95 37.66 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.44 -47.89 45.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.06 0.85 . . . . 0.0 110.731 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.2 t -78.28 -25.17 46.6 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.613 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.1 mmp_? -77.05 -30.86 55.81 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.231 169.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.83 14.34 59.62 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.685 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -171.75 168.67 6.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.522 0.661 . . . . 0.0 110.459 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 93.9 m-85 -60.13 121.52 12.11 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.077 0.951 . . . . 0.0 111.529 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.613 HD13 ' HG3' ' A' ' 183' ' ' ARG . 24.1 pt -131.73 178.16 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.327 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 133' ' ' LYS . 47.2 mm -71.58 140.22 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.598 0.561 . . . . 0.0 109.586 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' A' ' 178' ' ' ILE . 54.2 mtpt . . . . . 0 N--CA 1.478 0.927 0 O-C-N 123.706 0.629 . . . . 0.0 110.906 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.826 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -47.61 71.9 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.869 0.731 . . . . 0.0 111.812 -170.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 37.1 t -66.85 -38.81 87.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.4 0.68 . . . . 0.0 111.192 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.8 mt -66.31 -43.78 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.718 0.636 . . . . 0.0 109.475 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.45 -44.58 84.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.022 . . . . 0.0 110.803 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -59.62 -43.44 93.79 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.425 0.453 . . . . 0.0 111.064 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.1 mpmm? -63.26 -35.34 80.02 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 111.298 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 89.1 mt -67.57 -37.48 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 122.762 0.425 . . . . 0.0 110.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.6 t -63.45 -40.04 96.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.57 0.748 . . . . 0.0 111.33 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.02 -45.17 18.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.264 0.626 . . . . 0.0 112.146 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 73.3 m -82.3 -10.05 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.905 0.882 . . . . 0.0 112.741 -169.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.69 169.29 18.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.402 0.62 . . . . 0.0 112.473 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -158.03 160.36 37.36 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.963 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 m -70.04 99.81 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 114.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.173 0.589 . . . . 0.0 110.874 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.1 m -118.49 100.42 51.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.034 0.934 . . . . 0.0 109.229 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.57 -37.53 57.69 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.338 2.692 . . . . 0.0 113.293 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -15.26 56.98 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.875 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -88.94 -43.38 11.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 0.0 110.016 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.9 mt -72.57 -12.12 60.93 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 65.33 17.75 11.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.872 1.269 . . . . 0.0 111.538 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 71.8 m -104.61 136.0 19.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.741 0.816 . . . . 0.0 110.136 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.28 164.15 29.24 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.692 2.261 . . . . 0.0 111.125 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.8 mt -53.59 -47.43 70.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.42 0.688 . . . . 0.0 111.49 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.58 -41.83 70.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.857 1.263 . . . . 0.0 113.134 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.44 67.27 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.929 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 143' ' ' LEU . 20.8 pt -126.51 23.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.244 1.018 . . . . 0.0 110.409 -177.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.86 128.32 35.98 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.435 0.694 . . . . 0.0 110.242 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 39.2 t -70.04 110.86 7.48 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.72 -3.06 13.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.882 2.388 . . . . 0.0 112.714 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.9 mt -76.27 -51.51 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.184 0.993 . . . . 0.0 109.236 176.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p -99.68 -15.39 18.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.978 -173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.39 47.9 15.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.516 1.126 . . . . 0.0 111.793 -172.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 163.44 37.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.573 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.12 116.63 60.38 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 60.0 Cg_endo -71.18 161.17 46.77 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.024 2.483 . . . . 0.0 113.819 -173.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 8.2 pt-20 -87.19 -37.86 16.92 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.37 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 17.7 pttm -140.68 140.09 34.89 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.85 156.87 28.3 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.218 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.4 ' O ' HD12 ' A' ' 143' ' ' LEU . 11.1 pt -109.31 158.19 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 109.058 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -99.41 128.16 45.5 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.495 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 90.1 t -119.54 121.86 67.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.63 113.22 10.51 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.84 80.43 1.62 Allowed 'General case' 0 C--O 1.248 1.005 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -68.3 -30.39 69.38 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.223 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.86 -38.86 89.83 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.271 174.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.33 -67.46 1.83 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.103 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t 178.79 44.33 0.0 OUTLIER 'General case' 0 C--O 1.251 1.144 0 C-N-CA 123.864 0.865 . . . . 0.0 109.905 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 t70 70.31 8.33 6.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 123.951 0.901 . . . . 0.0 111.432 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.595 ' HA ' HG22 ' A' ' 187' ' ' ILE . 61.3 t -77.14 113.59 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.51 138.63 33.34 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 109.473 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.8 m -129.25 154.0 47.24 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.5 tp -90.17 121.39 32.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.495 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.0 m-85 -117.34 133.7 55.68 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 124.991 1.317 . . . . 0.0 107.824 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.6 t70 -59.78 135.55 57.72 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 118.846 0.748 . . . . 0.0 109.656 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.4 71.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.898 0.879 . . . . 0.0 111.575 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.37 -34.72 65.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.56 -37.67 71.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 111.771 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -76.92 -36.65 56.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.384 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.9 t -62.59 -30.24 71.19 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 124.01 0.819 . . . . 0.0 110.831 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.5 ttm-85 -64.87 -53.5 45.72 Favored 'General case' 0 C--O 1.218 -0.564 0 O-C-N 124.02 0.825 . . . . 0.0 109.981 170.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 73.2 mt -52.94 -47.84 67.75 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.949 0.5 . . . . 0.0 111.475 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.61 -51.36 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.659 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.51 73.5 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.269 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 29.6 mm-40 -87.48 -23.86 24.3 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 117.36 0.58 . . . . 0.0 110.185 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.86 53.59 Favored Glycine 0 N--CA 1.47 0.945 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.62 140.31 59.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.084 0.954 . . . . 0.0 109.63 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.56 -168.08 0.53 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.748 2.298 . . . . 0.0 112.608 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -60.66 131.41 91.0 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.353 1.061 . . . . 0.0 110.043 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.413 ' HG3' HG12 ' A' ' 121' ' ' ILE . 70.2 Cg_endo -68.79 -24.42 34.46 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.37 2.047 . . . . 0.0 113.444 -172.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.74 -65.15 1.04 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.9 t -102.71 -9.4 20.07 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.299 -167.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 62.22 24.04 14.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.782 1.233 . . . . 0.0 112.063 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -79.16 148.35 71.09 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.334 0.654 . . . . 0.0 110.062 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.93 123.09 12.24 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.702 2.268 . . . . 0.0 111.854 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.94 134.3 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.292 0.637 . . . . 0.0 110.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.1 t -141.14 160.61 39.73 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.917 0.887 . . . . 0.0 109.559 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.04 -23.97 67.69 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.913 0.885 . . . . 0.0 111.545 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.7 t -67.56 -41.27 84.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.783 0.833 . . . . 0.0 112.267 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -85.0 -8.67 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.8 tt -98.0 133.57 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.82 0.736 . . . . 0.0 109.151 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.04 174.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.725 1.21 . . . . 0.0 110.378 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 40.8 mtpt -102.62 164.5 11.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.145 0.578 . . . . 0.0 110.843 -175.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -73.68 -17.59 61.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.918 0.487 . . . . 0.0 111.595 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.49 -32.77 28.63 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.11 -29.89 49.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.331 0.652 . . . . 0.0 110.721 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 31.6 p -113.55 155.51 25.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.599 0.759 . . . . 0.0 109.643 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.39 164.23 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.312 1.045 . . . . 0.0 108.839 179.504 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.27 127.51 33.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 162.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.463 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -107.52 139.18 42.43 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.883 -0.511 . . . . 0.0 110.027 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.17 -50.86 13.43 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.248 0.968 . . . . 0.0 111.757 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 15.0 t -71.06 -33.53 70.36 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.19 0.45 . . . . 0.0 111.18 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.569 ' HG3' HD13 ' A' ' 187' ' ' ILE . 26.8 mmt180 -76.3 -27.95 56.78 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.917 0.487 . . . . 0.0 110.088 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.83 24.31 72.47 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.194 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -170.11 163.68 9.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.831 0.853 . . . . 0.0 108.824 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 89.0 m-85 -59.82 127.68 33.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.975 0.91 . . . . 0.0 111.182 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 140' ' ' VAL . 19.1 pt -138.71 -179.85 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.645 1.178 . . . . 0.0 108.989 170.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.8 152.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 122.995 0.518 . . . . 0.0 109.889 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.966 174.218 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.64 HE21 ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -30.7 70.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 0.0 112.155 -174.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -68.29 -46.97 68.9 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.099 0.96 . . . . 0.0 109.788 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 98' ' ' ILE . 79.6 mt -64.48 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.683 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -61.11 -38.38 86.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.717 1.207 . . . . 0.0 112.537 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -60.9 -41.23 95.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.456 0.473 . . . . 0.0 110.238 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -39.23 89.31 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 123.369 0.418 . . . . 0.0 110.614 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 94' ' ' ILE . 74.9 mt -65.25 -46.08 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.79 0.436 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -65.4 -36.02 82.7 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.879 0.872 . . . . 0.0 112.25 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -82.4 -42.55 18.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.988 0.515 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.85 -6.97 59.54 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.83 0.852 . . . . 0.0 112.386 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -75.26 163.62 27.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.186 0.517 . . . . 0.0 111.56 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -157.2 159.58 37.85 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.988 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.4 p -73.35 100.75 3.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.933 0.77 . . . . 0.0 109.409 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.87 120.88 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.865 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.98 96.1 32.65 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 0.0 109.149 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.44 -34.45 33.06 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.493 3.462 . . . . 0.0 115.625 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.29 -34.88 65.99 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.892 0.477 . . . . 0.0 110.74 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -82.12 -36.47 27.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.763 0.825 . . . . 0.0 110.057 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.54 -17.52 62.31 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.055 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.88 34.62 23.9 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.697 1.199 . . . . 0.0 110.893 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 69.6 m -115.08 135.77 22.54 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.199 0.999 . . . . 0.0 109.171 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.54 153.07 63.75 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.455 2.104 . . . . 0.0 111.708 169.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 59.4 mt -52.57 -48.07 66.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.354 1.061 . . . . 0.0 111.766 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.26 -35.98 78.76 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.336 1.055 . . . . 0.0 112.571 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.39 66.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.67 . . . . 0.0 111.658 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.429 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.3 pt -124.06 24.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.645 0.778 . . . . 0.0 110.46 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.5 tt0 -68.85 135.66 51.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.853 174.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.5 112.08 10.87 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.12 -6.7 19.78 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.861 2.374 . . . . 0.0 112.791 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.52 -53.21 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.788 0.835 . . . . 0.0 109.466 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -91.94 -11.1 37.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.65 0.78 . . . . 0.0 112.596 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.91 36.65 12.62 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.015 0.926 . . . . 0.0 111.431 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -151.64 149.1 28.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.482 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.1 tm0? -67.14 121.6 79.06 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 123.49 0.716 . . . . 0.0 109.371 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 153.21 41.19 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.535 2.157 . . . . 0.0 113.747 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.36 -17.18 32.98 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.46 170.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -150.72 130.69 13.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.594 1.157 . . . . 0.0 108.368 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.46 169.2 39.81 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.667 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 171' ' ' ILE . 12.8 pt -118.61 154.47 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.201 1.401 . . . . 0.0 110.058 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.36 121.26 37.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 95.2 t -120.11 122.52 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.5 ptmt -68.52 120.16 14.13 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.359 0.599 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -74.78 79.53 2.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 165.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HE2' ' A' ' 133' ' ' LYS . 12.5 t -68.72 -36.86 78.96 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.244 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.3 -35.03 76.21 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.476 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.79 -64.1 2.0 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.307 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -171.55 27.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.906 0.482 . . . . 0.0 111.105 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.6 m-20 62.79 25.07 14.9 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.359 1.063 . . . . 0.0 111.78 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 187' ' ' ILE . 70.6 t -85.92 124.52 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 0.0 109.225 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 28.6 p -83.27 130.13 35.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -174.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.2 m -120.34 140.08 51.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.097 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.429 HD23 ' HB ' ' A' ' 117' ' ' ILE . 36.8 tp -89.54 107.49 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.356 0.598 . . . . 0.0 110.105 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 88.8 m-85 -99.99 145.95 27.28 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.24 134.66 54.12 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.51 78.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.757 0.66 . . . . 0.0 111.879 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -31.39 64.75 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.653 0.595 . . . . 0.0 111.678 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -73.3 -39.77 65.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.059 0.543 . . . . 0.0 111.739 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -75.97 -35.24 59.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.4 t -59.6 -38.75 82.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.061 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 15.6 tpt180 -57.77 -49.63 75.94 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 124.275 0.984 . . . . 0.0 110.101 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.84 -46.32 81.8 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.693 0.621 . . . . 0.0 111.658 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 166' ' ' ILE . 70.5 t -65.4 -42.41 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.58 63.99 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.501 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.8 -12.51 55.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.277 0.631 . . . . 0.0 111.201 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.21 74.28 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.733 -0.212 . . . . 0.0 113.161 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.09 133.69 81.35 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.52 179.17 3.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.829 2.353 . . . . 0.0 112.641 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -58.07 128.08 80.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.73 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.47 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 44.7 Cg_endo -64.51 -25.32 62.85 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.617 2.211 . . . . 0.0 113.476 -167.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -53.7 4.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.958 0.503 . . . . 0.0 111.499 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.3 t -108.87 -13.01 14.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -171.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 36.6 mmt180 62.47 28.34 16.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.576 1.151 . . . . 0.0 112.129 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 162' ' ' THR . 22.9 mm-40 -83.18 158.35 64.25 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.623 0.769 . . . . 0.0 109.894 170.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.88 119.36 6.38 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.154 1.903 . . . . 0.0 111.495 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 153' ' ' VAL . 68.1 mt -60.05 128.35 20.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 t -140.69 155.81 46.38 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.145 0.978 . . . . 0.0 109.1 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.91 -22.54 66.51 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.1 m -63.04 -32.28 73.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.391 1.076 . . . . 0.0 112.889 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 47.6 pt -97.2 -7.8 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 130' ' ' ILE . 10.5 tt -96.54 133.73 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.224 0.92 . . . . 0.0 109.475 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.14 178.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.208 1.403 . . . . 0.0 109.736 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -100.34 170.2 8.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.252 0.621 . . . . 0.0 110.729 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -68.86 -27.97 66.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.661 0.384 . . . . 0.0 110.947 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.75 -42.45 81.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.633 0.773 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.13 -12.28 60.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.314 -168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 27.7 p -118.69 151.05 38.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.897 0.879 . . . . 0.0 109.742 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.36 160.03 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -68.62 127.47 33.14 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.1 t70 -106.73 127.95 53.81 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.05 -42.34 63.23 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.099 0.875 . . . . 0.0 112.176 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -79.25 -16.09 57.0 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.753 0.252 . . . . 0.0 111.383 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.57 -29.79 19.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.125 0.57 . . . . 0.0 110.541 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.64 18.14 77.91 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.981 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -162.07 160.14 27.08 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.545 0.738 . . . . 0.0 109.176 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.588 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 87.4 m-85 -61.37 124.59 21.03 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.608 1.163 . . . . 0.0 111.737 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.5 pt -128.77 179.58 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.224 1.01 . . . . 0.0 108.432 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 133' ' ' LYS . 23.5 mm -79.92 149.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 122.549 0.34 . . . . 0.0 110.473 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? . . . . . 0 N--CA 1.468 0.438 0 C-N-CA 124.061 0.944 . . . . 0.0 112.693 179.258 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -70.65 -42.59 70.6 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.061 0.945 . . . . 0.0 111.674 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.68 -45.39 70.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -167.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 35.3 t -71.52 -36.8 71.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.723 0.409 . . . . 0.0 110.693 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 98' ' ' ILE . 83.6 mt -63.23 -42.05 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -68.16 -31.95 71.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.467 1.107 . . . . 0.0 112.307 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -58.62 -46.55 86.82 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 168.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -67.08 -40.6 87.01 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.735 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 94' ' ' ILE . 85.3 mt -64.16 -44.8 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.247 0.476 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -66.82 -35.15 79.39 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.318 0.647 . . . . 0.0 112.48 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.679 0.391 . . . . 0.0 111.441 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.5 m -64.42 -21.33 66.61 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.58 1.152 . . . . 0.0 113.266 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.27 173.34 4.88 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 121.468 0.651 . . . . 0.0 112.316 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.23 159.51 36.12 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.777 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.7 t -77.41 108.67 10.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.79 134.64 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.102 -171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.2 m -135.82 94.86 14.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.244 1.017 . . . . 0.0 108.982 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.41 ' HB3' HD11 ' A' ' 117' ' ' ILE . 24.2 Cg_endo -58.18 -35.31 98.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.715 2.943 . . . . 0.0 113.833 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -31.66 32.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.008 0.523 . . . . 0.0 111.372 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -75.65 -40.4 56.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.565 0.346 . . . . 0.0 110.733 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 95.6 mt -71.82 -14.92 62.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.75 0.82 . . . . 0.0 111.946 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 64.27 10.52 5.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.763 1.225 . . . . 0.0 111.965 -172.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.465 ' SG ' ' HZ ' ' A' ' 186' ' ' PHE . 58.8 m -94.52 130.82 32.41 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.897 0.879 . . . . 0.0 110.156 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.41 155.02 72.08 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.612 2.208 . . . . 0.0 111.574 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 63.5 mt -52.57 -49.77 64.3 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.189 0.931 . . . . 0.0 111.962 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.24 -41.2 71.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.242 1.017 . . . . 0.0 112.941 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.06 63.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.509 0.724 . . . . 0.0 111.785 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.564 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.5 pt -126.63 17.8 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.663 0.785 . . . . 0.0 110.756 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 39.6 tt0 -69.84 137.59 51.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 111.064 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.454 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 34.9 t -73.7 112.11 14.95 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.97 -4.31 15.19 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.754 2.302 . . . . 0.0 112.759 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 mt -83.33 -54.82 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.837 0.855 . . . . 0.0 109.311 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -88.68 -12.38 42.56 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.079 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.11 36.34 18.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.954 0.902 . . . . 0.0 111.464 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -148.51 151.57 35.36 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.163 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.73 115.47 31.07 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.7 Cg_endo -71.82 160.11 48.79 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.569 2.18 . . . . 0.0 113.258 -167.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.2 pt-20 -83.9 -31.04 25.9 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.158 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.23 145.41 31.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.191 1.396 . . . . 0.0 108.203 174.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.02 169.69 40.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.871 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.77 153.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.187 1.395 . . . . 0.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -97.96 117.15 31.64 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 73.7 t -110.92 123.31 66.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 188' ' ' ILE . 18.4 ptmt -71.03 108.35 4.55 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.74 0.781 . . . . 0.0 110.426 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -75.91 76.04 2.82 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 t -69.51 -32.51 71.41 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.353 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.07 -44.63 91.88 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.084 0.865 . . . . 0.0 110.813 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.21 -67.34 1.94 Allowed Glycine 0 C--N 1.348 1.211 0 O-C-N 123.704 0.628 . . . . 0.0 112.868 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.8 m -170.78 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.973 0.909 . . . . 0.0 110.305 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.08 23.68 12.45 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.405 1.097 . . . . 0.0 111.086 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.6 124.59 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.575 ' SG ' HD13 ' A' ' 188' ' ' ILE . 56.8 m -83.42 118.82 23.99 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.504 HG21 HD11 ' A' ' 161' ' ' LEU . 18.1 m -111.86 134.21 53.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 117' ' ' ILE . 30.3 tp -90.41 103.29 15.99 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.721 0.638 . . . . 0.0 109.928 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 95.1 m-85 -97.05 136.91 36.93 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.6 t70 -57.8 130.48 46.67 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.31 -43.36 74.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.251 0.969 . . . . 0.0 111.908 -172.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.67 42.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.869 0.468 . . . . 0.0 111.705 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.77 65.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.935 0.494 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -77.02 -39.63 49.51 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -55.17 -34.59 63.98 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.583 1.153 . . . . 0.0 111.437 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.2 tpm_? -63.1 -54.32 39.69 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.858 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.9 mt -55.31 -44.4 75.74 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.361 1.038 . . . . 0.0 111.681 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 166' ' ' ILE . 60.8 t -64.78 -47.4 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.736 0.647 . . . . 0.0 109.44 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.47 -32.15 82.1 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.542 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.3 mm-40 -82.96 -28.93 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.335 0.654 . . . . 0.0 111.164 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.04 14.3 42.98 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.491 0.495 . . . . 0.0 112.668 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.55 134.63 57.67 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.162 0.985 . . . . 0.0 109.664 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.47 -171.25 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.704 2.269 . . . . 0.0 112.627 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.492 ' ND1' HG22 ' A' ' 162' ' ' THR . 49.0 t-80 -61.24 123.95 78.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.614 0.766 . . . . 0.0 108.981 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.91 -11.22 29.03 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.129 1.886 . . . . 0.0 113.189 -167.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 142' ' ' THR . 88.6 mt -96.49 -65.93 0.94 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.178 0.591 . . . . 0.0 110.616 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.492 HG22 ' ND1' ' A' ' 159' ' ' HIS . 11.1 t -98.71 -3.15 36.51 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.863 0.465 . . . . 0.0 111.997 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 66.01 15.56 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.581 1.553 . . . . 0.0 112.537 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.42 150.54 82.54 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 123.162 0.585 . . . . 0.0 110.97 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.34 113.6 2.33 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.246 1.964 . . . . 0.0 109.92 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.503 HG21 HG22 ' A' ' 153' ' ' VAL . 72.3 mt -56.21 128.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 O-C-N 123.808 0.693 . . . . 0.0 110.291 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.4 t -143.83 157.94 44.02 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.061 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.94 -15.37 63.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.439 0.696 . . . . 0.0 111.462 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -67.5 -48.15 67.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.027 0.931 . . . . 0.0 111.804 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 43.6 pt -83.42 -5.36 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.91 139.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 188' ' ' ILE . 29.0 m -125.45 170.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 0.0 109.751 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.37 150.05 28.6 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.146 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.402 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 17.7 p-80 -63.97 -18.79 64.62 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.882 0.739 . . . . 0.0 112.901 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.61 -24.2 24.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.411 0.684 . . . . 0.0 111.598 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -87.97 5.15 42.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.173 0.589 . . . . 0.0 110.563 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 24.6 p -129.0 130.71 47.0 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.26 157.74 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -67.36 119.04 11.55 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.486 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.1 t70 -99.59 134.94 41.75 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.92 -34.99 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.848 0.859 . . . . 0.0 111.957 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.6 t -80.61 -29.26 36.87 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.426 0.557 . . . . 0.0 110.695 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.553 ' HG3' HD13 ' A' ' 187' ' ' ILE . 25.4 mmt180 -82.2 -25.55 34.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.963 0.505 . . . . 0.0 110.404 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.7 18.19 79.79 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.824 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -166.66 164.38 16.78 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 93.8 m-85 -59.74 120.95 10.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.81 0.844 . . . . 0.0 111.405 175.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.553 HD13 ' HG3' ' A' ' 183' ' ' ARG . 13.2 pt -132.47 177.34 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.823 0.849 . . . . 0.0 109.227 168.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 133' ' ' LYS . 30.8 mm -76.06 153.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.262 0.625 . . . . 0.0 110.438 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.38 163.33 25.44 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.429 0.692 . . . . 0.0 111.325 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.13 -43.51 63.89 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.3 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 . . . . . 0 C--O 1.244 0.809 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.664 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -67.13 -36.89 82.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.138 0.975 . . . . 0.0 110.513 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -68.92 -21.43 64.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.51 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 39.5 t -68.27 -40.45 81.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.3 mt -63.26 -48.08 89.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -53.83 -44.89 70.64 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.424 1.089 . . . . 0.0 111.465 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -60.4 -44.85 95.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.508 0.723 . . . . 0.0 110.626 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -67.43 -32.9 74.08 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 123.253 0.621 . . . . 0.0 110.985 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.534 HG23 HD13 ' A' ' 130' ' ' ILE . 91.0 mt -67.7 -41.29 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.899 0.479 . . . . 0.0 109.839 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 m -66.35 -39.55 89.26 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.7 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -82.21 -30.5 30.82 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 78.3 m -89.88 -15.54 31.95 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.71 168.55 17.52 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.696 0.76 . . . . 0.0 112.444 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -156.71 155.62 31.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.988 172.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 110.14 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.09 107.54 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.098 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 40.3 m -112.25 95.96 33.03 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.552 1.141 . . . . 0.0 108.558 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.5 -36.95 95.3 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.714 2.943 . . . . 0.0 114.376 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.08 36.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -78.52 -39.36 38.25 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 86.5 mt -72.74 -22.2 60.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.07 0.948 . . . . 0.0 111.271 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 56.36 11.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.287 1.035 . . . . 0.0 113.213 -172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 58.4 m -84.35 138.48 38.97 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 123.681 0.792 . . . . 0.0 109.588 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.19 142.84 99.73 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.123 1.882 . . . . 0.0 110.446 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 125' ' ' GLN . 82.3 mt -52.64 -40.5 62.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 111.998 -173.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.28 -44.05 75.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.026 0.93 . . . . 0.0 112.273 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.33 69.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.565 0.746 . . . . 0.0 111.117 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 24.2 pt -112.32 23.34 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.31 129.69 34.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.017 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 29.2 t -68.97 111.56 8.8 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 -8.62 23.81 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.694 2.263 . . . . 0.0 112.759 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.2 mt -78.06 -57.43 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.113 0.965 . . . . 0.0 109.086 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.8 p -91.32 -6.02 53.71 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.457 -171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.3 31.35 19.36 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.026 0.931 . . . . 0.0 111.957 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.64 154.26 41.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.57 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -67.24 113.99 16.44 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 94.4 Cg_endo -76.56 165.7 28.53 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.157 2.572 . . . . 0.0 113.773 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.9 pt-20 -79.94 -36.14 36.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.293 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.554 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -151.29 146.43 26.03 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 108.0 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.47 169.43 41.12 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.959 -0.638 . . . . 0.0 114.397 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.534 HD13 HG23 ' A' ' 98' ' ' ILE . 11.6 pt -122.42 155.45 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 125.645 1.578 . . . . 0.0 109.863 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -94.82 121.88 36.87 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 88.6 t -127.02 121.56 58.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.623 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.8 ptmt -67.33 113.77 5.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.673 0.749 . . . . 0.0 110.425 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -71.29 85.37 0.79 Allowed 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 163.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.9 t -64.97 -45.97 83.44 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.163 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.84 -38.07 89.73 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.845 0.715 . . . . 0.0 111.235 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.11 -64.05 3.77 Favored Glycine 0 C--N 1.344 1.028 0 O-C-N 123.821 0.701 . . . . 0.0 112.684 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.9 m -160.56 14.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.29 0.636 . . . . 0.0 111.922 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.9 m-20 60.4 27.2 16.79 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.05 138.36 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.004 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.656 ' SG ' HD13 ' A' ' 188' ' ' ILE . 20.4 m -84.03 121.65 27.7 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.079 0.951 . . . . 0.0 108.56 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.1 m -118.91 141.7 48.42 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.7 tp -91.94 105.47 17.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 109.963 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 75.1 m-85 -98.94 143.36 29.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 15.8 t70 -60.96 129.62 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.73 81.02 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.906 0.754 . . . . 0.0 112.057 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.03 -28.26 60.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.78 0.432 . . . . 0.0 111.301 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.23 62.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.379 0.671 . . . . 0.0 111.477 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -76.06 -37.92 57.68 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.748 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 48.2 t -64.21 -32.76 74.47 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.256 0.622 . . . . 0.0 110.853 174.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.1 tpm_? -59.28 -53.35 59.21 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 123.833 0.708 . . . . 0.0 109.333 172.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.5 mt -53.66 -48.09 69.76 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.247 0.967 . . . . 0.0 111.572 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.36 -40.69 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.166 0.586 . . . . 0.0 110.471 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.94 76.44 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.826 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.8 mm-40 -90.71 -11.48 39.56 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.663 0.785 . . . . 0.0 111.208 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.31 75.89 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 123.048 0.356 . . . . 0.0 112.961 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.87 138.48 46.62 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.764 1.226 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.02 178.25 7.7 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.633 2.222 . . . . 0.0 112.581 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -51.92 132.47 39.09 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -173.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.21 -23.8 28.32 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.868 1.712 . . . . 0.0 113.426 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.32 -43.38 12.2 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.4 t -121.52 -14.1 8.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 63.42 28.18 15.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.519 1.128 . . . . 0.0 112.364 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 162' ' ' THR . 14.7 mm-40 -78.36 152.98 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.497 0.719 . . . . 0.0 110.131 172.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.78 114.71 2.53 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.738 2.292 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.465 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.8 mt -66.3 138.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.744 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 t -150.77 164.27 36.59 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.398 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.69 -23.23 66.1 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.753 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 m -66.34 -43.16 86.88 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.682 0.793 . . . . 0.0 111.571 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.2 pt -85.5 -10.27 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.32 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 188' ' ' ILE . 33.3 m -135.03 175.75 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.017 1.327 . . . . 0.0 110.156 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 37.2 mtmm -99.89 166.68 10.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.349 0.659 . . . . 0.0 110.54 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -55.3 -43.45 74.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.62 0.768 . . . . 0.0 112.206 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.86 -21.54 47.38 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.225 0.61 . . . . 0.0 111.524 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -81.19 -25.0 37.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.707 0.803 . . . . 0.0 110.332 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.4 p -105.53 153.66 21.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.276 1.03 . . . . 0.0 108.856 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.81 162.32 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -72.72 134.19 44.91 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.44 120.04 37.53 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.53 -42.39 71.27 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.897 0.748 . . . . 0.0 112.353 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.5 t -72.09 -30.09 64.76 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.784 0.265 . . . . 0.0 110.697 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -76.96 -32.97 57.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.367 0.667 . . . . 0.0 110.291 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.07 89.69 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.719 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -141.06 157.25 45.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -68.81 128.71 37.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.765 0.826 . . . . 0.0 109.977 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.2 175.2 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 172' ' ' VAL . 24.9 mm -79.75 143.07 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.5 159.55 12.72 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.506 0.723 . . . . 0.0 112.271 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.55 -8.55 28.42 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.595 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.247 0.954 0 C-N-CA 124.11 0.964 . . . . 0.0 109.541 177.091 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 26.6 mp0 -59.71 -49.73 76.58 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.68 0.613 . . . . 0.0 111.952 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.36 79.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.223 0.609 . . . . 0.0 111.44 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -66.44 -42.88 86.98 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.491 0.716 . . . . 0.0 109.872 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.94 -41.19 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.706 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 20.8 mm100 -58.43 -41.82 85.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.609 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -60.16 -41.42 92.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.558 0.536 . . . . 0.0 110.634 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -44.54 88.65 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.507 0.504 . . . . 0.0 110.618 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 130' ' ' ILE . 88.9 mt -59.21 -41.01 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.022 0.929 . . . . 0.0 109.951 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -64.66 -39.27 93.4 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.664 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -86.75 -23.59 25.41 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 79.7 m -89.25 -24.1 22.18 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.605 0.762 . . . . 0.0 111.657 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 130' ' ' ILE . 20.4 pttp -69.1 168.68 13.42 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.563 0.697 . . . . 0.0 112.015 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.95 164.87 37.94 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.695 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -67.92 99.12 0.81 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.66 96.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.496 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.3 m -100.05 98.61 7.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.185 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.14 -37.88 93.74 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.094 2.529 . . . . 0.0 113.772 -168.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.75 -31.54 68.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.461 0.704 . . . . 0.0 111.548 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -78.89 -36.75 41.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.964 0.505 . . . . 0.0 110.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.58 -21.62 63.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 69.5 -40.04 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.473 1.909 . . . . 0.0 113.56 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.45 134.59 76.72 Favored Pre-proline 0 C--N 1.353 0.729 0 C-N-CA 124.678 1.191 . . . . 0.0 109.419 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.47 166.93 10.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.205 2.604 . . . . 0.0 112.891 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 67.4 mt -51.17 -47.4 62.15 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.758 0.823 . . . . 0.0 111.581 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.25 -40.06 80.8 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.911 0.884 . . . . 0.0 112.461 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.51 65.65 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.459 0.704 . . . . 0.0 112.255 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' HD23 ' A' ' 143' ' ' LEU . 13.0 pt -120.35 11.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.06 0.944 . . . . 0.0 110.868 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 34.7 tt0 -70.3 134.42 47.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.51 1.124 . . . . 0.0 111.407 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.1 t -67.2 114.96 21.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 124.045 0.841 . . . . 0.0 109.211 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.558 ' HB2' HD21 ' A' ' 161' ' ' LEU . 92.3 Cg_endo -76.51 0.9 9.02 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.676 2.251 . . . . 0.0 113.049 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 160' ' ' PRO . 34.8 mt -84.79 -54.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.678 0.791 . . . . 0.0 109.084 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p -95.68 -8.3 35.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.735 -171.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.27 42.23 25.51 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.36 1.064 . . . . 0.0 111.791 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.08 153.67 35.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.161 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' HG2' HG13 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -72.18 118.7 69.52 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.34 163.46 34.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.897 2.398 . . . . 0.0 113.392 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 16.0 pt-20 -99.47 -20.71 16.3 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.413 172.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.9 133.09 26.29 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 125.629 1.571 . . . . 0.0 106.833 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.18 158.43 31.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.362 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.508 HG21 HG23 ' A' ' 98' ' ' ILE . 11.2 pt -113.77 156.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.905 1.282 . . . . 0.0 110.419 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.726 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 36.5 m-85 -99.32 118.34 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.932 172.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 91.5 t -123.17 119.39 57.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -67.66 114.41 6.26 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.638 0.586 . . . . 0.0 111.299 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -73.71 82.79 1.59 Allowed 'General case' 0 C--O 1.252 1.217 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.8 t -62.19 -33.97 75.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.038 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.7 -36.05 81.59 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.488 0.715 . . . . 0.0 111.54 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.15 -62.96 5.77 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 124.15 0.906 . . . . 0.0 111.349 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t 174.98 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.482 1.513 . . . . 0.0 107.433 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.46 16.79 10.7 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 121.866 0.841 . . . . 0.0 109.766 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 187' ' ' ILE . 58.5 t -78.59 124.48 37.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.86 -171.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 18.6 t -85.75 133.43 34.0 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.9 m -119.64 138.63 53.13 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.592 0.757 . . . . 0.0 109.406 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.6 tp -91.18 107.82 19.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.184 0.516 . . . . 0.0 109.725 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 94.9 m-85 -98.56 155.37 17.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.347 1.059 . . . . 0.0 108.264 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.8 140.31 53.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.16 97.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.978 0.799 . . . . 0.0 111.195 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.4 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.196 0.598 . . . . 0.0 112.101 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.81 -42.22 58.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.165 0.586 . . . . 0.0 111.187 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -74.95 -38.43 61.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.594 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.5 t -57.03 -37.32 71.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.648 0.779 . . . . 0.0 111.01 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.3 tpm_? -60.13 -57.1 14.27 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.266 0.978 . . . . 0.0 110.251 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.32 -44.14 68.16 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.329 1.018 . . . . 0.0 111.7 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 94.2 t -62.56 -48.02 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.159 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.26 -25.08 73.6 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.014 0.821 . . . . 0.0 113.283 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 10.1 mm-40 -78.65 -23.24 45.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.996 0.518 . . . . 0.0 110.541 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.61 24.07 26.84 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.595 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 69.4 mt -87.3 156.94 53.94 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.335 1.054 . . . . 0.0 110.728 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.44 -177.12 3.65 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.933 2.422 . . . . 0.0 112.829 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.425 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.3 t-80 -61.56 126.71 87.32 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.389 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.478 ' HG3' HG12 ' A' ' 121' ' ' ILE . 58.6 Cg_endo -64.92 -21.33 64.14 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.571 2.181 . . . . 0.0 113.371 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 120' ' ' PRO . 55.7 mt -89.57 -66.37 0.93 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.956 0.502 . . . . 0.0 110.995 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.4 t -104.56 -1.22 26.83 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.608 -167.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 62.24 26.61 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.94 1.296 . . . . 0.0 112.995 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -77.79 150.52 78.72 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.167 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.33 114.07 2.91 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.172 1.915 . . . . 0.0 110.072 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 62.8 mt -59.33 133.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 123.448 0.467 . . . . 0.0 110.226 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.7 t -151.55 166.19 31.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.719 0.808 . . . . 0.0 109.501 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.48 -18.98 65.27 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.37 1.068 . . . . 0.0 111.46 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -71.45 -42.43 68.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.802 0.841 . . . . 0.0 111.738 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 166' ' ' ILE . 32.6 pt -85.99 -8.56 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.4 tt -103.62 134.85 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.564 HG11 HD12 ' A' ' 188' ' ' ILE . 33.4 m -121.97 160.2 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.556 0.742 . . . . 0.0 109.892 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -73.32 149.67 42.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.864 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 20.5 p80 -63.7 -23.9 67.56 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.095 0.247 . . . . 0.0 111.452 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.81 -29.51 66.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.856 0.862 . . . . 0.0 110.873 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 189' ' ' LYS . 24.5 mm-40 -93.73 17.43 11.91 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 112.191 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 23.7 p -140.84 134.85 30.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.293 0.637 . . . . 0.0 109.365 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -131.86 159.51 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 107.561 -178.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -67.36 139.94 57.21 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -116.34 138.56 51.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.62 -45.91 84.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.955 1.41 . . . . 0.0 110.72 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 50.1 m -66.03 -48.56 70.7 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.875 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.538 ' HG3' HG21 ' A' ' 187' ' ' ILE . 32.9 mmt180 -82.08 -24.3 35.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.468 0.707 . . . . 0.0 110.949 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.3 22.27 73.7 Favored Glycine 0 N--CA 1.472 1.042 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.833 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -165.11 164.71 20.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.632 . . . . 0.0 110.005 -170.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -59.8 120.26 9.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 110.54 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.8 pp -134.36 169.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.546 1.138 . . . . 0.0 108.786 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 133' ' ' LYS . 15.6 mm -71.19 151.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 176' ' ' GLU . 53.3 mtpt -65.01 164.44 12.76 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.363 0.529 . . . . 0.0 112.046 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -126.18 74.19 0.42 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.899 -176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.598 0.759 . . . . 0.0 109.236 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 p . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.2 mp0 -52.66 -43.65 65.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.258 1.423 . . . . 0.0 112.47 -170.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.81 -49.37 68.5 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.139 0.899 . . . . 0.0 111.791 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 38.3 m -65.21 -36.93 85.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.895 0.878 . . . . 0.0 110.755 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 91' ' ' GLN . 44.3 mt -67.77 -45.76 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.576 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -54.41 -46.37 73.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.758 1.223 . . . . 0.0 111.2 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.6 m-80 -57.16 -49.96 74.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.769 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -63.72 -35.01 79.16 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 123.388 0.675 . . . . 0.0 111.603 -176.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 94' ' ' ILE . 93.9 mt -65.79 -44.48 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 t -65.66 -35.3 80.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.261 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.0 mm-40 -80.91 -49.79 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.903 0.481 . . . . 0.0 111.68 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -69.41 -21.52 63.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.413 1.085 . . . . 0.0 113.327 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.79 173.59 5.12 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -160.27 161.73 33.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.57 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -69.31 107.52 3.31 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 128' ' ' LYS . 92.8 t -72.64 99.32 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.298 0.57 . . . . 0.0 109.64 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 82.1 m -105.1 102.18 34.7 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.77 1.228 . . . . 0.0 108.014 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 11.3 Cg_endo -53.84 -27.56 44.25 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.693 2.929 . . . . 0.0 113.422 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.5 -40.52 70.13 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.548 0.739 . . . . 0.0 110.635 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.5 HH11 HD23 ' A' ' 110' ' ' LEU . 2.6 tmt_? -73.6 -44.19 57.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.553 0.741 . . . . 0.0 109.587 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 HH11 ' A' ' 109' ' ' ARG . 95.9 mt -71.72 -22.31 61.64 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.555 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 55.7 14.3 1.24 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 0.0 112.917 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.9 m -99.83 136.43 20.23 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 124.237 1.015 . . . . 0.0 108.663 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -53.95 150.42 30.72 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.929 2.419 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.6 mt -53.26 -49.34 67.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.251 1.02 . . . . 0.0 112.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.7 -35.5 76.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.148 0.979 . . . . 0.0 112.519 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.97 69.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.087 0.555 . . . . 0.0 111.623 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.514 ' HB ' HD23 ' A' ' 143' ' ' LEU . 22.9 pt -109.18 4.3 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.21 0.604 . . . . 0.0 111.038 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 4.6 tt0 -60.71 134.99 57.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 31.7 t -67.04 114.31 17.57 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.128 0.971 . . . . 0.0 108.807 175.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.526 ' HB2' HD21 ' A' ' 161' ' ' LEU . 73.9 Cg_endo -70.62 -9.14 25.19 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.616 2.211 . . . . 0.0 112.782 -176.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.5 -55.43 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.833 0.853 . . . . 0.0 109.669 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -98.9 -6.19 29.38 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.557 -170.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.55 34.37 20.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.054 0.942 . . . . 0.0 112.257 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.05 148.03 49.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.783 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.02 108.75 3.0 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 171.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 56.1 Cg_endo -68.69 154.93 70.4 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.562 2.174 . . . . 0.0 113.11 -167.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.0 pt-20 -81.91 -30.55 31.83 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.715 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -153.03 142.6 21.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.991 1.316 . . . . 0.0 108.471 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.7 177.69 40.17 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.301 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.28 161.29 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.695 1.598 . . . . 0.0 109.251 -173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 60.6 m-85 -106.47 116.65 32.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.878 0.471 . . . . 0.0 110.355 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 97.0 t -117.12 121.6 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 22.2 ptmt -73.25 114.23 11.21 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.57 0.7 . . . . 0.0 110.626 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -68.15 88.31 0.29 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.4 t -61.09 -41.62 97.0 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.391 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.85 -32.01 72.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.29 0.636 . . . . 0.0 110.956 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.59 36.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.597 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.2 m 84.79 45.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.14 1.776 . . . . 0.0 111.442 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 61.16 22.67 12.95 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.716 1.206 . . . . 0.0 112.274 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 185' ' ' ASN . 88.6 t -76.89 120.42 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.269 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 58.0 m -83.2 134.12 34.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.5 m -124.59 147.92 48.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 117' ' ' ILE . 26.8 tp -89.87 105.34 17.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.306 0.574 . . . . 0.0 110.513 -175.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 79.2 m-85 -102.74 133.63 47.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.561 1.144 . . . . 0.0 108.316 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.7 t70 -57.21 130.73 47.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.666 0.666 . . . . 0.0 109.378 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.34 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.733 0.813 . . . . 0.0 112.215 -171.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.99 63.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.799 0.44 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.96 76.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.686 0.794 . . . . 0.0 111.795 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -75.54 -38.73 59.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.3 t -62.96 -28.76 70.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.489 0.716 . . . . 0.0 111.03 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.5 tpm_? -63.84 -52.94 57.81 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 123.937 0.773 . . . . 0.0 110.218 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -57.64 -42.96 84.48 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.946 0.778 . . . . 0.0 111.359 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 166' ' ' ILE . 94.6 t -65.73 -44.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.829 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.01 -26.7 69.37 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.895 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 38.5 mm-40 -79.98 -30.29 39.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.95 20.78 35.36 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.454 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.94 150.66 78.44 Favored Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.216 1.006 . . . . 0.0 110.501 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.38 173.69 14.07 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.61 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.469 ' ND1' HG22 ' A' ' 162' ' ' THR . 59.6 t-80 -54.27 129.01 59.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.666 0.786 . . . . 0.0 110.366 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -62.06 -22.38 74.13 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.62 2.213 . . . . 0.0 113.673 -170.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 120' ' ' PRO . 60.5 mt -103.4 -53.16 2.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.745 0.418 . . . . 0.0 111.827 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.469 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -104.14 -8.33 19.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.08 22.45 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.468 1.107 . . . . 0.0 113.167 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -75.2 155.8 86.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.592 0.757 . . . . 0.0 109.984 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -58.35 115.23 2.39 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.403 2.069 . . . . 0.0 110.57 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.545 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.3 mt -63.31 131.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 t -153.66 162.11 41.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 109.923 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.92 65.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.145 0.978 . . . . 0.0 111.258 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.0 t -66.2 -48.31 71.07 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.1 0.96 . . . . 0.0 111.476 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.3 pt -88.92 -2.67 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.35 137.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.63 169.74 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 109.537 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 176' ' ' GLU . 52.1 mtmt -82.8 156.03 23.88 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.298 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -64.56 -23.65 67.34 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -87.9 -21.93 24.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.694 0.797 . . . . 0.0 109.892 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 7.1 tp10 -78.76 -17.05 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.069 0.948 . . . . 0.0 111.471 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.4 p -128.62 154.64 46.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.087 0.955 . . . . 0.0 109.33 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.435 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -135.83 164.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.374 1.069 . . . . 0.0 108.714 178.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 21.3 p90 -78.96 121.7 25.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -105.65 127.03 52.82 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.06 -40.31 75.16 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.313 -170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 t -74.32 -24.26 59.18 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-N 117.531 0.15 . . . . 0.0 111.222 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -80.25 -30.49 38.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.85 25.01 70.54 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.22 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 78.0 m-20 -156.24 160.98 40.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.275 -171.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 60.4 m-85 -74.13 126.73 31.21 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 168.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.1 pt -132.5 177.31 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.664 0.785 . . . . 0.0 110.066 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.03 143.89 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.548 0.739 . . . . 0.0 109.88 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.435 ' HG2' HD12 ' A' ' 178' ' ' ILE . 60.0 mtpt -66.59 157.41 32.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.163 0.585 . . . . 0.0 112.378 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -80.43 -91.77 0.47 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 125.385 1.474 . . . . 0.0 111.323 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.8 mp0 -49.62 -50.76 41.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.37 1.068 . . . . 0.0 112.154 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -38.24 75.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.523 0.729 . . . . 0.0 111.742 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.4 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 29.4 t -70.93 -43.63 67.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.87 0.868 . . . . 0.0 109.93 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 98' ' ' ILE . 73.6 mt -63.42 -50.23 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.41 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.64 -23.36 58.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.984 0.914 . . . . 0.0 112.036 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.42 -38.35 84.45 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -67.31 -37.32 83.15 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 123.05 0.54 . . . . 0.0 110.431 175.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 150' ' ' SER . 90.7 mt -65.49 -38.08 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.208 0.603 . . . . 0.0 110.125 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -60.84 -40.44 92.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.394 1.078 . . . . 0.0 111.74 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -86.76 -40.19 15.24 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.0 m -76.82 -16.49 59.42 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.634 0.774 . . . . 0.0 111.785 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -71.03 154.89 41.42 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.385 0.612 . . . . 0.0 111.15 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.74 161.02 42.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.696 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.6 m -65.53 96.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 110.039 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -77.08 97.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 m -110.65 107.22 58.12 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.18 -20.86 67.58 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.159 2.573 . . . . 0.0 113.016 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.92 -35.16 29.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.43 1.092 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.81 -49.0 13.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.974 0.509 . . . . 0.0 110.418 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.3 mt -69.05 -21.31 64.11 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.148 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 55.38 19.39 3.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 112.772 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.47 134.15 40.79 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.36 149.11 76.13 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.182 1.922 . . . . 0.0 110.632 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.8 mt -52.13 -43.68 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.7 0.8 . . . . 0.0 111.407 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.34 -37.7 81.49 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.759 0.824 . . . . 0.0 112.541 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.09 71.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.14 0.576 . . . . 0.0 111.107 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.5 pt -117.09 31.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.986 0.914 . . . . 0.0 110.005 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -70.86 128.59 36.52 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.837 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -74.78 109.95 8.6 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 162.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.94 -11.55 27.55 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 123.085 2.523 . . . . 0.0 112.694 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.82 -52.84 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.603 0.761 . . . . 0.0 109.123 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.9 p -92.7 -12.6 31.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.504 1.122 . . . . 0.0 112.573 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 61.42 37.8 16.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.858 0.863 . . . . 0.0 111.32 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.36 151.92 37.32 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 115.51 44.63 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 160.91 36.09 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.886 2.391 . . . . 0.0 113.458 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 12.5 pt-20 -87.87 -20.74 25.6 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.33 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.61 134.53 22.52 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 108.346 178.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.15 166.66 37.12 Favored Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.463 HG13 HG23 ' A' ' 132' ' ' VAL . 9.9 pt -124.87 155.46 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 0.0 109.386 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.61 115.07 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 130' ' ' ILE . 71.7 t -123.23 122.75 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -66.24 120.3 13.02 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.483 0.658 . . . . 0.0 110.962 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -72.7 84.25 1.18 Allowed 'General case' 0 C--O 1.249 1.065 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 161.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.7 t -67.76 -57.05 6.99 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.426 -168.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.02 -31.85 69.71 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.018 0.527 . . . . 0.0 111.42 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -63.38 4.66 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.035 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.2 m -149.92 5.68 0.59 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 65.73 21.32 11.56 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.187 0.995 . . . . 0.0 111.201 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.29 143.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.489 1.116 . . . . 0.0 109.291 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 31.1 p -86.21 140.52 30.06 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 117.921 0.328 . . . . 0.0 110.174 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.4 m -126.84 148.34 49.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.482 1.113 . . . . 0.0 108.184 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.8 tp -89.2 123.89 33.86 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.932 0.493 . . . . 0.0 109.87 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -120.76 132.89 55.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.104 0.961 . . . . 0.0 108.674 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.07 130.5 38.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.57 -46.36 77.21 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.079 0.862 . . . . 0.0 111.792 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.6 68.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.118 0.567 . . . . 0.0 111.619 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.62 62.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.696 0.798 . . . . 0.0 111.542 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.65 -41.85 64.99 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.803 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -63.5 -29.92 71.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.253 0.621 . . . . 0.0 110.867 176.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.8 tpm_? -61.53 -51.91 66.63 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 172.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -55.38 -43.93 75.6 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.295 0.997 . . . . 0.0 111.21 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 91' ' ' GLN . 46.5 t -67.44 -45.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.737 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.46 -27.6 66.09 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.306 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 19.1 mm-40 -78.65 -33.97 46.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.09 0.556 . . . . 0.0 110.828 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.81 28.52 11.02 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.73 144.12 28.95 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.669 1.188 . . . . 0.0 109.509 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.8 -177.83 4.08 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.795 2.33 . . . . 0.0 112.503 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' ND1' HG22 ' A' ' 162' ' ' THR . 57.4 t-80 -54.53 129.86 62.68 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.404 1.082 . . . . 0.0 110.902 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.24 -24.03 78.17 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.831 2.354 . . . . 0.0 114.087 -171.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.4 mt -103.06 -56.65 2.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.807 0.443 . . . . 0.0 111.882 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.413 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.6 t -102.52 -8.69 20.83 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.691 0.396 . . . . 0.0 111.384 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 63.5 24.71 14.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 0.0 112.546 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.0 154.82 90.77 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 114.11 2.95 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.017 1.811 . . . . 0.0 110.215 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.542 ' HA ' HD11 ' A' ' 170' ' ' ILE . 66.0 mt -63.05 134.75 28.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -149.37 163.39 37.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.074 0.95 . . . . 0.0 109.744 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.56 -18.09 65.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.851 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.5 t -70.96 -41.05 71.59 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 111.746 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -85.65 -11.41 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 130' ' ' ILE . 11.1 tt -99.61 133.43 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 188' ' ' ILE . 27.5 m -129.04 174.12 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.18 0.992 . . . . 0.0 110.18 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -94.17 164.35 13.09 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.229 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -57.29 -39.95 76.77 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.5 -4.64 57.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.146 0.43 . . . . 0.0 111.679 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -87.23 -21.93 25.54 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.515 0.674 . . . . 0.0 109.613 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.6 p -102.75 142.09 34.47 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 158.0 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 17.0 p90 -75.22 122.9 24.36 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -99.06 129.93 45.36 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -70.37 -34.71 72.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.385 1.053 . . . . 0.0 111.663 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 t -74.78 -28.4 60.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.214 0.206 . . . . 0.0 110.955 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 187' ' ' ILE . 37.4 mmt180 -82.14 -32.38 30.12 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 111.117 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.54 24.59 75.95 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.743 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -165.51 159.38 16.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.906 0.482 . . . . 0.0 109.876 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 90.7 m-85 -65.19 118.92 9.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.628 1.171 . . . . 0.0 111.111 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.429 HD13 ' HG3' ' A' ' 183' ' ' ARG . 21.8 pt -128.56 -179.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 108.06 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 172' ' ' VAL . 8.7 mm -83.57 156.26 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -62.54 153.79 30.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.974 0.91 . . . . 0.0 112.432 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.45 -20.95 28.17 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.791 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 123.914 0.885 . . . . 0.0 109.46 177.508 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -62.39 -43.45 98.78 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 124.629 1.172 . . . . 0.0 111.956 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -38.1 77.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.978 0.799 . . . . 0.0 111.984 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 49.6 m -66.9 -39.22 87.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.292 0.637 . . . . 0.0 110.711 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 58.0 mt -68.63 -41.88 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.605 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -56.87 -41.11 77.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.876 1.271 . . . . 0.0 110.887 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -61.39 -44.86 96.42 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.283 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -63.43 -39.65 95.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.964 0.506 . . . . 0.0 111.441 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 150' ' ' SER . 77.8 mt -65.3 -37.73 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.242 0.617 . . . . 0.0 110.333 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.1 t -62.3 -45.69 92.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.61 0.764 . . . . 0.0 111.789 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -78.17 -29.47 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.161 0.584 . . . . 0.0 112.187 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.8 -10.38 23.09 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.412 0.685 . . . . 0.0 112.496 -172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -74.24 160.17 31.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -152.1 160.26 43.47 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.361 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.7 t -66.78 100.06 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.083 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.75 107.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 84.1 m -118.69 87.11 31.36 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.816 0.847 . . . . 0.0 109.776 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HB3' HD11 ' A' ' 117' ' ' ILE . 1.7 Cg_endo -43.88 -45.75 11.18 Favored 'Trans proline' 0 C--N 1.385 2.452 1 C-N-CA 125.42 4.08 . . . . 0.0 115.129 -176.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -20.48 55.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.064 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -91.3 -31.91 15.92 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.918 0.487 . . . . 0.0 110.575 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.59 -20.17 61.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.588 0.755 . . . . 0.0 110.341 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 59.12 18.98 6.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.507 1.523 . . . . 0.0 112.237 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.5 m -100.35 138.11 20.13 Favored Pre-proline 0 C--O 1.245 0.836 0 C-N-CA 124.165 0.986 . . . . 0.0 108.877 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.18 157.51 34.62 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.426 2.084 . . . . 0.0 111.357 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 71.8 mt -55.98 -38.78 70.89 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.083 0.553 . . . . 0.0 111.373 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.12 -38.38 82.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.02 0.928 . . . . 0.0 112.825 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.87 66.86 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.086 0.554 . . . . 0.0 111.593 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 107' ' ' PRO . 26.5 pt -124.08 16.43 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.856 0.862 . . . . 0.0 111.107 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.42 125.39 24.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.204 1.002 . . . . 0.0 110.221 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.91 111.47 10.72 Favored Pre-proline 0 C--N 1.354 0.775 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.96 -3.99 14.74 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.741 2.294 . . . . 0.0 112.105 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -84.98 -58.55 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.895 0.878 . . . . 0.0 109.403 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 p -88.4 -13.0 41.61 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.721 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.99 33.63 17.17 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.584 0.754 . . . . 0.0 111.533 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.88 152.76 46.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -73.13 110.43 8.54 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 57.7 Cg_endo -68.08 153.84 73.96 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.434 2.756 . . . . 0.0 114.266 -167.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -80.48 -38.8 29.24 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.605 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.1 pttm -138.64 143.58 39.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.177 1.391 . . . . 0.0 107.459 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.94 166.25 37.43 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.278 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 98' ' ' ILE . 11.3 pt -121.64 155.27 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.985 1.314 . . . . 0.0 109.086 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.51 123.16 41.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.78 121.91 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.701 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -71.09 119.0 14.59 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.751 0.657 . . . . 0.0 110.775 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -74.03 81.73 1.73 Allowed 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.1 t -68.87 -28.53 66.78 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.386 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.29 -37.42 85.4 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.353 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.35 -65.0 2.56 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -178.5 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.984 0.914 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 61.98 23.27 13.68 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.178 0.991 . . . . 0.0 111.379 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.16 118.35 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 186' ' ' PHE . 20.6 p -84.36 138.87 32.64 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.41 0.624 . . . . 0.0 110.032 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.3 m -127.83 145.03 51.06 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.18 0.992 . . . . 0.0 108.785 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 117' ' ' ILE . 61.0 tp -88.28 111.54 21.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -105.44 138.03 42.29 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.661 1.184 . . . . 0.0 108.022 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.7 t70 -59.1 135.44 57.63 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.381 0.537 . . . . 0.0 109.722 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.89 92.27 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.74 0.816 . . . . 0.0 111.777 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.36 -35.17 65.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.544 0.528 . . . . 0.0 111.072 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 -48.33 59.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.626 0.77 . . . . 0.0 112.007 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 130' ' ' ILE . 44.2 t80 -70.0 -40.7 75.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.998 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.512 ' HB2' HG21 ' A' ' 98' ' ' ILE . 32.5 t -62.44 -32.31 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.564 0.54 . . . . 0.0 111.13 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 151' ' ' ARG . 1.4 tpm_? -64.65 -49.38 71.24 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 123.637 0.586 . . . . 0.0 110.401 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.69 -45.16 81.94 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.174 0.921 . . . . 0.0 111.182 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 84.3 t -61.92 -46.77 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.217 0.607 . . . . 0.0 110.209 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.73 -31.19 79.95 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.041 0.838 . . . . 0.0 113.228 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.61 -15.66 53.97 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.653 0.781 . . . . 0.0 111.662 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.87 31.87 38.33 Favored Glycine 0 N--CA 1.47 0.966 0 O-C-N 123.204 0.315 . . . . 0.0 112.551 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.7 mt -90.24 150.82 43.86 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.663 1.185 . . . . 0.0 110.025 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.52 -179.43 5.31 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.685 2.257 . . . . 0.0 113.088 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.417 ' ND1' HG22 ' A' ' 162' ' ' THR . 47.1 t-80 -56.76 127.14 73.48 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.174 0.99 . . . . 0.0 111.317 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.09 -1.74 8.46 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.995 2.464 . . . . 0.0 114.069 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.63 -64.52 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.689 0.395 . . . . 0.0 110.624 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.417 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.1 t -98.39 -4.64 34.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.984 -167.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 61.55 20.96 11.7 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.496 1.118 . . . . 0.0 112.906 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.19 152.28 73.56 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.514 0.726 . . . . 0.0 110.589 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.78 115.06 2.69 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.056 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 70.3 mt -63.27 130.8 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.744 0.417 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -141.53 162.69 34.86 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 109.571 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.38 66.24 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.409 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.4 m -64.91 -41.68 95.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.51 0.724 . . . . 0.0 112.065 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.9 pt -85.61 -7.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.33 135.5 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.12 0.873 . . . . 0.0 109.337 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 188' ' ' ILE . 31.1 m -133.19 179.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 109.844 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -101.66 164.96 11.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.837 0.455 . . . . 0.0 110.578 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.25 -15.61 33.18 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.32 -26.82 56.19 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.099 0.952 . . . . 0.0 109.339 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 28.9 p -105.02 161.07 14.53 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.933 165.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -137.33 162.98 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.386 0.674 . . . . 0.0 109.265 175.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -72.59 135.01 45.44 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 163.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.0 t70 -119.02 127.05 53.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.55 -43.69 47.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.8 t -76.58 -28.48 56.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.172 0.442 . . . . 0.0 110.808 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -72.03 -31.8 66.53 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.22 81.2 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.598 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -149.33 150.12 31.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.026 0.93 . . . . 0.0 110.232 -170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.584 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 35.3 m-85 -63.42 119.24 9.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.668 0.787 . . . . 0.0 109.968 168.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.2 pt -127.15 177.84 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 0.0 109.723 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' A' ' 133' ' ' LYS . 37.1 mm -85.83 151.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.386 0.674 . . . . 0.0 110.129 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.94 155.23 37.11 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.101 0.477 . . . . 0.0 111.743 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -100.22 -41.23 2.85 Favored Glycine 0 N--CA 1.467 0.745 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 124.814 1.246 . . . . 0.0 108.485 174.203 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -73.89 -40.49 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.448 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -41.47 67.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.927 0.891 . . . . 0.0 112.591 -168.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 41.4 t -65.7 -46.09 80.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.535 0.734 . . . . 0.0 110.04 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.5 mt -63.73 -41.14 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.128 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -59.8 -42.63 93.85 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.517 1.127 . . . . 0.0 110.622 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -61.87 -43.27 99.18 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.372 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -64.23 -31.32 72.47 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.242 0.617 . . . . 0.0 111.325 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.457 HG23 HD13 ' A' ' 130' ' ' ILE . 95.3 mt -70.42 -40.57 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.309 0.644 . . . . 0.0 109.671 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 t -65.57 -33.42 75.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.312 0.645 . . . . 0.0 111.292 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -74.95 -46.75 33.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.293 1.037 . . . . 0.0 112.327 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.593 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 71.0 m -82.33 -17.35 46.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.48 0.712 . . . . 0.0 112.845 -169.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -70.55 165.7 22.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.447 0.641 . . . . 0.0 112.603 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -156.41 159.65 38.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.381 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.6 m -66.97 102.58 1.0 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.626 0.579 . . . . 0.0 109.713 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.06 102.46 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.191 0.596 . . . . 0.0 110.148 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.1 m -112.29 106.84 55.86 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.158 0.983 . . . . 0.0 108.745 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HB3' HD11 ' A' ' 117' ' ' ILE . 24.1 Cg_endo -60.3 -18.95 55.49 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.3 2.667 . . . . 0.0 112.745 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.6 -35.9 70.66 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.557 0.743 . . . . 0.0 110.277 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -83.73 -49.47 9.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.084 0.554 . . . . 0.0 110.347 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.5 -23.18 65.44 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.381 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 54.02 21.02 2.69 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.434 1.094 . . . . 0.0 112.783 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -103.81 136.87 19.14 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.273 1.029 . . . . 0.0 108.337 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.9 154.16 28.15 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.753 2.302 . . . . 0.0 111.801 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.7 mt -49.88 -46.33 51.49 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.848 0.717 . . . . 0.0 111.271 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.35 -40.66 74.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.835 1.254 . . . . 0.0 113.038 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.46 66.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.762 0.825 . . . . 0.0 111.633 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.576 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.9 pt -114.63 7.68 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.211 1.005 . . . . 0.0 111.153 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 35.3 tt0 -68.18 136.05 53.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.146 0.978 . . . . 0.0 111.055 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 36.8 t -69.26 110.26 5.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 124.411 1.069 . . . . 0.0 108.405 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.72 -1.04 10.2 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.056 2.504 . . . . 0.0 112.735 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.493 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.5 mt -84.35 -52.83 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.142 1.377 . . . . 0.0 109.756 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -97.89 -9.34 26.48 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.322 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.9 37.37 15.27 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.193 0.997 . . . . 0.0 111.894 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.49 151.13 37.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.195 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.2 tm0? -71.04 118.12 62.69 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 94.9 Cg_endo -74.03 162.5 38.87 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.074 2.516 . . . . 0.0 114.07 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.639 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -82.47 -32.17 29.0 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.67 172.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.639 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.3 pttt -147.67 143.64 27.79 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.315 1.446 . . . . 0.0 107.345 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.69 160.6 33.79 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.183 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 98' ' ' ILE . 10.2 pt -114.37 152.36 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.833 1.653 . . . . 0.0 109.365 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -93.66 120.38 33.86 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 98.4 t -120.34 119.51 60.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -69.09 118.82 12.47 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.635 0.731 . . . . 0.0 110.417 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -70.19 81.38 0.52 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 163.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -67.34 -56.34 10.11 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.875 -168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.05 -28.42 68.2 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.533 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.98 -65.73 2.14 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.193 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 m -152.68 10.98 0.49 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.1 t70 66.39 14.42 9.69 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 124.047 0.939 . . . . 0.0 111.116 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.17 124.93 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.498 0.719 . . . . 0.0 110.037 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 26.1 p -84.56 132.79 34.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.0 m -121.48 147.0 46.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 117' ' ' ILE . 27.0 tp -92.85 105.15 17.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 85.4 m-85 -99.77 140.04 34.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.619 1.168 . . . . 0.0 107.895 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.4 t70 -61.04 140.84 57.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.646 0.657 . . . . 0.0 109.676 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.44 74.93 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.106 0.879 . . . . 0.0 111.276 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.92 67.34 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.344 0.657 . . . . 0.0 111.621 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -48.12 60.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.478 0.711 . . . . 0.0 112.026 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 41.7 t80 -71.17 -39.63 71.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.965 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.44 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -60.25 -35.44 75.51 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.822 0.701 . . . . 0.0 110.898 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 41.1 ttt85 -62.35 -53.41 55.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.016 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.74 -45.76 67.14 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.292 0.637 . . . . 0.0 112.054 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 48.7 t -61.79 -49.67 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.69 -18.93 70.72 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.849 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.1 mm-40 -82.48 -29.08 30.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.387 0.675 . . . . 0.0 109.857 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.11 23.9 16.19 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 64.5 mt -91.46 147.97 36.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.397 1.079 . . . . 0.0 110.047 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.15 -167.02 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.939 2.426 . . . . 0.0 112.165 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' ND1' HG22 ' A' ' 162' ' ' THR . 45.0 t-80 -62.55 126.5 88.39 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 109.784 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -10.2 28.12 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.844 2.363 . . . . 0.0 113.851 -171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.08 -64.97 1.01 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.923 0.489 . . . . 0.0 110.04 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.457 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -98.0 -5.06 34.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.291 0.636 . . . . 0.0 112.097 -167.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 62.66 21.64 12.84 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.526 1.13 . . . . 0.0 112.746 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -80.46 151.52 71.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.138 0.575 . . . . 0.0 111.009 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.2 118.91 5.81 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.521 2.147 . . . . 0.0 111.357 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 71.8 mt -64.93 135.02 28.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.349 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 t -148.78 163.36 37.59 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.844 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.96 -24.12 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.946 0.898 . . . . 0.0 111.356 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -64.74 -45.85 84.72 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.665 0.786 . . . . 0.0 111.928 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.5 pt -80.98 -8.43 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.95 130.39 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 118.713 0.688 . . . . 0.0 109.391 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.6 m -132.73 173.84 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.211 1.404 . . . . 0.0 109.882 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.593 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 52.6 mtpt -101.5 169.85 8.59 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.029 0.442 . . . . 0.0 110.754 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -59.23 -28.53 66.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.523 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -78.66 -33.02 47.41 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.529 0.732 . . . . 0.0 111.387 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.62 -15.32 42.88 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.189 0.519 . . . . 0.0 110.857 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 30.5 p -112.9 146.94 38.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.603 0.761 . . . . 0.0 109.044 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.68 154.16 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 37.9 p90 -67.78 134.99 51.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 165.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.504 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.6 t70 -112.83 133.99 54.56 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.93 -49.97 33.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.598 1.159 . . . . 0.0 112.099 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 t -71.33 -24.55 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.049 0.386 . . . . 0.0 111.184 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.464 ' HA ' ' HE ' ' A' ' 183' ' ' ARG . 2.3 mmp_? -84.87 -34.05 22.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.358 0.663 . . . . 0.0 110.718 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.19 73.39 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.96 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -148.05 143.68 27.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.364 1.066 . . . . 0.0 109.481 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 25.5 m-85 -68.64 115.97 8.62 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 180' ' ' ASP . 24.1 pt -122.91 178.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.307 1.043 . . . . 0.0 108.611 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 133' ' ' LYS . 38.3 mm -83.87 155.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -68.06 159.36 31.01 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 120.981 0.419 . . . . 0.0 110.39 174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 149.21 67.95 0.01 OUTLIER Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.676 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 55.3 t30 . . . . . 0 CA--C 1.556 1.205 0 C-N-CA 124.314 1.045 . . . . 0.0 111.623 -175.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.084 0.469 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -67.29 -39.83 86.04 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.774 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.54 -51.43 36.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -72.99 -43.18 62.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.473 0.309 . . . . 0.0 110.655 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.51 -49.35 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.476 0.71 . . . . 0.0 111.081 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.432 ' HA ' HD12 ' A' ' 98' ' ' ILE . 40.2 mt-30 -67.6 -29.55 68.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.567 0.747 . . . . 0.0 111.367 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 4.1 m-80 -62.35 -43.18 99.42 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 170.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -40.67 94.08 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 122.823 0.449 . . . . 0.0 110.078 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.499 HG23 HD13 ' A' ' 130' ' ' ILE . 94.9 mt -61.43 -38.32 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.732 0.813 . . . . 0.0 111.136 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.3 m -70.48 -32.56 70.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.136 0.574 . . . . 0.0 110.964 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 34.8 mt-30 -83.55 -39.42 20.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.105 0.562 . . . . 0.0 111.633 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -80.13 -19.97 46.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.545 -171.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -69.78 162.39 27.94 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 123.531 0.519 . . . . 0.0 110.877 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -148.11 159.65 43.71 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -68.34 97.97 0.79 Allowed 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.06 97.62 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 57.9 m -108.21 102.12 44.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.851 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 117' ' ' ILE . 12.9 Cg_endo -54.61 -29.75 62.27 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.666 2.91 . . . . 0.0 112.666 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 8.9 pt-20 -69.79 -35.42 74.86 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.635 1.174 . . . . 0.0 111.54 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.699 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 50.7 mtt180 -93.84 -36.4 12.26 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.669 0.787 . . . . 0.0 111.209 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.37 -18.43 62.37 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.705 0.802 . . . . 0.0 111.977 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 63.53 17.68 10.53 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.882 1.273 . . . . 0.0 111.483 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -104.46 129.48 24.96 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 124.309 1.044 . . . . 0.0 109.615 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.24 166.45 19.05 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.733 2.289 . . . . 0.0 111.748 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.7 mt -53.25 -47.14 69.31 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.737 0.648 . . . . 0.0 111.022 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -52.14 -43.38 64.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.98 0.912 . . . . 0.0 112.852 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.65 69.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.332 0.653 . . . . 0.0 111.415 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 107' ' ' PRO . 15.1 pt -122.01 29.42 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.905 0.882 . . . . 0.0 110.322 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -73.82 121.83 21.49 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.188 0.995 . . . . 0.0 109.439 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.1 t -68.74 114.95 25.97 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.28 -12.7 34.42 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.801 2.334 . . . . 0.0 112.755 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.61 -51.88 16.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.843 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.8 p -96.75 -19.54 18.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.348 1.059 . . . . 0.0 112.324 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 57.85 46.81 16.31 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.318 1.047 . . . . 0.0 111.823 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.46 152.64 38.41 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.802 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.25 113.38 27.78 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.75 167.04 18.97 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.009 2.473 . . . . 0.0 113.451 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.02 -23.45 26.79 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -143.46 140.69 30.49 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.102 1.361 . . . . 0.0 108.43 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.45 157.08 29.39 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.335 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 98' ' ' ILE . 7.1 pt -110.77 161.26 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.038 1.335 . . . . 0.0 109.775 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -104.89 118.17 35.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.588 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.5 t -114.67 125.55 72.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.3 ptmt -73.75 114.61 12.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 124.004 0.815 . . . . 0.0 110.037 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -71.95 80.45 0.91 Allowed 'General case' 0 C--O 1.247 0.943 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 36.7 t -64.8 -49.43 70.71 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.716 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.73 -27.96 68.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.564 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.43 2.58 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.366 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.0 m -161.53 17.91 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.464 0.706 . . . . 0.0 111.198 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 13.6 t70 67.03 22.09 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.394 1.078 . . . . 0.0 111.235 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 187' ' ' ILE . 90.5 t -96.19 134.67 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.319 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 55.9 m -87.0 139.83 30.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.624 0.77 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.2 m -127.28 147.72 50.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.249 1.02 . . . . 0.0 108.853 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 tp -85.28 112.48 20.81 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.03 0.443 . . . . 0.0 110.222 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.47 137.17 46.86 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -58.34 137.43 57.2 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.177 0.444 . . . . 0.0 109.95 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.42 85.97 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.159 0.912 . . . . 0.0 111.15 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.54 -34.29 62.94 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.783 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.8 -44.09 61.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 112.118 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -73.48 -39.0 65.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.761 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -63.08 -37.98 89.37 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.583 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 48.4 ttt180 -53.64 -53.2 55.32 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.765 0.666 . . . . 0.0 109.481 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.26 -42.52 73.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.01 0.819 . . . . 0.0 111.829 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 149' ' ' PHE . 58.8 t -64.57 -46.9 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.416 0.448 . . . . 0.0 110.091 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.38 -36.06 91.93 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.825 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 45.3 mt-10 -75.95 -27.47 57.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.644 0.777 . . . . 0.0 110.819 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.79 20.44 34.02 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.747 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.86 144.16 47.62 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.035 0.934 . . . . 0.0 109.573 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.83 -170.3 0.88 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.992 2.462 . . . . 0.0 112.422 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.478 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.4 t-80 -62.5 126.81 89.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.571 0.749 . . . . 0.0 109.343 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.87 -14.87 39.71 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.23 1.954 . . . . 0.0 113.331 -170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.8 mt -96.12 -66.01 0.93 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 122.589 0.356 . . . . 0.0 110.886 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.478 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.0 t -90.51 -10.1 44.84 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 63.31 16.81 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.755 1.222 . . . . 0.0 112.843 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -80.12 144.69 59.2 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 122.87 12.37 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.702 2.268 . . . . 0.0 111.544 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.405 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -62.25 131.85 27.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 123.54 0.525 . . . . 0.0 110.104 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -143.77 161.95 37.29 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.89 0.876 . . . . 0.0 109.172 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -66.57 -23.04 66.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.665 174.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.2 m -69.44 -22.35 63.67 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.018 0.927 . . . . 0.0 112.728 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 48.0 pt -105.9 -2.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.8 tt -97.79 140.53 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.394 -0.816 . . . . 0.0 109.887 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.553 HG11 HD12 ' A' ' 188' ' ' ILE . 27.3 m -141.35 -179.89 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.793 1.237 . . . . 0.0 110.049 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.7 168.63 10.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.641 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 83.9 t60 -68.02 -24.89 65.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.842 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.12 -22.2 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.766 0.426 . . . . 0.0 110.68 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -85.63 -21.54 28.38 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.218 0.533 . . . . 0.0 111.042 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.2 p -101.65 145.45 29.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 167.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -128.7 143.64 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -65.85 102.05 0.73 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -72.75 124.19 24.85 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.63 -34.59 67.44 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.189 0.996 . . . . 0.0 111.585 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.8 t -80.32 -25.43 39.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.119 0.168 . . . . 0.0 111.159 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -100.98 -14.63 17.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.811 0.445 . . . . 0.0 111.53 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.48 79.76 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.156 -0.802 . . . . 0.0 114.942 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -165.79 162.49 18.55 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 117.694 0.747 . . . . 0.0 110.47 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 83.9 m-85 -59.92 125.76 24.9 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 111.754 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -133.34 169.51 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.443 1.097 . . . . 0.0 109.134 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.553 HD12 HG11 ' A' ' 172' ' ' VAL . 42.6 mm -70.88 140.3 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.421 0.688 . . . . 0.0 110.733 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -63.75 165.32 8.58 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.561 0.696 . . . . 0.0 111.884 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.98 -24.66 24.44 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.513 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 124.139 0.975 . . . . 0.0 108.942 176.939 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.864 0.84 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 21.2 mp0 -79.6 -33.9 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.47 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.27 -55.5 12.49 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 113.48 -164.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -66.27 -34.79 78.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.281 0.632 . . . . 0.0 111.092 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 98' ' ' ILE . 67.1 mt -69.62 -45.18 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.697 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -57.89 -44.1 86.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.853 1.261 . . . . 0.0 111.214 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.07 -45.42 87.12 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.702 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG2' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -66.82 -34.11 77.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.948 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.8 mt -65.84 -43.08 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.2 t -65.03 -33.94 77.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.792 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -77.77 -44.93 26.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.281 0.632 . . . . 0.0 111.829 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 82.8 m -76.61 -20.98 56.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.705 0.802 . . . . 0.0 112.675 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -71.08 168.27 17.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.645 0.736 . . . . 0.0 112.606 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -158.78 160.57 36.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.446 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.3 m -69.1 99.16 1.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.706 0.628 . . . . 0.0 109.469 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.32 119.89 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.411 0.685 . . . . 0.0 110.091 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 79.5 m -133.73 101.82 12.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.007 0.923 . . . . 0.0 109.386 -176.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 10.8 Cg_endo -52.39 -23.28 18.23 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.891 3.061 . . . . 0.0 114.008 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.9 pt-20 -73.14 -38.13 66.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.708 0.803 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 90.9 mtt-85 -93.43 -21.7 19.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.689 0.796 . . . . 0.0 111.514 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.17 -20.91 26.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.621 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 59.7 24.23 13.11 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.299 1.04 . . . . 0.0 111.46 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.4 m -110.31 137.21 20.56 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.128 0.971 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.1 162.67 28.65 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.275 1.983 . . . . 0.0 111.488 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 93.8 mt -54.26 -46.25 72.6 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.477 0.711 . . . . 0.0 111.289 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.13 -41.72 72.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.051 0.94 . . . . 0.0 112.694 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.98 68.88 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.579 0.752 . . . . 0.0 111.993 -175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 pt -122.95 30.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.039 0.936 . . . . 0.0 109.81 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.4 tt0 -78.62 134.98 37.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.442 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 18.7 t -71.49 114.94 32.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 109.185 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.36 -4.8 16.04 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.936 2.424 . . . . 0.0 113.497 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.498 HG12 ' HG3' ' A' ' 160' ' ' PRO . 59.7 mt -80.3 -53.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.87 0.868 . . . . 0.0 109.311 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -95.12 -11.01 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.148 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.63 37.06 19.49 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.986 0.914 . . . . 0.0 111.53 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.45 148.92 29.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.289 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -72.05 118.64 68.88 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.282 0.633 . . . . 0.0 109.444 175.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.72 161.89 18.95 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.769 2.313 . . . . 0.0 113.493 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -88.02 -14.13 39.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.049 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -151.7 134.21 15.41 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.844 0.858 . . . . 0.0 109.93 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.23 165.38 38.55 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.31 -172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 143' ' ' LEU . 9.2 pt -114.41 158.97 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.654 1.582 . . . . 0.0 110.395 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.04 123.65 44.52 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 90.5 t -118.86 119.95 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.1 ptmt -74.83 114.15 12.95 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 123.763 0.664 . . . . 0.0 110.047 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -73.39 72.96 1.35 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 171.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 35.1 t -68.13 -55.41 12.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.819 -167.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -58.32 -34.39 70.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.178 0.991 . . . . 0.0 112.14 -173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.98 -62.4 2.36 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.637 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.9 t -149.33 3.93 0.59 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 22.9 t70 59.33 47.23 11.62 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.792 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.08 124.6 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 122.948 0.499 . . . . 0.0 110.26 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 65.1 m -84.21 128.68 34.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.251 0.621 . . . . 0.0 109.66 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.0 m -122.8 143.39 49.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.347 1.059 . . . . 0.0 109.66 -171.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 130' ' ' ILE . 46.9 tp -88.91 106.34 18.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.237 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 89.2 m-85 -99.43 149.96 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 12.1 t70 -65.73 137.54 57.34 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.59 -52.96 62.84 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.985 0.803 . . . . 0.0 111.707 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.44 56.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.112 0.565 . . . . 0.0 111.966 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.6 -36.63 60.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.182 0.593 . . . . 0.0 110.771 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.6 t80 -73.14 -38.43 66.27 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -61.51 -31.52 71.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.923 0.889 . . . . 0.0 110.839 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.0 tpm_? -63.21 -54.26 40.25 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.947 0.779 . . . . 0.0 109.564 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.3 mt -54.8 -47.0 74.57 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.252 0.97 . . . . 0.0 111.376 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 166' ' ' ILE . 99.4 t -60.67 -50.47 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.801 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -59.94 -32.83 76.38 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 124.112 0.883 . . . . 0.0 113.371 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 28.6 mm-40 -75.86 -30.93 59.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.392 0.677 . . . . 0.0 111.187 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.71 9.42 49.75 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.243 -171.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.74 139.76 74.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.934 0.894 . . . . 0.0 109.201 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.48 -164.55 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.404 2.07 . . . . 0.0 112.242 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.79 131.25 92.92 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.321 1.049 . . . . 0.0 110.143 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.498 ' HG3' HG12 ' A' ' 121' ' ' ILE . 72.1 Cg_endo -70.96 -24.7 23.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.296 1.998 . . . . 0.0 113.265 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -85.23 -59.21 2.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.966 0.506 . . . . 0.0 111.051 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -108.27 -7.86 15.84 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.939 -167.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 65.86 19.12 11.27 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.629 1.172 . . . . 0.0 112.247 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -71.36 144.42 89.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.174 0.589 . . . . 0.0 110.117 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.37 116.5 3.79 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.406 2.071 . . . . 0.0 110.816 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 153' ' ' VAL . 77.3 mt -61.21 132.91 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.66 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -147.15 164.79 31.97 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.278 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -65.46 -24.62 67.21 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.541 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.8 t -69.3 -26.11 64.57 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.942 0.897 . . . . 0.0 112.333 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.4 pt -100.69 -6.1 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 118.317 0.508 . . . . 0.0 112.236 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.2 tt -100.7 136.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.05 0.841 . . . . 0.0 109.773 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.04 171.57 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.142 1.377 . . . . 0.0 110.829 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 43.9 mtmt -92.95 164.2 13.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.402 0.681 . . . . 0.0 110.595 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -66.1 -33.54 76.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.703 0.801 . . . . 0.0 111.61 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -80.28 -20.24 44.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.308 0.643 . . . . 0.0 110.848 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -84.8 -27.95 26.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.974 0.91 . . . . 0.0 110.998 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.3 p -105.7 151.67 24.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -136.78 158.95 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.166 0.987 . . . . 0.0 108.457 177.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -64.6 130.36 43.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.538 ' HB2' HG13 ' A' ' 187' ' ' ILE . 11.3 t70 -106.13 135.6 47.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.97 -50.68 10.74 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.363 1.039 . . . . 0.0 111.816 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -72.38 -26.4 61.88 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.795 0.27 . . . . 0.0 111.64 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -93.01 -28.65 16.26 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.892 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.15 28.51 44.77 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.489 0.493 . . . . 0.0 114.176 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -169.84 161.8 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.167 0.484 . . . . 0.0 110.313 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 88.5 m-85 -60.33 124.41 20.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.746 1.219 . . . . 0.0 111.879 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' A' ' 180' ' ' ASP . 2.8 pp -139.14 177.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.165 1.386 . . . . 0.0 109.31 174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.0 mm -77.16 146.0 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.319 0.648 . . . . 0.0 110.569 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.08 162.05 9.99 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.502 0.721 . . . . 0.0 112.05 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.88 66.97 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.0 t30 . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 126.006 1.722 . . . . 0.0 107.994 -166.574 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 119.791 -0.147 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 18.3 mp0 -59.74 -50.58 73.26 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.693 0.797 . . . . 0.0 110.641 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -30.21 70.97 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.416 0.286 . . . . 0.0 111.605 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -71.6 -48.03 50.8 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.169 0.588 . . . . 0.0 109.614 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.6 mt -60.03 -50.26 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.9 0.88 . . . . 0.0 110.217 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.478 ' HA ' HD12 ' A' ' 98' ' ' ILE . 43.6 mt-30 -69.49 -28.36 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.309 1.044 . . . . 0.0 111.649 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.45 -44.26 96.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.32 -33.19 74.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.428 0.691 . . . . 0.0 110.886 177.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 95' ' ' GLN . 92.2 mt -63.17 -45.08 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 122.942 0.497 . . . . 0.0 109.73 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 m -65.51 -29.74 70.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.664 0.786 . . . . 0.0 112.52 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.98 -46.25 16.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.93 0.492 . . . . 0.0 111.819 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.1 -19.59 50.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.824 0.85 . . . . 0.0 112.878 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -67.27 172.24 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -156.47 157.09 34.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.974 172.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m -70.21 102.07 2.02 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.47 98.22 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.287 0.635 . . . . 0.0 109.797 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.6 m -103.48 103.23 34.48 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.992 0.917 . . . . 0.0 109.005 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HB3' HD11 ' A' ' 117' ' ' ILE . 29.8 Cg_endo -60.22 -28.9 87.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.243 2.629 . . . . 0.0 112.506 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.66 -33.52 75.84 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.833 0.853 . . . . 0.0 110.756 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -88.12 -46.57 9.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.961 -174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.1 -22.98 63.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.366 0.666 . . . . 0.0 111.274 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 57.58 13.46 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.56 1.144 . . . . 0.0 113.662 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.59 133.92 31.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-O 118.289 -0.862 . . . . 0.0 108.752 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.34 149.29 23.23 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.983 2.455 . . . . 0.0 112.623 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.6 -46.7 63.64 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.114 0.966 . . . . 0.0 111.865 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.04 -36.83 78.15 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.865 0.866 . . . . 0.0 112.271 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.29 68.43 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.491 0.717 . . . . 0.0 111.459 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 107' ' ' PRO . 17.9 pt -107.65 5.34 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 110.807 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.9 128.15 35.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.428 1.091 . . . . 0.0 110.855 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.0 t -64.0 110.32 3.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.75 -3.07 13.14 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.814 2.342 . . . . 0.0 112.43 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.541 HG12 ' HG3' ' A' ' 160' ' ' PRO . 36.7 mt -81.04 -53.25 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.866 0.867 . . . . 0.0 109.197 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.1 p -96.32 -10.22 28.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.96 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.21 53.32 10.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.758 1.223 . . . . 0.0 111.449 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.12 160.59 38.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.026 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -73.76 120.3 80.53 Favored Pre-proline 0 CA--C 1.559 1.3 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 73.9 Cg_endo -76.05 157.97 38.22 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.203 2.602 . . . . 0.0 113.829 -173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 10.7 pt-20 -81.24 -36.77 29.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.365 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.9 pttm -145.25 148.44 33.49 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.504 1.522 . . . . 0.0 107.369 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.04 159.81 32.65 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.302 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -113.98 166.45 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.527 1.531 . . . . 0.0 109.685 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -106.07 125.88 51.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.421 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 70.8 t -115.82 124.6 72.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.1 ptmt -74.92 104.44 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.904 0.859 . . . . 0.0 110.288 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -78.53 71.47 5.0 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 4.9 t -69.36 -26.89 64.9 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.419 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.7 -39.83 95.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.271 1.028 . . . . 0.0 110.709 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.39 -63.99 3.04 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -176.34 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.192 0.997 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 18.4 t70 62.44 27.26 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.412 1.085 . . . . 0.0 110.804 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.98 109.21 9.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.035 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 186' ' ' PHE . 58.4 m -83.49 119.62 24.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.3 m -118.86 145.33 45.78 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -170.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' HB ' ' A' ' 117' ' ' ILE . 31.1 tp -86.63 103.9 15.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.484 0.659 . . . . 0.0 110.58 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 92.8 m-85 -102.84 133.4 47.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 107.905 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.5 t70 -56.59 134.17 54.18 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.605 0.639 . . . . 0.0 109.653 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.48 -44.75 80.93 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.018 0.824 . . . . 0.0 111.555 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.63 40.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.861 0.465 . . . . 0.0 111.758 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.45 38.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.44 0.696 . . . . 0.0 111.705 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.0 t80 -74.26 -39.48 62.98 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -61.66 -35.03 76.78 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.938 0.774 . . . . 0.0 110.961 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 10.7 tpt180 -57.3 -52.16 66.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.16 0.584 . . . . 0.0 109.499 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.8 mt -54.8 -41.93 71.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.041 0.838 . . . . 0.0 111.956 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 166' ' ' ILE . 21.9 t -69.02 -41.34 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 123.939 0.774 . . . . 0.0 109.768 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.93 -29.16 73.41 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.174 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -84.01 -24.21 30.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.213 0.605 . . . . 0.0 110.784 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 19.79 56.55 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.842 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.1 147.48 73.25 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.078 0.951 . . . . 0.0 110.668 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.53 175.87 10.8 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.411 2.074 . . . . 0.0 111.91 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -55.43 131.81 70.43 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.417 1.087 . . . . 0.0 111.114 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HG3' HG12 ' A' ' 121' ' ' ILE . 71.7 Cg_endo -69.08 -17.82 40.47 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.413 2.075 . . . . 0.0 113.822 -169.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.05 -62.32 1.25 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.875 0.47 . . . . 0.0 111.302 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 t -104.99 -7.21 19.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.753 -168.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.29 26.11 14.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.54 1.136 . . . . 0.0 112.201 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.17 154.69 92.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.033 0.933 . . . . 0.0 110.116 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.07 113.36 2.58 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 121.919 1.746 . . . . 0.0 109.799 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.573 HG21 HG22 ' A' ' 153' ' ' VAL . 61.0 mt -60.87 122.58 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.2 t -147.32 162.41 39.01 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.809 0.844 . . . . 0.0 109.493 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -72.24 -14.88 61.89 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.84 0.456 . . . . 0.0 110.973 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.9 m -70.12 -30.61 67.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.729 0.812 . . . . 0.0 111.921 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.9 pt -99.5 -8.4 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 168' ' ' ALA . 8.4 tt -88.39 138.66 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.34 168.21 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.577 0.751 . . . . 0.0 111.135 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -90.35 153.27 20.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.812 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -65.02 -23.72 67.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -85.31 -21.96 28.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.57 0.748 . . . . 0.0 110.441 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.41 -17.86 37.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.993 . . . . 0.0 111.247 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 23.9 p -130.35 152.8 49.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.432 1.093 . . . . 0.0 109.325 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.414 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -138.93 164.88 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.746 1.218 . . . . 0.0 109.104 -177.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 5.3 p90 -73.84 128.45 35.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.495 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.2 t70 -106.63 140.2 39.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -79.22 -48.66 13.8 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.756 0.822 . . . . 0.0 112.523 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.478 HG23 ' HE ' ' A' ' 183' ' ' ARG . 10.1 t -71.29 -24.68 62.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.472 0.578 . . . . 0.0 111.544 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HE ' HG23 ' A' ' 182' ' ' THR . 5.0 mmp_? -81.2 -32.51 33.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 170.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.05 22.12 74.67 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.704 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -167.6 162.37 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.102 0.961 . . . . 0.0 108.87 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 70.7 m-85 -64.11 128.69 36.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.477 1.111 . . . . 0.0 112.012 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 180' ' ' ASP . 29.4 pt -132.57 177.35 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.644 1.177 . . . . 0.0 109.65 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 133' ' ' LYS . 48.7 mm -75.42 151.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.18 0.592 . . . . 0.0 109.6 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.5 mtpm? -73.13 159.31 33.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.102 0.561 . . . . 0.0 111.369 175.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -42.07 6.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.363 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 124.026 0.93 . . . . 0.0 109.122 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.412 ' HG3' HG12 ' A' ' 153' ' ' VAL . 16.3 mp0 -53.0 -47.68 68.08 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.736 0.814 . . . . 0.0 112.547 -176.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -44.82 78.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.744 0.652 . . . . 0.0 111.473 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.9 t -67.03 -43.52 82.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 98' ' ' ILE . 63.6 mt -64.24 -44.54 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 123.713 0.633 . . . . 0.0 110.114 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.77 -44.05 90.55 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.526 1.13 . . . . 0.0 110.727 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.725 173.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.1 -35.49 81.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.714 0.805 . . . . 0.0 111.222 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 94' ' ' ILE . 94.3 mt -65.47 -41.36 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.6 t -64.27 -40.18 95.46 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.46 0.704 . . . . 0.0 111.69 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -80.39 -28.42 37.9 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.574 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 84.1 m -96.51 -18.08 20.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.121 0.568 . . . . 0.0 112.362 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.84 169.15 16.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 111.47 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -155.8 158.03 37.45 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m -68.05 96.53 0.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.03 100.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.235 0.614 . . . . 0.0 110.178 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.1 m -101.82 99.17 11.26 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.099 0.96 . . . . 0.0 108.581 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.75 -36.08 98.53 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.833 2.355 . . . . 0.0 112.331 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.16 -22.49 59.4 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.145 0.903 . . . . 0.0 111.87 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.8 mmp_? -91.72 -42.31 10.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.101 0.56 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.535 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 96.9 mt -64.8 -19.21 65.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.654 0.782 . . . . 0.0 112.391 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 55.98 22.37 5.75 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.331 1.052 . . . . 0.0 112.442 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.619 ' HG ' ' HZ ' ' A' ' 186' ' ' PHE . 55.8 m -95.24 141.54 23.36 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 123.9 0.88 . . . . 0.0 109.698 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.96 145.95 75.86 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.028 1.819 . . . . 0.0 110.236 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 99.5 mt -51.47 -43.82 62.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.967 0.907 . . . . 0.0 112.398 -173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.75 -36.8 79.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.61 0.764 . . . . 0.0 112.855 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.2 64.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.939 0.496 . . . . 0.0 110.865 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.04 27.92 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.943 0.897 . . . . 0.0 110.361 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -85.69 129.3 34.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.298 0.639 . . . . 0.0 109.35 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 t -68.74 111.9 9.7 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.25 0.46 9.37 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.748 2.299 . . . . 0.0 112.669 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -84.61 -55.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.702 0.801 . . . . 0.0 108.85 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.0 p -92.84 -8.83 42.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.828 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.56 39.74 21.18 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.545 1.138 . . . . 0.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.39 152.17 31.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.77 117.83 51.81 Favored Pre-proline 0 CA--C 1.557 1.246 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.73 166.31 23.76 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.084 2.523 . . . . 0.0 113.688 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.5 pt-20 -86.28 -28.0 24.04 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.846 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.52 145.41 31.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.089 1.356 . . . . 0.0 107.753 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.49 166.89 39.71 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.356 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 143' ' ' LEU . 10.1 pt -115.03 153.82 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 125.298 1.439 . . . . 0.0 109.496 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -97.04 122.15 39.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 79.6 t -114.68 123.73 70.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.5 ptmt -69.04 107.44 3.15 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -73.36 89.66 1.62 Allowed 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -63.62 -36.73 84.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.173 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.5 -26.6 66.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.41 0.684 . . . . 0.0 110.818 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.4 13.83 43.92 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.462 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.0 m 77.26 44.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.31 1.444 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.89 24.46 14.47 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.607 1.163 . . . . 0.0 112.264 174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 187' ' ' ILE . 98.0 t -79.94 125.53 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.171 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.4 129.62 34.77 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.632 0.773 . . . . 0.0 110.295 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.4 m -123.77 139.74 53.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.184 0.994 . . . . 0.0 109.002 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 130' ' ' ILE . 45.1 tp -89.27 111.31 22.09 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.372 0.42 . . . . 0.0 110.061 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 84.5 m-85 -103.79 141.71 35.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.413 1.085 . . . . 0.0 108.243 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.52 132.26 51.87 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.781 0.675 . . . . 0.0 111.834 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.57 55.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.889 0.476 . . . . 0.0 111.455 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.13 69.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.72 0.808 . . . . 0.0 111.561 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.7 t80 -74.32 -40.41 62.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.543 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -63.84 -30.51 71.6 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.464 0.706 . . . . 0.0 111.011 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -62.43 -52.23 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.781 0.833 . . . . 0.0 109.686 172.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.43 -47.62 81.28 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 123.735 0.647 . . . . 0.0 111.228 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 166' ' ' ILE . 97.2 t -61.15 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.269 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.54 92.45 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 124.069 0.856 . . . . 0.0 112.943 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -73.46 -23.31 60.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.168 0.587 . . . . 0.0 111.503 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.06 18.98 37.78 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.375 0.422 . . . . 0.0 112.872 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.0 149.4 70.03 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.734 1.213 . . . . 0.0 110.497 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.85 -174.44 2.23 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.984 2.456 . . . . 0.0 112.466 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.44 ' ND1' HG22 ' A' ' 162' ' ' THR . 53.7 t-80 -64.55 127.54 92.45 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.821 0.848 . . . . 0.0 109.082 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.31 -17.92 49.91 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.217 1.945 . . . . 0.0 113.217 -168.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.0 mt -95.46 -62.83 1.23 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.184 0.594 . . . . 0.0 111.15 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.44 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.9 t -91.42 -11.67 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.527 0.331 . . . . 0.0 111.492 -172.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 59.63 23.43 12.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.119 1.368 . . . . 0.0 112.838 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 162' ' ' THR . 46.0 mm-40 -91.68 154.93 44.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.739 0.816 . . . . 0.0 109.77 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.91 123.53 12.42 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.438 2.092 . . . . 0.0 112.068 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 153' ' ' VAL . 81.2 mt -63.33 136.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.149 0.58 . . . . 0.0 109.952 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -147.33 161.51 40.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.371 0.668 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -68.61 -19.87 64.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.403 1.081 . . . . 0.0 110.997 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -69.58 -24.96 63.76 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.954 0.902 . . . . 0.0 112.561 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 49.4 pt -105.21 -5.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 168' ' ' ALA . 9.6 tt -96.94 132.13 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.881 0.764 . . . . 0.0 109.486 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.33 175.4 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.311 1.044 . . . . 0.0 110.06 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 95.5 mttt -96.77 165.74 11.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.615 0.366 . . . . 0.0 110.662 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -63.53 -27.01 68.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.372 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -77.93 -27.18 49.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.66 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -85.88 -20.52 28.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.965 0.906 . . . . 0.0 111.785 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.1 p -117.41 150.96 38.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.01 0.924 . . . . 0.0 109.574 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 160.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.196 0.999 . . . . 0.0 108.753 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.94 140.12 57.84 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.33 139.41 53.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.879 0.471 . . . . 0.0 110.008 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.42 -52.69 9.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.331 1.052 . . . . 0.0 111.64 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -74.72 -26.71 59.99 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -80.83 -33.54 34.54 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.542 0.737 . . . . 0.0 109.824 169.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.74 25.89 48.14 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.626 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.34 170.73 2.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.228 0.611 . . . . 0.0 111.043 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.619 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 89.9 m-85 -61.88 122.05 14.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.692 1.197 . . . . 0.0 111.527 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.9 pp -134.71 173.95 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.713 1.205 . . . . 0.0 109.904 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 133' ' ' LYS . 43.8 mm -73.54 143.74 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.726 0.81 . . . . 0.0 110.684 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -66.12 150.56 48.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.484 0.713 . . . . 0.0 112.05 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -103.93 -20.92 10.04 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.379 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 CA--C 1.552 1.053 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.653 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.827 0.346 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 16.2 mp0 -84.86 -29.08 25.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.269 0.627 . . . . 0.0 111.254 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.81 -49.37 49.06 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.232 1.013 . . . . 0.0 113.334 -164.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.508 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 17.2 m -70.29 -41.04 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.277 0.631 . . . . 0.0 109.95 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.7 mt -66.12 -45.33 90.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.381 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -57.69 -46.14 84.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.854 1.261 . . . . 0.0 110.704 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.74 -37.39 86.37 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.024 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -66.39 -44.4 83.17 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 123.216 0.606 . . . . 0.0 110.224 177.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.5 mt -60.49 -39.0 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 109.666 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -67.32 -41.08 85.88 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.132 0.973 . . . . 0.0 111.011 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -83.19 -14.56 53.15 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.672 0.789 . . . . 0.0 112.984 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 93.5 m -103.55 -25.37 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.309 0.644 . . . . 0.0 112.601 -173.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -68.92 166.09 18.58 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -156.72 158.05 36.22 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.373 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.5 m -67.07 100.65 0.78 Allowed 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.706 0.802 . . . . 0.0 109.47 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.75 101.61 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.0 m -112.33 96.87 37.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HB3' HD11 ' A' ' 117' ' ' ILE . 8.0 Cg_endo -50.86 -23.52 11.88 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.938 3.092 . . . . 0.0 113.927 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.59 -30.18 59.51 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -93.47 -40.19 10.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.392 0.677 . . . . 0.0 111.135 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.06 -24.33 64.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.067 0.547 . . . . 0.0 110.237 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 45.41 50.42 10.11 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 124.889 1.276 . . . . 0.0 111.698 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.6 m -124.3 148.72 58.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.391 1.076 . . . . 0.0 110.038 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.67 141.67 97.45 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.348 2.032 . . . . 0.0 110.772 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 52.4 mt -55.06 -37.82 67.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.831 0.852 . . . . 0.0 111.666 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.01 -38.13 81.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.785 0.834 . . . . 0.0 112.192 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.27 66.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.065 0.546 . . . . 0.0 111.014 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 107' ' ' PRO . 33.3 pt -116.12 26.59 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.235 1.014 . . . . 0.0 110.302 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.57 127.54 33.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.308 1.043 . . . . 0.0 110.15 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 t -74.38 110.83 10.51 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.9 -2.75 12.68 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.78 2.32 . . . . 0.0 112.947 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.0 mt -85.12 -57.33 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.769 0.828 . . . . 0.0 109.499 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p -80.37 -23.67 40.32 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.024 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 62.74 49.9 3.58 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.124 0.964 . . . . 0.0 110.291 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.45 154.33 34.2 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.214 171.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -72.05 112.17 13.46 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.9 Cg_endo -71.32 159.78 50.73 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.205 2.604 . . . . 0.0 114.459 -167.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 6.4 pt-20 -80.81 -39.84 25.99 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.683 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -146.57 146.23 30.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.801 1.24 . . . . 0.0 108.044 178.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.35 42.36 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.461 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.2 pt -122.54 159.81 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.719 1.608 . . . . 0.0 109.197 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 141' ' ' CYS . 40.7 m-85 -104.85 119.8 39.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 170.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.3 121.43 66.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.653 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.9 ptmt -64.35 127.26 30.72 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 124.099 0.874 . . . . 0.0 112.77 -172.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -76.86 72.72 3.47 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -42.9 99.74 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.417 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.65 -40.38 92.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.502 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.63 -66.54 2.1 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.68 -171.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' VAL . 42.7 m -161.3 22.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.162 0.585 . . . . 0.0 111.569 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.42 31.33 17.23 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.884 1.326 . . . . 0.0 110.314 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.614 ' HA ' HG22 ' A' ' 187' ' ' ILE . 60.0 t -81.72 177.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.413 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' PHE . 26.4 p -134.3 140.78 46.64 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.401 HG21 HD11 ' A' ' 161' ' ' LEU . 89.5 m -118.94 146.34 45.04 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.06 109.38 20.44 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.235 0.541 . . . . 0.0 110.67 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.24 130.72 54.71 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 108.173 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.1 t70 -55.56 132.11 47.87 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.889 0.768 . . . . 0.0 109.17 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.45 77.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 112.154 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -33.0 63.34 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.621 0.575 . . . . 0.0 110.963 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -72.23 -36.76 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.0 t80 -80.27 -36.81 34.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -63.92 -29.8 70.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.365 0.666 . . . . 0.0 110.789 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 8.5 tpt180 -59.18 -59.08 6.03 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.924 0.765 . . . . 0.0 108.995 169.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.26 -46.83 72.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.019 0.825 . . . . 0.0 111.915 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 166' ' ' ILE . 95.4 t -61.99 -48.93 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 110.135 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -62.97 -35.78 92.55 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 123.995 0.81 . . . . 0.0 113.045 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 8.9 mm-40 -67.81 -34.97 77.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.521 0.729 . . . . 0.0 110.289 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.65 27.32 8.05 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.305 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 54.4 mt -90.19 149.04 40.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.375 1.07 . . . . 0.0 109.779 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.21 -176.38 3.24 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.463 2.109 . . . . 0.0 112.399 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.09 128.61 81.76 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.204 1.002 . . . . 0.0 110.569 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.64 -13.76 37.9 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.323 2.015 . . . . 0.0 113.971 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 142' ' ' THR . 57.2 mt -101.17 -56.11 2.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.735 0.414 . . . . 0.0 111.766 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.5 t -104.01 -10.29 18.19 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.876 0.47 . . . . 0.0 111.271 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 63.75 21.46 12.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.623 1.169 . . . . 0.0 112.999 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.06 151.41 78.79 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.299 0.64 . . . . 0.0 109.873 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.16 122.73 12.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.778 2.319 . . . . 0.0 110.991 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.587 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.7 mt -66.34 128.38 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 t -146.13 159.61 43.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.161 0.984 . . . . 0.0 109.377 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.7 -19.7 65.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.612 0.765 . . . . 0.0 111.158 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -70.25 -39.51 74.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.929 0.891 . . . . 0.0 111.788 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.6 pt -90.66 -12.19 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.16 137.34 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.144 0.884 . . . . 0.0 108.728 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.52 HG11 HD12 ' A' ' 188' ' ' ILE . 28.8 m -130.22 171.67 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.283 1.033 . . . . 0.0 109.113 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 58.6 mtpt -88.52 165.72 14.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.159 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 21.0 t60 -73.62 -23.27 59.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.39 0.614 . . . . 0.0 109.649 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.44 -31.49 71.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.8 10.18 41.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.602 0.761 . . . . 0.0 111.726 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.9 p -139.57 138.07 35.93 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.635 -0.666 . . . . 0.0 110.457 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.82 162.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.756 1.223 . . . . 0.0 108.579 -174.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -66.47 124.46 22.83 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 166.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.568 ' HB2' HG12 ' A' ' 187' ' ' ILE . 12.4 t70 -105.32 134.02 49.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.83 -36.57 42.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.15 0.906 . . . . 0.0 112.337 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.408 HG22 ' OD1' ' A' ' 180' ' ' ASP . 1.1 t -76.53 -23.64 53.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' ' 187' ' ' ILE . 40.0 mmt180 -86.98 -33.92 19.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.841 0.857 . . . . 0.0 110.661 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.84 18.63 77.65 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.45 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -148.41 150.71 33.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.413 1.085 . . . . 0.0 109.934 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -60.48 117.33 5.14 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.394 0.678 . . . . 0.0 110.303 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 140' ' ' VAL . 13.3 pt -129.68 178.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.828 0.851 . . . . 0.0 108.91 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 133' ' ' LYS . 8.8 mm -70.84 154.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.427 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.6 mtpm? -70.82 148.16 48.16 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.273 0.559 . . . . 0.0 111.357 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -107.45 -42.49 1.47 Allowed Glycine 0 N--CA 1.461 0.365 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.961 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 C--O 1.249 1.068 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.504 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.374 0.607 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.439 ' HG3' HG12 ' A' ' 153' ' ' VAL . 6.7 mp0 -60.9 -44.44 97.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.086 -176.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -41.96 82.57 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.196 0.598 . . . . 0.0 111.615 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.7 t -72.84 -50.93 21.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.512 0.725 . . . . 0.0 110.609 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.8 mt -64.01 -44.37 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.303 0.641 . . . . 0.0 111.196 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.75 -27.73 64.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.119 0.567 . . . . 0.0 111.567 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 2.6 m-80 -64.58 -41.21 96.41 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.43 -34.69 78.89 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.86 0.864 . . . . 0.0 110.67 177.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.535 HG23 HD13 ' A' ' 130' ' ' ILE . 92.8 mt -67.44 -37.74 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.279 0.631 . . . . 0.0 109.44 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.5 t -67.15 -36.49 81.95 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.5 mm-40 -74.56 -53.96 8.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.685 0.394 . . . . 0.0 110.737 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.638 ' SG ' ' HE3' ' A' ' 173' ' ' LYS . 72.5 m -71.81 -19.96 61.92 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.066 0.946 . . . . 0.0 112.983 -167.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.1 170.97 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.789 0.804 . . . . 0.0 112.825 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -160.02 156.68 27.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.935 173.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 p -70.95 104.5 2.98 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 143' ' ' LEU . 45.6 t -77.72 96.98 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 -171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.81 105.41 41.27 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.6 -31.17 86.79 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.967 2.445 . . . . 0.0 113.522 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 -30.29 49.74 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.48 0.488 . . . . 0.0 110.581 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -78.79 -35.03 45.0 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.52 -19.23 53.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.536 0.734 . . . . 0.0 111.691 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 57.23 22.34 7.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.025 0.93 . . . . 0.0 112.621 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -104.94 146.35 32.49 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 123.717 0.807 . . . . 0.0 109.649 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.58 152.66 80.93 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.317 2.011 . . . . 0.0 111.101 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.34 -40.95 68.51 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.887 0.742 . . . . 0.0 111.549 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.64 -41.03 80.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.323 1.049 . . . . 0.0 112.688 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.82 62.91 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.435 0.694 . . . . 0.0 111.434 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 12.0 pt -126.5 33.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.899 0.879 . . . . 0.0 109.506 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.6 tt0 -84.47 137.94 33.07 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.829 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.5 t -76.85 113.64 31.92 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.84 0.49 8.2 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.168 2.579 . . . . 0.0 113.107 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.0 mt -85.24 -54.75 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p -86.28 -18.88 30.88 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.189 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 66.45 36.52 5.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.342 1.057 . . . . 0.0 111.445 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.73 151.7 30.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.479 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -69.64 113.2 15.44 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.873 0.869 . . . . 0.0 108.673 174.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 92.5 Cg_endo -73.59 163.82 36.48 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.57 2.18 . . . . 0.0 113.867 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -17.69 28.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.189 0.996 . . . . 0.0 110.261 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 146' ' ' ALA . 1.3 pptp? -153.27 140.87 19.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.152 0.981 . . . . 0.0 108.957 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.77 168.49 41.38 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.507 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.535 HD13 HG23 ' A' ' 98' ' ' ILE . 13.7 pt -121.0 156.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.547 1.539 . . . . 0.0 109.87 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.6 123.42 43.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 169.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 72.9 t -123.83 122.1 63.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.678 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -69.9 116.96 10.88 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.435 0.636 . . . . 0.0 110.164 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.05 85.28 1.81 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 27.9 t -66.19 -39.84 89.97 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.204 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.35 -35.79 82.04 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.978 0.911 . . . . 0.0 111.105 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.51 -63.97 2.89 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -169.8 23.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.415 0.686 . . . . 0.0 110.631 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.9 m-20 59.29 31.33 21.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.425 1.09 . . . . 0.0 111.698 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.2 t -94.08 128.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.186 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 27.7 p -84.39 132.11 34.62 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -124.52 146.61 48.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 105' ' ' VAL . 44.6 tp -90.43 115.33 27.51 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.4 m-85 -111.78 137.92 49.06 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.492 1.117 . . . . 0.0 108.114 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.723 0.692 . . . . 0.0 109.302 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -57.15 -42.83 81.74 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.93 0.769 . . . . 0.0 111.926 -173.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.69 -36.05 60.15 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.84 0.456 . . . . 0.0 111.593 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.78 69.28 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.125 0.57 . . . . 0.0 111.625 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.6 t80 -71.62 -37.02 70.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.124 0.57 . . . . 0.0 109.881 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -63.03 -36.7 84.44 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.702 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 79.1 ttt180 -60.39 -45.88 91.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.63 -47.05 77.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.137 0.575 . . . . 0.0 111.224 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' A' ' 91' ' ' GLN . 38.7 t -66.04 -46.25 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.227 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.87 -33.07 84.16 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 124.262 0.976 . . . . 0.0 113.312 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.527 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 23.9 mm-40 -75.59 -32.22 60.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.08 21.8 10.6 Favored Glycine 0 N--CA 1.468 0.825 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.753 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 50.6 mt -85.18 153.08 59.35 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 0.0 111.146 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.0 174.95 11.9 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.216 2.611 . . . . 0.0 113.081 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -55.14 134.39 68.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.041 1.336 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.98 -26.14 58.83 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.654 2.236 . . . . 0.0 113.876 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.74 -60.7 1.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.6 t -105.34 -4.19 21.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.646 -167.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 60.22 28.19 17.76 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.106 0.963 . . . . 0.0 112.729 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -80.11 159.99 69.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.18 0.992 . . . . 0.0 111.371 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.4 112.72 2.66 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.119 1.879 . . . . 0.0 111.006 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.428 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.9 mt -62.65 131.79 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.635 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 162.67 38.77 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.363 0.665 . . . . 0.0 110.446 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.12 66.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.705 0.802 . . . . 0.0 111.691 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -68.54 -41.0 80.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 111.581 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -84.94 -7.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.4 tt -97.95 132.83 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.015 0.825 . . . . 0.0 109.876 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.467 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -133.76 178.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.136 1.375 . . . . 0.0 110.029 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.638 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 3.3 mptt -104.26 166.47 10.38 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.481 0.712 . . . . 0.0 109.755 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -70.78 -16.12 62.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.145 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -79.65 -35.29 39.51 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.577 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -83.72 -23.1 31.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.737 0.815 . . . . 0.0 110.602 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 31.7 p -115.78 142.2 47.07 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.867 0.867 . . . . 0.0 108.897 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.4 163.26 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.491 1.116 . . . . 0.0 109.045 -174.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -71.49 136.82 47.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -119.44 132.88 55.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.87 -51.35 22.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.664 1.186 . . . . 0.0 111.906 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 t -73.15 -23.23 60.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.269 0.228 . . . . 0.0 111.536 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.423 ' HG3' HD13 ' A' ' 187' ' ' ILE . 12.7 mmp_? -81.03 -33.98 33.16 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.13 0.572 . . . . 0.0 110.561 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.84 76.11 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.284 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -146.46 146.89 30.73 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.2 1.0 . . . . 0.0 109.446 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.514 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 97.9 m-85 -66.7 116.43 7.61 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 167.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.447 HG12 ' HB2' ' A' ' 180' ' ' ASP . 27.9 pt -127.21 178.95 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.075 0.95 . . . . 0.0 109.365 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 133' ' ' LYS . 21.1 mm -85.82 148.28 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -60.49 154.03 21.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.541 0.736 . . . . 0.0 111.989 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.76 62.92 4.48 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 . . . . . 0 CA--C 1.557 1.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.424 -168.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.955 -0.017 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -58.01 -41.33 82.9 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.95 -45.39 67.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.282 1.033 . . . . 0.0 112.106 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 t -66.05 -39.24 89.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.63 0.772 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.2 mt -69.56 -45.51 77.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.938 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.92 -45.31 90.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.157 . . . . 0.0 111.219 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -59.77 -40.91 89.83 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -62.85 -44.86 95.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.144 0.578 . . . . 0.0 110.727 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 150' ' ' SER . 87.7 mt -60.58 -39.19 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.804 0.842 . . . . 0.0 110.206 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.7 t -64.85 -40.12 94.65 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.988 0.915 . . . . 0.0 111.805 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -83.61 -27.33 29.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.284 0.634 . . . . 0.0 112.601 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.1 m -95.69 -12.23 25.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.578 0.751 . . . . 0.0 112.448 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -74.01 165.25 25.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.635 0.731 . . . . 0.0 112.877 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.06 154.59 35.18 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.422 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -75.61 105.06 6.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.2 130.91 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.918 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 39.3 m -122.38 81.56 46.04 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.695 0.798 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.97 -39.15 40.19 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.163 3.242 . . . . 0.0 113.802 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.6 pt-20 -60.95 -45.71 93.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.206 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 67.4 mtp180 -83.47 -31.59 26.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.088 0.555 . . . . 0.0 111.483 -174.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.33 -18.59 63.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.228 0.611 . . . . 0.0 111.013 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.65 2.67 3.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.301 1.44 . . . . 0.0 112.299 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 62.0 m -92.3 133.13 30.49 Favored Pre-proline 0 C--O 1.247 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 109.17 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.08 158.59 21.08 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.64 2.227 . . . . 0.0 112.164 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -53.47 -43.96 68.57 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.881 0.738 . . . . 0.0 111.488 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.4 -38.45 77.38 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.215 1.006 . . . . 0.0 112.731 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.99 64.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.694 0.798 . . . . 0.0 112.099 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.525 ' HB ' HD23 ' A' ' 143' ' ' LEU . 8.9 pt -127.24 11.59 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.739 0.816 . . . . 0.0 110.57 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.4 tt0 -63.98 132.53 50.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.991 0.916 . . . . 0.0 111.097 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 34.6 t -67.58 111.87 8.71 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.85 -3.56 13.97 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.54 2.16 . . . . 0.0 112.647 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -79.62 -54.0 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.469 1.108 . . . . 0.0 109.431 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p -101.09 -4.23 27.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.255 -169.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.32 33.34 20.86 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.88 0.872 . . . . 0.0 112.258 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.16 153.5 39.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.516 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 21.4 tm0? -70.61 123.85 89.84 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 72.6 Cg_endo -76.24 154.6 36.89 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.367 2.712 . . . . 0.0 114.386 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.5 pt-20 -83.26 -35.79 25.06 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.479 174.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 48.6 pttt -138.33 138.86 38.75 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.16 157.41 28.26 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.062 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 98' ' ' ILE . 9.8 pt -113.2 156.34 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.474 1.509 . . . . 0.0 109.602 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -98.81 116.88 32.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 65.4 t -116.54 122.36 69.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.3 ptmt -69.55 110.51 4.83 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.515 0.674 . . . . 0.0 109.413 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.07 81.11 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 162.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -69.49 -68.79 0.38 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.292 -167.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.43 -35.0 71.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.934 0.894 . . . . 0.0 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.49 -62.55 4.51 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.42 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 m -150.93 4.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -170.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 62.37 22.55 13.3 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.866 0.841 . . . . 0.0 111.061 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 185' ' ' ASN . 55.4 t -105.87 129.99 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.67 0.788 . . . . 0.0 110.897 -173.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 56.5 m -84.16 127.72 34.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.797 0.839 . . . . 0.0 108.838 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.6 m -126.04 146.98 49.68 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' A' ' 117' ' ' ILE . 40.3 tp -88.24 105.28 17.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.091 0.472 . . . . 0.0 109.897 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.424 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 85.8 m-85 -98.6 143.28 29.17 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.3 t70 -63.63 136.37 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.38 73.48 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.201 0.938 . . . . 0.0 111.593 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.0 -31.66 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.074 0.55 . . . . 0.0 111.696 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.587 0.755 . . . . 0.0 111.817 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -76.57 -37.77 56.02 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.495 ' HB2' HG21 ' A' ' 98' ' ' ILE . 27.5 t -63.27 -30.21 71.4 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.742 174.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.5 tpm_? -64.36 -52.64 57.31 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.384 172.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.61 -45.77 73.71 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 123.912 0.757 . . . . 0.0 111.392 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.02 -43.37 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.515 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.82 -16.66 74.62 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.027 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -91.12 -23.54 20.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.322 0.649 . . . . 0.0 110.992 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.11 13.4 58.94 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.439 0.462 . . . . 0.0 112.734 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.36 139.63 52.05 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.067 0.947 . . . . 0.0 109.924 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.83 -176.97 2.59 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.765 2.31 . . . . 0.0 113.012 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.406 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.9 t-80 -58.65 126.32 79.46 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.121 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.427 ' HG3' HG12 ' A' ' 121' ' ' ILE . 66.1 Cg_endo -66.51 -15.71 48.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.79 2.327 . . . . 0.0 113.462 -170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.0 mt -97.32 -64.9 1.0 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.757 0.423 . . . . 0.0 111.243 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.406 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.7 t -94.33 -8.86 37.69 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 122.645 0.378 . . . . 0.0 111.796 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 61.04 21.02 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.904 1.281 . . . . 0.0 112.759 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -87.29 161.07 47.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.311 1.044 . . . . 0.0 110.213 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.21 121.06 8.58 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.018 1.812 . . . . 0.0 111.82 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.484 ' HA ' HD11 ' A' ' 170' ' ' ILE . 71.3 mt -65.65 139.47 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.024 0.53 . . . . 0.0 109.584 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.2 t -153.41 165.34 36.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.398 0.436 . . . . 0.0 111.277 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.46 -22.89 66.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.352 1.061 . . . . 0.0 111.941 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -68.11 -43.69 77.87 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.715 0.806 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.1 pt -85.19 -12.87 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 97' ' ' LYS . 7.7 tt -98.61 136.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.593 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -137.47 173.57 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.927 1.291 . . . . 0.0 110.45 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -91.14 164.07 14.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -66.11 -25.17 66.88 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.686 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.21 -29.09 21.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.5 1.12 . . . . 0.0 110.639 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.06 -25.68 34.36 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.808 0.843 . . . . 0.0 111.357 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.2 p -104.76 154.97 19.31 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -132.0 157.12 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 19.2 p90 -71.0 122.19 19.57 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.435 ' HB2' HG12 ' A' ' 187' ' ' ILE . 10.9 t70 -106.98 114.49 28.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.71 -21.52 44.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -168.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -83.55 -25.84 30.63 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.599 0.636 . . . . 0.0 110.803 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -79.95 -27.77 39.71 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.46 85.53 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.139 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.412 ' HB3' HG13 ' A' ' 140' ' ' VAL . 18.7 m120 -148.34 158.11 43.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.869 0.868 . . . . 0.0 109.854 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 64.6 m-85 -64.6 127.33 31.07 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 180' ' ' ASP . 22.0 pt -134.31 178.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.3 1.04 . . . . 0.0 108.8 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.593 HD12 HG11 ' A' ' 172' ' ' VAL . 33.9 mm -79.38 145.62 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.98 163.29 8.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.278 0.631 . . . . 0.0 112.232 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.74 -55.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.64 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.619 1.168 . . . . 0.0 109.353 178.184 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 121.27 0.557 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.482 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 22.3 mp0 -74.28 -39.65 62.82 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.839 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.01 -50.33 36.5 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.745 0.818 . . . . 0.0 113.028 -164.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 40.4 t -65.57 -43.64 89.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.805 0.442 . . . . 0.0 110.481 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.5 mt -64.8 -46.03 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.91 -47.75 81.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.717 1.207 . . . . 0.0 111.699 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -65.29 -35.8 82.13 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.077 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -64.7 -38.19 90.17 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 122.952 0.501 . . . . 0.0 110.634 176.057 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.489 HG21 ' HB2' ' A' ' 150' ' ' SER . 89.3 mt -65.82 -39.39 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.253 0.621 . . . . 0.0 109.966 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -64.58 -34.89 79.32 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.456 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -87.48 -27.9 22.38 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 75.6 m -93.39 -11.63 31.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -73.94 168.12 20.12 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.653 0.739 . . . . 0.0 111.849 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.88 157.32 34.66 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.449 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 p -68.8 98.6 0.94 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.37 99.7 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 56.7 m -111.2 104.75 56.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.169 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 117' ' ' ILE . 9.9 Cg_endo -52.91 -26.58 31.9 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 -37.33 61.62 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.059 0.544 . . . . 0.0 110.409 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -83.78 -39.93 19.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 0.0 110.864 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.92 -20.89 62.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.505 0.722 . . . . 0.0 111.206 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 53.78 36.16 23.25 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.639 1.176 . . . . 0.0 111.027 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.3 140.57 26.67 Favored Pre-proline 0 C--O 1.248 1.018 0 C-N-CA 124.383 1.073 . . . . 0.0 108.874 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.0 157.22 50.06 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.18 1.92 . . . . 0.0 111.899 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.43 -46.62 66.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.661 0.784 . . . . 0.0 112.054 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 1.6 pm0 -67.68 -30.96 70.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.408 0.683 . . . . 0.0 112.444 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.08 -27.1 67.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.73 0.412 . . . . 0.0 111.43 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' HD23 ' A' ' 143' ' ' LEU . 16.8 pt -119.08 17.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.491 0.716 . . . . 0.0 110.604 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 46.5 tt0 -63.5 129.99 42.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.994 0.918 . . . . 0.0 110.542 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.42 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.1 t -67.75 109.74 4.31 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.566 ' HB2' HD21 ' A' ' 161' ' ' LEU . 87.7 Cg_endo -78.3 5.88 5.13 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.732 2.288 . . . . 0.0 112.734 -174.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -83.39 -53.95 10.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 124.124 0.969 . . . . 0.0 108.841 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.4 p -96.35 -10.29 28.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.924 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.49 39.06 25.39 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.206 1.002 . . . . 0.0 111.79 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.59 159.84 43.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.425 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -74.62 121.22 84.76 Favored Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 73.3 Cg_endo -76.4 159.16 36.45 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.075 2.517 . . . . 0.0 113.441 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.3 pt-20 -90.15 -26.09 20.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.692 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.2 pttt -147.06 140.39 25.43 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.3 158.67 31.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.824 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 98' ' ' ILE . 12.2 pt -110.84 155.09 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.739 1.216 . . . . 0.0 109.767 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -93.09 129.02 39.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 167.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.5 t -124.85 124.29 67.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 171.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.655 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -64.93 105.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.029 0.919 . . . . 0.0 110.373 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.28 78.54 0.73 Allowed 'General case' 0 C--O 1.25 1.084 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 34.2 t -65.42 -37.57 87.31 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.156 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.51 -36.56 69.33 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.297 1.039 . . . . 0.0 112.251 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.47 -63.41 2.62 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.398 0.436 . . . . 0.0 113.049 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -169.61 30.83 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.269 0.628 . . . . 0.0 110.203 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.7 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 0.4 OUTLIER 65.13 26.12 12.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.022 0.929 . . . . 0.0 111.225 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.6 t -86.09 142.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.89 0.876 . . . . 0.0 110.021 -174.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 188' ' ' ILE . 60.6 m -85.46 122.54 29.74 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.6 m -118.17 137.31 53.07 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 117' ' ' ILE . 56.7 tp -92.91 114.44 26.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.687 0.395 . . . . 0.0 110.487 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.34 150.77 26.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.632 1.173 . . . . 0.0 108.521 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.28 137.74 54.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.466 0.575 . . . . 0.0 109.548 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.23 86.25 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.022 0.826 . . . . 0.0 111.95 -175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.43 -36.92 66.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 0.0 111.698 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.01 56.64 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.412 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.62 -40.97 84.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.352 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.0 t -62.41 -36.88 83.73 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.748 0.655 . . . . 0.0 110.839 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 58.6 ttt180 -63.43 -48.85 76.05 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.73 -46.75 70.95 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.399 0.679 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.42 -47.43 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.821 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -64.1 -29.3 74.52 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 124.191 0.932 . . . . 0.0 113.447 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 61.5 mm-40 -72.95 -25.34 60.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.199 0.6 . . . . 0.0 110.317 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 15.76 43.32 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.098 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.67 145.6 54.81 Favored Pre-proline 0 C--O 1.242 0.659 0 C-N-CA 123.866 0.867 . . . . 0.0 110.073 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.34 -179.47 5.1 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.551 2.168 . . . . 0.0 112.017 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -55.02 131.82 67.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.8 -26.31 79.38 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.924 2.416 . . . . 0.0 113.573 -172.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.5 mt -97.75 -52.59 3.69 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.637 0.375 . . . . 0.0 111.308 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 67.8 p -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.412 0.685 . . . . 0.0 112.195 -168.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 64.04 22.24 12.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.555 1.142 . . . . 0.0 111.352 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.71 149.73 86.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.575 0.75 . . . . 0.0 110.296 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.22 111.19 1.53 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.219 1.946 . . . . 0.0 110.702 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.09 135.39 25.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.053 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.6 t -149.18 163.11 38.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.091 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -64.75 -23.92 67.4 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.958 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -69.99 -26.16 63.95 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.887 0.875 . . . . 0.0 113.033 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.7 pt -100.7 -11.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 168' ' ' ALA . 7.7 tt -94.39 134.04 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.607 HG11 HD12 ' A' ' 188' ' ' ILE . 26.9 m -133.81 172.11 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.528 1.131 . . . . 0.0 110.795 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 7.1 mtpm? -103.82 166.83 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.026 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -71.2 -18.11 62.49 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.12 -22.1 23.04 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.3 0.64 . . . . 0.0 110.544 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -75.88 -38.51 57.77 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.742 0.817 . . . . 0.0 109.546 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.38 140.95 29.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.616 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 152.91 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -66.15 128.8 37.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.546 ' HB2' HG12 ' A' ' 187' ' ' ILE . 14.0 t70 -108.03 135.3 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.29 -49.47 16.9 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.055 0.847 . . . . 0.0 111.655 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.7 t -73.76 -23.44 59.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.122 0.169 . . . . 0.0 111.412 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 3.4 mmp_? -83.65 -33.0 25.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.185 0.594 . . . . 0.0 110.549 171.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.68 26.32 59.04 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.918 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -171.37 162.93 6.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.186 0.595 . . . . 0.0 109.851 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -60.2 121.16 11.26 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.1 0.96 . . . . 0.0 111.13 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 180' ' ' ASP . 23.3 pt -126.73 174.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.196 171.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 133' ' ' LYS . 27.1 mm -70.74 151.05 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.349 0.659 . . . . 0.0 109.746 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 148.31 51.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.224 0.535 . . . . 0.0 111.393 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.87 -26.24 3.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.173 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -62.29 -42.92 99.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -35.66 81.0 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.352 0.408 . . . . 0.0 111.588 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 32.7 t -68.37 -43.51 77.2 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.44 0.696 . . . . 0.0 109.449 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 98' ' ' ILE . 64.6 mt -66.35 -46.61 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.579 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -58.53 -43.47 89.22 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.326 1.45 . . . . 0.0 111.346 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.77 -41.78 96.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.268 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -69.23 -32.34 71.52 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 123.262 0.625 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 94' ' ' ILE . 83.5 mt -66.02 -40.86 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.2 m -63.05 -40.71 98.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 111.583 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -83.0 -22.68 33.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.514 0.726 . . . . 0.0 112.701 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.592 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 80.4 m -95.35 -22.89 17.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.999 0.52 . . . . 0.0 112.293 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -70.3 168.21 16.39 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.722 0.772 . . . . 0.0 112.508 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -156.12 157.7 36.44 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.599 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.0 p -72.22 99.65 2.41 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 143' ' ' LEU . 21.9 t -71.56 109.25 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.249 -171.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.95 104.43 55.53 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.72 0.808 . . . . 0.0 109.458 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 117' ' ' ILE . 15.5 Cg_endo -59.92 -27.63 85.34 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.982 2.455 . . . . 0.0 112.647 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.72 -31.37 69.33 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.254 0.622 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -90.59 -30.61 17.1 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.656 0.782 . . . . 0.0 110.868 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.3 -23.04 57.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.846 0.458 . . . . 0.0 111.216 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 52.74 33.1 13.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.028 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -114.62 140.69 25.62 Favored Pre-proline 0 C--O 1.245 0.844 0 C-N-CA 124.424 1.09 . . . . 0.0 108.859 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.92 158.67 45.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.462 2.108 . . . . 0.0 111.785 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.32 -45.68 72.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.806 . . . . 0.0 111.8 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.68 -38.97 72.97 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.316 1.046 . . . . 0.0 113.062 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.04 65.42 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.161 0.585 . . . . 0.0 111.734 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 107' ' ' PRO . 19.5 pt -127.97 31.39 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.681 1.192 . . . . 0.0 109.535 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.66 125.02 27.79 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.379 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 10.4 t -68.47 109.93 4.94 Favored Pre-proline 0 C--N 1.349 0.557 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.91 -3.35 13.63 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.782 2.321 . . . . 0.0 112.852 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.2 -52.3 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.4 p -90.98 -10.64 41.61 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.96 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.29 36.26 23.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.851 1.261 . . . . 0.0 111.889 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.87 152.65 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.352 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.21 121.38 80.03 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.523 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.52 164.2 28.73 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.116 2.544 . . . . 0.0 114.602 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 12.9 pt-20 -86.43 -29.82 22.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.463 173.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 52.0 pttt -141.62 135.07 29.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.7 1.6 . . . . 0.0 106.904 176.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -161.74 154.9 26.0 Favored Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.503 -175.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -110.19 159.38 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 125.251 1.42 . . . . 0.0 109.555 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 37.3 m-85 -103.34 118.15 36.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 169.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.7 t -115.16 121.49 67.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 21.9 ptmt -72.2 108.48 5.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.864 0.84 . . . . 0.0 110.627 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -66.55 83.36 0.1 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.42 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 46.4 t -64.21 -41.64 96.96 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.212 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.14 -32.27 73.88 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.006 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.29 -66.36 2.11 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.27 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.2 m -168.44 26.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.317 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 9.5 m-20 58.34 26.1 13.61 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.635 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -80.52 123.72 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.384 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 40.5 m -82.7 122.98 28.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.499 HG21 HD11 ' A' ' 161' ' ' LEU . 25.9 m -119.41 145.03 46.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 105' ' ' VAL . 34.2 tp -86.65 114.13 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.35 0.407 . . . . 0.0 110.286 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -113.35 135.49 53.8 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.595 1.158 . . . . 0.0 108.466 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 13.1 t70 -59.26 137.62 57.91 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.674 0.39 . . . . 0.0 110.046 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.13 90.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.553 0.741 . . . . 0.0 111.672 -174.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.12 44.85 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.319 0.648 . . . . 0.0 112.124 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.42 -39.21 54.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.177 0.591 . . . . 0.0 111.673 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.0 t80 -72.15 -38.3 69.2 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -56.67 -38.73 72.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.069 0.948 . . . . 0.0 111.452 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -57.65 -52.16 66.55 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.817 0.698 . . . . 0.0 109.953 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.77 -46.52 81.42 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.149 0.906 . . . . 0.0 111.089 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 166' ' ' ILE . 94.8 t -62.38 -47.07 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.744 . . . . 0.0 110.852 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.45 -34.37 88.1 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.715 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 16.4 mm-40 -75.27 -31.53 60.78 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.413 0.685 . . . . 0.0 111.218 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 25.68 20.07 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 86.7 mt -80.6 151.6 71.69 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.93 -179.43 5.11 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.469 2.112 . . . . 0.0 112.64 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.3 t-80 -59.26 127.85 84.72 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.333 1.053 . . . . 0.0 109.917 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.67 -2.99 12.99 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.305 2.003 . . . . 0.0 113.973 -170.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 142' ' ' THR . 63.5 mt -104.26 -57.27 2.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.552 0.341 . . . . 0.0 111.018 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.441 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -105.0 -11.81 16.46 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 66.08 22.24 11.15 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.781 1.232 . . . . 0.0 113.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.434 ' H ' HG23 ' A' ' 162' ' ' THR . 31.2 mm-40 -76.84 152.26 82.65 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.345 0.658 . . . . 0.0 110.591 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.21 121.08 8.94 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.558 2.172 . . . . 0.0 111.837 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.603 HG21 HG22 ' A' ' 153' ' ' VAL . 71.5 mt -65.73 130.95 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -150.34 164.95 34.5 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.819 0.848 . . . . 0.0 110.609 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -63.55 -24.04 67.64 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.373 171.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.0 m -66.3 -33.2 75.19 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.836 0.855 . . . . 0.0 112.841 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 166' ' ' ILE . 44.2 pt -99.39 -3.16 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 101' ' ' CYS . 11.6 tt -102.16 134.2 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.4 167.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.529 1.132 . . . . 0.0 110.133 -173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 28.0 mtpp -85.97 161.43 19.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -65.69 -24.69 67.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.301 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.6 -22.24 28.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.052 0.541 . . . . 0.0 110.982 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -82.51 -24.11 34.29 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.396 0.678 . . . . 0.0 110.768 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.3 p -113.38 155.59 24.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.18 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.14 157.12 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.606 1.163 . . . . 0.0 108.424 177.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -70.59 129.92 40.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.77 126.74 55.55 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.28 -39.41 71.56 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.484 1.115 . . . . 0.0 112.486 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.6 t -84.03 -15.8 46.25 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.866 0.303 . . . . 0.0 111.747 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -83.22 -32.03 26.73 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 163.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.23 7.51 84.75 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.316 -170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -137.76 157.0 47.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.698 1.199 . . . . 0.0 108.836 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.26 129.71 40.72 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.08 175.59 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.756 1.222 . . . . 0.0 109.778 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.407 HD13 ' SG ' ' A' ' 141' ' ' CYS . 28.7 mm -76.13 148.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.492 0.717 . . . . 0.0 110.205 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -64.82 163.79 13.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.318 0.647 . . . . 0.0 111.248 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -73.81 -45.17 28.6 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.869 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 123.869 0.868 . . . . 0.0 109.921 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 94' ' ' ILE . 12.4 mp0 -63.29 -34.19 77.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.726 0.81 . . . . 0.0 111.584 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.02 -50.1 59.2 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.416 1.087 . . . . 0.0 112.154 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -63.73 -36.16 82.95 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.121 0.968 . . . . 0.0 111.1 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 91' ' ' GLN . 35.6 mt -71.31 -48.53 53.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.737 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -55.96 -46.07 78.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.563 1.145 . . . . 0.0 111.371 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.05 -45.12 93.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -32.89 74.57 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.93 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.483 HG23 HD13 ' A' ' 130' ' ' ILE . 96.4 mt -65.2 -41.59 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 118.728 0.694 . . . . 0.0 109.903 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.8 t -64.91 -36.0 82.96 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.842 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -81.43 -30.47 33.48 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.847 0.859 . . . . 0.0 112.945 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 99.1 m -91.46 -19.5 22.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.868 0.867 . . . . 0.0 111.604 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -72.83 165.46 24.84 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.566 0.698 . . . . 0.0 111.938 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.91 159.43 34.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.943 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -69.91 97.02 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.7 t -66.36 113.43 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.374 0.669 . . . . 0.0 110.531 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.6 m -114.49 90.77 22.26 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.415 1.086 . . . . 0.0 109.093 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -58.44 -39.14 86.33 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.081 2.521 . . . . 0.0 113.293 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -38.01 65.67 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.05 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -74.83 -41.21 60.35 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 97.7 mt -68.44 -15.61 63.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 111.57 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 61.47 16.75 7.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 -172.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 61.6 m -93.11 124.62 57.54 Favored Pre-proline 0 C--O 1.243 0.755 0 C-N-CA 123.36 0.664 . . . . 0.0 109.5 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.46 150.99 78.12 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.557 2.171 . . . . 0.0 111.7 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.01 -47.92 67.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.903 0.881 . . . . 0.0 112.264 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.28 -35.16 78.15 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.383 0.673 . . . . 0.0 112.354 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.06 62.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.36 0.664 . . . . 0.0 111.792 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 112' ' ' CYS . 24.5 pt -127.61 29.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.662 0.785 . . . . 0.0 110.221 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -79.04 132.48 36.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.789 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.17 111.34 7.59 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.34 -2.46 12.59 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.841 2.361 . . . . 0.0 112.172 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.5 mt -82.16 -55.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.6 p -95.23 -7.87 37.77 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.16 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.85 48.24 20.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.15 0.98 . . . . 0.0 111.257 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.81 149.98 20.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.757 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.66 116.42 51.51 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.4 161.2 37.93 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.78 2.32 . . . . 0.0 113.434 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.45 -19.03 20.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.712 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 2.2 pptp? -144.87 128.8 17.44 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.71 167.3 37.78 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.859 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 98' ' ' ILE . 11.5 pt -122.03 151.81 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 109.348 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.53 115.61 28.96 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 130' ' ' ILE . 64.2 t -117.69 122.39 69.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -69.71 122.39 19.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.432 0.634 . . . . 0.0 110.928 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -72.83 80.86 1.15 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 161.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 25.1 t -70.09 -44.86 68.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.781 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.28 -34.76 79.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.059 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.09 -64.86 2.22 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.835 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.9 m -157.44 18.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.318 0.559 . . . . 0.0 112.475 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.7 m-20 59.63 20.62 9.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.98 0.912 . . . . 0.0 112.283 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.7 124.08 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 28.0 p -85.5 133.12 34.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 m -121.81 145.56 47.94 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.19 108.81 20.13 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.53 136.42 42.39 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.42 132.31 52.72 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.629 0.65 . . . . 0.0 109.359 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.74 70.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.043 0.839 . . . . 0.0 111.892 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . . . -75.29 -40.23 58.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.986 0.514 . . . . 0.0 111.599 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.37 89.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.064 0.545 . . . . 0.0 111.807 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 130' ' ' ILE . 33.5 t80 -76.97 -38.35 53.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.966 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 98' ' ' ILE . 28.8 t -64.08 -28.94 70.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.434 0.459 . . . . 0.0 110.819 175.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 13.0 tpt180 -64.39 -55.69 19.33 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.541 -0.754 . . . . 0.0 108.973 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.7 -45.6 70.47 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.088 0.867 . . . . 0.0 111.818 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.414 HG11 ' HB ' ' A' ' 94' ' ' ILE . 86.3 t -65.93 -47.56 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.298 0.639 . . . . 0.0 110.378 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.27 -17.88 68.73 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.274 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 63.7 mm-40 -87.15 -23.97 24.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.619 0.768 . . . . 0.0 110.857 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.03 36.79 12.35 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.54 149.12 36.12 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.57 1.148 . . . . 0.0 109.527 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -69.89 177.26 5.85 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.353 2.702 . . . . 0.0 113.531 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.447 ' ND1' HG22 ' A' ' 162' ' ' THR . 60.1 t-80 -59.81 124.66 77.52 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.58 -12.46 35.19 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.675 2.25 . . . . 0.0 114.202 -168.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.81 -66.97 0.87 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.643 0.377 . . . . 0.0 110.819 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.447 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.5 t -90.36 -8.66 50.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.57 0.348 . . . . 0.0 111.605 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 59.88 24.46 13.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.841 1.256 . . . . 0.0 112.961 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -88.75 155.77 50.28 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.93 0.892 . . . . 0.0 110.05 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -64.2 112.16 1.81 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.461 2.107 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.519 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.8 mt -56.64 140.05 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.788 0.835 . . . . 0.0 110.076 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 160.55 43.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.851 0.861 . . . . 0.0 109.849 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.22 -23.93 67.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.508 0.723 . . . . 0.0 111.903 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -67.49 -46.21 73.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 111.954 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.7 pt -79.06 -10.43 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' A' ' 101' ' ' CYS . 10.5 tt -99.33 132.35 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.477 0.58 . . . . 0.0 109.614 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.67 174.02 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.461 1.104 . . . . 0.0 109.762 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 29.3 mtpp -91.1 166.18 13.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.664 0.386 . . . . 0.0 110.137 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -62.89 -34.97 78.53 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.552 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.2 -9.76 59.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.183 0.593 . . . . 0.0 111.351 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -93.88 -2.95 52.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.814 0.846 . . . . 0.0 110.551 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 29.8 p -134.9 144.26 47.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.161 0.984 . . . . 0.0 109.379 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -123.21 155.62 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.595 -0.691 . . . . 0.0 109.279 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -67.95 110.84 4.06 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 159.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.45 125.13 39.85 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -79.3 -36.17 40.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.552 0.741 . . . . 0.0 111.829 -169.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -74.84 -27.3 60.22 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.405 0.548 . . . . 0.0 110.402 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.6 mmt180 -77.5 -32.74 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.84 81.26 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.794 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -145.92 157.67 43.89 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.29 1.036 . . . . 0.0 109.42 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.452 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 37.1 m-85 -72.34 118.57 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.179 0.591 . . . . 0.0 109.569 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' A' ' 183' ' ' ARG . 27.2 pt -128.32 177.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 133' ' ' LYS . 39.6 mm -80.2 145.11 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 178' ' ' ILE . 48.6 mtpt -63.42 149.7 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.066 0.854 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.96 25.31 0.21 Allowed Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.511 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.751 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.591 0.234 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HG3' HG12 ' A' ' 153' ' ' VAL . 24.9 mp0 -70.12 -46.11 65.48 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -170.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -47.59 30.1 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.357 1.063 . . . . 0.0 113.47 -170.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.428 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 18.8 m -65.07 -46.08 82.61 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.273 1.029 . . . . 0.0 111.227 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.483 HD13 HG22 ' A' ' 166' ' ' ILE . 62.1 mt -70.66 -46.24 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.159 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -55.18 -44.67 75.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.742 1.217 . . . . 0.0 110.616 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.447 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 93.9 m-20 -59.67 -46.26 89.59 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.319 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -61.2 -39.59 90.79 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.533 0.52 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 87.1 mt -62.75 -37.48 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.364 0.665 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 t -65.51 -36.87 85.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.992 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 26.6 mt-30 -85.63 -31.16 22.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.113 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.5 m -87.83 -17.11 32.24 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.235 0.614 . . . . 0.0 111.766 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.19 169.26 17.42 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-O 121.21 0.529 . . . . 0.0 111.577 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.89 160.8 41.44 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.607 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 99.21 1.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.75 98.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.3 m -112.28 99.52 46.83 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.929 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.15 -31.65 46.33 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.875 3.05 . . . . 0.0 114.547 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 11.1 pt-20 -70.04 -43.56 71.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.747 0.819 . . . . 0.0 110.68 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 76.4 mtp180 -81.34 -26.69 35.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.086 0.554 . . . . 0.0 110.565 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.0 mt -77.81 -20.69 52.79 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.088 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 58.44 27.75 15.92 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.749 0.819 . . . . 0.0 111.331 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.4 m -116.52 144.72 33.72 Favored Pre-proline 0 C--O 1.245 0.834 0 C-N-CA 124.024 0.93 . . . . 0.0 109.995 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.92 160.98 44.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.43 2.087 . . . . 0.0 111.66 172.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -43.13 78.59 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.922 0.764 . . . . 0.0 112.014 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.1 -37.06 83.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.049 0.94 . . . . 0.0 112.606 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.62 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.069 0.548 . . . . 0.0 111.154 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.14 31.28 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.899 0.88 . . . . 0.0 110.007 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -85.23 131.54 34.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.697 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.8 t -67.75 114.22 18.79 Favored Pre-proline 0 C--N 1.346 0.434 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.62 -11.23 30.56 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.427 2.085 . . . . 0.0 112.862 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 36.1 mt -78.08 -56.23 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.851 0.86 . . . . 0.0 109.558 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p -99.33 -11.87 20.83 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.207 1.003 . . . . 0.0 111.932 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.24 27.7 17.38 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.362 1.065 . . . . 0.0 112.305 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -104.67 164.1 12.01 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.34 99.72 8.95 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 165.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 163.87 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.714 2.276 . . . . 0.0 113.759 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -94.93 -16.66 22.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.117 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -142.86 135.1 27.37 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.839 1.256 . . . . 0.0 108.184 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.47 29.95 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.879 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.93 158.96 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.532 1.133 . . . . 0.0 110.262 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -102.3 122.09 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.53 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 78.6 t -119.61 124.69 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -69.02 117.1 10.25 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 123.823 0.702 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -74.93 80.65 2.16 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 166.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 t -58.83 -33.14 70.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.619 1.168 . . . . 0.0 110.748 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.94 -42.09 94.96 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.648 0.593 . . . . 0.0 111.581 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.51 -65.33 3.22 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.621 0.576 . . . . 0.0 111.817 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 t 176.65 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.603 1.161 . . . . 0.0 108.405 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.69 23.95 13.7 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.523 1.129 . . . . 0.0 110.413 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.11 109.96 10.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 60.8 m -83.64 131.89 34.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.819 0.448 . . . . 0.0 110.046 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.4 m -121.23 149.17 43.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 48.2 tp -88.71 104.48 16.92 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.324 0.583 . . . . 0.0 109.551 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 93.9 m-85 -97.61 136.73 37.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.47 134.71 56.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.7 -41.67 82.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.135 0.897 . . . . 0.0 111.638 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.95 -32.32 45.42 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.458 0.474 . . . . 0.0 111.799 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.68 62.83 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.518 0.727 . . . . 0.0 111.393 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.3 t80 -71.76 -39.29 70.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.8 t -61.91 -31.43 71.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 111.44 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.4 tpt180 -64.31 -52.87 56.34 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 123.564 0.54 . . . . 0.0 109.594 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.87 -42.74 76.36 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.859 0.724 . . . . 0.0 111.574 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 166' ' ' ILE . 94.4 t -63.15 -49.34 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.817 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.26 -16.12 68.65 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 124.134 0.896 . . . . 0.0 113.673 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.1 mm-40 -93.38 -11.94 31.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 111.107 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.67 30.24 56.53 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.35 0.407 . . . . 0.0 112.501 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -92.8 148.13 35.39 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.614 1.165 . . . . 0.0 109.787 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.16 -176.12 2.89 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.794 2.329 . . . . 0.0 112.584 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -55.64 132.13 71.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.261 1.025 . . . . 0.0 110.382 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 73.2 Cg_endo -68.91 -28.62 29.28 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.907 1.738 . . . . 0.0 113.303 -170.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.33 -56.49 3.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.557 0.343 . . . . 0.0 111.31 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 t -108.78 -8.79 15.29 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -169.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 32.9 mmt180 66.7 21.42 10.59 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.391 1.077 . . . . 0.0 112.634 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -72.27 141.08 83.04 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.143 0.577 . . . . 0.0 109.646 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.81 115.22 2.79 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.388 2.059 . . . . 0.0 111.677 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.555 HG21 HG22 ' A' ' 153' ' ' VAL . 71.4 mt -60.95 127.97 21.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 CA-C-O 120.934 0.397 . . . . 0.0 110.491 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -148.17 165.23 31.51 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.142 0.977 . . . . 0.0 109.402 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.12 -20.18 66.07 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.655 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m -65.37 -44.27 88.13 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.307 0.643 . . . . 0.0 112.452 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.7 pt -86.89 -7.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.24 129.96 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.02 178.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.065 0.946 . . . . 0.0 110.847 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.9 161.68 13.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.465 0.706 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -67.76 -22.76 65.19 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.7 0.8 . . . . 0.0 112.467 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.73 -22.71 23.21 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.947 0.499 . . . . 0.0 111.083 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.13 -26.88 28.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.034 0.934 . . . . 0.0 110.955 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 27.0 p -115.86 150.6 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.535 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -133.71 160.7 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.051 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 32.3 p90 -69.12 115.0 7.9 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 165.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.554 ' HB2' HG12 ' A' ' 187' ' ' ILE . 11.3 t70 -91.79 129.95 37.66 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.44 -47.89 45.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.06 0.85 . . . . 0.0 110.731 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.2 t -78.28 -25.17 46.6 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.613 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.1 mmp_? -77.05 -30.86 55.81 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.231 169.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.83 14.34 59.62 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.685 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -171.75 168.67 6.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.522 0.661 . . . . 0.0 110.459 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 93.9 m-85 -60.13 121.52 12.11 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.077 0.951 . . . . 0.0 111.529 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.613 HD13 ' HG3' ' A' ' 183' ' ' ARG . 24.1 pt -131.73 178.16 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.327 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 133' ' ' LYS . 47.2 mm -71.58 140.22 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.598 0.561 . . . . 0.0 109.586 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' A' ' 178' ' ' ILE . 54.2 mtpt -60.4 148.06 38.63 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.706 0.629 . . . . 0.0 110.906 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.18 83.77 1.72 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.101 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -58.59 -48.68 80.15 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.412 -172.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -47.61 71.9 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.869 0.731 . . . . 0.0 111.812 -170.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 37.1 t -66.85 -38.81 87.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.4 0.68 . . . . 0.0 111.192 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.8 mt -66.31 -43.78 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.718 0.636 . . . . 0.0 109.475 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.45 -44.58 84.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.022 . . . . 0.0 110.803 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -59.62 -43.44 93.79 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.425 0.453 . . . . 0.0 111.064 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.1 mpmm? -63.26 -35.34 80.02 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 111.298 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 89.1 mt -67.57 -37.48 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 122.762 0.425 . . . . 0.0 110.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.6 t -63.45 -40.04 96.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.57 0.748 . . . . 0.0 111.33 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.02 -45.17 18.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.264 0.626 . . . . 0.0 112.146 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 73.3 m -82.3 -10.05 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.905 0.882 . . . . 0.0 112.741 -169.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.69 169.29 18.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.402 0.62 . . . . 0.0 112.473 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -158.03 160.36 37.36 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.963 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 m -70.04 99.81 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 114.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.173 0.589 . . . . 0.0 110.874 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.1 m -118.49 100.42 51.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.034 0.934 . . . . 0.0 109.229 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.57 -37.53 57.69 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.338 2.692 . . . . 0.0 113.293 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -15.26 56.98 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.875 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -88.94 -43.38 11.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 0.0 110.016 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.9 mt -72.57 -12.12 60.93 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 65.33 17.75 11.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.872 1.269 . . . . 0.0 111.538 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 71.8 m -104.61 136.0 19.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.741 0.816 . . . . 0.0 110.136 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.28 164.15 29.24 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.692 2.261 . . . . 0.0 111.125 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.8 mt -53.59 -47.43 70.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.42 0.688 . . . . 0.0 111.49 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.58 -41.83 70.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.857 1.263 . . . . 0.0 113.134 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.44 67.27 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.929 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 143' ' ' LEU . 20.8 pt -126.51 23.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.244 1.018 . . . . 0.0 110.409 -177.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.86 128.32 35.98 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.435 0.694 . . . . 0.0 110.242 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 39.2 t -70.04 110.86 7.48 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.72 -3.06 13.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.882 2.388 . . . . 0.0 112.714 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.9 mt -76.27 -51.51 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.184 0.993 . . . . 0.0 109.236 176.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p -99.68 -15.39 18.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.978 -173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.39 47.9 15.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.516 1.126 . . . . 0.0 111.793 -172.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 163.44 37.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.573 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.12 116.63 60.38 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 60.0 Cg_endo -71.18 161.17 46.77 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.024 2.483 . . . . 0.0 113.819 -173.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 8.2 pt-20 -87.19 -37.86 16.92 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.37 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 17.7 pttm -140.68 140.09 34.89 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.85 156.87 28.3 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.218 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.4 ' O ' HD12 ' A' ' 143' ' ' LEU . 11.1 pt -109.31 158.19 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 109.058 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -99.41 128.16 45.5 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.495 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 90.1 t -119.54 121.86 67.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.63 113.22 10.51 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.84 80.43 1.62 Allowed 'General case' 0 C--O 1.248 1.005 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -68.3 -30.39 69.38 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.223 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.86 -38.86 89.83 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.271 174.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.33 -67.46 1.83 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.103 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t 178.79 44.33 0.0 OUTLIER 'General case' 0 C--O 1.251 1.144 0 C-N-CA 123.864 0.865 . . . . 0.0 109.905 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 t70 70.31 8.33 6.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 123.951 0.901 . . . . 0.0 111.432 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.595 ' HA ' HG22 ' A' ' 187' ' ' ILE . 61.3 t -77.14 113.59 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.51 138.63 33.34 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 109.473 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.8 m -129.25 154.0 47.24 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.5 tp -90.17 121.39 32.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.495 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.0 m-85 -117.34 133.7 55.68 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 124.991 1.317 . . . . 0.0 107.824 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.6 t70 -59.78 135.55 57.72 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 118.846 0.748 . . . . 0.0 109.656 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.4 71.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.898 0.879 . . . . 0.0 111.575 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.37 -34.72 65.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.56 -37.67 71.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 111.771 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -76.92 -36.65 56.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.384 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.9 t -62.59 -30.24 71.19 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 124.01 0.819 . . . . 0.0 110.831 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.5 ttm-85 -64.87 -53.5 45.72 Favored 'General case' 0 C--O 1.218 -0.564 0 O-C-N 124.02 0.825 . . . . 0.0 109.981 170.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 73.2 mt -52.94 -47.84 67.75 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.949 0.5 . . . . 0.0 111.475 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.61 -51.36 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.659 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.51 73.5 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.269 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 29.6 mm-40 -87.48 -23.86 24.3 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 117.36 0.58 . . . . 0.0 110.185 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.86 53.59 Favored Glycine 0 N--CA 1.47 0.945 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.62 140.31 59.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.084 0.954 . . . . 0.0 109.63 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.56 -168.08 0.53 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.748 2.298 . . . . 0.0 112.608 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -60.66 131.41 91.0 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.353 1.061 . . . . 0.0 110.043 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.413 ' HG3' HG12 ' A' ' 121' ' ' ILE . 70.2 Cg_endo -68.79 -24.42 34.46 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.37 2.047 . . . . 0.0 113.444 -172.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.74 -65.15 1.04 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.9 t -102.71 -9.4 20.07 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.299 -167.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 62.22 24.04 14.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.782 1.233 . . . . 0.0 112.063 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -79.16 148.35 71.09 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.334 0.654 . . . . 0.0 110.062 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.93 123.09 12.24 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.702 2.268 . . . . 0.0 111.854 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.94 134.3 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.292 0.637 . . . . 0.0 110.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.1 t -141.14 160.61 39.73 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.917 0.887 . . . . 0.0 109.559 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.04 -23.97 67.69 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.913 0.885 . . . . 0.0 111.545 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.7 t -67.56 -41.27 84.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.783 0.833 . . . . 0.0 112.267 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -85.0 -8.67 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.8 tt -98.0 133.57 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.82 0.736 . . . . 0.0 109.151 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.04 174.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.725 1.21 . . . . 0.0 110.378 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 40.8 mtpt -102.62 164.5 11.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.145 0.578 . . . . 0.0 110.843 -175.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -73.68 -17.59 61.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.918 0.487 . . . . 0.0 111.595 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.49 -32.77 28.63 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.11 -29.89 49.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.331 0.652 . . . . 0.0 110.721 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 31.6 p -113.55 155.51 25.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.599 0.759 . . . . 0.0 109.643 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.39 164.23 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.312 1.045 . . . . 0.0 108.839 179.504 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.27 127.51 33.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 162.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.463 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -107.52 139.18 42.43 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.883 -0.511 . . . . 0.0 110.027 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.17 -50.86 13.43 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.248 0.968 . . . . 0.0 111.757 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 15.0 t -71.06 -33.53 70.36 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.19 0.45 . . . . 0.0 111.18 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.569 ' HG3' HD13 ' A' ' 187' ' ' ILE . 26.8 mmt180 -76.3 -27.95 56.78 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.917 0.487 . . . . 0.0 110.088 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.83 24.31 72.47 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.194 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -170.11 163.68 9.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.831 0.853 . . . . 0.0 108.824 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 89.0 m-85 -59.82 127.68 33.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.975 0.91 . . . . 0.0 111.182 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 140' ' ' VAL . 19.1 pt -138.71 -179.85 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.645 1.178 . . . . 0.0 108.989 170.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.8 152.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 122.995 0.518 . . . . 0.0 109.889 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.85 104.37 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.966 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -117.35 -0.01 18.68 Favored Glycine 0 N--CA 1.465 0.591 0 CA-C-N 113.779 -1.555 . . . . 0.0 111.831 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 42.5 t30 . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 123.657 0.783 . . . . 0.0 109.074 178.061 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 110.556 -0.165 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -49.49 77.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.296 1.038 . . . . 0.0 111.878 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -30.7 70.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 0.0 112.155 -174.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -68.29 -46.97 68.9 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.099 0.96 . . . . 0.0 109.788 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 98' ' ' ILE . 79.6 mt -64.48 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.683 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -61.11 -38.38 86.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.717 1.207 . . . . 0.0 112.537 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -60.9 -41.23 95.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.456 0.473 . . . . 0.0 110.238 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -39.23 89.31 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 123.369 0.418 . . . . 0.0 110.614 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 94' ' ' ILE . 74.9 mt -65.25 -46.08 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.79 0.436 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -65.4 -36.02 82.7 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.879 0.872 . . . . 0.0 112.25 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -82.4 -42.55 18.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.988 0.515 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.85 -6.97 59.54 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.83 0.852 . . . . 0.0 112.386 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -75.26 163.62 27.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.186 0.517 . . . . 0.0 111.56 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -157.2 159.58 37.85 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.988 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.4 p -73.35 100.75 3.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.933 0.77 . . . . 0.0 109.409 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.87 120.88 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.865 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.98 96.1 32.65 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 0.0 109.149 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.44 -34.45 33.06 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.493 3.462 . . . . 0.0 115.625 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.29 -34.88 65.99 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.892 0.477 . . . . 0.0 110.74 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -82.12 -36.47 27.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.763 0.825 . . . . 0.0 110.057 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.54 -17.52 62.31 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.055 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.88 34.62 23.9 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.697 1.199 . . . . 0.0 110.893 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 69.6 m -115.08 135.77 22.54 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.199 0.999 . . . . 0.0 109.171 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.54 153.07 63.75 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.455 2.104 . . . . 0.0 111.708 169.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 59.4 mt -52.57 -48.07 66.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.354 1.061 . . . . 0.0 111.766 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.26 -35.98 78.76 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.336 1.055 . . . . 0.0 112.571 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.39 66.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.67 . . . . 0.0 111.658 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.429 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.3 pt -124.06 24.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.645 0.778 . . . . 0.0 110.46 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 5.5 tt0 -68.85 135.66 51.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.853 174.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.5 112.08 10.87 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.12 -6.7 19.78 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.861 2.374 . . . . 0.0 112.791 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.52 -53.21 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.788 0.835 . . . . 0.0 109.466 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -91.94 -11.1 37.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.65 0.78 . . . . 0.0 112.596 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.91 36.65 12.62 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.015 0.926 . . . . 0.0 111.431 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -151.64 149.1 28.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.482 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.1 tm0? -67.14 121.6 79.06 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 123.49 0.716 . . . . 0.0 109.371 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 153.21 41.19 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.535 2.157 . . . . 0.0 113.747 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.36 -17.18 32.98 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.46 170.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -150.72 130.69 13.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.594 1.157 . . . . 0.0 108.368 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.46 169.2 39.81 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.667 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 171' ' ' ILE . 12.8 pt -118.61 154.47 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.201 1.401 . . . . 0.0 110.058 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.36 121.26 37.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 95.2 t -120.11 122.52 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.5 ptmt -68.52 120.16 14.13 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.359 0.599 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -74.78 79.53 2.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 165.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HE2' ' A' ' 133' ' ' LYS . 12.5 t -68.72 -36.86 78.96 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.244 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.3 -35.03 76.21 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.476 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.79 -64.1 2.0 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.307 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -171.55 27.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.906 0.482 . . . . 0.0 111.105 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.6 m-20 62.79 25.07 14.9 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.359 1.063 . . . . 0.0 111.78 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 187' ' ' ILE . 70.6 t -85.92 124.52 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 0.0 109.225 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 28.6 p -83.27 130.13 35.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -174.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.2 m -120.34 140.08 51.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.097 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.429 HD23 ' HB ' ' A' ' 117' ' ' ILE . 36.8 tp -89.54 107.49 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.356 0.598 . . . . 0.0 110.105 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 88.8 m-85 -99.99 145.95 27.28 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.24 134.66 54.12 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.51 78.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.757 0.66 . . . . 0.0 111.879 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -31.39 64.75 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.653 0.595 . . . . 0.0 111.678 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -73.3 -39.77 65.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.059 0.543 . . . . 0.0 111.739 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -75.97 -35.24 59.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.4 t -59.6 -38.75 82.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.061 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 15.6 tpt180 -57.77 -49.63 75.94 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 124.275 0.984 . . . . 0.0 110.101 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.84 -46.32 81.8 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.693 0.621 . . . . 0.0 111.658 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 166' ' ' ILE . 70.5 t -65.4 -42.41 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.58 63.99 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.501 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.8 -12.51 55.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.277 0.631 . . . . 0.0 111.201 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.21 74.28 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.733 -0.212 . . . . 0.0 113.161 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.09 133.69 81.35 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.52 179.17 3.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.829 2.353 . . . . 0.0 112.641 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -58.07 128.08 80.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.73 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.47 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 44.7 Cg_endo -64.51 -25.32 62.85 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.617 2.211 . . . . 0.0 113.476 -167.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -53.7 4.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.958 0.503 . . . . 0.0 111.499 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.3 t -108.87 -13.01 14.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -171.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 36.6 mmt180 62.47 28.34 16.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.576 1.151 . . . . 0.0 112.129 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 162' ' ' THR . 22.9 mm-40 -83.18 158.35 64.25 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.623 0.769 . . . . 0.0 109.894 170.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.88 119.36 6.38 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.154 1.903 . . . . 0.0 111.495 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 153' ' ' VAL . 68.1 mt -60.05 128.35 20.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 t -140.69 155.81 46.38 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.145 0.978 . . . . 0.0 109.1 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.91 -22.54 66.51 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.1 m -63.04 -32.28 73.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.391 1.076 . . . . 0.0 112.889 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 47.6 pt -97.2 -7.8 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 130' ' ' ILE . 10.5 tt -96.54 133.73 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.224 0.92 . . . . 0.0 109.475 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.14 178.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.208 1.403 . . . . 0.0 109.736 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -100.34 170.2 8.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.252 0.621 . . . . 0.0 110.729 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -68.86 -27.97 66.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.661 0.384 . . . . 0.0 110.947 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.75 -42.45 81.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.633 0.773 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.13 -12.28 60.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.314 -168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 27.7 p -118.69 151.05 38.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.897 0.879 . . . . 0.0 109.742 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.36 160.03 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -68.62 127.47 33.14 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.1 t70 -106.73 127.95 53.81 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.05 -42.34 63.23 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.099 0.875 . . . . 0.0 112.176 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -79.25 -16.09 57.0 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.753 0.252 . . . . 0.0 111.383 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.57 -29.79 19.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.125 0.57 . . . . 0.0 110.541 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.64 18.14 77.91 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.981 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -162.07 160.14 27.08 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.545 0.738 . . . . 0.0 109.176 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.588 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 87.4 m-85 -61.37 124.59 21.03 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.608 1.163 . . . . 0.0 111.737 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.5 pt -128.77 179.58 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.224 1.01 . . . . 0.0 108.432 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 133' ' ' LYS . 23.5 mm -79.92 149.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 122.549 0.34 . . . . 0.0 110.473 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -65.1 155.75 33.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.061 0.944 . . . . 0.0 112.693 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.62 -4.52 55.9 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.947 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 124.392 1.077 . . . . 0.0 109.091 176.731 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 . . . . . 0 C--O 1.22 -0.492 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.68 -45.39 70.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -167.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 35.3 t -71.52 -36.8 71.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.723 0.409 . . . . 0.0 110.693 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 98' ' ' ILE . 83.6 mt -63.23 -42.05 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -68.16 -31.95 71.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.467 1.107 . . . . 0.0 112.307 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -58.62 -46.55 86.82 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 168.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -67.08 -40.6 87.01 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.735 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 94' ' ' ILE . 85.3 mt -64.16 -44.8 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.247 0.476 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -66.82 -35.15 79.39 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.318 0.647 . . . . 0.0 112.48 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.679 0.391 . . . . 0.0 111.441 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.5 m -64.42 -21.33 66.61 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.58 1.152 . . . . 0.0 113.266 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.27 173.34 4.88 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 121.468 0.651 . . . . 0.0 112.316 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.23 159.51 36.12 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.777 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.7 t -77.41 108.67 10.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.79 134.64 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.102 -171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.2 m -135.82 94.86 14.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.244 1.017 . . . . 0.0 108.982 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.41 ' HB3' HD11 ' A' ' 117' ' ' ILE . 24.2 Cg_endo -58.18 -35.31 98.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.715 2.943 . . . . 0.0 113.833 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -31.66 32.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.008 0.523 . . . . 0.0 111.372 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -75.65 -40.4 56.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.565 0.346 . . . . 0.0 110.733 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 95.6 mt -71.82 -14.92 62.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.75 0.82 . . . . 0.0 111.946 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 64.27 10.52 5.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.763 1.225 . . . . 0.0 111.965 -172.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.465 ' SG ' ' HZ ' ' A' ' 186' ' ' PHE . 58.8 m -94.52 130.82 32.41 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.897 0.879 . . . . 0.0 110.156 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.41 155.02 72.08 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.612 2.208 . . . . 0.0 111.574 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 63.5 mt -52.57 -49.77 64.3 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.189 0.931 . . . . 0.0 111.962 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.24 -41.2 71.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.242 1.017 . . . . 0.0 112.941 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.06 63.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.509 0.724 . . . . 0.0 111.785 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.564 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.5 pt -126.63 17.8 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.663 0.785 . . . . 0.0 110.756 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 39.6 tt0 -69.84 137.59 51.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 111.064 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.454 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 34.9 t -73.7 112.11 14.95 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.97 -4.31 15.19 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.754 2.302 . . . . 0.0 112.759 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 mt -83.33 -54.82 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.837 0.855 . . . . 0.0 109.311 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -88.68 -12.38 42.56 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.079 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.11 36.34 18.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.954 0.902 . . . . 0.0 111.464 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -148.51 151.57 35.36 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.163 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.8 tm0? -68.73 115.47 31.07 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.7 Cg_endo -71.82 160.11 48.79 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.569 2.18 . . . . 0.0 113.258 -167.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.2 pt-20 -83.9 -31.04 25.9 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.158 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.23 145.41 31.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.191 1.396 . . . . 0.0 108.203 174.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.02 169.69 40.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.871 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.77 153.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.187 1.395 . . . . 0.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -97.96 117.15 31.64 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 73.7 t -110.92 123.31 66.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 188' ' ' ILE . 18.4 ptmt -71.03 108.35 4.55 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.74 0.781 . . . . 0.0 110.426 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -75.91 76.04 2.82 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 t -69.51 -32.51 71.41 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.353 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.07 -44.63 91.88 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.084 0.865 . . . . 0.0 110.813 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.21 -67.34 1.94 Allowed Glycine 0 C--N 1.348 1.211 0 O-C-N 123.704 0.628 . . . . 0.0 112.868 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.8 m -170.78 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.973 0.909 . . . . 0.0 110.305 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.08 23.68 12.45 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.405 1.097 . . . . 0.0 111.086 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.6 124.59 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.575 ' SG ' HD13 ' A' ' 188' ' ' ILE . 56.8 m -83.42 118.82 23.99 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.504 HG21 HD11 ' A' ' 161' ' ' LEU . 18.1 m -111.86 134.21 53.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 117' ' ' ILE . 30.3 tp -90.41 103.29 15.99 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.721 0.638 . . . . 0.0 109.928 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 95.1 m-85 -97.05 136.91 36.93 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.6 t70 -57.8 130.48 46.67 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.31 -43.36 74.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.251 0.969 . . . . 0.0 111.908 -172.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.67 42.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.869 0.468 . . . . 0.0 111.705 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.77 65.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.935 0.494 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -77.02 -39.63 49.51 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -55.17 -34.59 63.98 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.583 1.153 . . . . 0.0 111.437 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.2 tpm_? -63.1 -54.32 39.69 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.858 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.9 mt -55.31 -44.4 75.74 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.361 1.038 . . . . 0.0 111.681 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 166' ' ' ILE . 60.8 t -64.78 -47.4 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.736 0.647 . . . . 0.0 109.44 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.47 -32.15 82.1 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.542 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.3 mm-40 -82.96 -28.93 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.335 0.654 . . . . 0.0 111.164 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.04 14.3 42.98 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.491 0.495 . . . . 0.0 112.668 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.55 134.63 57.67 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.162 0.985 . . . . 0.0 109.664 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.47 -171.25 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.704 2.269 . . . . 0.0 112.627 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.492 ' ND1' HG22 ' A' ' 162' ' ' THR . 49.0 t-80 -61.24 123.95 78.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.614 0.766 . . . . 0.0 108.981 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.91 -11.22 29.03 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.129 1.886 . . . . 0.0 113.189 -167.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 142' ' ' THR . 88.6 mt -96.49 -65.93 0.94 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.178 0.591 . . . . 0.0 110.616 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.492 HG22 ' ND1' ' A' ' 159' ' ' HIS . 11.1 t -98.71 -3.15 36.51 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.863 0.465 . . . . 0.0 111.997 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 66.01 15.56 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.581 1.553 . . . . 0.0 112.537 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.42 150.54 82.54 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 123.162 0.585 . . . . 0.0 110.97 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.34 113.6 2.33 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.246 1.964 . . . . 0.0 109.92 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.503 HG21 HG22 ' A' ' 153' ' ' VAL . 72.3 mt -56.21 128.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 O-C-N 123.808 0.693 . . . . 0.0 110.291 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.4 t -143.83 157.94 44.02 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.061 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.94 -15.37 63.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.439 0.696 . . . . 0.0 111.462 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -67.5 -48.15 67.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.027 0.931 . . . . 0.0 111.804 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 43.6 pt -83.42 -5.36 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.91 139.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 188' ' ' ILE . 29.0 m -125.45 170.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 0.0 109.751 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.37 150.05 28.6 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.146 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.402 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 17.7 p-80 -63.97 -18.79 64.62 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.882 0.739 . . . . 0.0 112.901 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.61 -24.2 24.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.411 0.684 . . . . 0.0 111.598 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -87.97 5.15 42.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.173 0.589 . . . . 0.0 110.563 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 24.6 p -129.0 130.71 47.0 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.26 157.74 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -67.36 119.04 11.55 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.486 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.1 t70 -99.59 134.94 41.75 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.92 -34.99 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.848 0.859 . . . . 0.0 111.957 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.6 t -80.61 -29.26 36.87 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.426 0.557 . . . . 0.0 110.695 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.553 ' HG3' HD13 ' A' ' 187' ' ' ILE . 25.4 mmt180 -82.2 -25.55 34.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.963 0.505 . . . . 0.0 110.404 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.7 18.19 79.79 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.824 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -166.66 164.38 16.78 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 93.8 m-85 -59.74 120.95 10.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.81 0.844 . . . . 0.0 111.405 175.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.553 HD13 ' HG3' ' A' ' 183' ' ' ARG . 13.2 pt -132.47 177.34 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.823 0.849 . . . . 0.0 109.227 168.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 133' ' ' LYS . 30.8 mm -76.06 153.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.262 0.625 . . . . 0.0 110.438 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 123.429 0.692 . . . . 0.0 111.325 175.141 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 121.297 0.57 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -68.92 -21.43 64.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.51 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 39.5 t -68.27 -40.45 81.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.3 mt -63.26 -48.08 89.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -53.83 -44.89 70.64 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.424 1.089 . . . . 0.0 111.465 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.85 95.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.508 0.723 . . . . 0.0 110.626 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -67.43 -32.9 74.08 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 123.253 0.621 . . . . 0.0 110.985 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.534 HG23 HD13 ' A' ' 130' ' ' ILE . 91.0 mt -67.7 -41.29 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.899 0.479 . . . . 0.0 109.839 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 m -66.35 -39.55 89.26 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.7 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -82.21 -30.5 30.82 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 78.3 m -89.88 -15.54 31.95 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.71 168.55 17.52 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.696 0.76 . . . . 0.0 112.444 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -156.71 155.62 31.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.988 172.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 110.14 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.09 107.54 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.098 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 40.3 m -112.25 95.96 33.03 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.552 1.141 . . . . 0.0 108.558 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.5 -36.95 95.3 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.714 2.943 . . . . 0.0 114.376 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.08 36.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -78.52 -39.36 38.25 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 86.5 mt -72.74 -22.2 60.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.07 0.948 . . . . 0.0 111.271 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 56.36 11.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.287 1.035 . . . . 0.0 113.213 -172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 58.4 m -84.35 138.48 38.97 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 123.681 0.792 . . . . 0.0 109.588 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.19 142.84 99.73 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.123 1.882 . . . . 0.0 110.446 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 125' ' ' GLN . 82.3 mt -52.64 -40.5 62.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 111.998 -173.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.28 -44.05 75.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.026 0.93 . . . . 0.0 112.273 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.33 69.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.565 0.746 . . . . 0.0 111.117 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 24.2 pt -112.32 23.34 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.31 129.69 34.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.017 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 29.2 t -68.97 111.56 8.8 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 -8.62 23.81 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.694 2.263 . . . . 0.0 112.759 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.2 mt -78.06 -57.43 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.113 0.965 . . . . 0.0 109.086 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.8 p -91.32 -6.02 53.71 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.457 -171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.3 31.35 19.36 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.026 0.931 . . . . 0.0 111.957 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.64 154.26 41.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.57 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -67.24 113.99 16.44 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 94.4 Cg_endo -76.56 165.7 28.53 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.157 2.572 . . . . 0.0 113.773 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.9 pt-20 -79.94 -36.14 36.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.293 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.554 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -151.29 146.43 26.03 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 108.0 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.47 169.43 41.12 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.959 -0.638 . . . . 0.0 114.397 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.534 HD13 HG23 ' A' ' 98' ' ' ILE . 11.6 pt -122.42 155.45 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 125.645 1.578 . . . . 0.0 109.863 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -94.82 121.88 36.87 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 88.6 t -127.02 121.56 58.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.623 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.8 ptmt -67.33 113.77 5.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.673 0.749 . . . . 0.0 110.425 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -71.29 85.37 0.79 Allowed 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 163.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.9 t -64.97 -45.97 83.44 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.163 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.84 -38.07 89.73 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.845 0.715 . . . . 0.0 111.235 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.11 -64.05 3.77 Favored Glycine 0 C--N 1.344 1.028 0 O-C-N 123.821 0.701 . . . . 0.0 112.684 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.9 m -160.56 14.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.29 0.636 . . . . 0.0 111.922 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.9 m-20 60.4 27.2 16.79 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.05 138.36 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.004 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.656 ' SG ' HD13 ' A' ' 188' ' ' ILE . 20.4 m -84.03 121.65 27.7 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.079 0.951 . . . . 0.0 108.56 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.1 m -118.91 141.7 48.42 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.7 tp -91.94 105.47 17.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 109.963 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 75.1 m-85 -98.94 143.36 29.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 15.8 t70 -60.96 129.62 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.73 81.02 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.906 0.754 . . . . 0.0 112.057 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.03 -28.26 60.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.78 0.432 . . . . 0.0 111.301 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.23 62.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.379 0.671 . . . . 0.0 111.477 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -76.06 -37.92 57.68 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.748 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 48.2 t -64.21 -32.76 74.47 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.256 0.622 . . . . 0.0 110.853 174.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.1 tpm_? -59.28 -53.35 59.21 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 123.833 0.708 . . . . 0.0 109.333 172.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.5 mt -53.66 -48.09 69.76 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.247 0.967 . . . . 0.0 111.572 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.36 -40.69 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.166 0.586 . . . . 0.0 110.471 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.94 76.44 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.826 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.8 mm-40 -90.71 -11.48 39.56 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.663 0.785 . . . . 0.0 111.208 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.31 75.89 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 123.048 0.356 . . . . 0.0 112.961 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.87 138.48 46.62 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.764 1.226 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.02 178.25 7.7 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.633 2.222 . . . . 0.0 112.581 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -51.92 132.47 39.09 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -173.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.21 -23.8 28.32 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.868 1.712 . . . . 0.0 113.426 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.32 -43.38 12.2 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.4 t -121.52 -14.1 8.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 63.42 28.18 15.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.519 1.128 . . . . 0.0 112.364 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 162' ' ' THR . 14.7 mm-40 -78.36 152.98 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.497 0.719 . . . . 0.0 110.131 172.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.78 114.71 2.53 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.738 2.292 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.465 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.8 mt -66.3 138.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.744 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 t -150.77 164.27 36.59 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.398 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.69 -23.23 66.1 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.753 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 m -66.34 -43.16 86.88 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.682 0.793 . . . . 0.0 111.571 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.2 pt -85.5 -10.27 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.32 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 188' ' ' ILE . 33.3 m -135.03 175.75 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.017 1.327 . . . . 0.0 110.156 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 37.2 mtmm -99.89 166.68 10.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.349 0.659 . . . . 0.0 110.54 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -55.3 -43.45 74.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.62 0.768 . . . . 0.0 112.206 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.86 -21.54 47.38 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.225 0.61 . . . . 0.0 111.524 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -81.19 -25.0 37.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.707 0.803 . . . . 0.0 110.332 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.4 p -105.53 153.66 21.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.276 1.03 . . . . 0.0 108.856 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.81 162.32 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -72.72 134.19 44.91 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.44 120.04 37.53 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.53 -42.39 71.27 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.897 0.748 . . . . 0.0 112.353 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.5 t -72.09 -30.09 64.76 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.784 0.265 . . . . 0.0 110.697 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -76.96 -32.97 57.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.367 0.667 . . . . 0.0 110.291 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.07 89.69 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.719 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -141.06 157.25 45.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -68.81 128.71 37.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.765 0.826 . . . . 0.0 109.977 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.2 175.2 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 172' ' ' VAL . 24.9 mm -79.75 143.07 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.506 0.723 . . . . 0.0 112.271 176.457 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 26.6 mp0 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.36 79.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.223 0.609 . . . . 0.0 111.44 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -66.44 -42.88 86.98 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.491 0.716 . . . . 0.0 109.872 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.94 -41.19 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.706 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 46.7 mm-40 -58.43 -41.82 85.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.609 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -60.16 -41.42 92.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.558 0.536 . . . . 0.0 110.634 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -44.54 88.65 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.507 0.504 . . . . 0.0 110.618 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 130' ' ' ILE . 88.9 mt -59.21 -41.01 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.022 0.929 . . . . 0.0 109.951 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -64.66 -39.27 93.4 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.664 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -86.75 -23.59 25.41 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 79.7 m -89.25 -24.1 22.18 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.605 0.762 . . . . 0.0 111.657 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 130' ' ' ILE . 20.4 pttp -69.1 168.68 13.42 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.563 0.697 . . . . 0.0 112.015 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.95 164.87 37.94 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.695 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -67.92 99.12 0.81 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.493 HG12 ' NE2' ' A' ' 125' ' ' GLN . 59.8 t -70.66 96.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.496 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.3 m -100.05 98.61 7.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.185 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.14 -37.88 93.74 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.094 2.529 . . . . 0.0 113.772 -168.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.75 -31.54 68.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.461 0.704 . . . . 0.0 111.548 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -78.89 -36.75 41.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.964 0.505 . . . . 0.0 110.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.58 -21.62 63.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 69.5 -40.04 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.473 1.909 . . . . 0.0 113.56 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.45 134.59 76.72 Favored Pre-proline 0 C--N 1.353 0.729 0 C-N-CA 124.678 1.191 . . . . 0.0 109.419 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.47 166.93 10.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.205 2.604 . . . . 0.0 112.891 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 67.4 mt -51.17 -47.4 62.15 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.758 0.823 . . . . 0.0 111.581 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.25 -40.06 80.8 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.911 0.884 . . . . 0.0 112.461 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.51 65.65 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.459 0.704 . . . . 0.0 112.255 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' HD23 ' A' ' 143' ' ' LEU . 13.0 pt -120.35 11.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.06 0.944 . . . . 0.0 110.868 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 34.7 tt0 -70.3 134.42 47.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.51 1.124 . . . . 0.0 111.407 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.1 t -67.2 114.96 21.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 124.045 0.841 . . . . 0.0 109.211 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.558 ' HB2' HD21 ' A' ' 161' ' ' LEU . 92.3 Cg_endo -76.51 0.9 9.02 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.676 2.251 . . . . 0.0 113.049 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 160' ' ' PRO . 34.8 mt -84.79 -54.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.678 0.791 . . . . 0.0 109.084 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p -95.68 -8.3 35.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.735 -171.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.27 42.23 25.51 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.36 1.064 . . . . 0.0 111.791 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.08 153.67 35.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.161 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.493 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.2 tm0? -72.18 118.7 69.52 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.34 163.46 34.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.897 2.398 . . . . 0.0 113.392 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 16.0 pt-20 -99.47 -20.71 16.3 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.413 172.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.9 133.09 26.29 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 125.629 1.571 . . . . 0.0 106.833 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.18 158.43 31.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.362 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.508 HG21 HG23 ' A' ' 98' ' ' ILE . 11.2 pt -113.77 156.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.905 1.282 . . . . 0.0 110.419 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.726 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 36.5 m-85 -99.32 118.34 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.932 172.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 91.5 t -123.17 119.39 57.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -67.66 114.41 6.26 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.638 0.586 . . . . 0.0 111.299 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -73.71 82.79 1.59 Allowed 'General case' 0 C--O 1.252 1.217 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.8 t -62.19 -33.97 75.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.038 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.7 -36.05 81.59 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.488 0.715 . . . . 0.0 111.54 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.15 -62.96 5.77 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 124.15 0.906 . . . . 0.0 111.349 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t 174.98 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.482 1.513 . . . . 0.0 107.433 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.46 16.79 10.7 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 121.866 0.841 . . . . 0.0 109.766 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 187' ' ' ILE . 58.5 t -78.59 124.48 37.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.86 -171.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 18.6 t -85.75 133.43 34.0 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.9 m -119.64 138.63 53.13 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.592 0.757 . . . . 0.0 109.406 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.6 tp -91.18 107.82 19.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.184 0.516 . . . . 0.0 109.725 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 94.9 m-85 -98.56 155.37 17.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.347 1.059 . . . . 0.0 108.264 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.8 140.31 53.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.16 97.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.978 0.799 . . . . 0.0 111.195 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.4 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.196 0.598 . . . . 0.0 112.101 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.81 -42.22 58.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.165 0.586 . . . . 0.0 111.187 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -74.95 -38.43 61.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.594 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.5 t -57.03 -37.32 71.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.648 0.779 . . . . 0.0 111.01 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.3 tpm_? -60.13 -57.1 14.27 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.266 0.978 . . . . 0.0 110.251 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.32 -44.14 68.16 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.329 1.018 . . . . 0.0 111.7 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 94.2 t -62.56 -48.02 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.159 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.26 -25.08 73.6 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.014 0.821 . . . . 0.0 113.283 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 10.1 mm-40 -78.65 -23.24 45.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.996 0.518 . . . . 0.0 110.541 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.61 24.07 26.84 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.595 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 69.4 mt -87.3 156.94 53.94 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.335 1.054 . . . . 0.0 110.728 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.44 -177.12 3.65 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.933 2.422 . . . . 0.0 112.829 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.425 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.3 t-80 -61.56 126.71 87.32 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.389 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.478 ' HG3' HG12 ' A' ' 121' ' ' ILE . 58.6 Cg_endo -64.92 -21.33 64.14 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.571 2.181 . . . . 0.0 113.371 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 120' ' ' PRO . 55.7 mt -89.57 -66.37 0.93 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.956 0.502 . . . . 0.0 110.995 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.4 t -104.56 -1.22 26.83 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.608 -167.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 62.24 26.61 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.94 1.296 . . . . 0.0 112.995 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -77.79 150.52 78.72 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.167 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.33 114.07 2.91 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.172 1.915 . . . . 0.0 110.072 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 62.8 mt -59.33 133.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 123.448 0.467 . . . . 0.0 110.226 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.7 t -151.55 166.19 31.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.719 0.808 . . . . 0.0 109.501 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.48 -18.98 65.27 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.37 1.068 . . . . 0.0 111.46 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -71.45 -42.43 68.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.802 0.841 . . . . 0.0 111.738 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 166' ' ' ILE . 32.6 pt -85.99 -8.56 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.4 tt -103.62 134.85 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.564 HG11 HD12 ' A' ' 188' ' ' ILE . 33.4 m -121.97 160.2 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.556 0.742 . . . . 0.0 109.892 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -73.32 149.67 42.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.864 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 20.5 p80 -63.7 -23.9 67.56 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.095 0.247 . . . . 0.0 111.452 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.81 -29.51 66.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.856 0.862 . . . . 0.0 110.873 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 189' ' ' LYS . 24.5 mm-40 -93.73 17.43 11.91 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 112.191 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 23.7 p -140.84 134.85 30.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.293 0.637 . . . . 0.0 109.365 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -131.86 159.51 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 107.561 -178.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -67.36 139.94 57.21 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -116.34 138.56 51.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.62 -45.91 84.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.955 1.41 . . . . 0.0 110.72 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 50.1 m -66.03 -48.56 70.7 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.875 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.538 ' HG3' HG21 ' A' ' 187' ' ' ILE . 32.9 mmt180 -82.08 -24.3 35.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.468 0.707 . . . . 0.0 110.949 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.3 22.27 73.7 Favored Glycine 0 N--CA 1.472 1.042 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.833 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -165.11 164.71 20.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.632 . . . . 0.0 110.005 -170.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -59.8 120.26 9.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 110.54 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.8 pp -134.36 169.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.546 1.138 . . . . 0.0 108.786 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 133' ' ' LYS . 15.6 mm -71.19 151.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 176' ' ' GLU . 53.3 mtpt . . . . . 0 N--CA 1.486 1.352 0 CA-C-N 118.363 0.529 . . . . 0.0 112.046 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.2 mp0 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.81 -49.37 68.5 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.139 0.899 . . . . 0.0 111.791 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 38.3 m -65.21 -36.93 85.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.895 0.878 . . . . 0.0 110.755 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 91' ' ' GLN . 44.3 mt -67.77 -45.76 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.576 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -54.41 -46.37 73.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.758 1.223 . . . . 0.0 111.2 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.6 m-80 -57.16 -49.96 74.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.769 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -63.72 -35.01 79.16 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 123.388 0.675 . . . . 0.0 111.603 -176.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 94' ' ' ILE . 93.9 mt -65.79 -44.48 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 t -65.66 -35.3 80.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.261 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.0 mm-40 -80.91 -49.79 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.903 0.481 . . . . 0.0 111.68 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -69.41 -21.52 63.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.413 1.085 . . . . 0.0 113.327 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.79 173.59 5.12 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -160.27 161.73 33.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.57 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -69.31 107.52 3.31 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 128' ' ' LYS . 92.8 t -72.64 99.32 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.298 0.57 . . . . 0.0 109.64 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 82.1 m -105.1 102.18 34.7 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.77 1.228 . . . . 0.0 108.014 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 11.3 Cg_endo -53.84 -27.56 44.25 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.693 2.929 . . . . 0.0 113.422 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.5 -40.52 70.13 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.548 0.739 . . . . 0.0 110.635 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.5 HH11 HD23 ' A' ' 110' ' ' LEU . 2.6 tmt_? -73.6 -44.19 57.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.553 0.741 . . . . 0.0 109.587 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 HH11 ' A' ' 109' ' ' ARG . 95.9 mt -71.72 -22.31 61.64 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.555 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 55.7 14.3 1.24 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 0.0 112.917 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.9 m -99.83 136.43 20.23 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 124.237 1.015 . . . . 0.0 108.663 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -53.95 150.42 30.72 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.929 2.419 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.6 mt -53.26 -49.34 67.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.251 1.02 . . . . 0.0 112.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.7 -35.5 76.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.148 0.979 . . . . 0.0 112.519 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.97 69.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.087 0.555 . . . . 0.0 111.623 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.514 ' HB ' HD23 ' A' ' 143' ' ' LEU . 22.9 pt -109.18 4.3 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.21 0.604 . . . . 0.0 111.038 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 36.8 tt0 -60.71 134.99 57.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 31.7 t -67.04 114.31 17.57 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.128 0.971 . . . . 0.0 108.807 175.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.526 ' HB2' HD21 ' A' ' 161' ' ' LEU . 73.9 Cg_endo -70.62 -9.14 25.19 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.616 2.211 . . . . 0.0 112.782 -176.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.5 -55.43 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.833 0.853 . . . . 0.0 109.669 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -98.9 -6.19 29.38 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.557 -170.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.55 34.37 20.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.054 0.942 . . . . 0.0 112.257 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.05 148.03 49.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.783 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.02 108.75 3.0 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 171.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 56.1 Cg_endo -68.69 154.93 70.4 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.562 2.174 . . . . 0.0 113.11 -167.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.0 pt-20 -81.91 -30.55 31.83 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.715 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -153.03 142.6 21.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.991 1.316 . . . . 0.0 108.471 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.7 177.69 40.17 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.301 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.28 161.29 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.695 1.598 . . . . 0.0 109.251 -173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 60.6 m-85 -106.47 116.65 32.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.878 0.471 . . . . 0.0 110.355 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 97.0 t -117.12 121.6 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 22.2 ptmt -73.25 114.23 11.21 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.57 0.7 . . . . 0.0 110.626 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -68.15 88.31 0.29 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.4 t -61.09 -41.62 97.0 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.391 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.85 -32.01 72.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.29 0.636 . . . . 0.0 110.956 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.59 36.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.597 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.2 m 84.79 45.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.14 1.776 . . . . 0.0 111.442 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 61.16 22.67 12.95 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.716 1.206 . . . . 0.0 112.274 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 185' ' ' ASN . 88.6 t -76.89 120.42 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.269 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 58.0 m -83.2 134.12 34.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.5 m -124.59 147.92 48.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 117' ' ' ILE . 26.8 tp -89.87 105.34 17.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.306 0.574 . . . . 0.0 110.513 -175.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 79.2 m-85 -102.74 133.63 47.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.561 1.144 . . . . 0.0 108.316 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.7 t70 -57.21 130.73 47.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.666 0.666 . . . . 0.0 109.378 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.34 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.733 0.813 . . . . 0.0 112.215 -171.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.99 63.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.799 0.44 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.96 76.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.686 0.794 . . . . 0.0 111.795 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -75.54 -38.73 59.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.3 t -62.96 -28.76 70.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.489 0.716 . . . . 0.0 111.03 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.5 tpm_? -63.84 -52.94 57.81 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 123.937 0.773 . . . . 0.0 110.218 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -57.64 -42.96 84.48 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.946 0.778 . . . . 0.0 111.359 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 166' ' ' ILE . 94.6 t -65.73 -44.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.829 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.01 -26.7 69.37 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.895 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 38.5 mm-40 -79.98 -30.29 39.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.95 20.78 35.36 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.454 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.94 150.66 78.44 Favored Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.216 1.006 . . . . 0.0 110.501 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.38 173.69 14.07 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.61 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.469 ' ND1' HG22 ' A' ' 162' ' ' THR . 59.6 t-80 -54.27 129.01 59.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.666 0.786 . . . . 0.0 110.366 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -62.06 -22.38 74.13 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.62 2.213 . . . . 0.0 113.673 -170.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 120' ' ' PRO . 60.5 mt -103.4 -53.16 2.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.745 0.418 . . . . 0.0 111.827 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.469 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -104.14 -8.33 19.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.08 22.45 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.468 1.107 . . . . 0.0 113.167 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -75.2 155.8 86.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.592 0.757 . . . . 0.0 109.984 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -58.35 115.23 2.39 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.403 2.069 . . . . 0.0 110.57 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.545 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.3 mt -63.31 131.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 t -153.66 162.11 41.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 109.923 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.92 65.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.145 0.978 . . . . 0.0 111.258 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.0 t -66.2 -48.31 71.07 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.1 0.96 . . . . 0.0 111.476 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.3 pt -88.92 -2.67 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.35 137.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.63 169.74 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 109.537 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 176' ' ' GLU . 52.1 mtmt -82.8 156.03 23.88 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.298 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -64.56 -23.65 67.34 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -87.9 -21.93 24.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.694 0.797 . . . . 0.0 109.892 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 7.1 tp10 -78.76 -17.05 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.069 0.948 . . . . 0.0 111.471 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.4 p -128.62 154.64 46.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.087 0.955 . . . . 0.0 109.33 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.435 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -135.83 164.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.374 1.069 . . . . 0.0 108.714 178.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 21.3 p90 -78.96 121.7 25.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -105.65 127.03 52.82 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.06 -40.31 75.16 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.313 -170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 t -74.32 -24.26 59.18 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-N 117.531 0.15 . . . . 0.0 111.222 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -80.25 -30.49 38.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.85 25.01 70.54 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.22 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 78.0 m-20 -156.24 160.98 40.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.275 -171.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 60.4 m-85 -74.13 126.73 31.21 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 168.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.1 pt -132.5 177.31 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.664 0.785 . . . . 0.0 110.066 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.03 143.89 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.548 0.739 . . . . 0.0 109.88 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.435 ' HG2' HD12 ' A' ' 178' ' ' ILE . 60.0 mtpt . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.163 0.585 . . . . 0.0 112.378 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.8 mp0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -38.24 75.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.523 0.729 . . . . 0.0 111.742 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.4 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 29.4 t -70.93 -43.63 67.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.87 0.868 . . . . 0.0 109.93 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 98' ' ' ILE . 73.6 mt -63.42 -50.23 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.41 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.64 -23.36 58.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.984 0.914 . . . . 0.0 112.036 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.42 -38.35 84.45 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -67.31 -37.32 83.15 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 123.05 0.54 . . . . 0.0 110.431 175.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 150' ' ' SER . 90.7 mt -65.49 -38.08 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.208 0.603 . . . . 0.0 110.125 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -60.84 -40.44 92.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.394 1.078 . . . . 0.0 111.74 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -86.76 -40.19 15.24 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.0 m -76.82 -16.49 59.42 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.634 0.774 . . . . 0.0 111.785 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -71.03 154.89 41.42 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.385 0.612 . . . . 0.0 111.15 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.74 161.02 42.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.696 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.6 m -65.53 96.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 110.039 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' NE2' ' A' ' 125' ' ' GLN . 40.6 t -77.08 97.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 m -110.65 107.22 58.12 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD3' HE22 ' A' ' 125' ' ' GLN . 48.4 Cg_endo -64.18 -20.86 67.58 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.159 2.573 . . . . 0.0 113.016 -174.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.92 -35.16 29.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.43 1.092 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.81 -49.0 13.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.974 0.509 . . . . 0.0 110.418 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.3 mt -69.05 -21.31 64.11 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.148 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 55.38 19.39 3.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 112.772 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.47 134.15 40.79 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.36 149.11 76.13 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.182 1.922 . . . . 0.0 110.632 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.8 mt -52.13 -43.68 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.7 0.8 . . . . 0.0 111.407 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.34 -37.7 81.49 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.759 0.824 . . . . 0.0 112.541 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.09 71.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.14 0.576 . . . . 0.0 111.107 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.5 pt -117.09 31.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.986 0.914 . . . . 0.0 110.005 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -70.86 128.59 36.52 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.837 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -74.78 109.95 8.6 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 162.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.94 -11.55 27.55 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 123.085 2.523 . . . . 0.0 112.694 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.82 -52.84 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.603 0.761 . . . . 0.0 109.123 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.9 p -92.7 -12.6 31.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.504 1.122 . . . . 0.0 112.573 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 61.42 37.8 16.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.858 0.863 . . . . 0.0 111.32 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.36 151.92 37.32 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' NE2' HG12 ' A' ' 105' ' ' VAL . 24.0 tm0? -74.65 115.51 44.63 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 160.91 36.09 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.886 2.391 . . . . 0.0 113.458 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 12.5 pt-20 -87.87 -20.74 25.6 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.33 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.61 134.53 22.52 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 108.346 178.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.15 166.66 37.12 Favored Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.463 HG13 HG23 ' A' ' 132' ' ' VAL . 9.9 pt -124.87 155.46 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 0.0 109.386 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.61 115.07 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 130' ' ' ILE . 71.7 t -123.23 122.75 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -66.24 120.3 13.02 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.483 0.658 . . . . 0.0 110.962 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -72.7 84.25 1.18 Allowed 'General case' 0 C--O 1.249 1.065 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 161.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.7 t -67.76 -57.05 6.99 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.426 -168.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.02 -31.85 69.71 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.018 0.527 . . . . 0.0 111.42 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -63.38 4.66 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.035 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.2 m -149.92 5.68 0.59 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 65.73 21.32 11.56 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.187 0.995 . . . . 0.0 111.201 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.29 143.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.489 1.116 . . . . 0.0 109.291 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 31.1 p -86.21 140.52 30.06 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 117.921 0.328 . . . . 0.0 110.174 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.4 m -126.84 148.34 49.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.482 1.113 . . . . 0.0 108.184 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.8 tp -89.2 123.89 33.86 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.932 0.493 . . . . 0.0 109.87 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -120.76 132.89 55.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.104 0.961 . . . . 0.0 108.674 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.07 130.5 38.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.57 -46.36 77.21 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.079 0.862 . . . . 0.0 111.792 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.6 68.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.118 0.567 . . . . 0.0 111.619 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.62 62.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.696 0.798 . . . . 0.0 111.542 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.65 -41.85 64.99 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.803 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -63.5 -29.92 71.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.253 0.621 . . . . 0.0 110.867 176.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.8 tpm_? -61.53 -51.91 66.63 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 172.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -55.38 -43.93 75.6 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.295 0.997 . . . . 0.0 111.21 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 91' ' ' GLN . 46.5 t -67.44 -45.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.737 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.46 -27.6 66.09 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.306 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 19.1 mm-40 -78.65 -33.97 46.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.09 0.556 . . . . 0.0 110.828 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.81 28.52 11.02 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.73 144.12 28.95 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.669 1.188 . . . . 0.0 109.509 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.8 -177.83 4.08 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.795 2.33 . . . . 0.0 112.503 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.413 ' ND1' HG22 ' A' ' 162' ' ' THR . 57.4 t-80 -54.53 129.86 62.68 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.404 1.082 . . . . 0.0 110.902 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.24 -24.03 78.17 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.831 2.354 . . . . 0.0 114.087 -171.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.4 mt -103.06 -56.65 2.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.807 0.443 . . . . 0.0 111.882 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.413 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.6 t -102.52 -8.69 20.83 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.691 0.396 . . . . 0.0 111.384 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 63.5 24.71 14.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 0.0 112.546 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.0 154.82 90.77 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 114.11 2.95 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.017 1.811 . . . . 0.0 110.215 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.542 ' HA ' HD11 ' A' ' 170' ' ' ILE . 66.0 mt -63.05 134.75 28.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -149.37 163.39 37.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.074 0.95 . . . . 0.0 109.744 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.56 -18.09 65.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.851 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.5 t -70.96 -41.05 71.59 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 111.746 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -85.65 -11.41 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 130' ' ' ILE . 11.1 tt -99.61 133.43 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 188' ' ' ILE . 27.5 m -129.04 174.12 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.18 0.992 . . . . 0.0 110.18 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -94.17 164.35 13.09 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.229 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -57.29 -39.95 76.77 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.5 -4.64 57.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.146 0.43 . . . . 0.0 111.679 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -87.23 -21.93 25.54 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.515 0.674 . . . . 0.0 109.613 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.6 p -102.75 142.09 34.47 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 158.0 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 17.0 p90 -75.22 122.9 24.36 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -99.06 129.93 45.36 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -70.37 -34.71 72.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.385 1.053 . . . . 0.0 111.663 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 t -74.78 -28.4 60.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.214 0.206 . . . . 0.0 110.955 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 187' ' ' ILE . 37.4 mmt180 -82.14 -32.38 30.12 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 111.117 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.54 24.59 75.95 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.743 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -165.51 159.38 16.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.906 0.482 . . . . 0.0 109.876 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 90.7 m-85 -65.19 118.92 9.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.628 1.171 . . . . 0.0 111.111 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.429 HD13 ' HG3' ' A' ' 183' ' ' ARG . 21.8 pt -128.56 -179.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 108.06 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 172' ' ' VAL . 8.7 mm -83.57 156.26 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 123.974 0.91 . . . . 0.0 112.432 176.385 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 . . . . . 0 C--O 1.219 -0.547 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -38.1 77.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.978 0.799 . . . . 0.0 111.984 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 49.6 m -66.9 -39.22 87.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.292 0.637 . . . . 0.0 110.711 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 58.0 mt -68.63 -41.88 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.605 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -56.87 -41.11 77.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.876 1.271 . . . . 0.0 110.887 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -61.39 -44.86 96.42 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.283 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -63.43 -39.65 95.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.964 0.506 . . . . 0.0 111.441 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 150' ' ' SER . 77.8 mt -65.3 -37.73 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.242 0.617 . . . . 0.0 110.333 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.1 t -62.3 -45.69 92.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.61 0.764 . . . . 0.0 111.789 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -78.17 -29.47 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.161 0.584 . . . . 0.0 112.187 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.8 -10.38 23.09 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.412 0.685 . . . . 0.0 112.496 -172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -74.24 160.17 31.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -152.1 160.26 43.47 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.361 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.7 t -66.78 100.06 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.083 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.75 107.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 84.1 m -118.69 87.11 31.36 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.816 0.847 . . . . 0.0 109.776 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HB3' HD11 ' A' ' 117' ' ' ILE . 1.7 Cg_endo -43.88 -45.75 11.18 Favored 'Trans proline' 0 C--N 1.385 2.452 1 C-N-CA 125.42 4.08 . . . . 0.0 115.129 -176.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -20.48 55.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.064 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -91.3 -31.91 15.92 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.918 0.487 . . . . 0.0 110.575 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.59 -20.17 61.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.588 0.755 . . . . 0.0 110.341 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 59.12 18.98 6.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.507 1.523 . . . . 0.0 112.237 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.5 m -100.35 138.11 20.13 Favored Pre-proline 0 C--O 1.245 0.836 0 C-N-CA 124.165 0.986 . . . . 0.0 108.877 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.18 157.51 34.62 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.426 2.084 . . . . 0.0 111.357 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 71.8 mt -55.98 -38.78 70.89 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.083 0.553 . . . . 0.0 111.373 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.12 -38.38 82.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.02 0.928 . . . . 0.0 112.825 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.87 66.86 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.086 0.554 . . . . 0.0 111.593 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 107' ' ' PRO . 26.5 pt -124.08 16.43 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.856 0.862 . . . . 0.0 111.107 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.42 125.39 24.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.204 1.002 . . . . 0.0 110.221 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.91 111.47 10.72 Favored Pre-proline 0 C--N 1.354 0.775 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.96 -3.99 14.74 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.741 2.294 . . . . 0.0 112.105 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -84.98 -58.55 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.895 0.878 . . . . 0.0 109.403 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 p -88.4 -13.0 41.61 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.721 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.99 33.63 17.17 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.584 0.754 . . . . 0.0 111.533 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.88 152.76 46.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -73.13 110.43 8.54 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 57.7 Cg_endo -68.08 153.84 73.96 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.434 2.756 . . . . 0.0 114.266 -167.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -80.48 -38.8 29.24 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.605 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.1 pttm -138.64 143.58 39.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.177 1.391 . . . . 0.0 107.459 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.94 166.25 37.43 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.278 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 98' ' ' ILE . 11.3 pt -121.64 155.27 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.985 1.314 . . . . 0.0 109.086 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.51 123.16 41.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.78 121.91 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.701 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -71.09 119.0 14.59 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.751 0.657 . . . . 0.0 110.775 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -74.03 81.73 1.73 Allowed 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.1 t -68.87 -28.53 66.78 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.386 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.29 -37.42 85.4 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.353 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.35 -65.0 2.56 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -178.5 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.984 0.914 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 61.98 23.27 13.68 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.178 0.991 . . . . 0.0 111.379 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.16 118.35 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 186' ' ' PHE . 20.6 p -84.36 138.87 32.64 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.41 0.624 . . . . 0.0 110.032 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.3 m -127.83 145.03 51.06 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.18 0.992 . . . . 0.0 108.785 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 117' ' ' ILE . 61.0 tp -88.28 111.54 21.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -105.44 138.03 42.29 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.661 1.184 . . . . 0.0 108.022 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.7 t70 -59.1 135.44 57.63 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.381 0.537 . . . . 0.0 109.722 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.89 92.27 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.74 0.816 . . . . 0.0 111.777 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.36 -35.17 65.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.544 0.528 . . . . 0.0 111.072 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 -48.33 59.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.626 0.77 . . . . 0.0 112.007 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 130' ' ' ILE . 44.2 t80 -70.0 -40.7 75.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.998 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.512 ' HB2' HG21 ' A' ' 98' ' ' ILE . 32.5 t -62.44 -32.31 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.564 0.54 . . . . 0.0 111.13 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 151' ' ' ARG . 1.4 tpm_? -64.65 -49.38 71.24 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 123.637 0.586 . . . . 0.0 110.401 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.69 -45.16 81.94 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.174 0.921 . . . . 0.0 111.182 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 84.3 t -61.92 -46.77 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.217 0.607 . . . . 0.0 110.209 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.73 -31.19 79.95 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.041 0.838 . . . . 0.0 113.228 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.61 -15.66 53.97 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.653 0.781 . . . . 0.0 111.662 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.87 31.87 38.33 Favored Glycine 0 N--CA 1.47 0.966 0 O-C-N 123.204 0.315 . . . . 0.0 112.551 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.7 mt -90.24 150.82 43.86 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.663 1.185 . . . . 0.0 110.025 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.52 -179.43 5.31 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.685 2.257 . . . . 0.0 113.088 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.417 ' ND1' HG22 ' A' ' 162' ' ' THR . 47.1 t-80 -56.76 127.14 73.48 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.174 0.99 . . . . 0.0 111.317 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.09 -1.74 8.46 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.995 2.464 . . . . 0.0 114.069 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.63 -64.52 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.689 0.395 . . . . 0.0 110.624 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.417 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.1 t -98.39 -4.64 34.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.984 -167.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 61.55 20.96 11.7 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.496 1.118 . . . . 0.0 112.906 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.19 152.28 73.56 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.514 0.726 . . . . 0.0 110.589 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.78 115.06 2.69 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.056 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 70.3 mt -63.27 130.8 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.744 0.417 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -141.53 162.69 34.86 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 109.571 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.38 66.24 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.409 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.4 m -64.91 -41.68 95.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.51 0.724 . . . . 0.0 112.065 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.9 pt -85.61 -7.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.33 135.5 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.12 0.873 . . . . 0.0 109.337 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 188' ' ' ILE . 31.1 m -133.19 179.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 109.844 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -101.66 164.96 11.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.837 0.455 . . . . 0.0 110.578 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.25 -15.61 33.18 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.32 -26.82 56.19 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.099 0.952 . . . . 0.0 109.339 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 28.9 p -105.02 161.07 14.53 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.933 165.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -137.33 162.98 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.386 0.674 . . . . 0.0 109.265 175.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -72.59 135.01 45.44 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 163.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.0 t70 -119.02 127.05 53.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.55 -43.69 47.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.8 t -76.58 -28.48 56.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.172 0.442 . . . . 0.0 110.808 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -72.03 -31.8 66.53 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.22 81.2 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.598 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -149.33 150.12 31.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.026 0.93 . . . . 0.0 110.232 -170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.584 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 35.3 m-85 -63.42 119.24 9.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.668 0.787 . . . . 0.0 109.968 168.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.2 pt -127.15 177.84 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 0.0 109.723 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' A' ' 133' ' ' LYS . 37.1 mm -85.83 151.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.386 0.674 . . . . 0.0 110.129 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 121.101 0.477 . . . . 0.0 111.743 174.384 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 119.559 -0.257 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -41.47 67.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.927 0.891 . . . . 0.0 112.591 -168.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 41.4 t -65.7 -46.09 80.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.535 0.734 . . . . 0.0 110.04 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.5 mt -63.73 -41.14 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.128 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -59.8 -42.63 93.85 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.517 1.127 . . . . 0.0 110.622 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -61.87 -43.27 99.18 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.372 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -64.23 -31.32 72.47 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.242 0.617 . . . . 0.0 111.325 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.457 HG23 HD13 ' A' ' 130' ' ' ILE . 95.3 mt -70.42 -40.57 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.309 0.644 . . . . 0.0 109.671 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 t -65.57 -33.42 75.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.312 0.645 . . . . 0.0 111.292 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -74.95 -46.75 33.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.293 1.037 . . . . 0.0 112.327 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.593 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 71.0 m -82.33 -17.35 46.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.48 0.712 . . . . 0.0 112.845 -169.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -70.55 165.7 22.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.447 0.641 . . . . 0.0 112.603 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -156.41 159.65 38.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.381 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.6 m -66.97 102.58 1.0 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.626 0.579 . . . . 0.0 109.713 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.467 HG12 ' NE2' ' A' ' 125' ' ' GLN . 58.7 t -77.06 102.46 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.191 0.596 . . . . 0.0 110.148 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.1 m -112.29 106.84 55.86 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.158 0.983 . . . . 0.0 108.745 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 24.1 Cg_endo -60.3 -18.95 55.49 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.3 2.667 . . . . 0.0 112.745 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.6 -35.9 70.66 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.557 0.743 . . . . 0.0 110.277 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -83.73 -49.47 9.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.084 0.554 . . . . 0.0 110.347 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.5 -23.18 65.44 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.381 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 54.02 21.02 2.69 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.434 1.094 . . . . 0.0 112.783 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -103.81 136.87 19.14 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.273 1.029 . . . . 0.0 108.337 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.9 154.16 28.15 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.753 2.302 . . . . 0.0 111.801 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.7 mt -49.88 -46.33 51.49 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.848 0.717 . . . . 0.0 111.271 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.35 -40.66 74.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.835 1.254 . . . . 0.0 113.038 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.46 66.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.762 0.825 . . . . 0.0 111.633 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.576 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.9 pt -114.63 7.68 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.211 1.005 . . . . 0.0 111.153 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 35.3 tt0 -68.18 136.05 53.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.146 0.978 . . . . 0.0 111.055 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 36.8 t -69.26 110.26 5.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 124.411 1.069 . . . . 0.0 108.405 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.72 -1.04 10.2 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.056 2.504 . . . . 0.0 112.735 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.493 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.5 mt -84.35 -52.83 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.142 1.377 . . . . 0.0 109.756 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -97.89 -9.34 26.48 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.322 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.9 37.37 15.27 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.193 0.997 . . . . 0.0 111.894 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.49 151.13 37.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.195 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.3 tm0? -71.04 118.12 62.69 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 94.9 Cg_endo -74.03 162.5 38.87 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.074 2.516 . . . . 0.0 114.07 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.639 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -82.47 -32.17 29.0 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.67 172.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.639 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.3 pttt -147.67 143.64 27.79 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.315 1.446 . . . . 0.0 107.345 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.69 160.6 33.79 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.183 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 98' ' ' ILE . 10.2 pt -114.37 152.36 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.833 1.653 . . . . 0.0 109.365 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -93.66 120.38 33.86 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 98.4 t -120.34 119.51 60.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -69.09 118.82 12.47 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.635 0.731 . . . . 0.0 110.417 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -70.19 81.38 0.52 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 163.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -67.34 -56.34 10.11 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.875 -168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.05 -28.42 68.2 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.533 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.98 -65.73 2.14 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.193 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 m -152.68 10.98 0.49 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.1 t70 66.39 14.42 9.69 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 124.047 0.939 . . . . 0.0 111.116 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.17 124.93 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.498 0.719 . . . . 0.0 110.037 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 26.1 p -84.56 132.79 34.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.0 m -121.48 147.0 46.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 117' ' ' ILE . 27.0 tp -92.85 105.15 17.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 85.4 m-85 -99.77 140.04 34.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.619 1.168 . . . . 0.0 107.895 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.4 t70 -61.04 140.84 57.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.646 0.657 . . . . 0.0 109.676 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.44 74.93 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.106 0.879 . . . . 0.0 111.276 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.92 67.34 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.344 0.657 . . . . 0.0 111.621 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -48.12 60.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.478 0.711 . . . . 0.0 112.026 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 41.7 t80 -71.17 -39.63 71.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.965 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.44 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -60.25 -35.44 75.51 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.822 0.701 . . . . 0.0 110.898 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 41.1 ttt85 -62.35 -53.41 55.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.016 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.74 -45.76 67.14 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.292 0.637 . . . . 0.0 112.054 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 48.7 t -61.79 -49.67 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.69 -18.93 70.72 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.849 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.1 mm-40 -82.48 -29.08 30.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.387 0.675 . . . . 0.0 109.857 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.11 23.9 16.19 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 64.5 mt -91.46 147.97 36.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.397 1.079 . . . . 0.0 110.047 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.15 -167.02 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.939 2.426 . . . . 0.0 112.165 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.457 ' ND1' HG22 ' A' ' 162' ' ' THR . 45.0 t-80 -62.55 126.5 88.39 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 109.784 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -10.2 28.12 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.844 2.363 . . . . 0.0 113.851 -171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.08 -64.97 1.01 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.923 0.489 . . . . 0.0 110.04 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.457 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -98.0 -5.06 34.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.291 0.636 . . . . 0.0 112.097 -167.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 62.66 21.64 12.84 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.526 1.13 . . . . 0.0 112.746 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -80.46 151.52 71.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.138 0.575 . . . . 0.0 111.009 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.2 118.91 5.81 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.521 2.147 . . . . 0.0 111.357 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 71.8 mt -64.93 135.02 28.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.349 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 t -148.78 163.36 37.59 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.844 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.96 -24.12 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.946 0.898 . . . . 0.0 111.356 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -64.74 -45.85 84.72 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.665 0.786 . . . . 0.0 111.928 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.5 pt -80.98 -8.43 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.95 130.39 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 118.713 0.688 . . . . 0.0 109.391 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.6 m -132.73 173.84 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.211 1.404 . . . . 0.0 109.882 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.593 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 52.6 mtpt -101.5 169.85 8.59 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.029 0.442 . . . . 0.0 110.754 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -59.23 -28.53 66.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.523 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -78.66 -33.02 47.41 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.529 0.732 . . . . 0.0 111.387 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.62 -15.32 42.88 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.189 0.519 . . . . 0.0 110.857 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 30.5 p -112.9 146.94 38.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.603 0.761 . . . . 0.0 109.044 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.68 154.16 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 37.9 p90 -67.78 134.99 51.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 165.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.504 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.6 t70 -112.83 133.99 54.56 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.93 -49.97 33.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.598 1.159 . . . . 0.0 112.099 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 t -71.33 -24.55 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.049 0.386 . . . . 0.0 111.184 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.464 ' HA ' ' HE ' ' A' ' 183' ' ' ARG . 2.3 mmp_? -84.87 -34.05 22.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.358 0.663 . . . . 0.0 110.718 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.19 73.39 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.96 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -148.05 143.68 27.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.364 1.066 . . . . 0.0 109.481 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 25.5 m-85 -68.64 115.97 8.62 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 180' ' ' ASP . 24.1 pt -122.91 178.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.307 1.043 . . . . 0.0 108.611 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 133' ' ' LYS . 38.3 mm -83.87 155.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt . . . . . 0 C--O 1.242 0.701 0 CA-C-O 120.981 0.419 . . . . 0.0 110.39 174.105 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.54 -51.43 36.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -72.99 -43.18 62.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.473 0.309 . . . . 0.0 110.655 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.51 -49.35 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.476 0.71 . . . . 0.0 111.081 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.432 ' HA ' HD12 ' A' ' 98' ' ' ILE . 40.2 mt-30 -67.6 -29.55 68.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.567 0.747 . . . . 0.0 111.367 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 4.1 m-80 -62.35 -43.18 99.42 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 170.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -40.67 94.08 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 122.823 0.449 . . . . 0.0 110.078 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.499 HG23 HD13 ' A' ' 130' ' ' ILE . 94.9 mt -61.43 -38.32 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.732 0.813 . . . . 0.0 111.136 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.3 m -70.48 -32.56 70.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.136 0.574 . . . . 0.0 110.964 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 34.8 mt-30 -83.55 -39.42 20.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.105 0.562 . . . . 0.0 111.633 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -80.13 -19.97 46.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.545 -171.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -69.78 162.39 27.94 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 123.531 0.519 . . . . 0.0 110.877 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -148.11 159.65 43.71 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -68.34 97.97 0.79 Allowed 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.06 97.62 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 57.9 m -108.21 102.12 44.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.851 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 117' ' ' ILE . 12.9 Cg_endo -54.61 -29.75 62.27 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.666 2.91 . . . . 0.0 112.666 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 8.9 pt-20 -69.79 -35.42 74.86 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.635 1.174 . . . . 0.0 111.54 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.699 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 50.7 mtt180 -93.84 -36.4 12.26 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.669 0.787 . . . . 0.0 111.209 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.37 -18.43 62.37 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.705 0.802 . . . . 0.0 111.977 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 63.53 17.68 10.53 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.882 1.273 . . . . 0.0 111.483 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -104.46 129.48 24.96 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 124.309 1.044 . . . . 0.0 109.615 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.24 166.45 19.05 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.733 2.289 . . . . 0.0 111.748 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.7 mt -53.25 -47.14 69.31 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.737 0.648 . . . . 0.0 111.022 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -52.14 -43.38 64.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.98 0.912 . . . . 0.0 112.852 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.65 69.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.332 0.653 . . . . 0.0 111.415 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 107' ' ' PRO . 15.1 pt -122.01 29.42 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.905 0.882 . . . . 0.0 110.322 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -73.82 121.83 21.49 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.188 0.995 . . . . 0.0 109.439 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.1 t -68.74 114.95 25.97 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.28 -12.7 34.42 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.801 2.334 . . . . 0.0 112.755 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.61 -51.88 16.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.843 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.8 p -96.75 -19.54 18.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.348 1.059 . . . . 0.0 112.324 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 57.85 46.81 16.31 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.318 1.047 . . . . 0.0 111.823 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.46 152.64 38.41 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.802 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 23.3 tm0? -76.25 113.38 27.78 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.75 167.04 18.97 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.009 2.473 . . . . 0.0 113.451 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.02 -23.45 26.79 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -143.46 140.69 30.49 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.102 1.361 . . . . 0.0 108.43 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.45 157.08 29.39 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.335 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 98' ' ' ILE . 7.1 pt -110.77 161.26 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.038 1.335 . . . . 0.0 109.775 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -104.89 118.17 35.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.588 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.5 t -114.67 125.55 72.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.3 ptmt -73.75 114.61 12.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 124.004 0.815 . . . . 0.0 110.037 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -71.95 80.45 0.91 Allowed 'General case' 0 C--O 1.247 0.943 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 36.7 t -64.8 -49.43 70.71 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.716 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.73 -27.96 68.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.564 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.43 2.58 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.366 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.0 m -161.53 17.91 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.464 0.706 . . . . 0.0 111.198 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 13.6 t70 67.03 22.09 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.394 1.078 . . . . 0.0 111.235 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 187' ' ' ILE . 90.5 t -96.19 134.67 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.319 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 55.9 m -87.0 139.83 30.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.624 0.77 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.2 m -127.28 147.72 50.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.249 1.02 . . . . 0.0 108.853 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 tp -85.28 112.48 20.81 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.03 0.443 . . . . 0.0 110.222 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.47 137.17 46.86 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -58.34 137.43 57.2 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.177 0.444 . . . . 0.0 109.95 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.42 85.97 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.159 0.912 . . . . 0.0 111.15 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.54 -34.29 62.94 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.783 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.8 -44.09 61.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 112.118 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -73.48 -39.0 65.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.761 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -63.08 -37.98 89.37 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.583 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 48.4 ttt180 -53.64 -53.2 55.32 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.765 0.666 . . . . 0.0 109.481 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.26 -42.52 73.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.01 0.819 . . . . 0.0 111.829 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 149' ' ' PHE . 58.8 t -64.57 -46.9 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.416 0.448 . . . . 0.0 110.091 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.38 -36.06 91.93 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.825 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 45.3 mt-10 -75.95 -27.47 57.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.644 0.777 . . . . 0.0 110.819 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.79 20.44 34.02 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.747 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.86 144.16 47.62 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.035 0.934 . . . . 0.0 109.573 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.83 -170.3 0.88 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.992 2.462 . . . . 0.0 112.422 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.478 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.4 t-80 -62.5 126.81 89.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.571 0.749 . . . . 0.0 109.343 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.87 -14.87 39.71 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.23 1.954 . . . . 0.0 113.331 -170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.8 mt -96.12 -66.01 0.93 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 122.589 0.356 . . . . 0.0 110.886 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.478 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.0 t -90.51 -10.1 44.84 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 63.31 16.81 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.755 1.222 . . . . 0.0 112.843 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -80.12 144.69 59.2 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 122.87 12.37 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.702 2.268 . . . . 0.0 111.544 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.405 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -62.25 131.85 27.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 123.54 0.525 . . . . 0.0 110.104 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -143.77 161.95 37.29 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.89 0.876 . . . . 0.0 109.172 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -66.57 -23.04 66.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.665 174.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.2 m -69.44 -22.35 63.67 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.018 0.927 . . . . 0.0 112.728 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 48.0 pt -105.9 -2.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.8 tt -97.79 140.53 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.394 -0.816 . . . . 0.0 109.887 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.553 HG11 HD12 ' A' ' 188' ' ' ILE . 27.3 m -141.35 -179.89 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.793 1.237 . . . . 0.0 110.049 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.7 168.63 10.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.641 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 43.7 t-80 -68.02 -24.89 65.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.842 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.12 -22.2 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.766 0.426 . . . . 0.0 110.68 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -85.63 -21.54 28.38 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.218 0.533 . . . . 0.0 111.042 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.2 p -101.65 145.45 29.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 167.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -128.7 143.64 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -65.85 102.05 0.73 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -72.75 124.19 24.85 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.63 -34.59 67.44 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.189 0.996 . . . . 0.0 111.585 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.8 t -80.32 -25.43 39.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.119 0.168 . . . . 0.0 111.159 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -100.98 -14.63 17.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.811 0.445 . . . . 0.0 111.53 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.48 79.76 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.156 -0.802 . . . . 0.0 114.942 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -165.79 162.49 18.55 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 117.694 0.747 . . . . 0.0 110.47 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 83.9 m-85 -59.92 125.76 24.9 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 111.754 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -133.34 169.51 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.443 1.097 . . . . 0.0 109.134 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.553 HD12 HG11 ' A' ' 172' ' ' VAL . 42.6 mm -70.88 140.3 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.421 0.688 . . . . 0.0 110.733 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.561 0.696 . . . . 0.0 111.884 175.256 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.539 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 21.2 mp0 . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.27 -55.5 12.49 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 113.48 -164.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -66.27 -34.79 78.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.281 0.632 . . . . 0.0 111.092 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 98' ' ' ILE . 67.1 mt -69.62 -45.18 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.697 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -57.89 -44.1 86.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.853 1.261 . . . . 0.0 111.214 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.07 -45.42 87.12 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.702 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG2' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -66.82 -34.11 77.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.948 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.8 mt -65.84 -43.08 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.2 t -65.03 -33.94 77.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.792 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -77.77 -44.93 26.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.281 0.632 . . . . 0.0 111.829 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 82.8 m -76.61 -20.98 56.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.705 0.802 . . . . 0.0 112.675 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -71.08 168.27 17.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.645 0.736 . . . . 0.0 112.606 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -158.78 160.57 36.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.446 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.3 m -69.1 99.16 1.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.706 0.628 . . . . 0.0 109.469 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.32 119.89 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.411 0.685 . . . . 0.0 110.091 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 79.5 m -133.73 101.82 12.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.007 0.923 . . . . 0.0 109.386 -176.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 10.8 Cg_endo -52.39 -23.28 18.23 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.891 3.061 . . . . 0.0 114.008 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.9 pt-20 -73.14 -38.13 66.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.708 0.803 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 90.9 mtt-85 -93.43 -21.7 19.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.689 0.796 . . . . 0.0 111.514 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.17 -20.91 26.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.621 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.7 24.23 13.11 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.299 1.04 . . . . 0.0 111.46 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.4 m -110.31 137.21 20.56 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.128 0.971 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.1 162.67 28.65 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.275 1.983 . . . . 0.0 111.488 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 93.8 mt -54.26 -46.25 72.6 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.477 0.711 . . . . 0.0 111.289 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.13 -41.72 72.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.051 0.94 . . . . 0.0 112.694 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.98 68.88 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.579 0.752 . . . . 0.0 111.993 -175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 pt -122.95 30.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.039 0.936 . . . . 0.0 109.81 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 40.8 tt0 -78.62 134.98 37.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.442 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 18.7 t -71.49 114.94 32.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 109.185 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.36 -4.8 16.04 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.936 2.424 . . . . 0.0 113.497 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.498 HG12 ' HG3' ' A' ' 160' ' ' PRO . 59.7 mt -80.3 -53.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.87 0.868 . . . . 0.0 109.311 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -95.12 -11.01 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.148 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.63 37.06 19.49 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.986 0.914 . . . . 0.0 111.53 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.45 148.92 29.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.289 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 114' ' ' LEU . 25.7 tm0? -72.05 118.64 68.88 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.282 0.633 . . . . 0.0 109.444 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.72 161.89 18.95 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.769 2.313 . . . . 0.0 113.493 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -88.02 -14.13 39.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.049 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -151.7 134.21 15.41 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.844 0.858 . . . . 0.0 109.93 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.23 165.38 38.55 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.31 -172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 143' ' ' LEU . 9.2 pt -114.41 158.97 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.654 1.582 . . . . 0.0 110.395 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.04 123.65 44.52 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 90.5 t -118.86 119.95 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.1 ptmt -74.83 114.15 12.95 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 123.763 0.664 . . . . 0.0 110.047 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -73.39 72.96 1.35 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 171.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 35.1 t -68.13 -55.41 12.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.819 -167.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -58.32 -34.39 70.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.178 0.991 . . . . 0.0 112.14 -173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.98 -62.4 2.36 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.637 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.9 t -149.33 3.93 0.59 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 22.9 t70 59.33 47.23 11.62 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.792 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.08 124.6 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 122.948 0.499 . . . . 0.0 110.26 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 65.1 m -84.21 128.68 34.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.251 0.621 . . . . 0.0 109.66 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.0 m -122.8 143.39 49.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.347 1.059 . . . . 0.0 109.66 -171.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 130' ' ' ILE . 46.9 tp -88.91 106.34 18.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.237 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 89.2 m-85 -99.43 149.96 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 12.1 t70 -65.73 137.54 57.34 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.59 -52.96 62.84 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.985 0.803 . . . . 0.0 111.707 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.44 56.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.112 0.565 . . . . 0.0 111.966 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.6 -36.63 60.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.182 0.593 . . . . 0.0 110.771 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.6 t80 -73.14 -38.43 66.27 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -61.51 -31.52 71.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.923 0.889 . . . . 0.0 110.839 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.0 tpm_? -63.21 -54.26 40.25 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.947 0.779 . . . . 0.0 109.564 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.3 mt -54.8 -47.0 74.57 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.252 0.97 . . . . 0.0 111.376 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 166' ' ' ILE . 99.4 t -60.67 -50.47 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.801 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -59.94 -32.83 76.38 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 124.112 0.883 . . . . 0.0 113.371 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 28.6 mm-40 -75.86 -30.93 59.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.392 0.677 . . . . 0.0 111.187 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.71 9.42 49.75 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.243 -171.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.74 139.76 74.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.934 0.894 . . . . 0.0 109.201 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.48 -164.55 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.404 2.07 . . . . 0.0 112.242 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.79 131.25 92.92 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.321 1.049 . . . . 0.0 110.143 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.498 ' HG3' HG12 ' A' ' 121' ' ' ILE . 72.1 Cg_endo -70.96 -24.7 23.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.296 1.998 . . . . 0.0 113.265 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -85.23 -59.21 2.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.966 0.506 . . . . 0.0 111.051 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -108.27 -7.86 15.84 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.939 -167.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 65.86 19.12 11.27 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.629 1.172 . . . . 0.0 112.247 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -71.36 144.42 89.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.174 0.589 . . . . 0.0 110.117 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.37 116.5 3.79 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.406 2.071 . . . . 0.0 110.816 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 153' ' ' VAL . 77.3 mt -61.21 132.91 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.66 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -147.15 164.79 31.97 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.278 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -65.46 -24.62 67.21 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.541 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.8 t -69.3 -26.11 64.57 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.942 0.897 . . . . 0.0 112.333 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.4 pt -100.69 -6.1 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 118.317 0.508 . . . . 0.0 112.236 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.2 tt -100.7 136.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.05 0.841 . . . . 0.0 109.773 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.04 171.57 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.142 1.377 . . . . 0.0 110.829 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 43.9 mtmt -92.95 164.2 13.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.402 0.681 . . . . 0.0 110.595 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -66.1 -33.54 76.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.703 0.801 . . . . 0.0 111.61 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -80.28 -20.24 44.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.308 0.643 . . . . 0.0 110.848 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -84.8 -27.95 26.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.974 0.91 . . . . 0.0 110.998 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.3 p -105.7 151.67 24.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -136.78 158.95 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.166 0.987 . . . . 0.0 108.457 177.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -64.6 130.36 43.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.538 ' HB2' HG13 ' A' ' 187' ' ' ILE . 11.3 t70 -106.13 135.6 47.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.97 -50.68 10.74 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.363 1.039 . . . . 0.0 111.816 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -72.38 -26.4 61.88 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.795 0.27 . . . . 0.0 111.64 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -93.01 -28.65 16.26 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.892 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.15 28.51 44.77 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.489 0.493 . . . . 0.0 114.176 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -169.84 161.8 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.167 0.484 . . . . 0.0 110.313 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 88.5 m-85 -60.33 124.41 20.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.746 1.219 . . . . 0.0 111.879 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' A' ' 180' ' ' ASP . 2.8 pp -139.14 177.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.165 1.386 . . . . 0.0 109.31 174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.0 mm -77.16 146.0 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.319 0.648 . . . . 0.0 110.569 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 123.502 0.721 . . . . 0.0 112.05 178.496 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 18.3 mp0 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 110.641 -0.133 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -30.21 70.97 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.416 0.286 . . . . 0.0 111.605 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -71.6 -48.03 50.8 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.169 0.588 . . . . 0.0 109.614 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.6 mt -60.03 -50.26 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.9 0.88 . . . . 0.0 110.217 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.478 ' HA ' HD12 ' A' ' 98' ' ' ILE . 43.6 mt-30 -69.49 -28.36 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.309 1.044 . . . . 0.0 111.649 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.45 -44.26 96.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.32 -33.19 74.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.428 0.691 . . . . 0.0 110.886 177.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 95' ' ' GLN . 92.2 mt -63.17 -45.08 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 122.942 0.497 . . . . 0.0 109.73 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 m -65.51 -29.74 70.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.664 0.786 . . . . 0.0 112.52 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.98 -46.25 16.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.93 0.492 . . . . 0.0 111.819 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.1 -19.59 50.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.824 0.85 . . . . 0.0 112.878 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -67.27 172.24 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -156.47 157.09 34.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.974 172.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m -70.21 102.07 2.02 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.47 98.22 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.287 0.635 . . . . 0.0 109.797 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.6 m -103.48 103.23 34.48 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.992 0.917 . . . . 0.0 109.005 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HB3' HD11 ' A' ' 117' ' ' ILE . 29.8 Cg_endo -60.22 -28.9 87.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.243 2.629 . . . . 0.0 112.506 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.66 -33.52 75.84 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.833 0.853 . . . . 0.0 110.756 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -88.12 -46.57 9.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.961 -174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.1 -22.98 63.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.366 0.666 . . . . 0.0 111.274 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 57.58 13.46 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.56 1.144 . . . . 0.0 113.662 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.59 133.92 31.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-O 118.289 -0.862 . . . . 0.0 108.752 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.34 149.29 23.23 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.983 2.455 . . . . 0.0 112.623 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.6 -46.7 63.64 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.114 0.966 . . . . 0.0 111.865 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.04 -36.83 78.15 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.865 0.866 . . . . 0.0 112.271 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.29 68.43 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.491 0.717 . . . . 0.0 111.459 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 107' ' ' PRO . 17.9 pt -107.65 5.34 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 110.807 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.9 128.15 35.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.428 1.091 . . . . 0.0 110.855 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.0 t -64.0 110.32 3.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.75 -3.07 13.14 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.814 2.342 . . . . 0.0 112.43 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.541 HG12 ' HG3' ' A' ' 160' ' ' PRO . 36.7 mt -81.04 -53.25 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.866 0.867 . . . . 0.0 109.197 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.1 p -96.32 -10.22 28.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.96 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.21 53.32 10.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.758 1.223 . . . . 0.0 111.449 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.12 160.59 38.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.026 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -73.76 120.3 80.53 Favored Pre-proline 0 CA--C 1.559 1.3 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 73.9 Cg_endo -76.05 157.97 38.22 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.203 2.602 . . . . 0.0 113.829 -173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 10.7 pt-20 -81.24 -36.77 29.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.365 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.9 pttm -145.25 148.44 33.49 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.504 1.522 . . . . 0.0 107.369 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.04 159.81 32.65 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.302 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -113.98 166.45 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.527 1.531 . . . . 0.0 109.685 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -106.07 125.88 51.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.421 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 70.8 t -115.82 124.6 72.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.1 ptmt -74.92 104.44 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.904 0.859 . . . . 0.0 110.288 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -78.53 71.47 5.0 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 4.9 t -69.36 -26.89 64.9 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.419 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.7 -39.83 95.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.271 1.028 . . . . 0.0 110.709 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.39 -63.99 3.04 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -176.34 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.192 0.997 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 18.4 t70 62.44 27.26 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.412 1.085 . . . . 0.0 110.804 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.98 109.21 9.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.035 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 186' ' ' PHE . 58.4 m -83.49 119.62 24.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.3 m -118.86 145.33 45.78 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -170.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' HB ' ' A' ' 117' ' ' ILE . 31.1 tp -86.63 103.9 15.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.484 0.659 . . . . 0.0 110.58 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 92.8 m-85 -102.84 133.4 47.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 107.905 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.5 t70 -56.59 134.17 54.18 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.605 0.639 . . . . 0.0 109.653 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.48 -44.75 80.93 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.018 0.824 . . . . 0.0 111.555 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.63 40.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.861 0.465 . . . . 0.0 111.758 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.45 38.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.44 0.696 . . . . 0.0 111.705 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.0 t80 -74.26 -39.48 62.98 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -61.66 -35.03 76.78 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.938 0.774 . . . . 0.0 110.961 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 10.7 tpt180 -57.3 -52.16 66.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.16 0.584 . . . . 0.0 109.499 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.8 mt -54.8 -41.93 71.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.041 0.838 . . . . 0.0 111.956 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 166' ' ' ILE . 21.9 t -69.02 -41.34 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 123.939 0.774 . . . . 0.0 109.768 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.93 -29.16 73.41 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.174 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -84.01 -24.21 30.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.213 0.605 . . . . 0.0 110.784 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 19.79 56.55 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.842 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.1 147.48 73.25 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.078 0.951 . . . . 0.0 110.668 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.53 175.87 10.8 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.411 2.074 . . . . 0.0 111.91 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -55.43 131.81 70.43 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.417 1.087 . . . . 0.0 111.114 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HG3' HG12 ' A' ' 121' ' ' ILE . 71.7 Cg_endo -69.08 -17.82 40.47 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.413 2.075 . . . . 0.0 113.822 -169.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.05 -62.32 1.25 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.875 0.47 . . . . 0.0 111.302 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 t -104.99 -7.21 19.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.753 -168.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.29 26.11 14.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.54 1.136 . . . . 0.0 112.201 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.17 154.69 92.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.033 0.933 . . . . 0.0 110.116 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.07 113.36 2.58 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 121.919 1.746 . . . . 0.0 109.799 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.573 HG21 HG22 ' A' ' 153' ' ' VAL . 61.0 mt -60.87 122.58 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.2 t -147.32 162.41 39.01 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.809 0.844 . . . . 0.0 109.493 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -72.24 -14.88 61.89 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.84 0.456 . . . . 0.0 110.973 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.9 m -70.12 -30.61 67.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.729 0.812 . . . . 0.0 111.921 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.9 pt -99.5 -8.4 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 168' ' ' ALA . 8.4 tt -88.39 138.66 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.34 168.21 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.577 0.751 . . . . 0.0 111.135 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -90.35 153.27 20.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.812 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -65.02 -23.72 67.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -85.31 -21.96 28.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.57 0.748 . . . . 0.0 110.441 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.41 -17.86 37.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.993 . . . . 0.0 111.247 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 23.9 p -130.35 152.8 49.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.432 1.093 . . . . 0.0 109.325 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.414 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -138.93 164.88 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.746 1.218 . . . . 0.0 109.104 -177.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 5.3 p90 -73.84 128.45 35.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.495 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.2 t70 -106.63 140.2 39.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -79.22 -48.66 13.8 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.756 0.822 . . . . 0.0 112.523 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.478 HG23 ' HE ' ' A' ' 183' ' ' ARG . 10.1 t -71.29 -24.68 62.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.472 0.578 . . . . 0.0 111.544 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HE ' HG23 ' A' ' 182' ' ' THR . 5.0 mmp_? -81.2 -32.51 33.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 170.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.05 22.12 74.67 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.704 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -167.6 162.37 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.102 0.961 . . . . 0.0 108.87 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 70.7 m-85 -64.11 128.69 36.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.477 1.111 . . . . 0.0 112.012 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 180' ' ' ASP . 29.4 pt -132.57 177.35 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.644 1.177 . . . . 0.0 109.65 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 133' ' ' LYS . 48.7 mm -75.42 151.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.18 0.592 . . . . 0.0 109.6 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.5 mtpm? . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 123.102 0.561 . . . . 0.0 111.369 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.412 ' HG3' HG12 ' A' ' 153' ' ' VAL . 16.3 mp0 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -44.82 78.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.744 0.652 . . . . 0.0 111.473 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.9 t -67.03 -43.52 82.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 98' ' ' ILE . 63.6 mt -64.24 -44.54 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 123.713 0.633 . . . . 0.0 110.114 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.77 -44.05 90.55 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.526 1.13 . . . . 0.0 110.727 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.725 173.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.1 -35.49 81.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.714 0.805 . . . . 0.0 111.222 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 94' ' ' ILE . 94.3 mt -65.47 -41.36 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.6 t -64.27 -40.18 95.46 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.46 0.704 . . . . 0.0 111.69 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -80.39 -28.42 37.9 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.574 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 84.1 m -96.51 -18.08 20.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.121 0.568 . . . . 0.0 112.362 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.84 169.15 16.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 111.47 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -155.8 158.03 37.45 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m -68.05 96.53 0.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.03 100.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.235 0.614 . . . . 0.0 110.178 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.1 m -101.82 99.17 11.26 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.099 0.96 . . . . 0.0 108.581 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD3' HE22 ' A' ' 125' ' ' GLN . 18.6 Cg_endo -57.75 -36.08 98.53 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.833 2.355 . . . . 0.0 112.331 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.16 -22.49 59.4 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.145 0.903 . . . . 0.0 111.87 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.8 mmp_? -91.72 -42.31 10.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.101 0.56 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.535 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 96.9 mt -64.8 -19.21 65.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.654 0.782 . . . . 0.0 112.391 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 55.98 22.37 5.75 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.331 1.052 . . . . 0.0 112.442 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.619 ' HG ' ' HZ ' ' A' ' 186' ' ' PHE . 55.8 m -95.24 141.54 23.36 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 123.9 0.88 . . . . 0.0 109.698 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.96 145.95 75.86 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.028 1.819 . . . . 0.0 110.236 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 99.5 mt -51.47 -43.82 62.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.967 0.907 . . . . 0.0 112.398 -173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.75 -36.8 79.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.61 0.764 . . . . 0.0 112.855 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.2 64.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.939 0.496 . . . . 0.0 110.865 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.04 27.92 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.943 0.897 . . . . 0.0 110.361 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.69 129.3 34.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.298 0.639 . . . . 0.0 109.35 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 t -68.74 111.9 9.7 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.25 0.46 9.37 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.748 2.299 . . . . 0.0 112.669 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -84.61 -55.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.702 0.801 . . . . 0.0 108.85 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.0 p -92.84 -8.83 42.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.828 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.56 39.74 21.18 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.545 1.138 . . . . 0.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.39 152.17 31.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.437 HE22 ' HD3' ' A' ' 107' ' ' PRO . 22.9 tm0? -67.77 117.83 51.81 Favored Pre-proline 0 CA--C 1.557 1.246 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.73 166.31 23.76 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.084 2.523 . . . . 0.0 113.688 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.5 pt-20 -86.28 -28.0 24.04 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.846 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.52 145.41 31.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.089 1.356 . . . . 0.0 107.753 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.49 166.89 39.71 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.356 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 143' ' ' LEU . 10.1 pt -115.03 153.82 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 125.298 1.439 . . . . 0.0 109.496 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -97.04 122.15 39.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 79.6 t -114.68 123.73 70.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.5 ptmt -69.04 107.44 3.15 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -73.36 89.66 1.62 Allowed 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -63.62 -36.73 84.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.173 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.5 -26.6 66.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.41 0.684 . . . . 0.0 110.818 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.4 13.83 43.92 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.462 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.0 m 77.26 44.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.31 1.444 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.89 24.46 14.47 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.607 1.163 . . . . 0.0 112.264 174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 187' ' ' ILE . 98.0 t -79.94 125.53 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.171 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.4 129.62 34.77 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.632 0.773 . . . . 0.0 110.295 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.4 m -123.77 139.74 53.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.184 0.994 . . . . 0.0 109.002 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 130' ' ' ILE . 45.1 tp -89.27 111.31 22.09 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.372 0.42 . . . . 0.0 110.061 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 84.5 m-85 -103.79 141.71 35.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.413 1.085 . . . . 0.0 108.243 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.52 132.26 51.87 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.781 0.675 . . . . 0.0 111.834 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.57 55.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.889 0.476 . . . . 0.0 111.455 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.13 69.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.72 0.808 . . . . 0.0 111.561 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.7 t80 -74.32 -40.41 62.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.543 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -63.84 -30.51 71.6 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.464 0.706 . . . . 0.0 111.011 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -62.43 -52.23 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.781 0.833 . . . . 0.0 109.686 172.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.43 -47.62 81.28 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 123.735 0.647 . . . . 0.0 111.228 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 166' ' ' ILE . 97.2 t -61.15 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.269 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.54 92.45 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 124.069 0.856 . . . . 0.0 112.943 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -73.46 -23.31 60.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.168 0.587 . . . . 0.0 111.503 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.06 18.98 37.78 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.375 0.422 . . . . 0.0 112.872 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.0 149.4 70.03 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.734 1.213 . . . . 0.0 110.497 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.85 -174.44 2.23 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.984 2.456 . . . . 0.0 112.466 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.44 ' ND1' HG22 ' A' ' 162' ' ' THR . 53.7 t-80 -64.55 127.54 92.45 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.821 0.848 . . . . 0.0 109.082 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.31 -17.92 49.91 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.217 1.945 . . . . 0.0 113.217 -168.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.0 mt -95.46 -62.83 1.23 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.184 0.594 . . . . 0.0 111.15 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.44 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.9 t -91.42 -11.67 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.527 0.331 . . . . 0.0 111.492 -172.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 59.63 23.43 12.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.119 1.368 . . . . 0.0 112.838 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 162' ' ' THR . 46.0 mm-40 -91.68 154.93 44.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.739 0.816 . . . . 0.0 109.77 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.91 123.53 12.42 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.438 2.092 . . . . 0.0 112.068 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 153' ' ' VAL . 81.2 mt -63.33 136.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.149 0.58 . . . . 0.0 109.952 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -147.33 161.51 40.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.371 0.668 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -68.61 -19.87 64.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.403 1.081 . . . . 0.0 110.997 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -69.58 -24.96 63.76 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.954 0.902 . . . . 0.0 112.561 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 49.4 pt -105.21 -5.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 168' ' ' ALA . 9.6 tt -96.94 132.13 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.881 0.764 . . . . 0.0 109.486 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.33 175.4 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.311 1.044 . . . . 0.0 110.06 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 95.5 mttt -96.77 165.74 11.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.615 0.366 . . . . 0.0 110.662 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -63.53 -27.01 68.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.372 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -77.93 -27.18 49.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.66 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -85.88 -20.52 28.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.965 0.906 . . . . 0.0 111.785 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.1 p -117.41 150.96 38.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.01 0.924 . . . . 0.0 109.574 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 160.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.196 0.999 . . . . 0.0 108.753 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.94 140.12 57.84 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.33 139.41 53.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.879 0.471 . . . . 0.0 110.008 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.42 -52.69 9.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.331 1.052 . . . . 0.0 111.64 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -74.72 -26.71 59.99 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -80.83 -33.54 34.54 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.542 0.737 . . . . 0.0 109.824 169.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.74 25.89 48.14 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.626 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.34 170.73 2.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.228 0.611 . . . . 0.0 111.043 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.619 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 89.9 m-85 -61.88 122.05 14.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.692 1.197 . . . . 0.0 111.527 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.9 pp -134.71 173.95 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.713 1.205 . . . . 0.0 109.904 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 133' ' ' LYS . 43.8 mm -73.54 143.74 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.726 0.81 . . . . 0.0 110.684 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp . . . . . 0 C--O 1.24 0.578 0 C-N-CA 123.484 0.713 . . . . 0.0 112.05 178.09 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 16.2 mp0 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.454 -0.308 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.81 -49.37 49.06 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.232 1.013 . . . . 0.0 113.334 -164.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.508 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 17.2 m -70.29 -41.04 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.277 0.631 . . . . 0.0 109.95 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.7 mt -66.12 -45.33 90.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.381 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -57.69 -46.14 84.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.854 1.261 . . . . 0.0 110.704 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.74 -37.39 86.37 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.024 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -66.39 -44.4 83.17 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 123.216 0.606 . . . . 0.0 110.224 177.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.5 mt -60.49 -39.0 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 109.666 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -67.32 -41.08 85.88 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.132 0.973 . . . . 0.0 111.011 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -83.19 -14.56 53.15 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.672 0.789 . . . . 0.0 112.984 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 93.5 m -103.55 -25.37 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.309 0.644 . . . . 0.0 112.601 -173.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -68.92 166.09 18.58 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -156.72 158.05 36.22 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.373 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.5 m -67.07 100.65 0.78 Allowed 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.706 0.802 . . . . 0.0 109.47 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.75 101.61 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.0 m -112.33 96.87 37.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HB3' HD11 ' A' ' 117' ' ' ILE . 8.0 Cg_endo -50.86 -23.52 11.88 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.938 3.092 . . . . 0.0 113.927 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.59 -30.18 59.51 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -93.47 -40.19 10.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.392 0.677 . . . . 0.0 111.135 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.06 -24.33 64.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.067 0.547 . . . . 0.0 110.237 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 45.41 50.42 10.11 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 124.889 1.276 . . . . 0.0 111.698 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.6 m -124.3 148.72 58.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.391 1.076 . . . . 0.0 110.038 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.67 141.67 97.45 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.348 2.032 . . . . 0.0 110.772 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 52.4 mt -55.06 -37.82 67.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.831 0.852 . . . . 0.0 111.666 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.01 -38.13 81.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.785 0.834 . . . . 0.0 112.192 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.27 66.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.065 0.546 . . . . 0.0 111.014 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 107' ' ' PRO . 33.3 pt -116.12 26.59 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.235 1.014 . . . . 0.0 110.302 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.57 127.54 33.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.308 1.043 . . . . 0.0 110.15 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 t -74.38 110.83 10.51 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.9 -2.75 12.68 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.78 2.32 . . . . 0.0 112.947 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.0 mt -85.12 -57.33 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.769 0.828 . . . . 0.0 109.499 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p -80.37 -23.67 40.32 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.024 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 62.74 49.9 3.58 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.124 0.964 . . . . 0.0 110.291 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.45 154.33 34.2 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.214 171.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -72.05 112.17 13.46 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.9 Cg_endo -71.32 159.78 50.73 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.205 2.604 . . . . 0.0 114.459 -167.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 6.4 pt-20 -80.81 -39.84 25.99 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.683 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -146.57 146.23 30.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.801 1.24 . . . . 0.0 108.044 178.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.35 42.36 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.461 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.2 pt -122.54 159.81 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.719 1.608 . . . . 0.0 109.197 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 141' ' ' CYS . 40.7 m-85 -104.85 119.8 39.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 170.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.3 121.43 66.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.653 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.9 ptmt -64.35 127.26 30.72 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 124.099 0.874 . . . . 0.0 112.77 -172.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -76.86 72.72 3.47 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -42.9 99.74 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.417 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.65 -40.38 92.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.502 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.63 -66.54 2.1 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.68 -171.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' VAL . 42.7 m -161.3 22.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.162 0.585 . . . . 0.0 111.569 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.42 31.33 17.23 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.884 1.326 . . . . 0.0 110.314 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.614 ' HA ' HG22 ' A' ' 187' ' ' ILE . 60.0 t -81.72 177.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.413 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' PHE . 26.4 p -134.3 140.78 46.64 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.401 HG21 HD11 ' A' ' 161' ' ' LEU . 89.5 m -118.94 146.34 45.04 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.06 109.38 20.44 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.235 0.541 . . . . 0.0 110.67 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.24 130.72 54.71 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 108.173 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.1 t70 -55.56 132.11 47.87 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.889 0.768 . . . . 0.0 109.17 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.45 77.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 112.154 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -33.0 63.34 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.621 0.575 . . . . 0.0 110.963 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -72.23 -36.76 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.0 t80 -80.27 -36.81 34.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -63.92 -29.8 70.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.365 0.666 . . . . 0.0 110.789 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 8.5 tpt180 -59.18 -59.08 6.03 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.924 0.765 . . . . 0.0 108.995 169.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.26 -46.83 72.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.019 0.825 . . . . 0.0 111.915 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 166' ' ' ILE . 95.4 t -61.99 -48.93 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 110.135 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -62.97 -35.78 92.55 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 123.995 0.81 . . . . 0.0 113.045 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 8.9 mm-40 -67.81 -34.97 77.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.521 0.729 . . . . 0.0 110.289 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.65 27.32 8.05 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.305 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 54.4 mt -90.19 149.04 40.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.375 1.07 . . . . 0.0 109.779 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.21 -176.38 3.24 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.463 2.109 . . . . 0.0 112.399 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.09 128.61 81.76 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.204 1.002 . . . . 0.0 110.569 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.64 -13.76 37.9 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.323 2.015 . . . . 0.0 113.971 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 142' ' ' THR . 57.2 mt -101.17 -56.11 2.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.735 0.414 . . . . 0.0 111.766 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.5 t -104.01 -10.29 18.19 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.876 0.47 . . . . 0.0 111.271 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 63.75 21.46 12.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.623 1.169 . . . . 0.0 112.999 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.06 151.41 78.79 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.299 0.64 . . . . 0.0 109.873 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.16 122.73 12.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.778 2.319 . . . . 0.0 110.991 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.587 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.7 mt -66.34 128.38 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 t -146.13 159.61 43.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.161 0.984 . . . . 0.0 109.377 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.7 -19.7 65.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.612 0.765 . . . . 0.0 111.158 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -70.25 -39.51 74.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.929 0.891 . . . . 0.0 111.788 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.6 pt -90.66 -12.19 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.16 137.34 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.144 0.884 . . . . 0.0 108.728 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.52 HG11 HD12 ' A' ' 188' ' ' ILE . 28.8 m -130.22 171.67 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.283 1.033 . . . . 0.0 109.113 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 58.6 mtpt -88.52 165.72 14.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.159 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 21.0 t60 -73.62 -23.27 59.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.39 0.614 . . . . 0.0 109.649 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.44 -31.49 71.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.8 10.18 41.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.602 0.761 . . . . 0.0 111.726 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.9 p -139.57 138.07 35.93 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.635 -0.666 . . . . 0.0 110.457 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.82 162.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.756 1.223 . . . . 0.0 108.579 -174.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -66.47 124.46 22.83 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 166.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.568 ' HB2' HG12 ' A' ' 187' ' ' ILE . 12.4 t70 -105.32 134.02 49.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.83 -36.57 42.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.15 0.906 . . . . 0.0 112.337 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.408 HG22 ' OD1' ' A' ' 180' ' ' ASP . 1.1 t -76.53 -23.64 53.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' ' 187' ' ' ILE . 40.0 mmt180 -86.98 -33.92 19.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.841 0.857 . . . . 0.0 110.661 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.84 18.63 77.65 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.45 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -148.41 150.71 33.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.413 1.085 . . . . 0.0 109.934 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -60.48 117.33 5.14 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.394 0.678 . . . . 0.0 110.303 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 140' ' ' VAL . 13.3 pt -129.68 178.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.828 0.851 . . . . 0.0 108.91 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 133' ' ' LYS . 8.8 mm -70.84 154.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.427 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.6 mtpm? . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.273 0.559 . . . . 0.0 111.357 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.439 ' HG3' HG12 ' A' ' 153' ' ' VAL . 6.7 mp0 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.26 0.076 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -41.96 82.57 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.196 0.598 . . . . 0.0 111.615 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.7 t -72.84 -50.93 21.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.512 0.725 . . . . 0.0 110.609 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.8 mt -64.01 -44.37 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.303 0.641 . . . . 0.0 111.196 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.75 -27.73 64.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.119 0.567 . . . . 0.0 111.567 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 2.6 m-80 -64.58 -41.21 96.41 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.43 -34.69 78.89 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.86 0.864 . . . . 0.0 110.67 177.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.535 HG23 HD13 ' A' ' 130' ' ' ILE . 92.8 mt -67.44 -37.74 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.279 0.631 . . . . 0.0 109.44 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.5 t -67.15 -36.49 81.95 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.5 mm-40 -74.56 -53.96 8.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.685 0.394 . . . . 0.0 110.737 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.638 ' SG ' ' HE3' ' A' ' 173' ' ' LYS . 72.5 m -71.81 -19.96 61.92 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.066 0.946 . . . . 0.0 112.983 -167.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.1 170.97 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.789 0.804 . . . . 0.0 112.825 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -160.02 156.68 27.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.935 173.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 p -70.95 104.5 2.98 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' NE2' ' A' ' 125' ' ' GLN . 45.6 t -77.72 96.98 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 -171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.81 105.41 41.27 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.6 -31.17 86.79 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.967 2.445 . . . . 0.0 113.522 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 -30.29 49.74 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.48 0.488 . . . . 0.0 110.581 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -78.79 -35.03 45.0 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.52 -19.23 53.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.536 0.734 . . . . 0.0 111.691 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 57.23 22.34 7.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.025 0.93 . . . . 0.0 112.621 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -104.94 146.35 32.49 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 123.717 0.807 . . . . 0.0 109.649 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.58 152.66 80.93 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.317 2.011 . . . . 0.0 111.101 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.34 -40.95 68.51 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.887 0.742 . . . . 0.0 111.549 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.64 -41.03 80.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.323 1.049 . . . . 0.0 112.688 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.82 62.91 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.435 0.694 . . . . 0.0 111.434 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 12.0 pt -126.5 33.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.899 0.879 . . . . 0.0 109.506 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 43.4 tt0 -84.47 137.94 33.07 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.829 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.5 t -76.85 113.64 31.92 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.84 0.49 8.2 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.168 2.579 . . . . 0.0 113.107 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.0 mt -85.24 -54.75 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p -86.28 -18.88 30.88 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.189 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 66.45 36.52 5.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.342 1.057 . . . . 0.0 111.445 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.73 151.7 30.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.479 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 25.5 tm0? -69.64 113.2 15.44 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.873 0.869 . . . . 0.0 108.673 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 92.5 Cg_endo -73.59 163.82 36.48 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.57 2.18 . . . . 0.0 113.867 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -17.69 28.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.189 0.996 . . . . 0.0 110.261 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 146' ' ' ALA . 1.3 pptp? -153.27 140.87 19.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.152 0.981 . . . . 0.0 108.957 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.77 168.49 41.38 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.507 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.535 HD13 HG23 ' A' ' 98' ' ' ILE . 13.7 pt -121.0 156.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.547 1.539 . . . . 0.0 109.87 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.6 123.42 43.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 169.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 72.9 t -123.83 122.1 63.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.678 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -69.9 116.96 10.88 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.435 0.636 . . . . 0.0 110.164 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.05 85.28 1.81 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 27.9 t -66.19 -39.84 89.97 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.204 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.35 -35.79 82.04 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.978 0.911 . . . . 0.0 111.105 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.51 -63.97 2.89 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -169.8 23.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.415 0.686 . . . . 0.0 110.631 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.9 m-20 59.29 31.33 21.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.425 1.09 . . . . 0.0 111.698 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.2 t -94.08 128.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.186 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 27.7 p -84.39 132.11 34.62 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -124.52 146.61 48.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 105' ' ' VAL . 44.6 tp -90.43 115.33 27.51 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.4 m-85 -111.78 137.92 49.06 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.492 1.117 . . . . 0.0 108.114 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.723 0.692 . . . . 0.0 109.302 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -57.15 -42.83 81.74 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.93 0.769 . . . . 0.0 111.926 -173.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.69 -36.05 60.15 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.84 0.456 . . . . 0.0 111.593 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.78 69.28 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.125 0.57 . . . . 0.0 111.625 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.6 t80 -71.62 -37.02 70.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.124 0.57 . . . . 0.0 109.881 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -63.03 -36.7 84.44 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.702 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 79.1 ttt180 -60.39 -45.88 91.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.63 -47.05 77.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.137 0.575 . . . . 0.0 111.224 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' A' ' 91' ' ' GLN . 38.7 t -66.04 -46.25 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.227 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.87 -33.07 84.16 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 124.262 0.976 . . . . 0.0 113.312 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.527 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 23.9 mm-40 -75.59 -32.22 60.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.08 21.8 10.6 Favored Glycine 0 N--CA 1.468 0.825 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.753 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 50.6 mt -85.18 153.08 59.35 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 0.0 111.146 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.0 174.95 11.9 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.216 2.611 . . . . 0.0 113.081 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -55.14 134.39 68.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.041 1.336 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.98 -26.14 58.83 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.654 2.236 . . . . 0.0 113.876 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.74 -60.7 1.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.6 t -105.34 -4.19 21.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.646 -167.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 60.22 28.19 17.76 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.106 0.963 . . . . 0.0 112.729 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -80.11 159.99 69.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.18 0.992 . . . . 0.0 111.371 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.4 112.72 2.66 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.119 1.879 . . . . 0.0 111.006 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.428 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.9 mt -62.65 131.79 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.635 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 162.67 38.77 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.363 0.665 . . . . 0.0 110.446 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.12 66.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.705 0.802 . . . . 0.0 111.691 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -68.54 -41.0 80.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 111.581 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -84.94 -7.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.4 tt -97.95 132.83 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.015 0.825 . . . . 0.0 109.876 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.467 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -133.76 178.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.136 1.375 . . . . 0.0 110.029 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.638 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 3.3 mptt -104.26 166.47 10.38 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.481 0.712 . . . . 0.0 109.755 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -70.78 -16.12 62.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.145 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -79.65 -35.29 39.51 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.577 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -83.72 -23.1 31.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.737 0.815 . . . . 0.0 110.602 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 31.7 p -115.78 142.2 47.07 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.867 0.867 . . . . 0.0 108.897 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.4 163.26 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.491 1.116 . . . . 0.0 109.045 -174.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -71.49 136.82 47.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -119.44 132.88 55.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.87 -51.35 22.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.664 1.186 . . . . 0.0 111.906 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 t -73.15 -23.23 60.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.269 0.228 . . . . 0.0 111.536 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.423 ' HG3' HD13 ' A' ' 187' ' ' ILE . 12.7 mmp_? -81.03 -33.98 33.16 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.13 0.572 . . . . 0.0 110.561 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.84 76.11 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.284 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -146.46 146.89 30.73 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.2 1.0 . . . . 0.0 109.446 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.514 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 97.9 m-85 -66.7 116.43 7.61 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 167.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.447 HG12 ' HB2' ' A' ' 180' ' ' ASP . 27.9 pt -127.21 178.95 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.075 0.95 . . . . 0.0 109.365 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 133' ' ' LYS . 21.1 mm -85.82 148.28 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.541 0.736 . . . . 0.0 111.989 177.367 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.449 0.166 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.95 -45.39 67.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.282 1.033 . . . . 0.0 112.106 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 t -66.05 -39.24 89.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.63 0.772 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.2 mt -69.56 -45.51 77.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.938 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -58.92 -45.31 90.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.157 . . . . 0.0 111.219 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -59.77 -40.91 89.83 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -62.85 -44.86 95.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.144 0.578 . . . . 0.0 110.727 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 150' ' ' SER . 87.7 mt -60.58 -39.19 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.804 0.842 . . . . 0.0 110.206 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.7 t -64.85 -40.12 94.65 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.988 0.915 . . . . 0.0 111.805 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -83.61 -27.33 29.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.284 0.634 . . . . 0.0 112.601 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.1 m -95.69 -12.23 25.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.578 0.751 . . . . 0.0 112.448 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -74.01 165.25 25.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.635 0.731 . . . . 0.0 112.877 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.06 154.59 35.18 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.422 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -75.61 105.06 6.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.2 130.91 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.918 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 39.3 m -122.38 81.56 46.04 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.695 0.798 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.97 -39.15 40.19 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.163 3.242 . . . . 0.0 113.802 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.6 pt-20 -60.95 -45.71 93.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.206 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 67.4 mtp180 -83.47 -31.59 26.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.088 0.555 . . . . 0.0 111.483 -174.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.33 -18.59 63.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.228 0.611 . . . . 0.0 111.013 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.65 2.67 3.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.301 1.44 . . . . 0.0 112.299 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 62.0 m -92.3 133.13 30.49 Favored Pre-proline 0 C--O 1.247 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 109.17 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.08 158.59 21.08 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.64 2.227 . . . . 0.0 112.164 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -53.47 -43.96 68.57 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.881 0.738 . . . . 0.0 111.488 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.4 -38.45 77.38 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.215 1.006 . . . . 0.0 112.731 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.99 64.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.694 0.798 . . . . 0.0 112.099 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.525 ' HB ' HD23 ' A' ' 143' ' ' LEU . 8.9 pt -127.24 11.59 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.739 0.816 . . . . 0.0 110.57 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.441 HE21 ' HA ' ' A' ' 123' ' ' LEU . 41.8 tt0 -63.98 132.53 50.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.991 0.916 . . . . 0.0 111.097 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 34.6 t -67.58 111.87 8.71 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.85 -3.56 13.97 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.54 2.16 . . . . 0.0 112.647 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -79.62 -54.0 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.469 1.108 . . . . 0.0 109.431 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p -101.09 -4.23 27.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.255 -169.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.441 ' HA ' HE21 ' A' ' 118' ' ' GLN . 4.0 mm? 60.32 33.34 20.86 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.88 0.872 . . . . 0.0 112.258 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.16 153.5 39.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.516 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 21.4 tm0? -70.61 123.85 89.84 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 72.6 Cg_endo -76.24 154.6 36.89 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.367 2.712 . . . . 0.0 114.386 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.5 pt-20 -83.26 -35.79 25.06 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.479 174.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 48.6 pttt -138.33 138.86 38.75 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.16 157.41 28.26 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.062 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 98' ' ' ILE . 9.8 pt -113.2 156.34 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.474 1.509 . . . . 0.0 109.602 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -98.81 116.88 32.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 65.4 t -116.54 122.36 69.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.3 ptmt -69.55 110.51 4.83 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.515 0.674 . . . . 0.0 109.413 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.07 81.11 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 162.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -69.49 -68.79 0.38 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.292 -167.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.43 -35.0 71.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.934 0.894 . . . . 0.0 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.49 -62.55 4.51 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.42 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 m -150.93 4.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -170.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 62.37 22.55 13.3 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.866 0.841 . . . . 0.0 111.061 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 185' ' ' ASN . 55.4 t -105.87 129.99 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.67 0.788 . . . . 0.0 110.897 -173.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 56.5 m -84.16 127.72 34.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.797 0.839 . . . . 0.0 108.838 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.6 m -126.04 146.98 49.68 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' A' ' 117' ' ' ILE . 40.3 tp -88.24 105.28 17.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.091 0.472 . . . . 0.0 109.897 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.424 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 85.8 m-85 -98.6 143.28 29.17 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.3 t70 -63.63 136.37 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.38 73.48 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.201 0.938 . . . . 0.0 111.593 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.0 -31.66 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.074 0.55 . . . . 0.0 111.696 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.587 0.755 . . . . 0.0 111.817 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -76.57 -37.77 56.02 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.495 ' HB2' HG21 ' A' ' 98' ' ' ILE . 27.5 t -63.27 -30.21 71.4 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.742 174.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.5 tpm_? -64.36 -52.64 57.31 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.384 172.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.61 -45.77 73.71 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 123.912 0.757 . . . . 0.0 111.392 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.02 -43.37 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.515 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.82 -16.66 74.62 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.027 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -91.12 -23.54 20.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.322 0.649 . . . . 0.0 110.992 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.11 13.4 58.94 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.439 0.462 . . . . 0.0 112.734 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.36 139.63 52.05 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.067 0.947 . . . . 0.0 109.924 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.83 -176.97 2.59 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.765 2.31 . . . . 0.0 113.012 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.406 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.9 t-80 -58.65 126.32 79.46 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.121 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.427 ' HG3' HG12 ' A' ' 121' ' ' ILE . 66.1 Cg_endo -66.51 -15.71 48.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.79 2.327 . . . . 0.0 113.462 -170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.0 mt -97.32 -64.9 1.0 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.757 0.423 . . . . 0.0 111.243 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.406 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.7 t -94.33 -8.86 37.69 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 122.645 0.378 . . . . 0.0 111.796 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 61.04 21.02 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.904 1.281 . . . . 0.0 112.759 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -87.29 161.07 47.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.311 1.044 . . . . 0.0 110.213 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.21 121.06 8.58 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.018 1.812 . . . . 0.0 111.82 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.484 ' HA ' HD11 ' A' ' 170' ' ' ILE . 71.3 mt -65.65 139.47 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.024 0.53 . . . . 0.0 109.584 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.2 t -153.41 165.34 36.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.398 0.436 . . . . 0.0 111.277 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.46 -22.89 66.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.352 1.061 . . . . 0.0 111.941 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -68.11 -43.69 77.87 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.715 0.806 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.1 pt -85.19 -12.87 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 97' ' ' LYS . 7.7 tt -98.61 136.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.593 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -137.47 173.57 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.927 1.291 . . . . 0.0 110.45 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -91.14 164.07 14.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -66.11 -25.17 66.88 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.686 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.21 -29.09 21.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.5 1.12 . . . . 0.0 110.639 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.06 -25.68 34.36 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.808 0.843 . . . . 0.0 111.357 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.2 p -104.76 154.97 19.31 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -132.0 157.12 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 19.2 p90 -71.0 122.19 19.57 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.435 ' HB2' HG12 ' A' ' 187' ' ' ILE . 10.9 t70 -106.98 114.49 28.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.71 -21.52 44.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -168.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -83.55 -25.84 30.63 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.599 0.636 . . . . 0.0 110.803 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -79.95 -27.77 39.71 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.46 85.53 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.139 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.412 ' HB3' HG13 ' A' ' 140' ' ' VAL . 18.7 m120 -148.34 158.11 43.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.869 0.868 . . . . 0.0 109.854 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 64.6 m-85 -64.6 127.33 31.07 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 180' ' ' ASP . 22.0 pt -134.31 178.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.3 1.04 . . . . 0.0 108.8 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.593 HD12 HG11 ' A' ' 172' ' ' VAL . 33.9 mm -79.38 145.62 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 123.278 0.631 . . . . 0.0 112.232 179.245 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.482 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 22.3 mp0 . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.01 -50.33 36.5 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.745 0.818 . . . . 0.0 113.028 -164.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 40.4 t -65.57 -43.64 89.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.805 0.442 . . . . 0.0 110.481 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.5 mt -64.8 -46.03 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 153' ' ' VAL . 30.2 mm-40 -57.91 -47.75 81.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.717 1.207 . . . . 0.0 111.699 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -65.29 -35.8 82.13 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.077 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -64.7 -38.19 90.17 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 122.952 0.501 . . . . 0.0 110.634 176.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.489 HG21 ' HB2' ' A' ' 150' ' ' SER . 89.3 mt -65.82 -39.39 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.253 0.621 . . . . 0.0 109.966 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -64.58 -34.89 79.32 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.456 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -87.48 -27.9 22.38 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 75.6 m -93.39 -11.63 31.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -73.94 168.12 20.12 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.653 0.739 . . . . 0.0 111.849 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.88 157.32 34.66 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.449 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 p -68.8 98.6 0.94 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.479 HG12 ' NE2' ' A' ' 125' ' ' GLN . 63.2 t -72.37 99.7 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 56.7 m -111.2 104.75 56.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.169 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.47 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 9.9 Cg_endo -52.91 -26.58 31.9 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 -37.33 61.62 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.059 0.544 . . . . 0.0 110.409 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -83.78 -39.93 19.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 0.0 110.864 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.92 -20.89 62.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.505 0.722 . . . . 0.0 111.206 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.46 ' HA ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER 53.78 36.16 23.25 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.639 1.176 . . . . 0.0 111.027 -176.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.3 140.57 26.67 Favored Pre-proline 0 C--O 1.248 1.018 0 C-N-CA 124.383 1.073 . . . . 0.0 108.874 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.0 157.22 50.06 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.18 1.92 . . . . 0.0 111.899 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.43 -46.62 66.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.661 0.784 . . . . 0.0 112.054 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 1.6 pm0 -67.68 -30.96 70.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.408 0.683 . . . . 0.0 112.444 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.08 -27.1 67.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.73 0.412 . . . . 0.0 111.43 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' HD23 ' A' ' 143' ' ' LEU . 16.8 pt -119.08 17.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.491 0.716 . . . . 0.0 110.604 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 46.5 tt0 -63.5 129.99 42.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.994 0.918 . . . . 0.0 110.542 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.42 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.1 t -67.75 109.74 4.31 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.566 ' HB2' HD21 ' A' ' 161' ' ' LEU . 87.7 Cg_endo -78.3 5.88 5.13 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.732 2.288 . . . . 0.0 112.734 -174.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -83.39 -53.95 10.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 124.124 0.969 . . . . 0.0 108.841 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.4 p -96.35 -10.29 28.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.924 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.49 39.06 25.39 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.206 1.002 . . . . 0.0 111.79 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.59 159.84 43.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.425 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.479 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.1 tm0? -74.62 121.22 84.76 Favored Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 73.3 Cg_endo -76.4 159.16 36.45 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.075 2.517 . . . . 0.0 113.441 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.3 pt-20 -90.15 -26.09 20.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.692 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.2 pttt -147.06 140.39 25.43 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.3 158.67 31.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.824 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 98' ' ' ILE . 12.2 pt -110.84 155.09 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.739 1.216 . . . . 0.0 109.767 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -93.09 129.02 39.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 167.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.5 t -124.85 124.29 67.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 171.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.655 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -64.93 105.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.029 0.919 . . . . 0.0 110.373 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.28 78.54 0.73 Allowed 'General case' 0 C--O 1.25 1.084 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 34.2 t -65.42 -37.57 87.31 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.156 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.51 -36.56 69.33 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.297 1.039 . . . . 0.0 112.251 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.47 -63.41 2.62 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.398 0.436 . . . . 0.0 113.049 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -169.61 30.83 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.269 0.628 . . . . 0.0 110.203 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.7 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 0.4 OUTLIER 65.13 26.12 12.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.022 0.929 . . . . 0.0 111.225 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.6 t -86.09 142.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.89 0.876 . . . . 0.0 110.021 -174.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 188' ' ' ILE . 60.6 m -85.46 122.54 29.74 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.6 m -118.17 137.31 53.07 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 117' ' ' ILE . 56.7 tp -92.91 114.44 26.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.687 0.395 . . . . 0.0 110.487 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.34 150.77 26.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.632 1.173 . . . . 0.0 108.521 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.28 137.74 54.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.466 0.575 . . . . 0.0 109.548 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.23 86.25 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.022 0.826 . . . . 0.0 111.95 -175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.43 -36.92 66.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 0.0 111.698 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.01 56.64 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.412 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.62 -40.97 84.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.352 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.0 t -62.41 -36.88 83.73 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.748 0.655 . . . . 0.0 110.839 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 58.6 ttt180 -63.43 -48.85 76.05 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.73 -46.75 70.95 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.399 0.679 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t -62.42 -47.43 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.821 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -64.1 -29.3 74.52 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 124.191 0.932 . . . . 0.0 113.447 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 61.5 mm-40 -72.95 -25.34 60.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.199 0.6 . . . . 0.0 110.317 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 15.76 43.32 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.098 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.67 145.6 54.81 Favored Pre-proline 0 C--O 1.242 0.659 0 C-N-CA 123.866 0.867 . . . . 0.0 110.073 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.34 -179.47 5.1 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.551 2.168 . . . . 0.0 112.017 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -55.02 131.82 67.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.8 -26.31 79.38 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.924 2.416 . . . . 0.0 113.573 -172.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.5 mt -97.75 -52.59 3.69 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.637 0.375 . . . . 0.0 111.308 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 67.8 p -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.412 0.685 . . . . 0.0 112.195 -168.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 64.04 22.24 12.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.555 1.142 . . . . 0.0 111.352 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.71 149.73 86.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.575 0.75 . . . . 0.0 110.296 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.22 111.19 1.53 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.219 1.946 . . . . 0.0 110.702 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.09 135.39 25.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.053 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.6 t -149.18 163.11 38.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.091 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -64.75 -23.92 67.4 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.958 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -69.99 -26.16 63.95 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.887 0.875 . . . . 0.0 113.033 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.7 pt -100.7 -11.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 168' ' ' ALA . 7.7 tt -94.39 134.04 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.607 HG11 HD12 ' A' ' 188' ' ' ILE . 26.9 m -133.81 172.11 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.528 1.131 . . . . 0.0 110.795 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 7.1 mtpm? -103.82 166.83 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.026 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -71.2 -18.11 62.49 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.12 -22.1 23.04 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.3 0.64 . . . . 0.0 110.544 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -75.88 -38.51 57.77 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.742 0.817 . . . . 0.0 109.546 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.38 140.95 29.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.616 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 152.91 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -66.15 128.8 37.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.546 ' HB2' HG12 ' A' ' 187' ' ' ILE . 14.0 t70 -108.03 135.3 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.29 -49.47 16.9 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.055 0.847 . . . . 0.0 111.655 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.7 t -73.76 -23.44 59.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.122 0.169 . . . . 0.0 111.412 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 3.4 mmp_? -83.65 -33.0 25.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.185 0.594 . . . . 0.0 110.549 171.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.68 26.32 59.04 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.918 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -171.37 162.93 6.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.186 0.595 . . . . 0.0 109.851 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -60.2 121.16 11.26 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.1 0.96 . . . . 0.0 111.13 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 180' ' ' ASP . 23.3 pt -126.73 174.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.196 171.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 133' ' ' LYS . 27.1 mm -70.74 151.05 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.349 0.659 . . . . 0.0 109.746 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.224 0.535 . . . . 0.0 111.393 172.752 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -35.66 81.0 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.352 0.408 . . . . 0.0 111.588 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 32.7 t -68.37 -43.51 77.2 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.44 0.696 . . . . 0.0 109.449 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 98' ' ' ILE . 64.6 mt -66.35 -46.61 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.579 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -58.53 -43.47 89.22 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.326 1.45 . . . . 0.0 111.346 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -41.78 96.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.268 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -69.23 -32.34 71.52 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 123.262 0.625 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 94' ' ' ILE . 83.5 mt -66.02 -40.86 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.2 m -63.05 -40.71 98.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 111.583 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -83.0 -22.68 33.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.514 0.726 . . . . 0.0 112.701 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.592 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 80.4 m -95.35 -22.89 17.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.999 0.52 . . . . 0.0 112.293 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -70.3 168.21 16.39 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.722 0.772 . . . . 0.0 112.508 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -156.12 157.7 36.44 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.599 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.0 p -72.22 99.65 2.41 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 143' ' ' LEU . 21.9 t -71.56 109.25 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.249 -171.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.95 104.43 55.53 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.72 0.808 . . . . 0.0 109.458 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 117' ' ' ILE . 15.5 Cg_endo -59.92 -27.63 85.34 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.982 2.455 . . . . 0.0 112.647 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.72 -31.37 69.33 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.254 0.622 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -90.59 -30.61 17.1 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.656 0.782 . . . . 0.0 110.868 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.3 -23.04 57.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.846 0.458 . . . . 0.0 111.216 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 52.74 33.1 13.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.028 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -114.62 140.69 25.62 Favored Pre-proline 0 C--O 1.245 0.844 0 C-N-CA 124.424 1.09 . . . . 0.0 108.859 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.92 158.67 45.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.462 2.108 . . . . 0.0 111.785 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.32 -45.68 72.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.806 . . . . 0.0 111.8 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.68 -38.97 72.97 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.316 1.046 . . . . 0.0 113.062 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.04 65.42 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.161 0.585 . . . . 0.0 111.734 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 107' ' ' PRO . 19.5 pt -127.97 31.39 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.681 1.192 . . . . 0.0 109.535 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.66 125.02 27.79 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.379 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 10.4 t -68.47 109.93 4.94 Favored Pre-proline 0 C--N 1.349 0.557 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.91 -3.35 13.63 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.782 2.321 . . . . 0.0 112.852 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.2 -52.3 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.4 p -90.98 -10.64 41.61 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.96 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.29 36.26 23.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.851 1.261 . . . . 0.0 111.889 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.87 152.65 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.352 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 24.1 tm0? -68.21 121.38 80.03 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.523 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.52 164.2 28.73 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.116 2.544 . . . . 0.0 114.602 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 12.9 pt-20 -86.43 -29.82 22.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.463 173.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 52.0 pttt -141.62 135.07 29.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.7 1.6 . . . . 0.0 106.904 176.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -161.74 154.9 26.0 Favored Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.503 -175.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -110.19 159.38 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 125.251 1.42 . . . . 0.0 109.555 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 37.3 m-85 -103.34 118.15 36.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 169.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.7 t -115.16 121.49 67.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 21.9 ptmt -72.2 108.48 5.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.864 0.84 . . . . 0.0 110.627 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -66.55 83.36 0.1 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.42 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 46.4 t -64.21 -41.64 96.96 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.212 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.14 -32.27 73.88 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.006 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.29 -66.36 2.11 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.27 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.2 m -168.44 26.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.317 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 9.5 m-20 58.34 26.1 13.61 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.635 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -80.52 123.72 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.384 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 40.5 m -82.7 122.98 28.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.499 HG21 HD11 ' A' ' 161' ' ' LEU . 25.9 m -119.41 145.03 46.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 105' ' ' VAL . 34.2 tp -86.65 114.13 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.35 0.407 . . . . 0.0 110.286 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -113.35 135.49 53.8 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.595 1.158 . . . . 0.0 108.466 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 13.1 t70 -59.26 137.62 57.91 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.674 0.39 . . . . 0.0 110.046 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.13 90.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.553 0.741 . . . . 0.0 111.672 -174.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.12 44.85 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.319 0.648 . . . . 0.0 112.124 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.42 -39.21 54.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.177 0.591 . . . . 0.0 111.673 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.0 t80 -72.15 -38.3 69.2 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -56.67 -38.73 72.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.069 0.948 . . . . 0.0 111.452 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -57.65 -52.16 66.55 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.817 0.698 . . . . 0.0 109.953 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.77 -46.52 81.42 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.149 0.906 . . . . 0.0 111.089 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 166' ' ' ILE . 94.8 t -62.38 -47.07 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.744 . . . . 0.0 110.852 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.45 -34.37 88.1 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.715 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 16.4 mm-40 -75.27 -31.53 60.78 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.413 0.685 . . . . 0.0 111.218 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 25.68 20.07 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 86.7 mt -80.6 151.6 71.69 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.93 -179.43 5.11 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.469 2.112 . . . . 0.0 112.64 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.3 t-80 -59.26 127.85 84.72 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.333 1.053 . . . . 0.0 109.917 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.67 -2.99 12.99 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.305 2.003 . . . . 0.0 113.973 -170.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 142' ' ' THR . 63.5 mt -104.26 -57.27 2.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.552 0.341 . . . . 0.0 111.018 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.441 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -105.0 -11.81 16.46 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 66.08 22.24 11.15 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.781 1.232 . . . . 0.0 113.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.434 ' H ' HG23 ' A' ' 162' ' ' THR . 31.2 mm-40 -76.84 152.26 82.65 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.345 0.658 . . . . 0.0 110.591 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.21 121.08 8.94 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.558 2.172 . . . . 0.0 111.837 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.603 HG21 HG22 ' A' ' 153' ' ' VAL . 71.5 mt -65.73 130.95 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -150.34 164.95 34.5 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.819 0.848 . . . . 0.0 110.609 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -63.55 -24.04 67.64 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.373 171.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.0 m -66.3 -33.2 75.19 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.836 0.855 . . . . 0.0 112.841 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 166' ' ' ILE . 44.2 pt -99.39 -3.16 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 101' ' ' CYS . 11.6 tt -102.16 134.2 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.4 167.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.529 1.132 . . . . 0.0 110.133 -173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 28.0 mtpp -85.97 161.43 19.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -65.69 -24.69 67.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.301 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.6 -22.24 28.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.052 0.541 . . . . 0.0 110.982 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -82.51 -24.11 34.29 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.396 0.678 . . . . 0.0 110.768 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.3 p -113.38 155.59 24.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.18 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.14 157.12 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.606 1.163 . . . . 0.0 108.424 177.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -70.59 129.92 40.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.77 126.74 55.55 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.28 -39.41 71.56 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.484 1.115 . . . . 0.0 112.486 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.6 t -84.03 -15.8 46.25 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.866 0.303 . . . . 0.0 111.747 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -83.22 -32.03 26.73 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 163.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.23 7.51 84.75 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.316 -170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -137.76 157.0 47.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.698 1.199 . . . . 0.0 108.836 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.26 129.71 40.72 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.08 175.59 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.756 1.222 . . . . 0.0 109.778 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.407 HD13 ' SG ' ' A' ' 141' ' ' CYS . 28.7 mm -76.13 148.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.492 0.717 . . . . 0.0 110.205 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 123.318 0.647 . . . . 0.0 111.248 176.081 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 94' ' ' ILE . 12.4 mp0 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.02 -50.1 59.2 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.416 1.087 . . . . 0.0 112.154 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -63.73 -36.16 82.95 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.121 0.968 . . . . 0.0 111.1 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 91' ' ' GLN . 35.6 mt -71.31 -48.53 53.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.737 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -55.96 -46.07 78.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.563 1.145 . . . . 0.0 111.371 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.05 -45.12 93.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -32.89 74.57 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.93 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.483 HG23 HD13 ' A' ' 130' ' ' ILE . 96.4 mt -65.2 -41.59 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 118.728 0.694 . . . . 0.0 109.903 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.8 t -64.91 -36.0 82.96 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.842 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -81.43 -30.47 33.48 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.847 0.859 . . . . 0.0 112.945 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 99.1 m -91.46 -19.5 22.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.868 0.867 . . . . 0.0 111.604 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -72.83 165.46 24.84 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.566 0.698 . . . . 0.0 111.938 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.91 159.43 34.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.943 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -69.91 97.02 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.7 t -66.36 113.43 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.374 0.669 . . . . 0.0 110.531 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.6 m -114.49 90.77 22.26 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.415 1.086 . . . . 0.0 109.093 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -58.44 -39.14 86.33 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.081 2.521 . . . . 0.0 113.293 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -38.01 65.67 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.05 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -74.83 -41.21 60.35 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 97.7 mt -68.44 -15.61 63.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 111.57 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 61.47 16.75 7.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 -172.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 61.6 m -93.11 124.62 57.54 Favored Pre-proline 0 C--O 1.243 0.755 0 C-N-CA 123.36 0.664 . . . . 0.0 109.5 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.46 150.99 78.12 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.557 2.171 . . . . 0.0 111.7 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.01 -47.92 67.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.903 0.881 . . . . 0.0 112.264 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.28 -35.16 78.15 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.383 0.673 . . . . 0.0 112.354 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.06 62.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.36 0.664 . . . . 0.0 111.792 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 112' ' ' CYS . 24.5 pt -127.61 29.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.662 0.785 . . . . 0.0 110.221 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -79.04 132.48 36.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.789 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.17 111.34 7.59 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.34 -2.46 12.59 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.841 2.361 . . . . 0.0 112.172 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.5 mt -82.16 -55.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.6 p -95.23 -7.87 37.77 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.16 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.85 48.24 20.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.15 0.98 . . . . 0.0 111.257 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.81 149.98 20.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.757 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.66 116.42 51.51 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.4 161.2 37.93 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.78 2.32 . . . . 0.0 113.434 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.45 -19.03 20.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.712 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 2.2 pptp? -144.87 128.8 17.44 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.71 167.3 37.78 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.859 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 98' ' ' ILE . 11.5 pt -122.03 151.81 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 109.348 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.53 115.61 28.96 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 130' ' ' ILE . 64.2 t -117.69 122.39 69.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -69.71 122.39 19.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.432 0.634 . . . . 0.0 110.928 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -72.83 80.86 1.15 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 161.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 25.1 t -70.09 -44.86 68.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.781 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.28 -34.76 79.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.059 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.09 -64.86 2.22 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.835 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.9 m -157.44 18.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.318 0.559 . . . . 0.0 112.475 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.7 m-20 59.63 20.62 9.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.98 0.912 . . . . 0.0 112.283 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.7 124.08 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 28.0 p -85.5 133.12 34.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 m -121.81 145.56 47.94 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.19 108.81 20.13 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.53 136.42 42.39 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.42 132.31 52.72 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.629 0.65 . . . . 0.0 109.359 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.74 70.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.043 0.839 . . . . 0.0 111.892 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . . . -75.29 -40.23 58.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.986 0.514 . . . . 0.0 111.599 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.37 89.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.064 0.545 . . . . 0.0 111.807 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 130' ' ' ILE . 33.5 t80 -76.97 -38.35 53.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.966 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 98' ' ' ILE . 28.8 t -64.08 -28.94 70.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.434 0.459 . . . . 0.0 110.819 175.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 13.0 tpt180 -64.39 -55.69 19.33 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.541 -0.754 . . . . 0.0 108.973 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.7 -45.6 70.47 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.088 0.867 . . . . 0.0 111.818 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.414 HG11 ' HB ' ' A' ' 94' ' ' ILE . 86.3 t -65.93 -47.56 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.298 0.639 . . . . 0.0 110.378 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.27 -17.88 68.73 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.274 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 63.7 mm-40 -87.15 -23.97 24.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.619 0.768 . . . . 0.0 110.857 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.03 36.79 12.35 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.54 149.12 36.12 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.57 1.148 . . . . 0.0 109.527 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -69.89 177.26 5.85 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.353 2.702 . . . . 0.0 113.531 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.447 ' ND1' HG22 ' A' ' 162' ' ' THR . 60.1 t-80 -59.81 124.66 77.52 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.58 -12.46 35.19 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.675 2.25 . . . . 0.0 114.202 -168.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.81 -66.97 0.87 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.643 0.377 . . . . 0.0 110.819 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.447 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.5 t -90.36 -8.66 50.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.57 0.348 . . . . 0.0 111.605 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 59.88 24.46 13.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.841 1.256 . . . . 0.0 112.961 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -88.75 155.77 50.28 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.93 0.892 . . . . 0.0 110.05 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -64.2 112.16 1.81 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.461 2.107 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.519 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.8 mt -56.64 140.05 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.788 0.835 . . . . 0.0 110.076 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 160.55 43.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.851 0.861 . . . . 0.0 109.849 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.22 -23.93 67.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.508 0.723 . . . . 0.0 111.903 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -67.49 -46.21 73.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 111.954 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.7 pt -79.06 -10.43 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' A' ' 101' ' ' CYS . 10.5 tt -99.33 132.35 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.477 0.58 . . . . 0.0 109.614 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.67 174.02 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.461 1.104 . . . . 0.0 109.762 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 29.3 mtpp -91.1 166.18 13.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.664 0.386 . . . . 0.0 110.137 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -62.89 -34.97 78.53 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.552 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.2 -9.76 59.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.183 0.593 . . . . 0.0 111.351 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -93.88 -2.95 52.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.814 0.846 . . . . 0.0 110.551 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 29.8 p -134.9 144.26 47.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.161 0.984 . . . . 0.0 109.379 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -123.21 155.62 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.595 -0.691 . . . . 0.0 109.279 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -67.95 110.84 4.06 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 159.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.45 125.13 39.85 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -79.3 -36.17 40.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.552 0.741 . . . . 0.0 111.829 -169.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -74.84 -27.3 60.22 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.405 0.548 . . . . 0.0 110.402 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.6 mmt180 -77.5 -32.74 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.84 81.26 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.794 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -145.92 157.67 43.89 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.29 1.036 . . . . 0.0 109.42 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.452 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 37.1 m-85 -72.34 118.57 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.179 0.591 . . . . 0.0 109.569 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' A' ' 183' ' ' ARG . 27.2 pt -128.32 177.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 133' ' ' LYS . 39.6 mm -80.2 145.11 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 178' ' ' ILE . 48.6 mtpt . . . . . 0 N--CA 1.471 0.615 0 O-C-N 124.066 0.854 . . . . 0.0 111.654 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HG3' HG12 ' A' ' 153' ' ' VAL . 24.9 mp0 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -47.59 30.1 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.357 1.063 . . . . 0.0 113.47 -170.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.428 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 18.8 m -65.07 -46.08 82.61 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.273 1.029 . . . . 0.0 111.227 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.483 HD13 HG22 ' A' ' 166' ' ' ILE . 62.1 mt -70.66 -46.24 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.159 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -55.18 -44.67 75.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.742 1.217 . . . . 0.0 110.616 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.447 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 93.9 m-20 -59.67 -46.26 89.59 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.319 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -61.2 -39.59 90.79 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.533 0.52 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 87.1 mt -62.75 -37.48 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.364 0.665 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 t -65.51 -36.87 85.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.992 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 26.6 mt-30 -85.63 -31.16 22.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.113 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.5 m -87.83 -17.11 32.24 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.235 0.614 . . . . 0.0 111.766 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.19 169.26 17.42 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-O 121.21 0.529 . . . . 0.0 111.577 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.89 160.8 41.44 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.607 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 99.21 1.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.75 98.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.3 m -112.28 99.52 46.83 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.929 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.15 -31.65 46.33 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.875 3.05 . . . . 0.0 114.547 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 11.1 pt-20 -70.04 -43.56 71.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.747 0.819 . . . . 0.0 110.68 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 76.4 mtp180 -81.34 -26.69 35.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.086 0.554 . . . . 0.0 110.565 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.0 mt -77.81 -20.69 52.79 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.088 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 58.44 27.75 15.92 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.749 0.819 . . . . 0.0 111.331 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.4 m -116.52 144.72 33.72 Favored Pre-proline 0 C--O 1.245 0.834 0 C-N-CA 124.024 0.93 . . . . 0.0 109.995 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.92 160.98 44.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.43 2.087 . . . . 0.0 111.66 172.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -43.13 78.59 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.922 0.764 . . . . 0.0 112.014 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.1 -37.06 83.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.049 0.94 . . . . 0.0 112.606 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.62 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.069 0.548 . . . . 0.0 111.154 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.14 31.28 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.899 0.88 . . . . 0.0 110.007 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -85.23 131.54 34.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.697 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.8 t -67.75 114.22 18.79 Favored Pre-proline 0 C--N 1.346 0.434 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.62 -11.23 30.56 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.427 2.085 . . . . 0.0 112.862 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 36.1 mt -78.08 -56.23 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.851 0.86 . . . . 0.0 109.558 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p -99.33 -11.87 20.83 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.207 1.003 . . . . 0.0 111.932 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.24 27.7 17.38 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.362 1.065 . . . . 0.0 112.305 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -104.67 164.1 12.01 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.34 99.72 8.95 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 165.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 163.87 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.714 2.276 . . . . 0.0 113.759 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -94.93 -16.66 22.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.117 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -142.86 135.1 27.37 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.839 1.256 . . . . 0.0 108.184 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.47 29.95 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.879 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.93 158.96 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.532 1.133 . . . . 0.0 110.262 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -102.3 122.09 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.53 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 78.6 t -119.61 124.69 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -69.02 117.1 10.25 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 123.823 0.702 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -74.93 80.65 2.16 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 166.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 t -58.83 -33.14 70.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.619 1.168 . . . . 0.0 110.748 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.94 -42.09 94.96 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.648 0.593 . . . . 0.0 111.581 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.51 -65.33 3.22 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.621 0.576 . . . . 0.0 111.817 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 t 176.65 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.603 1.161 . . . . 0.0 108.405 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.69 23.95 13.7 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.523 1.129 . . . . 0.0 110.413 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.11 109.96 10.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 60.8 m -83.64 131.89 34.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.819 0.448 . . . . 0.0 110.046 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.4 m -121.23 149.17 43.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 48.2 tp -88.71 104.48 16.92 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.324 0.583 . . . . 0.0 109.551 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 93.9 m-85 -97.61 136.73 37.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.47 134.71 56.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.7 -41.67 82.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.135 0.897 . . . . 0.0 111.638 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.95 -32.32 45.42 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.458 0.474 . . . . 0.0 111.799 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.68 62.83 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.518 0.727 . . . . 0.0 111.393 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.3 t80 -71.76 -39.29 70.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.8 t -61.91 -31.43 71.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 111.44 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.4 tpt180 -64.31 -52.87 56.34 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 123.564 0.54 . . . . 0.0 109.594 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.87 -42.74 76.36 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.859 0.724 . . . . 0.0 111.574 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 166' ' ' ILE . 94.4 t -63.15 -49.34 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.817 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.26 -16.12 68.65 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 124.134 0.896 . . . . 0.0 113.673 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.1 mm-40 -93.38 -11.94 31.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 111.107 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.67 30.24 56.53 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.35 0.407 . . . . 0.0 112.501 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -92.8 148.13 35.39 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.614 1.165 . . . . 0.0 109.787 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.16 -176.12 2.89 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.794 2.329 . . . . 0.0 112.584 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -55.64 132.13 71.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.261 1.025 . . . . 0.0 110.382 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 73.2 Cg_endo -68.91 -28.62 29.28 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.907 1.738 . . . . 0.0 113.303 -170.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.33 -56.49 3.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.557 0.343 . . . . 0.0 111.31 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 t -108.78 -8.79 15.29 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -169.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 32.9 mmt180 66.7 21.42 10.59 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.391 1.077 . . . . 0.0 112.634 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -72.27 141.08 83.04 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.143 0.577 . . . . 0.0 109.646 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.81 115.22 2.79 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.388 2.059 . . . . 0.0 111.677 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.555 HG21 HG22 ' A' ' 153' ' ' VAL . 71.4 mt -60.95 127.97 21.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 CA-C-O 120.934 0.397 . . . . 0.0 110.491 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -148.17 165.23 31.51 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.142 0.977 . . . . 0.0 109.402 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.12 -20.18 66.07 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.655 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m -65.37 -44.27 88.13 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.307 0.643 . . . . 0.0 112.452 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.7 pt -86.89 -7.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.24 129.96 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.02 178.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.065 0.946 . . . . 0.0 110.847 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.9 161.68 13.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.465 0.706 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -67.76 -22.76 65.19 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.7 0.8 . . . . 0.0 112.467 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.73 -22.71 23.21 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.947 0.499 . . . . 0.0 111.083 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.13 -26.88 28.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.034 0.934 . . . . 0.0 110.955 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 27.0 p -115.86 150.6 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.535 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -133.71 160.7 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.051 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 32.3 p90 -69.12 115.0 7.9 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 165.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.554 ' HB2' HG12 ' A' ' 187' ' ' ILE . 11.3 t70 -91.79 129.95 37.66 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.44 -47.89 45.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.06 0.85 . . . . 0.0 110.731 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.2 t -78.28 -25.17 46.6 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.613 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.1 mmp_? -77.05 -30.86 55.81 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.231 169.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.83 14.34 59.62 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.685 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -171.75 168.67 6.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.522 0.661 . . . . 0.0 110.459 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 93.9 m-85 -60.13 121.52 12.11 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.077 0.951 . . . . 0.0 111.529 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.613 HD13 ' HG3' ' A' ' 183' ' ' ARG . 24.1 pt -131.73 178.16 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.327 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 133' ' ' LYS . 47.2 mm -71.58 140.22 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.598 0.561 . . . . 0.0 109.586 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' A' ' 178' ' ' ILE . 54.2 mtpt . . . . . 0 N--CA 1.478 0.927 0 O-C-N 123.706 0.629 . . . . 0.0 110.906 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -47.61 71.9 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.869 0.731 . . . . 0.0 111.812 -170.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 37.1 t -66.85 -38.81 87.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.4 0.68 . . . . 0.0 111.192 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.8 mt -66.31 -43.78 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.718 0.636 . . . . 0.0 109.475 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -57.45 -44.58 84.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.022 . . . . 0.0 110.803 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -59.62 -43.44 93.79 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.425 0.453 . . . . 0.0 111.064 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.1 mpmm? -63.26 -35.34 80.02 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 111.298 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 89.1 mt -67.57 -37.48 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 122.762 0.425 . . . . 0.0 110.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.6 t -63.45 -40.04 96.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.57 0.748 . . . . 0.0 111.33 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.02 -45.17 18.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.264 0.626 . . . . 0.0 112.146 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 73.3 m -82.3 -10.05 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.905 0.882 . . . . 0.0 112.741 -169.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.69 169.29 18.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.402 0.62 . . . . 0.0 112.473 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -158.03 160.36 37.36 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.963 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 m -70.04 99.81 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 114.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.173 0.589 . . . . 0.0 110.874 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.1 m -118.49 100.42 51.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.034 0.934 . . . . 0.0 109.229 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.57 -37.53 57.69 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.338 2.692 . . . . 0.0 113.293 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -15.26 56.98 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.875 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -88.94 -43.38 11.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 0.0 110.016 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.9 mt -72.57 -12.12 60.93 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 65.33 17.75 11.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.872 1.269 . . . . 0.0 111.538 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 71.8 m -104.61 136.0 19.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.741 0.816 . . . . 0.0 110.136 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.28 164.15 29.24 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.692 2.261 . . . . 0.0 111.125 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.8 mt -53.59 -47.43 70.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.42 0.688 . . . . 0.0 111.49 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.58 -41.83 70.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.857 1.263 . . . . 0.0 113.134 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.44 67.27 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.929 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 143' ' ' LEU . 20.8 pt -126.51 23.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.244 1.018 . . . . 0.0 110.409 -177.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -69.86 128.32 35.98 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.435 0.694 . . . . 0.0 110.242 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 39.2 t -70.04 110.86 7.48 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.72 -3.06 13.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.882 2.388 . . . . 0.0 112.714 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.9 mt -76.27 -51.51 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.184 0.993 . . . . 0.0 109.236 176.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p -99.68 -15.39 18.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.978 -173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.39 47.9 15.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.516 1.126 . . . . 0.0 111.793 -172.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 163.44 37.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.573 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -78.12 116.63 60.38 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 60.0 Cg_endo -71.18 161.17 46.77 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.024 2.483 . . . . 0.0 113.819 -173.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 8.2 pt-20 -87.19 -37.86 16.92 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.37 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 17.7 pttm -140.68 140.09 34.89 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.85 156.87 28.3 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.218 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.4 ' O ' HD12 ' A' ' 143' ' ' LEU . 11.1 pt -109.31 158.19 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 109.058 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -99.41 128.16 45.5 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.495 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 90.1 t -119.54 121.86 67.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.63 113.22 10.51 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.84 80.43 1.62 Allowed 'General case' 0 C--O 1.248 1.005 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -68.3 -30.39 69.38 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.223 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.86 -38.86 89.83 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.271 174.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.33 -67.46 1.83 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.103 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t 178.79 44.33 0.0 OUTLIER 'General case' 0 C--O 1.251 1.144 0 C-N-CA 123.864 0.865 . . . . 0.0 109.905 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 t70 70.31 8.33 6.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 123.951 0.901 . . . . 0.0 111.432 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.595 ' HA ' HG22 ' A' ' 187' ' ' ILE . 61.3 t -77.14 113.59 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.51 138.63 33.34 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 109.473 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.8 m -129.25 154.0 47.24 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.5 tp -90.17 121.39 32.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.495 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.0 m-85 -117.34 133.7 55.68 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 124.991 1.317 . . . . 0.0 107.824 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.6 t70 -59.78 135.55 57.72 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 118.846 0.748 . . . . 0.0 109.656 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.4 71.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.898 0.879 . . . . 0.0 111.575 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.37 -34.72 65.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.56 -37.67 71.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 111.771 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -76.92 -36.65 56.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.384 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.9 t -62.59 -30.24 71.19 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 124.01 0.819 . . . . 0.0 110.831 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.5 ttm-85 -64.87 -53.5 45.72 Favored 'General case' 0 C--O 1.218 -0.564 0 O-C-N 124.02 0.825 . . . . 0.0 109.981 170.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 73.2 mt -52.94 -47.84 67.75 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.949 0.5 . . . . 0.0 111.475 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.61 -51.36 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.659 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.51 73.5 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.269 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 29.6 mm-40 -87.48 -23.86 24.3 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 117.36 0.58 . . . . 0.0 110.185 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.86 53.59 Favored Glycine 0 N--CA 1.47 0.945 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.62 140.31 59.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.084 0.954 . . . . 0.0 109.63 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.56 -168.08 0.53 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.748 2.298 . . . . 0.0 112.608 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -60.66 131.41 91.0 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.353 1.061 . . . . 0.0 110.043 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.413 ' HG3' HG12 ' A' ' 121' ' ' ILE . 70.2 Cg_endo -68.79 -24.42 34.46 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.37 2.047 . . . . 0.0 113.444 -172.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.74 -65.15 1.04 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.9 t -102.71 -9.4 20.07 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.299 -167.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 62.22 24.04 14.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.782 1.233 . . . . 0.0 112.063 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -79.16 148.35 71.09 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.334 0.654 . . . . 0.0 110.062 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.93 123.09 12.24 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.702 2.268 . . . . 0.0 111.854 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.94 134.3 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.292 0.637 . . . . 0.0 110.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.1 t -141.14 160.61 39.73 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.917 0.887 . . . . 0.0 109.559 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.04 -23.97 67.69 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.913 0.885 . . . . 0.0 111.545 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.7 t -67.56 -41.27 84.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.783 0.833 . . . . 0.0 112.267 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -85.0 -8.67 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.8 tt -98.0 133.57 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.82 0.736 . . . . 0.0 109.151 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.04 174.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.725 1.21 . . . . 0.0 110.378 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 40.8 mtpt -102.62 164.5 11.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.145 0.578 . . . . 0.0 110.843 -175.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -73.68 -17.59 61.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.918 0.487 . . . . 0.0 111.595 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.49 -32.77 28.63 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.11 -29.89 49.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.331 0.652 . . . . 0.0 110.721 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 31.6 p -113.55 155.51 25.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.599 0.759 . . . . 0.0 109.643 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.39 164.23 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.312 1.045 . . . . 0.0 108.839 179.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.27 127.51 33.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 162.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.463 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -107.52 139.18 42.43 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.883 -0.511 . . . . 0.0 110.027 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.17 -50.86 13.43 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.248 0.968 . . . . 0.0 111.757 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 15.0 t -71.06 -33.53 70.36 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.19 0.45 . . . . 0.0 111.18 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.569 ' HG3' HD13 ' A' ' 187' ' ' ILE . 26.8 mmt180 -76.3 -27.95 56.78 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.917 0.487 . . . . 0.0 110.088 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.83 24.31 72.47 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.194 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -170.11 163.68 9.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.831 0.853 . . . . 0.0 108.824 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 89.0 m-85 -59.82 127.68 33.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.975 0.91 . . . . 0.0 111.182 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 140' ' ' VAL . 19.1 pt -138.71 -179.85 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.645 1.178 . . . . 0.0 108.989 170.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.8 152.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 122.995 0.518 . . . . 0.0 109.889 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.966 174.218 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -30.7 70.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 0.0 112.155 -174.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -68.29 -46.97 68.9 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.099 0.96 . . . . 0.0 109.788 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 98' ' ' ILE . 79.6 mt -64.48 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.683 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -61.11 -38.38 86.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.717 1.207 . . . . 0.0 112.537 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.9 -41.23 95.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.456 0.473 . . . . 0.0 110.238 173.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -39.23 89.31 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 123.369 0.418 . . . . 0.0 110.614 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 94' ' ' ILE . 74.9 mt -65.25 -46.08 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.79 0.436 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -65.4 -36.02 82.7 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.879 0.872 . . . . 0.0 112.25 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -82.4 -42.55 18.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.988 0.515 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.85 -6.97 59.54 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.83 0.852 . . . . 0.0 112.386 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -75.26 163.62 27.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.186 0.517 . . . . 0.0 111.56 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -157.2 159.58 37.85 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.988 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.4 p -73.35 100.75 3.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.933 0.77 . . . . 0.0 109.409 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.87 120.88 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.865 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.98 96.1 32.65 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 0.0 109.149 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.44 -34.45 33.06 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.493 3.462 . . . . 0.0 115.625 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.29 -34.88 65.99 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.892 0.477 . . . . 0.0 110.74 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -82.12 -36.47 27.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.763 0.825 . . . . 0.0 110.057 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.54 -17.52 62.31 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.055 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.88 34.62 23.9 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.697 1.199 . . . . 0.0 110.893 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 69.6 m -115.08 135.77 22.54 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.199 0.999 . . . . 0.0 109.171 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.54 153.07 63.75 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.455 2.104 . . . . 0.0 111.708 169.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 59.4 mt -52.57 -48.07 66.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.354 1.061 . . . . 0.0 111.766 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.26 -35.98 78.76 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.336 1.055 . . . . 0.0 112.571 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.39 66.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.67 . . . . 0.0 111.658 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.429 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.3 pt -124.06 24.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.645 0.778 . . . . 0.0 110.46 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 42.0 tt0 -68.85 135.66 51.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.853 174.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.5 112.08 10.87 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.12 -6.7 19.78 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.861 2.374 . . . . 0.0 112.791 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.52 -53.21 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.788 0.835 . . . . 0.0 109.466 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -91.94 -11.1 37.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.65 0.78 . . . . 0.0 112.596 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.91 36.65 12.62 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.015 0.926 . . . . 0.0 111.431 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -151.64 149.1 28.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.482 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.1 tm0? -67.14 121.6 79.06 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 123.49 0.716 . . . . 0.0 109.371 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 153.21 41.19 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.535 2.157 . . . . 0.0 113.747 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.36 -17.18 32.98 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.46 170.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -150.72 130.69 13.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.594 1.157 . . . . 0.0 108.368 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.46 169.2 39.81 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.667 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 171' ' ' ILE . 12.8 pt -118.61 154.47 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.201 1.401 . . . . 0.0 110.058 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.36 121.26 37.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 95.2 t -120.11 122.52 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.5 ptmt -68.52 120.16 14.13 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.359 0.599 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -74.78 79.53 2.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 165.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HE2' ' A' ' 133' ' ' LYS . 12.5 t -68.72 -36.86 78.96 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.244 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.3 -35.03 76.21 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.476 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.79 -64.1 2.0 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.307 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -171.55 27.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.906 0.482 . . . . 0.0 111.105 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.6 m-20 62.79 25.07 14.9 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.359 1.063 . . . . 0.0 111.78 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 187' ' ' ILE . 70.6 t -85.92 124.52 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 0.0 109.225 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 28.6 p -83.27 130.13 35.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -174.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.2 m -120.34 140.08 51.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.097 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.429 HD23 ' HB ' ' A' ' 117' ' ' ILE . 36.8 tp -89.54 107.49 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.356 0.598 . . . . 0.0 110.105 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 88.8 m-85 -99.99 145.95 27.28 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.24 134.66 54.12 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.51 78.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.757 0.66 . . . . 0.0 111.879 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -31.39 64.75 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.653 0.595 . . . . 0.0 111.678 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -73.3 -39.77 65.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.059 0.543 . . . . 0.0 111.739 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -75.97 -35.24 59.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.4 t -59.6 -38.75 82.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.061 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 15.6 tpt180 -57.77 -49.63 75.94 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 124.275 0.984 . . . . 0.0 110.101 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.84 -46.32 81.8 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.693 0.621 . . . . 0.0 111.658 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 166' ' ' ILE . 70.5 t -65.4 -42.41 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.58 63.99 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.501 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.8 -12.51 55.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.277 0.631 . . . . 0.0 111.201 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.21 74.28 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.733 -0.212 . . . . 0.0 113.161 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.09 133.69 81.35 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.52 179.17 3.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.829 2.353 . . . . 0.0 112.641 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -58.07 128.08 80.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.73 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.47 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 44.7 Cg_endo -64.51 -25.32 62.85 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.617 2.211 . . . . 0.0 113.476 -167.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -53.7 4.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.958 0.503 . . . . 0.0 111.499 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.3 t -108.87 -13.01 14.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -171.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 36.6 mmt180 62.47 28.34 16.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.576 1.151 . . . . 0.0 112.129 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 162' ' ' THR . 22.9 mm-40 -83.18 158.35 64.25 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.623 0.769 . . . . 0.0 109.894 170.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.88 119.36 6.38 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.154 1.903 . . . . 0.0 111.495 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 153' ' ' VAL . 68.1 mt -60.05 128.35 20.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 t -140.69 155.81 46.38 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.145 0.978 . . . . 0.0 109.1 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.91 -22.54 66.51 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.1 m -63.04 -32.28 73.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.391 1.076 . . . . 0.0 112.889 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 47.6 pt -97.2 -7.8 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 130' ' ' ILE . 10.5 tt -96.54 133.73 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.224 0.92 . . . . 0.0 109.475 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.14 178.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.208 1.403 . . . . 0.0 109.736 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -100.34 170.2 8.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.252 0.621 . . . . 0.0 110.729 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -68.86 -27.97 66.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.661 0.384 . . . . 0.0 110.947 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.75 -42.45 81.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.633 0.773 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.13 -12.28 60.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.314 -168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 27.7 p -118.69 151.05 38.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.897 0.879 . . . . 0.0 109.742 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.36 160.03 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -68.62 127.47 33.14 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.1 t70 -106.73 127.95 53.81 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.05 -42.34 63.23 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.099 0.875 . . . . 0.0 112.176 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -79.25 -16.09 57.0 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.753 0.252 . . . . 0.0 111.383 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.57 -29.79 19.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.125 0.57 . . . . 0.0 110.541 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.64 18.14 77.91 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.981 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -162.07 160.14 27.08 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.545 0.738 . . . . 0.0 109.176 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.588 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 87.4 m-85 -61.37 124.59 21.03 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.608 1.163 . . . . 0.0 111.737 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.5 pt -128.77 179.58 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.224 1.01 . . . . 0.0 108.432 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 133' ' ' LYS . 23.5 mm -79.92 149.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 122.549 0.34 . . . . 0.0 110.473 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? . . . . . 0 N--CA 1.468 0.438 0 C-N-CA 124.061 0.944 . . . . 0.0 112.693 179.258 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -70.65 -42.59 70.6 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.061 0.945 . . . . 0.0 111.674 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.68 -45.39 70.32 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -167.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 35.3 t -71.52 -36.8 71.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.723 0.409 . . . . 0.0 110.693 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 98' ' ' ILE . 83.6 mt -63.23 -42.05 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -68.16 -31.95 71.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.467 1.107 . . . . 0.0 112.307 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -58.62 -46.55 86.82 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 168.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -67.08 -40.6 87.01 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.735 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 94' ' ' ILE . 85.3 mt -64.16 -44.8 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.247 0.476 . . . . 0.0 109.936 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.7 t -66.82 -35.15 79.39 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.318 0.647 . . . . 0.0 112.48 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.679 0.391 . . . . 0.0 111.441 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.5 m -64.42 -21.33 66.61 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.58 1.152 . . . . 0.0 113.266 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.27 173.34 4.88 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-O 121.468 0.651 . . . . 0.0 112.316 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -158.23 159.51 36.12 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.777 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.7 t -77.41 108.67 10.72 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.79 134.64 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.102 -171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.2 m -135.82 94.86 14.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.244 1.017 . . . . 0.0 108.982 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.41 ' HB3' HD11 ' A' ' 117' ' ' ILE . 24.2 Cg_endo -58.18 -35.31 98.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.715 2.943 . . . . 0.0 113.833 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -31.66 32.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.008 0.523 . . . . 0.0 111.372 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -75.65 -40.4 56.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.565 0.346 . . . . 0.0 110.733 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 95.6 mt -71.82 -14.92 62.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.75 0.82 . . . . 0.0 111.946 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 64.27 10.52 5.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.763 1.225 . . . . 0.0 111.965 -172.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.465 ' SG ' ' HZ ' ' A' ' 186' ' ' PHE . 58.8 m -94.52 130.82 32.41 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.897 0.879 . . . . 0.0 110.156 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.41 155.02 72.08 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.612 2.208 . . . . 0.0 111.574 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 63.5 mt -52.57 -49.77 64.3 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.189 0.931 . . . . 0.0 111.962 -173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.24 -41.2 71.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.242 1.017 . . . . 0.0 112.941 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.06 63.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.509 0.724 . . . . 0.0 111.785 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.564 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.5 pt -126.63 17.8 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.663 0.785 . . . . 0.0 110.756 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 39.6 tt0 -69.84 137.59 51.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 111.064 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.454 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 34.9 t -73.7 112.11 14.95 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.97 -4.31 15.19 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.754 2.302 . . . . 0.0 112.759 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.5 mt -83.33 -54.82 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.837 0.855 . . . . 0.0 109.311 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p -88.68 -12.38 42.56 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.079 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.11 36.34 18.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.954 0.902 . . . . 0.0 111.464 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -148.51 151.57 35.36 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.163 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.8 tm0? -68.73 115.47 31.07 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.7 Cg_endo -71.82 160.11 48.79 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.569 2.18 . . . . 0.0 113.258 -167.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.2 pt-20 -83.9 -31.04 25.9 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.158 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.23 145.41 31.29 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.191 1.396 . . . . 0.0 108.203 174.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.02 169.69 40.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.871 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.77 153.45 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.187 1.395 . . . . 0.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -97.96 117.15 31.64 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 73.7 t -110.92 123.31 66.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 188' ' ' ILE . 18.4 ptmt -71.03 108.35 4.55 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.74 0.781 . . . . 0.0 110.426 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -75.91 76.04 2.82 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 t -69.51 -32.51 71.41 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.353 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.07 -44.63 91.88 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.084 0.865 . . . . 0.0 110.813 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.21 -67.34 1.94 Allowed Glycine 0 C--N 1.348 1.211 0 O-C-N 123.704 0.628 . . . . 0.0 112.868 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.8 m -170.78 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.973 0.909 . . . . 0.0 110.305 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.08 23.68 12.45 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.405 1.097 . . . . 0.0 111.086 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.6 124.59 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.575 ' SG ' HD13 ' A' ' 188' ' ' ILE . 56.8 m -83.42 118.82 23.99 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.504 HG21 HD11 ' A' ' 161' ' ' LEU . 18.1 m -111.86 134.21 53.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 117' ' ' ILE . 30.3 tp -90.41 103.29 15.99 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.721 0.638 . . . . 0.0 109.928 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 95.1 m-85 -97.05 136.91 36.93 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.6 t70 -57.8 130.48 46.67 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.31 -43.36 74.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.251 0.969 . . . . 0.0 111.908 -172.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.67 42.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.869 0.468 . . . . 0.0 111.705 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.77 65.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.935 0.494 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -77.02 -39.63 49.51 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -55.17 -34.59 63.98 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 124.583 1.153 . . . . 0.0 111.437 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.2 tpm_? -63.1 -54.32 39.69 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.858 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.9 mt -55.31 -44.4 75.74 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.361 1.038 . . . . 0.0 111.681 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 166' ' ' ILE . 60.8 t -64.78 -47.4 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.736 0.647 . . . . 0.0 109.44 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.47 -32.15 82.1 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.542 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.3 mm-40 -82.96 -28.93 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.335 0.654 . . . . 0.0 111.164 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.04 14.3 42.98 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.491 0.495 . . . . 0.0 112.668 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.55 134.63 57.67 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.162 0.985 . . . . 0.0 109.664 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.47 -171.25 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.704 2.269 . . . . 0.0 112.627 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.492 ' ND1' HG22 ' A' ' 162' ' ' THR . 49.0 t-80 -61.24 123.95 78.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.614 0.766 . . . . 0.0 108.981 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.91 -11.22 29.03 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.129 1.886 . . . . 0.0 113.189 -167.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 142' ' ' THR . 88.6 mt -96.49 -65.93 0.94 Allowed 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.178 0.591 . . . . 0.0 110.616 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.492 HG22 ' ND1' ' A' ' 159' ' ' HIS . 11.1 t -98.71 -3.15 36.51 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.863 0.465 . . . . 0.0 111.997 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 66.01 15.56 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.581 1.553 . . . . 0.0 112.537 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.42 150.54 82.54 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 123.162 0.585 . . . . 0.0 110.97 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.34 113.6 2.33 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.246 1.964 . . . . 0.0 109.92 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.503 HG21 HG22 ' A' ' 153' ' ' VAL . 72.3 mt -56.21 128.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 O-C-N 123.808 0.693 . . . . 0.0 110.291 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.4 t -143.83 157.94 44.02 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.061 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.94 -15.37 63.64 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.439 0.696 . . . . 0.0 111.462 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -67.5 -48.15 67.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.027 0.931 . . . . 0.0 111.804 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 43.6 pt -83.42 -5.36 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 7.6 tt -100.91 139.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 188' ' ' ILE . 29.0 m -125.45 170.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 0.0 109.751 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.37 150.05 28.6 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.146 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.402 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 17.7 p-80 -63.97 -18.79 64.62 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.882 0.739 . . . . 0.0 112.901 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.61 -24.2 24.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.411 0.684 . . . . 0.0 111.598 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -87.97 5.15 42.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.173 0.589 . . . . 0.0 110.563 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 24.6 p -129.0 130.71 47.0 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.26 157.74 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -67.36 119.04 11.55 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.486 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.1 t70 -99.59 134.94 41.75 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.92 -34.99 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.848 0.859 . . . . 0.0 111.957 -172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.6 t -80.61 -29.26 36.87 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.426 0.557 . . . . 0.0 110.695 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.553 ' HG3' HD13 ' A' ' 187' ' ' ILE . 25.4 mmt180 -82.2 -25.55 34.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.963 0.505 . . . . 0.0 110.404 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.7 18.19 79.79 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.824 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -166.66 164.38 16.78 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HZ ' ' SG ' ' A' ' 112' ' ' CYS . 93.8 m-85 -59.74 120.95 10.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.81 0.844 . . . . 0.0 111.405 175.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.553 HD13 ' HG3' ' A' ' 183' ' ' ARG . 13.2 pt -132.47 177.34 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.823 0.849 . . . . 0.0 109.227 168.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 133' ' ' LYS . 30.8 mm -76.06 153.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.262 0.625 . . . . 0.0 110.438 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.38 163.33 25.44 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.429 0.692 . . . . 0.0 111.325 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.13 -43.51 63.89 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.3 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 . . . . . 0 C--O 1.244 0.809 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -67.13 -36.89 82.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.138 0.975 . . . . 0.0 110.513 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -68.92 -21.43 64.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.51 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 39.5 t -68.27 -40.45 81.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.3 mt -63.26 -48.08 89.16 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -53.83 -44.89 70.64 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.424 1.089 . . . . 0.0 111.465 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.85 95.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.508 0.723 . . . . 0.0 110.626 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -67.43 -32.9 74.08 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 123.253 0.621 . . . . 0.0 110.985 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.534 HG23 HD13 ' A' ' 130' ' ' ILE . 91.0 mt -67.7 -41.29 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.899 0.479 . . . . 0.0 109.839 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.3 m -66.35 -39.55 89.26 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.7 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -82.21 -30.5 30.82 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 78.3 m -89.88 -15.54 31.95 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.71 168.55 17.52 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.696 0.76 . . . . 0.0 112.444 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -156.71 155.62 31.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.988 172.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.5 p -73.02 110.14 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.09 107.54 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.098 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 40.3 m -112.25 95.96 33.03 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.552 1.141 . . . . 0.0 108.558 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.5 -36.95 95.3 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.714 2.943 . . . . 0.0 114.376 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -28.08 36.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -78.52 -39.36 38.25 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.494 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 86.5 mt -72.74 -22.2 60.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.07 0.948 . . . . 0.0 111.271 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 56.36 11.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.287 1.035 . . . . 0.0 113.213 -172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 58.4 m -84.35 138.48 38.97 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 123.681 0.792 . . . . 0.0 109.588 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.19 142.84 99.73 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.123 1.882 . . . . 0.0 110.446 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 125' ' ' GLN . 82.3 mt -52.64 -40.5 62.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 111.998 -173.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.28 -44.05 75.29 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.026 0.93 . . . . 0.0 112.273 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.33 69.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.565 0.746 . . . . 0.0 111.117 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 24.2 pt -112.32 23.34 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.31 129.69 34.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.017 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 29.2 t -68.97 111.56 8.8 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 -8.62 23.81 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.694 2.263 . . . . 0.0 112.759 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.2 mt -78.06 -57.43 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.113 0.965 . . . . 0.0 109.086 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.8 p -91.32 -6.02 53.71 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.457 -171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.3 31.35 19.36 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.026 0.931 . . . . 0.0 111.957 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.64 154.26 41.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.371 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.57 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -67.24 113.99 16.44 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 94.4 Cg_endo -76.56 165.7 28.53 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.157 2.572 . . . . 0.0 113.773 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.9 pt-20 -79.94 -36.14 36.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.293 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.554 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -151.29 146.43 26.03 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.688 1.195 . . . . 0.0 108.0 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.47 169.43 41.12 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 120.959 -0.638 . . . . 0.0 114.397 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.534 HD13 HG23 ' A' ' 98' ' ' ILE . 11.6 pt -122.42 155.45 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 125.645 1.578 . . . . 0.0 109.863 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -94.82 121.88 36.87 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 88.6 t -127.02 121.56 58.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.623 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.8 ptmt -67.33 113.77 5.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.673 0.749 . . . . 0.0 110.425 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -71.29 85.37 0.79 Allowed 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 163.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 42.9 t -64.97 -45.97 83.44 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.163 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.84 -38.07 89.73 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.845 0.715 . . . . 0.0 111.235 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.11 -64.05 3.77 Favored Glycine 0 C--N 1.344 1.028 0 O-C-N 123.821 0.701 . . . . 0.0 112.684 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.9 m -160.56 14.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.29 0.636 . . . . 0.0 111.922 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.9 m-20 60.4 27.2 16.79 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.935 0.894 . . . . 0.0 111.737 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.05 138.36 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.004 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.656 ' SG ' HD13 ' A' ' 188' ' ' ILE . 20.4 m -84.03 121.65 27.7 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.079 0.951 . . . . 0.0 108.56 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.1 m -118.91 141.7 48.42 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.7 tp -91.94 105.47 17.72 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 109.963 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 75.1 m-85 -98.94 143.36 29.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 15.8 t70 -60.96 129.62 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.73 81.02 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.906 0.754 . . . . 0.0 112.057 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.03 -28.26 60.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.78 0.432 . . . . 0.0 111.301 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.23 62.81 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.379 0.671 . . . . 0.0 111.477 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -76.06 -37.92 57.68 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.748 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 48.2 t -64.21 -32.76 74.47 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.256 0.622 . . . . 0.0 110.853 174.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 6.1 tpm_? -59.28 -53.35 59.21 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 123.833 0.708 . . . . 0.0 109.333 172.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.5 mt -53.66 -48.09 69.76 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.247 0.967 . . . . 0.0 111.572 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.36 -40.69 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.166 0.586 . . . . 0.0 110.471 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.94 76.44 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.826 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.8 mm-40 -90.71 -11.48 39.56 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.663 0.785 . . . . 0.0 111.208 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.73 15.31 75.89 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 123.048 0.356 . . . . 0.0 112.961 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.87 138.48 46.62 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.764 1.226 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.02 178.25 7.7 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.633 2.222 . . . . 0.0 112.581 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -51.92 132.47 39.09 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -173.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.21 -23.8 28.32 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.868 1.712 . . . . 0.0 113.426 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.32 -43.38 12.2 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.4 t -121.52 -14.1 8.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 63.42 28.18 15.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.519 1.128 . . . . 0.0 112.364 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 162' ' ' THR . 14.7 mm-40 -78.36 152.98 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.497 0.719 . . . . 0.0 110.131 172.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.78 114.71 2.53 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.738 2.292 . . . . 0.0 111.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.465 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.8 mt -66.3 138.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.744 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 t -150.77 164.27 36.59 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.398 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.69 -23.23 66.1 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.753 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 m -66.34 -43.16 86.88 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.682 0.793 . . . . 0.0 111.571 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.2 pt -85.5 -10.27 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.32 135.46 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.735 HG11 HD12 ' A' ' 188' ' ' ILE . 33.3 m -135.03 175.75 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.017 1.327 . . . . 0.0 110.156 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 37.2 mtmm -99.89 166.68 10.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.349 0.659 . . . . 0.0 110.54 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -55.3 -43.45 74.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.62 0.768 . . . . 0.0 112.206 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.86 -21.54 47.38 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.225 0.61 . . . . 0.0 111.524 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -81.19 -25.0 37.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.707 0.803 . . . . 0.0 110.332 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.4 p -105.53 153.66 21.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.276 1.03 . . . . 0.0 108.856 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.81 162.32 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -72.72 134.19 44.91 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.44 120.04 37.53 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.53 -42.39 71.27 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.897 0.748 . . . . 0.0 112.353 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.5 t -72.09 -30.09 64.76 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.784 0.265 . . . . 0.0 110.697 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -76.96 -32.97 57.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.367 0.667 . . . . 0.0 110.291 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.07 89.69 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.719 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -141.06 157.25 45.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.649 0.78 . . . . 0.0 110.837 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -68.81 128.71 37.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.765 0.826 . . . . 0.0 109.977 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.2 175.2 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 172' ' ' VAL . 24.9 mm -79.75 143.07 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.5 159.55 12.72 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.506 0.723 . . . . 0.0 112.271 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.55 -8.55 28.42 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.595 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.247 0.954 0 C-N-CA 124.11 0.964 . . . . 0.0 109.541 177.091 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 26.6 mp0 -59.71 -49.73 76.58 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.68 0.613 . . . . 0.0 111.952 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.36 79.75 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.223 0.609 . . . . 0.0 111.44 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.2 t -66.44 -42.88 86.98 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.491 0.716 . . . . 0.0 109.872 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.94 -41.19 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.706 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 46.7 mm-40 -58.43 -41.82 85.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.609 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -60.16 -41.42 92.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.558 0.536 . . . . 0.0 110.634 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -44.54 88.65 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.507 0.504 . . . . 0.0 110.618 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 130' ' ' ILE . 88.9 mt -59.21 -41.01 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.022 0.929 . . . . 0.0 109.951 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -64.66 -39.27 93.4 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.664 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -86.75 -23.59 25.41 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 79.7 m -89.25 -24.1 22.18 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.605 0.762 . . . . 0.0 111.657 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 130' ' ' ILE . 20.4 pttp -69.1 168.68 13.42 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.563 0.697 . . . . 0.0 112.015 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -155.95 164.87 37.94 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.695 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 t -67.92 99.12 0.81 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.493 HG12 ' NE2' ' A' ' 125' ' ' GLN . 59.8 t -70.66 96.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.496 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.3 m -100.05 98.61 7.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.185 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.14 -37.88 93.74 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.094 2.529 . . . . 0.0 113.772 -168.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.75 -31.54 68.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.461 0.704 . . . . 0.0 111.548 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -78.89 -36.75 41.61 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.964 0.505 . . . . 0.0 110.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.58 -21.62 63.59 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 69.5 -40.04 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.473 1.909 . . . . 0.0 113.56 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.45 134.59 76.72 Favored Pre-proline 0 C--N 1.353 0.729 0 C-N-CA 124.678 1.191 . . . . 0.0 109.419 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.47 166.93 10.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.205 2.604 . . . . 0.0 112.891 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 67.4 mt -51.17 -47.4 62.15 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.758 0.823 . . . . 0.0 111.581 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.25 -40.06 80.8 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.911 0.884 . . . . 0.0 112.461 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.51 65.65 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.459 0.704 . . . . 0.0 112.255 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' HD23 ' A' ' 143' ' ' LEU . 13.0 pt -120.35 11.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.06 0.944 . . . . 0.0 110.868 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 34.7 tt0 -70.3 134.42 47.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.51 1.124 . . . . 0.0 111.407 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.1 t -67.2 114.96 21.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 124.045 0.841 . . . . 0.0 109.211 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.558 ' HB2' HD21 ' A' ' 161' ' ' LEU . 92.3 Cg_endo -76.51 0.9 9.02 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.676 2.251 . . . . 0.0 113.049 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 160' ' ' PRO . 34.8 mt -84.79 -54.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.678 0.791 . . . . 0.0 109.084 173.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p -95.68 -8.3 35.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.735 -171.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.27 42.23 25.51 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.36 1.064 . . . . 0.0 111.791 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.08 153.67 35.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.161 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.493 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.2 tm0? -72.18 118.7 69.52 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 175.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.34 163.46 34.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.897 2.398 . . . . 0.0 113.392 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 16.0 pt-20 -99.47 -20.71 16.3 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.413 172.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.9 133.09 26.29 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 125.629 1.571 . . . . 0.0 106.833 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.18 158.43 31.04 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.362 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.508 HG21 HG23 ' A' ' 98' ' ' ILE . 11.2 pt -113.77 156.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.905 1.282 . . . . 0.0 110.419 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.726 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 36.5 m-85 -99.32 118.34 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.932 172.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 91.5 t -123.17 119.39 57.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -67.66 114.41 6.26 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 123.638 0.586 . . . . 0.0 111.299 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -73.71 82.79 1.59 Allowed 'General case' 0 C--O 1.252 1.217 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 165.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.8 t -62.19 -33.97 75.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.038 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.7 -36.05 81.59 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.488 0.715 . . . . 0.0 111.54 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.15 -62.96 5.77 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 124.15 0.906 . . . . 0.0 111.349 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t 174.98 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.482 1.513 . . . . 0.0 107.433 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.46 16.79 10.7 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 121.866 0.841 . . . . 0.0 109.766 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 187' ' ' ILE . 58.5 t -78.59 124.48 37.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.86 -171.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 18.6 t -85.75 133.43 34.0 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.9 m -119.64 138.63 53.13 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.592 0.757 . . . . 0.0 109.406 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.6 tp -91.18 107.82 19.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.184 0.516 . . . . 0.0 109.725 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 94.9 m-85 -98.56 155.37 17.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.347 1.059 . . . . 0.0 108.264 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.8 140.31 53.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.16 97.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.978 0.799 . . . . 0.0 111.195 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.4 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.196 0.598 . . . . 0.0 112.101 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.81 -42.22 58.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.165 0.586 . . . . 0.0 111.187 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -74.95 -38.43 61.73 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.594 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.5 t -57.03 -37.32 71.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.648 0.779 . . . . 0.0 111.01 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.3 tpm_? -60.13 -57.1 14.27 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 124.266 0.978 . . . . 0.0 110.251 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.32 -44.14 68.16 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.329 1.018 . . . . 0.0 111.7 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 94.2 t -62.56 -48.02 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.159 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.26 -25.08 73.6 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.014 0.821 . . . . 0.0 113.283 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 10.1 mm-40 -78.65 -23.24 45.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.996 0.518 . . . . 0.0 110.541 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.61 24.07 26.84 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.595 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 69.4 mt -87.3 156.94 53.94 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.335 1.054 . . . . 0.0 110.728 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.44 -177.12 3.65 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.933 2.422 . . . . 0.0 112.829 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.425 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.3 t-80 -61.56 126.71 87.32 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.052 0.941 . . . . 0.0 109.389 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.478 ' HG3' HG12 ' A' ' 121' ' ' ILE . 58.6 Cg_endo -64.92 -21.33 64.14 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.571 2.181 . . . . 0.0 113.371 -169.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' A' ' 120' ' ' PRO . 55.7 mt -89.57 -66.37 0.93 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 122.956 0.502 . . . . 0.0 110.995 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.4 t -104.56 -1.22 26.83 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.608 -167.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 62.24 26.61 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.94 1.296 . . . . 0.0 112.995 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -77.79 150.52 78.72 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.167 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.33 114.07 2.91 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.172 1.915 . . . . 0.0 110.072 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 62.8 mt -59.33 133.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 123.448 0.467 . . . . 0.0 110.226 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.7 t -151.55 166.19 31.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.719 0.808 . . . . 0.0 109.501 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.48 -18.98 65.27 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.37 1.068 . . . . 0.0 111.46 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -71.45 -42.43 68.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.802 0.841 . . . . 0.0 111.738 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 166' ' ' ILE . 32.6 pt -85.99 -8.56 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' VAL . 11.4 tt -103.62 134.85 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.564 HG11 HD12 ' A' ' 188' ' ' ILE . 33.4 m -121.97 160.2 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.556 0.742 . . . . 0.0 109.892 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -73.32 149.67 42.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.864 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 20.5 p80 -63.7 -23.9 67.56 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.095 0.247 . . . . 0.0 111.452 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.81 -29.51 66.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.856 0.862 . . . . 0.0 110.873 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 189' ' ' LYS . 24.5 mm-40 -93.73 17.43 11.91 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 112.191 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 23.7 p -140.84 134.85 30.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.293 0.637 . . . . 0.0 109.365 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -131.86 159.51 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 107.561 -178.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -67.36 139.94 57.21 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -116.34 138.56 51.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.62 -45.91 84.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.955 1.41 . . . . 0.0 110.72 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 50.1 m -66.03 -48.56 70.7 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.875 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.538 ' HG3' HG21 ' A' ' 187' ' ' ILE . 32.9 mmt180 -82.08 -24.3 35.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.468 0.707 . . . . 0.0 110.949 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.3 22.27 73.7 Favored Glycine 0 N--CA 1.472 1.042 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.833 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -165.11 164.71 20.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.632 . . . . 0.0 110.005 -170.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -59.8 120.26 9.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 110.54 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.8 pp -134.36 169.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.546 1.138 . . . . 0.0 108.786 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 133' ' ' LYS . 15.6 mm -71.19 151.53 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 176' ' ' GLU . 53.3 mtpt -65.01 164.44 12.76 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.363 0.529 . . . . 0.0 112.046 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -126.18 74.19 0.42 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.899 -176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.598 0.759 . . . . 0.0 109.236 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.1 p . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 94' ' ' ILE . 6.2 mp0 -52.66 -43.65 65.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.258 1.423 . . . . 0.0 112.47 -170.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.81 -49.37 68.5 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.139 0.899 . . . . 0.0 111.791 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 38.3 m -65.21 -36.93 85.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.895 0.878 . . . . 0.0 110.755 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 91' ' ' GLN . 44.3 mt -67.77 -45.76 83.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.576 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -54.41 -46.37 73.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.758 1.223 . . . . 0.0 111.2 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.6 m-80 -57.16 -49.96 74.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.769 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -63.72 -35.01 79.16 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 123.388 0.675 . . . . 0.0 111.603 -176.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 94' ' ' ILE . 93.9 mt -65.79 -44.48 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 t -65.66 -35.3 80.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.261 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.0 mm-40 -80.91 -49.79 10.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.903 0.481 . . . . 0.0 111.68 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -69.41 -21.52 63.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.413 1.085 . . . . 0.0 113.327 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.79 173.59 5.12 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -160.27 161.73 33.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.57 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -69.31 107.52 3.31 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 128' ' ' LYS . 92.8 t -72.64 99.32 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.298 0.57 . . . . 0.0 109.64 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 82.1 m -105.1 102.18 34.7 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.77 1.228 . . . . 0.0 108.014 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 11.3 Cg_endo -53.84 -27.56 44.25 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.693 2.929 . . . . 0.0 113.422 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.5 -40.52 70.13 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.548 0.739 . . . . 0.0 110.635 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.5 HH11 HD23 ' A' ' 110' ' ' LEU . 2.6 tmt_? -73.6 -44.19 57.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.553 0.741 . . . . 0.0 109.587 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 HH11 ' A' ' 109' ' ' ARG . 95.9 mt -71.72 -22.31 61.64 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.555 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 55.7 14.3 1.24 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 0.0 112.917 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.9 m -99.83 136.43 20.23 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 124.237 1.015 . . . . 0.0 108.663 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -53.95 150.42 30.72 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.929 2.419 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.6 mt -53.26 -49.34 67.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.251 1.02 . . . . 0.0 112.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.7 -35.5 76.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.148 0.979 . . . . 0.0 112.519 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.97 69.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.087 0.555 . . . . 0.0 111.623 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.514 ' HB ' HD23 ' A' ' 143' ' ' LEU . 22.9 pt -109.18 4.3 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.21 0.604 . . . . 0.0 111.038 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 36.8 tt0 -60.71 134.99 57.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 31.7 t -67.04 114.31 17.57 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.128 0.971 . . . . 0.0 108.807 175.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.526 ' HB2' HD21 ' A' ' 161' ' ' LEU . 73.9 Cg_endo -70.62 -9.14 25.19 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.616 2.211 . . . . 0.0 112.782 -176.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.5 -55.43 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.833 0.853 . . . . 0.0 109.669 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -98.9 -6.19 29.38 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.557 -170.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.55 34.37 20.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.054 0.942 . . . . 0.0 112.257 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.05 148.03 49.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.783 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 1.0 OUTLIER -68.02 108.75 3.0 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 171.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 56.1 Cg_endo -68.69 154.93 70.4 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.562 2.174 . . . . 0.0 113.11 -167.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 5.0 pt-20 -81.91 -30.55 31.83 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.715 174.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.2 pptp? -153.03 142.6 21.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.991 1.316 . . . . 0.0 108.471 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.7 177.69 40.17 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 121.22 -0.514 . . . . 0.0 114.301 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.28 161.29 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.695 1.598 . . . . 0.0 109.251 -173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 60.6 m-85 -106.47 116.65 32.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.878 0.471 . . . . 0.0 110.355 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 97.0 t -117.12 121.6 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 22.2 ptmt -73.25 114.23 11.21 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.57 0.7 . . . . 0.0 110.626 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -68.15 88.31 0.29 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 164.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 41.4 t -61.09 -41.62 97.0 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.391 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.85 -32.01 72.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.29 0.636 . . . . 0.0 110.956 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.92 13.59 36.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.597 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.2 m 84.79 45.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.14 1.776 . . . . 0.0 111.442 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 61.16 22.67 12.95 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.716 1.206 . . . . 0.0 112.274 171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 185' ' ' ASN . 88.6 t -76.89 120.42 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.269 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 58.0 m -83.2 134.12 34.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.5 m -124.59 147.92 48.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 117' ' ' ILE . 26.8 tp -89.87 105.34 17.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.306 0.574 . . . . 0.0 110.513 -175.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 79.2 m-85 -102.74 133.63 47.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.561 1.144 . . . . 0.0 108.316 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 13.7 t70 -57.21 130.73 47.49 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.666 0.666 . . . . 0.0 109.378 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.34 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.733 0.813 . . . . 0.0 112.215 -171.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.99 63.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.799 0.44 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.96 76.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.686 0.794 . . . . 0.0 111.795 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -75.54 -38.73 59.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.3 t -62.96 -28.76 70.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.489 0.716 . . . . 0.0 111.03 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.5 tpm_? -63.84 -52.94 57.81 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 123.937 0.773 . . . . 0.0 110.218 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.3 mt -57.64 -42.96 84.48 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.946 0.778 . . . . 0.0 111.359 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 166' ' ' ILE . 94.6 t -65.73 -44.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.829 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.01 -26.7 69.37 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.895 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 38.5 mm-40 -79.98 -30.29 39.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.95 20.78 35.36 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.454 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.94 150.66 78.44 Favored Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.216 1.006 . . . . 0.0 110.501 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.38 173.69 14.07 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.597 2.198 . . . . 0.0 111.61 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.469 ' ND1' HG22 ' A' ' 162' ' ' THR . 59.6 t-80 -54.27 129.01 59.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.666 0.786 . . . . 0.0 110.366 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -62.06 -22.38 74.13 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.62 2.213 . . . . 0.0 113.673 -170.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 120' ' ' PRO . 60.5 mt -103.4 -53.16 2.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.745 0.418 . . . . 0.0 111.827 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.469 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -104.14 -8.33 19.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.08 22.45 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.468 1.107 . . . . 0.0 113.167 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -75.2 155.8 86.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.592 0.757 . . . . 0.0 109.984 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -58.35 115.23 2.39 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.403 2.069 . . . . 0.0 110.57 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.545 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.3 mt -63.31 131.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 t -153.66 162.11 41.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 109.923 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.92 65.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.145 0.978 . . . . 0.0 111.258 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.0 t -66.2 -48.31 71.07 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.1 0.96 . . . . 0.0 111.476 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.3 pt -88.92 -2.67 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.35 137.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.63 169.74 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 109.537 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 176' ' ' GLU . 52.1 mtmt -82.8 156.03 23.88 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.298 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -64.56 -23.65 67.34 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -87.9 -21.93 24.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.694 0.797 . . . . 0.0 109.892 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 7.1 tp10 -78.76 -17.05 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.069 0.948 . . . . 0.0 111.471 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.4 p -128.62 154.64 46.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.087 0.955 . . . . 0.0 109.33 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.435 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -135.83 164.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.374 1.069 . . . . 0.0 108.714 178.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 21.3 p90 -78.96 121.7 25.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -105.65 127.03 52.82 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.06 -40.31 75.16 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.313 -170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 t -74.32 -24.26 59.18 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-N 117.531 0.15 . . . . 0.0 111.222 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -80.25 -30.49 38.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.85 25.01 70.54 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.22 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 78.0 m-20 -156.24 160.98 40.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.275 -171.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 60.4 m-85 -74.13 126.73 31.21 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 168.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.1 pt -132.5 177.31 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.664 0.785 . . . . 0.0 110.066 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.03 143.89 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 123.548 0.739 . . . . 0.0 109.88 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.435 ' HG2' HD12 ' A' ' 178' ' ' ILE . 60.0 mtpt -66.59 157.41 32.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.163 0.585 . . . . 0.0 112.378 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -80.43 -91.77 0.47 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 125.385 1.474 . . . . 0.0 111.323 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.529 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.8 mp0 -49.62 -50.76 41.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.37 1.068 . . . . 0.0 112.154 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -38.24 75.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.523 0.729 . . . . 0.0 111.742 -174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.4 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 29.4 t -70.93 -43.63 67.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.87 0.868 . . . . 0.0 109.93 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 98' ' ' ILE . 73.6 mt -63.42 -50.23 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.41 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.64 -23.36 58.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.984 0.914 . . . . 0.0 112.036 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.42 -38.35 84.45 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -67.31 -37.32 83.15 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 123.05 0.54 . . . . 0.0 110.431 175.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 150' ' ' SER . 90.7 mt -65.49 -38.08 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.208 0.603 . . . . 0.0 110.125 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 40.0 t -60.84 -40.44 92.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.394 1.078 . . . . 0.0 111.74 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -86.76 -40.19 15.24 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.0 m -76.82 -16.49 59.42 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.634 0.774 . . . . 0.0 111.785 -171.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -71.03 154.89 41.42 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.385 0.612 . . . . 0.0 111.15 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.74 161.02 42.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.696 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.6 m -65.53 96.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 110.039 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' NE2' ' A' ' 125' ' ' GLN . 40.6 t -77.08 97.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 m -110.65 107.22 58.12 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD3' HE22 ' A' ' 125' ' ' GLN . 48.4 Cg_endo -64.18 -20.86 67.58 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.159 2.573 . . . . 0.0 113.016 -174.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -81.92 -35.16 29.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.43 1.092 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -78.81 -49.0 13.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.974 0.509 . . . . 0.0 110.418 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 68.3 mt -69.05 -21.31 64.11 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.148 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 55.38 19.39 3.05 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 112.772 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.1 m -85.47 134.15 40.79 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.36 149.11 76.13 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.182 1.922 . . . . 0.0 110.632 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.8 mt -52.13 -43.68 64.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.7 0.8 . . . . 0.0 111.407 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.34 -37.7 81.49 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.759 0.824 . . . . 0.0 112.541 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.09 71.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.14 0.576 . . . . 0.0 111.107 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.5 pt -117.09 31.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.986 0.914 . . . . 0.0 110.005 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -70.86 128.59 36.52 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.837 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -74.78 109.95 8.6 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 162.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.94 -11.55 27.55 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 123.085 2.523 . . . . 0.0 112.694 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.82 -52.84 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.603 0.761 . . . . 0.0 109.123 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.9 p -92.7 -12.6 31.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.504 1.122 . . . . 0.0 112.573 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 61.42 37.8 16.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.858 0.863 . . . . 0.0 111.32 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.36 151.92 37.32 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' NE2' HG12 ' A' ' 105' ' ' VAL . 24.0 tm0? -74.65 115.51 44.63 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 160.91 36.09 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.886 2.391 . . . . 0.0 113.458 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 12.5 pt-20 -87.87 -20.74 25.6 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.33 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.61 134.53 22.52 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.784 1.234 . . . . 0.0 108.346 178.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.15 166.66 37.12 Favored Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.463 HG13 HG23 ' A' ' 132' ' ' VAL . 9.9 pt -124.87 155.46 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 0.0 109.386 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.61 115.07 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 130' ' ' ILE . 71.7 t -123.23 122.75 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -66.24 120.3 13.02 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.483 0.658 . . . . 0.0 110.962 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -72.7 84.25 1.18 Allowed 'General case' 0 C--O 1.249 1.065 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 161.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.7 t -67.76 -57.05 6.99 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 113.501 -1.681 . . . . 0.0 111.426 -168.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.02 -31.85 69.71 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.018 0.527 . . . . 0.0 111.42 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -63.38 4.66 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.035 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.2 m -149.92 5.68 0.59 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.6 t70 65.73 21.32 11.56 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.187 0.995 . . . . 0.0 111.201 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.29 143.95 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.489 1.116 . . . . 0.0 109.291 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 31.1 p -86.21 140.52 30.06 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 117.921 0.328 . . . . 0.0 110.174 -177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.4 m -126.84 148.34 49.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.482 1.113 . . . . 0.0 108.184 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.8 tp -89.2 123.89 33.86 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.932 0.493 . . . . 0.0 109.87 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -120.76 132.89 55.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.104 0.961 . . . . 0.0 108.674 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.07 130.5 38.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -55.57 -46.36 77.21 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.079 0.862 . . . . 0.0 111.792 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.6 68.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.118 0.567 . . . . 0.0 111.619 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.62 62.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.696 0.798 . . . . 0.0 111.542 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.65 -41.85 64.99 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.803 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -63.5 -29.92 71.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.253 0.621 . . . . 0.0 110.867 176.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.8 tpm_? -61.53 -51.91 66.63 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 172.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.2 mt -55.38 -43.93 75.6 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.295 0.997 . . . . 0.0 111.21 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 91' ' ' GLN . 46.5 t -67.44 -45.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.737 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.46 -27.6 66.09 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.306 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 19.1 mm-40 -78.65 -33.97 46.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.09 0.556 . . . . 0.0 110.828 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.81 28.52 11.02 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.73 144.12 28.95 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.669 1.188 . . . . 0.0 109.509 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.8 -177.83 4.08 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.795 2.33 . . . . 0.0 112.503 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' ND1' HG22 ' A' ' 162' ' ' THR . 57.4 t-80 -54.53 129.86 62.68 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.404 1.082 . . . . 0.0 110.902 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.24 -24.03 78.17 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.831 2.354 . . . . 0.0 114.087 -171.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.4 mt -103.06 -56.65 2.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.807 0.443 . . . . 0.0 111.882 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.413 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.6 t -102.52 -8.69 20.83 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.691 0.396 . . . . 0.0 111.384 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 63.5 24.71 14.18 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 0.0 112.546 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.0 154.82 90.77 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.46 114.11 2.95 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.017 1.811 . . . . 0.0 110.215 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.542 ' HA ' HD11 ' A' ' 170' ' ' ILE . 66.0 mt -63.05 134.75 28.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -149.37 163.39 37.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.074 0.95 . . . . 0.0 109.744 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.56 -18.09 65.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.851 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.5 t -70.96 -41.05 71.59 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 111.746 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -85.65 -11.41 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 130' ' ' ILE . 11.1 tt -99.61 133.43 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 188' ' ' ILE . 27.5 m -129.04 174.12 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.18 0.992 . . . . 0.0 110.18 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -94.17 164.35 13.09 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.229 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -57.29 -39.95 76.77 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.5 -4.64 57.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.146 0.43 . . . . 0.0 111.679 177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -87.23 -21.93 25.54 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.515 0.674 . . . . 0.0 109.613 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.6 p -102.75 142.09 34.47 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.28 158.0 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 17.0 p90 -75.22 122.9 24.36 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -99.06 129.93 45.36 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -70.37 -34.71 72.92 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.385 1.053 . . . . 0.0 111.663 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 t -74.78 -28.4 60.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.214 0.206 . . . . 0.0 110.955 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 187' ' ' ILE . 37.4 mmt180 -82.14 -32.38 30.12 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 111.117 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.54 24.59 75.95 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.743 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -165.51 159.38 16.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.906 0.482 . . . . 0.0 109.876 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 90.7 m-85 -65.19 118.92 9.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.628 1.171 . . . . 0.0 111.111 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.429 HD13 ' HG3' ' A' ' 183' ' ' ARG . 21.8 pt -128.56 -179.99 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 108.06 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 172' ' ' VAL . 8.7 mm -83.57 156.26 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -62.54 153.79 30.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.974 0.91 . . . . 0.0 112.432 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -94.45 -20.95 28.17 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.791 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 123.914 0.885 . . . . 0.0 109.46 177.508 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -62.39 -43.45 98.78 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 124.629 1.172 . . . . 0.0 111.956 -173.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -38.1 77.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.978 0.799 . . . . 0.0 111.984 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 49.6 m -66.9 -39.22 87.38 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.292 0.637 . . . . 0.0 110.711 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 58.0 mt -68.63 -41.88 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.605 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -56.87 -41.11 77.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.876 1.271 . . . . 0.0 110.887 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -61.39 -44.86 96.42 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.283 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -63.43 -39.65 95.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.964 0.506 . . . . 0.0 111.441 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 150' ' ' SER . 77.8 mt -65.3 -37.73 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.242 0.617 . . . . 0.0 110.333 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 42.1 t -62.3 -45.69 92.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.61 0.764 . . . . 0.0 111.789 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -78.17 -29.47 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.161 0.584 . . . . 0.0 112.187 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.8 -10.38 23.09 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.412 0.685 . . . . 0.0 112.496 -172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -74.24 160.17 31.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -152.1 160.26 43.47 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.361 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.7 t -66.78 100.06 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.083 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.75 107.81 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 84.1 m -118.69 87.11 31.36 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.816 0.847 . . . . 0.0 109.776 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HB3' HD11 ' A' ' 117' ' ' ILE . 1.7 Cg_endo -43.88 -45.75 11.18 Favored 'Trans proline' 0 C--N 1.385 2.452 1 C-N-CA 125.42 4.08 . . . . 0.0 115.129 -176.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -20.48 55.39 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.064 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -91.3 -31.91 15.92 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.918 0.487 . . . . 0.0 110.575 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.59 -20.17 61.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.588 0.755 . . . . 0.0 110.341 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 59.12 18.98 6.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.507 1.523 . . . . 0.0 112.237 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.5 m -100.35 138.11 20.13 Favored Pre-proline 0 C--O 1.245 0.836 0 C-N-CA 124.165 0.986 . . . . 0.0 108.877 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.18 157.51 34.62 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.426 2.084 . . . . 0.0 111.357 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 71.8 mt -55.98 -38.78 70.89 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.083 0.553 . . . . 0.0 111.373 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.12 -38.38 82.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.02 0.928 . . . . 0.0 112.825 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.87 66.86 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.086 0.554 . . . . 0.0 111.593 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 107' ' ' PRO . 26.5 pt -124.08 16.43 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.856 0.862 . . . . 0.0 111.107 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.42 125.39 24.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.204 1.002 . . . . 0.0 110.221 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.91 111.47 10.72 Favored Pre-proline 0 C--N 1.354 0.775 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.96 -3.99 14.74 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.741 2.294 . . . . 0.0 112.105 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -84.98 -58.55 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.895 0.878 . . . . 0.0 109.403 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 p -88.4 -13.0 41.61 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.721 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.99 33.63 17.17 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.584 0.754 . . . . 0.0 111.533 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.88 152.76 46.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -73.13 110.43 8.54 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 57.7 Cg_endo -68.08 153.84 73.96 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.434 2.756 . . . . 0.0 114.266 -167.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -80.48 -38.8 29.24 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.605 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.1 pttm -138.64 143.58 39.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.177 1.391 . . . . 0.0 107.459 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.94 166.25 37.43 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.278 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 98' ' ' ILE . 11.3 pt -121.64 155.27 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.985 1.314 . . . . 0.0 109.086 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.51 123.16 41.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.78 121.91 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.701 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -71.09 119.0 14.59 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.751 0.657 . . . . 0.0 110.775 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -74.03 81.73 1.73 Allowed 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.1 t -68.87 -28.53 66.78 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.386 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.29 -37.42 85.4 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.353 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.35 -65.0 2.56 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -178.5 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.984 0.914 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 61.98 23.27 13.68 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.178 0.991 . . . . 0.0 111.379 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.16 118.35 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 186' ' ' PHE . 20.6 p -84.36 138.87 32.64 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.41 0.624 . . . . 0.0 110.032 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.3 m -127.83 145.03 51.06 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.18 0.992 . . . . 0.0 108.785 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 117' ' ' ILE . 61.0 tp -88.28 111.54 21.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -105.44 138.03 42.29 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.661 1.184 . . . . 0.0 108.022 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.7 t70 -59.1 135.44 57.63 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.381 0.537 . . . . 0.0 109.722 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.89 92.27 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.74 0.816 . . . . 0.0 111.777 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.36 -35.17 65.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.544 0.528 . . . . 0.0 111.072 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.84 -48.33 59.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.626 0.77 . . . . 0.0 112.007 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 130' ' ' ILE . 44.2 t80 -70.0 -40.7 75.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.998 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.512 ' HB2' HG21 ' A' ' 98' ' ' ILE . 32.5 t -62.44 -32.31 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.564 0.54 . . . . 0.0 111.13 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 151' ' ' ARG . 1.4 tpm_? -64.65 -49.38 71.24 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 123.637 0.586 . . . . 0.0 110.401 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.69 -45.16 81.94 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.174 0.921 . . . . 0.0 111.182 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 84.3 t -61.92 -46.77 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.217 0.607 . . . . 0.0 110.209 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.73 -31.19 79.95 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.041 0.838 . . . . 0.0 113.228 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.61 -15.66 53.97 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.653 0.781 . . . . 0.0 111.662 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.87 31.87 38.33 Favored Glycine 0 N--CA 1.47 0.966 0 O-C-N 123.204 0.315 . . . . 0.0 112.551 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.7 mt -90.24 150.82 43.86 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.663 1.185 . . . . 0.0 110.025 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.52 -179.43 5.31 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.685 2.257 . . . . 0.0 113.088 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.417 ' ND1' HG22 ' A' ' 162' ' ' THR . 47.1 t-80 -56.76 127.14 73.48 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.174 0.99 . . . . 0.0 111.317 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.09 -1.74 8.46 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.995 2.464 . . . . 0.0 114.069 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.1 mt -110.63 -64.52 1.26 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.689 0.395 . . . . 0.0 110.624 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.417 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.1 t -98.39 -4.64 34.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.984 -167.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 61.55 20.96 11.7 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.496 1.118 . . . . 0.0 112.906 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.19 152.28 73.56 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.514 0.726 . . . . 0.0 110.589 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.78 115.06 2.69 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.056 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 70.3 mt -63.27 130.8 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.744 0.417 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -141.53 162.69 34.86 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.04 0.936 . . . . 0.0 109.571 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.38 66.24 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.409 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.4 m -64.91 -41.68 95.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.51 0.724 . . . . 0.0 112.065 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 166' ' ' ILE . 45.9 pt -85.61 -7.84 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.33 135.5 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.12 0.873 . . . . 0.0 109.337 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 188' ' ' ILE . 31.1 m -133.19 179.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 109.844 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -101.66 164.96 11.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.837 0.455 . . . . 0.0 110.578 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.25 -15.61 33.18 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.813 0.445 . . . . 0.0 111.256 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -76.32 -26.82 56.19 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.099 0.952 . . . . 0.0 109.339 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 28.9 p -105.02 161.07 14.53 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.933 165.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -137.33 162.98 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.386 0.674 . . . . 0.0 109.265 175.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -72.59 135.01 45.44 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 163.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' HG12 ' A' ' 187' ' ' ILE . 9.0 t70 -119.02 127.05 53.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.55 -43.69 47.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.8 t -76.58 -28.48 56.23 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.172 0.442 . . . . 0.0 110.808 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -72.03 -31.8 66.53 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.22 81.2 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.598 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -149.33 150.12 31.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.026 0.93 . . . . 0.0 110.232 -170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.584 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 35.3 m-85 -63.42 119.24 9.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.668 0.787 . . . . 0.0 109.968 168.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.2 pt -127.15 177.84 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 0.0 109.723 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' A' ' 133' ' ' LYS . 37.1 mm -85.83 151.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.386 0.674 . . . . 0.0 110.129 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -65.94 155.23 37.11 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.101 0.477 . . . . 0.0 111.743 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -100.22 -41.23 2.85 Favored Glycine 0 N--CA 1.467 0.745 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 124.814 1.246 . . . . 0.0 108.485 174.203 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -73.89 -40.49 63.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.448 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -41.47 67.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.927 0.891 . . . . 0.0 112.591 -168.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 41.4 t -65.7 -46.09 80.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.535 0.734 . . . . 0.0 110.04 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.5 mt -63.73 -41.14 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.128 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -59.8 -42.63 93.85 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.517 1.127 . . . . 0.0 110.622 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -61.87 -43.27 99.18 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.372 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -64.23 -31.32 72.47 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.242 0.617 . . . . 0.0 111.325 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.457 HG23 HD13 ' A' ' 130' ' ' ILE . 95.3 mt -70.42 -40.57 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.309 0.644 . . . . 0.0 109.671 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 t -65.57 -33.42 75.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.312 0.645 . . . . 0.0 111.292 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -74.95 -46.75 33.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.293 1.037 . . . . 0.0 112.327 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.593 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 71.0 m -82.33 -17.35 46.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.48 0.712 . . . . 0.0 112.845 -169.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -70.55 165.7 22.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.447 0.641 . . . . 0.0 112.603 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -156.41 159.65 38.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.381 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.6 m -66.97 102.58 1.0 Allowed 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.626 0.579 . . . . 0.0 109.713 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.467 HG12 ' NE2' ' A' ' 125' ' ' GLN . 58.7 t -77.06 102.46 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.191 0.596 . . . . 0.0 110.148 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 62.1 m -112.29 106.84 55.86 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.158 0.983 . . . . 0.0 108.745 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 24.1 Cg_endo -60.3 -18.95 55.49 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.3 2.667 . . . . 0.0 112.745 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.6 -35.9 70.66 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.557 0.743 . . . . 0.0 110.277 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -83.73 -49.47 9.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.084 0.554 . . . . 0.0 110.347 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.5 -23.18 65.44 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.381 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 54.02 21.02 2.69 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.434 1.094 . . . . 0.0 112.783 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -103.81 136.87 19.14 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.273 1.029 . . . . 0.0 108.337 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.9 154.16 28.15 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.753 2.302 . . . . 0.0 111.801 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.7 mt -49.88 -46.33 51.49 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.848 0.717 . . . . 0.0 111.271 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.35 -40.66 74.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.835 1.254 . . . . 0.0 113.038 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.46 66.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.762 0.825 . . . . 0.0 111.633 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.576 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.9 pt -114.63 7.68 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.211 1.005 . . . . 0.0 111.153 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 35.3 tt0 -68.18 136.05 53.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.146 0.978 . . . . 0.0 111.055 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 36.8 t -69.26 110.26 5.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 124.411 1.069 . . . . 0.0 108.405 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.72 -1.04 10.2 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.056 2.504 . . . . 0.0 112.735 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.493 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.5 mt -84.35 -52.83 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.142 1.377 . . . . 0.0 109.756 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -97.89 -9.34 26.48 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.322 -174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.9 37.37 15.27 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.193 0.997 . . . . 0.0 111.894 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.49 151.13 37.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.195 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.3 tm0? -71.04 118.12 62.69 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 94.9 Cg_endo -74.03 162.5 38.87 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.074 2.516 . . . . 0.0 114.07 -171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.639 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 7.7 pt-20 -82.47 -32.17 29.0 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.67 172.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.639 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.3 pttt -147.67 143.64 27.79 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.315 1.446 . . . . 0.0 107.345 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.69 160.6 33.79 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.183 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 98' ' ' ILE . 10.2 pt -114.37 152.36 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.833 1.653 . . . . 0.0 109.365 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -93.66 120.38 33.86 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 98.4 t -120.34 119.51 60.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.8 ptmt -69.09 118.82 12.47 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.635 0.731 . . . . 0.0 110.417 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -70.19 81.38 0.52 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 163.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.9 t -67.34 -56.34 10.11 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.875 -168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.05 -28.42 68.2 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.533 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.98 -65.73 2.14 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.193 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 m -152.68 10.98 0.49 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.1 t70 66.39 14.42 9.69 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 124.047 0.939 . . . . 0.0 111.116 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.17 124.93 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.498 0.719 . . . . 0.0 110.037 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 26.1 p -84.56 132.79 34.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.0 m -121.48 147.0 46.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 117' ' ' ILE . 27.0 tp -92.85 105.15 17.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.318 0.58 . . . . 0.0 110.079 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 85.4 m-85 -99.77 140.04 34.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.619 1.168 . . . . 0.0 107.895 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.4 t70 -61.04 140.84 57.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.646 0.657 . . . . 0.0 109.676 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.44 74.93 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.106 0.879 . . . . 0.0 111.276 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.92 67.34 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.344 0.657 . . . . 0.0 111.621 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -48.12 60.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.478 0.711 . . . . 0.0 112.026 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 41.7 t80 -71.17 -39.63 71.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.965 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.44 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -60.25 -35.44 75.51 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.822 0.701 . . . . 0.0 110.898 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 41.1 ttt85 -62.35 -53.41 55.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.016 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.74 -45.76 67.14 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.292 0.637 . . . . 0.0 112.054 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 166' ' ' ILE . 48.7 t -61.79 -49.67 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.946 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.69 -18.93 70.72 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.849 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 13.1 mm-40 -82.48 -29.08 30.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.387 0.675 . . . . 0.0 109.857 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.11 23.9 16.19 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 64.5 mt -91.46 147.97 36.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.397 1.079 . . . . 0.0 110.047 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.15 -167.02 0.45 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.939 2.426 . . . . 0.0 112.165 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.457 ' ND1' HG22 ' A' ' 162' ' ' THR . 45.0 t-80 -62.55 126.5 88.39 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.575 0.75 . . . . 0.0 109.784 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -10.2 28.12 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.844 2.363 . . . . 0.0 113.851 -171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.08 -64.97 1.01 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.923 0.489 . . . . 0.0 110.04 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.457 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -98.0 -5.06 34.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.291 0.636 . . . . 0.0 112.097 -167.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 62.66 21.64 12.84 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.526 1.13 . . . . 0.0 112.746 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -80.46 151.52 71.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 123.138 0.575 . . . . 0.0 111.009 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.2 118.91 5.81 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.521 2.147 . . . . 0.0 111.357 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.495 HG21 HG22 ' A' ' 153' ' ' VAL . 71.8 mt -64.93 135.02 28.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.349 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 t -148.78 163.36 37.59 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.844 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.96 -24.12 66.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.946 0.898 . . . . 0.0 111.356 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -64.74 -45.85 84.72 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.665 0.786 . . . . 0.0 111.928 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.5 pt -80.98 -8.43 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.9 tt -96.95 130.39 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 118.713 0.688 . . . . 0.0 109.391 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.6 m -132.73 173.84 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.211 1.404 . . . . 0.0 109.882 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.593 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 52.6 mtpt -101.5 169.85 8.59 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.029 0.442 . . . . 0.0 110.754 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -59.23 -28.53 66.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.523 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -78.66 -33.02 47.41 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.529 0.732 . . . . 0.0 111.387 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.62 -15.32 42.88 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.189 0.519 . . . . 0.0 110.857 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 30.5 p -112.9 146.94 38.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.603 0.761 . . . . 0.0 109.044 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.68 154.16 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 37.9 p90 -67.78 134.99 51.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 165.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.504 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.6 t70 -112.83 133.99 54.56 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.93 -49.97 33.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.598 1.159 . . . . 0.0 112.099 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 t -71.33 -24.55 62.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.049 0.386 . . . . 0.0 111.184 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.464 ' HA ' ' HE ' ' A' ' 183' ' ' ARG . 2.3 mmp_? -84.87 -34.05 22.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.358 0.663 . . . . 0.0 110.718 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.19 73.39 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.96 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -148.05 143.68 27.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.364 1.066 . . . . 0.0 109.481 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 25.5 m-85 -68.64 115.97 8.62 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 180' ' ' ASP . 24.1 pt -122.91 178.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.307 1.043 . . . . 0.0 108.611 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 133' ' ' LYS . 38.3 mm -83.87 155.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -68.06 159.36 31.01 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 120.981 0.419 . . . . 0.0 110.39 174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 149.21 67.95 0.01 OUTLIER Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.676 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 55.3 t30 . . . . . 0 CA--C 1.556 1.205 0 C-N-CA 124.314 1.045 . . . . 0.0 111.623 -175.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.084 0.469 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -67.29 -39.83 86.04 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.774 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.54 -51.43 36.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -72.99 -43.18 62.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.473 0.309 . . . . 0.0 110.655 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.51 -49.35 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.476 0.71 . . . . 0.0 111.081 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.432 ' HA ' HD12 ' A' ' 98' ' ' ILE . 40.2 mt-30 -67.6 -29.55 68.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.567 0.747 . . . . 0.0 111.367 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 4.1 m-80 -62.35 -43.18 99.42 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 170.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -40.67 94.08 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 122.823 0.449 . . . . 0.0 110.078 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.499 HG23 HD13 ' A' ' 130' ' ' ILE . 94.9 mt -61.43 -38.32 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.732 0.813 . . . . 0.0 111.136 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.3 m -70.48 -32.56 70.13 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.136 0.574 . . . . 0.0 110.964 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 34.8 mt-30 -83.55 -39.42 20.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.105 0.562 . . . . 0.0 111.633 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.2 m -80.13 -19.97 46.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.545 -171.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -69.78 162.39 27.94 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 123.531 0.519 . . . . 0.0 110.877 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -148.11 159.65 43.71 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -68.34 97.97 0.79 Allowed 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.06 97.62 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 57.9 m -108.21 102.12 44.98 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.851 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 117' ' ' ILE . 12.9 Cg_endo -54.61 -29.75 62.27 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.666 2.91 . . . . 0.0 112.666 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 8.9 pt-20 -69.79 -35.42 74.86 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.635 1.174 . . . . 0.0 111.54 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.699 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 50.7 mtt180 -93.84 -36.4 12.26 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.669 0.787 . . . . 0.0 111.209 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.37 -18.43 62.37 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.705 0.802 . . . . 0.0 111.977 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 63.53 17.68 10.53 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.882 1.273 . . . . 0.0 111.483 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -104.46 129.48 24.96 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 124.309 1.044 . . . . 0.0 109.615 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.24 166.45 19.05 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.733 2.289 . . . . 0.0 111.748 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.7 mt -53.25 -47.14 69.31 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.737 0.648 . . . . 0.0 111.022 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -52.14 -43.38 64.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.98 0.912 . . . . 0.0 112.852 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.65 69.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.332 0.653 . . . . 0.0 111.415 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 107' ' ' PRO . 15.1 pt -122.01 29.42 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.905 0.882 . . . . 0.0 110.322 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -73.82 121.83 21.49 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.188 0.995 . . . . 0.0 109.439 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 37.1 t -68.74 114.95 25.97 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.28 -12.7 34.42 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.801 2.334 . . . . 0.0 112.755 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.61 -51.88 16.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 C-N-CA 123.629 0.772 . . . . 0.0 109.843 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.8 p -96.75 -19.54 18.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.348 1.059 . . . . 0.0 112.324 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 57.85 46.81 16.31 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.318 1.047 . . . . 0.0 111.823 -171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.46 152.64 38.41 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.802 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 23.3 tm0? -76.25 113.38 27.78 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.75 167.04 18.97 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.009 2.473 . . . . 0.0 113.451 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.02 -23.45 26.79 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -143.46 140.69 30.49 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.102 1.361 . . . . 0.0 108.43 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.45 157.08 29.39 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.335 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 98' ' ' ILE . 7.1 pt -110.77 161.26 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.038 1.335 . . . . 0.0 109.775 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -104.89 118.17 35.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.588 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.5 t -114.67 125.55 72.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.3 ptmt -73.75 114.61 12.22 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 124.004 0.815 . . . . 0.0 110.037 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -71.95 80.45 0.91 Allowed 'General case' 0 C--O 1.247 0.943 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 36.7 t -64.8 -49.43 70.71 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.716 -172.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.73 -27.96 68.7 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.564 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.43 2.58 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.366 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.0 m -161.53 17.91 0.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.464 0.706 . . . . 0.0 111.198 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 13.6 t70 67.03 22.09 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.394 1.078 . . . . 0.0 111.235 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 187' ' ' ILE . 90.5 t -96.19 134.67 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.319 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 55.9 m -87.0 139.83 30.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.624 0.77 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.2 m -127.28 147.72 50.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.249 1.02 . . . . 0.0 108.853 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 tp -85.28 112.48 20.81 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.03 0.443 . . . . 0.0 110.222 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.47 137.17 46.86 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -58.34 137.43 57.2 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.177 0.444 . . . . 0.0 109.95 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.42 85.97 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 124.159 0.912 . . . . 0.0 111.15 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.54 -34.29 62.94 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.783 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.8 -44.09 61.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 112.118 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.7 t80 -73.48 -39.0 65.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.761 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -63.08 -37.98 89.37 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.583 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 48.4 ttt180 -53.64 -53.2 55.32 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.765 0.666 . . . . 0.0 109.481 172.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.26 -42.52 73.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.01 0.819 . . . . 0.0 111.829 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 149' ' ' PHE . 58.8 t -64.57 -46.9 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.416 0.448 . . . . 0.0 110.091 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.38 -36.06 91.93 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.825 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 45.3 mt-10 -75.95 -27.47 57.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.644 0.777 . . . . 0.0 110.819 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.79 20.44 34.02 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.747 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.86 144.16 47.62 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.035 0.934 . . . . 0.0 109.573 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.83 -170.3 0.88 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.992 2.462 . . . . 0.0 112.422 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.478 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.4 t-80 -62.5 126.81 89.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.571 0.749 . . . . 0.0 109.343 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.87 -14.87 39.71 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.23 1.954 . . . . 0.0 113.331 -170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.8 mt -96.12 -66.01 0.93 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 122.589 0.356 . . . . 0.0 110.886 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.478 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.0 t -90.51 -10.1 44.84 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -168.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 63.31 16.81 9.77 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.755 1.222 . . . . 0.0 112.843 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -80.12 144.69 59.2 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 122.87 12.37 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.702 2.268 . . . . 0.0 111.544 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.405 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -62.25 131.85 27.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 O-C-N 123.54 0.525 . . . . 0.0 110.104 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -143.77 161.95 37.29 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.89 0.876 . . . . 0.0 109.172 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -66.57 -23.04 66.15 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.665 174.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.2 m -69.44 -22.35 63.67 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.018 0.927 . . . . 0.0 112.728 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 48.0 pt -105.9 -2.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.8 tt -97.79 140.53 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.394 -0.816 . . . . 0.0 109.887 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.553 HG11 HD12 ' A' ' 188' ' ' ILE . 27.3 m -141.35 -179.89 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.793 1.237 . . . . 0.0 110.049 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -97.7 168.63 10.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.641 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 43.7 t-80 -68.02 -24.89 65.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.842 170.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.12 -22.2 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.766 0.426 . . . . 0.0 110.68 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -85.63 -21.54 28.38 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.218 0.533 . . . . 0.0 111.042 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.2 p -101.65 145.45 29.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 167.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -128.7 143.64 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -65.85 102.05 0.73 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -72.75 124.19 24.85 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.63 -34.59 67.44 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.189 0.996 . . . . 0.0 111.585 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.8 t -80.32 -25.43 39.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.119 0.168 . . . . 0.0 111.159 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -100.98 -14.63 17.79 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.811 0.445 . . . . 0.0 111.53 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.48 79.76 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.156 -0.802 . . . . 0.0 114.942 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -165.79 162.49 18.55 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 117.694 0.747 . . . . 0.0 110.47 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 83.9 m-85 -59.92 125.76 24.9 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 111.754 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.7 pp -133.34 169.51 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.443 1.097 . . . . 0.0 109.134 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.553 HD12 HG11 ' A' ' 172' ' ' VAL . 42.6 mm -70.88 140.3 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.421 0.688 . . . . 0.0 110.733 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -63.75 165.32 8.58 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.561 0.696 . . . . 0.0 111.884 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.98 -24.66 24.44 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.513 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 124.139 0.975 . . . . 0.0 108.942 176.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.864 0.84 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 21.2 mp0 -79.6 -33.9 41.2 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.47 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.27 -55.5 12.49 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 113.48 -164.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -66.27 -34.79 78.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.281 0.632 . . . . 0.0 111.092 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 98' ' ' ILE . 67.1 mt -69.62 -45.18 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.697 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -57.89 -44.1 86.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.853 1.261 . . . . 0.0 111.214 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.07 -45.42 87.12 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.702 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG2' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -66.82 -34.11 77.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.948 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.8 mt -65.84 -43.08 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.2 t -65.03 -33.94 77.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.792 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -77.77 -44.93 26.06 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.281 0.632 . . . . 0.0 111.829 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 82.8 m -76.61 -20.98 56.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.705 0.802 . . . . 0.0 112.675 -169.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -71.08 168.27 17.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.645 0.736 . . . . 0.0 112.606 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -158.78 160.57 36.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.446 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.3 m -69.1 99.16 1.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.706 0.628 . . . . 0.0 109.469 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.32 119.89 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.411 0.685 . . . . 0.0 110.091 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 79.5 m -133.73 101.82 12.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.007 0.923 . . . . 0.0 109.386 -176.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 106' ' ' CYS . 10.8 Cg_endo -52.39 -23.28 18.23 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.891 3.061 . . . . 0.0 114.008 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.9 pt-20 -73.14 -38.13 66.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.708 0.803 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 90.9 mtt-85 -93.43 -21.7 19.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.689 0.796 . . . . 0.0 111.514 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.17 -20.91 26.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.621 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.7 24.23 13.11 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.299 1.04 . . . . 0.0 111.46 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.4 m -110.31 137.21 20.56 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.128 0.971 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.1 162.67 28.65 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.275 1.983 . . . . 0.0 111.488 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 93.8 mt -54.26 -46.25 72.6 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.477 0.711 . . . . 0.0 111.289 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.13 -41.72 72.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.051 0.94 . . . . 0.0 112.694 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.48 -27.98 68.88 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.579 0.752 . . . . 0.0 111.993 -175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 pt -122.95 30.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.039 0.936 . . . . 0.0 109.81 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 40.8 tt0 -78.62 134.98 37.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.442 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 18.7 t -71.49 114.94 32.3 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 109.185 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.36 -4.8 16.04 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.936 2.424 . . . . 0.0 113.497 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.498 HG12 ' HG3' ' A' ' 160' ' ' PRO . 59.7 mt -80.3 -53.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.87 0.868 . . . . 0.0 109.311 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -95.12 -11.01 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.148 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.63 37.06 19.49 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.986 0.914 . . . . 0.0 111.53 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.45 148.92 29.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.289 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 114' ' ' LEU . 25.7 tm0? -72.05 118.64 68.88 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.282 0.633 . . . . 0.0 109.444 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -81.72 161.89 18.95 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.769 2.313 . . . . 0.0 113.493 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -88.02 -14.13 39.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.049 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -151.7 134.21 15.41 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.844 0.858 . . . . 0.0 109.93 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.23 165.38 38.55 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.31 -172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 143' ' ' LEU . 9.2 pt -114.41 158.97 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.654 1.582 . . . . 0.0 110.395 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.04 123.65 44.52 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 90.5 t -118.86 119.95 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.1 ptmt -74.83 114.15 12.95 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 123.763 0.664 . . . . 0.0 110.047 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -73.39 72.96 1.35 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 171.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 35.1 t -68.13 -55.41 12.53 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.819 -167.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -58.32 -34.39 70.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.178 0.991 . . . . 0.0 112.14 -173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.98 -62.4 2.36 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.637 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.9 t -149.33 3.93 0.59 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 22.9 t70 59.33 47.23 11.62 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.516 0.726 . . . . 0.0 110.792 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.08 124.6 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 122.948 0.499 . . . . 0.0 110.26 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 65.1 m -84.21 128.68 34.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.251 0.621 . . . . 0.0 109.66 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.0 m -122.8 143.39 49.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.347 1.059 . . . . 0.0 109.66 -171.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 130' ' ' ILE . 46.9 tp -88.91 106.34 18.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.237 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 89.2 m-85 -99.43 149.96 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 12.1 t70 -65.73 137.54 57.34 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.59 -52.96 62.84 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.985 0.803 . . . . 0.0 111.707 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.37 -27.44 56.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.112 0.565 . . . . 0.0 111.966 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.6 -36.63 60.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.182 0.593 . . . . 0.0 110.771 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.6 t80 -73.14 -38.43 66.27 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -61.51 -31.52 71.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.923 0.889 . . . . 0.0 110.839 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.0 tpm_? -63.21 -54.26 40.25 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.947 0.779 . . . . 0.0 109.564 173.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.3 mt -54.8 -47.0 74.57 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.252 0.97 . . . . 0.0 111.376 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 166' ' ' ILE . 99.4 t -60.67 -50.47 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.801 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -59.94 -32.83 76.38 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 124.112 0.883 . . . . 0.0 113.371 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 28.6 mm-40 -75.86 -30.93 59.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.392 0.677 . . . . 0.0 111.187 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.71 9.42 49.75 Favored Glycine 0 N--CA 1.469 0.871 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.243 -171.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.74 139.76 74.17 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.934 0.894 . . . . 0.0 109.201 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.48 -164.55 0.25 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.404 2.07 . . . . 0.0 112.242 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.79 131.25 92.92 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.321 1.049 . . . . 0.0 110.143 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.498 ' HG3' HG12 ' A' ' 121' ' ' ILE . 72.1 Cg_endo -70.96 -24.7 23.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.296 1.998 . . . . 0.0 113.265 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -85.23 -59.21 2.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.966 0.506 . . . . 0.0 111.051 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -108.27 -7.86 15.84 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.939 -167.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 65.86 19.12 11.27 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.629 1.172 . . . . 0.0 112.247 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -71.36 144.42 89.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.174 0.589 . . . . 0.0 110.117 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.37 116.5 3.79 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.406 2.071 . . . . 0.0 110.816 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 153' ' ' VAL . 77.3 mt -61.21 132.91 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.66 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -147.15 164.79 31.97 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.278 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -65.46 -24.62 67.21 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.541 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.8 t -69.3 -26.11 64.57 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.942 0.897 . . . . 0.0 112.333 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.4 pt -100.69 -6.1 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 118.317 0.508 . . . . 0.0 112.236 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 168' ' ' ALA . 10.2 tt -100.7 136.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.05 0.841 . . . . 0.0 109.773 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.04 171.57 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.142 1.377 . . . . 0.0 110.829 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 43.9 mtmt -92.95 164.2 13.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.402 0.681 . . . . 0.0 110.595 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -66.1 -33.54 76.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.703 0.801 . . . . 0.0 111.61 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -80.28 -20.24 44.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.308 0.643 . . . . 0.0 110.848 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -84.8 -27.95 26.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.974 0.91 . . . . 0.0 110.998 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.3 p -105.7 151.67 24.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 186' ' ' PHE . 0.2 OUTLIER -136.78 158.95 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.166 0.987 . . . . 0.0 108.457 177.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -64.6 130.36 43.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.538 ' HB2' HG13 ' A' ' 187' ' ' ILE . 11.3 t70 -106.13 135.6 47.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.97 -50.68 10.74 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.363 1.039 . . . . 0.0 111.816 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -72.38 -26.4 61.88 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.795 0.27 . . . . 0.0 111.64 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -93.01 -28.65 16.26 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.892 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.15 28.51 44.77 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.489 0.493 . . . . 0.0 114.176 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -169.84 161.8 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 117.167 0.484 . . . . 0.0 110.313 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 88.5 m-85 -60.33 124.41 20.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.746 1.219 . . . . 0.0 111.879 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.538 HG13 ' HB2' ' A' ' 180' ' ' ASP . 2.8 pp -139.14 177.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.165 1.386 . . . . 0.0 109.31 174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.0 mm -77.16 146.0 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.319 0.648 . . . . 0.0 110.569 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -62.08 162.05 9.99 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.502 0.721 . . . . 0.0 112.05 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.88 66.97 0.78 Allowed Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.0 t30 . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 126.006 1.722 . . . . 0.0 107.994 -166.574 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 119.791 -0.147 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 18.3 mp0 -59.74 -50.58 73.26 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.693 0.797 . . . . 0.0 110.641 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -30.21 70.97 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.416 0.286 . . . . 0.0 111.605 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -71.6 -48.03 50.8 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.169 0.588 . . . . 0.0 109.614 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.6 mt -60.03 -50.26 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.9 0.88 . . . . 0.0 110.217 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.478 ' HA ' HD12 ' A' ' 98' ' ' ILE . 43.6 mt-30 -69.49 -28.36 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.309 1.044 . . . . 0.0 111.649 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.45 -44.26 96.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.32 -33.19 74.73 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.428 0.691 . . . . 0.0 110.886 177.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 95' ' ' GLN . 92.2 mt -63.17 -45.08 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 122.942 0.497 . . . . 0.0 109.73 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 m -65.51 -29.74 70.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.664 0.786 . . . . 0.0 112.52 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.98 -46.25 16.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.93 0.492 . . . . 0.0 111.819 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.1 -19.59 50.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.824 0.85 . . . . 0.0 112.878 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -67.27 172.24 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -156.47 157.09 34.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.974 172.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m -70.21 102.07 2.02 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.47 98.22 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.287 0.635 . . . . 0.0 109.797 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.6 m -103.48 103.23 34.48 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.992 0.917 . . . . 0.0 109.005 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HB3' HD11 ' A' ' 117' ' ' ILE . 29.8 Cg_endo -60.22 -28.9 87.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.243 2.629 . . . . 0.0 112.506 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.66 -33.52 75.84 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.833 0.853 . . . . 0.0 110.756 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -88.12 -46.57 9.18 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.961 -174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.1 -22.98 63.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.366 0.666 . . . . 0.0 111.274 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 57.58 13.46 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.56 1.144 . . . . 0.0 113.662 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.59 133.92 31.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-O 118.289 -0.862 . . . . 0.0 108.752 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.34 149.29 23.23 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.983 2.455 . . . . 0.0 112.623 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.6 -46.7 63.64 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.114 0.966 . . . . 0.0 111.865 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.04 -36.83 78.15 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.865 0.866 . . . . 0.0 112.271 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.29 68.43 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.491 0.717 . . . . 0.0 111.459 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 107' ' ' PRO . 17.9 pt -107.65 5.34 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 110.807 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.9 128.15 35.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.428 1.091 . . . . 0.0 110.855 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.0 t -64.0 110.32 3.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 169.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.75 -3.07 13.14 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.814 2.342 . . . . 0.0 112.43 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.541 HG12 ' HG3' ' A' ' 160' ' ' PRO . 36.7 mt -81.04 -53.25 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.866 0.867 . . . . 0.0 109.197 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.1 p -96.32 -10.22 28.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.96 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 55.21 53.32 10.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.758 1.223 . . . . 0.0 111.449 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.12 160.59 38.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.026 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -73.76 120.3 80.53 Favored Pre-proline 0 CA--C 1.559 1.3 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 73.9 Cg_endo -76.05 157.97 38.22 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.203 2.602 . . . . 0.0 113.829 -173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 10.7 pt-20 -81.24 -36.77 29.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.365 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 19.9 pttm -145.25 148.44 33.49 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.504 1.522 . . . . 0.0 107.369 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -164.04 159.81 32.65 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.302 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -113.98 166.45 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.527 1.531 . . . . 0.0 109.685 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -106.07 125.88 51.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.421 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 70.8 t -115.82 124.6 72.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.1 ptmt -74.92 104.44 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.904 0.859 . . . . 0.0 110.288 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -78.53 71.47 5.0 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 4.9 t -69.36 -26.89 64.9 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.419 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.7 -39.83 95.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.271 1.028 . . . . 0.0 110.709 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.39 -63.99 3.04 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -176.34 35.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.192 0.997 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 18.4 t70 62.44 27.26 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.412 1.085 . . . . 0.0 110.804 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.98 109.21 9.4 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.035 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 186' ' ' PHE . 58.4 m -83.49 119.62 24.91 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.3 m -118.86 145.33 45.78 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -170.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' HB ' ' A' ' 117' ' ' ILE . 31.1 tp -86.63 103.9 15.55 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.484 0.659 . . . . 0.0 110.58 -176.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 92.8 m-85 -102.84 133.4 47.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.671 1.188 . . . . 0.0 107.905 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 18.5 t70 -56.59 134.17 54.18 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.605 0.639 . . . . 0.0 109.653 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.48 -44.75 80.93 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.018 0.824 . . . . 0.0 111.555 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.63 40.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.861 0.465 . . . . 0.0 111.758 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.45 38.15 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.44 0.696 . . . . 0.0 111.705 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.0 t80 -74.26 -39.48 62.98 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 t -61.66 -35.03 76.78 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.938 0.774 . . . . 0.0 110.961 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 10.7 tpt180 -57.3 -52.16 66.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.16 0.584 . . . . 0.0 109.499 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 85.8 mt -54.8 -41.93 71.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.041 0.838 . . . . 0.0 111.956 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 166' ' ' ILE . 21.9 t -69.02 -41.34 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 123.939 0.774 . . . . 0.0 109.768 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.93 -29.16 73.41 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.174 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -84.01 -24.21 30.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.213 0.605 . . . . 0.0 110.784 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 19.79 56.55 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.842 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.1 147.48 73.25 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.078 0.951 . . . . 0.0 110.668 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.53 175.87 10.8 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.411 2.074 . . . . 0.0 111.91 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -55.43 131.81 70.43 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.417 1.087 . . . . 0.0 111.114 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HG3' HG12 ' A' ' 121' ' ' ILE . 71.7 Cg_endo -69.08 -17.82 40.47 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.413 2.075 . . . . 0.0 113.822 -169.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.05 -62.32 1.25 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.875 0.47 . . . . 0.0 111.302 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 t -104.99 -7.21 19.41 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.753 -168.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.29 26.11 14.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.54 1.136 . . . . 0.0 112.201 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.17 154.69 92.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.033 0.933 . . . . 0.0 110.116 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.07 113.36 2.58 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 121.919 1.746 . . . . 0.0 109.799 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.573 HG21 HG22 ' A' ' 153' ' ' VAL . 61.0 mt -60.87 122.58 11.7 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.2 t -147.32 162.41 39.01 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.809 0.844 . . . . 0.0 109.493 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -72.24 -14.88 61.89 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.84 0.456 . . . . 0.0 110.973 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.9 m -70.12 -30.61 67.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.729 0.812 . . . . 0.0 111.921 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.9 pt -99.5 -8.4 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 168' ' ' ALA . 8.4 tt -88.39 138.66 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.34 168.21 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.577 0.751 . . . . 0.0 111.135 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -90.35 153.27 20.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.812 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -65.02 -23.72 67.28 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -85.31 -21.96 28.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.57 0.748 . . . . 0.0 110.441 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -84.41 -17.86 37.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.993 . . . . 0.0 111.247 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 23.9 p -130.35 152.8 49.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.432 1.093 . . . . 0.0 109.325 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.414 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -138.93 164.88 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.746 1.218 . . . . 0.0 109.104 -177.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 5.3 p90 -73.84 128.45 35.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.495 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.2 t70 -106.63 140.2 39.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -79.22 -48.66 13.8 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.756 0.822 . . . . 0.0 112.523 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.478 HG23 ' HE ' ' A' ' 183' ' ' ARG . 10.1 t -71.29 -24.68 62.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.472 0.578 . . . . 0.0 111.544 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HE ' HG23 ' A' ' 182' ' ' THR . 5.0 mmp_? -81.2 -32.51 33.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 170.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.05 22.12 74.67 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.704 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -167.6 162.37 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.102 0.961 . . . . 0.0 108.87 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 70.7 m-85 -64.11 128.69 36.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.477 1.111 . . . . 0.0 112.012 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 180' ' ' ASP . 29.4 pt -132.57 177.35 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.644 1.177 . . . . 0.0 109.65 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 133' ' ' LYS . 48.7 mm -75.42 151.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.18 0.592 . . . . 0.0 109.6 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.5 mtpm? -73.13 159.31 33.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.102 0.561 . . . . 0.0 111.369 175.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -42.07 6.63 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.363 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 124.026 0.93 . . . . 0.0 109.122 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.412 ' HG3' HG12 ' A' ' 153' ' ' VAL . 16.3 mp0 -53.0 -47.68 68.08 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.736 0.814 . . . . 0.0 112.547 -176.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -44.82 78.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 123.744 0.652 . . . . 0.0 111.473 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.9 t -67.03 -43.52 82.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 98' ' ' ILE . 63.6 mt -64.24 -44.54 97.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 123.713 0.633 . . . . 0.0 110.114 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -58.77 -44.05 90.55 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.526 1.13 . . . . 0.0 110.727 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.725 173.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.1 -35.49 81.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.714 0.805 . . . . 0.0 111.222 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 94' ' ' ILE . 94.3 mt -65.47 -41.36 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.6 t -64.27 -40.18 95.46 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.46 0.704 . . . . 0.0 111.69 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -80.39 -28.42 37.9 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.574 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 84.1 m -96.51 -18.08 20.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.121 0.568 . . . . 0.0 112.362 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.84 169.15 16.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 111.47 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -155.8 158.03 37.45 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.413 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m -68.05 96.53 0.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.8 t -70.03 100.37 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.235 0.614 . . . . 0.0 110.178 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.1 m -101.82 99.17 11.26 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.099 0.96 . . . . 0.0 108.581 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD3' HE22 ' A' ' 125' ' ' GLN . 18.6 Cg_endo -57.75 -36.08 98.53 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.833 2.355 . . . . 0.0 112.331 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.16 -22.49 59.4 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.145 0.903 . . . . 0.0 111.87 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.8 mmp_? -91.72 -42.31 10.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.101 0.56 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.535 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 96.9 mt -64.8 -19.21 65.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.654 0.782 . . . . 0.0 112.391 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 55.98 22.37 5.75 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.331 1.052 . . . . 0.0 112.442 -172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.619 ' HG ' ' HZ ' ' A' ' 186' ' ' PHE . 55.8 m -95.24 141.54 23.36 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 123.9 0.88 . . . . 0.0 109.698 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.96 145.95 75.86 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.028 1.819 . . . . 0.0 110.236 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 99.5 mt -51.47 -43.82 62.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.967 0.907 . . . . 0.0 112.398 -173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.75 -36.8 79.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.61 0.764 . . . . 0.0 112.855 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.2 64.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.939 0.496 . . . . 0.0 110.865 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.04 27.92 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.943 0.897 . . . . 0.0 110.361 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.69 129.3 34.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.298 0.639 . . . . 0.0 109.35 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.2 t -68.74 111.9 9.7 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.25 0.46 9.37 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.748 2.299 . . . . 0.0 112.669 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -84.61 -55.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.702 0.801 . . . . 0.0 108.85 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.0 p -92.84 -8.83 42.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.828 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.56 39.74 21.18 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.545 1.138 . . . . 0.0 111.964 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.39 152.17 31.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.437 HE22 ' HD3' ' A' ' 107' ' ' PRO . 22.9 tm0? -67.77 117.83 51.81 Favored Pre-proline 0 CA--C 1.557 1.246 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.73 166.31 23.76 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.084 2.523 . . . . 0.0 113.688 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.595 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 10.5 pt-20 -86.28 -28.0 24.04 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.846 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -145.52 145.41 31.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.089 1.356 . . . . 0.0 107.753 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.49 166.89 39.71 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.356 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 143' ' ' LEU . 10.1 pt -115.03 153.82 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 125.298 1.439 . . . . 0.0 109.496 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -97.04 122.15 39.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 79.6 t -114.68 123.73 70.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.5 ptmt -69.04 107.44 3.15 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -73.36 89.66 1.62 Allowed 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -63.62 -36.73 84.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.173 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.5 -26.6 66.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.41 0.684 . . . . 0.0 110.818 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.4 13.83 43.92 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.462 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.0 m 77.26 44.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.31 1.444 . . . . 0.0 111.096 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.89 24.46 14.47 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.607 1.163 . . . . 0.0 112.264 174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 187' ' ' ILE . 98.0 t -79.94 125.53 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.171 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.4 129.62 34.77 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.632 0.773 . . . . 0.0 110.295 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.4 m -123.77 139.74 53.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.184 0.994 . . . . 0.0 109.002 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 130' ' ' ILE . 45.1 tp -89.27 111.31 22.09 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.372 0.42 . . . . 0.0 110.061 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 84.5 m-85 -103.79 141.71 35.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.413 1.085 . . . . 0.0 108.243 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.52 132.26 51.87 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.781 0.675 . . . . 0.0 111.834 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.57 55.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.889 0.476 . . . . 0.0 111.455 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.13 69.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.72 0.808 . . . . 0.0 111.561 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.7 t80 -74.32 -40.41 62.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.543 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -63.84 -30.51 71.6 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.464 0.706 . . . . 0.0 111.011 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -62.43 -52.23 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.781 0.833 . . . . 0.0 109.686 172.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.43 -47.62 81.28 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 123.735 0.647 . . . . 0.0 111.228 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 166' ' ' ILE . 97.2 t -61.15 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.269 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.54 92.45 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 124.069 0.856 . . . . 0.0 112.943 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -73.46 -23.31 60.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.168 0.587 . . . . 0.0 111.503 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.06 18.98 37.78 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.375 0.422 . . . . 0.0 112.872 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -80.0 149.4 70.03 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.734 1.213 . . . . 0.0 110.497 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.85 -174.44 2.23 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.984 2.456 . . . . 0.0 112.466 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.44 ' ND1' HG22 ' A' ' 162' ' ' THR . 53.7 t-80 -64.55 127.54 92.45 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.821 0.848 . . . . 0.0 109.082 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.31 -17.92 49.91 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.217 1.945 . . . . 0.0 113.217 -168.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.0 mt -95.46 -62.83 1.23 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.184 0.594 . . . . 0.0 111.15 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.44 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.9 t -91.42 -11.67 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.527 0.331 . . . . 0.0 111.492 -172.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 59.63 23.43 12.19 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.119 1.368 . . . . 0.0 112.838 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 162' ' ' THR . 46.0 mm-40 -91.68 154.93 44.04 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.739 0.816 . . . . 0.0 109.77 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.91 123.53 12.42 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.438 2.092 . . . . 0.0 112.068 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 153' ' ' VAL . 81.2 mt -63.33 136.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.149 0.58 . . . . 0.0 109.952 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -147.33 161.51 40.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.371 0.668 . . . . 0.0 110.525 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -68.61 -19.87 64.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.403 1.081 . . . . 0.0 110.997 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 m -69.58 -24.96 63.76 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.954 0.902 . . . . 0.0 112.561 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 49.4 pt -105.21 -5.47 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 168' ' ' ALA . 9.6 tt -96.94 132.13 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 118.881 0.764 . . . . 0.0 109.486 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.33 175.4 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.311 1.044 . . . . 0.0 110.06 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 95.5 mttt -96.77 165.74 11.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.615 0.366 . . . . 0.0 110.662 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -63.53 -27.01 68.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.372 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -77.93 -27.18 49.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.66 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -85.88 -20.52 28.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.965 0.906 . . . . 0.0 111.785 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 28.1 p -117.41 150.96 38.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.01 0.924 . . . . 0.0 109.574 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 160.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.196 0.999 . . . . 0.0 108.753 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.94 140.12 57.84 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.33 139.41 53.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.879 0.471 . . . . 0.0 110.008 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.42 -52.69 9.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.331 1.052 . . . . 0.0 111.64 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.4 t -74.72 -26.71 59.99 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -80.83 -33.54 34.54 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.542 0.737 . . . . 0.0 109.824 169.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.74 25.89 48.14 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.626 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.34 170.73 2.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.228 0.611 . . . . 0.0 111.043 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.619 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 89.9 m-85 -61.88 122.05 14.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.692 1.197 . . . . 0.0 111.527 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 140' ' ' VAL . 2.9 pp -134.71 173.95 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.713 1.205 . . . . 0.0 109.904 176.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 133' ' ' LYS . 43.8 mm -73.54 143.74 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.726 0.81 . . . . 0.0 110.684 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -66.12 150.56 48.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.484 0.713 . . . . 0.0 112.05 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -103.93 -20.92 10.04 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.379 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 CA--C 1.552 1.053 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.653 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.827 0.346 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 16.2 mp0 -84.86 -29.08 25.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.269 0.627 . . . . 0.0 111.254 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.81 -49.37 49.06 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.232 1.013 . . . . 0.0 113.334 -164.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.508 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 17.2 m -70.29 -41.04 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.277 0.631 . . . . 0.0 109.95 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.7 mt -66.12 -45.33 90.66 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.381 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -57.69 -46.14 84.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.854 1.261 . . . . 0.0 110.704 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.74 -37.39 86.37 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.024 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -66.39 -44.4 83.17 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 123.216 0.606 . . . . 0.0 110.224 177.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 94' ' ' ILE . 90.5 mt -60.49 -39.0 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.765 0.826 . . . . 0.0 109.666 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.7 t -67.32 -41.08 85.88 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.132 0.973 . . . . 0.0 111.011 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -83.19 -14.56 53.15 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.672 0.789 . . . . 0.0 112.984 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 93.5 m -103.55 -25.37 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.309 0.644 . . . . 0.0 112.601 -173.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -68.92 166.09 18.58 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -156.72 158.05 36.22 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.373 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.5 m -67.07 100.65 0.78 Allowed 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.706 0.802 . . . . 0.0 109.47 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.75 101.61 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 61.0 m -112.33 96.87 37.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HB3' HD11 ' A' ' 117' ' ' ILE . 8.0 Cg_endo -50.86 -23.52 11.88 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.938 3.092 . . . . 0.0 113.927 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.59 -30.18 59.51 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.008 0.923 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -93.47 -40.19 10.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.392 0.677 . . . . 0.0 111.135 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -69.06 -24.33 64.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.067 0.547 . . . . 0.0 110.237 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 45.41 50.42 10.11 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 124.889 1.276 . . . . 0.0 111.698 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.6 m -124.3 148.72 58.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.391 1.076 . . . . 0.0 110.038 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.67 141.67 97.45 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.348 2.032 . . . . 0.0 110.772 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 125' ' ' GLN . 52.4 mt -55.06 -37.82 67.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.831 0.852 . . . . 0.0 111.666 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.01 -38.13 81.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.785 0.834 . . . . 0.0 112.192 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.27 66.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.065 0.546 . . . . 0.0 111.014 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 107' ' ' PRO . 33.3 pt -116.12 26.59 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.235 1.014 . . . . 0.0 110.302 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.57 127.54 33.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.308 1.043 . . . . 0.0 110.15 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 t -74.38 110.83 10.51 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.9 -2.75 12.68 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.78 2.32 . . . . 0.0 112.947 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.0 mt -85.12 -57.33 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.769 0.828 . . . . 0.0 109.499 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p -80.37 -23.67 40.32 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.024 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 62.74 49.9 3.58 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.124 0.964 . . . . 0.0 110.291 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.45 154.33 34.2 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.214 171.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.4 OUTLIER -72.05 112.17 13.46 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 71.9 Cg_endo -71.32 159.78 50.73 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.205 2.604 . . . . 0.0 114.459 -167.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.544 ' HG3' ' HG3' ' A' ' 128' ' ' LYS . 6.4 pt-20 -80.81 -39.84 25.99 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.683 175.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.544 ' HG3' ' HG3' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -146.57 146.23 30.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.801 1.24 . . . . 0.0 108.044 178.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.35 42.36 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.461 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.2 pt -122.54 159.81 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.719 1.608 . . . . 0.0 109.197 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 141' ' ' CYS . 40.7 m-85 -104.85 119.8 39.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 170.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.3 121.43 66.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.653 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.9 ptmt -64.35 127.26 30.72 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 124.099 0.874 . . . . 0.0 112.77 -172.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -76.86 72.72 3.47 Favored 'General case' 0 C--O 1.249 1.029 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -42.9 99.74 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.417 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.65 -40.38 92.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.502 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.63 -66.54 2.1 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.68 -171.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.544 ' HB2' HG23 ' A' ' 140' ' ' VAL . 42.7 m -161.3 22.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.162 0.585 . . . . 0.0 111.569 -176.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 62.42 31.33 17.23 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.884 1.326 . . . . 0.0 110.314 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.614 ' HA ' HG22 ' A' ' 187' ' ' ILE . 60.0 t -81.72 177.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.413 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' PHE . 26.4 p -134.3 140.78 46.64 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.401 HG21 HD11 ' A' ' 161' ' ' LEU . 89.5 m -118.94 146.34 45.04 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.06 109.38 20.44 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.235 0.541 . . . . 0.0 110.67 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.24 130.72 54.71 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 108.173 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.1 t70 -55.56 132.11 47.87 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.889 0.768 . . . . 0.0 109.17 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.01 -43.45 77.73 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 112.154 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -33.0 63.34 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.621 0.575 . . . . 0.0 110.963 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -72.23 -36.76 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.0 t80 -80.27 -36.81 34.0 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -63.92 -29.8 70.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.365 0.666 . . . . 0.0 110.789 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 8.5 tpt180 -59.18 -59.08 6.03 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.924 0.765 . . . . 0.0 108.995 169.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.26 -46.83 72.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.019 0.825 . . . . 0.0 111.915 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 166' ' ' ILE . 95.4 t -61.99 -48.93 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 110.135 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -62.97 -35.78 92.55 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 123.995 0.81 . . . . 0.0 113.045 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 8.9 mm-40 -67.81 -34.97 77.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.521 0.729 . . . . 0.0 110.289 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.65 27.32 8.05 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.305 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 54.4 mt -90.19 149.04 40.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.375 1.07 . . . . 0.0 109.779 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.21 -176.38 3.24 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.463 2.109 . . . . 0.0 112.399 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.09 128.61 81.76 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.204 1.002 . . . . 0.0 110.569 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.64 -13.76 37.9 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.323 2.015 . . . . 0.0 113.971 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 142' ' ' THR . 57.2 mt -101.17 -56.11 2.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.735 0.414 . . . . 0.0 111.766 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.5 t -104.01 -10.29 18.19 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.876 0.47 . . . . 0.0 111.271 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 63.75 21.46 12.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.623 1.169 . . . . 0.0 112.999 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.06 151.41 78.79 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.299 0.64 . . . . 0.0 109.873 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.16 122.73 12.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.778 2.319 . . . . 0.0 110.991 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.587 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.7 mt -66.34 128.38 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 t -146.13 159.61 43.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.161 0.984 . . . . 0.0 109.377 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.7 -19.7 65.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.612 0.765 . . . . 0.0 111.158 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -70.25 -39.51 74.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.929 0.891 . . . . 0.0 111.788 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' A' ' 166' ' ' ILE . 47.6 pt -90.66 -12.19 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.5 tt -95.16 137.34 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.144 0.884 . . . . 0.0 108.728 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.52 HG11 HD12 ' A' ' 188' ' ' ILE . 28.8 m -130.22 171.67 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.283 1.033 . . . . 0.0 109.113 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 58.6 mtpt -88.52 165.72 14.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.159 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 177' ' ' CYS . 21.0 t60 -73.62 -23.27 59.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.39 0.614 . . . . 0.0 109.649 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.44 -31.49 71.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.8 10.18 41.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.602 0.761 . . . . 0.0 111.726 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 174' ' ' HIS . 30.9 p -139.57 138.07 35.93 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.635 -0.666 . . . . 0.0 110.457 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -133.82 162.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.756 1.223 . . . . 0.0 108.579 -174.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -66.47 124.46 22.83 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 166.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.568 ' HB2' HG12 ' A' ' 187' ' ' ILE . 12.4 t70 -105.32 134.02 49.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.83 -36.57 42.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.15 0.906 . . . . 0.0 112.337 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.408 HG22 ' OD1' ' A' ' 180' ' ' ASP . 1.1 t -76.53 -23.64 53.65 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.51 ' HG3' HG21 ' A' ' 187' ' ' ILE . 40.0 mmt180 -86.98 -33.92 19.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.841 0.857 . . . . 0.0 110.661 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.84 18.63 77.65 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.45 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -148.41 150.71 33.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.413 1.085 . . . . 0.0 109.934 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -60.48 117.33 5.14 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.394 0.678 . . . . 0.0 110.303 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 140' ' ' VAL . 13.3 pt -129.68 178.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.828 0.851 . . . . 0.0 108.91 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 133' ' ' LYS . 8.8 mm -70.84 154.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.427 ' HG2' HD12 ' A' ' 178' ' ' ILE . 9.6 mtpm? -70.82 148.16 48.16 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.273 0.559 . . . . 0.0 111.357 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -107.45 -42.49 1.47 Allowed Glycine 0 N--CA 1.461 0.365 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.961 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 C--O 1.249 1.068 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.504 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.374 0.607 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.439 ' HG3' HG12 ' A' ' 153' ' ' VAL . 6.7 mp0 -60.9 -44.44 97.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.086 -176.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -41.96 82.57 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.196 0.598 . . . . 0.0 111.615 -175.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 46.7 t -72.84 -50.93 21.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.512 0.725 . . . . 0.0 110.609 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' ILE . 96.8 mt -64.01 -44.37 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.303 0.641 . . . . 0.0 111.196 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.75 -27.73 64.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.119 0.567 . . . . 0.0 111.567 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 2.6 m-80 -64.58 -41.21 96.41 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -65.43 -34.69 78.89 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.86 0.864 . . . . 0.0 110.67 177.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.535 HG23 HD13 ' A' ' 130' ' ' ILE . 92.8 mt -67.44 -37.74 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.279 0.631 . . . . 0.0 109.44 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.5 t -67.15 -36.49 81.95 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.5 mm-40 -74.56 -53.96 8.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.685 0.394 . . . . 0.0 110.737 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.638 ' SG ' ' HE3' ' A' ' 173' ' ' LYS . 72.5 m -71.81 -19.96 61.92 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.066 0.946 . . . . 0.0 112.983 -167.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.1 170.97 7.53 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.789 0.804 . . . . 0.0 112.825 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -160.02 156.68 27.41 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.935 173.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 p -70.95 104.5 2.98 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' NE2' ' A' ' 125' ' ' GLN . 45.6 t -77.72 96.98 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 -171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.81 105.41 41.27 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.6 -31.17 86.79 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.967 2.445 . . . . 0.0 113.522 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 -30.29 49.74 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.48 0.488 . . . . 0.0 110.581 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -78.79 -35.03 45.0 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.52 -19.23 53.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.536 0.734 . . . . 0.0 111.691 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 57.23 22.34 7.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.025 0.93 . . . . 0.0 112.621 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 79.4 m -104.94 146.35 32.49 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 123.717 0.807 . . . . 0.0 109.649 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.58 152.66 80.93 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.317 2.011 . . . . 0.0 111.101 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.34 -40.95 68.51 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.887 0.742 . . . . 0.0 111.549 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.64 -41.03 80.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.323 1.049 . . . . 0.0 112.688 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.82 62.91 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.435 0.694 . . . . 0.0 111.434 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 126' ' ' PRO . 12.0 pt -126.5 33.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.899 0.879 . . . . 0.0 109.506 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 43.4 tt0 -84.47 137.94 33.07 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.829 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.5 t -76.85 113.64 31.92 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.84 0.49 8.2 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.168 2.579 . . . . 0.0 113.107 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.0 mt -85.24 -54.75 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p -86.28 -18.88 30.88 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.189 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 66.45 36.52 5.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.342 1.057 . . . . 0.0 111.445 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.73 151.7 30.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.479 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 25.5 tm0? -69.64 113.2 15.44 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.873 0.869 . . . . 0.0 108.673 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 117' ' ' ILE . 92.5 Cg_endo -73.59 163.82 36.48 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.57 2.18 . . . . 0.0 113.867 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -17.69 28.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.189 0.996 . . . . 0.0 110.261 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 146' ' ' ALA . 1.3 pptp? -153.27 140.87 19.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.152 0.981 . . . . 0.0 108.957 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.77 168.49 41.38 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.507 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.535 HD13 HG23 ' A' ' 98' ' ' ILE . 13.7 pt -121.0 156.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.547 1.539 . . . . 0.0 109.87 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.6 123.42 43.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 169.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 72.9 t -123.83 122.1 63.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.678 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -69.9 116.96 10.88 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.435 0.636 . . . . 0.0 110.164 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.05 85.28 1.81 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 27.9 t -66.19 -39.84 89.97 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.204 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.35 -35.79 82.04 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.978 0.911 . . . . 0.0 111.105 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.51 -63.97 2.89 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -169.8 23.72 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.415 0.686 . . . . 0.0 110.631 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.9 m-20 59.29 31.33 21.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.425 1.09 . . . . 0.0 111.698 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.2 t -94.08 128.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.186 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 27.7 p -84.39 132.11 34.62 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -124.52 146.61 48.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 105' ' ' VAL . 44.6 tp -90.43 115.33 27.51 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.4 m-85 -111.78 137.92 49.06 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.492 1.117 . . . . 0.0 108.114 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.723 0.692 . . . . 0.0 109.302 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 128' ' ' LYS . . . -57.15 -42.83 81.74 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.93 0.769 . . . . 0.0 111.926 -173.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.69 -36.05 60.15 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.84 0.456 . . . . 0.0 111.593 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.78 69.28 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.125 0.57 . . . . 0.0 111.625 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' O ' HG23 ' A' ' 153' ' ' VAL . 36.6 t80 -71.62 -37.02 70.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.124 0.57 . . . . 0.0 109.881 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -63.03 -36.7 84.44 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.702 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 79.1 ttt180 -60.39 -45.88 91.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.63 -47.05 77.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.137 0.575 . . . . 0.0 111.224 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' A' ' 91' ' ' GLN . 38.7 t -66.04 -46.25 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.227 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.87 -33.07 84.16 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 124.262 0.976 . . . . 0.0 113.312 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.527 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 23.9 mm-40 -75.59 -32.22 60.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.08 21.8 10.6 Favored Glycine 0 N--CA 1.468 0.825 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.753 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 50.6 mt -85.18 153.08 59.35 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 0.0 111.146 -175.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.0 174.95 11.9 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.216 2.611 . . . . 0.0 113.081 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -55.14 134.39 68.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.041 1.336 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.98 -26.14 58.83 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.654 2.236 . . . . 0.0 113.876 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.74 -60.7 1.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.6 t -105.34 -4.19 21.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.646 -167.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 60.22 28.19 17.76 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.106 0.963 . . . . 0.0 112.729 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -80.11 159.99 69.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.18 0.992 . . . . 0.0 111.371 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.4 112.72 2.66 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.119 1.879 . . . . 0.0 111.006 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.428 ' HA ' HD11 ' A' ' 170' ' ' ILE . 72.9 mt -62.65 131.79 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.635 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 162.67 38.77 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.363 0.665 . . . . 0.0 110.446 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.75 -22.12 66.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.705 0.802 . . . . 0.0 111.691 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -68.54 -41.0 80.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 111.581 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.3 pt -84.94 -7.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -175.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.4 tt -97.95 132.83 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.015 0.825 . . . . 0.0 109.876 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.467 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -133.76 178.22 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.136 1.375 . . . . 0.0 110.029 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.638 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 3.3 mptt -104.26 166.47 10.38 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.481 0.712 . . . . 0.0 109.755 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -70.78 -16.12 62.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.145 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -79.65 -35.29 39.51 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.577 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -83.72 -23.1 31.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.737 0.815 . . . . 0.0 110.602 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 31.7 p -115.78 142.2 47.07 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.867 0.867 . . . . 0.0 108.897 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.4 163.26 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.491 1.116 . . . . 0.0 109.045 -174.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -71.49 136.82 47.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -119.44 132.88 55.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.87 -51.35 22.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.664 1.186 . . . . 0.0 111.906 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 t -73.15 -23.23 60.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.269 0.228 . . . . 0.0 111.536 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.423 ' HG3' HD13 ' A' ' 187' ' ' ILE . 12.7 mmp_? -81.03 -33.98 33.16 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.13 0.572 . . . . 0.0 110.561 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.84 76.11 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.284 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -146.46 146.89 30.73 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.2 1.0 . . . . 0.0 109.446 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.514 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 97.9 m-85 -66.7 116.43 7.61 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 167.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.447 HG12 ' HB2' ' A' ' 180' ' ' ASP . 27.9 pt -127.21 178.95 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.075 0.95 . . . . 0.0 109.365 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 133' ' ' LYS . 21.1 mm -85.82 148.28 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -60.49 154.03 21.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.541 0.736 . . . . 0.0 111.989 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.76 62.92 4.48 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 . . . . . 0 CA--C 1.557 1.23 0 C-N-CA 125.753 1.621 . . . . 0.0 109.424 -168.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.955 -0.017 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -58.01 -41.33 82.9 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.51 1.124 . . . . 0.0 110.575 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.95 -45.39 67.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.282 1.033 . . . . 0.0 112.106 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 t -66.05 -39.24 89.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.63 0.772 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 98' ' ' ILE . 52.2 mt -69.56 -45.51 77.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.938 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -58.92 -45.31 90.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.157 . . . . 0.0 111.219 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -59.77 -40.91 89.83 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -62.85 -44.86 95.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.144 0.578 . . . . 0.0 110.727 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 150' ' ' SER . 87.7 mt -60.58 -39.19 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.804 0.842 . . . . 0.0 110.206 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.7 t -64.85 -40.12 94.65 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.988 0.915 . . . . 0.0 111.805 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -83.61 -27.33 29.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.284 0.634 . . . . 0.0 112.601 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.1 m -95.69 -12.23 25.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.578 0.751 . . . . 0.0 112.448 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -74.01 165.25 25.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.635 0.731 . . . . 0.0 112.877 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.06 154.59 35.18 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.422 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.3 p -75.61 105.06 6.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.2 130.91 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.918 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 39.3 m -122.38 81.56 46.04 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.695 0.798 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.97 -39.15 40.19 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.163 3.242 . . . . 0.0 113.802 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 10.6 pt-20 -60.95 -45.71 93.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.206 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 67.4 mtp180 -83.47 -31.59 26.45 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.088 0.555 . . . . 0.0 111.483 -174.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.33 -18.59 63.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.228 0.611 . . . . 0.0 111.013 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.65 2.67 3.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.301 1.44 . . . . 0.0 112.299 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 62.0 m -92.3 133.13 30.49 Favored Pre-proline 0 C--O 1.247 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 109.17 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.08 158.59 21.08 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.64 2.227 . . . . 0.0 112.164 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -53.47 -43.96 68.57 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.881 0.738 . . . . 0.0 111.488 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.4 -38.45 77.38 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.215 1.006 . . . . 0.0 112.731 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.99 64.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.694 0.798 . . . . 0.0 112.099 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.525 ' HB ' HD23 ' A' ' 143' ' ' LEU . 8.9 pt -127.24 11.59 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.739 0.816 . . . . 0.0 110.57 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.441 HE21 ' HA ' ' A' ' 123' ' ' LEU . 41.8 tt0 -63.98 132.53 50.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.991 0.916 . . . . 0.0 111.097 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 34.6 t -67.58 111.87 8.71 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 174.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.85 -3.56 13.97 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.54 2.16 . . . . 0.0 112.647 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -79.62 -54.0 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.469 1.108 . . . . 0.0 109.431 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p -101.09 -4.23 27.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.255 -169.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.441 ' HA ' HE21 ' A' ' 118' ' ' GLN . 4.0 mm? 60.32 33.34 20.86 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.88 0.872 . . . . 0.0 112.258 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.16 153.5 39.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.516 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 21.4 tm0? -70.61 123.85 89.84 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 72.6 Cg_endo -76.24 154.6 36.89 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.367 2.712 . . . . 0.0 114.386 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.5 pt-20 -83.26 -35.79 25.06 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.479 174.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 48.6 pttt -138.33 138.86 38.75 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.16 157.41 28.26 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.062 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 98' ' ' ILE . 9.8 pt -113.2 156.34 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.474 1.509 . . . . 0.0 109.602 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -98.81 116.88 32.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 144' ' ' PHE . 65.4 t -116.54 122.36 69.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.3 ptmt -69.55 110.51 4.83 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.515 0.674 . . . . 0.0 109.413 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.07 81.11 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 162.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -69.49 -68.79 0.38 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.292 -167.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.43 -35.0 71.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.934 0.894 . . . . 0.0 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.49 -62.55 4.51 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.201 -0.909 . . . . 0.0 113.42 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 m -150.93 4.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -170.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 62.37 22.55 13.3 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.866 0.841 . . . . 0.0 111.061 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 185' ' ' ASN . 55.4 t -105.87 129.99 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.67 0.788 . . . . 0.0 110.897 -173.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 56.5 m -84.16 127.72 34.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.797 0.839 . . . . 0.0 108.838 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.6 m -126.04 146.98 49.68 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' A' ' 117' ' ' ILE . 40.3 tp -88.24 105.28 17.44 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.091 0.472 . . . . 0.0 109.897 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.424 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 85.8 m-85 -98.6 143.28 29.17 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 11.3 t70 -63.63 136.37 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.38 73.48 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.201 0.938 . . . . 0.0 111.593 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.0 -31.66 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.074 0.55 . . . . 0.0 111.696 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.43 -40.09 64.49 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.587 0.755 . . . . 0.0 111.817 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -76.57 -37.77 56.02 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.495 ' HB2' HG21 ' A' ' 98' ' ' ILE . 27.5 t -63.27 -30.21 71.4 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.742 174.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 3.5 tpm_? -64.36 -52.64 57.31 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.384 172.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.61 -45.77 73.71 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 123.912 0.757 . . . . 0.0 111.392 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.02 -43.37 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.515 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.82 -16.66 74.62 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.027 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 10.1 mm-40 -91.12 -23.54 20.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.322 0.649 . . . . 0.0 110.992 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.11 13.4 58.94 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.439 0.462 . . . . 0.0 112.734 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.36 139.63 52.05 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.067 0.947 . . . . 0.0 109.924 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.83 -176.97 2.59 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.765 2.31 . . . . 0.0 113.012 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.406 ' ND1' HG22 ' A' ' 162' ' ' THR . 46.9 t-80 -58.65 126.32 79.46 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.121 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.427 ' HG3' HG12 ' A' ' 121' ' ' ILE . 66.1 Cg_endo -66.51 -15.71 48.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.79 2.327 . . . . 0.0 113.462 -170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.0 mt -97.32 -64.9 1.0 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.757 0.423 . . . . 0.0 111.243 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.406 HG22 ' ND1' ' A' ' 159' ' ' HIS . 9.7 t -94.33 -8.86 37.69 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 122.645 0.378 . . . . 0.0 111.796 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 61.04 21.02 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.904 1.281 . . . . 0.0 112.759 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -87.29 161.07 47.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.311 1.044 . . . . 0.0 110.213 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.21 121.06 8.58 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.018 1.812 . . . . 0.0 111.82 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.484 ' HA ' HD11 ' A' ' 170' ' ' ILE . 71.3 mt -65.65 139.47 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.024 0.53 . . . . 0.0 109.584 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.2 t -153.41 165.34 36.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.398 0.436 . . . . 0.0 111.277 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.46 -22.89 66.8 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.352 1.061 . . . . 0.0 111.941 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -68.11 -43.69 77.87 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.715 0.806 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.1 pt -85.19 -12.87 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 97' ' ' LYS . 7.7 tt -98.61 136.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.593 HG11 HD12 ' A' ' 188' ' ' ILE . 27.6 m -137.47 173.57 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.927 1.291 . . . . 0.0 110.45 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -91.14 164.07 14.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.014 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -66.11 -25.17 66.88 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.686 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.21 -29.09 21.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.5 1.12 . . . . 0.0 110.639 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.06 -25.68 34.36 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.808 0.843 . . . . 0.0 111.357 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 29.2 p -104.76 154.97 19.31 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -132.0 157.12 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 19.2 p90 -71.0 122.19 19.57 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.435 ' HB2' HG12 ' A' ' 187' ' ' ILE . 10.9 t70 -106.98 114.49 28.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.71 -21.52 44.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -168.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.5 t -83.55 -25.84 30.63 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.599 0.636 . . . . 0.0 110.803 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -79.95 -27.77 39.71 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 167.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.06 10.46 85.53 Favored Glycine 0 N--CA 1.469 0.88 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.139 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.412 ' HB3' HG13 ' A' ' 140' ' ' VAL . 18.7 m120 -148.34 158.11 43.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.869 0.868 . . . . 0.0 109.854 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 64.6 m-85 -64.6 127.33 31.07 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 180' ' ' ASP . 22.0 pt -134.31 178.12 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.3 1.04 . . . . 0.0 108.8 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.593 HD12 HG11 ' A' ' 172' ' ' VAL . 33.9 mm -79.38 145.62 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.98 163.29 8.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.278 0.631 . . . . 0.0 112.232 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.74 -55.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.64 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.619 1.168 . . . . 0.0 109.353 178.184 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 121.27 0.557 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.482 ' HG2' ' HA2' ' A' ' 154' ' ' GLY . 22.3 mp0 -74.28 -39.65 62.82 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.839 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.01 -50.33 36.5 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.745 0.818 . . . . 0.0 113.028 -164.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 40.4 t -65.57 -43.64 89.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.805 0.442 . . . . 0.0 110.481 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 98' ' ' ILE . 56.5 mt -64.8 -46.03 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 153' ' ' VAL . 30.2 mm-40 -57.91 -47.75 81.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.717 1.207 . . . . 0.0 111.699 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -65.29 -35.8 82.13 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.077 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -64.7 -38.19 90.17 Favored 'General case' 0 C--O 1.206 -1.21 0 C-N-CA 122.952 0.501 . . . . 0.0 110.634 176.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.489 HG21 ' HB2' ' A' ' 150' ' ' SER . 89.3 mt -65.82 -39.39 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.253 0.621 . . . . 0.0 109.966 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -64.58 -34.89 79.32 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.456 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -87.48 -27.9 22.38 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 75.6 m -93.39 -11.63 31.78 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 -173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -73.94 168.12 20.12 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.653 0.739 . . . . 0.0 111.849 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.88 157.32 34.66 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.449 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 p -68.8 98.6 0.94 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.479 HG12 ' NE2' ' A' ' 125' ' ' GLN . 63.2 t -72.37 99.7 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 56.7 m -111.2 104.75 56.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.169 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.47 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 9.9 Cg_endo -52.91 -26.58 31.9 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 -37.33 61.62 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.059 0.544 . . . . 0.0 110.409 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -83.78 -39.93 19.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.608 0.763 . . . . 0.0 110.864 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.92 -20.89 62.43 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.505 0.722 . . . . 0.0 111.206 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.46 ' HA ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER 53.78 36.16 23.25 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.639 1.176 . . . . 0.0 111.027 -176.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.3 140.57 26.67 Favored Pre-proline 0 C--O 1.248 1.018 0 C-N-CA 124.383 1.073 . . . . 0.0 108.874 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.0 157.22 50.06 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.18 1.92 . . . . 0.0 111.899 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.43 -46.62 66.46 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.661 0.784 . . . . 0.0 112.054 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 1.6 pm0 -67.68 -30.96 70.62 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.408 0.683 . . . . 0.0 112.444 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.08 -27.1 67.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.73 0.412 . . . . 0.0 111.43 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' HD23 ' A' ' 143' ' ' LEU . 16.8 pt -119.08 17.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.491 0.716 . . . . 0.0 110.604 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 46.5 tt0 -63.5 129.99 42.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.994 0.918 . . . . 0.0 110.542 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.42 ' H ' ' HD3' ' A' ' 126' ' ' PRO . 17.1 t -67.75 109.74 4.31 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.566 ' HB2' HD21 ' A' ' 161' ' ' LEU . 87.7 Cg_endo -78.3 5.88 5.13 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.732 2.288 . . . . 0.0 112.734 -174.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -83.39 -53.95 10.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 124.124 0.969 . . . . 0.0 108.841 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.4 p -96.35 -10.29 28.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.924 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.49 39.06 25.39 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.206 1.002 . . . . 0.0 111.79 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.59 159.84 43.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.425 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.479 ' NE2' HG12 ' A' ' 105' ' ' VAL . 23.1 tm0? -74.62 121.22 84.76 Favored Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' A' ' 119' ' ' CYS . 73.3 Cg_endo -76.4 159.16 36.45 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.075 2.517 . . . . 0.0 113.441 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 11.3 pt-20 -90.15 -26.09 20.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.692 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 47.2 pttt -147.06 140.39 25.43 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.3 158.67 31.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.824 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 98' ' ' ILE . 12.2 pt -110.84 155.09 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.739 1.216 . . . . 0.0 109.767 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -93.09 129.02 39.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 167.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.5 t -124.85 124.29 67.53 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 171.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.655 ' HB3' HD11 ' A' ' 188' ' ' ILE . 22.0 ptmt -64.93 105.01 0.93 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.029 0.919 . . . . 0.0 110.373 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -71.28 78.54 0.73 Allowed 'General case' 0 C--O 1.25 1.084 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 34.2 t -65.42 -37.57 87.31 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.156 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -56.51 -36.56 69.33 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.297 1.039 . . . . 0.0 112.251 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.47 -63.41 2.62 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.398 0.436 . . . . 0.0 113.049 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -169.61 30.83 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.269 0.628 . . . . 0.0 110.203 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.7 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 0.4 OUTLIER 65.13 26.12 12.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.022 0.929 . . . . 0.0 111.225 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.6 t -86.09 142.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.89 0.876 . . . . 0.0 110.021 -174.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 188' ' ' ILE . 60.6 m -85.46 122.54 29.74 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 34.6 m -118.17 137.31 53.07 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 117' ' ' ILE . 56.7 tp -92.91 114.44 26.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.687 0.395 . . . . 0.0 110.487 -174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.34 150.77 26.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.632 1.173 . . . . 0.0 108.521 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.28 137.74 54.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.466 0.575 . . . . 0.0 109.548 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.23 86.25 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.022 0.826 . . . . 0.0 111.95 -175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.43 -36.92 66.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 0.0 111.698 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.01 56.64 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.412 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.62 -40.97 84.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.352 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.0 t -62.41 -36.88 83.73 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.748 0.655 . . . . 0.0 110.839 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 58.6 ttt180 -63.43 -48.85 76.05 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.73 -46.75 70.95 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.399 0.679 . . . . 0.0 111.741 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t -62.42 -47.43 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.821 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 91' ' ' GLN . . . -64.1 -29.3 74.52 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 124.191 0.932 . . . . 0.0 113.447 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 61.5 mm-40 -72.95 -25.34 60.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.199 0.6 . . . . 0.0 110.317 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 15.76 43.32 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.098 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.67 145.6 54.81 Favored Pre-proline 0 C--O 1.242 0.659 0 C-N-CA 123.866 0.867 . . . . 0.0 110.073 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.34 -179.47 5.1 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.551 2.168 . . . . 0.0 112.017 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -55.02 131.82 67.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.8 -26.31 79.38 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.924 2.416 . . . . 0.0 113.573 -172.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.5 mt -97.75 -52.59 3.69 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.637 0.375 . . . . 0.0 111.308 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 67.8 p -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.412 0.685 . . . . 0.0 112.195 -168.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 64.04 22.24 12.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.555 1.142 . . . . 0.0 111.352 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.71 149.73 86.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.575 0.75 . . . . 0.0 110.296 171.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.22 111.19 1.53 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.219 1.946 . . . . 0.0 110.702 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.6 mt -61.09 135.39 25.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.053 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.6 t -149.18 163.11 38.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.091 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -64.75 -23.92 67.4 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.958 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -69.99 -26.16 63.95 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.887 0.875 . . . . 0.0 113.033 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.7 pt -100.7 -11.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 168' ' ' ALA . 7.7 tt -94.39 134.04 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.607 HG11 HD12 ' A' ' 188' ' ' ILE . 26.9 m -133.81 172.11 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.528 1.131 . . . . 0.0 110.795 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 7.1 mtpm? -103.82 166.83 10.17 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.026 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -71.2 -18.11 62.49 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.12 -22.1 23.04 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.3 0.64 . . . . 0.0 110.544 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -75.88 -38.51 57.77 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.742 0.817 . . . . 0.0 109.546 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.38 140.95 29.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.616 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 152.91 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -66.15 128.8 37.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.546 ' HB2' HG12 ' A' ' 187' ' ' ILE . 14.0 t70 -108.03 135.3 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.29 -49.47 16.9 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.055 0.847 . . . . 0.0 111.655 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.7 t -73.76 -23.44 59.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.122 0.169 . . . . 0.0 111.412 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 3.4 mmp_? -83.65 -33.0 25.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.185 0.594 . . . . 0.0 110.549 171.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.68 26.32 59.04 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.918 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -171.37 162.93 6.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.186 0.595 . . . . 0.0 109.851 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -60.2 121.16 11.26 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.1 0.96 . . . . 0.0 111.13 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.546 HG12 ' HB2' ' A' ' 180' ' ' ASP . 23.3 pt -126.73 174.94 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.196 171.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 133' ' ' LYS . 27.1 mm -70.74 151.05 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.349 0.659 . . . . 0.0 109.746 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 148.31 51.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.224 0.535 . . . . 0.0 111.393 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -114.87 -26.24 3.64 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.173 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -62.29 -42.92 99.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -35.66 81.0 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.352 0.408 . . . . 0.0 111.588 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 32.7 t -68.37 -43.51 77.2 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.44 0.696 . . . . 0.0 109.449 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 98' ' ' ILE . 64.6 mt -66.35 -46.61 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.579 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -58.53 -43.47 89.22 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.326 1.45 . . . . 0.0 111.346 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -41.78 96.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.268 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -69.23 -32.34 71.52 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 123.262 0.625 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 94' ' ' ILE . 83.5 mt -66.02 -40.86 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.2 m -63.05 -40.71 98.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 111.583 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -83.0 -22.68 33.58 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.514 0.726 . . . . 0.0 112.701 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.592 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 80.4 m -95.35 -22.89 17.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.999 0.52 . . . . 0.0 112.293 -176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -70.3 168.21 16.39 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.722 0.772 . . . . 0.0 112.508 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -156.12 157.7 36.44 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.599 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.0 p -72.22 99.65 2.41 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 143' ' ' LEU . 21.9 t -71.56 109.25 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.249 -171.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.4 m -109.95 104.43 55.53 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.72 0.808 . . . . 0.0 109.458 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 117' ' ' ILE . 15.5 Cg_endo -59.92 -27.63 85.34 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.982 2.455 . . . . 0.0 112.647 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.72 -31.37 69.33 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.254 0.622 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -90.59 -30.61 17.1 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.656 0.782 . . . . 0.0 110.868 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.3 -23.04 57.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.846 0.458 . . . . 0.0 111.216 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 52.74 33.1 13.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.028 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -114.62 140.69 25.62 Favored Pre-proline 0 C--O 1.245 0.844 0 C-N-CA 124.424 1.09 . . . . 0.0 108.859 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.92 158.67 45.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.462 2.108 . . . . 0.0 111.785 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.32 -45.68 72.69 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.806 . . . . 0.0 111.8 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.68 -38.97 72.97 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.316 1.046 . . . . 0.0 113.062 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.04 65.42 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.161 0.585 . . . . 0.0 111.734 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 107' ' ' PRO . 19.5 pt -127.97 31.39 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.681 1.192 . . . . 0.0 109.535 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.66 125.02 27.79 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.379 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 10.4 t -68.47 109.93 4.94 Favored Pre-proline 0 C--N 1.349 0.557 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.91 -3.35 13.63 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.782 2.321 . . . . 0.0 112.852 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.2 -52.3 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.4 p -90.98 -10.64 41.61 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.96 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.29 36.26 23.54 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.851 1.261 . . . . 0.0 111.889 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.87 152.65 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.352 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.48 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 24.1 tm0? -68.21 121.38 80.03 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.523 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.52 164.2 28.73 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.116 2.544 . . . . 0.0 114.602 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 12.9 pt-20 -86.43 -29.82 22.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.463 173.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 52.0 pttt -141.62 135.07 29.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.7 1.6 . . . . 0.0 106.904 176.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -161.74 154.9 26.0 Favored Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.503 -175.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -110.19 159.38 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 125.251 1.42 . . . . 0.0 109.555 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 141' ' ' CYS . 37.3 m-85 -103.34 118.15 36.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 169.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.7 t -115.16 121.49 67.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 170' ' ' ILE . 21.9 ptmt -72.2 108.48 5.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.864 0.84 . . . . 0.0 110.627 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -66.55 83.36 0.1 Allowed 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.42 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 46.4 t -64.21 -41.64 96.96 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.212 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.14 -32.27 73.88 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.006 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.29 -66.36 2.11 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.27 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.2 m -168.44 26.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.317 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 9.5 m-20 58.34 26.1 13.61 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.635 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -80.52 123.72 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.384 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . 40.5 m -82.7 122.98 28.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.499 HG21 HD11 ' A' ' 161' ' ' LEU . 25.9 m -119.41 145.03 46.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -172.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 105' ' ' VAL . 34.2 tp -86.65 114.13 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.35 0.407 . . . . 0.0 110.286 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -113.35 135.49 53.8 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.595 1.158 . . . . 0.0 108.466 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 148' ' ' ALA . 13.1 t70 -59.26 137.62 57.91 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.674 0.39 . . . . 0.0 110.046 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.13 90.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.553 0.741 . . . . 0.0 111.672 -174.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.12 44.85 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.319 0.648 . . . . 0.0 112.124 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.42 -39.21 54.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.177 0.591 . . . . 0.0 111.673 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.0 t80 -72.15 -38.3 69.2 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -56.67 -38.73 72.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.069 0.948 . . . . 0.0 111.452 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -57.65 -52.16 66.55 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.817 0.698 . . . . 0.0 109.953 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.77 -46.52 81.42 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.149 0.906 . . . . 0.0 111.089 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 166' ' ' ILE . 94.8 t -62.38 -47.07 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.744 . . . . 0.0 110.852 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.45 -34.37 88.1 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.715 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 16.4 mm-40 -75.27 -31.53 60.78 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.413 0.685 . . . . 0.0 111.218 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 25.68 20.07 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 86.7 mt -80.6 151.6 71.69 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.93 -179.43 5.11 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.469 2.112 . . . . 0.0 112.64 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' ND1' HG22 ' A' ' 162' ' ' THR . 50.3 t-80 -59.26 127.85 84.72 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.333 1.053 . . . . 0.0 109.917 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.67 -2.99 12.99 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.305 2.003 . . . . 0.0 113.973 -170.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 142' ' ' THR . 63.5 mt -104.26 -57.27 2.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.552 0.341 . . . . 0.0 111.018 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.441 HG22 ' ND1' ' A' ' 159' ' ' HIS . 8.8 t -105.0 -11.81 16.46 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 66.08 22.24 11.15 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.781 1.232 . . . . 0.0 113.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.434 ' H ' HG23 ' A' ' 162' ' ' THR . 31.2 mm-40 -76.84 152.26 82.65 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.345 0.658 . . . . 0.0 110.591 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.21 121.08 8.94 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.558 2.172 . . . . 0.0 111.837 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.603 HG21 HG22 ' A' ' 153' ' ' VAL . 71.5 mt -65.73 130.95 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.9 t -150.34 164.95 34.5 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.819 0.848 . . . . 0.0 110.609 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 171' ' ' ILE . . . -63.55 -24.04 67.64 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.373 171.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.0 m -66.3 -33.2 75.19 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.836 0.855 . . . . 0.0 112.841 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 166' ' ' ILE . 44.2 pt -99.39 -3.16 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 101' ' ' CYS . 11.6 tt -102.16 134.2 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.4 167.26 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.529 1.132 . . . . 0.0 110.133 -173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 28.0 mtpp -85.97 161.43 19.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -65.69 -24.69 67.06 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.301 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.6 -22.24 28.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.052 0.541 . . . . 0.0 110.982 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -82.51 -24.11 34.29 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.396 0.678 . . . . 0.0 110.768 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 24.3 p -113.38 155.59 24.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.18 172.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.14 157.12 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.606 1.163 . . . . 0.0 108.424 177.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -70.59 129.92 40.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.77 126.74 55.55 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.28 -39.41 71.56 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.484 1.115 . . . . 0.0 112.486 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.6 t -84.03 -15.8 46.25 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.866 0.303 . . . . 0.0 111.747 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -83.22 -32.03 26.73 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 163.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.23 7.51 84.75 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.316 -170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -137.76 157.0 47.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.698 1.199 . . . . 0.0 108.836 -169.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.26 129.71 40.72 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 167.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.08 175.59 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.756 1.222 . . . . 0.0 109.778 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.407 HD13 ' SG ' ' A' ' 141' ' ' CYS . 28.7 mm -76.13 148.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.492 0.717 . . . . 0.0 110.205 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -64.82 163.79 13.57 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.318 0.647 . . . . 0.0 111.248 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -73.81 -45.17 28.6 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.869 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--O 1.247 0.961 0 C-N-CA 123.869 0.868 . . . . 0.0 109.921 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 94' ' ' ILE . 12.4 mp0 -63.29 -34.19 77.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.726 0.81 . . . . 0.0 111.584 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.02 -50.1 59.2 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.416 1.087 . . . . 0.0 112.154 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 m -63.73 -36.16 82.95 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.121 0.968 . . . . 0.0 111.1 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 91' ' ' GLN . 35.6 mt -71.31 -48.53 53.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.737 -175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -55.96 -46.07 78.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.563 1.145 . . . . 0.0 111.371 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.05 -45.12 93.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -32.89 74.57 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-O 118.6 -0.714 . . . . 0.0 111.93 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.483 HG23 HD13 ' A' ' 130' ' ' ILE . 96.4 mt -65.2 -41.59 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 118.728 0.694 . . . . 0.0 109.903 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.8 t -64.91 -36.0 82.96 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.842 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -81.43 -30.47 33.48 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.847 0.859 . . . . 0.0 112.945 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 99.1 m -91.46 -19.5 22.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.868 0.867 . . . . 0.0 111.604 -173.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -72.83 165.46 24.84 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.566 0.698 . . . . 0.0 111.938 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -158.91 159.43 34.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.943 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -69.91 97.02 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.7 t -66.36 113.43 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.374 0.669 . . . . 0.0 110.531 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 63.6 m -114.49 90.77 22.26 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.415 1.086 . . . . 0.0 109.093 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -58.44 -39.14 86.33 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.081 2.521 . . . . 0.0 113.293 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -38.01 65.67 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.05 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -74.83 -41.21 60.35 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 97.7 mt -68.44 -15.61 63.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 111.57 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 61.47 16.75 7.82 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 -172.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 110' ' ' LEU . 61.6 m -93.11 124.62 57.54 Favored Pre-proline 0 C--O 1.243 0.755 0 C-N-CA 123.36 0.664 . . . . 0.0 109.5 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.46 150.99 78.12 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.557 2.171 . . . . 0.0 111.7 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.01 -47.92 67.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.903 0.881 . . . . 0.0 112.264 -171.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.28 -35.16 78.15 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.383 0.673 . . . . 0.0 112.354 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.06 62.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.36 0.664 . . . . 0.0 111.792 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 112' ' ' CYS . 24.5 pt -127.61 29.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.662 0.785 . . . . 0.0 110.221 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -79.04 132.48 36.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.789 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.17 111.34 7.59 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.34 -2.46 12.59 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.841 2.361 . . . . 0.0 112.172 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.5 mt -82.16 -55.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.6 p -95.23 -7.87 37.77 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.16 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.85 48.24 20.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.15 0.98 . . . . 0.0 111.257 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.81 149.98 20.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.757 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.66 116.42 51.51 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.4 161.2 37.93 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.78 2.32 . . . . 0.0 113.434 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.45 -19.03 20.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.712 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 2.2 pptp? -144.87 128.8 17.44 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -163.71 167.3 37.78 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.859 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 98' ' ' ILE . 11.5 pt -122.03 151.81 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.055 1.342 . . . . 0.0 109.348 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.53 115.61 28.96 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 130' ' ' ILE . 64.2 t -117.69 122.39 69.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 21.0 ptmt -69.71 122.39 19.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.432 0.634 . . . . 0.0 110.928 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -72.83 80.86 1.15 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 161.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 25.1 t -70.09 -44.86 68.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.781 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.28 -34.76 79.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.059 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.09 -64.86 2.22 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.835 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.9 m -157.44 18.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.318 0.559 . . . . 0.0 112.475 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 6.7 m-20 59.63 20.62 9.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.98 0.912 . . . . 0.0 112.283 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.7 124.08 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 28.0 p -85.5 133.12 34.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 m -121.81 145.56 47.94 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -175.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.5 tp -91.19 108.81 20.13 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -102.53 136.42 42.39 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.42 132.31 52.72 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 118.629 0.65 . . . . 0.0 109.359 175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.74 70.29 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.043 0.839 . . . . 0.0 111.892 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . . . -75.29 -40.23 58.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.986 0.514 . . . . 0.0 111.599 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.37 89.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.064 0.545 . . . . 0.0 111.807 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 130' ' ' ILE . 33.5 t80 -76.97 -38.35 53.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.966 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 98' ' ' ILE . 28.8 t -64.08 -28.94 70.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.434 0.459 . . . . 0.0 110.819 175.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 13.0 tpt180 -64.39 -55.69 19.33 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.541 -0.754 . . . . 0.0 108.973 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.0 mt -53.7 -45.6 70.47 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.088 0.867 . . . . 0.0 111.818 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.414 HG11 ' HB ' ' A' ' 94' ' ' ILE . 86.3 t -65.93 -47.56 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.298 0.639 . . . . 0.0 110.378 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.27 -17.88 68.73 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.274 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 63.7 mm-40 -87.15 -23.97 24.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.619 0.768 . . . . 0.0 110.857 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.03 36.79 12.35 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.54 149.12 36.12 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.57 1.148 . . . . 0.0 109.527 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -69.89 177.26 5.85 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.353 2.702 . . . . 0.0 113.531 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.447 ' ND1' HG22 ' A' ' 162' ' ' THR . 60.1 t-80 -59.81 124.66 77.52 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.58 -12.46 35.19 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.675 2.25 . . . . 0.0 114.202 -168.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.81 -66.97 0.87 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.643 0.377 . . . . 0.0 110.819 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.447 HG22 ' ND1' ' A' ' 159' ' ' HIS . 10.5 t -90.36 -8.66 50.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.57 0.348 . . . . 0.0 111.605 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 59.88 24.46 13.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.841 1.256 . . . . 0.0 112.961 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -88.75 155.77 50.28 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.93 0.892 . . . . 0.0 110.05 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -64.2 112.16 1.81 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.461 2.107 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.519 ' HA ' HD11 ' A' ' 170' ' ' ILE . 59.8 mt -56.64 140.05 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.788 0.835 . . . . 0.0 110.076 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 160.55 43.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.851 0.861 . . . . 0.0 109.849 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.22 -23.93 67.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.508 0.723 . . . . 0.0 111.903 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -67.49 -46.21 73.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 111.954 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 166' ' ' ILE . 49.7 pt -79.06 -10.43 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' A' ' 101' ' ' CYS . 10.5 tt -99.33 132.35 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.477 0.58 . . . . 0.0 109.614 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.67 174.02 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.461 1.104 . . . . 0.0 109.762 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 29.3 mtpp -91.1 166.18 13.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.664 0.386 . . . . 0.0 110.137 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -62.89 -34.97 78.53 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.552 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.2 -9.76 59.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.183 0.593 . . . . 0.0 111.351 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -93.88 -2.95 52.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.814 0.846 . . . . 0.0 110.551 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 29.8 p -134.9 144.26 47.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.161 0.984 . . . . 0.0 109.379 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -123.21 155.62 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.595 -0.691 . . . . 0.0 109.279 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -67.95 110.84 4.06 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 159.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.45 125.13 39.85 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -79.3 -36.17 40.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.552 0.741 . . . . 0.0 111.829 -169.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.6 t -74.84 -27.3 60.22 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.405 0.548 . . . . 0.0 110.402 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.6 mmt180 -77.5 -32.74 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.84 81.26 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.794 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -145.92 157.67 43.89 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.29 1.036 . . . . 0.0 109.42 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.452 ' HZ ' ' HG ' ' A' ' 112' ' ' CYS . 37.1 m-85 -72.34 118.57 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.179 0.591 . . . . 0.0 109.569 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' A' ' 183' ' ' ARG . 27.2 pt -128.32 177.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 133' ' ' LYS . 39.6 mm -80.2 145.11 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 178' ' ' ILE . 48.6 mtpt -63.42 149.7 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.066 0.854 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.96 25.31 0.21 Allowed Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.511 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.751 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.591 0.234 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HG3' HG12 ' A' ' 153' ' ' VAL . 24.9 mp0 -70.12 -46.11 65.48 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -170.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -47.59 30.1 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.357 1.063 . . . . 0.0 113.47 -170.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.428 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 18.8 m -65.07 -46.08 82.61 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.273 1.029 . . . . 0.0 111.227 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.483 HD13 HG22 ' A' ' 166' ' ' ILE . 62.1 mt -70.66 -46.24 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.159 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -55.18 -44.67 75.48 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.742 1.217 . . . . 0.0 110.616 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.447 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 93.9 m-20 -59.67 -46.26 89.59 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.319 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.2 mpmm? -61.2 -39.59 90.79 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.533 0.52 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 87.1 mt -62.75 -37.48 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.364 0.665 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 t -65.51 -36.87 85.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.992 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 26.6 mt-30 -85.63 -31.16 22.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.113 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.5 m -87.83 -17.11 32.24 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.235 0.614 . . . . 0.0 111.766 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.19 169.26 17.42 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-O 121.21 0.529 . . . . 0.0 111.577 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -154.89 160.8 41.44 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.607 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.4 m -69.03 99.21 1.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.75 98.88 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.3 m -112.28 99.52 46.83 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.929 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.15 -31.65 46.33 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.875 3.05 . . . . 0.0 114.547 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HG3' ' HG3' ' A' ' 109' ' ' ARG . 11.1 pt-20 -70.04 -43.56 71.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.747 0.819 . . . . 0.0 110.68 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HG3' ' HG3' ' A' ' 108' ' ' GLU . 76.4 mtp180 -81.34 -26.69 35.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.086 0.554 . . . . 0.0 110.565 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.0 mt -77.81 -20.69 52.79 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.088 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 58.44 27.75 15.92 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.749 0.819 . . . . 0.0 111.331 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.4 m -116.52 144.72 33.72 Favored Pre-proline 0 C--O 1.245 0.834 0 C-N-CA 124.024 0.93 . . . . 0.0 109.995 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.92 160.98 44.45 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.43 2.087 . . . . 0.0 111.66 172.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -43.13 78.59 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.922 0.764 . . . . 0.0 112.014 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.1 -37.06 83.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.049 0.94 . . . . 0.0 112.606 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.62 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.069 0.548 . . . . 0.0 111.154 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.4 pt -121.14 31.28 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.899 0.88 . . . . 0.0 110.007 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -85.23 131.54 34.41 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.697 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.8 t -67.75 114.22 18.79 Favored Pre-proline 0 C--N 1.346 0.434 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.62 -11.23 30.56 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.427 2.085 . . . . 0.0 112.862 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 36.1 mt -78.08 -56.23 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.851 0.86 . . . . 0.0 109.558 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p -99.33 -11.87 20.83 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.207 1.003 . . . . 0.0 111.932 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.24 27.7 17.38 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.362 1.065 . . . . 0.0 112.305 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -104.67 164.1 12.01 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.34 99.72 8.95 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 165.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 163.87 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.714 2.276 . . . . 0.0 113.759 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -94.93 -16.66 22.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.117 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -142.86 135.1 27.37 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.839 1.256 . . . . 0.0 108.184 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.47 29.95 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.879 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.93 158.96 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.532 1.133 . . . . 0.0 110.262 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -102.3 122.09 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.53 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 78.6 t -119.61 124.69 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 188' ' ' ILE . 21.7 ptmt -69.02 117.1 10.25 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 123.823 0.702 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -74.93 80.65 2.16 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 166.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 t -58.83 -33.14 70.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.619 1.168 . . . . 0.0 110.748 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.94 -42.09 94.96 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.648 0.593 . . . . 0.0 111.581 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.51 -65.33 3.22 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.621 0.576 . . . . 0.0 111.817 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 t 176.65 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.603 1.161 . . . . 0.0 108.405 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.69 23.95 13.7 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.523 1.129 . . . . 0.0 110.413 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.11 109.96 10.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 60.8 m -83.64 131.89 34.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.819 0.448 . . . . 0.0 110.046 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.4 m -121.23 149.17 43.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 48.2 tp -88.71 104.48 16.92 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.324 0.583 . . . . 0.0 109.551 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 93.9 m-85 -97.61 136.73 37.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.47 134.71 56.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.7 -41.67 82.14 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.135 0.897 . . . . 0.0 111.638 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.95 -32.32 45.42 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.458 0.474 . . . . 0.0 111.799 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.68 62.83 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.518 0.727 . . . . 0.0 111.393 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.3 t80 -71.76 -39.29 70.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.8 t -61.91 -31.43 71.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 111.44 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.4 tpt180 -64.31 -52.87 56.34 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 123.564 0.54 . . . . 0.0 109.594 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.87 -42.74 76.36 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.859 0.724 . . . . 0.0 111.574 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 166' ' ' ILE . 94.4 t -63.15 -49.34 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.817 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.26 -16.12 68.65 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 124.134 0.896 . . . . 0.0 113.673 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.1 mm-40 -93.38 -11.94 31.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 111.107 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.67 30.24 56.53 Favored Glycine 0 C--N 1.344 0.982 0 O-C-N 123.35 0.407 . . . . 0.0 112.501 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.4 mt -92.8 148.13 35.39 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.614 1.165 . . . . 0.0 109.787 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.16 -176.12 2.89 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.794 2.329 . . . . 0.0 112.584 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -55.64 132.13 71.77 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.261 1.025 . . . . 0.0 110.382 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.452 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 73.2 Cg_endo -68.91 -28.62 29.28 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.907 1.738 . . . . 0.0 113.303 -170.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.33 -56.49 3.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.557 0.343 . . . . 0.0 111.31 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 t -108.78 -8.79 15.29 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -169.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 32.9 mmt180 66.7 21.42 10.59 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.391 1.077 . . . . 0.0 112.634 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -72.27 141.08 83.04 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.143 0.577 . . . . 0.0 109.646 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.81 115.22 2.79 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.388 2.059 . . . . 0.0 111.677 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.555 HG21 HG22 ' A' ' 153' ' ' VAL . 71.4 mt -60.95 127.97 21.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 CA-C-O 120.934 0.397 . . . . 0.0 110.491 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -148.17 165.23 31.51 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.142 0.977 . . . . 0.0 109.402 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.12 -20.18 66.07 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.655 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m -65.37 -44.27 88.13 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.307 0.643 . . . . 0.0 112.452 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 166' ' ' ILE . 46.7 pt -86.89 -7.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.24 129.96 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.02 178.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.065 0.946 . . . . 0.0 110.847 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.9 161.68 13.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.465 0.706 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -67.76 -22.76 65.19 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.7 0.8 . . . . 0.0 112.467 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.73 -22.71 23.21 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.947 0.499 . . . . 0.0 111.083 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.13 -26.88 28.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.034 0.934 . . . . 0.0 110.955 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 27.0 p -115.86 150.6 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.535 HD12 ' HG2' ' A' ' 189' ' ' LYS . 0.1 OUTLIER -133.71 160.7 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.051 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 186' ' ' PHE . 32.3 p90 -69.12 115.0 7.9 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 165.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.554 ' HB2' HG12 ' A' ' 187' ' ' ILE . 11.3 t70 -91.79 129.95 37.66 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.44 -47.89 45.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.06 0.85 . . . . 0.0 110.731 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.2 t -78.28 -25.17 46.6 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.613 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.1 mmp_? -77.05 -30.86 55.81 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.231 169.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 89.83 14.34 59.62 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.685 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -171.75 168.67 6.11 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.522 0.661 . . . . 0.0 110.459 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 179' ' ' TYR . 93.9 m-85 -60.13 121.52 12.11 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.077 0.951 . . . . 0.0 111.529 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.613 HD13 ' HG3' ' A' ' 183' ' ' ARG . 24.1 pt -131.73 178.16 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.327 172.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 133' ' ' LYS . 47.2 mm -71.58 140.22 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.598 0.561 . . . . 0.0 109.586 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' A' ' 178' ' ' ILE . 54.2 mtpt -60.4 148.06 38.63 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.706 0.629 . . . . 0.0 110.906 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.18 83.77 1.72 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.101 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -58.59 -48.68 80.15 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.412 -172.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -47.61 71.9 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.869 0.731 . . . . 0.0 111.812 -170.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 37.1 t -66.85 -38.81 87.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.4 0.68 . . . . 0.0 111.192 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 69.8 mt -66.31 -43.78 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.718 0.636 . . . . 0.0 109.475 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -57.45 -44.58 84.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.022 . . . . 0.0 110.803 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -59.62 -43.44 93.79 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.425 0.453 . . . . 0.0 111.064 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 93' ' ' SER . 1.1 mpmm? -63.26 -35.34 80.02 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 111.298 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 89.1 mt -67.57 -37.48 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 122.762 0.425 . . . . 0.0 110.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.6 t -63.45 -40.04 96.08 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.57 0.748 . . . . 0.0 111.33 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.02 -45.17 18.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.264 0.626 . . . . 0.0 112.146 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . 73.3 m -82.3 -10.05 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.905 0.882 . . . . 0.0 112.741 -169.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.69 169.29 18.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.402 0.62 . . . . 0.0 112.473 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -158.03 160.36 37.36 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.963 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 m -70.04 99.81 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.69 114.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.173 0.589 . . . . 0.0 110.874 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 65.1 m -118.49 100.42 51.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.034 0.934 . . . . 0.0 109.229 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.57 -37.53 57.69 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.338 2.692 . . . . 0.0 113.293 -172.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -15.26 56.98 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.875 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -88.94 -43.38 11.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 0.0 110.016 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.9 mt -72.57 -12.12 60.93 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 65.33 17.75 11.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.872 1.269 . . . . 0.0 111.538 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 71.8 m -104.61 136.0 19.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.741 0.816 . . . . 0.0 110.136 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.28 164.15 29.24 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.692 2.261 . . . . 0.0 111.125 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.8 mt -53.59 -47.43 70.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.42 0.688 . . . . 0.0 111.49 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.58 -41.83 70.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.857 1.263 . . . . 0.0 113.134 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.44 67.27 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.929 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 143' ' ' LEU . 20.8 pt -126.51 23.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.244 1.018 . . . . 0.0 110.409 -177.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -69.86 128.32 35.98 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.435 0.694 . . . . 0.0 110.242 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 39.2 t -70.04 110.86 7.48 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.72 -3.06 13.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.882 2.388 . . . . 0.0 112.714 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.9 mt -76.27 -51.51 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.184 0.993 . . . . 0.0 109.236 176.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p -99.68 -15.39 18.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.978 -173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.39 47.9 15.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.516 1.126 . . . . 0.0 111.793 -172.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 163.44 37.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.573 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -78.12 116.63 60.38 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 60.0 Cg_endo -71.18 161.17 46.77 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.024 2.483 . . . . 0.0 113.819 -173.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 8.2 pt-20 -87.19 -37.86 16.92 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.37 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HG2' ' HG3' ' A' ' 127' ' ' GLU . 17.7 pttm -140.68 140.09 34.89 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.85 156.87 28.3 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.218 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.4 ' O ' HD12 ' A' ' 143' ' ' LEU . 11.1 pt -109.31 158.19 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 109.058 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -99.41 128.16 45.5 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.495 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 90.1 t -119.54 121.86 67.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -73.63 113.22 10.51 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.84 80.43 1.62 Allowed 'General case' 0 C--O 1.248 1.005 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.4 t -68.3 -30.39 69.38 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.223 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.86 -38.86 89.83 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.271 174.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.33 -67.46 1.83 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.103 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.2 t 178.79 44.33 0.0 OUTLIER 'General case' 0 C--O 1.251 1.144 0 C-N-CA 123.864 0.865 . . . . 0.0 109.905 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.2 t70 70.31 8.33 6.59 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 123.951 0.901 . . . . 0.0 111.432 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.595 ' HA ' HG22 ' A' ' 187' ' ' ILE . 61.3 t -77.14 113.59 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.51 138.63 33.34 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 109.473 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.8 m -129.25 154.0 47.24 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 117' ' ' ILE . 37.5 tp -90.17 121.39 32.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.495 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 87.0 m-85 -117.34 133.7 55.68 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 124.991 1.317 . . . . 0.0 107.824 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 14.6 t70 -59.78 135.55 57.72 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 118.846 0.748 . . . . 0.0 109.656 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.4 71.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.898 0.879 . . . . 0.0 111.575 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.37 -34.72 65.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.56 -37.67 71.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.507 0.723 . . . . 0.0 111.771 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -76.92 -36.65 56.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.384 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.9 t -62.59 -30.24 71.19 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 124.01 0.819 . . . . 0.0 110.831 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.5 ttm-85 -64.87 -53.5 45.72 Favored 'General case' 0 C--O 1.218 -0.564 0 O-C-N 124.02 0.825 . . . . 0.0 109.981 170.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 73.2 mt -52.94 -47.84 67.75 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.949 0.5 . . . . 0.0 111.475 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.61 -51.36 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.659 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.51 73.5 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.269 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 29.6 mm-40 -87.48 -23.86 24.3 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 117.36 0.58 . . . . 0.0 110.185 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.86 53.59 Favored Glycine 0 N--CA 1.47 0.945 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.62 140.31 59.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.084 0.954 . . . . 0.0 109.63 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.56 -168.08 0.53 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.748 2.298 . . . . 0.0 112.608 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -60.66 131.41 91.0 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.353 1.061 . . . . 0.0 110.043 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.413 ' HG3' HG12 ' A' ' 121' ' ' ILE . 70.2 Cg_endo -68.79 -24.42 34.46 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.37 2.047 . . . . 0.0 113.444 -172.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.74 -65.15 1.04 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.9 t -102.71 -9.4 20.07 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.299 -167.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 62.22 24.04 14.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.782 1.233 . . . . 0.0 112.063 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -79.16 148.35 71.09 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.334 0.654 . . . . 0.0 110.062 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.93 123.09 12.24 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.702 2.268 . . . . 0.0 111.854 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.94 134.3 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.292 0.637 . . . . 0.0 110.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.1 t -141.14 160.61 39.73 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.917 0.887 . . . . 0.0 109.559 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.04 -23.97 67.69 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.913 0.885 . . . . 0.0 111.545 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.7 t -67.56 -41.27 84.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.783 0.833 . . . . 0.0 112.267 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 47.6 pt -85.0 -8.67 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.8 tt -98.0 133.57 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.82 0.736 . . . . 0.0 109.151 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.04 174.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.725 1.21 . . . . 0.0 110.378 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 101' ' ' CYS . 40.8 mtpt -102.62 164.5 11.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.145 0.578 . . . . 0.0 110.843 -175.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -73.68 -17.59 61.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.918 0.487 . . . . 0.0 111.595 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.49 -32.77 28.63 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.11 -29.89 49.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.331 0.652 . . . . 0.0 110.721 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 31.6 p -113.55 155.51 25.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.599 0.759 . . . . 0.0 109.643 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -135.39 164.23 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.312 1.045 . . . . 0.0 108.839 179.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.27 127.51 33.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 162.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.463 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.0 t70 -107.52 139.18 42.43 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.883 -0.511 . . . . 0.0 110.027 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.17 -50.86 13.43 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.248 0.968 . . . . 0.0 111.757 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 15.0 t -71.06 -33.53 70.36 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.19 0.45 . . . . 0.0 111.18 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.569 ' HG3' HD13 ' A' ' 187' ' ' ILE . 26.8 mmt180 -76.3 -27.95 56.78 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.917 0.487 . . . . 0.0 110.088 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.83 24.31 72.47 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.194 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -170.11 163.68 9.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.831 0.853 . . . . 0.0 108.824 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 178' ' ' ILE . 89.0 m-85 -59.82 127.68 33.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.975 0.91 . . . . 0.0 111.182 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 140' ' ' VAL . 19.1 pt -138.71 -179.85 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.645 1.178 . . . . 0.0 108.989 170.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.8 152.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 122.995 0.518 . . . . 0.0 109.889 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.85 104.37 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.966 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -117.35 -0.01 18.68 Favored Glycine 0 N--CA 1.465 0.591 0 CA-C-N 113.779 -1.555 . . . . 0.0 111.831 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 42.5 t30 . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 123.657 0.783 . . . . 0.0 109.074 178.061 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 110.556 -0.165 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -49.49 77.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.296 1.038 . . . . 0.0 111.878 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -30.7 70.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 0.0 112.155 -174.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -68.29 -46.97 68.9 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.099 0.96 . . . . 0.0 109.788 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 98' ' ' ILE . 79.6 mt -64.48 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.683 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -61.11 -38.38 86.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.717 1.207 . . . . 0.0 112.537 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.9 -41.23 95.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.456 0.473 . . . . 0.0 110.238 173.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -39.23 89.31 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 123.369 0.418 . . . . 0.0 110.614 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 94' ' ' ILE . 74.9 mt -65.25 -46.08 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 122.79 0.436 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -65.4 -36.02 82.7 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.879 0.872 . . . . 0.0 112.25 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -82.4 -42.55 18.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.988 0.515 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.85 -6.97 59.54 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.83 0.852 . . . . 0.0 112.386 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -75.26 163.62 27.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.186 0.517 . . . . 0.0 111.56 172.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -157.2 159.58 37.85 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.988 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.4 p -73.35 100.75 3.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.933 0.77 . . . . 0.0 109.409 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.87 120.88 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.865 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.98 96.1 32.65 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 0.0 109.149 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.44 -34.45 33.06 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 124.493 3.462 . . . . 0.0 115.625 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.29 -34.88 65.99 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.892 0.477 . . . . 0.0 110.74 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -82.12 -36.47 27.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.763 0.825 . . . . 0.0 110.057 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.54 -17.52 62.31 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.055 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.88 34.62 23.9 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.697 1.199 . . . . 0.0 110.893 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 69.6 m -115.08 135.77 22.54 Favored Pre-proline 0 C--O 1.242 0.69 0 C-N-CA 124.199 0.999 . . . . 0.0 109.171 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.54 153.07 63.75 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.455 2.104 . . . . 0.0 111.708 169.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 125' ' ' GLN . 59.4 mt -52.57 -48.07 66.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.354 1.061 . . . . 0.0 111.766 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.26 -35.98 78.76 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.336 1.055 . . . . 0.0 112.571 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.39 66.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.67 . . . . 0.0 111.658 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.429 ' HB ' HD23 ' A' ' 143' ' ' LEU . 25.3 pt -124.06 24.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.645 0.778 . . . . 0.0 110.46 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 125' ' ' GLN . 42.0 tt0 -68.85 135.66 51.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.853 174.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 t -69.5 112.08 10.87 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 168.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.12 -6.7 19.78 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.861 2.374 . . . . 0.0 112.791 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 26.5 mt -83.52 -53.21 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.788 0.835 . . . . 0.0 109.466 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -91.94 -11.1 37.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.65 0.78 . . . . 0.0 112.596 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.91 36.65 12.62 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.015 0.926 . . . . 0.0 111.431 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -151.64 149.1 28.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.482 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 24.1 tm0? -67.14 121.6 79.06 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 123.49 0.716 . . . . 0.0 109.371 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 153.21 41.19 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.535 2.157 . . . . 0.0 113.747 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.36 -17.18 32.98 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.46 170.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -150.72 130.69 13.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.594 1.157 . . . . 0.0 108.368 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.46 169.2 39.81 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.667 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 171' ' ' ILE . 12.8 pt -118.61 154.47 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.201 1.401 . . . . 0.0 110.058 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.36 121.26 37.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 144' ' ' PHE . 95.2 t -120.11 122.52 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HB3' HD11 ' A' ' 188' ' ' ILE . 20.5 ptmt -68.52 120.16 14.13 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.359 0.599 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -74.78 79.53 2.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 165.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HE2' ' A' ' 133' ' ' LYS . 12.5 t -68.72 -36.86 78.96 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.244 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.3 -35.03 76.21 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.476 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.79 -64.1 2.0 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.307 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.2 t -171.55 27.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.906 0.482 . . . . 0.0 111.105 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 10.6 m-20 62.79 25.07 14.9 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.359 1.063 . . . . 0.0 111.78 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 187' ' ' ILE . 70.6 t -85.92 124.52 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 0.0 109.225 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 177' ' ' CYS . 28.6 p -83.27 130.13 35.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -174.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.2 m -120.34 140.08 51.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.097 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.429 HD23 ' HB ' ' A' ' 117' ' ' ILE . 36.8 tp -89.54 107.49 19.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.356 0.598 . . . . 0.0 110.105 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CE2' ' HB ' ' A' ' 132' ' ' VAL . 88.8 m-85 -99.99 145.95 27.28 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.24 134.66 54.12 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.51 78.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.757 0.66 . . . . 0.0 111.879 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -31.39 64.75 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.653 0.595 . . . . 0.0 111.678 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . -73.3 -39.77 65.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.059 0.543 . . . . 0.0 111.739 -177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -75.97 -35.24 59.72 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.4 t -59.6 -38.75 82.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.061 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 148' ' ' ALA . 15.6 tpt180 -57.77 -49.63 75.94 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 124.275 0.984 . . . . 0.0 110.101 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.84 -46.32 81.8 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.693 0.621 . . . . 0.0 111.658 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 166' ' ' ILE . 70.5 t -65.4 -42.41 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.58 63.99 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.501 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.8 -12.51 55.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.277 0.631 . . . . 0.0 111.201 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.21 74.28 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.733 -0.212 . . . . 0.0 113.161 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.09 133.69 81.35 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.52 179.17 3.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.829 2.353 . . . . 0.0 112.641 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -58.07 128.08 80.9 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.73 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.47 ' HA ' ' NH1' ' A' ' 163' ' ' ARG . 44.7 Cg_endo -64.51 -25.32 62.85 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.617 2.211 . . . . 0.0 113.476 -167.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -53.7 4.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.958 0.503 . . . . 0.0 111.499 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 164' ' ' GLU . 5.3 t -108.87 -13.01 14.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -171.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 160' ' ' PRO . 36.6 mmt180 62.47 28.34 16.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.576 1.151 . . . . 0.0 112.129 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 162' ' ' THR . 22.9 mm-40 -83.18 158.35 64.25 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.623 0.769 . . . . 0.0 109.894 170.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.88 119.36 6.38 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.154 1.903 . . . . 0.0 111.495 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 153' ' ' VAL . 68.1 mt -60.05 128.35 20.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 t -140.69 155.81 46.38 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.145 0.978 . . . . 0.0 109.1 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.91 -22.54 66.51 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.1 m -63.04 -32.28 73.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.391 1.076 . . . . 0.0 112.889 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 47.6 pt -97.2 -7.8 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 130' ' ' ILE . 10.5 tt -96.54 133.73 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.224 0.92 . . . . 0.0 109.475 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.14 178.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.208 1.403 . . . . 0.0 109.736 -173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -100.34 170.2 8.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.252 0.621 . . . . 0.0 110.729 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -68.86 -27.97 66.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.661 0.384 . . . . 0.0 110.947 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.75 -42.45 81.8 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.633 0.773 . . . . 0.0 109.858 172.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.13 -12.28 60.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.314 -168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 141' ' ' CYS . 27.7 p -118.69 151.05 38.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.897 0.879 . . . . 0.0 109.742 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -136.36 160.03 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -68.62 127.47 33.14 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 187' ' ' ILE . 13.1 t70 -106.73 127.95 53.81 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.05 -42.34 63.23 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.099 0.875 . . . . 0.0 112.176 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -79.25 -16.09 57.0 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 117.753 0.252 . . . . 0.0 111.383 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.57 -29.79 19.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.125 0.57 . . . . 0.0 110.541 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.64 18.14 77.91 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.981 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -162.07 160.14 27.08 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.545 0.738 . . . . 0.0 109.176 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.588 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 87.4 m-85 -61.37 124.59 21.03 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.608 1.163 . . . . 0.0 111.737 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 180' ' ' ASP . 19.5 pt -128.77 179.58 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.224 1.01 . . . . 0.0 108.432 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 133' ' ' LYS . 23.5 mm -79.92 149.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 122.549 0.34 . . . . 0.0 110.473 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -65.1 155.75 33.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.061 0.944 . . . . 0.0 112.693 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.62 -4.52 55.9 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.947 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 124.392 1.077 . . . . 0.0 109.091 176.731 . . . . . . . . 0 0 . 1 stop_ save_